Citrus Sinensis ID: 037607
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 842 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FLJ8 | 842 | Probable receptor-like pr | yes | no | 0.940 | 0.940 | 0.689 | 0.0 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.902 | 0.865 | 0.583 | 0.0 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.897 | 0.867 | 0.574 | 0.0 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.965 | 0.950 | 0.500 | 0.0 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.885 | 0.899 | 0.510 | 0.0 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.906 | 0.919 | 0.486 | 0.0 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.877 | 0.896 | 0.475 | 0.0 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.903 | 0.896 | 0.442 | 0.0 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.902 | 0.849 | 0.435 | 1e-173 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.899 | 0.882 | 0.428 | 1e-171 |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1154 bits (2986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/809 (68%), Positives = 658/809 (81%), Gaps = 17/809 (2%)
Query: 10 SPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKS 69
S S+++P DNYLIDCGS S++T L DGR FKSD +S ++L T EDI+TSVDSIP+ +
Sbjct: 24 SSSSFTPADNYLIDCGS--SDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSN 81
Query: 70 SPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKF 129
+ S PLY +ARIF G+S Y F+IS+PG HW+RLHFYP+ H LT++VF+V TD
Sbjct: 82 A---STLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTT 138
Query: 130 VLLHDFSIGNTTSLVFKEYLINITGRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAAST 189
VLLHDFS G+T+S+VFKEYLI +LS+ FKPHK S AFINA+E+VS P ++ D+AS+
Sbjct: 139 VLLHDFSAGDTSSIVFKEYLIYAAEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASS 198
Query: 190 VAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPK 249
V F GLS+F+ E+ +R+N+GG L++PK D LSRTWLSD+ YN FPEGS V+V+P
Sbjct: 199 VPQAPDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTVDPS 258
Query: 250 NVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVS 309
+ YPDGGAT IAPN VYA+A++M +AQ QPNFNL+W+MSVD Y IR HFCDIVS
Sbjct: 259 TITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVS 318
Query: 310 KSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNA 369
KSLNDL+FNV+IN+ A S+LDLSSLT+AL TAYY DFVLNA+ + N SI VQVGP N
Sbjct: 319 KSLNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGSILVQVGPTPNL 378
Query: 370 QSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAG---TKMKIVAGVGLLMGVTAI 426
QS PNAILNGLE++KL+N AGS DGLF VDG YKG G +K +AG+G +M +TA
Sbjct: 379 QSGKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGIGFVMALTAF 438
Query: 427 VFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSK--SSSRRSSLFGSRKSKS- 483
+ + ++ VRWQRRP DW K+ SFSSWLLPLH++ +S++SSK S+SRR S+FGS+KSKS
Sbjct: 439 LGVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSKSN 498
Query: 484 GYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG 543
G+S FSNQGLGR+F FTELQ ATQNFDENAV GVGGFGKVYIG ++ G +VAIKRG+
Sbjct: 499 GFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQS 558
Query: 544 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ--- 600
SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE EMILVYEYM+NGP RDHLYG+ +
Sbjct: 559 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDP 618
Query: 601 ---PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
P LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV+DFGLSK
Sbjct: 619 NPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSK 678
Query: 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
APMD G+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARPVINP+LPRE
Sbjct: 679 DAPMDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPRE 738
Query: 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777
QV+LAE+A+ HRKG+LEKIIDP I TI K SLRK+VEAAEKCLAEYGVDRPGMGDVLW
Sbjct: 739 QVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLW 798
Query: 778 NLEYAMQLQEASTQIDHPEDKSANLIALD 806
NLEYA+QLQEAS Q+D EDK+ I +D
Sbjct: 799 NLEYALQLQEASAQVDLSEDKTTMNIEMD 827
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 930 bits (2404), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/792 (58%), Positives = 571/792 (72%), Gaps = 32/792 (4%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCP 73
+ P D+ LIDCGS SS +T DGR FKSD E+ Y+ KEDI+ S P K
Sbjct: 52 FKPADDILIDCGSKSSSKTP--DGRVFKSDQETIQYIEAKEDIQVSA---PPSDKV---- 102
Query: 74 SAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLH 133
A P+Y +ARIF E+ Y+F +++PG HWVRLHF P+ L A F+V T+K+VLLH
Sbjct: 103 -ASPIYLTARIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLH 161
Query: 134 DFSIGN----TTSLVFKEYLINIT-GRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAAS 188
+F I N + + V KEYL+N+T + ++ F+P K S AFINAIEVVSAP +ISD+ +
Sbjct: 162 NFKISNNNNDSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGT 221
Query: 189 TVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEP 248
+ P F+GLS++A++ YR+NVGGPL+ P+NDTL RTW+ D+ + ++ V P
Sbjct: 222 ALFPVIGFSGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTP 281
Query: 249 KNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIV 308
+ YP TP IAP VYA+A +M + + PNFN++W +PSF+YLIR HFCDIV
Sbjct: 282 SAIKYPPE-VTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIV 340
Query: 309 SKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASN 368
SKSLNDL FNVYIN A S LDLS++ L+ YYKD V+NAT + + VQ+GP
Sbjct: 341 SKSLNDLYFNVYINGKTAISGLDLSTVAGNLAAPYYKDIVVNAT-LMGPELQVQIGPMGE 399
Query: 369 AQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTAIVF 428
+ NAILNG+EV+K+SN S DG F VDG G K +VA G +M A +
Sbjct: 400 -DTGTKNAILNGVEVLKMSNSVNSLDGEFGVDGRTTGMG--KHGMVATAGFVMMFGAFIG 456
Query: 429 LGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGL 488
LG + +W++RP DW KR SFSSWLLP+H+ ++F++SK S++S+ + S
Sbjct: 457 LGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNS---------- 506
Query: 489 FSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGI 548
GLGR+F+ +ELQ AT+NF+ + +IGVGGFG VYIG L+DG KVA+KRGNP SEQGI
Sbjct: 507 --TLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGI 564
Query: 549 NEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQR 608
EFQTEIQMLSKLRHRHLVSLIG+CDE SEMILVYE+M+NGPFRDHLYG N PL+WKQR
Sbjct: 565 TEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQR 624
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
LEICIGSARGLHYLHTG AQGIIHRDVK+TNILLDE LVAKVADFGLSK + +VST
Sbjct: 625 LEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVST 684
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728
AVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL E LCARP INP+LPREQV+LAEWA+Q
Sbjct: 685 AVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQW 744
Query: 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788
RKG+LEKIIDP +A TI ES++K+ EAAEKCL +YGVDRP MGDVLWNLEYA+QLQEA
Sbjct: 745 KRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEA 804
Query: 789 STQIDHPEDKSA 800
TQ E ++A
Sbjct: 805 FTQGKAEETENA 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 920 bits (2378), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/788 (57%), Positives = 571/788 (72%), Gaps = 32/788 (4%)
Query: 9 SSPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAK 68
S + + P D+ LIDCGS SS +T +GR FKSD E+ Y+ K+DI+ S
Sbjct: 46 SPTAGFKPADDILIDCGSKSSTKTP--EGRVFKSDSETVQYIEAKDDIQVSA------PP 97
Query: 69 SSPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDK 128
S PS P+Y +A+IF E+ Y+F +++PG HWVRLHF+ P+ L A F+V T+K
Sbjct: 98 SDKLPS--PIYLTAKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEK 155
Query: 129 FVLLHDFSIGN----TTSLVFKEYLINIT-GRLSIIFKPHKDSHAFINAIEVVSAPGSII 183
+VLLH+F + N + + V KEYL+N+T + ++ FKP K S AFIN IE+VSAP +I
Sbjct: 156 YVLLHNFKLSNDNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELI 215
Query: 184 SDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEA 243
SDA +++ P + F+GLS++A++ YR+NVGGPL+TP+NDTL RTW D+ Y ++
Sbjct: 216 SDAGTSLFPVNGFSGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKD 275
Query: 244 VSVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFH 303
V P + YP G TP IAP VYA+ +M ++Q + PNFN+TW +PSF Y IR H
Sbjct: 276 VKTNPTAIIYPPG-VTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLH 334
Query: 304 FCDIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQV 363
FCDI+SKSLNDL FNVYIN A S LDLS++ LS YYKD V+N+T + ++ + VQ+
Sbjct: 335 FCDIISKSLNDLYFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSE-LQVQI 393
Query: 364 GPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGV 423
GP + NAILNG+EV+K+SN S DG F VDG + G K +VA G +M
Sbjct: 394 GPMGE-DTGKKNAILNGVEVLKMSNSVNSLDGEFGVDGQ-RASMG-KQGMVATAGFVMMF 450
Query: 424 TAIVFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKS 483
A V LG + +W++RP DW KR SFSSWLLP+H+ ++F++SK+ S +S+L+ S
Sbjct: 451 GAFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSA---- 506
Query: 484 GYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG 543
GLGR+F+ +ELQ T+NFD + +IGVGGFG VYIG ++DG +VAIKRGNP
Sbjct: 507 --------LGLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQ 558
Query: 544 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPL 603
SEQGI EF TEIQMLSKLRHRHLVSLIG+CDE +EMILVYEYM+NGPFRDHLYG N PL
Sbjct: 559 SEQGITEFHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPL 618
Query: 604 SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663
+WKQRLEICIG+ARGLHYLHTG AQGIIHRDVK+TNILLDE LVAKVADFGLSK +
Sbjct: 619 TWKQRLEICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQ 678
Query: 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723
+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL E LCARP INP+LPREQV+LAE
Sbjct: 679 NHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAE 738
Query: 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783
WA+ +KG+LEKIIDP + + ES++K+ EAAEKCLA+YGVDRP MGDVLWNLEYA+
Sbjct: 739 WAMLWKQKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYAL 798
Query: 784 QLQEASTQ 791
QLQEA +Q
Sbjct: 799 QLQEAFSQ 806
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/857 (50%), Positives = 560/857 (65%), Gaps = 44/857 (5%)
Query: 8 SSSPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKA 67
++S + ++P DNYLI CGS Q R F D SS + + + V
Sbjct: 20 TTSSALFNPPDNYLISCGS---SQNITFQNRIFVPDSLHSSLV-------LKIGNSSVAT 69
Query: 68 KSSPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTD 127
++ S +Y++AR+F+ + YRF I+ G HW+RLHF P+ +S+ LT A TV T+
Sbjct: 70 STTSNNSTNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTE 129
Query: 128 KFVLLHDFSIGNTT-SLVFKEYLINITGR-LSIIFKPHKDSHAFINAIEVVSAPGSIISD 185
FVLL++FS N S +FKEY +N+T L++ F P +S F+NAIEVVS P ++I D
Sbjct: 130 DFVLLNNFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPD 189
Query: 186 AASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVS 245
A + P F+GLS AFE YRLN+GGPL+T +NDTL R W +D Y V+
Sbjct: 190 QALALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVLVVT 249
Query: 246 VEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFC 305
P ++ Y T APN VYA+A M +A V P+FN+TW + VDP F Y +R HFC
Sbjct: 250 ANPSSIKY-SPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFC 308
Query: 306 DIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGP 365
DIVS++LN L+FN+Y+N+ +A SLDLS+LTN L Y+KDF+ N + + +TV VGP
Sbjct: 309 DIVSQALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGP 368
Query: 366 ASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKM--------KIVAGV 417
++Q+ + NA +NGLEV+K+SNEA S G+ +V G +G+K +V V
Sbjct: 369 --DSQADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAV 426
Query: 418 GLLMGVTAIVFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFG 477
L++ + + +V R QR + LPL+ + S +S
Sbjct: 427 TLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTAS-------- 478
Query: 478 SRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAI 537
KS + ++ LGR F F E+ +AT FDE++++GVGGFG+VY G LEDG KVA+
Sbjct: 479 -HKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAV 537
Query: 538 KRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG 597
KRGNP SEQG+ EF+TEI+MLSKLRHRHLVSLIG+CDE+SEMILVYEYMANGP R HLYG
Sbjct: 538 KRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG 597
Query: 598 TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
+ PPLSWKQRLEICIG+ARGLHYLHTGA+Q IIHRDVKTTNILLDENLVAKVADFGLSK
Sbjct: 598 ADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSK 657
Query: 658 AAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPR 716
P +D+ +VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL EVLC RP +NP LPR
Sbjct: 658 TGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPR 717
Query: 717 EQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
EQV++AEWA+ +KG+L++I+D + + SL+K+ E AEKCLAEYGVDRP MGDVL
Sbjct: 718 EQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVL 777
Query: 777 WNLEYAMQLQEASTQIDHPEDKSANLI-----ALDKPCEN----LSREDL--AVAVSDNS 825
WNLEYA+QL+E S+ + P+D S N I A +P +N + R + D++
Sbjct: 778 WNLEYALQLEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDA 837
Query: 826 EIAAGSSLFSPVGKVRG 842
E A S++FS + RG
Sbjct: 838 EDATTSAVFSQLVHPRG 854
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/796 (51%), Positives = 514/796 (64%), Gaps = 50/796 (6%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCP 73
Y P DNYLI+CGS ++ + R F SD+ +S++L++ +I +S
Sbjct: 25 YVPVDNYLINCGSSTNVTVT---SRVFISDNLASNFLTSPNEI----------LAASNRN 71
Query: 74 SAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLH 133
S +Y++ARIFTG S+YRF +++ G HW+RLHF P + + ++ A F+V ++ VLL
Sbjct: 72 SNSDIYQTARIFTGISKYRFSVAR-GRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLS 130
Query: 134 DFSIGNTTSLVFKEYLINI-TGRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTVAP 192
DF++ +S V KEY +N+ T L + F P DS AF+NA+EVVS P ++ S S
Sbjct: 131 DFTV---SSRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGS 187
Query: 193 RDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVH 252
F GLS A E YR+N+GGP VTP NDTLSR W D + ++VS + +V
Sbjct: 188 PGKFQGLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVS-KIASVD 246
Query: 253 YPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSL 312
Y G AT AP VY + +M A NFN+TW VDP F Y +RFHFCDIVSK+L
Sbjct: 247 YVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKAL 306
Query: 313 NDLLFNVYINEFMAASSLDLSS-LTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQS 371
N L FN+Y++ +LDLSS L+N LS AY DFV +A I V +G +S +
Sbjct: 307 NQLYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFV-TGSAKLTKRIRVSIGRSS-VHT 364
Query: 372 SLPNAILNGLEVIKLSNEAGSFD-GLFAVDGTYKGDAGTKMKIVAGVGLLMG-VTAIVFL 429
P AILNGLE++K++N G F G+ + TK + +GL +G + A+V L
Sbjct: 365 DYPTAILNGLEIMKMNNSKSQLSIGTFLPSGS---SSTTKKNVGMIIGLTIGSLLALVVL 421
Query: 430 GIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLF 489
G FV +++R D D +W+ PL S T+ SS + S S S Y
Sbjct: 422 GGFFVLYKKRGRDQDGNSK--TWI-PLSSNGTT------SSSNGTTLASIASNSSYR--- 469
Query: 490 SNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN 549
++ AT +FDEN IGVGGFGKVY G L DG KVA+KR NP S+QG+
Sbjct: 470 --------IPLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLA 521
Query: 550 EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
EF+TEI+MLS+ RHRHLVSLIG+CDE +EMILVYEYM NG + HLYG+ LSWKQRL
Sbjct: 522 EFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRL 581
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDRGYVST 668
EICIGSARGLHYLHTG A+ +IHRDVK+ NILLDENL+AKVADFGLSK P +D+ +VST
Sbjct: 582 EICIGSARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVST 641
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728
AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV+FEVLCARPVI+P L RE V+LAEWA++
Sbjct: 642 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKW 701
Query: 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788
+KG LE IIDP + I +SLRK+ E EKCLA+YGVDRP MGDVLWNLEYA+QLQEA
Sbjct: 702 QKKGQLEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEA 761
Query: 789 STQIDHPEDKSANLIA 804
D PED S N+I
Sbjct: 762 VVDGD-PED-STNMIG 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 718 bits (1853), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/818 (48%), Positives = 524/818 (64%), Gaps = 55/818 (6%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCP 73
++P DNYLI+CGS ++ GR F SD SS L++ ++I SV
Sbjct: 25 FTPVDNYLINCGSPTNGTLM---GRIFLSDKLSSKLLTSSKEILASVGG----------N 71
Query: 74 SAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLH 133
S +Y +AR+FT S Y+F +++ G HWVRL+F P + + K+ A F V + VLL
Sbjct: 72 SGSDIYHTARVFTEVSSYKFSVTR-GRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLS 130
Query: 134 DFSIGNTTSLVFKEYLINIT-GRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTVAP 192
DF++ T+S V KEY +N+T L + F P S AF+NAIEV+S P ++I+ + V
Sbjct: 131 DFTV--TSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLITGSPRFVGN 188
Query: 193 RDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVH 252
F +S E +R+N+GGPLV NDTL+RTW+ D + ++++S + V+
Sbjct: 189 PAQFPDMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMS-KFSTVN 247
Query: 253 YPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSL 312
+ G AT AP VY S +M A FN+TW+ VDP F Y RFHFCDIVS SL
Sbjct: 248 FVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSL 307
Query: 313 NDLLFNVYINEFMAASSLDLSSLT-NALSTAYYKDFVLNATAVKNDSITVQVGPASNAQS 371
N L FN+Y++ +AA+ +DLS+L N L+ AY DFV T ++ + V +GP S +
Sbjct: 308 NQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFV-TQTPKGSNKVRVSIGP-STVHT 365
Query: 372 SLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMG-----VTAI 426
PNAI+NGLE++K++N G GT+ G+ + +GL++G + A+
Sbjct: 366 DYPNAIVNGLEIMKMNNSKGQLS-----TGTFV--PGSSSSSKSNLGLIVGSAIGSLLAV 418
Query: 427 VFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYS 486
VFLG FV +++R D +W+ P TS S S+ + S + + Y
Sbjct: 419 VFLGSCFVLYKKRKRGQDGHSK--TWM-PFSINGTSMGSKYSNG---TTLTSITTNANYR 472
Query: 487 GLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ 546
F +++AT NFDE+ IGVGGFGKVY G L DG KVA+KRGNP S+Q
Sbjct: 473 -----------IPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQ 521
Query: 547 GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWK 606
G+ EF+TEI+MLS+ RHRHLVSLIG+CDE +EMIL+YEYM NG + HLYG+ P L+WK
Sbjct: 522 GLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWK 581
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDRGY 665
QRLEICIG+ARGLHYLHTG ++ +IHRDVK+ NILLDEN +AKVADFGLSK P +D+ +
Sbjct: 582 QRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTH 641
Query: 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWA 725
VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARPVI+P LPRE V+LAEWA
Sbjct: 642 VSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA 701
Query: 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785
++ +KG L++IID + I +SLRK+ E EKCLA+YGVDRP MGDVLWNLEYA+QL
Sbjct: 702 MKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQL 761
Query: 786 QEASTQID-HPEDKSANLIA-LDKPCENLSREDLAVAV 821
QEA ID PED S N+I L N S+ D +V V
Sbjct: 762 QEAV--IDGEPEDNSTNMIGELPPQINNFSQGDTSVNV 797
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 671 bits (1732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/800 (47%), Positives = 517/800 (64%), Gaps = 61/800 (7%)
Query: 12 STYSPRDNYLIDCGSGSSEQTSLDDGRTFKSD--HESSSYLSTKEDIETSVDSIPVKAKS 69
+ ++P DNYLI+ SGS+ TS R+F SD SS+LST I S +
Sbjct: 24 AAFTPTDNYLIN--SGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISIS--------DT 73
Query: 70 SPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKF 129
+P P + LY +AR+F Y+F ++ G H++RLHF P S L A F V + F
Sbjct: 74 NPSPDSPVLYNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGF 133
Query: 130 VLLHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHKDS-HAFINAIEVVSAPGSIISDAA 187
+++ FS T+S+V KE+++ I L I F P K S F+NA+EV SAP I D
Sbjct: 134 SVINSFS---TSSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQG 190
Query: 188 ST-VAPR--DTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAV 244
+ V P F+ LS+ E +R+NVGG +TP NDTL RTW+ D+ Y +
Sbjct: 191 TKLVIPNSAQIFSNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLL-LRAAARR 249
Query: 245 SVEPKNVHYPDGGATPYIAPNWVYASAQKM-KEAQVMQPNFNLTWKMSVDPS-FSYLIRF 302
+ + +Y +GGAT IAP+ VY +AQ+M ++ Q +Q FN++W VD +L+R
Sbjct: 250 AWTTHSPNYQNGGATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRL 309
Query: 303 HFCDIVSKSLNDLLFNVYINEFMAASSLDLSSLT-NALSTAYYKDFVLNATAVKNDSITV 361
HFCDIVS SLN L FNV+INE++A +DLS+LT + L++ Y DFV A + ++ + +
Sbjct: 310 HFCDIVSSSLNQLYFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFV--AESDRSGMLRI 367
Query: 362 QVGPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLM 421
VGP+ + + NA+LNG+E++++ + S + +G + + VG ++
Sbjct: 368 SVGPSDLSNPARVNALLNGVEIMRILSPVSS-----------EVVSGKRNVVWIVVGSVL 416
Query: 422 GVTAIVFLGIVFVR---WQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGS 478
G VFL + F+ RR ++ + + W PL + S S+ ++ R+
Sbjct: 417 G--GFVFLSLFFLSVLCLCRRKNNKTRSSESTGWT-PLRRFRGS--SNSRTTERTV---- 467
Query: 479 RKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIK 538
S SGY L +F ELQ+ T NFD + VIGVGGFG V+ G L+D KVA+K
Sbjct: 468 --SSSGYHTLR--------ISFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVK 517
Query: 539 RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGT 598
RG+PGS QG+ EF +EI +LSK+RHRHLVSL+G+C+EQSEMILVYEYM GP + HLYG+
Sbjct: 518 RGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGS 577
Query: 599 NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
PPLSWKQRLE+CIG+ARGLHYLHTG++QGIIHRD+K+TNILLD N VAKVADFGLS++
Sbjct: 578 TNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRS 637
Query: 659 AP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
P +D +VST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARP ++P L RE
Sbjct: 638 GPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPAVDPLLVRE 697
Query: 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777
QV+LAEWA++ RKG+L++I+DP IA+ I SL+K+ E AEKC A+YGVDRP +GDVLW
Sbjct: 698 QVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLW 757
Query: 778 NLEYAMQLQEASTQIDHPED 797
NLE+ +QLQE S ++ PE+
Sbjct: 758 NLEHVLQLQE-SGPLNIPEE 776
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/825 (44%), Positives = 503/825 (60%), Gaps = 64/825 (7%)
Query: 20 YLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYP-L 78
+L+DCGS ++ + DGRT+ D + ++ + D+I A +S S Y +
Sbjct: 33 FLVDCGSNATTEV---DGRTWVGDLSPNKSVTLQ-----GFDAIT--ASTSKGSSVYAEI 82
Query: 79 YRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIG 138
Y++AR+F Y F G ++VRLHF P + + ++ F+V D L+ D +I
Sbjct: 83 YKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIA 142
Query: 139 N----------------TTSLVFKEYLINIT-GRLSIIFKPHKDSHAFINAIEVVSAPGS 181
T S + KE+L+ G+L + F P K S F+NAIE+VS
Sbjct: 143 GEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDK 202
Query: 182 IISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKND-TLSRTWLSDEAYNAFPEG 240
+ ++ + V + GL E YRLNVGGP + P D L RTW +D +Y
Sbjct: 203 LFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVI--- 259
Query: 241 SEAVSVEPKN---VHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFS 297
E VE KN + Y +P +AP VY +A+ M +V++ FN++WK VDP+F
Sbjct: 260 -ENAGVEVKNSSNITYALADDSP-VAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFD 317
Query: 298 YLIRFHFCDIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKND 357
YL+R HFC+++ N +F +YIN AA + D+ + + Y+D+ L+ + KND
Sbjct: 318 YLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDY-LDPVSSKND 376
Query: 358 SITVQVGPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIV--- 414
+ +Q+GP S+ +S +A+L+GLE+ KLS G+ L D T + +KM+I+
Sbjct: 377 VLWIQLGPDSSVGAS-GDALLSGLEIFKLSKN-GNLAHLIRFDSTGHSVSDSKMRIIWIS 434
Query: 415 AGVGLLMGVTAIVFLGIVFVRW--QRRPHDWDKRKSFSSW---LLPLHSTKTSFLSSKSS 469
G G+ + + VFLGI+ V +RR + + + W L ++++ + ++ S
Sbjct: 435 VGAGIAI-IIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGS 493
Query: 470 SRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVL 529
R ++L S +GR FT E++ AT+NFD+ IGVGGFGKVY G L
Sbjct: 494 LRLNTLAAST--------------MGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGEL 539
Query: 530 EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589
EDG +AIKR P S+QG+ EF+TEI MLS+LRHRHLVSLIGFCDE +EMILVYEYMANG
Sbjct: 540 EDGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANG 599
Query: 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAK 649
R HL+G+N PPLSWKQRLE CIGSARGLHYLHTG+ +GIIHRDVKTTNILLDEN VAK
Sbjct: 600 TLRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAK 659
Query: 650 VADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
++DFGLSKA P MD +VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE +CAR
Sbjct: 660 MSDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARA 719
Query: 709 VINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD 768
VINP LP++Q++LAEWAL ++ LE IID + ESL KY E AEKCLA+ G +
Sbjct: 720 VINPTLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKN 779
Query: 769 RPGMGDVLWNLEYAMQLQEASTQIDHPEDKSANLIALDKPCENLS 813
RP MG+VLW+LEY +Q+ EA + + E+ ++ A+++ E+ +
Sbjct: 780 RPMMGEVLWSLEYVLQIHEAWLRKQNGENSFSSSQAVEEAPESFT 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1567), Expect = e-173, Method: Compositional matrix adjust.
Identities = 355/816 (43%), Positives = 493/816 (60%), Gaps = 56/816 (6%)
Query: 10 SPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKS 69
S + YSP + L++CG G+S T D+ R + SD +S +LS+ + + ++
Sbjct: 26 SAADYSPTEKILLNCGGGASNLTDTDN-RIWISDVKSK-FLSSSSEDSKTSPALTQDPSV 83
Query: 70 SPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKF 129
P Y +AR+F Y F ++ G +VRL+FYP + + T+++F+V +
Sbjct: 84 PEVP-----YMTARVFRSPFTYTFPVAS-GRKFVRLYFYPNSYDGLNATNSLFSVSFGPY 137
Query: 130 VLLHDFSIGNTT-----SLVFKEYLINITG-RLSIIFKPHK---DSHAFINAIEVVSAPG 180
LL +FS T + + KE+++N+ G L++ F P +++AF+N IEV S P
Sbjct: 138 TLLKNFSASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPD 197
Query: 181 --SIISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDT-LSRTWLSDEAYNAF 237
S + V + T ++ A E YRLNVGG ++P DT L R+W D+ Y F
Sbjct: 198 MYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPY-IF 256
Query: 238 PEGSEAVSVEPKN--VHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPS 295
G N + YP G T Y+AP VY++A+ M + N+NLTW S+D
Sbjct: 257 GAGLGIPETADPNMTIKYPTGTPT-YVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSG 315
Query: 296 FSYLIRFHFCDIVSK--SLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNA-T 352
F+YL+R HFC++ S +N +F +Y+N A D+ + T++ ++KD+V+N
Sbjct: 316 FTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPE 375
Query: 353 AVKNDSITVQVGPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDG----------- 401
+ + + P + +++LNG+E+ K++ G+ G + G
Sbjct: 376 GNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVL 435
Query: 402 ---TYKGDAGTKMKIVAGVGLLMGVTAIVFLGIVFVRWQRRPH-DWDKRKSFSSWLLPLH 457
T K + T + A G + V A++ VF ++RR D+ +S LPL
Sbjct: 436 RPTTRKSKSNTAIIAGAASGAV--VLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLS 493
Query: 458 STKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIG 517
S + S +++ GS S L SN L R F+F E++ AT+NFDE+ V+G
Sbjct: 494 LYGNSH---SAGSAKTNTTGSYASS-----LPSN--LCRHFSFAEIKAATKNFDESRVLG 543
Query: 518 VGGFGKVYIGVLEDGN-KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ 576
VGGFGKVY G ++ G KVAIKRGNP SEQG++EFQTEI+MLSKLRHRHLVSLIG+C+E
Sbjct: 544 VGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN 603
Query: 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636
EMILVY+YMA+G R+HLY T P L WKQRLEICIG+ARGLHYLHTGA IIHRDVK
Sbjct: 604 CEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVK 663
Query: 637 TTNILLDENLVAKVADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
TTNILLDE VAKV+DFGLSK P +D +VST VKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 664 TTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYS 723
Query: 696 FGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYV 755
FGVVLFE LCARP +NP L +EQVSLAEWA C++KG+L++I+DP + I E +K+
Sbjct: 724 FGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFA 783
Query: 756 EAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQ 791
E A KC+ + G++RP MGDVLWNLE+A+QLQE++ +
Sbjct: 784 ETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEE 819
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1551), Expect = e-171, Method: Compositional matrix adjust.
Identities = 349/814 (42%), Positives = 476/814 (58%), Gaps = 57/814 (7%)
Query: 10 SPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKS 69
SPS + +D I G+SE D + ++ D + +L T + P +
Sbjct: 21 SPSQSNGQD---ISLSCGASEPAVDQDKKKWEPD---TKFLKTPNTVHA-----PATYQD 69
Query: 70 SPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKF 129
S P Y ++RIFT + Y + H +RLHFYP ++ + + D+ F+V +
Sbjct: 70 PSLLSTVP-YMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDL 128
Query: 130 VLLHDFSIGNTTSLVFKEYLI-------NITGRLSIIFKP---HKDSHAFINAIEVVSAP 179
LL +FS T + + YL+ + LSIIF P H + AFIN IEV+ P
Sbjct: 129 TLLSNFSAAITCQALTQAYLVREYSLAPSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMP 188
Query: 180 GSIISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDT--LSRTWLSDEAYNAF 237
+ D AS V D + + +RLNVGG + D+ L+RTW +D Y F
Sbjct: 189 E--LFDTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLTRTWYNDAPY-IF 245
Query: 238 PEGSEAVSVEPKNVHYPDGGATPY-IAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSF 296
G V+++ N D P AP VY +A+ + NLTW VD +F
Sbjct: 246 SAGL-GVTLQASNNFRIDYQKMPVSTAPADVYKTARSQGPNGDINMKSNLTWMFQVDTNF 304
Query: 297 SYLIRFHFCDIVSKSLNDLLFNVYINEFMA---ASSLDLSSLTNALSTAYYKDFVLNA-- 351
+Y++R HFC+ +N +FN++IN A + D+ T YKD+ +
Sbjct: 305 TYIMRLHFCEFQLAKINQKVFNIFINNRTAQGDTNPADILGWTGGKGIPTYKDYAIYVDA 364
Query: 352 -TAVKNDSITVQVGPASNAQSSLPNAILNGLEVIK---LSNEAGS------FDGLFAVDG 401
T + I++Q+ P++ Q ++ LNGLE+ K + N AG V
Sbjct: 365 NTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKIDTMKNLAGPNPKPSPMQANEDVKK 424
Query: 402 TYKGDAGTKMKIVAGVGLLMGVTAIVFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKT 461
++GD ++ G GV A++F + F +QR+ SSWL P++
Sbjct: 425 DFQGDKRITAFVIGSAG---GVAAVLFCALCFTMYQRKRKFSGSDSHTSSWL-PIYG--- 477
Query: 462 SFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGF 521
+S +S+ +S++ G + S S L + GL R F+ +E+++ T NFDE+ VIGVGGF
Sbjct: 478 ---NSHTSATKSTISGKSNNGSHLSNLAA--GLCRRFSLSEIKHGTHNFDESNVIGVGGF 532
Query: 522 GKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581
GKVY GV++ G KVAIK+ NP SEQG+NEF+TEI++LS+LRH+HLVSLIG+CDE EM L
Sbjct: 533 GKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCL 592
Query: 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 641
+Y+YM+ G R+HLY T +P L+WK+RLEI IG+ARGLHYLHTGA IIHRDVKTTNIL
Sbjct: 593 IYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNIL 652
Query: 642 LDENLVAKVADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 700
LDEN VAKV+DFGLSK P M+ G+V+T VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL
Sbjct: 653 LDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 712
Query: 701 FEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEK 760
FEVLCARP +NP L +EQVSL +WA+ C RKG LE IIDP + I E L+K+ + AEK
Sbjct: 713 FEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEK 772
Query: 761 CLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDH 794
CL++ G+DRP MGDVLWNLE+A+QLQE + H
Sbjct: 773 CLSDSGLDRPTMGDVLWNLEFALQLQETADGSRH 806
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 842 | ||||||
| 255547323 | 1646 | kinase, putative [Ricinus communis] gi|2 | 0.978 | 0.500 | 0.715 | 0.0 | |
| 224124206 | 776 | predicted protein [Populus trichocarpa] | 0.920 | 0.998 | 0.725 | 0.0 | |
| 15240228 | 842 | putative receptor-like protein kinase [A | 0.940 | 0.940 | 0.689 | 0.0 | |
| 359491313 | 1383 | PREDICTED: probable receptor-like protei | 0.971 | 0.591 | 0.697 | 0.0 | |
| 297793687 | 842 | kinase family protein [Arabidopsis lyrat | 0.940 | 0.940 | 0.687 | 0.0 | |
| 449441067 | 880 | PREDICTED: probable receptor-like protei | 0.982 | 0.939 | 0.660 | 0.0 | |
| 359474779 | 846 | PREDICTED: probable receptor-like protei | 0.900 | 0.895 | 0.625 | 0.0 | |
| 255543779 | 863 | kinase, putative [Ricinus communis] gi|2 | 0.894 | 0.872 | 0.614 | 0.0 | |
| 356565117 | 941 | PREDICTED: probable receptor-like protei | 0.969 | 0.867 | 0.590 | 0.0 | |
| 449436080 | 876 | PREDICTED: probable receptor-like protei | 0.912 | 0.876 | 0.592 | 0.0 |
| >gi|255547323|ref|XP_002514719.1| kinase, putative [Ricinus communis] gi|223546323|gb|EEF47825.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1189 bits (3077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/833 (71%), Positives = 685/833 (82%), Gaps = 9/833 (1%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAK--SSP 71
YSP D++LIDCGS S+ T+LDDGRTFKSD S SYL T E+++ SVDS+ V A SS
Sbjct: 647 YSPPDDFLIDCGS--SQDTTLDDGRTFKSDSSSRSYLETNEEVQVSVDSVLVNATYSSSS 704
Query: 72 CPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVL 131
SA PLYR+ARI T +S+Y IS PG HWVRL+FYP+PH LT+AVF++ D+FVL
Sbjct: 705 PSSALPLYRTARILTSDSKYILHISHPGWHWVRLYFYPLPHPKFDLTNAVFSIAADEFVL 764
Query: 132 LHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTV 190
LH+FS+ + TS+VFKEYL N+T R S+IFKP K+S AFINAIEVVSAP S+ISD+ STV
Sbjct: 765 LHEFSVRDNTSVVFKEYLFNLTSERFSLIFKPIKNSFAFINAIEVVSAPESLISDSVSTV 824
Query: 191 APRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKN 250
TF+GL N+AFEVSYRLNVGG ++TPKNDTLSRTWL D YN FP G++ VSV +
Sbjct: 825 PQGGTFSGLCNYAFEVSYRLNVGGTIITPKNDTLSRTWLPDALYNTFPLGAQNVSVPSSS 884
Query: 251 VHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSK 310
V Y GA+PYIAP WVYA+A +M +++ M P+FNLTW+M VD FSYLIR HFCDIVSK
Sbjct: 885 VKYQKDGASPYIAPPWVYATADQMADSETMLPSFNLTWEMRVDTGFSYLIRMHFCDIVSK 944
Query: 311 SLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQ 370
SLNDL FNVYIN M S LDLSS+TNALSTAY+ DFVLNA+++ N SI VQVG AS +
Sbjct: 945 SLNDLYFNVYINGMMGVSGLDLSSITNALSTAYFADFVLNASSITNSSIKVQVGTASGIE 1004
Query: 371 SSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTAIVFLG 430
S L NAILNGLE+IK+SN+ GS +G F DG+ + + MKI AG+GL MG+TA++ L
Sbjct: 1005 SGLANAILNGLEIIKMSNKVGSLNGFFGADGS---NGVSIMKIAAGIGLAMGLTAMLLLA 1061
Query: 431 IVFVRWQRRPHDWDKRKSFSSWLLPLHST-KTSFLSSKSSSRRSSLFGSRKSKSGYSGLF 489
I+F+RWQ+RP DW KR SFSSWLLPL T ++FLSSKSSSRRSS+FGSRKSKSGYSG F
Sbjct: 1062 IIFIRWQKRPQDWQKRNSFSSWLLPLQGTYNSTFLSSKSSSRRSSMFGSRKSKSGYSGYF 1121
Query: 490 SNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN 549
SNQG GR+FTF+ELQNATQNFDE AVIGVGGFGKVY G LEDG K AIKRGNP S+QGIN
Sbjct: 1122 SNQGFGRYFTFSELQNATQNFDEKAVIGVGGFGKVYFGELEDGTKTAIKRGNPSSQQGIN 1181
Query: 550 EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
EFQTEIQMLSKLRHRHLVSLIGF DEQSEMILVYEYMANGP RDH+YG+N P LSWKQRL
Sbjct: 1182 EFQTEIQMLSKLRHRHLVSLIGFSDEQSEMILVYEYMANGPLRDHIYGSNLPSLSWKQRL 1241
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
EICIG+ARGLHYLHTGA+QGIIHRDVKTTNILLDENLVAKV+DFGLSKAA MD+G+VSTA
Sbjct: 1242 EICIGAARGLHYLHTGASQGIIHRDVKTTNILLDENLVAKVSDFGLSKAASMDQGHVSTA 1301
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729
VKGSFGYLDPEYFR+QQLTEKSDVYSFGVVLFEVLCARPVINP LPREQVSLAEWA+Q H
Sbjct: 1302 VKGSFGYLDPEYFRKQQLTEKSDVYSFGVVLFEVLCARPVINPALPREQVSLAEWAMQWH 1361
Query: 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789
RKG++EKIIDP IA TI ESL+KYVEAAEKCLAEYGVDRPGMGDVLWNLEYA+QLQEAS
Sbjct: 1362 RKGLIEKIIDPKIAGTINAESLKKYVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQEAS 1421
Query: 790 TQIDHPEDKSANLIALDKPCENLSREDLAVAVSDNSEIAAGSSLFSPVGKVRG 842
Q + P+DKS NLIAL+KP D + SD+SE+ GS ++S +G G
Sbjct: 1422 CQAEAPDDKSTNLIALEKPGSMNPEGDSGITASDDSEVTVGSPMYSQIGTFHG 1474
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124206|ref|XP_002330131.1| predicted protein [Populus trichocarpa] gi|222871265|gb|EEF08396.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1158 bits (2996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 567/781 (72%), Positives = 655/781 (83%), Gaps = 6/781 (0%)
Query: 8 SSSPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKA 67
SSS + Y+P DNYLIDCGS + T LDDGRTFKSD S SYL T ED++TSVDSI VK
Sbjct: 1 SSSVAAYTPPDNYLIDCGS--PQDTKLDDGRTFKSDSASRSYLETNEDVQTSVDSISVKG 58
Query: 68 KSSPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTD 127
S SA PL+RSARI T S+Y F+I++PG HWVR +F+P+PH LT AVF++ TD
Sbjct: 59 FSVSS-SALPLFRSARILTAVSKYTFYITRPGWHWVRFYFHPLPHPVYNLTSAVFSITTD 117
Query: 128 KFVLLHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHKDSHAFINAIEVVSAPGSIISDA 186
+FVLLHDF + + ++L FKEYL N++G R S++FKP + S AFINAIEVVSAP +ISD+
Sbjct: 118 EFVLLHDFFVKDNSTLAFKEYLFNVSGDRFSLLFKPKERSFAFINAIEVVSAPDGLISDS 177
Query: 187 ASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSV 246
ASTV T GL AFEV YRLNVGGP +TP NDTLSRTWL D YN FP+G++ S+
Sbjct: 178 ASTVPQDGTLNGLFQHAFEVCYRLNVGGPTITPMNDTLSRTWLPDTPYNVFPQGAQNASI 237
Query: 247 EPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCD 306
P V Y GATPYIAP+WVYA+A +M E++ +QPNFNLTW+M+VDP FSYLIR HFCD
Sbjct: 238 IPSAVKYQQSGATPYIAPSWVYATADEMAESETLQPNFNLTWQMNVDPGFSYLIRMHFCD 297
Query: 307 IVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPA 366
+VS++LNDL FNVYIN M+ S LDLSS+ NALSTAYY DFVLNA++++N S+ VQVGPA
Sbjct: 298 VVSQALNDLYFNVYINSMMSVSGLDLSSINNALSTAYYTDFVLNASSIRNGSVRVQVGPA 357
Query: 367 SNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTAI 426
S QS + NAILNGLEVIK+SN S DGLF VDG+ G G MKI AGVGL MGVTA+
Sbjct: 358 SGMQSGISNAILNGLEVIKISNSVRSLDGLFGVDGSSGG--GRTMKIAAGVGLAMGVTAM 415
Query: 427 VFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYS 486
+ L IV +RWQ+RP DW+KR SFSSWLLPLH++++ F +SKSSSRRSS+FGSR SKSG+S
Sbjct: 416 LLLAIVCIRWQQRPRDWEKRNSFSSWLLPLHTSQSFFSNSKSSSRRSSIFGSRTSKSGFS 475
Query: 487 GLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ 546
FSNQGLGR+F+F+ELQNATQNFDE AVIGVGGFGKVY+GV EDG K+AIKRGNPGSEQ
Sbjct: 476 SYFSNQGLGRYFSFSELQNATQNFDEKAVIGVGGFGKVYLGVFEDGTKMAIKRGNPGSEQ 535
Query: 547 GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWK 606
GINEFQTEIQMLS LRHRHLVSL+GF DEQSEMILVYEYMANGP RDH+YG+ + PLSWK
Sbjct: 536 GINEFQTEIQMLSMLRHRHLVSLVGFSDEQSEMILVYEYMANGPLRDHIYGSKKAPLSWK 595
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666
QRLEICIG+ARGLHYLHTGAAQGIIHRDVKTTNIL+DENLVAKV+DFGLSKAAPM++ YV
Sbjct: 596 QRLEICIGAARGLHYLHTGAAQGIIHRDVKTTNILVDENLVAKVSDFGLSKAAPMEQQYV 655
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726
STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV+NP LPREQV+LAEWA+
Sbjct: 656 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVLNPALPREQVNLAEWAM 715
Query: 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786
QCHRKG+L KIIDP IA +I +ESL+ YVEAAEKCLAE+GVDRPGMGDVLWNLEYA+QLQ
Sbjct: 716 QCHRKGVLNKIIDPHIAGSINEESLKTYVEAAEKCLAEHGVDRPGMGDVLWNLEYALQLQ 775
Query: 787 E 787
E
Sbjct: 776 E 776
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15240228|ref|NP_200943.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|75262670|sp|Q9FLJ8.1|Y5613_ARATH RecName: Full=Probable receptor-like protein kinase At5g61350; Flags: Precursor gi|9757856|dbj|BAB08490.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|332010074|gb|AED97457.1| putative receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1154 bits (2986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/809 (68%), Positives = 658/809 (81%), Gaps = 17/809 (2%)
Query: 10 SPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKS 69
S S+++P DNYLIDCGS S++T L DGR FKSD +S ++L T EDI+TSVDSIP+ +
Sbjct: 24 SSSSFTPADNYLIDCGS--SDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSN 81
Query: 70 SPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKF 129
+ S PLY +ARIF G+S Y F+IS+PG HW+RLHFYP+ H LT++VF+V TD
Sbjct: 82 A---STLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTT 138
Query: 130 VLLHDFSIGNTTSLVFKEYLINITGRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAAST 189
VLLHDFS G+T+S+VFKEYLI +LS+ FKPHK S AFINA+E+VS P ++ D+AS+
Sbjct: 139 VLLHDFSAGDTSSIVFKEYLIYAAEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASS 198
Query: 190 VAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPK 249
V F GLS+F+ E+ +R+N+GG L++PK D LSRTWLSD+ YN FPEGS V+V+P
Sbjct: 199 VPQAPDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTVDPS 258
Query: 250 NVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVS 309
+ YPDGGAT IAPN VYA+A++M +AQ QPNFNL+W+MSVD Y IR HFCDIVS
Sbjct: 259 TITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVS 318
Query: 310 KSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNA 369
KSLNDL+FNV+IN+ A S+LDLSSLT+AL TAYY DFVLNA+ + N SI VQVGP N
Sbjct: 319 KSLNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGSILVQVGPTPNL 378
Query: 370 QSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAG---TKMKIVAGVGLLMGVTAI 426
QS PNAILNGLE++KL+N AGS DGLF VDG YKG G +K +AG+G +M +TA
Sbjct: 379 QSGKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGIGFVMALTAF 438
Query: 427 VFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSK--SSSRRSSLFGSRKSKS- 483
+ + ++ VRWQRRP DW K+ SFSSWLLPLH++ +S++SSK S+SRR S+FGS+KSKS
Sbjct: 439 LGVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSKSN 498
Query: 484 GYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG 543
G+S FSNQGLGR+F FTELQ ATQNFDENAV GVGGFGKVYIG ++ G +VAIKRG+
Sbjct: 499 GFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQS 558
Query: 544 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ--- 600
SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE EMILVYEYM+NGP RDHLYG+ +
Sbjct: 559 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDP 618
Query: 601 ---PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
P LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV+DFGLSK
Sbjct: 619 NPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSK 678
Query: 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
APMD G+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARPVINP+LPRE
Sbjct: 679 DAPMDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPRE 738
Query: 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777
QV+LAE+A+ HRKG+LEKIIDP I TI K SLRK+VEAAEKCLAEYGVDRPGMGDVLW
Sbjct: 739 QVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLW 798
Query: 778 NLEYAMQLQEASTQIDHPEDKSANLIALD 806
NLEYA+QLQEAS Q+D EDK+ I +D
Sbjct: 799 NLEYALQLQEASAQVDLSEDKTTMNIEMD 827
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491313|ref|XP_002284678.2| PREDICTED: probable receptor-like protein kinase At5g61350 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1150 bits (2976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 578/829 (69%), Positives = 683/829 (82%), Gaps = 11/829 (1%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCP 73
Y+P DNYLI+CGS S T L+DGRTFKSD ES+SYLST ED++T+V+SI V SS
Sbjct: 558 YTPDDNYLINCGS--SHSTRLEDGRTFKSDPESASYLSTNEDVQTTVNSISVSDSSS--- 612
Query: 74 SAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLH 133
+ LY SARIF +S Y FFI++PG HW+RL+FYP+ H LT AVFTV TDK VLLH
Sbjct: 613 MSLTLYLSARIFPDQSTYSFFIARPGRHWIRLYFYPLLHPLYDLTAAVFTVSTDKVVLLH 672
Query: 134 DFSIGNTTSLVFKEYLINIT-GRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTVAP 192
DFS+ + T+L+FKEYL+NI+ R+ + F P K+S+A+INAIE+VSAP S+ISD+AS V+P
Sbjct: 673 DFSMKDNTTLMFKEYLVNISSNRVFLRFSPKKNSYAYINAIELVSAPDSLISDSASAVSP 732
Query: 193 RDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVH 252
F+GLSN+A E+SYRLNVGGPL+T ND+LSRTW D + FP+G++ VSV PK +
Sbjct: 733 VGNFSGLSNYALEISYRLNVGGPLITSANDSLSRTWEPDNEFMTFPQGAQNVSVSPKIIE 792
Query: 253 YPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSL 312
YP+GGAT IAPNWVYASA +M E+ V +PNFNLTWKMSV P FSYLIR HFCDIVSKSL
Sbjct: 793 YPEGGATQLIAPNWVYASADEMAESGVSEPNFNLTWKMSVSPGFSYLIRMHFCDIVSKSL 852
Query: 313 NDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSS 372
NDL FNVYIN M S LDLS+LT+ L+ AYYKDFVLNATA+ N SI VQVGPASN S
Sbjct: 853 NDLYFNVYINGMMGVSGLDLSTLTSGLAIAYYKDFVLNATAITNGSIMVQVGPASNLGSG 912
Query: 373 LPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGT-KMKIVAGVGLLMGVTAIVFLGI 431
NAILNGLEV+K+SN AGS DGLF VD ++KG +G+ KMKI+A VGL+M +TA++ LG+
Sbjct: 913 QSNAILNGLEVMKMSNMAGSLDGLFNVDESFKGSSGSKKMKILAAVGLIMAITAMLLLGM 972
Query: 432 VFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSN 491
VF RWQ+RP DW+K+ SFSSWLLPLH+ ++SFLSSKS S+RS+L+GS KSKSGYS S+
Sbjct: 973 VFFRWQKRPKDWEKKNSFSSWLLPLHAGQSSFLSSKSGSQRSNLYGSHKSKSGYSSFLSS 1032
Query: 492 Q-GLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINE 550
GLGR F+F ELQ+AT+NFDE AVIGVGGFGKVY+G LEDG K+AIKRGN SEQGINE
Sbjct: 1033 GLGLGRLFSFAELQDATRNFDEKAVIGVGGFGKVYLGELEDGTKLAIKRGNANSEQGINE 1092
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
FQTEIQMLSKLRHRHLVSLIG+CDEQSEMILVYEYMANGP RDH+YG+N P LSWKQRL+
Sbjct: 1093 FQTEIQMLSKLRHRHLVSLIGYCDEQSEMILVYEYMANGPLRDHIYGSNLPHLSWKQRLD 1152
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDRGYVSTA 669
ICIG+ARGLHYLHTGAAQGIIHRDVKTTNILLD+N VAKV+DFGLSKAAP +++ +VSTA
Sbjct: 1153 ICIGAARGLHYLHTGAAQGIIHRDVKTTNILLDDNFVAKVSDFGLSKAAPTLEQTHVSTA 1212
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729
VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP INP LPREQV+LAEWA+Q +
Sbjct: 1213 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPAINPALPREQVNLAEWAMQWN 1272
Query: 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789
RKG++EKI+DP IA T+ SL+KYVEAAEKCLAE+GVDRP MGDVLWNLEYA+Q+QEAS
Sbjct: 1273 RKGMIEKIVDPHIAGTVSSGSLKKYVEAAEKCLAEHGVDRPSMGDVLWNLEYALQMQEAS 1332
Query: 790 TQIDHPEDKSANLIALDKPCENLSREDLAVAVSDNSEIAAGSSLFSPVG 838
+ ID P D SA LI L+ P + + + VSD+SE+ GS +FS G
Sbjct: 1333 SLID-PLDSSAKLITLE-PGKEEPKGAASTPVSDDSEVTVGSPVFSQTG 1379
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793687|ref|XP_002864728.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310563|gb|EFH40987.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1148 bits (2969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/809 (68%), Positives = 658/809 (81%), Gaps = 17/809 (2%)
Query: 10 SPSTYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKS 69
S S+++P DNYLIDCGS S +T L DGR FKSD +S ++L T EDI+TSVDSIP+ +
Sbjct: 24 SSSSFTPADNYLIDCGS--SGETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPISDSN 81
Query: 70 SPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKF 129
S S PLY +ARIF G+S Y F+IS+PG HW+RLHFYP+ H LT++VF+V TD
Sbjct: 82 S---STLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDAT 138
Query: 130 VLLHDFSIGNTTSLVFKEYLINITGRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAAST 189
VLLHDFS G+T+S+ FKEYLI +LS+ FKPHK S AFINA+E+VS P ++ D+AS+
Sbjct: 139 VLLHDFSAGDTSSIAFKEYLIYAAEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASS 198
Query: 190 VAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPK 249
V F GLS+F+ E+ +R+N+GG L++PK D LSRTWLSD+ YN FPEGS V+V+P
Sbjct: 199 VPQAPDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNLFPEGSRNVTVDPS 258
Query: 250 NVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVS 309
+ YPDGGAT IAPN VYA+A++M +AQ QPNFNL+W+MSVD Y IR HFCDIVS
Sbjct: 259 TITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVS 318
Query: 310 KSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNA 369
KSLNDL+FNV+IN+ A S+LDLSSLTNAL AYY DFVLNA+ + N SI VQVGP +
Sbjct: 319 KSLNDLVFNVFINKLSAISALDLSSLTNALGAAYYADFVLNASTITNGSILVQVGPTPSL 378
Query: 370 QSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAG---TKMKIVAGVGLLMGVTAI 426
QS PNAILNGLE++KL+N AGS DGLF VDG YKG G +K +AG+G +M +TA+
Sbjct: 379 QSGKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGIGFVMALTAL 438
Query: 427 VFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSK--SSSRRSSLFGSRKSKS- 483
+ + ++ VRWQRRP DW K+ SFSSWLLPLH++ +S++SSK S+SRR S+FGS+KSKS
Sbjct: 439 LGVVMLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSKSN 498
Query: 484 GYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG 543
G+S FSNQGLGR+F FTELQ ATQNFDEN+VIGVGGFGKVYIG ++ G +VAIKRG+
Sbjct: 499 GFSSFFSNQGLGRYFPFTELQIATQNFDENSVIGVGGFGKVYIGEIDGGTQVAIKRGSQS 558
Query: 544 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ--- 600
SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE EMILVYEYM+NGP RDHLYG+ +
Sbjct: 559 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDP 618
Query: 601 ---PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
P LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV+DFGLSK
Sbjct: 619 NPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSK 678
Query: 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
APM++G+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARPVINP+LPRE
Sbjct: 679 DAPMEQGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPRE 738
Query: 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777
QV+LAE+A+ HRKG+LEKIIDP I TI K SLRK+VEAAEKCLAEYGVDRPGMGDVLW
Sbjct: 739 QVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLW 798
Query: 778 NLEYAMQLQEASTQIDHPEDKSANLIALD 806
NLEYA+QLQEAS Q+D EDK+ I +D
Sbjct: 799 NLEYALQLQEASAQVDLSEDKTTMNIEMD 827
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441067|ref|XP_004138305.1| PREDICTED: probable receptor-like protein kinase At5g61350-like [Cucumis sativus] gi|449477567|ref|XP_004155059.1| PREDICTED: probable receptor-like protein kinase At5g61350-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1117 bits (2888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/842 (66%), Positives = 676/842 (80%), Gaps = 15/842 (1%)
Query: 13 TYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPC 72
+++PRD YLIDCGS S QT LDDGR FKSD ES+S LST+ED++ SVDSIP A SP
Sbjct: 41 SFTPRDVYLIDCGSPS--QTRLDDGRIFKSDRESTSLLSTEEDVQASVDSIPSNALVSPL 98
Query: 73 PS-AYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVL 131
S + PL+ +ARIF +S Y FFISQPG HW+RL+FYP+P+++ LTD+VFTV TD VL
Sbjct: 99 SSWSLPLFLTARIFPTDSTYTFFISQPGRHWIRLYFYPLPNANFNLTDSVFTVTTDSVVL 158
Query: 132 LHDFSIGNTTSLVFKEYLINIT-GRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTV 190
LHDFSI +VF+EYLINIT R S+ FKP K+S AFINAIE+VSAP ++ SD+A++V
Sbjct: 159 LHDFSIKPNPKIVFREYLINITTDRFSLEFKPKKNSFAFINAIEIVSAPDALFSDSANSV 218
Query: 191 APRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKN 250
+P F GLSN A ++ +R+NVGGP + PKNDTLSRTW +D AYN FP+GS+ VSV+ +
Sbjct: 219 SPVGFFNGLSNIALQICHRVNVGGPEIVPKNDTLSRTWETDAAYNKFPQGSKNVSVDLDS 278
Query: 251 VHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSK 310
+ YP TP IAPNWVYA+A+ M++ + MQ NFN++W +V+ S+SYLIR HFCDIVSK
Sbjct: 279 IKYPGIELTPLIAPNWVYATAEDMQDPKTMQVNFNMSWSFNVEQSYSYLIRLHFCDIVSK 338
Query: 311 SLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQ 370
LN+L FNVYIN M + LDLS LT LST YY+D VLNA+ +KN++I +QVGP SN
Sbjct: 339 VLNNLYFNVYINGMMGIADLDLSQLTGDLSTPYYRDLVLNASDIKNNTIMIQVGP-SNVD 397
Query: 371 SSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAG-TKMKIVAGVGLLMGVTAIVFL 429
S L +AILNG+E++K+SN+A S DGLF+VDGTY G + + MKI+A VGL +G AIVFL
Sbjct: 398 SGLQDAILNGVEIMKMSNDAQSLDGLFSVDGTYMGGSTLSTMKIIAVVGLGIGAIAIVFL 457
Query: 430 GIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSK-----SG 484
G++F+RW RP+ W+KR SFSSWLLPL++ ++ +S SS+ SS S +G
Sbjct: 458 GVMFLRWHNRPNGWEKRHSFSSWLLPLNNNNSTNTASFFSSKSSSRRSSTVFSSRRSRTG 517
Query: 485 YSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS 544
+SG++SN GLGRFF+ ELQ ATQNF+E AVIGVGGFGKVY+G LEDG KVAIKRGNP S
Sbjct: 518 FSGIYSNVGLGRFFSLNELQVATQNFEEKAVIGVGGFGKVYVGALEDGTKVAIKRGNPSS 577
Query: 545 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS 604
+QGINEF+TEI+MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG+N PPLS
Sbjct: 578 DQGINEFRTEIEMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGSNLPPLS 637
Query: 605 WKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDR 663
WKQRLEICIG+ARGLHYLHTGAAQGIIHRDVKTTNILLDEN VAKVADFGLSKAAP +++
Sbjct: 638 WKQRLEICIGAARGLHYLHTGAAQGIIHRDVKTTNILLDENFVAKVADFGLSKAAPSLEQ 697
Query: 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723
+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCAR VINP LPREQV+LAE
Sbjct: 698 THVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARQVINPTLPREQVNLAE 757
Query: 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783
WA+Q +RKG LEKIIDP I+ +I + SL+K+VEAAEKCLAEYGVDRP MGDVLWNLEYA+
Sbjct: 758 WAMQNYRKGKLEKIIDPKISSSIVEGSLKKFVEAAEKCLAEYGVDRPSMGDVLWNLEYAL 817
Query: 784 QLQEASTQIDHP-EDKSANLIALDKPCENLSRE-DLAVAVSDN-SEIAAGSSLFSPVGKV 840
QLQEA ++++ P EDK L+ALDKP +N + + +VSD+ SE++ + LFS V
Sbjct: 818 QLQEAVSELEDPDEDKCEGLVALDKPNDNQPKAGSTSASVSDDTSEVSVSAPLFSEVQSF 877
Query: 841 RG 842
+G
Sbjct: 878 QG 879
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474779|ref|XP_002280183.2| PREDICTED: probable receptor-like protein kinase At4g39110-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2596), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/788 (62%), Positives = 615/788 (78%), Gaps = 30/788 (3%)
Query: 8 SSSP-STYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVK 66
S++P STY+P+D+YLIDCG +S + L DGR FK+D +++ Y+S+++DI+ SV S V
Sbjct: 23 SAAPASTYTPQDSYLIDCGGTTS--SPLPDGRVFKTDQQAAPYISSEDDIQISVPSADV- 79
Query: 67 AKSSPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQT 126
PS P+Y +ARIF ++ Y F +S+PG HWVRLHF+P+ ++ L AVF+V T
Sbjct: 80 ------PS--PIYLTARIFVEDTTYSFRMSRPGWHWVRLHFFPMNNTEFDLQHAVFSVST 131
Query: 127 DKFVLLHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHKDSHAFINAIEVVSAPGSIISD 185
D+ VLLH F++ N+T V KEYL+N+T R ++ F P ++S AF+NAIEVVSAP +I+D
Sbjct: 132 DQVVLLHSFNLDNSTEWVLKEYLVNVTNERFTLKFSPMRNSVAFVNAIEVVSAPDILITD 191
Query: 186 AASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVS 245
S + P F+GLS+++++V YRLN+GGPL+ +NDTL RTW+SD Y +++VS
Sbjct: 192 TGSALFPVGDFSGLSSYSYQVVYRLNMGGPLINSQNDTLGRTWVSDHPYLKSDVLAKSVS 251
Query: 246 VEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFC 305
V P + YP+G +P IAP VYASA +M +A+V PNFN+TW ++DPSF YLIR HFC
Sbjct: 252 VSPSVITYPEG-ESPLIAPQLVYASAIQMADARVTNPNFNVTWNFNIDPSFGYLIRMHFC 310
Query: 306 DIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGP 365
DIVSKSLNDL FNVYIN MA S LDLS++T+AL+T YYKD V+N T++ +D +TVQ+GP
Sbjct: 311 DIVSKSLNDLYFNVYINGRMAISGLDLSTITSALATPYYKDIVVN-TSLLSDQLTVQIGP 369
Query: 366 ASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTA 425
+ S+ NAI+NGLE++K+SN S DG F VDG+ K + + VA VG M A
Sbjct: 370 MNQDTGSV-NAIINGLEILKMSNSVNSLDGEFGVDGS-KAETSSNRNAVAAVGFAMMFGA 427
Query: 426 IVFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGY 485
V LG + ++WQRRPHDW+KR SFSSWLLPLH+ TSF++SK+S GS KS
Sbjct: 428 FVGLGAMVIKWQRRPHDWEKRNSFSSWLLPLHAGDTSFMTSKNS------LGSHKS---- 477
Query: 486 SGLFSNQ-GLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS 544
G +S+ GLGR+F+FTELQ AT+NFD NA+IGVGGFG VY+G ++DG KVA+KRGNP S
Sbjct: 478 -GFYSSTLGLGRYFSFTELQEATKNFDSNAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS 536
Query: 545 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS 604
EQGI EFQTEIQMLSKLRHRHLVSLIG+CDE SEMILVYEYM+NGPFRDHLYG N LS
Sbjct: 537 EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLASLS 596
Query: 605 WKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDR 663
WKQRLEICIG+ARGLHYLHTGAAQGIIHRDVKTTNILLD+N +AKVADFGLSK AP M++
Sbjct: 597 WKQRLEICIGAARGLHYLHTGAAQGIIHRDVKTTNILLDDNFIAKVADFGLSKNAPTMEQ 656
Query: 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723
G+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL E LCARP INP+LPREQV+LAE
Sbjct: 657 GHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAE 716
Query: 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783
WA+Q RKG+L+KIIDP++A TI ES++K+ EAAEKCLA++GVDRP MGDVLWNLEYA+
Sbjct: 717 WAMQWKRKGLLDKIIDPLLAGTINPESMKKFAEAAEKCLADHGVDRPSMGDVLWNLEYAL 776
Query: 784 QLQEASTQ 791
QLQEAS Q
Sbjct: 777 QLQEASLQ 784
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543779|ref|XP_002512952.1| kinase, putative [Ricinus communis] gi|223547963|gb|EEF49455.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 970 bits (2507), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/781 (61%), Positives = 586/781 (75%), Gaps = 28/781 (3%)
Query: 12 STYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSP 71
S+++P D LI CGS S +++ DGR FK+DHE+ S L T+EDI V A S+
Sbjct: 42 SSFAPADQILISCGSKS--LSAIPDGRVFKTDHEAQSLLKTEEDIL-------VSAPSAD 92
Query: 72 CPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVL 131
PS P+Y SARIF ES Y F + PG HW RLHF+P ++ L A F+V TDK+VL
Sbjct: 93 VPS--PIYLSARIFVQESTYAFTMKSPGWHWFRLHFFPFNNTRFDLQSATFSVSTDKYVL 150
Query: 132 LHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTV 190
LH+F++ N T KEYL+N+T ++++ F+P K+S AFINAIEVVSAP +ISD S +
Sbjct: 151 LHNFNVNNQTKPFLKEYLVNVTDPKVTLKFQPMKNSAAFINAIEVVSAPDILISDEGSGL 210
Query: 191 APRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKN 250
P +F+GL+N+ ++V YRLNVGGPL+T KNDTL RTW +D+ + +++VS+ +
Sbjct: 211 FPVSSFSGLTNYGYQVVYRLNVGGPLITSKNDTLWRTWENDKPFLKDQSLAQSVSIPTSS 270
Query: 251 VHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSK 310
+ Y G +P IAP VYASAQ+M E++ M PNFN+TWK VD +F+YL+R HF DIVSK
Sbjct: 271 IKY-GTGTSPLIAPATVYASAQEMAESKTMLPNFNVTWKFEVDTAFNYLVRLHFADIVSK 329
Query: 311 SLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQ 370
SLNDL FNVYIN A S LDLSS+TN L+ YYKD V+N+T + N + VQ+GP N
Sbjct: 330 SLNDLYFNVYINGKTAISGLDLSSITNQLAAPYYKDIVVNSTLMSN-GLNVQIGPM-NED 387
Query: 371 SSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTAIVFLG 430
+ NAILNGLE++K+SN S DG F VDG A VA VG M A V LG
Sbjct: 388 TGSTNAILNGLEILKMSNSVDSLDGEFGVDGRM---AIASRSTVAAVGFAMMFGAFVGLG 444
Query: 431 IVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFS 490
+ ++W +RP DW KR SFSSWLLP+H+ TSF++SK+S GS K+ S L
Sbjct: 445 AMVIKWHKRPQDWQKRNSFSSWLLPIHAGDTSFMTSKTS------LGSHKTNMYSSTL-- 496
Query: 491 NQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINE 550
GLGR+F+F+ELQ AT+NFD++A+IGVGGFG VY+GV++D +VA+KRGNP SEQGI E
Sbjct: 497 --GLGRYFSFSELQEATKNFDQSAIIGVGGFGNVYLGVIDDATQVAVKRGNPQSEQGITE 554
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
FQTEIQMLSKLRHRHLVSLIG+CDE EMILVYEYM+NGPFRDHLYG N PPLSWKQRLE
Sbjct: 555 FQTEIQMLSKLRHRHLVSLIGYCDENDEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE 614
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I IG+ARGLHYLHTG AQGIIHRDVKTTNILLD+ VAKVADFGLSK APM +G+VSTAV
Sbjct: 615 ISIGAARGLHYLHTGTAQGIIHRDVKTTNILLDDAFVAKVADFGLSKDAPMGQGHVSTAV 674
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730
KGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLCARP INP+LPREQV+LAEWA+Q R
Sbjct: 675 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 734
Query: 731 KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAST 790
KG+LEKIIDP++ TI ES++K+ EAAEKCLAE+GVDRP MGDVLWNLEYA+QLQEA +
Sbjct: 735 KGLLEKIIDPILVGTINPESMKKFAEAAEKCLAEHGVDRPSMGDVLWNLEYALQLQEAFS 794
Query: 791 Q 791
Q
Sbjct: 795 Q 795
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565117|ref|XP_003550791.1| PREDICTED: probable receptor-like protein kinase At5g61350-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 967 bits (2499), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/841 (59%), Positives = 633/841 (75%), Gaps = 25/841 (2%)
Query: 12 STYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSP 71
S++SP NYLIDCGS S T L DGR FKSD E++S LST ED+ S++S S
Sbjct: 115 SSFSPNVNYLIDCGS--SHPTQLKDGRIFKSDRETTSLLSTTEDLHISLNS----NLSPS 168
Query: 72 CPS-AYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFV 130
PS + PLY++AR+F ES Y F+IS+ G W+RL+F+P+P S LT AVF+VQT+ V
Sbjct: 169 IPSLSLPLYQTARVFQEESTYSFYISKSGRLWIRLYFFPLPDPSFNLTSAVFSVQTNHHV 228
Query: 131 LLHDFSIGNTTSLVFKEYLINITGRL-SIIFKPHKDSHAFINAIEVVSAPGSIISDAAST 189
LLH+FS N + VFKEYL+N++ + S+ FKP K+S AFINAIEVVSAP ++ISD+A+
Sbjct: 229 LLHEFSAWNNDTPVFKEYLVNVSDSIFSLEFKPKKNSFAFINAIEVVSAPDTLISDSATA 288
Query: 190 VAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPK 249
++P F GL N A EVSYR+NVGGP++TP NDTLSRTW +D +YN FP+GS VSV K
Sbjct: 289 LSPLGEFKGLLNSALEVSYRINVGGPVITPDNDTLSRTWETDGSYNIFPQGSVNVSVSNK 348
Query: 250 NVHYPDGGA-TPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIV 308
++ YP G TP IAPN VYASA MK+A+VM+PNFNL+W ++V+ +SYLIR HFCDIV
Sbjct: 349 SIKYPRTGILTPLIAPNSVYASAVHMKDARVMEPNFNLSWVVNVESGYSYLIRIHFCDIV 408
Query: 309 SKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASN 368
SKSLN L FNVYIN SSLDLS T AL+TA+YKDFVLNA ++ + SI VQVGPA N
Sbjct: 409 SKSLNRLYFNVYINGIEGVSSLDLSLQTKALATAFYKDFVLNAFSITSGSILVQVGPA-N 467
Query: 369 AQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAG-TK-MKIVAGVGLLMGVTAI 426
Q + +AI NG+EV+K+SN A S DG F+VDG YKG + TK +KI A VG+ + VT +
Sbjct: 468 LQHGMTDAIANGIEVMKMSNNADSLDGFFSVDGKYKGPSSPTKAIKIFACVGIALAVTTM 527
Query: 427 VFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYS 486
+ L ++ +RW++RP DW+ FSSWLLP HS + +SSKSS R S+ F S KS
Sbjct: 528 LLLAMICIRWKKRPQDWETHNRFSSWLLPFHSAR--MVSSKSSFRSSNAFSSHKSNKHGH 585
Query: 487 GLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ 546
G+ S +G RFF F+E+ AT NFDE VIG+GGFGKVY+G LEDG KVAIKRG+ SEQ
Sbjct: 586 GV-SQKGRERFFPFSEMLQATNNFDEKKVIGIGGFGKVYLGTLEDGTKVAIKRGSGSSEQ 644
Query: 547 GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWK 606
GINEF+TE++MLSKLRHRHLVSL+GFCDE SEM+LVYEYMANGPFR HLYG+N P LSW+
Sbjct: 645 GINEFRTELEMLSKLRHRHLVSLMGFCDENSEMVLVYEYMANGPFRSHLYGSNLPLLSWE 704
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666
+RLEICIG+ARGLHYLHTGAAQ I HRDVKTTNILLDEN VAKV+DFGLSKA P ++ V
Sbjct: 705 KRLEICIGAARGLHYLHTGAAQSITHRDVKTTNILLDENYVAKVSDFGLSKAVP-EKAQV 763
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726
STAVKGS GYLDPEY+R QQLT+KSD+YSFGVVL EVLCARPVI P LPRE+++LA+WA+
Sbjct: 764 STAVKGSLGYLDPEYYRTQQLTQKSDIYSFGVVLIEVLCARPVICPTLPREEINLADWAM 823
Query: 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786
HR+ +L ++IDP I ++I +SL +V+ AE+CL++ GVDRP +GDVLW+LEYA++LQ
Sbjct: 824 AQHRRRVLNEVIDPRIIKSISPQSLNVFVQIAERCLSDSGVDRPSVGDVLWHLEYALRLQ 883
Query: 787 EASTQIDHPEDKSANLIALDKPC---ENLSRE--DLAVAVSDNSEIAAGSSLFSPVGKVR 841
+ +T+I ++K +++ C +N++ D A VS++++ A S+LFS + +
Sbjct: 884 DDATRIKELDEKIESIVT--NECNDNDNVAGHSGDPASDVSNSTD--ANSALFSQIANFQ 939
Query: 842 G 842
G
Sbjct: 940 G 940
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436080|ref|XP_004135822.1| PREDICTED: probable receptor-like protein kinase At4g39110-like [Cucumis sativus] gi|449528585|ref|XP_004171284.1| PREDICTED: probable receptor-like protein kinase At4g39110-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 948 bits (2451), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/795 (59%), Positives = 585/795 (73%), Gaps = 27/795 (3%)
Query: 1 SSPSSSPSSSP-STYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETS 59
+ P+ + ++ P +++ P+DN+LIDCG+ + E +L DGR FK+D +S YL K+DI
Sbjct: 34 NCPNIAFATGPGASFIPKDNFLIDCGA-NKEVGALPDGRVFKTDEQSKQYLDAKDDI--- 89
Query: 60 VDSIPVKAKSSPCPSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTD 119
I PS P+ +AR+F E+ Y F +++PG HW+RLHF PV + L
Sbjct: 90 ---IATATPEMKAPS--PVDLTARVFLQEATYIFQMAEPGWHWLRLHFLPVKSNDFDLLQ 144
Query: 120 AVFTVQTDKFVLLHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHKDSHAFINAIEVVSA 178
A F+V T+ +VLLH F+I N ++ V KE+L+NIT +LSI F P ++S AFINAIEVVSA
Sbjct: 145 AKFSVATENYVLLHSFNINNESTFVLKEFLLNITEPKLSIKFLPMRNSAAFINAIEVVSA 204
Query: 179 PGSIISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFP 238
P +I+D+ ++P T GLS +AF+ YRLN+GGP++TP+NDTL RTW +DE Y
Sbjct: 205 PVDLIADSNVELSPVGTIEGLSKYAFQTLYRLNMGGPIITPRNDTLGRTWETDEVYRTPK 264
Query: 239 EGSEAVSVEPKNVHYPDG--GATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSF 296
+V V+ ++ Y G IAP VYASA +M +AQV PNFN+TWK DPSF
Sbjct: 265 AAGSSVVVQTNSIKYQGGLKETGMLIAPPSVYASAVQMGDAQVSVPNFNITWKFEADPSF 324
Query: 297 SYLIRFHFCDIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKN 356
YL+RFHFCDIVSK LND+ FNVY+N A ++LDLS +L+TAYYKD V+NA+ +
Sbjct: 325 GYLVRFHFCDIVSKVLNDIYFNVYVNGKAAITNLDLSHKLGSLATAYYKDVVVNASLIV- 383
Query: 357 DSITVQVGPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAG 416
D +TVQ+ PA N + NAILNG+EV+K+SN S DG F VDG K G+ VA
Sbjct: 384 DGLTVQISPA-NVDTGDSNAILNGIEVLKISNSVNSLDGEFGVDG--KSANGSNRGTVAA 440
Query: 417 VGLLMGVTAIVFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLF 476
VG M A V LG + ++W +RP DW KR SFSSWLLP+H+ +SF++SK+S +
Sbjct: 441 VGFAMMFGAFVGLGAMVMKWHKRPQDWQKRNSFSSWLLPVHAGDSSFMTSKTS------Y 494
Query: 477 GSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVA 536
GS K+ YS S GLGRFFT ELQ AT+NFD N++IGVGGFG VY+GV+++G KVA
Sbjct: 495 GSHKTNI-YS---STLGLGRFFTLAELQEATKNFDPNSIIGVGGFGNVYLGVIDEGTKVA 550
Query: 537 IKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLY 596
+KRGNP SEQGI EFQTEIQMLSKLRHRHLVSLIG+CDE +EMILVYE+M+NGPFRDHLY
Sbjct: 551 VKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEFMSNGPFRDHLY 610
Query: 597 GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
G + PLSWKQRLEICIG+ARGLHYLHTG AQGIIHRDVKTTNILLDEN AKVADFGLS
Sbjct: 611 GKDISPLSWKQRLEICIGAARGLHYLHTGTAQGIIHRDVKTTNILLDENFTAKVADFGLS 670
Query: 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPR 716
K APM +G+VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL E LCARP INP L R
Sbjct: 671 KDAPMGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEALCARPAINPSLTR 730
Query: 717 EQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
EQV+LA+WA+QC +KG LEKI+DP++ I ES++K+ EA+EKCLAE+GVDRP MGDVL
Sbjct: 731 EQVNLADWAMQCKKKGCLEKIMDPLLVGAINPESMKKFAEASEKCLAEHGVDRPSMGDVL 790
Query: 777 WNLEYAMQLQEASTQ 791
WNLEYA+QLQEA +Q
Sbjct: 791 WNLEYALQLQEAFSQ 805
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 842 | ||||||
| TAIR|locus:2163158 | 842 | AT5G61350 [Arabidopsis thalian | 0.934 | 0.934 | 0.672 | 4.9e-291 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.957 | 0.942 | 0.508 | 2.1e-210 | |
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.380 | 0.385 | 0.683 | 1.3e-189 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.355 | 0.360 | 0.721 | 1.2e-186 | |
| TAIR|locus:2136338 | 878 | AT4G39110 [Arabidopsis thalian | 0.624 | 0.599 | 0.638 | 3e-179 | |
| TAIR|locus:2050080 | 871 | AT2G21480 [Arabidopsis thalian | 0.615 | 0.594 | 0.626 | 4e-177 | |
| TAIR|locus:2178707 | 824 | AT5G24010 [Arabidopsis thalian | 0.353 | 0.361 | 0.693 | 1.7e-176 | |
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.923 | 0.916 | 0.437 | 1.4e-165 | |
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.891 | 0.875 | 0.426 | 3.2e-152 | |
| TAIR|locus:2081895 | 895 | FER "FERONIA" [Arabidopsis tha | 0.889 | 0.836 | 0.427 | 4.7e-151 |
| TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2795 (988.9 bits), Expect = 4.9e-291, P = 4.9e-291
Identities = 543/808 (67%), Positives = 632/808 (78%)
Query: 13 TYSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPC 72
+++P DNYLIDCGS S++T L DGR FKSD +S ++L T EDI+TSVDSIP+ ++
Sbjct: 27 SFTPADNYLIDCGS--SDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNA-- 82
Query: 73 PSAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLL 132
S PLY +ARIF G+S Y F+IS+PG HW+RLHFYP+ H LT++VF+V TD VLL
Sbjct: 83 -STLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLL 141
Query: 133 HDFSIGNTTSLVFKEYLINITGRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTVAP 192
HDFS G+T+S+VFKEYLI +LS+ FKPHK S AFINA+E+VS P ++ D+AS+V
Sbjct: 142 HDFSAGDTSSIVFKEYLIYAAEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASSVPQ 201
Query: 193 RDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVH 252
F GLS+F+ E+ +R+N+GG L++PK D LSRTWLSD+ YN FPEGS V+V+P +
Sbjct: 202 APDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTVDPSTIT 261
Query: 253 YPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSL 312
YPDGGAT IAPN VYA+A++M +AQ QPNFNL+W+MSVD Y IR HFCDIVSKSL
Sbjct: 262 YPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVSKSL 321
Query: 313 NDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSS 372
NDL+FNV+IN+ A S+LDLSSLT+AL TAYY DFVLNA+ + N SI VQVGP N QS
Sbjct: 322 NDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGSILVQVGPTPNLQSG 381
Query: 373 LPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAG---TKMKIVAGVGLLMGVTAIVFL 429
PNAILNGLE++KL+N AGS DGLF VDG YKG G +K +AG+G +M +TA FL
Sbjct: 382 KPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGIGFVMALTA--FL 439
Query: 430 GIV--FVRWQRRPHDWDKRKSFSSWLLPLHXXXXXXXXXXXXXXXXXXX---XXXXXXXX 484
G+V VRWQRRP DW K+ SFSSWLLPLH
Sbjct: 440 GVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSKSNG 499
Query: 485 YSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS 544
+S FSNQGLGR+F FTELQ ATQNFDENAV GVGGFGKVYIG ++ G +VAIKRG+ S
Sbjct: 500 FSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQSS 559
Query: 545 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ---- 600
EQGINEFQTEIQMLSKLRHRHLVSLIGFCDE EMILVYEYM+NGP RDHLYG+ +
Sbjct: 560 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDPN 619
Query: 601 --PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
P LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV+DFGLSK
Sbjct: 620 PIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKD 679
Query: 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
APMD G+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARPVINP+LPREQ
Sbjct: 680 APMDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPREQ 739
Query: 719 VSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778
V+LAE+A+ HRKG+LEKIIDP I TI K SLRK+VEAAEKCLAEYGVDRPGMGDVLWN
Sbjct: 740 VNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLWN 799
Query: 779 LEYAMQLQEASTQIDHPEDKSANLIALD 806
LEYA+QLQEAS Q+D EDK+ I +D
Sbjct: 800 LEYALQLQEASAQVDLSEDKTTMNIEMD 827
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2034 (721.1 bits), Expect = 2.1e-210, P = 2.1e-210
Identities = 433/852 (50%), Positives = 558/852 (65%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCP 73
++P DNYLI CGS S+ + + R F D SS + ++ S+ S+
Sbjct: 26 FNPPDNYLISCGS--SQNITFQN-RIFVPDSLHSSLV-----LKIGNSSVATSTTSNN-- 75
Query: 74 SAYPLYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLH 133
S +Y++AR+F+ + YRF I+ G HW+RLHF P+ +S+ LT A TV T+ FVLL+
Sbjct: 76 STNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLN 135
Query: 134 DFSIGNTT-SLVFKEYLINITGR-LSIIFKPHKDSHAFINAIEVVSAPGSIISDAASTVA 191
+FS N S +FKEY +N+T L++ F P +S F+NAIEVVS P ++I D A +
Sbjct: 136 NFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQALALN 195
Query: 192 PRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNV 251
P F+GLS AFE YRLN+GGPL+T +NDTL R W +D Y V+ P ++
Sbjct: 196 PSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVLVVTANPSSI 255
Query: 252 HYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKS 311
Y T APN VYA+A M +A V P+FN+TW + VDP F Y +R HFCDIVS++
Sbjct: 256 KYSPS-VTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQA 314
Query: 312 LNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQS 371
LN L+FN+Y+N+ +A SLDLS+LTN L Y+KDF+ N + + +TV VGP S Q+
Sbjct: 315 LNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGPDS--QA 372
Query: 372 SLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGV-GLLMG-VTAIVFL 429
+ NA +NGLEV+K+SNEA S G+ +V G +G+K K A + G L+G VT I+ +
Sbjct: 373 DITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAVTLILLI 432
Query: 430 GI------VFVRWQRRPHDWDKRKSFSSWL-LPLHXXXXXXXXXXXXXXXXXXXXXXXXX 482
+ V R QR + WL LPL+
Sbjct: 433 AVCCYCCLVASRKQRSTSPQEGGNGHP-WLPLPLYGLSQTLTKSTASHKSATASCIS--- 488
Query: 483 XXYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNP 542
++ LGR F F E+ +AT FDE++++GVGGFG+VY G LEDG KVA+KRGNP
Sbjct: 489 ------LASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNP 542
Query: 543 GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPP 602
SEQG+ EF+TEI+MLSKLRHRHLVSLIG+CDE+SEMILVYEYMANGP R HLYG + PP
Sbjct: 543 RSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPP 602
Query: 603 LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-M 661
LSWKQRLEICIG+ARGLHYLHTGA+Q IIHRDVKTTNILLDENLVAKVADFGLSK P +
Sbjct: 603 LSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSL 662
Query: 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
D+ +VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL EVLC RP +NP LPREQV++
Sbjct: 663 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNI 722
Query: 722 AEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781
AEWA+ +KG+L++I+D + + SL+K+ E AEKCLAEYGVDRP MGDVLWNLEY
Sbjct: 723 AEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEY 782
Query: 782 AMQLQEASTQIDHPEDKSANLI-----ALDKPCEN----LSREDL--AVAVSDNSEIAAG 830
A+QL+E S+ + P+D S N I A +P +N + R + D++E A
Sbjct: 783 ALQLEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATT 842
Query: 831 SSLFSPVGKVRG 842
S++FS + RG
Sbjct: 843 SAVFSQLVHPRG 854
|
|
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1147 (408.8 bits), Expect = 1.3e-189, Sum P(2) = 1.3e-189
Identities = 222/325 (68%), Positives = 263/325 (80%)
Query: 500 FTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLS 559
F +++AT NFDE+ IGVGGFGKVY G L DG KVA+KRGNP S+QG+ EF+TEI+MLS
Sbjct: 475 FAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLS 534
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
+ RHRHLVSLIG+CDE +EMIL+YEYM NG + HLYG+ P L+WKQRLEICIG+ARGL
Sbjct: 535 QFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGL 594
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDRGYVSTAVKGSFGYLD 678
HYLHTG ++ +IHRDVK+ NILLDEN +AKVADFGLSK P +D+ +VSTAVKGSFGYLD
Sbjct: 595 HYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLD 654
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738
PEYFRRQQLT+KSDVYSFGVVLFEVLCARPVI+P LPRE V+LAEWA++ +KG L++II
Sbjct: 655 PEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQII 714
Query: 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQID-HPED 797
D + I +SLRK+ E EKCLA+YGVDRP MGDVLWNLEYA+QLQEA ID PED
Sbjct: 715 DQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAV--IDGEPED 772
Query: 798 KSANLIA-LDKPCENLSREDLAVAV 821
S N+I L N S+ D +V V
Sbjct: 773 NSTNMIGELPPQINNFSQGDTSVNV 797
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 1.2e-186, Sum P(2) = 1.2e-186
Identities = 218/302 (72%), Positives = 250/302 (82%)
Query: 503 LQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR 562
++ AT +FDEN IGVGGFGKVY G L DG KVA+KR NP S+QG+ EF+TEI+MLS+ R
Sbjct: 475 VKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFR 534
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
HRHLVSLIG+CDE +EMILVYEYM NG + HLYG+ LSWKQRLEICIGSARGLHYL
Sbjct: 535 HRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYL 594
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEY 681
HTG A+ +IHRDVK+ NILLDENL+AKVADFGLSK P +D+ +VSTAVKGSFGYLDPEY
Sbjct: 595 HTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 654
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741
FRRQQLTEKSDVYSFGVV+FEVLCARPVI+P L RE V+LAEWA++ +KG LE IIDP
Sbjct: 655 FRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPS 714
Query: 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPEDKSAN 801
+ I +SLRK+ E EKCLA+YGVDRP MGDVLWNLEYA+QLQEA D PED S N
Sbjct: 715 LRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGD-PED-STN 772
Query: 802 LI 803
+I
Sbjct: 773 MI 774
|
|
| TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1740 (617.6 bits), Expect = 3.0e-179, P = 3.0e-179
Identities = 346/542 (63%), Positives = 403/542 (74%)
Query: 259 TPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSLNDLLFN 318
TP IAP VYA+A +M + + PNFN++W +PSF+YLIR HFCDIVSKSLNDL FN
Sbjct: 291 TPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFN 350
Query: 319 VYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSSLPNAIL 378
VYIN A S LDLS++ L+ YYKD V+NAT + + VQ+GP + NAIL
Sbjct: 351 VYINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLM-GPELQVQIGPMGE-DTGTKNAIL 408
Query: 379 NGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTAIVFLGIVFVRWQR 438
NG+EV+K+SN S DG F VDG G G K +VA G +M A + LG + +W++
Sbjct: 409 NGVEVLKMSNSVNSLDGEFGVDGRTTG-MG-KHGMVATAGFVMMFGAFIGLGAMVYKWKK 466
Query: 439 RPHDWDKRKSFSSWLLPLHXXXXXXXXXXXXXXXXXXXXXXXXXXXYSGLFSNQGLGRFF 498
RP DW KR SFSSWLLP+H Y+ S GLGR+F
Sbjct: 467 RPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNF---------YN---STLGLGRYF 514
Query: 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQML 558
+ +ELQ AT+NF+ + +IGVGGFG VYIG L+DG KVA+KRGNP SEQGI EFQTEIQML
Sbjct: 515 SLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQML 574
Query: 559 SKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARG 618
SKLRHRHLVSLIG+CDE SEMILVYE+M+NGPFRDHLYG N PL+WKQRLEICIGSARG
Sbjct: 575 SKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARG 634
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
LHYLHTG AQGIIHRDVK+TNILLDE LVAKVADFGLSK + +VSTAVKGSFGYLD
Sbjct: 635 LHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLD 694
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738
PEYFRRQQLT+KSDVYSFGVVL E LCARP INP+LPREQV+LAEWA+Q RKG+LEKII
Sbjct: 695 PEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 754
Query: 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPEDK 798
DP +A TI ES++K+ EAAEKCL +YGVDRP MGDVLWNLEYA+QLQEA TQ E +
Sbjct: 755 DPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETE 814
Query: 799 SA 800
+A
Sbjct: 815 NA 816
|
|
| TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
Identities = 336/536 (62%), Positives = 399/536 (74%)
Query: 257 GATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSLNDLL 316
G TP IAP VYA+ +M ++Q + PNFN+TW +PSF Y IR HFCDI+SKSLNDL
Sbjct: 288 GVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDLY 347
Query: 317 FNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSSLPNA 376
FNVYIN A S LDLS++ LS YYKD V+N+T + ++ + VQ+GP + NA
Sbjct: 348 FNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSE-LQVQIGPMGE-DTGKKNA 405
Query: 377 ILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIVAGVGLLMGVTAIVFLGIVFVRW 436
ILNG+EV+K+SN S DG F VDG + G K +VA G +M A V LG + +W
Sbjct: 406 ILNGVEVLKMSNSVNSLDGEFGVDGQ-RASMG-KQGMVATAGFVMMFGAFVGLGAMVYKW 463
Query: 437 QRRPHDWDKRKSFSSWLLPLHXXXXXXXXXXXXXXXXXXXXXXXXXXXYSGLFSNQ-GLG 495
++RP DW KR SFSSWLLP+H S L+++ GLG
Sbjct: 464 KKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHK-------------SNLYNSALGLG 510
Query: 496 RFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEI 555
R+F+ +ELQ T+NFD + +IGVGGFG VYIG ++DG +VAIKRGNP SEQGI EF TEI
Sbjct: 511 RYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEI 570
Query: 556 QMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGS 615
QMLSKLRHRHLVSLIG+CDE +EMILVYEYM+NGPFRDHLYG N PL+WKQRLEICIG+
Sbjct: 571 QMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGA 630
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
ARGLHYLHTG AQGIIHRDVK+TNILLDE LVAKVADFGLSK + +VSTAVKGSFG
Sbjct: 631 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFG 690
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735
YLDPEYFRRQQLT+KSDVYSFGVVL E LCARP INP+LPREQV+LAEWA+ +KG+LE
Sbjct: 691 YLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLE 750
Query: 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQ 791
KIIDP + + ES++K+ EAAEKCLA+YGVDRP MGDVLWNLEYA+QLQEA +Q
Sbjct: 751 KIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQ 806
|
|
| TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 1.7e-176, Sum P(2) = 1.7e-176
Identities = 208/300 (69%), Positives = 254/300 (84%)
Query: 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQML 558
+F ELQ+ T NFD + VIGVGGFG V+ G L+D KVA+KRG+PGS QG+ EF +EI +L
Sbjct: 478 SFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITIL 537
Query: 559 SKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARG 618
SK+RHRHLVSL+G+C+EQSEMILVYEYM GP + HLYG+ PPLSWKQRLE+CIG+ARG
Sbjct: 538 SKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARG 597
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP-MDRGYVSTAVKGSFGYL 677
LHYLHTG++QGIIHRD+K+TNILLD N VAKVADFGLS++ P +D +VST VKGSFGYL
Sbjct: 598 LHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYL 657
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737
DPEYFRRQQLT+KSDVYSFGVVLFEVLCARP ++P L REQV+LAEWA++ RKG+L++I
Sbjct: 658 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQI 717
Query: 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPED 797
+DP IA+ I SL+K+ E AEKC A+YGVDRP +GDVLWNLE+ +QLQE S ++ PE+
Sbjct: 718 VDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQE-SGPLNIPEE 776
|
|
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1611 (572.2 bits), Expect = 1.4e-165, P = 1.4e-165
Identities = 365/834 (43%), Positives = 495/834 (59%)
Query: 19 NYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETS-VDSIPVKAKSSPCPSAYP 77
++L+DCGS ++ + DGRT+ D LS + + D+I A +S S Y
Sbjct: 32 SFLVDCGSNATTEV---DGRTWVGD------LSPNKSVTLQGFDAIT--ASTSKGSSVYA 80
Query: 78 -LYRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFS 136
+Y++AR+F Y F G ++VRLHF P + + ++ F+V D L+ D +
Sbjct: 81 EIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDIN 140
Query: 137 IGN----------------TTSLVFKEYLINI-TGRLSIIFKPHKDSHAFINAIEVVSAP 179
I T S + KE+L+ G+L + F P K S F+NAIE+VS
Sbjct: 141 IAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVD 200
Query: 180 GSIISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDT-LSRTWLSDEAYNAFP 238
+ ++ + V + GL E YRLNVGGP + P D L RTW +D +Y
Sbjct: 201 DKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIE 260
Query: 239 EGSEAVSVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSY 298
V N+ Y +P +AP VY +A+ M +V++ FN++WK VDP+F Y
Sbjct: 261 NAGVEVK-NSSNITYALADDSP-VAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDY 318
Query: 299 LIRFHFCDIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDS 358
L+R HFC+++ N +F +YIN AA + D+ + + Y+D+ L+ + KND
Sbjct: 319 LVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDY-LDPVSSKNDV 377
Query: 359 ITVQVGPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDGTYKGDAGTKMKIV---A 415
+ +Q+GP S+ +S +A+L+GLE+ KLS G+ L D T + +KM+I+
Sbjct: 378 LWIQLGPDSSVGAS-GDALLSGLEIFKLSKN-GNLAHLIRFDSTGHSVSDSKMRIIWISV 435
Query: 416 GVGLLMGVTAIVFLGIVFVRW--QRRPHDWDKRKSFSSWLLPLHXXXXXXXXXXXXXXXX 473
G G+ + + VFLGI+ V +RR + + + W PL
Sbjct: 436 GAGIAI-IIFFVFLGILVVCLCKKRRSKSDESKNNPPGWR-PLFLHVNNSTANAKATGGS 493
Query: 474 XXXXXXXXXXXYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGN 533
+GR FT E++ AT+NFD+ IGVGGFGKVY G LEDG
Sbjct: 494 LRLNTLAAST----------MGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGT 543
Query: 534 KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD 593
+AIKR P S+QG+ EF+TEI MLS+LRHRHLVSLIGFCDE +EMILVYEYMANG R
Sbjct: 544 LIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRS 603
Query: 594 HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653
HL+G+N PPLSWKQRLE CIGSARGLHYLHTG+ +GIIHRDVKTTNILLDEN VAK++DF
Sbjct: 604 HLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDF 663
Query: 654 GLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINP 712
GLSKA P MD +VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE +CAR VINP
Sbjct: 664 GLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINP 723
Query: 713 KLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGM 772
LP++Q++LAEWAL ++ LE IID + ESL KY E AEKCLA+ G +RP M
Sbjct: 724 TLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMM 783
Query: 773 GDVLWNLEYAMQLQEASTQIDHPEDKSANLIALDKPCENLSREDLAVAVSDNSE 826
G+VLW+LEY +Q+ EA + + E+ ++ A+++ E+ + A + D+SE
Sbjct: 784 GEVLWSLEYVLQIHEAWLRKQNGENSFSSSQAVEEAPESFTLP--ACSNQDSSE 835
|
|
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1485 (527.8 bits), Expect = 3.2e-152, P = 3.2e-152
Identities = 341/799 (42%), Positives = 457/799 (57%)
Query: 22 IDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPLYRS 81
I G+SE D + ++ D + +L T + P + S P Y +
Sbjct: 30 ISLSCGASEPAVDQDKKKWEPD---TKFLKTPNTVHA-----PATYQDPSLLSTVP-YMT 80
Query: 82 ARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIGNTT 141
+RIFT + Y + H +RLHFYP ++ + + D+ F+V + LL +FS T
Sbjct: 81 SRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDLTLLSNFSAAITC 140
Query: 142 SLVFKEYLINITGR-------LSIIFKP---HKDSHAFINAIEVVSAPGSIISDAASTVA 191
+ + YL+ LSIIF P H + AFIN IEV+ P + D AS V
Sbjct: 141 QALTQAYLVREYSLAPSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMPE--LFDTASLVG 198
Query: 192 PRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDT--LSRTWLSDEAYNAFPEGSEAVSVEPK 249
D + + +RLNVGG + D+ L+RTW +D Y F G V+++
Sbjct: 199 FSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLTRTWYNDAPY-IFSAGL-GVTLQAS 256
Query: 250 NVHYPDGGATPY-IAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIV 308
N D P AP VY +A+ + NLTW VD +F+Y++R HFC+
Sbjct: 257 NNFRIDYQKMPVSTAPADVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQ 316
Query: 309 SKSLNDLLFNVYINEFMA---ASSLDLSSLTNALSTAYYKDFVLNA---TAVKNDSITVQ 362
+N +FN++IN A + D+ T YKD+ + T + I++Q
Sbjct: 317 LAKINQKVFNIFINNRTAQGDTNPADILGWTGGKGIPTYKDYAIYVDANTGGGGEEISLQ 376
Query: 363 VGPASNAQSSLPNAILNGLEVIKLS---NEAGSF---DGLFAVDGTYKGDAGTKMKIVAG 416
+ P++ Q ++ LNGLE+ K+ N AG + A + K G K
Sbjct: 377 MTPSTFGQPEYYDSQLNGLEIFKIDTMKNLAGPNPKPSPMQANEDVKKDFQGDKRITAFV 436
Query: 417 VGLLMGVTAIVFLGIVFVRWQRRPHDWDKRKSFSSWLLPLHXXXXXXXXXXXXXXXXXXX 476
+G GV A++F + F +QR+ SSWL P++
Sbjct: 437 IGSAGGVAAVLFCALCFTMYQRKRKFSGSDSHTSSWL-PIYGNSHTSATKSTISGKSNNG 495
Query: 477 XXXXXXXXYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVA 536
S L + GL R F+ +E+++ T NFDE+ VIGVGGFGKVY GV++ G KVA
Sbjct: 496 SHL------SNLAA--GLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVA 547
Query: 537 IKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLY 596
IK+ NP SEQG+NEF+TEI++LS+LRH+HLVSLIG+CDE EM L+Y+YM+ G R+HLY
Sbjct: 548 IKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLY 607
Query: 597 GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
T +P L+WK+RLEI IG+ARGLHYLHTGA IIHRDVKTTNILLDEN VAKV+DFGLS
Sbjct: 608 NTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLS 667
Query: 657 KAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP 715
K P M+ G+V+T VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP +NP L
Sbjct: 668 KTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLS 727
Query: 716 REQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDV 775
+EQVSL +WA+ C RKG LE IIDP + I E L+K+ + AEKCL++ G+DRP MGDV
Sbjct: 728 KEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDV 787
Query: 776 LWNLEYAMQLQEASTQIDH 794
LWNLE+A+QLQE + H
Sbjct: 788 LWNLEFALQLQETADGSRH 806
|
|
| TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1474 (523.9 bits), Expect = 4.7e-151, P = 4.7e-151
Identities = 350/819 (42%), Positives = 473/819 (57%)
Query: 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETS--------VDSIP- 64
YSP + L++CG G+S T D+ R + SD +S S+ ED +TS V +P
Sbjct: 30 YSPTEKILLNCGGGASNLTDTDN-RIWISDVKSKFLSSSSEDSKTSPALTQDPSVPEVPY 88
Query: 65 --VKAKSSPCPSAYPLYRSARIFTGESRYRFFI-SQPGPHWVRLHFYPVPHSSIKLTDAV 121
+ SP +P+ S R F R F+ S G + + V L
Sbjct: 89 MTARVFRSPFTYTFPV-ASGRKFV---RLYFYPNSYDGLNATN-SLFSVSFGPYTLLKNF 143
Query: 122 FTVQTDKFVLLHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHK---DSHAFINAIEVVS 177
QT + + T + + KE+++N+ G L++ F P +++AF+N IEV S
Sbjct: 144 SASQTAEAL---------TYAFIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTS 194
Query: 178 APGSIIS-DAASTVAPRDTFTGLSNF-AFEVSYRLNVGGPLVTPKNDT-LSRTWLSDEAY 234
P S D T+ + N A E YRLNVGG ++P DT L R+W D+ Y
Sbjct: 195 MPDMYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPY 254
Query: 235 NAFPEG-SEAVSVEPK-NVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSV 292
F G + +P + YP G T Y+AP VY++A+ M + N+NLTW S+
Sbjct: 255 -IFGAGLGIPETADPNMTIKYPTGTPT-YVAPVDVYSTARSMGPTAQINLNYNLTWIFSI 312
Query: 293 DPSFSYLIRFHFCDIVSK--SLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLN 350
D F+YL+R HFC++ S +N +F +Y+N A D+ + T++ ++KD+V+N
Sbjct: 313 DSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVN 372
Query: 351 ATAVKNDS-ITVQVGPASNAQSSLPNAILNGLEVIKLSNEAGSFDGLFAVDG-------- 401
+ + + P + +++LNG+E+ K++ G+ G + G
Sbjct: 373 PPEGNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPS 432
Query: 402 ------TYKGDAGTKMKIVAGVGLLMGVTAIVFLGIVFVRWQRRPH-DWDKRKSFSSWLL 454
T K + T I+AG V A++ VF ++RR D+ +S L
Sbjct: 433 KVLRPTTRKSKSNTA--IIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWL 490
Query: 455 PLHXXXXXXXXXXXXXXXXXXXXXXXXXXXYSGLFSNQGLGRFFTFTELQNATQNFDENA 514
PL S L SN L R F+F E++ AT+NFDE+
Sbjct: 491 PLSLYGNSHSAGSAKTNTTGSYA--------SSLPSN--LCRHFSFAEIKAATKNFDESR 540
Query: 515 VIGVGGFGKVYIGVLEDGN-KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
V+GVGGFGKVY G ++ G KVAIKRGNP SEQG++EFQTEI+MLSKLRHRHLVSLIG+C
Sbjct: 541 VLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 600
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+E EMILVY+YMA+G R+HLY T P L WKQRLEICIG+ARGLHYLHTGA IIHR
Sbjct: 601 EENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 660
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
DVKTTNILLDE VAKV+DFGLSK P +D +VST VKGSFGYLDPEYFRRQQLTEKSD
Sbjct: 661 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 720
Query: 693 VYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLR 752
VYSFGVVLFE LCARP +NP L +EQVSLAEWA C++KG+L++I+DP + I E +
Sbjct: 721 VYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFK 780
Query: 753 KYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQ 791
K+ E A KC+ + G++RP MGDVLWNLE+A+QLQE++ +
Sbjct: 781 KFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEE 819
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FLJ8 | Y5613_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6897 | 0.9406 | 0.9406 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.129.121.1 | hypothetical protein (776 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 842 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 9e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 5e-55
Identities = 76/202 (37%), Positives = 109/202 (53%), Gaps = 12/202 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FG+VY G L+ VA+K SEQ I EF E +++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L+G C E+ + +V EYM G +L N+P LS L + ARG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE---SK 121
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
IHRD+ N L+ ENLV K++DFGLS+ D Y K ++ PE + + T
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 689 EKSDVYSFGVVLFEV--LCARP 708
KSDV+SFGV+L+E+ L +P
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 75/202 (37%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FG+VY G L+ VA+K SEQ I EF E +++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L+G C E+ +++V EYM G D+L LS L + ARG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
IHRD+ N L+ ENLV K++DFGLS+ D Y K ++ PE + + T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 689 EKSDVYSFGVVLFEV--LCARP 708
KSDV+SFGV+L+E+ L P
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 6e-52
Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKR-GNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FG+VY G L+ + VA+K SE+ +F E +++ KL H ++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL-------YGTNQPPLSWKQRLEICIGSARGLHYL 622
+G C E+ + LV EYM G D+L + LS K L I A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-----VKGSFGYL 677
++ +HRD+ N L+ E+LV K++DFGLS+ D Y ++ ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WM 174
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 708
PE + T KSDV+SFGV+L+E+ L A P
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 515 VIGVGGFGKVYIGVL-----EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FG+VY G L KVA+K G SE+ EF E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L+G C + + +V EYM G D L + L+ K L++ + A+G+ YL ++
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-----VKGSFGYLDPEYFR 683
+HRD+ N L+ ENLV K++DFGLS+ D Y +K ++ PE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLK 177
Query: 684 RQQLTEKSDVYSFGVVLFEVLC 705
+ T KSDV+SFGV+L+E+
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 78/191 (40%), Positives = 108/191 (56%), Gaps = 9/191 (4%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G GGFG VY+ + G KVAIK S + E EI++L KL H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
++++ + LV EY G +D L N+ LS + L I + GL YLH + GIIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 634 DVKTTNILLDE-NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ-LTEKS 691
D+K NILLD N K+ADFGLSK D+ + T V G+ Y+ PE + +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 692 DVYSFGVVLFE 702
D++S GV+L+E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-49
Identities = 88/381 (23%), Positives = 146/381 (38%), Gaps = 62/381 (16%)
Query: 22 IDCGSGSSEQ-TSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPLYR 80
IDCG S+E T G T+ SD + ++ T + S ++ Y+
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSD---AGFIDTGKSGNISKENSS--------SFLSKPYK 49
Query: 81 SARIFTGESR--YRFFISQPG--PHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFS 136
+ R F R Y ++ + +R F + L D L +
Sbjct: 50 TLRSFPDGKRNCYTLPVTPGKGTKYLIRATFLYGNYDG--LNSVSSPPSFD---LYLGVN 104
Query: 137 I-------GNTTSLVFKEYLINIT--GRLSIIFKPHKDSHAFINAIEVVSAPGSIISDAA 187
+ ++ V KEY+I++T LS+ FI+A+E+ P S+
Sbjct: 105 LWTTVNLSNDSGDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLY---- 160
Query: 188 STVAPRDTFTGLSNFAFEVSYRLNVG--GPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVS 245
+ + A ++ RLN G + +D R W E + + P S+ +
Sbjct: 161 --------PSSGGSQALKLVARLNFGGSEGTIRYPDDVYDRIW---EPFFSSPGWSQIST 209
Query: 246 VEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFC 305
++ PYI P+ V +A A N TW + VDP+F Y + HF
Sbjct: 210 SLSVDI---SSNNAPYIPPSAVLQTAVTPTNAS---APLNFTWDL-VDPNFEYYVYLHFA 262
Query: 306 DIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGP 365
+I SL F++YIN + L + A Y DF +N + + + + P
Sbjct: 263 EIQ--SLETREFDIYINGKTVYGDVSPKYLG-TDTGALYLDFPVNVSG--GGLLNISLVP 317
Query: 366 ASNAQSSLPNAILNGLEVIKL 386
S S+LP +LN LE+ K+
Sbjct: 318 TSG--STLP-PLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 86/267 (32%), Positives = 130/267 (48%), Gaps = 22/267 (8%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---EIQMLSKLRHRHLVSLI 570
+G G FG VY G VA+K + + QT EI++L +L H ++V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
+++ + LV EY G D+L + PLS + +I + RGL YLH + GI
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE-YFRRQQLTE 689
IHRD+K NILLDEN V K+ADFGL+K ++T V G+ Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178
Query: 690 KSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749
K DV+S GV+L+E+L +P + + +Q LQ R+ + + + E
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQ-------LQLIRRILGPPLEFDEPKWSSGSE 231
Query: 750 SLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ + +KCL + RP ++L
Sbjct: 232 EAKDLI---KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINE-FQTEIQMLSKLRHRHLVSLIGF 572
+G G FGKVY+ + G VAIK + E EI++L KL+H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+++ ++ LV EY G D L + LS + L YLH ++GI+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
RD+K NILLDE+ K+ADFGL++ +D G T G+ Y+ PE + + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 693 VYSFGVVLFEVLCARP 708
++S GV+L+E+L +P
Sbjct: 179 IWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 23/207 (11%)
Query: 515 VIGVGGFGKVYIGVLED-GNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
++G G FG VY+ + +D G +A+K + SE+ + + EI++LS L+H ++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 572 FC-DEQSEMILVY-EYMANGPFRDHL--YGTNQPPL--SW-KQRLEICIGSARGLHYLHT 624
DE+ + ++ EY++ G L +G P+ + +Q LE GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GLAYLH- 118
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTAVKGSFGYLDPEYF 682
+ GI+HRD+K NIL+D + V K+ADFG +K + V+G+ ++ PE
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMAPEVI 175
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPV 709
R ++ +D++S G + E+ +P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 71/209 (33%), Positives = 113/209 (54%), Gaps = 13/209 (6%)
Query: 514 AVIGVGGFGKVYIGVLEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
A IG G FG V +G G KVA+K + + + Q F E +++ LRH +LV L+G
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLG 67
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ + + +V EYMA G D+L + ++ Q+L + G+ YL + +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
HRD+ N+L+ E+LVAKV+DFGL+K A + VK + PE R ++ + KS
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----WTAPEALREKKFSTKS 180
Query: 692 DVYSFGVVLFEVLCARPVINPKLPREQVS 720
DV+SFG++L+E+ V P++P + V
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 516 IGVGGFGKVYIGVLE-----DGNKVAIKRGNP-GSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FGKV + + G +VA+K N G EQ ++F+ EI++L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 570 IGFCDEQSEMI--LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
G C++ L+ EY+ +G RD+L ++ ++ K+ L +G+ YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGS--- 127
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS---FGYLDPEYFRR 684
Q IHRD+ NIL++ + K++DFGL+K P D+ Y G F Y PE R
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 685 QQLTEKSDVYSFGVVLFEVL 704
+ + SDV+SFGV L+E+
Sbjct: 187 SKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 72/190 (37%), Positives = 106/190 (55%), Gaps = 9/190 (4%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG V++G + KVAIK G SE+ +F E Q++ KL H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
E+S + LV+E+M +G D+L + S + L +C+ G+ YL + +IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
D+ N L+ EN V KV+DFG+++ D+ ST K + PE F + + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 694 YSFGVVLFEV 703
+SFGV+++EV
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 4/188 (2%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V+ G+ ++ +VAIK +FQ E+Q L +LRH+HL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ ++ E M G L L +++ A G+ YL Q IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
NIL+ E+LV KVADFGL++ + Y+S+ K + + PE + KSDV+S
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189
Query: 696 FGVVLFEV 703
FG++L+E+
Sbjct: 190 FGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 65/189 (34%), Positives = 98/189 (51%), Gaps = 7/189 (3%)
Query: 515 VIGVGGFGKVYIG-VLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG GGFG+VY G +VAIK S++ + EIQ+L K +H ++V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
++ E+ +V E+ + G +D L TNQ L+ Q +C +GL YLH + GIIHR
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---SNGIIHR 122
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
D+K NILL + K+ DFGLS A + + G+ ++ PE + K+D+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 694 YSFGVVLFE 702
+S G+ E
Sbjct: 181 WSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+IG G FG VY G+ LE G+ VAIK+ + E+ + EI +L L+H ++V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 572 FCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLS---WKQRLEICIGSARGLHYLHTGA 626
+ + ++ EY NG R + +G L Q L+ GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLHE-- 117
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
QG+IHRD+K NIL ++ V K+ADFG++ ++ V G+ ++ PE
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSG 175
Query: 687 LTEKSDVYSFGVVLFEVLCARP 708
+ SD++S G + E+L P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
IG G FGKVY+ DG +K + SE+ + E+++L KL H +++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 572 FCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
+E+ ++ +V EY G + P +Q L+ + L YLH+ +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
I+HRD+K NI L N + K+ DFG+SK T V G+ YL PE + +
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYNY 182
Query: 690 KSDVYSFGVVLFEVLCARP 708
KSD++S G VL+E+ +
Sbjct: 183 KSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 35/215 (16%)
Query: 515 VIGVGGFGKVYIGVL------EDGNKVAIKRGNPGSEQGINE-FQTEIQMLSKLRHRHLV 567
+G G FGKV++G D VA+K + + F+ E ++L+ +H ++V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 568 SLIGFCDEQSEMILVYEYM----------ANGPFRDHLYGTNQP--PLSWKQRLEICIGS 615
G C E I+V+EYM ++GP L + P L+ Q L+I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST---AVKG 672
A G+ YL A+Q +HRD+ T N L+ +LV K+ DFG M R +T V G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFG------MSRDVYTTDYYRVGG 182
Query: 673 S----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 703
++ PE ++ T +SDV+SFGVVL+E+
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 63/189 (33%), Positives = 97/189 (51%), Gaps = 4/189 (2%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V+ G+ + VA+K PG+ +F E Q++ KLRH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + +V E M G ++L G L Q +++ A G+ YL AQ IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
N+L+ EN + KVADFGL++ D K + PE + + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 696 FGVVLFEVL 704
FG++L E++
Sbjct: 190 FGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 72/206 (34%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPG---SEQGINEFQTEIQMLSKLRHR 564
+F+ VIG G FGKV I D K+ A+K N + + E ++L +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 565 HLVSL-IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ-RLEIC-IGSARGLHY 621
LV+L F DE+ M LV + + G R HL + + S +Q + IC I A L Y
Sbjct: 61 FLVNLWYSFQDEE-NMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEY 115
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
LH+ +GIIHRD+K NILLDE + DF + A + ++T+ G+ GY+ PE
Sbjct: 116 LHS---KGIIHRDIKPDNILLDEQGHVHITDFNI--ATKVTPDTLTTSTSGTPGYMAPEV 170
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCAR 707
RQ + D +S GV +E L +
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G FG V++G VAIK G SE ++F E +++ KL H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+Q + +V EYMANG ++L + L + L++C + YL + G IHR
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHR 124
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
D+ N L+ E+ V KV+DFGL++ D+ S K + PE F + + KSDV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 694 YSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736
+SFGV+++EV K+P E+ S +E L +
Sbjct: 185 WSFGVLMWEVFSE-----GKMPYERFSNSEVVESVSAGYRLYR 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 69/189 (36%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++G KVA+K PG+ F E Q++ KLRH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + +V EYM+ G D L L Q +++ A G+ YL ++ IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVS-TAVKGSFGYLDPEYFRRQQLTEKSDVY 694
NIL+ ENLV K+ADFGL++ D Y + K + PE + T KSDV+
Sbjct: 130 AARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 695 SFGVVLFEV 703
SFG++L E+
Sbjct: 189 SFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIK-RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG-F 572
IG G FG V +G GNKVA+K N + Q F E ++++LRH +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+E+ + +V EYMA G D+L + L L+ + + YL A +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
RD+ N+L+ E+ VAKV+DFGL+K A + VK + PE R ++ + KSD
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSD 181
Query: 693 VYSFGVVLFEVLCARPVINPKLPREQV 719
V+SFG++L+E+ V P++P + V
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG VY GVL+ +VA+K R + +F E ++L + H ++V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
++ + +V E + G L + L+ K+ L++ + +A G+ YL ++ IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG-SFGYLDPEYFRRQQLTEKSD 692
D+ N L+ EN V K++DFG+S+ VS +K + PE + T +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 693 VYSFGVVLFEVL----CARPVINPKLPREQV 719
V+S+G++L+E P ++ + RE++
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 513 NAVIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
VIG G FG+V G L+ K VAIK G S++ +F TE ++ + H +++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L G + ++++ EYM NG D N + Q + + G A G+ YL +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKA-APMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
+HRD+ NIL++ NLV KV+DFGLS+ + Y + K + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 687 LTEKSDVYSFGVVLFEVL 704
T SDV+SFG+V++EV+
Sbjct: 185 FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 75/237 (31%), Positives = 118/237 (49%), Gaps = 29/237 (12%)
Query: 516 IGVGGFGKVYIG----VLEDGNK--VAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FGKV++ +L + +K VA+K SE +FQ E ++L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLY-----------GTNQP--PLSWKQRLEICIGSA 616
G C E +++V+EYM +G L G + L+ Q L I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGSFG 675
G+ YL A+ +HRD+ T N L+ + LV K+ DFG+S+ D V
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732
++ PE ++ T +SD++SFGVVL+E+ K P Q+S E A++C +G
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTY-----GKQPWYQLSNTE-AIECITQG 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 72/208 (34%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINE---FQTEIQMLSKLRH-RHLVSLI 570
+G G FG+VY+ D VA+K E E F EIQ+L+ L H ++V L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 571 GFCDEQSEMILVYEYMANGPFRDHL-YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
F ++ + LV EY+ G D L + PLS + L I L YLH+ +G
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 630 IIHRDVKTTNILLDENL-VAKVADFGLSKAAPMDRG-----YVSTAVKGSFGYLDPEYFR 683
IIHRD+K NILLD + V K+ DFGL+K P + + G+ GY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 684 RQQL---TEKSDVYSFGVVLFEVLCARP 708
L + SD++S G+ L+E+L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 500 FTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQML 558
+ + + IG G G+VY G +VAIK+ Q EI ++
Sbjct: 11 IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIM 69
Query: 559 SKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARG 618
+H ++V E+ +V EYM G D + N ++ Q +C +G
Sbjct: 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ-NFVRMNEPQIAYVCREVLQG 128
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSF 674
L YLH +Q +IHRD+K+ NILL ++ K+ADFG L+K V T
Sbjct: 129 LEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY---- 181
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFE 702
++ PE +R+ K D++S G++ E
Sbjct: 182 -WMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 4e-26
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 516 IGVGGFGKVYIGVL------EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FGKV++ +D VA+K S+ +F E ++L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 570 IGFCDEQSEMILVYEYMANGP----FRDH-----LYGTNQPP--LSWKQRLEICIGSARG 618
G C E +I+V+EYM +G R H L P L+ Q L I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGSFGYL 677
+ YL A+Q +HRD+ T N L+ ENL+ K+ DFG+S+ D V ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
PE ++ T +SDV+S GVVL+E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 67/189 (35%), Positives = 98/189 (51%), Gaps = 7/189 (3%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG V G VAIK GS +EF E +++ KL H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
Q + +V EYM+NG ++L + Q LE+C G+ YL + + IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLES---KQFIHRDL 126
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVST-AVKGSFGYLDPEYFRRQQLTEKSDVY 694
N L+D+ KV+DFGLS+ +D Y S+ K + PE + + KSDV+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 695 SFGVVLFEV 703
+FGV+++EV
Sbjct: 186 AFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FG+V+ G+L+ + VAIK PG +E+ +F +E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
G + +++ EYM NG D + S Q + + G A G+ YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMD--RGYVSTAVKGSFGYLDPEYFRRQQL 687
+HRD+ NIL++ NL KV+DFGLS+ D Y ++ K + PE ++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 688 TEKSDVYSFGVVLFEVL 704
T SDV+SFG+V++EV+
Sbjct: 188 TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 516 IGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI- 570
+G G FGKV + +D K+ +K+ + + TE +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
F E+ + LV EY G HL + + I A L YLH + GI
Sbjct: 61 AFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA--LEYLH---SLGI 114
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
I+RD+K NILLD + K+ DFGL+K + +T G+ YL PE + +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKA 173
Query: 691 SDVYSFGVVLFEVLCARP 708
D +S GV+L+E+L +P
Sbjct: 174 VDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 75/234 (32%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++G +VAIK PG+ F E Q++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + +V EYM+ G D L G L Q +++ A G+ Y+ +HRD+
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
+ NIL+ ENLV KVADFGL++ + K + PE + T KSDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 696 FGVVLFEVLCARPVINPKLPREQV------------------SLAEWALQCHRK 731
FG++L E+ V P + +V SL + QC RK
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 242
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL 566
+ FD +G G +G VY + E G VAIK E+ + E EI +L + ++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V G + +++ +V EY G D + TN+ L+ ++ I + +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLH--- 116
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
+ IHRD+K NILL+E AK+ADFG+S +T V G+ ++ PE +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 687 LTEKSDVYSFGVVLFEVLCARP 708
K+D++S G+ E+ +P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+IG G FG V G G KVA+K N + F E +++KL H++LV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ +V E M+ G + L + +S Q L+ + A G+ YL + + ++HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
D+ NIL+ E+ VAKV+DFGL++ M VK + PE + ++ + KSDV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFSSKSDV 180
Query: 694 YSFGVVLFEVLCARPVINPKLPREQVS 720
+S+GV+L+EV PK+ ++V
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 69/191 (36%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G FG V++G KVAIK N G SE+ +F E +++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+Q + +V E+M NG ++L Q LS L +C G+ YL IHR
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-VKGSFGYLDPEYFRRQQLTEKSD 692
D+ N L+ V KV+DFG+++ +D Y S++ K + PE F + + KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 693 VYSFGVVLFEV 703
V+SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR-----GNPGSEQGINEFQTEIQMLSKLR 562
N+ ++G G FG+VY+ ++ G ++A+K+ +P +++ +N + EIQ+L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 563 HRHLVSLIGFCDEQSEMILVY-EYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGL 619
H +V G C E + ++ EYM G +D L YG ++ K +I G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGYVSTAVKGSFGY 676
YLH+ I+HRD+K NIL D K+ DFG SK + + V G+ +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYW 173
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ PE + K+DV+S G + E+L +P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 4/207 (1%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++G + KVA+K PG+ + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + ++ EYMA G D L + + ++ A G+ Y+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
+ N+L+ E+L+ K+ADFGL++ + K + PE T KSDV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 696 FGVVLFEVLCARPVINPKLPREQVSLA 722
FG++L+E++ + P + V A
Sbjct: 190 FGILLYEIVTYGKIPYPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 17/225 (7%)
Query: 509 NFDENAVIGVGGFGKVYIG-----VLEDGNK-VAIKRGNPGSEQGI-NEFQTEIQMLSKL 561
N E +G G FG+V++ E G V +K ++ + +EF+ E+ M KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ-------PPLSWKQRLEICIG 614
H+++V L+G C E ++ EY G + L T PPLS KQ++ +C
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
A G+ +L +HRD+ N L+ KV+ LSK Y
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
+L PE + + KSDV+SFGV+++EV + L E+V
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 35/218 (16%)
Query: 516 IGVGGFGKVY----IGVL--EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
IG G FG+V+ G+L E VA+K S +FQ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHL--------------------YGTNQPPLSWKQR 608
L+G C M L++EYMA G + L G N PLS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGY 665
L I A G+ YL + + +HRD+ T N L+ EN+V K+ADFGLS+ +A +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 703
+ A+ ++ PE + T +SDV+++GVVL+E+
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 23/202 (11%)
Query: 516 IGVGGFGKVYI---GVLED--GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
+G G FG V + L+D G VA+K+ + + + +F+ EI++L L+H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 571 GFCDE--QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSARGLHYLHT 624
G C + + LV EY+ G RD+L ++ L ++ L +IC +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQIC----KGMEYL-- 124
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS---FGYLDPEY 681
++ +HRD+ T NIL++ K+ DFGL+K P D+ Y G F Y PE
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PES 182
Query: 682 FRRQQLTEKSDVYSFGVVLFEV 703
+ + SDV+SFGVVL+E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHL 566
V+G G FGKV + + N VA+K R +Q + ++ EI +L L H ++
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENI 68
Query: 567 VSLIGFCDEQSEMI--LVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSARGLH 620
V G C EQ L+ EY+ G RD+L L+ Q L +IC G+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQIC----EGMA 121
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS---FGYL 677
YLH +Q IHRD+ N+LLD + + K+ DFGL+KA P Y G F Y
Sbjct: 122 YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
E + + + SDV+SFGV L+E+L
Sbjct: 179 -VECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/201 (34%), Positives = 110/201 (54%), Gaps = 17/201 (8%)
Query: 515 VIGVGGFGKVYIGVL--EDGNKV--AIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FG VY G L DG K+ A+K N ++ + + +F E ++ H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 570 IGFC--DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
+G C E S ++ V YM +G R+ + P + K + + A+G+ YL A+
Sbjct: 62 LGICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS----TAVKGSFGYLDPEYFR 683
+ +HRD+ N +LDE+ KVADFGL++ D+ Y S T K ++ E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 684 RQQLTEKSDVYSFGVVLFEVL 704
Q+ T KSDV+SFGV+L+E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 67/212 (31%), Positives = 114/212 (53%), Gaps = 13/212 (6%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN-EFQTEIQMLSKLRHRHLVSLIGFC 573
++G G FG+V+ G L+D VA+K Q + +F +E ++L + H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
++ + +V E + G F L + L KQ ++ + +A G+ YL + + IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRG-YVSTAVKG-SFGYLDPEYFRRQQLTEKS 691
D+ N L+ EN V K++DFG+S+ D G Y S+ +K + PE + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 692 DVYSFGVVLFEV----LCARPVINPKLPREQV 719
DV+S+G++L+E +C P + + REQV
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 514 AVIGVGGFGKVYIGV---LEDGNK--VAIKR-GNPGSEQGINEFQTEIQMLSKLRHRHLV 567
V+G G FG VY GV + K VAIK S + E E +++ + H H+V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L+G C S++ L+ + M G D++ ++ + + L C+ A+G+ YL
Sbjct: 73 RLLGIC-LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLEE--- 127
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQ 686
+ ++HRD+ N+L+ K+ DFGL+K +D Y + K ++ E +
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 687 LTEKSDVYSFGVVLFEVLC--ARP 708
T KSDV+S+GV ++E++ A+P
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 5/204 (2%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++G KVAIK PG+ F E Q++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + +V E+M G D L + L Q +++ A G+ Y+ IHRD+
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
+ NIL+ +NLV K+ADFGL++ + K + PE + T KSDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 696 FGVVLFEVLCARPVINPKLPREQV 719
FG++L E++ V P + +V
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 23/234 (9%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++G KVA+K PG+ F E Q++ KLRH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + +V EYM+ G D L L +++ A G+ Y+ IHRD+
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
++ NIL+ + LV K+ADFGL++ + K + PE + T KSDV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 696 FGVVLFEVLCA----RPVINPKLPREQV--------------SLAEWALQCHRK 731
FG++L E++ P +N + EQV SL E LQC +K
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIGF 572
IG G +G VY G VAIK+ E EI++L +L H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+ ++ LV+E+M + L Q L +GL + H + GI+H
Sbjct: 67 FRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRG----YVSTAVKGSFGYLDPE-YFRRQQL 687
RD+K N+L++ V K+ADFGL+++ YV T Y PE +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
+ D++S G + E+L RP
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 516 IGVGGFGKVYIGVLEDGN----KVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLI 570
+G G FG V GV + +VA+K G EF E ++++L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
G C + ++LV E GP +L + + E+ A G+ YL + +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLES---KHF 116
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSFGYLDPEYFRRQQLT 688
+HRD+ N+LL AK++DFG+S+A Y +TA + + PE + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 689 EKSDVYSFGVVLFEVL 704
KSDV+S+GV L+E
Sbjct: 177 SKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 5/189 (2%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++G KVAIK GS F E ++ +L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ I + EYM NG D L L+ + +++ A G+ ++ + IHRD+
Sbjct: 73 EPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
+ NIL+ E L K+ADFGL++ + K + PE T KSDV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 696 FGVVLFEVL 704
FG++L E++
Sbjct: 189 FGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSE-----QGINEFQTEIQMLSKLRHRHLVSL 569
+G G FG VY G+ L+DG+ A+K + + + + + + EI +LSKL+H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPP---LSWKQRLEICIGSARGLHYLHT 624
+G E+ + + E + G L YG+ P L +Q L GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH- 119
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ +HRD+K NIL+D N V K+ADFG++K S KGS ++ PE +
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ 175
Query: 685 QQL-TEKSDVYSFGVVLFEVLCARP 708
Q +D++S G + E+ +P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 516 IGVGGFGKVYIGVL------EDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLVS 568
+G G FG VY G+ E +VAIK N + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGT--------NQPPLSWKQRLEICIGSARGLH 620
L+G ++V E MA G + +L P + ++ +++ A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL--- 677
YL AA+ +HRD+ N ++ E+L K+ DFG+++ D KG G L
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 678 --DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
PE + T KSDV+SFGVVL+E+ L +P L E+V
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNEEV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 516 IGVGGFGKVYIG------VLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FGKV++ +D VA+K + +FQ E ++L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL--YGTN-------QP-----PLSWKQRLEICIGS 615
G C + +I+V+EYM +G L +G + QP L Q L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGSF 674
A G+ YL A+Q +HRD+ T N L+ NL+ K+ DFG+S+ D V
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
++ PE ++ T +SDV+SFGV+L+E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 510 FDENAVIGVGGFGKVY-IGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHL 566
++ IG G FG V + DG + K + G +E+ + +E+ +L +L+H ++
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 567 VSLIG-FCDEQSEMI-LVYEYMANGPFRD------HLYGTNQP---PLSWKQRLEICIGS 615
V D ++ + +V EY G D + W+ ++ +
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGG---DLAQLIQKCKKERKYIEEEFIWRILTQLLLA- 117
Query: 616 ARGLHYLHTGAAQG--IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS 673
L+ H + G ++HRD+K NI LD N K+ DFGL+K D + T V G+
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 674 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPREQVSLAE 723
Y+ PE EKSD++S G +++E LCA P P R Q+ LA
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LCALSP---PFTARNQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 11/192 (5%)
Query: 516 IGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G +G+VY GV + VA+K + + + EF E ++ +++H +LV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
+ ++ E+M G D+L N+ ++ L + + + YL + IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS---FGYLDPEYFRRQQLTEKS 691
+ N L+ EN + KVADFGLS+ + G TA G+ + PE + + KS
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 692 DVYSFGVVLFEV 703
DV++FGV+L+E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FGKVY V L+ G +A+K R + I E E+++L L+H +LV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 573 CDEQSEMILVYEYMANGPFRDHL-YGTNQPPLSWKQRLEICIGS-----ARGLHYLHTGA 626
+ ++ + EY + G + L +G E I GL YLH+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD--------EHVIRVYTLQLLEGLAYLHS-- 117
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
GI+HRD+K NI LD N V K+ DFG L V + G+ Y+ PE
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVI 175
Query: 683 RRQQLTEK---SDVYSFGVVLFEVLCARP 708
+ +D++S G V+ E+ +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 36/215 (16%)
Query: 515 VIGVGGFGKVYIGVLE-DGNKV--AIKRGNP-GSEQGINEFQTEIQMLSKL-RHRHLVSL 569
VIG G FG+V +++ DG K+ AIK SE +F E+++L KL H ++++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL---------------YGTNQPPLSWKQRLEICIG 614
+G C+ + + + EY G D L +GT L+ +Q L+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT-ASTLTSQQLLQFASD 127
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
A G+ YL + + IHRD+ N+L+ ENL +K+ADFGLS+ VK +
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGE-------EVYVKKTM 177
Query: 675 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 704
G L + + L T KSDV+SFGV+L+E++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FG+V G L+ K VAIK G +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
G + +++V EYM NG D + + Q + + G A G+ YL + G
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMD--RGYVSTAVKGSFGYLDPEYFRRQQL 687
+HRD+ NIL++ NLV KV+DFGLS+ D Y + K + PE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 688 TEKSDVYSFGVVLFEVL 704
T SDV+S+G+V++EV+
Sbjct: 187 TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHL 566
+ + V+G G G VY G A+K+ + G E+ + E++ L ++
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLY---GTNQPPLSWKQRLEICIGSARGLHYLH 623
V G ++ E+ +V EYM G D L +P L+ I +GL YLH
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH 116
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
T IIHRD+K +N+L++ K+ADFG+SK +T V G+ Y+ PE +
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729
+ + +D++S G+ L E + P LP Q S + L
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK---FPFLPPGQPSF--FELMQA 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 516 IGVGGFGKVYIGVL------EDGNKVAIKRGNPGSEQGI-NEFQTEIQMLSKLRHRHLVS 568
+G G FGKVY G L VAIK +E + EF+ E +++S L+H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLEICIG 614
L+G C ++ +++EY+A+G + L T + L L I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS- 673
A G+ YL ++ +HRD+ N L+ E L K++DFGLS+ Y + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR-----DIYSADYYRVQS 184
Query: 674 -----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 703
++ PE + T +SD++SFGVVL+E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 515 VIGVGGFGKVYIGVL----EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVS 568
V+G G FG L ED + V K N SE+ + EI +LS L+H ++++
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 569 LIG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
F D+ + +I + EY G D + + L + Y+H
Sbjct: 64 YYNHFMDDNTLLIEM-EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--- 119
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
GI+HRD+KT NI L + + K+ DFG+SK + T V G+ Y+ PE + +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 688 TEKSDVYSFGVVLFEVLCAR 707
KSD+++ G VL+E+L +
Sbjct: 179 NFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 516 IGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGI--NEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FG V+ V + +V A+K+ + E E ++L+KL +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
++ ++ +V EY NG L PL Q I GL +LH+ + I+H
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILH 124
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
RD+K+ N+ LD K+ D G++K + + +T V G+ YL PE + EKSD
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKSD 183
Query: 693 VYSFGVVLFEVLC 705
V++ GVVL+E C
Sbjct: 184 VWALGVVLYE-CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 63/229 (27%), Positives = 121/229 (52%), Gaps = 28/229 (12%)
Query: 516 IGVGGFGKVY----IGVLEDGNK----VAIKR-GNPGSEQGINEFQTEIQMLSKL-RHRH 565
+G G FG+V +G+ +D K VA+K + +E+ +++ +E++M+ + +H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQP--------------PLSWKQRLEI 611
+++L+G C + + ++ EY + G R++L P +++K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK-AAPMDRGYVSTAV 670
ARG+ YL A+Q IHRD+ N+L+ EN V K+ADFGL++ +D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
+ ++ PE + T +SDV+SFGV+++E+ P +P E++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-VAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FG+VY + + N+ VAIK + +E I + Q EIQ LS+ R ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 573 CDEQSEMILVYEYMANGPFRDHL-YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ S++ ++ EY G D L G L I GL YLH +G I
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKI 120
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
HRD+K NILL E K+ADFG+S +T V F ++ PE ++ EK+
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF-WMAPEVIKQSGYDEKA 179
Query: 692 DVYSFGVVLFEVLCARP 708
D++S G+ E+ P
Sbjct: 180 DIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 71/225 (31%), Positives = 107/225 (47%), Gaps = 27/225 (12%)
Query: 515 VIGVGGFGKVYIGVL--EDGN----KVAIK-RGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+G G FG+VY G+ DG+ +VA+K SEQ ++F E ++SK H+++V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLY----GTNQP-PLSWKQRLEICIGSARGLHYL 622
LIG E+ ++ E MA G + L +P L+ K L A+G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 623 HTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSK---AAPMDR--GYVSTAVKGSF 674
IHRD+ N LL VAK+ADFG+++ A R G +K
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK--- 186
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
++ PE F T K+DV+SFGV+L+E+ + P ++V
Sbjct: 187 -WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 516 IGVGGFGKVYIGVLE-----DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FGKV + + G +VA+K P S I + + EI++L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 570 IGFCDEQ--SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
G C E + + L+ E++ +G +++L N+ ++ KQ+L+ + +G+ YL G+
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSFGYLDPEYFRRQ 685
Q +HRD+ N+L++ K+ DFGL+KA D+ Y V + + PE +
Sbjct: 129 Q-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 686 QLTEKSDVYSFGVVLFEVL 704
+ SDV+SFGV L+E+L
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 65/232 (28%), Positives = 118/232 (50%), Gaps = 38/232 (16%)
Query: 516 IGVGGFGKVYIGVLEDGNK------VAIK--RGNPGSEQGINEFQTEIQMLSKL-RHRHL 566
+G G FG+V + VA+K + + +E+ +++ +E++M+ + +H+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPP---------------LSWKQRLEI 611
++L+G C ++ + +V EY A+G RD L +PP L+ K +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671
ARG+ +L A++ IHRD+ N+L+ E+ V K+ADFGL++ D ++ K
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRK 190
Query: 672 GSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
+ G L PE + T +SDV+SFGV+L+E+ P +P E+
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 53/221 (23%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEF-QT---EIQMLSKLRHRHLVSLI 570
IG G +G+VY + G VA+K+ E F T EI++L KLRH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 571 GFC--DEQSEMILVYEYMANGPFRDH-LYG---TNQPPLS-------WKQRLEICIGSAR 617
+ + +V+EYM DH L G + + + KQ LE
Sbjct: 65 EIVTSKGKGSIYMVFEYM------DHDLTGLLDSPEVKFTESQIKCYMKQLLE------- 111
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTAVKGSFG 675
GL YLH+ GI+HRD+K +NIL++ + V K+ADFGL++ Y + + +
Sbjct: 112 GLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLW 166
Query: 676 YLDPE-------YFRRQQLTEKSDVYSFGVVLFEVLCARPV 709
Y PE Y + D++S G +L E+ +P+
Sbjct: 167 YRPPELLLGATRY------GPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FG+V G L+ K VAIK G +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
G + ++++ E+M NG D N + Q + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGYVST-AVKGSFGYLDPEYFRRQ 685
+HRD+ NIL++ NLV KV+DFGLS+ D Y S+ K + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 686 QLTEKSDVYSFGVVLFEVL 704
+ T SDV+S+G+V++EV+
Sbjct: 187 KFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 11/195 (5%)
Query: 516 IGVGGFGKVYIGV-LEDGNK---VAIKRGNPGSEQGI-NEFQTEIQMLSKLRHRHLVSLI 570
+G G FG V G G K VA+K I ++F E ++ L H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
G +++V E G D L + + A G+ YL + +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-YVSTA-VKGSFGYLDPEYFRRQQLT 688
IHRD+ NILL + K+ DFGL +A P + YV +K F + PE R + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 689 EKSDVYSFGVVLFEV 703
SDV+ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 44/239 (18%)
Query: 516 IGVGGFGKVYI------------GVLEDGNK-----VAIKRGNPG-SEQGINEFQTEIQM 557
+G G FG+V++ E+ N VA+K P S+ +F E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLY---------GTNQPPLSWKQR 608
LS+L ++ L+G C + ++ EYM NG L N LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
L + A G+ YL + +HRD+ T N L+ +N K+ADFG+S+ Y S
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-----YSSD 184
Query: 669 --AVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
V+G ++ E + T KSDV++FGV L+E+ LC L +QV
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 516 IGVGGFGKVYIG----VLEDGN---KVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRH 565
+G G FG+VY G +L G+ +VA+K +G E+ EF E ++S H +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYG----TNQPP-LSWKQRLEICIGSARGLH 620
+V L+G C ++ E M G +L PP L+ K+ L+IC+ A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 621 YLHTGAAQGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAAPMDRGY-VSTAVKGSF 674
YL IHRD+ N L+ E + V K+ DFGL++ Y
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
++ PE + T +SDV+SFGV+++E+L
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-VAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSL 569
+IG G F V + ++ NK AIK + E+ + + E ++L++L H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 570 IG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
F DE + V EY NG ++ L K L YLH ++
Sbjct: 68 YYTFQDE-ENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLH---SK 121
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG---------------- 672
GIIHRD+K NILLD+++ K+ DFG +K +D + KG
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAK--VLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 673 -SF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
SF G Y+ PE + + SD+++ G +++++L +P
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 513 NAVIGVGGFGKVYIGVLEDGN----KVAIKRGNPGSEQGINE-FQTEIQMLSKLRHRHLV 567
IG G FG VY GV VA+K + + E F E ++ + H H+V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
LIG E + +V E G R +L N+ L + + L YL +
Sbjct: 71 KLIGVITENP-VWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+ +HRD+ N+L+ K+ DFGLS+ + Y ++ K ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 688 TEKSDVYSFGVVLFEVL 704
T SDV+ FGV ++E+L
Sbjct: 186 TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 66/229 (28%), Positives = 123/229 (53%), Gaps = 28/229 (12%)
Query: 516 IGVGGFGKVY----IGVLEDG----NKVAIKR-GNPGSEQGINEFQTEIQMLSKL-RHRH 565
+G G FG+V IG+ ++ KVA+K + +E+ +++ +E++M+ + +H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHL-----------YGTNQPP---LSWKQRLEI 611
+++L+G C + + ++ EY + G R++L Y Q P LS+K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK-AAPMDRGYVSTAV 670
ARG+ YL A++ IHRD+ N+L+ E+ V K+ADFGL++ +D +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
+ ++ PE + T +SDV+SFGV+L+E+ P +P E++
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 66/230 (28%), Positives = 124/230 (53%), Gaps = 30/230 (13%)
Query: 516 IGVGGFGKVY----IGVLEDG-NK---VAIKR-GNPGSEQGINEFQTEIQMLSKL-RHRH 565
+G G FG+V IG+ +D NK VA+K + +++ +++ +E++M+ + +H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPP---------------LSWKQRLE 610
+++L+G C + + ++ EY + G R++L +PP L++K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRA-RRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK-AAPMDRGYVSTA 669
ARG+ YL A+Q IHRD+ N+L+ E+ V K+ADFGL++ +D +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
+ ++ PE + T +SDV+SFGV+L+E+ P +P E++
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIKR--GNPGSEQG-------INEFQTEIQMLSKLRH 563
A+IG G FG VY+G+ G +A+K+ S ++ EI +L +L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSW---KQRLEICIGSARG 618
++V +G + + + EY+ G L YG + L +Q L +G
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KG 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK-----AAPMDRGYVSTAVKGS 673
L+YLH +GIIHRD+K NIL+D K++DFG+SK + +++GS
Sbjct: 119 LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 674 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
++ PE ++ T K+D++S G ++ E+L
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 509 NFDENAVIGVGGFGKVYI------GVLEDGNKVAIKRGNPGSEQGINE-FQTEIQMLSKL 561
+ + +G G F Y G L +V R ++ + E + EI+++++L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGL 619
H H++ ++G E S L E+MA G L YG + + ++ RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGL 116
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSK--AAPMDR-GYVSTAVKGSFG 675
YLH IIHRDVK N+L+D ++ADFG + AA G + G+
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
++ PE R +Q DV+S G V+ E+ A+P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 516 IGVGGFGKVYIGVLEDGNK---VAIKRGNPGSEQGI-NEFQTEIQMLSKLRHRHLVSLIG 571
+G G FG V GV + K VAIK +E+ + +E E +++ +L + ++V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
C+ ++ M LV E + GP L G + ++ +E+ + G+ YL + +
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSFGYLDPEYFRRQQLTE 689
HRD+ N+LL AK++DFGLSKA D Y +A K + PE ++ +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 690 KSDVYSFGVVLFEVL 704
+SDV+S+G+ ++E
Sbjct: 178 RSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 496 RFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNK----VAIKR-GNPGSEQGIN 549
R TEL+ ++G G FG V+ G+ + +G+ VAIK + Q
Sbjct: 2 RILKETELRKLK-------LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 550 EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
E + + L H ++V L+G C + + LV + G DH+ ++ L ++ L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLL 112
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVST 668
C+ A+G++YL ++HR++ NILL + + ++ADFG++ P D+ Y +
Sbjct: 113 NWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
K ++ E + T +SDV+S+GV ++E++
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 33/214 (15%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKR--------GNPGSEQG--INEFQTEIQMLSKLRH 563
+IG G +G+VY+ + + G +A+K+ G S Q + ++EI+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLS---WKQRLEICIGSARG 618
++V +GF + + + EY+ G L YG + L +Q LE G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------G 120
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS---TAVKGSFG 675
L YLH+ +GI+HRD+K N+L+D + + K++DFG+SK + D Y + +++GS
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS--DDIYDNDQNMSMQGSVF 175
Query: 676 YLDPE--YFRRQQLTEKSDVYSFGVVLFEVLCAR 707
++ PE + Q + K D++S G V+ E+ R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 515 VIGVGGFGKVYIG-VLEDGNKV--AIKR-GNPGSEQGINEFQTEIQMLSKL-RHRHLVSL 569
VIG G FG+V + +DG ++ AIKR S+ +F E+++L KL H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGT--------------NQPPLSWKQRLEICIGS 615
+G C+ + + L EY +G D L + LS +Q L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
ARG+ YL + + IHRD+ NIL+ EN VAK+ADFGLS+ VK + G
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMG 183
Query: 676 YLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 704
L + + L T SDV+S+GV+L+E++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGVLED-GNKVAIKR-----GNPGSEQGINEFQTEIQMLSKLR 562
N+ ++G G FG+VY+ D G ++A+K+ +P + + +N + EIQ+L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 563 HRHLVSLIGFCDEQSEMIL--VYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARG 618
H +V G + E L E+M G +D L YG ++ K +I G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EG 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD--RGYVSTAVKGSFGY 676
+ YLH+ I+HRD+K NIL D K+ DFG SK G +V G+ +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ PE + K+D++S G + E+L +P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 53/148 (35%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 510 FDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
++ IG G +G VY + G VAIK Q EI ML + RH ++V+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
G + ++ +V EY G +D +Y + PLS Q +C + +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE---T 120
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLS 656
G IHRD+K NILL E+ K+ADFG+S
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 516 IGVGGFGKVY-IGVLEDGNKVAIKRGNPGS------EQGINEFQTEIQMLSKLRHRHLVS 568
+G G +G VY + L D A+K + GS E +NE I++L+ + H +++S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE----IRILASVNHPNIIS 63
Query: 569 LI-GFCDEQSEMILVYEYMANGPFRDHLYGTNQPP------LSWKQRLEICIGSARGLHY 621
F D + +V EY G + + W+ +++ RGL
Sbjct: 64 YKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQA 118
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
LH Q I+HRD+K+ NILL N + K+ D G+SK + ++ G+ Y+ PE
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEV 172
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARPVINPK 713
++ + + KSD++S G +L+E+ P +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 71/215 (33%), Positives = 107/215 (49%), Gaps = 36/215 (16%)
Query: 515 VIGVGGFGKVYIGVLE-DGNKV--AIKR-GNPGSEQGINEFQTEIQMLSKL-RHRHLVSL 569
VIG G FG+V ++ DG ++ AIKR S+ +F E+++L KL H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL---------------YGTNQPPLSWKQRLEICIG 614
+G C+ + + L EY +G D L T LS +Q L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSSQQLLHFAAD 120
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
ARG+ YL + + IHRD+ NIL+ EN VAK+ADFGLS+ VK +
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTM 170
Query: 675 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 704
G L + + L T SDV+S+GV+L+E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 5/189 (2%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
+G G FG+V++ KVA+K PGS + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+ + ++ E+MA G D L + ++ A G+ ++ + IHRD+
Sbjct: 73 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 128
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
+ NIL+ +LV K+ADFGL++ + K + PE T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 696 FGVVLFEVL 704
FG++L E++
Sbjct: 189 FGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 516 IGVGGFGKVYI-GVLEDGNKVAIKR-GNPGSEQGI-NEFQTEIQMLSKLRHRHLVSLIGF 572
IG G G V+ E G VA+K+ E GI N+ EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
S +LV EYM + + + PL Q +G+ Y+H A GI+H
Sbjct: 68 FPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMH 122
Query: 633 RDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTAVKGSFGYLDPE-YFRRQQLTE 689
RD+K N+L+ + V K+ADFGL++ + R Y S V + Y PE + ++
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAPELLYGARKYDP 180
Query: 690 KSDVYSFGVVLFEVLCARP 708
D+++ G + E+L P
Sbjct: 181 GVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 509 NFDENAVIGVGGFGKVYIGVLED-GNKVAIKR--GNPGSEQG---INEFQTEIQMLSKLR 562
N+ ++G G FG+VY+ D G ++A+K+ +P S++ +N + EIQ+L LR
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 563 HRHLVSLIGFC---DEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSAR 617
H +V G C E+ ++ + EYM G +D L YG ++ + +I +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM--DRGYVSTAVKGSFG 675
G+ YLH+ I+HRD+K NIL D K+ DFG SK G +V G+
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
++ PE + K+DV+S + E+L +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR-----GNPGSEQGINEFQTEIQMLSKLR 562
N+ ++G G FG+VY+ ++ G ++A K+ +P + + ++ + EIQ+L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARG 618
H +V G +++E + + EYM G +D L YG ++ K +I G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM--DRGYVSTAVKGSFGY 676
+ YLH+ I+HRD+K NIL D K+ DFG SK G +V G+ +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ PE + K+DV+S G + E+L +P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 20/243 (8%)
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC 612
+EI + KL+H ++V LIG C + L++EY+ + L LSW++R +I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 613 IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVK 671
IG A+ L +LH + ++ ++ I++D + L D + ++S+A
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA-- 843
Query: 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV--SLAEWALQCH 729
Y+ PE + +TEKSD+Y FG++L E+L + +P V S+ EWA C+
Sbjct: 844 ----YVAPETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCY 896
Query: 730 RKGILEKIIDPVIAE--TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787
L+ IDP I ++ + + + + A C A RP DVL LE A +
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
Query: 788 AST 790
+
Sbjct: 957 SCV 959
|
Length = 968 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRH 565
+++ V+G G FG V++ + K+ I + P ++ Q E Q+L L H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
++ E +++V EY G +++ L L + LH++HT
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT- 119
Query: 626 AAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ I+HRD+KT NILLD++ +V K+ DFG+SK + T V G+ Y+ PE
Sbjct: 120 --KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYISPELCEG 175
Query: 685 QQLTEKSDVYSFGVVLFEVL 704
+ +KSD+++ G VL+E+
Sbjct: 176 KPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 516 IGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI- 570
I G +G+V++ + + IK+ + + +++ TE +LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 571 GFCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
F + + LV EY+ G G+ ++ EI + L YLH +
Sbjct: 61 SFQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLH---SN 112
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR----GYVSTAVKGSFG---YLDPEY 681
GIIHRD+K NIL+D N K+ DFGLSK + R K G Y+ PE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
Q ++ D +S G +L+E L P + + P E
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
VIGVG VY + L + KVAIKR + + ++E + E+Q +S+ H ++V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 573 CDEQSEMILVYEYMANGPFRDHL-YGTNQPPLSWKQRLEICI-----GSARGLHYLHTGA 626
E+ LV Y++ G D + + L E I +GL YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-----EAIIATVLKEVLKGLEYLHS-- 120
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGY-VSTAVKGSFGYLDPEYFR 683
G IHRD+K NILL E+ K+ADFG+S A DR V G+ ++ PE
Sbjct: 121 -NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 684 RQQ-LTEKSDVYSFGVVLFE 702
+ K+D++SFG+ E
Sbjct: 180 QVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKR------GNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
V+G G +G VY G+ G +A+K+ +E+ + Q E+ +L L+H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
+G C + + + + E++ G L +G P+ K +I G+ YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL----DGVAYLHNNC 122
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS-----TAVKGSFGYLDPEY 681
++HRD+K N++L N + K+ DFG ++ + + ++ G+ ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARP 708
KSD++S G +FE+ +P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 5e-18
Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQT---EIQMLSKLRHRHLVSL 569
+G G +G VY + G VA+K R + E GI T EI +L +L+H ++V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-GIP--STALREISLLKELKHPNIVKL 63
Query: 570 IGFCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
+ + ++ LV+EY D PLS I RGL Y H +
Sbjct: 64 LDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
I+HRD+K NIL++ + V K+ADFGL++A
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 516 IGVGGFGKVYIGVL-----EDGNKVAIKR-GNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G FGK+Y G L + VAIK + + Q EFQ E ++++L H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLY---------------GTNQPPLSWKQRLEICIG 614
+G ++ + +++EY+ G + L GT + L L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGS 673
A G+ YL ++ +H+D+ NIL+ E L K++D GLS+ D V
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 674 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
++ PE + + SD++SFGVVL+E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGIN-EFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG+V+ G L D VA+K + +F E ++L + H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
++ + +V E + G F L T P L K+ +++ +A G+ YL + + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLES---KHCIHR 118
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA------VKGSFGYLDPEYFRRQQL 687
D+ N L+ E V K++DFG+S+ D Y ST VK + PE +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVK----WTAPEALNYGRY 173
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
+ +SDV+SFG++L+E V L +Q
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGN----PGSEQGINEFQTEIQMLSKLRH 563
++ IG G FGK+Y+ + D IK + P E+ + + E+ +L+K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKH 58
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
++V+ E + +V EY G + S Q L + + GL ++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 624 TGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
+ I+HRD+K+ NI L +N +VAK+ DFG+++ T V G+ YL PE
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCA 706
+ + K+D++S G VL+E LC
Sbjct: 175 QNRPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 516 IGVGGFGKVYIGVLEDGNKV-AIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+G GGFG+V ++ K+ A K+ + +G E ++L K+ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSARGLHYLHTGAA 627
+ + ++ LV M G + H+Y +P + + +I G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+ I++RD+K N+LLD++ +++D GL A + G G+ GY+ PE + +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGL--AVELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 688 TEKSDVYSFGVVLFEVLCAR 707
D ++ G L+E++ R
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 535 VAIKR-GNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANGPFR 592
VA+K + +++ + + +E++++ + +H+++++L+G C ++ + ++ EY A G R
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 593 DHLYGTNQP--------------PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTT 638
+ L P LS+K + ARG+ YL ++ IHRD+
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAAR 163
Query: 639 NILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRRQQLTEKSDVYSF 696
N+L+ E+ V K+ADFGL++ D Y G ++ PE + T +SDV+SF
Sbjct: 164 NVLVTEDNVMKIADFGLARGV-HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 697 GVVLFEVLCARPVINPKLPREQV 719
G++++E+ P +P E++
Sbjct: 223 GILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 515 VIGVGGFGKVY------IGVLEDGNKVAIKRGNPGSEQGINE-FQTEIQMLSKL-RHRHL 566
+G G FGKV + + KVA+K P + E +E++++S L H ++
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V+L+G C ++++ EY G + L + L+ + L A+G+ +L A
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS----FGYLDPEYF 682
++ IHRD+ N+LL + K+ DFGL++ D YV VKG+ ++ PE
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESI 215
Query: 683 RRQQLTEKSDVYSFGVVLFEV 703
T +SDV+S+G++L+E+
Sbjct: 216 FNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 515 VIGVGGFGKVYIGVL--EDGN--KVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
++G G FG V G L +DG+ KVA+K + + + I EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 569 LIGFCDEQSEM------ILVYEYMANGPFRDHLY----GTNQPPLSWKQRLEICIGSARG 618
LIG C E S + +++ +M +G L G L + L+ + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST-AVKGSFGYL 677
+ YL + IHRD+ N +L E++ VADFGLSK Y K ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
E + T KSDV++FGV ++E+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 502 ELQNATQNFDENAVIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQ 556
EL N + + ++G G FG++ G L+ +K VAI G S++ F E
Sbjct: 1 ELDNKSIKIER--ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA 616
L + H ++V L G + M++V EYM+NG D ++ L Q + + G A
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLA 117
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
G+ YL + G +H+ + +L++ +LV K++ F + + Y + + K +
Sbjct: 118 SGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
PE + + SDV+SFG+V++EV+
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 516 IGVGGFGKVYI----GVLE-----------DGNKVAIKRGNPG-SEQGINEFQTEIQMLS 559
+G G FG+V++ G+ E VA+K ++ N+F EI+++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL----------YGTNQPPLSWKQRL 609
+L++ +++ L+G C + ++ EYM NG L + N P +S L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
+ + A G+ YL A+ +HRD+ T N L+ + K+ADFG+S+ Y
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY---R 186
Query: 670 VKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LC 705
++G ++ E + T SDV++FGV L+E+ LC
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 516 IGVGGFGKVYIGV---LEDGNKVAIKRGNPGSEQGINEF---QTEIQMLSKLRHRHLVSL 569
+G G FG VY+ ++ + + P E NE E Q+LSKL H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
E+ ++ EY L LS Q E I G+HY+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+ I+HRD+K NI L NL+ K+ DFG+S+ M ++T G+ Y+ PE + Q
Sbjct: 125 RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 688 TEKSDVYSFGVVLFEVLC 705
KSD++S G +L+E+ C
Sbjct: 183 DSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 503 LQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL 561
L + T F+ VIG G +GKVY + G VAIK + ++ E + E +L K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 562 -RHRHLVSLIGF------CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE---- 610
H ++ + G ++ LV E G D + G +RL+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL----RKKGKRLKEEWI 115
Query: 611 --ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--GYV 666
I + RGL YLH +IHRD+K NILL +N K+ DFG+S A +D G
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRR 170
Query: 667 STAVKGSFGYLDPE-----YFRRQQLTEKSDVYSFGVVLFE 702
+T + G+ ++ PE +SDV+S G+ E
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FGKVY E G A K SE+ + +F EI +LS+ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
++++ ++ E+ G D + + L+ Q +C L++LH + +IHRD
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY-----FRRQQLTE 689
+K NILL + K+ADFG+S T + G+ ++ PE F+
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187
Query: 690 KSDVYSFGVVLFEVLCARP 708
K+D++S G+ L E+ P
Sbjct: 188 KADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ----GINEFQT---EIQMLSK 560
+++ +G G + VY E G VAIK+ G + GIN T EI++L +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQE 58
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWKQRLEICIGSARG 618
L+H +++ L+ +S + LV+E+M D + L+ + + RG
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTAVKGSFGY 676
L YLH + I+HRD+K N+L+ + V K+ADFGL++ +P + V + Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV--TRWY 168
Query: 677 LDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE F + D++S G + E+L P
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 516 IGVGGFGKVYIGVL------EDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FG VY G+ E +VAIK N S + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYG--------TNQPPLSWKQRLEICIGSARGLH 620
L+G + +++ E M G + +L Q P S K+ +++ A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG--SFGYLD 678
YL+ A +HRD+ N ++ E+ K+ DFG+++ + Y KG ++
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMS 189
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEV 703
PE + T SDV+SFGVVL+E+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 516 IGVGGFGKVYIGVLEDGNK-VAIKRGNPGSEQGINEFQ---TEIQMLSKLRHRHLVSLIG 571
IG G FG VY N+ VAIK+ + +Q ++Q E++ L +LRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ LV EY G D + ++ PL + IC G+ +GL YLH+ I
Sbjct: 83 CYLREHTAWLVMEYCL-GSASD-ILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERI 137
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY---FRRQQLT 688
HRD+K NILL E K+ADFG + +V T ++ PE Q
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPY-----WMAPEVILAMDEGQYD 192
Query: 689 EKSDVYSFGVVLFEVLCARP 708
K DV+S G+ E+ +P
Sbjct: 193 GKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 47/243 (19%)
Query: 554 EIQMLSKLRHRHLVSLIG-FCDEQSEMI-LVYEYMANGPFRDHLYG--------TNQPPL 603
E+++ + ++V G F DE S I + EY G D +Y + L
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL 107
Query: 604 SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663
+I +GL YLH+ + IIHRD+K +NILL K+ DFG+S
Sbjct: 108 -----GKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVS------- 152
Query: 664 GYVSTAVKGSFG----YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQ 718
G + ++ G+F Y+ PE + + + SDV+S G+ L EV R P P
Sbjct: 153 GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-- 210
Query: 719 VSLAEWALQCHRKGILEKIIDPVIAETI-CKESLRKYVEA----AEKCLAEYGVDRPGMG 773
+ E +L I++ E + K+ E ++CL + RP
Sbjct: 211 LGPIE---------LLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW 261
Query: 774 DVL 776
D+L
Sbjct: 262 DML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGS-------EQGINEFQTEIQMLS 559
+F+ +G G FG+V + + K A+K + E +NE ++L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE----KRILQ 56
Query: 560 KLRHRHLVSLIG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ--RLEICIGSA 616
+RH LV+L G F D+ + + LV EY+ G HL + + P + ++ +
Sbjct: 57 SIRHPFLVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA-- 113
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
L YLH+ I++RD+K N+LLD + K+ DFG +K R Y + G+ Y
Sbjct: 114 --LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTY---TLCGTPEY 164
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
L PE + + D ++ G++++E+L P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 514 AVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVS 568
V+G G FGKV + L+ +++ +K+ + + TE ++L+ +H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 569 LIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
L Q++ + V EY+ G H+ + + + I GL +LH
Sbjct: 61 L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE-- 114
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
+GII+RD+K N+LLD K+ADFG+ K + ST G+ Y+ PE Q
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQP 172
Query: 687 LTEKSDVYSFGVVLFEVLCARP 708
D ++ GV+L+E+L +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 516 IGVGGFGKVYIGVLED------GNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FG VY G D +VA+K N S + EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYG--------TNQPPLSWKQRLEICIGSARGLH 620
L+G + ++V E MA+G + +L +PP + ++ +++ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG--SFGYLD 678
YL+ A+ +HRD+ N ++ + K+ DFG+++ + Y KG ++
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
PE + T SD++SFGVVL+E+ L +P L EQV
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-16
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 530 EDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI--GFCDEQSEMILVYE 584
G++VAIK P E F+ E + ++L H ++V+L+ G + V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL-- 642
Y+ R+ L L + + + L H QGI+HRD+K NI++
Sbjct: 60 YVPGRTLREVL--AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 643 -DENLVAKVADFGLS------KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 695
AKV DFG+ + A + +T V G+ Y PE R + +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 696 FGVVLFEVLCARPV---------INPKLPREQVSLAEWALQCHRKG 732
+G++ E L + V + +L VSL W + H G
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPW-IAGHPLG 219
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 78/261 (29%), Positives = 121/261 (46%), Gaps = 47/261 (18%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIG 571
+G+G FG V G VAIK+ P S + + +T E+++L LRH +++SL
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK-RTYRELKLLKHLRHENIISLSD 76
Query: 572 -FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE------ICIGSARGLHYLHT 624
F ++ V E L GT+ L + LE RGL Y+H+
Sbjct: 77 IFISPLEDIYFVTE----------LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGSFGYLDPE-YF 682
G++HRD+K +NIL++EN K+ DFGL++ P GYVST Y PE
Sbjct: 127 A---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIML 178
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP-- 740
Q+ + D++S G + E+L +P+ K Q S+ I + + P
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI-----------ITDLLGTPPD 227
Query: 741 -VIAETICKESLRKYVEAAEK 760
VI TIC E+ ++V++ K
Sbjct: 228 DVI-NTICSENTLRFVQSLPK 247
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 516 IGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQ---TEIQMLSKLRHRHLVSLI- 570
+G GG+G+V++ +D G VA+KR +NE + TE +L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ-RLEIC--IGSARGLHYLHTGAA 627
F D++ + L EY+ G FR L N LS R + + LH L
Sbjct: 69 AFQDDEY-LYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHEL----- 120
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
G IHRD+K N L+D + K+ DFGLSK Y ++ V GS Y+ PE R +
Sbjct: 121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVLRGKGY 175
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
D +S G +L+E LC P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 516 IGVGGFGKVYIGVLE--DGNK-VAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
+G G FG V G+ + K VA+K + + +E E ++ +L + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
G C+ +S M LV E GP L ++ K E+ + G+ YL
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRRQQLT 688
+HRD+ N+LL AK++DFGLSKA D Y G + + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 689 EKSDVYSFGVVLFE 702
KSDV+SFGV+++E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 7e-16
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 71/232 (30%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---------EIQMLSKLRHR 564
IG G +G V V G KVAIK+ + N F EI++L LRH
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHE 59
Query: 565 HLVSLIGF-----CDEQSEMILVYEYM---------ANGPFR-DH----LYGTNQPPLSW 605
+++ L+ ++ +++ +V E M + P DH LY
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY--------- 110
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
Q L RGL YLH+ +IHRD+K +NIL++ N K+ DFGL+ RG
Sbjct: 111 -QIL-------RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA------RGV 153
Query: 666 VSTAVKGSF--GYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARP 708
+ F Y+ ++R + T+ D++S G + E+L +P
Sbjct: 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 510 FDENAVIGVGGFGKV-YIGVLEDGNKVAIKR-------GNPGSEQGINEFQTEIQMLSKL 561
F + V+G GGFG+V V G A KR G +NE Q+L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNE----KQILEKV 57
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSAR 617
+ +V+L + + + LV M G + H+Y P ++ L EI G
Sbjct: 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG--- 114
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP---MDRGYVSTAVKGSF 674
L LH + ++RD+K NILLD+ +++D GL+ P RG V G+
Sbjct: 115 -LEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTV 165
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
GY+ PE Q+ T D + G +++E++
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 519 GGFGKVYIGVL--EDGNK---VAIKR-GNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
G FG+++ G+L E K V +K + SE + E +L L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 573 CDEQSEMILV-YEYMANGPFRDHLY------GTNQPPLSWKQRLEICIGSARGLHYLHTG 625
C E E V Y YM G + L N LS +Q + + I A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGSFGYLDPEYFRR 684
+G+IH+D+ N ++DE L K+ D LS+ PMD + ++ E
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 685 QQLTEKSDVYSFGVVLFE 702
++ + SDV+SFGV+L+E
Sbjct: 194 KEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 515 VIGVGGFGKVYIGV------LEDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLV 567
+G G FGKV VA+K + + + +E +L ++ H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL----------------------YGTNQPPLSW 605
L G C + ++L+ EY G R L ++ L+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
+ +RG+ YL A ++HRD+ N+L+ E K++DFGLS+ + Y
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 666 VSTA-----VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
V + VK ++ E T +SDV+SFGV+L+E++
Sbjct: 184 VKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 58/197 (29%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKV----AIKRGNPGSEQGIN-EFQTEIQMLSKLRHRHLVS 568
V+G G FG VY G+ + +G V AIK N + N EF E +++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L+G C + + LV + M +G D+++ ++ + + L C+ A+G+ YL +
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEE---R 128
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPEYFRRQQL 687
++HRD+ N+L+ K+ DFGL++ D + Y + K ++ E ++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 688 TEKSDVYSFGVVLFEVL 704
T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGN----PGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
IG G G VY + + G +VAIK+ N P E INE I ++ + +H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE----ILVMRENKHPNIVNYL 82
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
E+ +V EY+A G D + T + Q +C + L +LH + +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQV 136
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
IHRD+K+ NILL + K+ DFG ++ ST V G+ ++ PE R+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 691 SDVYSFGVVLFEVLCARP 708
D++S G++ E++ P
Sbjct: 196 VDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 510 FDENAVIGVGGFGKV------YIGVLEDGNKVAIKR--GNPGSEQGINEFQTEIQMLSKL 561
F + V+G GGFG+V G + K+ KR G +NE Q+L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNE----KQILEKV 57
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSAR 617
R +VSL + + + LV M G + H+Y + + + EIC G
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG--- 114
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD---RGYVSTAVKGSF 674
L LH + I++RD+K NILLD++ +++D GL+ P +G V G+
Sbjct: 115 -LEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTV 165
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIN---PKLPREQV 719
GY+ PE + ++ T D ++ G +L+E++ + K+ RE+V
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 509 NFDENAVIGVGGFGKVYIG-VLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
D IG G G V I G +VA+K+ + +Q E+ ++ +H ++V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
+ E+ +V E++ G D + T ++ +Q +C+ + L +LH A
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLH---A 133
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
QG+IHRD+K+ +ILL + K++DFG +SK P + V T ++ PE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-----WMAPEVIS 188
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP 708
R + D++S G+++ E++ P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 68/251 (27%), Positives = 104/251 (41%), Gaps = 36/251 (14%)
Query: 516 IGVGGFGKVYIGVL-----EDGN----KVAIKRGNPGSEQGINE-FQTEIQMLSKLRHRH 565
+G G F +Y GVL D +V++ GS+ + F ++S+L H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLY-GTNQPPLSWKQRLEICIGSARGLHYLHT 624
LV L G C E I+V EY+ GP L+ N L WK L++ A LHYL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 625 GAAQGIIHRDVKTTNILLDEN-------LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677
+ ++H +V NIL+ K++D G+ P+ V+ ++
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVERI-PWI 171
Query: 678 DPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735
PE R Q LT +D +SFG L E+ N + P +S +E + L
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEPLSTLSSSEKERFYQDQHRLP 226
Query: 736 KIIDPVIAETI 746
+A I
Sbjct: 227 MPDCAELANLI 237
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 45/228 (19%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAI-------KRGNP-----------GSEQGINEFQTEIQM 557
+G G FG+V++ + + + ++G P ++ N+F E+++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL-------------YGTNQ---- 600
LS+L+ +++ L+G C ++ + ++ EYM NG L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 601 PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660
P +S+ L + + A G+ YL ++ +HRD+ T N L+ ENL K+ADFG+S+
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 661 MDRGYVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
Y ++G ++ E + T SDV++FGV L+E+L
Sbjct: 190 AGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 510 FDENAVIGVGGFGKVYIGV-LEDGNK----VAIKRGNPGSEQGIN-EFQTEIQMLSKLRH 563
F + V+G G FG VY G+ + +G K VAIK + N E E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
H+ L+G C S + L+ + M G D++ ++ + + L C+ A+G++YL
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPEYF 682
+ ++HRD+ N+L+ K+ DFGL+K D + Y + K ++ E
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 683 RRQQLTEKSDVYSFGVVLFEVL 704
+ T +SDV+S+GV ++E++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 37/219 (16%)
Query: 508 QNFDENAVIGVGGFGKVY-IGVLEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHR 564
++ V+G G +G V G VAIK + + E E+++L +LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRD-HLYGTNQPP-----LSWKQRLEICIGSARG 618
++V+L + + LV+EY+ PP W Q L +
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-QLL-------QA 112
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA--APMDRGYVSTAVKGSFGY 676
+ Y H + IIHRD+K NIL+ E+ V K+ DFG ++A A Y
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD--------Y 161
Query: 677 LDPEYFRRQQLTEKS-------DVYSFGVVLFEVLCARP 708
+ ++R +L DV++ G ++ E+L P
Sbjct: 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 69/249 (27%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKR--------GNPGSEQGINEFQTEIQMLSKLRHRHL 566
+G G FG+VY ++ G VA+K+ G P I + EI++L KL+H ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP-----ITALR-EIKILKKLKHPNV 69
Query: 567 VSLIGFCDEQSEMILVYE----------YMANGPFRDH-LYGTNQPP----------LSW 605
V LI +M + YM P+ DH L G + P
Sbjct: 70 VPLI-------DMAVERPDKSKRKRGSVYMVT-PYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL---------- 655
Q LE G++YLH I+HRD+K NIL+D + K+ADFGL
Sbjct: 122 LQLLE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 656 --SKAAPMDRGYVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARPVINP 712
R Y + V + Y PE ++ T D++ G V E+ RP++
Sbjct: 172 PKGGGGGGTRKYTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229
Query: 713 KLPREQVSL 721
K +Q+ L
Sbjct: 230 KSDIDQLHL 238
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 21/162 (12%)
Query: 510 FDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQT-EIQMLSKLR---H 563
++E A IG G +G VY L G VA+K+ P SE+GI EI +L +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 564 RHLVSLIGFC-----DEQSEMILVYEYMANGPFRD-HLYGTNQPP--LSWKQRLEICIGS 615
++V L+ C D + ++ LV+E++ +D Y + P L + ++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
RG+ +LH+ I+HRD+K NIL+ + K+ADFGL++
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 38/211 (18%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT--------EIQMLSKL-RHRH 565
+G G FG VY+ E G VAIK+ +F + E++ L KL H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGT----NQPPLSWKQRLEICIGSARGLHY 621
+V L E E+ V+EYM +LY P S I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGYVSTAVKGSFGYLD 678
+H G HRD+K N+L+ V K+ADFGL++ + P YVST Y
Sbjct: 115 IHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRA 166
Query: 679 PEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 708
PE R + D+++ G ++ E+ RP
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSK 560
+N ++F+ IG G +G VY + G AIK + PG + + Q EI M+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKD 62
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWKQRLEICIGSARG 618
+H ++V+ G + ++ + E+ G +D H+ G PLS Q + + +G
Sbjct: 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQG 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
L+YLH+ +G +HRD+K NILL +N K+ADFG+S
Sbjct: 119 LYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 516 IGVGGFGKVYIGVLEDGNKV-AIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG+V+ G+ KV AIK + +E I + Q EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQP-PLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+ +++ ++ EY+ G D L +P PL Q I +GL YLH+ + IH
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKIH 124
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
RD+K N+LL E+ K+ADFG++ D G+ ++ PE ++ K+D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 693 VYSFGVVLFEVLCARP 708
++S G+ E+ P
Sbjct: 184 IWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 60/262 (22%), Positives = 116/262 (44%), Gaps = 38/262 (14%)
Query: 531 DGNKVAI---KRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGF----CDEQSEMILVY 583
+ +V I K+ + G + I+ + EI+ L ++ +++ + GF D+ + L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD 643
EY G R+ L + LS+K +L++ I +GL+ L+ ++++ + + L+
Sbjct: 102 EYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVT 157
Query: 644 ENLVAKVADFGLSK---AAPMDRGYVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGV 698
EN K+ GL K + P V+ V Y + + T K D+YS GV
Sbjct: 158 ENYKLKIICHGLEKILSSPPFKN--VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 699 VLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAA 758
VL+E+ K+P E ++ K I + II+ + + + +
Sbjct: 211 VLWEIFTG------KIPFENLTT---------KEIYDLIINKNNSLKLPLDCPLEIKCIV 255
Query: 759 EKCLAEYGVDRPGMGDVLWNLE 780
E C + + RP + ++L+NL
Sbjct: 256 EACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL 566
+ D IG G G V I + G +VA+K+ + +Q E+ ++ H ++
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V + E+ +V E++ G D + T ++ +Q +C+ R L YLH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHN-- 136
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
QG+IHRD+K+ +ILL + K++DFG +SK P + V T ++ PE
Sbjct: 137 -QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY-----WMAPEVI 190
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARP 708
R + D++S G+++ E++ P
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 7/192 (3%)
Query: 516 IGVGGFGK-VYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FGK + + EDG + IK N S + E + E+ +LS ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+E + +V +Y G + Q L+ + L ++H + I+H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILH 124
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
RD+K+ NI L ++ K+ DFG+++ T + G+ YL PE + KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSD 183
Query: 693 VYSFGVVLFEVL 704
+++ G VL+E+
Sbjct: 184 IWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 516 IGVGGFGKVY------IGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G GGFG+V G L K+ KR +G E ++L+K+ R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK--KRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQ--PPLSWKQRLEICIGSARGLHYLHTGAA 627
++++ LV M G R H+Y ++ P + GL +LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLS----KAAPMDRGYVSTAVKGSFGYLDPEYFR 683
+ II+RD+K N+LLD + +++D GL+ +GY T G++ PE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP-----GFMAPELLQ 170
Query: 684 RQQLTEKSDVYSFGVVLFEVLCAR 707
++ D ++ GV L+E++ AR
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 515 VIGVGGFGKV-YIGVLEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSLI- 570
V+G G +G+V + DG + IK+ N S + + E Q+LS+L+H ++V+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
+ E + +V + G L L Q +E + A L YLH + I
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
+HRD+KT N+ L + KV D G+++ ST + G+ Y+ PE F + K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYK 182
Query: 691 SDVYSFGVVLFEVLCARPVINPK 713
SDV++ G ++E+ + N K
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAK 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 78/289 (26%)
Query: 505 NATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT-------EIQ 556
+ + + IG G +G V G KVAIK+ +P E QT EI+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP------FEHQTFCQRTLREIK 55
Query: 557 MLSKLRHRHLVSLI-----GFCDEQSEMILVYEYMANGPFR---------DH----LYGT 598
+L + +H +++ ++ + +++ +V E M ++ DH LY
Sbjct: 56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-- 113
Query: 599 NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
Q L RGL Y+H + ++HRD+K +N+LL+ N K+ DFGL++
Sbjct: 114 --------QIL-------RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
Query: 659 APMDRG-------YVSTAVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPVI 710
A + YV+T Y PE + K+ D++S G +L E+L RP+
Sbjct: 156 ADPEHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
Query: 711 NPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE--TICKESLRKYVEA 757
K Q++L IL + P + I R Y+++
Sbjct: 211 PGKDYLHQLNL-----------ILGVLGTPSQEDLNCIISLRARNYIKS 248
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 516 IGVGGFGKVYI-GVLEDGNKVAIKRGNPGS--EQGINE-FQTEIQMLSKLRHRHLVSLI- 570
+GVGGFG+V + V A+K E G E +E ++L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 571 GFCDEQSEMILVY---EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
F D++ +Y EY G L + C+ A YLH
Sbjct: 61 TFKDKKY----IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLH---N 111
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+GII+RD+K N+LLD N K+ DFG +K + G + G+ Y+ PE +
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKK--LKSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
D +S G++L+E+L RP
Sbjct: 170 DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 514 AVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQML---SKLRHRHL 566
AV+G G FGKV + + ++ A+K+G+ + + E ++ + RH L
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V+L + + V EY A G H++ T+ C+ GL YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACV--VLGLQYLHE-- 119
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
I++RD+K N+LLD K+ADFGL K M G ++ G+ +L PE
Sbjct: 120 -NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 687 LTEKSDVYSFGVVLFEVL 704
T D + GV+++E+L
Sbjct: 178 YTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 514 AVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINEFQTEIQMLSK------LRHRHL 566
V+G G FGKV + L+ N+ AIK + + + E M+ + H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALK--KDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 567 VSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL---EICIGSARGLHY 621
L FC Q++ + V EY+ G H+ + + + + R EI G L +
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARFYAAEIICG----LQF 111
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
LH +GII+RD+K N+LLD++ K+ADFG+ K G ST G+ Y+ PE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEI 167
Query: 682 FRRQQLTEKSDVYSFGVVLFEVL 704
+ Q+ E D +SFGV+L+E+L
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 510 FDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLV 567
F+ V+G G +G+VY G ++ G AIK + +E E + EI ML K HR++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 568 SLIGFCDEQS------EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
+ G ++S ++ LV E+ G D + T L IC RGL +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--GYVSTAVKGSFGYLDP 679
LH A +IHRD+K N+LL EN K+ DFG+S A +DR G +T + G+ ++ P
Sbjct: 137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWMAP 190
Query: 680 EYFRRQQLTE-----KSDVYSFGVVLFEVLCARP 708
E + + +SD++S G+ E+ P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 47/240 (19%)
Query: 510 FDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQG---INEFQTEIQMLSKLRHRH 565
FD IG G +G+VY +D G VA+K+ +E+ I + EI++L +L HR+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 566 LVSL----------IGFCDEQSEMILVYEYMANGPFRDH-LYGTNQPPLS---------- 604
+V+L + F ++ LV+EYM DH L G + L
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDHIKSF 121
Query: 605 WKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-- 662
KQ LE GL+Y H + +HRD+K +NILL+ K+ADFGL++ +
Sbjct: 122 MKQLLE-------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 663 RGYVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
R Y + + + Y PE ++ DV+S G +L E+ +P+ Q+ L
Sbjct: 172 RPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 76/270 (28%), Positives = 113/270 (41%), Gaps = 33/270 (12%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQ---TEIQMLSKLRHRHLVSLIG 571
IG G FG VY + + VAIK+ + +Q ++Q E++ L KLRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ LV EY G D L ++ PL + + G+ +GL YLH+ +I
Sbjct: 83 CYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY---FRRQQLT 688
HRDVK NILL E + K+ DFG + +V T ++ PE Q
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY-----WMAPEVILAMDEGQYD 192
Query: 689 EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748
K DV+S G+ E+ +P P +S Q P +
Sbjct: 193 GKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQNE---------SPALQSGHWS 240
Query: 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778
E R +V++ CL + DRP +VL
Sbjct: 241 EYFRNFVDS---CLQKIPQDRP-TSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-13
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 499 TFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN----PGSEQGINEFQT 553
T + + + + IG G G V+ + + G +VAIK+ N P E INE
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE--- 66
Query: 554 EIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICI 613
I ++ +L++ ++V+ + E+ +V EY+A G D + T + Q +C
Sbjct: 67 -ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCR 122
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS 673
+ L +LH A +IHRD+K+ N+LL + K+ DFG ++ ST V G+
Sbjct: 123 ECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 674 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
++ PE R+ K D++S G++ E++ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 515 VIGVGGFGKVYIGVL--EDGN--KVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
++G G FG V L EDG+ KVA+K + + S I EF E + + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 569 LIGFCDEQSEM------ILVYEYMANGPFRDHLY----GTNQPPLSWKQRLEICIGSARG 618
LIG +++ +M +G L G L + + I A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYL 677
+ YL +++ IHRD+ N +L+EN+ VADFGLSK Y A K +L
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
E T SDV++FGV ++E++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 516 IGVGGFGKVYIGVLEDGNK--VAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FG+VY G+ ++ K VAIK + +E I + Q EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQP-PLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ +++ ++ EY+ G D L +P PL I +GL YLH+ + I
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
HRD+K N+LL E K+ADFG++ + +T V F ++ PE ++ K+
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDFKA 182
Query: 692 DVYSFGVVLFEVLCARP 708
D++S G+ E+ P
Sbjct: 183 DIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 60/198 (30%), Positives = 82/198 (41%), Gaps = 25/198 (12%)
Query: 519 GGFGKVYIGVL---EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575
G G+V++ E KV +K G G EI +L + HR +++LI
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRW 157
Query: 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635
+S + +V F Y PL +Q + I L YLH +GIIHRDV
Sbjct: 158 KSTVCMVMPKYKCDLFT---YVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDV 211
Query: 636 KTTNILLDENLVAKVADFG------LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
KT NI LDE A + DFG P G+ T S PE
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS-----PELLALDPYCA 266
Query: 690 KSDVYSFGVVLFEVLCAR 707
K+D++S G+VLFE+
Sbjct: 267 KTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 516 IGVGGFGKVYIGVLEDGNK-VAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
IG G G V I ++ K VA+K+ + +Q E+ ++ +H ++V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
E+ +V E++ G D + T ++ +Q +C+ + L LH AQG+IHRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIHRD 141
Query: 635 VKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
+K+ +ILL + K++DFG +SK P + V T ++ PE R +
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-----WMAPELISRLPYGPE 196
Query: 691 SDVYSFGVVLFEVLCARP 708
D++S G+++ E++ P
Sbjct: 197 VDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 516 IGVGGFGKVY------------IGVLEDGNKVAIKR-GNPGSEQGINEFQTEIQMLSKLR 562
I G FG VY I VL+ + +A + N +E+ I Q E ++KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSW-KQRL-EICIGSARGLH 620
+ + + LV EY+ G + P W KQ + E+ +G +
Sbjct: 64 YSF--------QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG----VE 111
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
LH +GIIHRD+K N+L+D+ K+ DFGLS+ G + G+ YL PE
Sbjct: 112 DLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPE 163
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
+ SD +S G V+FE L P + + P
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSK 560
+N +++ +G G +G VY L G A+K + PG + + Q EI M+ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKE 62
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWKQRLEICIGSARG 618
+H ++V+ G + ++ + EY G +D H+ G PLS Q +C + +G
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQG 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
L YLH+ +G +HRD+K NILL +N K+ADFG++
Sbjct: 119 LAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSL 569
VIG G + KV + L+ +++ +K+ ++ I+ QTE + + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ--RLEICIGSARGLHYLHTGAA 627
S + LV EY+ G H+ + P + EICI L++LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLHE--- 114
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+GII+RD+K N+LLD + K+ D+G+ K + G ++ G+ Y+ PE R ++
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG-LGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738
D ++ GV++FE++ R + ++ ++ Q ILEK I
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----ILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 59/228 (25%)
Query: 515 VIGVGGFGKV-YIGVLEDGNKVAIK----RGNPGSEQGINEFQTEIQML------SKLR- 562
V+G G G V + DG A+K G SE N Q E+ L S ++
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 563 HRHLVSLIGFCDEQSE-----MILVYEYM--------------ANGPFRDHLYGTNQPPL 603
H D ++ + LV +Y N FR+H G L
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG-----L 147
Query: 604 SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663
+ Q L +H++H+ + +IHRD+K+ NILL N + K+ DFG SK M
Sbjct: 148 LFIQVL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSK---MYA 194
Query: 664 GYVSTAVKGSFG----YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
VS V +F Y+ PE +RR+ ++K+D++S GV+L+E+L +
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 515 VIGVGGFGKVYIGV-LEDGNK----VAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
V+G G FG VY G+ + DG VAIK R N S + E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L+G C S + LV + M G D++ N+ + + L C+ A+G+ YL
Sbjct: 73 RLLGIC-LTSTVQLVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQ 686
++HRD+ N+L+ K+ DFGL++ +D Y + K ++ E ++
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 687 LTEKSDVYSFGVVLFEVL 704
T +SDV+S+GV ++E++
Sbjct: 188 FTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 515 VIGVGGFGKVYIGVLEDGN-KVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
V+G G FG+ + + + K A+K P S + + + E +L+K++H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 573 CDEQSEMILVYEYMANGPF-------RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+ + +V EY G R L+ L W +++C+G + ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLF-PEDTILQW--FVQMCLG----VQHIHE- 118
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
+ ++HRD+K+ NI L +N K+ DFG ++ Y T V G+ Y+ PE +
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 686 QLTEKSDVYSFGVVLFEVLC 705
KSD++S G +L+E LC
Sbjct: 176 PYNNKSDIWSLGCILYE-LC 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLS-KLRHRHLVSL 569
++G G FGKV++ L+ N+ A+K+ + + E ++LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 570 IGFCDEQSE--MILVYEYMANGPFRDHLYGTNQ---PPLSWKQRLEICIGSARGLHYLHT 624
+C Q++ + V EY+ G H+ ++ P ++ IC GL +LH+
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS 114
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+GI++RD+K NILLD + K+ADFG+ K + T G+ Y+ PE
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 685 QQLTEKSDVYSFGVVLFEVL 704
Q+ D +SFGV+L+E+L
Sbjct: 171 QKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 516 IGVGGFGKVYIGVLEDGN---KVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLI 570
+G G FG V G L + KVA+K + + +F +E + + H +++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 571 GFCDEQSEM------ILVYEYMANGPFRDHLYGT---NQPPLSWKQRL-EICIGSARGLH 620
G C + E +++ +M +G L + + P Q L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV-KGSFGYLDP 679
YL + + IHRD+ N +L+EN+ VADFGLSK Y + K ++
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEV 703
E + T KSDV+SFGV ++E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 31/223 (13%)
Query: 502 ELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSK 560
E + E V+G G +G VY L ++AIK + + EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL------YGTNQPPLSW--KQRLEIC 612
L+HR++V +G E + E + G L N+ + + KQ LE
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-- 119
Query: 613 IGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSK----AAPMDRGYVS 667
GL YLH I+HRD+K N+L++ + V K++DFG SK P +
Sbjct: 120 -----GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-----T 166
Query: 668 TAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARP 708
G+ Y+ PE + +D++S G + E+ +P
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 510 FDENAVIGVGGFGKV-YIGVLEDGNKVAIKR-------GNPGSEQGINEFQTEIQMLSKL 561
F V+G GGFG+V V G A K+ G +NE Q+L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE----KQILEKV 57
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSAR 617
R +VSL + + + LV M G + H+Y P ++ + EI G
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG--- 114
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD---RGYVSTAVKGSF 674
L LH + I++RD+K NILLD+ +++D GL+ P RG V G+
Sbjct: 115 -LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-----GTV 165
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI---NPKLPREQV 719
GY+ PE + ++ T D + G +++E++ + K+ RE+V
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 47/183 (25%)
Query: 549 NEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG---------PFRDHLYGTN 599
N+F EI+++S+L+ +++ L+ C + ++ EYM NG ++ +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 600 QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659
+S+ + + A G+ YL ++ +HRD+ T N L+ +N K+ADFG+S+
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRN- 179
Query: 660 PMDRGYVSTAVKGSFGYLDPEYFRRQ------------------QLTEKSDVYSFGVVLF 701
+ G +Y+R Q + T SDV++FGV L+
Sbjct: 180 -LYSG---------------DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 702 EVL 704
E+L
Sbjct: 224 EIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 509 NFDENAVIGVGGFGKVY----IGVLEDGNKVAIKRGNPGS----EQGINEFQTEIQMLSK 560
NF+ V+G G +GKV+ +G + G A+K + + +TE Q+L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 561 LRHR-HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGS-ARG 618
+R LV+L +++ L+ +Y+ G HLY S + + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +LH GII+RD+K NILLD + DFGLSK + + + G+ Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 679 PEYFRRQQLTEKS--DVYSFGVVLFEVL 704
PE R D +S GV+ FE+L
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 51/154 (33%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 591 FRDHLYG---TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647
+ LY PL Q L I GL YLH AQ IIHRDVKT NI +++
Sbjct: 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQ 195
Query: 648 AKVADFGLSK---AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
+ D G ++ AP G T + PE R + K+D++S G+VLFE+L
Sbjct: 196 VCIGDLGAAQFPVVAPAFLGLAGTVETNA-----PEVLARDKYNSKADIWSAGIVLFEML 250
Query: 705 CARPVINPKLPREQVSLAEWALQCHRKGILEKII 738
I P + E+ CH L KII
Sbjct: 251 AYPSTIFEDPPS---TPEEYVKSCHSH--LLKII 279
|
Length = 357 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 516 IGVGGFGKVYIGVLEDGNKV-AIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG+V+ G+ +V AIK + +E I + Q EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ +++ ++ EY+ G D L P Q + +GL YLH+ + IHR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIHR 125
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
D+K N+LL E K+ADFG++ + +T V F ++ PE ++ K+D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKADI 184
Query: 694 YSFGVVLFEVLCARP 708
+S G+ E+ P
Sbjct: 185 WSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 503 LQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSK 560
L++ F+ ++G G +G+VY G ++ G AIK + G E+ E + EI ML K
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE--EEIKQEINMLKK 58
Query: 561 L-RHRHLVSLIGFCDEQS------EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICI 613
HR++ + G +++ ++ LV E+ G D + T L + IC
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--GYVSTAVK 671
RGL +LH +IHRD+K N+LL EN K+ DFG+S A +DR G +T +
Sbjct: 119 EILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI- 172
Query: 672 GSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVLCARP 708
G+ ++ PE + + KSD++S G+ E+ P
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
IG G G V I + G +VA+K + +Q E+ ++ +H+++V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
E+ ++ E++ G D + +Q L+ +Q +C + L YLH +QG+IHRD
Sbjct: 89 VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRD 142
Query: 635 VKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
+K+ +ILL + K++DFG +SK P + V T ++ PE R +
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-----WMAPEVISRTPYGTE 197
Query: 691 SDVYSFGVVLFEVLCARP 708
D++S G+++ E++ P
Sbjct: 198 VDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 63/232 (27%), Positives = 93/232 (40%), Gaps = 49/232 (21%)
Query: 515 VIGVGGFGKVYIGVLE--DGNKVAIKRGNPG----SEQGINEFQTEIQMLSKLRHRHLVS 568
VIG G FG+V++ V + G A+K Q I + E +L+ +V
Sbjct: 8 VIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVK 65
Query: 569 LI-GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL--EICIGSARGLHYLHTG 625
L F DE+ + LV EYM G + L + P + E+ + L +H
Sbjct: 66 LYYSFQDEEH-LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA----LDSVHK- 119
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSK---------------------------- 657
G IHRD+K NIL+D + K+ADFGL K
Sbjct: 120 --LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 658 -AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
R ++ V G+ Y+ PE R + D +S GV+L+E+L P
Sbjct: 178 RDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 7e-13
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGN----PGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
IG G G VY + + G +VAIK+ N P E INE I ++ + ++ ++V+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE----ILVMRENKNPNIVNYL 82
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
E+ +V EY+A G D + T + Q +C + L +LH+ +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQ---V 136
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
IHRD+K+ NILL + K+ DFG ++ ST V G+ ++ PE R+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 691 SDVYSFGVVLFEVLCARP 708
D++S G++ E++ P
Sbjct: 196 VDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 554 EIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLY-----GTNQPPLSWKQR 608
E+ +L K ++V G ++ + EYM G D + + L
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILG---- 103
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
+I + +GL YLH IIHRDVK +NIL++ K+ DFG+S V++
Sbjct: 104 -KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ------LVNS 154
Query: 669 AVKGSFG---YLDPEYFRRQQLTEKSDVYSFGVVLFEV 703
K G Y+ PE + + KSD++S G+ L E+
Sbjct: 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSL 569
VIG G + KV + L+ ++ +K+ ++ I+ QTE + + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
+S + V EY+ G H+ + P + I A L+YLH +G
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHE---RG 116
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
II+RD+K N+LLD K+ D+G+ K + G ++ G+ Y+ PE R +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 690 KSDVYSFGVVLFEVLCAR 707
D ++ GV++FE++ R
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 516 IGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIG- 571
+G G +G+V + G KVAIK+ + + I+ +T E+++L + H +++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL---EICI---GSARGLHYLHTG 625
F S Y+ HL G + + Q+L I RGL Y+H+
Sbjct: 83 FTPASSLEDFQDVYLVT-----HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPE-YFR 683
GIIHRD+K +NI ++E+ K+ DFGL++ + GYV+T Y PE
Sbjct: 138 ---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 189
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP 708
+ D++S G ++ E+L +
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 516 IGVGGFGKVYIGVLEDGNK-VAIKRGNPGSEQGINEFQ---TEIQMLSKLRHRHLVSLIG 571
IG G FG VY N+ VA+K+ + +Q ++Q E++ L +L+H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
++ LV EY G D L ++ PL + I G+ +GL YLH+ +I
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY---FRRQQLT 688
HRD+K NILL E K+ADFG + + +V T ++ PE Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-----WMAPEVILAMDEGQYD 198
Query: 689 EKSDVYSFGVVLFEVLCARP 708
K DV+S G+ E+ +P
Sbjct: 199 GKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 38/89 (42%), Positives = 56/89 (62%), Gaps = 4/89 (4%)
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
A L +LH+ GII+RD+K NILLDE K+ DFGLSK + +D + + G+
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVE 163
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
Y+ PE R+ T+ +D +SFGV++FE+L
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 57/189 (30%), Positives = 93/189 (49%), Gaps = 23/189 (12%)
Query: 530 EDGNKVAIKRGNPGSEQG-INEFQT-EIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587
E G VAIK+ + + + EI+ML +LRH +LV+LI + + LV+E++
Sbjct: 24 ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83
Query: 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647
+ D N S ++ I RG+ + H+ IIHRD+K NIL+ ++ V
Sbjct: 84 HTVLDDLEKYPNGLDESRVRKYLFQI--LRGIEFCHS---HNIIHRDIKPENILVSQSGV 138
Query: 648 AKVADFGLSK--AAPMD--RGYVST----AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 699
K+ DFG ++ AAP + YV+T A + G D +Y R D+++ G +
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYGR------AVDIWAVGCL 190
Query: 700 LFEVLCARP 708
+ E+L P
Sbjct: 191 VTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIG 571
IG G +G V + G KVAIK+ + +T E+++L +H +++++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 572 -FCDEQSEMILVYEYM------------ANGPFRDH-----LYGTNQPPLSWKQRLEICI 613
++ VY M ++ P + LY Q L
Sbjct: 72 ILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY----------QLL---- 117
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA---PMDRGYVSTAV 670
RGL Y+H + +IHRD+K +N+L++E+ ++ DFG+++ P + Y T
Sbjct: 118 ---RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 671 KGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
+ Y PE + T D++S G + E+L R + K Q+ L
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 42/274 (15%)
Query: 516 IGVGGFGKVYIGVLEDG--NKVAIK----------RGNPGSEQGINEFQTEIQMLSK-LR 562
+G G FG VY ++ N +A+K + ++ I + +E+ ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL------YGTNQPPLSWKQRLEICIGSA 616
H ++V E + +V + + P +H W +++ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
L YLH + I+HRD+ NI+L E+ + DFGL+K T+V G+ Y
Sbjct: 126 --LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK--QPESKLTSVVGTILY 179
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736
PE + + EK+DV++FG +L+++ +P P +SLA I+E
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQP---PFYSTNMLSLA--------TKIVEA 228
Query: 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP 770
+ +P+ E + E + + CL RP
Sbjct: 229 VYEPL-PEGMYSEDVTDVI---TSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 85/271 (31%)
Query: 515 VIGVGGFGKVY------IGVLEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKL-RHR 564
V+G G FGKV I N VA+K G SE +E+++L + H
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKILIHIGNHL 71
Query: 565 HLVSLIGFCDE-QSEMILVYEYMANG--------------PFRD---------------- 593
++V+L+G C + ++++ E+ G P+R+
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 594 --------------------HLYGTNQPPLS----WKQRLE----ICIG--SARGLHYLH 623
G+ PP WK L IC ARG+ +L
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS----FGYLDP 679
A++ IHRD+ NILL EN V K+ DFGL++ D YV KGS ++ P
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---KGSARLPLKWMAP 245
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEV--LCARP 708
E + T +SDV+SFGV+L+E+ L A P
Sbjct: 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQG---INEFQTEIQMLSKLRHR 564
F++ IG G +G VY G VA+K+ +E+ I+ + EI +L LRH
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 565 HLVSL----IGFCDEQSEMILVYEY----MANGPFRDHLYGTNQPPLSWKQRLEICIGSA 616
++V L +G + LV EY +A+ L P S Q + +
Sbjct: 67 NIVELKEVVVG--KHLDSIFLVMEYCEQDLAS------LLDNMPTPFSESQVKCLMLQLL 118
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA-APMDRGYVSTAVKGSFG 675
RGL YLH IIHRD+K +N+LL + K+ADFGL++ + V +
Sbjct: 119 RGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLW 173
Query: 676 YLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
Y PE T D+++ G +L E+L +P++ K EQ+ L
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 515 VIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLI 570
V+G G FGKV + L E G A+K + + TE ++LS R+ ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 571 GFCDEQSE-MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
C + + + V E++ G H+ + + + + I SA L +LH +G
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHD---KG 116
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
II+RD+K N+LLD K+ADFG+ K + G ++ G+ Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 690 KSDVYSFGVVLFEVLC 705
D ++ GV+L+E+LC
Sbjct: 176 SVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 40/230 (17%)
Query: 516 IGVGGFGKVYIGVLEDGNKVA---IKR----GNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
IG G FGKV +G G A +K P EQ F E+Q +L H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-DEQ--LLFLQEVQPYRELNHPNVLQ 59
Query: 569 LIGFCDEQSEMILVYEYMANGPF-------RDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
+G C E +LV E+ G R + Q + + E+ G LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL-WLHQ 118
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA-PMDRGYVSTAVKGSFG--YLD 678
IH D+ N L +L K+ D+GL+ P D Y T + +L
Sbjct: 119 AD------FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED--YYITKDCHAVPLRWLA 170
Query: 679 PEYF--RRQQL-----TEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
PE R Q L T+KS+++S GV ++E+ +P P L EQV
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 510 FDENAVIGVGGFGKV------YIGVLEDGNKVAIKR--GNPGSEQGINEFQTEIQMLSKL 561
F V+G GGFG+V G + K+ KR G +NE ++L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE----KRILEKV 57
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSAR 617
R +VSL + + + LV M G + H+Y P ++ + E+C G
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG--- 114
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD---RGYVSTAVKGSF 674
L L + I++RD+K NILLD+ +++D GL+ P RG V G+
Sbjct: 115 -LEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-----GTV 165
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
GY+ PE ++ T D + G +++E++
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 516 IGVGGFGKV-YIGVLEDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+G GGFG+V + V G A K+ + + G E ++L K+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ ++ + LV M G + H+Y + L ++ + G+ +LH+ I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
+RD+K N+LLD+ +++D GL A + G T G+ GY+ PE + + +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 692 DVYSFGVVLFEVLCAR 707
D ++ G ++E++ R
Sbjct: 176 DWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 516 IGVGGFGKVYIGVLE--DGNKVAIKRGNPGSEQGINEFQT---------EIQMLSKLRHR 564
IG G FG V+ V + DG +VA+K+ N FQ E++ML +H
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKM-------PNVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 565 HLVSLI-----GFCDEQSEMILVYEYMANGPFRD-HLYGTNQPPLSWKQRLEICIGSARG 618
+++S + D E+ +V E M + D H + PLS RG
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQS----DLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L YLH+ GI+HRD+K N+L++ N V K+ DFGL++ D T + Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 679 PEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
PE + T D++S G + E+L R + + P +Q+ L
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRH---RHLVSL 569
+IG G +G VY G + G VA+K N + +++ Q E+ +LS+LR ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG-----SARGLHYLHT 624
G + + ++ EY G R + P++ E I L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIA-----EKYISVIIREVLVALKYIHK 119
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
G+IHRD+K NIL+ K+ DFG++ + ST V G+ ++ PE
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 685 -QQLTEKSDVYSFGVVLFEVLCARP 708
+ K+D++S G+ ++E+ P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 516 IGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINEFQ---TEIQMLSKLRHRHLVSLIG 571
IG G FG VY N+V AIK+ + +Q ++Q E++ L +++H + + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ LV EY G D L ++ PL + I G+ +GL YLH+ +I
Sbjct: 93 CYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 147
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY---FRRQQLT 688
HRD+K NILL E K+ADFG + A +V T ++ PE Q
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY-----WMAPEVILAMDEGQYD 202
Query: 689 EKSDVYSFGVVLFEVLCARP 708
K DV+S G+ E+ +P
Sbjct: 203 GKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FGKVY E G A K SE+ + ++ EI++L+ H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
++ ++ E+ G D + L+ Q IC L YLH+ IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRD 135
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE----- 689
+K N+LL + K+ADFG+S A + + G+ ++ PE + + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 690 KSDVYSFGVVLFEVLCARP 708
K+D++S G+ L E+ P
Sbjct: 195 KADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 502 ELQNATQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPGSEQGI-NEFQTE 554
E+ +T F E +G FGKVY G L E VAIK +E + EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 555 IQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--------YGTNQPPLSWK 606
M S+L+H ++V L+G ++ + +++ Y ++ + L G+ + K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 607 QRLE------ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660
LE I A G+ +L ++ ++H+D+ T N+L+ + L K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 661 MDRGYVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
Y + G+ ++ PE + + SD++S+GVVL+EV
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSL 569
VIG G + KV + L+ ++ IK+ ++ I+ QTE + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ--RLEICIGSARGLHYLHTGAA 627
+S + V E+++ G H+ + P + EI + L++LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHER-- 115
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
GII+RD+K N+LLD K+ D+G+ K + G ++ G+ Y+ PE R +
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-IRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 688 TEKSDVYSFGVVLFEVLCAR 707
D ++ GV++FE++ R
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 6e-12
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGN----PGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
IG G G VY + + G +VAI++ N P E INE I ++ + ++ ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE----ILVMRENKNPNIVNYL 83
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
E+ +V EY+A G D + T + Q +C + L +LH+ +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ---V 137
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
IHRD+K+ NILL + K+ DFG ++ ST V G+ ++ PE R+ K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 691 SDVYSFGVVLFEVLCARP 708
D++S G++ E++ P
Sbjct: 197 VDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 48/231 (20%)
Query: 510 FDENAVIGVGGFGKVYIGVL---EDGNKVAIKRGNPGSEQGINEFQT---EIQMLSKLRH 563
++ IG G +G+VY +DG + AIK+ EQ Q+ EI +L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 564 RHLVSLIGFCDEQSEMI--LVYEYMANG----------PFRDHLYGTNQPPLSWKQRLEI 611
++VSL+ E ++ L+++Y + R + + L W Q L
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN- 119
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSK--AAPMDRGY 665
G+HYLH + ++HRD+K NIL+ E V K+ D GL++ AP+
Sbjct: 120 ------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 666 VSTAVKGSFGYLDPE-------YFRRQQLTEKSDVYSFGVVLFEVLCARPV 709
V + Y PE Y T+ D+++ G + E+L P+
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSE-QGINEFQT-EIQMLSKLRHRH 565
+++ IG G +G V+ E VA+KR + +G+ EI +L +L+H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 566 LVSLIGFCDEQSEMILVYEYMANG--PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
+V L ++ LV+EY + D G P + ++ +GL + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL----KGLAFCH 116
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
+ ++HRD+K N+L+++N K+ADFGL++A
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 554 EIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC- 612
E+Q++ + R ++VS G ++ + + E+M G D +Y P +EI
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP-----IPVEILG 106
Query: 613 ---IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
+ GL YL+ I+HRD+K +NIL++ K+ DFG+S G + +
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS-------GELINS 157
Query: 670 VKGSF----GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
+ +F Y+ PE + + T KSDV+S G+ + E+ +
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 62/200 (31%), Positives = 86/200 (43%), Gaps = 13/200 (6%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQ-----MLSKLRHRHLVS 568
VIG G FGKV + DG A+K + E Q I +L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L ++ V +Y+ G HL P + I SA G YLH+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---L 115
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
II+RD+K NILLD + DFGL K ++ ++ G+ YL PE R+Q
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEG-IEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 689 EKSDVYSFGVVLFEVLCARP 708
D + G VL+E+L P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FGKVY E G A K + SE+ + ++ EI +L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
++ + ++ E+ A G D + + PL+ Q +C + L+YLH IIHRD
Sbjct: 73 YENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRD 128
Query: 635 VKTTNILLDENLVAKVADFGLS--KAAPMDRGYVSTAVKGSFGYLDPEYF-----RRQQL 687
+K NIL + K+ADFG+S + R + G+ ++ PE + +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
K+DV+S G+ L E+ P
Sbjct: 186 DYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 26/252 (10%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGN--KVAIKRGNPGS---EQGINEFQTEIQMLSKLR 562
++F+ +G G FG+V + ++ + VAIKR ++ ++ +E ++L+ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
H V+L G ++S + LV E++ G F L + P C +A+ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIF 144
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
+ I++RD+K N+LLD++ K+ DFG +K R Y + G+ Y+ PE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTY---TLCGTPEYIAPEIL 200
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID-PV 741
+ +D ++ G+ ++E+L P P L ++K ILE II P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----------LLIYQK-ILEGIIYFPK 249
Query: 742 IAETICKESLRK 753
+ CK ++K
Sbjct: 250 FLDNNCKHLMKK 261
|
Length = 340 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 46/225 (20%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQ-----------TE 554
NF IG G F VY + L DG VA+K+ + F+ E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK--------VQIFEMMDAKARQDCLKE 52
Query: 555 IQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFR---DHLYGTNQP---PLSWKQR 608
I +L +L H +++ + E +E+ +V E G H + WK
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
+++C L ++H+ + I+HRD+K N+ + V K+ D GL + + S+
Sbjct: 113 VQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGR-------FFSS 158
Query: 669 AVKGSFG------YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
+ Y+ PE KSD++S G +L+E+ +
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 41/99 (41%), Positives = 57/99 (57%), Gaps = 12/99 (12%)
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS-- 673
ARG+ +L A++ IHRD+ NILL EN V K+ DFGL++ D YV KG
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---KGDAR 236
Query: 674 --FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 708
++ PE + T +SDV+SFGV+L+E+ L A P
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
++G G FGKV + + K +K+ ++ + TE ++L RH L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
+ + V EY+ G HL + + S + L YLH+G I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGK---I 116
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
++RD+K N++LD++ K+ DFGL K D + T G+ YL PE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 691 SDVYSFGVVLFEVLCAR 707
D + GVV++E++C R
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 79/289 (27%), Positives = 119/289 (41%), Gaps = 46/289 (15%)
Query: 501 TELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKV----------AIKRGNPGSEQGINE 550
T+L+ ++FD VIG G FG+V + + +V IKR S+
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR----SDSAF-- 89
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQ- 607
F E +++ +V L Q + + +V EYM G + L P W +
Sbjct: 90 FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARF 146
Query: 608 -RLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR-GY 665
E+ + L +H+ G IHRDVK N+LLD++ K+ADFG MD G
Sbjct: 147 YTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGM 197
Query: 666 V--STAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
V TAV G+ Y+ PE + Q + D +S GV L+E+L P V
Sbjct: 198 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT---PFYADSLV 253
Query: 720 SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD 768
+ K L D I++ K+ + ++ E L GVD
Sbjct: 254 GTYSKIMD--HKNSLTFPDDIEISKQ-AKDLICAFLTDREVRLGRNGVD 299
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINEFQTEIQMLSKL------RHRHLV 567
V+G G FGKV + + +++ AIK + I + E M+ K + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILK--KDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
L + V EY+ G H+ G + P + EI IG L +LH+
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHS- 119
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
+GII+RD+K N++LD K+ADFG+ K G + G+ Y+ PE Q
Sbjct: 120 --KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTRTFCGTPDYIAPEIIAYQ 176
Query: 686 QLTEKSDVYSFGVVLFEVLCARP 708
+ D ++FGV+L+E+L +P
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVA----IKRGNPGSEQGINEFQTEIQMLSKLRH 563
+F+ +G G FG+V I + + +K+ + + E +L +L H
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 564 RHLVSLI-GFCDEQSEMILVYEYMANGPFRDHLYGTNQPP--LSWKQRLEICIGSARGLH 620
+V+++ F DE + + E++ G HL + P ++ E+ +
Sbjct: 78 PFIVNMMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FE 132
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
YLH+ + II+RD+K N+LLD KV DFG +K P DR + + G+ YL PE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGTPEYLAPE 185
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ + + D ++ GV+L+E + P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 56/220 (25%)
Query: 516 IGVGGFGKVY-IGVLEDGNKVAIKRGNP---GSEQGINEFQTEIQMLSKLR-HRHLVSLI 570
IG G F +V + G AIK EQ +N + EIQ L +L H +++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLR-EIQALRRLSPHPNILRLI 64
Query: 571 GFC-DEQS----------EMILVYEYMANGPFRDHLYGTNQPPLSWKQRL-EICIGSARG 618
D ++ +M L YE + R P K + ++ +
Sbjct: 65 EVLFDRKTGRLALVFELMDMNL-YELIKG---RKRPL----PEKRVKSYMYQLL----KS 112
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG----YVSTAVKGSF 674
L ++H GI HRD+K NIL+ ++++ K+ADFG S + Y+ST
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDDIL-KLADFG-SCRGIYSKPPYTEYISTR----- 162
Query: 675 GYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
Y PE Y+ K D+++ G V FE+L P
Sbjct: 163 WYRAPECLLTDGYY-----GPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 56/223 (25%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIGF 572
IG G +G V E KVAIK+ + I+ +T EI++L L H +++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 573 C-----DEQSEMILVYEYM---------ANGPF-RDH----LYGTNQPPLSWKQRLEICI 613
+ +++ +VYE M ++ DH LY Q L
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY----------QLL---- 118
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS 673
RGL Y+H+ ++HRD+K +N+LL+ N K+ DFGL++ +++
Sbjct: 119 ---RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE----- 167
Query: 674 FGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 709
Y+ ++R +L T DV+S G + E+L +P+
Sbjct: 168 --YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 503 LQNATQNFDENAVIGVGGFGKVY-IGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL 561
L + T ++ IG G +GKVY + +DG+ A+K +P S+ E + E +L L
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSL 75
Query: 562 -RHRHLVSLIGF---CDEQS--EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE----- 610
H ++V G D+ ++ LV E G + + G L QRL+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LICGQRLDEAMIS 131
Query: 611 -ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
I G+ GL +LH IIHRDVK NILL K+ DFG+S R +T+
Sbjct: 132 YILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 670 VKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEV 703
V F ++ PE +Q + S DV+S G+ E+
Sbjct: 189 VGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKR--------GNPGSEQGINEFQTEIQMLSKLRHRHL 566
IG G +G VY G VA+K+ G P + I E I +L +L H ++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPST--AIRE----ISLLKELNHPNI 60
Query: 567 VSLIGFCDEQSEMILVYEY--MANGPFRDHLYGTNQPPLSWKQRL-EICIGSARGLHYLH 623
V L+ ++++ LV+E+ + + D T P K L ++ +G+ Y H
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCH 116
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA--APMDRGYVSTAVKGSFGYLDPEY 681
+ ++HRD+K N+L+D K+ADFGL++A P+ R Y V + Y PE
Sbjct: 117 S---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEI 170
Query: 682 F--RRQQLTEKSDVYSFGVVLFEVLCARP 708
RQ T D++S G + E++ RP
Sbjct: 171 LLGSRQYST-PVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 516 IGVGGFGKVYIGV---LEDGNK-----VAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+G G F K++ G+ + D + V +K + F M+S+L H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL-YGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
G C E I+V EY+ G +L N +SWK LE+ A LH+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD------PE 680
+G+ H +V N+LL K + K + D G +S V L+ PE
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS--DPG-ISITVLPKEILLERIPWVPPE 174
Query: 681 YFRR-QQLTEKSDVYSFGVVLFEVLC 705
Q L+ +D +SFG L+E+
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGN--------KVAIKRGNPGSEQGINEFQTEIQMLSK 560
NF+ V+G G +GKV++ G+ KV K + +TE Q+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 561 LRHR-HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGS-ARG 618
+R LV+L +++ L+ +Y+ G HL +Q +Q ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +LH GII+RD+K NILLD N + DFGLSK D + + G+ Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 679 PEYFRRQQLTEKS--DVYSFGVVLFEVL 704
P+ R D +S GV+++E+L
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 66/212 (31%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-----EQGINEFQTEIQMLSK-LRHRHL 566
VIG G FGKV + + DG+ A+K + EQ N E +L K L+H L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ--NHIMAERNVLLKNLKHPFL 58
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARG-------- 618
V L ++ V +Y+ G HL QR E C R
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHL-----------QR-ERCFLEPRARFYAAEVA 106
Query: 619 --LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
+ YLH+ II+RD+K NILLD + DFGL K ST G+ Y
Sbjct: 107 SAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEY 162
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
L PE R++ D + G VL+E+L P
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 10/132 (7%)
Query: 579 MILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636
+ V EY+ G H+ G + P + EI +G L +LH +GII+RD+K
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHR---RGIIYRDLK 128
Query: 637 TTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSF 696
N++LD K+ADFG+ K +D G + G+ Y+ PE Q + D +++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187
Query: 697 GVVLFEVLCARP 708
GV+L+E+L +P
Sbjct: 188 GVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQT--EIQMLSKLR---HRHL 566
A IGVG +G VY G+ VA+K +E G+ T E+ +L +L H ++
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-PLSTVREVALLKRLEAFDHPNI 64
Query: 567 VSLIGFC-----DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
V L+ C D ++++ LV+E++ + R +L P L + ++ RGL +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
LH I+HRD+K NIL+ K+ADFGL++ V + Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARPV 709
+ D++S G + E+ +P+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNK-VAIKRGNPGSEQGINEFQT--EIQMLSKLR- 562
Q ++ A IG G +GKV+ L++G + VA+KR + + T E+ +L L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 563 --HRHLVSLIGFC-----DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGS 615
H ++V L C D ++++ LV+E++ + +L +P + + ++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
RGL +LH+ ++HRD+K NIL+ + K+ADFGL++ T+V +
Sbjct: 120 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLW 174
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709
Y PE + D++S G + E+ +P+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 40/105 (38%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-VKGSF 674
A+G+ +L A++ IHRD+ NILL EN V K+ DFGL++ D YV +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPRE 717
++ PE + T +SDV+SFGV+L+E+ L A P K+ E
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSE-QGINEFQT-EIQMLSKLRHRHLVSLIGF 572
IG G +G VY G + G VA+K+ SE +G+ EI +L +L+H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 573 CDEQSEMILVYEY--MANGPFRDHLYGTNQPPLS-----WKQRLEICIGSARGLHYLHTG 625
++S + L++E+ M + D L Q L+ G+ + H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ-------GILFCH-- 118
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA--APMDRGYVSTAVKGSFGYLDPEYFR 683
++ ++HRD+K N+L+D V K+ADFGL++A P+ R Y V + Y PE
Sbjct: 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVV--TLWYRAPEVLL 174
Query: 684 -RQQLTEKSDVYSFGVVLFEVLCARPV 709
+ + D++S G + E+ +P+
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGN--------KVAIKRGNPGSEQGINEFQTEIQMLSK 560
NF+ V+G G +GKV++ G+ KV K + + +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 561 LRHR-HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA-RG 618
+R LV+L ++++ L+ +Y++ G HLY Q + + G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILA 117
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +LH GI++RD+K NILLD + DFGLSK + + + G+ Y+
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 679 PEYFRRQQLTEKS-DVYSFGVVLFEVL 704
PE R + K+ D +S G+++FE+L
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 579 MILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636
+ V EY+ G + G + P + EI IG L +LH+ +GII+RD+K
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHS---KGIIYRDLK 128
Query: 637 TTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSF 696
N++LD K+ADFG+ K D G + G+ Y+ PE Q + D ++F
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187
Query: 697 GVVLFEVLCARP 708
GV+L+E+L +
Sbjct: 188 GVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRH 565
NF + IG G +G VY G VA+K R + +E + EI +L +L H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+V L+ ++++ LV+E++ + + + + + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA--APMDRGYVSTAVKGSFGYLDPEYFR 683
+ ++HRD+K N+L++ K+ADFGL++A P+ R Y V + Y PE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 173
Query: 684 RQQL-TEKSDVYSFGVVLFEVLCAR 707
+ + D++S G + E++ R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNK-VAIKRGNPG---SEQGINEFQTEIQMLSKLRH 563
+ + +G G FG+V++ A+K + E ++L ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG----TNQPPLSWKQRLEICIGSARGL 619
++ L +Q + ++ EY+ G +L +N L + + +C L
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VC-----AL 114
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDP 679
YLH+ + I++RD+K NILLD+ K+ DFG +K DR + + G+ YL P
Sbjct: 115 EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAP 167
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
E + + + D ++ G++++E+L P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 30/163 (18%)
Query: 514 AVIGVGGFGKVY-IGVLEDGNKVAIKR---GNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
A IG G FG+V+ + VA+K+ N I + EI++L L+H ++V+L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 570 IGFCDEQSEM--------ILVYEYMANGPFRDH-LYGTNQPP-----LSWKQRLEICIGS 615
I C ++ LV+E F +H L G LS +++ + +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFE------FCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
GL+Y+H I+HRD+K NIL+ ++ + K+ADFGL++A
Sbjct: 131 --GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 67/260 (25%), Positives = 112/260 (43%), Gaps = 45/260 (17%)
Query: 516 IGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV------- 567
+G G G V+ V D +VA+K+ Q + EI+++ +L H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 568 -------SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLH 620
+G E + + +V EYM D Q PLS + RGL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQLLRGLK 128
Query: 621 YLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMD-----RGYVSTAVKGSF 674
Y+H+ ++HRD+K N+ ++ E+LV K+ DFGL++ +D +GY+S + +
Sbjct: 129 YIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKW 183
Query: 675 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733
Y P T+ D+++ G + E+L +P+ EQ+ L I
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL-----------I 231
Query: 734 LEKIIDPVIAETICKESLRK 753
LE + PV+ E E L
Sbjct: 232 LESV--PVVREEDRNELLNV 249
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 47/157 (29%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLY--GTNQPPLSWKQRLE 610
TE ++L RH L +L + V EY G HL + E
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I SA L YLH+ +++RD+K N++LD++ K+ DFGL K D + T
Sbjct: 104 IV--SA--LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
G+ YL PE D + GVV++E++C R
Sbjct: 157 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 15/177 (8%)
Query: 549 NEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQR 608
N+ E+++L + ++V G E+ + E+M G L + P + +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK 103
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
+ I + RGL YL I+HRDVK +NIL++ K+ DFG+S G +
Sbjct: 104 ISIAV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLID 152
Query: 669 AVKGSF----GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
++ SF Y+ PE + T +SD++S G+ L E+ R I P +E ++
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLS-KLRHRHLVSL 569
V+G G FGKV + L+ + A+K+ + + E ++L+ + L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPL---SWKQRLEICIGSARGLHYLHTGA 626
+ + V E++ G H+ + L ++ +C GL +LH+
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHS-- 114
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
+GII+RD+K N++LD + K+ADFG+ K ST G+ Y+ PE + +
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172
Query: 687 LTEKSDVYSFGVVLFEVL 704
T D +SFGV+L+E+L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 19/120 (15%)
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VST 668
+I + + L YLH+ + +IHRDVK +N+L++ N K+ DFG+S GY V +
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 669 AVK----GSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQV 719
K G Y+ PE ++ KSDV+S G+ + E+ R P + K P +Q+
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 515 VIGVGGFGKVYIGVLEDGN--------KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL 566
V+G GG+GKV+ G KV K +++ + E +L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLY--GTNQPPLSWKQRLEICIGSARGLHYLHT 624
V LI ++ L+ EY++ G HL G + EI + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQ 118
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
QGII+RD+K NILLD K+ DFGL K + + G V+ G+ Y+ PE R
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKES-IHEGTVTHTFCGTIEYMAPEILMR 174
Query: 685 QQLTEKSDVYSFGVVLFEVLCARP 708
+ D +S G +++++L P
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 31/110 (28%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 554 EIQMLSKLRHRHLVSL--IGFCDEQSEMILVYEYMANGPFRDH----LYGTNQPPLSWKQ 607
EI +L KL+H ++V++ + ++ +V EY+ +H L T + P +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSE 107
Query: 608 RLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
+ + G+ +LH I+HRD+KT+N+LL+ + K+ DFGL++
Sbjct: 108 VKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 65/240 (27%)
Query: 513 NAVIGVGGFGKVYIGV-LEDGNKVAIKR--------GNPGSEQ-----GINEFQT--EIQ 556
A +G G +GKV G VAIK+ Q GI+ F T E++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH-FTTLRELK 72
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEI----C 612
++++++H +++ L+ E + LV + MA + + K RL C
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA---------SDLKKVVDRKIRLTESQVKC 123
Query: 613 IGSA--RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I GL+ LH +HRD+ NI ++ + K+ADFGL+ R Y
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLA------RRYGYPPY 174
Query: 671 KGSFGYLDPEYF-RRQQLTEK---------------------SDVYSFGVVLFEVLCARP 708
+ E RR+++T K D++S G + E+L +P
Sbjct: 175 SDT--LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 33/88 (37%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
LHYL G+IHRDVK +NILLD + K+ DFG+S + +A G Y+
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMA 182
Query: 679 PEYFRRQQLTEK----SDVYSFGVVLFE 702
PE K +DV+S G+ L E
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 47/244 (19%)
Query: 493 GLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIG--VLEDGNKVAIKRGNPGSEQGIN- 549
G G+ T+ +L +G G + VY G L D N VA+K E+G
Sbjct: 1 GFGKLETYIKLDK----------LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPC 49
Query: 550 EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
E+ +L L+H ++V+L + + LV+EY+ KQ L
Sbjct: 50 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK---------------DLKQYL 94
Query: 610 EICIGSA-------------RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
+ C S RGL+Y H + ++HRD+K N+L++E K+ADFGL+
Sbjct: 95 DDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLA 151
Query: 657 KAAPMDRGYVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP 715
+A + S V + Y P+ + + D++ G + +E+ RP+
Sbjct: 152 RAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210
Query: 716 REQV 719
EQ+
Sbjct: 211 EEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLS-KLRHRHLVSL 569
V+G G FGKV + L+ ++V +K+ + ++ TE ++L+ +H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 570 IGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
C Q++ + V EY+ G + + + + + A L +LH
Sbjct: 62 --HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHR--- 114
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
G+I+RD+K NILLD K+ADFG+ K + G +T G+ Y+ PE + +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG-ILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
D ++ GV+++E++ +P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKR-GNP-GSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
+G G +G V + G KVAIK+ P SE E+++L ++H +++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 573 ------CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE------ICIGSARGLH 620
D + LV +M GT+ L ++L + +GL
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM----------GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDP 679
Y+H A GIIHRD+K N+ ++E+ K+ DFGL++ + GYV T Y P
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAP 184
Query: 680 EY-FRRQQLTEKSDVYSFGVVLFEVLCARPV 709
E T+ D++S G ++ E+L +P+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 516 IGVGGFGKVY-IGVLEDGNKVAIKRGNPGSEQG-INEFQT-EIQMLSKLRHRHLVSLIGF 572
IG G +G V+ E G VAIK+ + I + EI+ML +L+H +LV+LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 573 CDEQSEMILVYEYMANGPFRDH--LYGTNQPP--LSWKQRLEICIGSARGLHYLHTGAAQ 628
+ ++ LV+EY DH L + P + +I + + +++ H
Sbjct: 69 FRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 629 GIIHRDVKTTNILLDENLVAKVADFG----LSKAAPMDRGYVSTAVKGSFGYLDPEYF-R 683
IHRDVK NIL+ + K+ DFG L+ YV+T Y PE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVG 174
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARPV 709
Q DV++ G V E+L +P+
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 17/101 (16%)
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I + + + L+YL IIHRDVK +NILLD N K+ DFG+S G + ++
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSI 162
Query: 671 K-----GSFGYLDPEY---FRRQQLTEKSDVYSFGVVLFEV 703
G Y+ PE R +SDV+S G+ L+EV
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 7/169 (4%)
Query: 549 NEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQR 608
N+ E+Q+L + ++V G E+ + E+M G L + P +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
+ I + RGL YL I+HRDVK +NIL++ K+ DFG+S +D ++
Sbjct: 108 VSIAV--LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MAN 160
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
+ G+ Y+ PE + + +SD++S G+ L E+ R I P +E
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 41/137 (29%), Positives = 64/137 (46%), Gaps = 10/137 (7%)
Query: 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642
Y A R P LS+ + A G+ +L A++ +HRD+ N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272
Query: 643 DENLVAKVADFGLSKAAPMDRGYVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGV 698
E + K+ DFGL++ D Y+S KGS ++ PE T SDV+SFG+
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329
Query: 699 VLFEVLCARPVINPKLP 715
+L+E+ P+LP
Sbjct: 330 LLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 60/228 (26%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIG 571
VIG G +G V + G KVAIK+ N E + + EI++L LRH +V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 572 FC-----DEQSEMILVYEYM---------ANGPF-RDH----LYGTNQPPLSWKQRLEIC 612
E ++ +V+E M AN +H LY Q L
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY----------QLL--- 113
Query: 613 IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-------Y 665
R L Y+HT + HRD+K NIL + + K+ DFGL++ A D Y
Sbjct: 114 ----RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 666 VSTAVKGSFGYLDPE----YFRRQQLTEKSDVYSFGVVLFEVLCARPV 709
V+T Y PE +F + T D++S G + EVL +P+
Sbjct: 167 VATR-----WYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGS-EQGINEFQ-TEIQMLSKLRHR-HLVSLIG 571
IG G +GKVY G VA+K+ E+GI EI +L L ++V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 572 FCDEQSE-------MILVYEYMANG--PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
E E + LV+EY+ + F D PL K +G+ +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 623 HTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKA 658
H G++HRD+K N+L+D + + K+AD GL +A
Sbjct: 127 H---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 10/106 (9%)
Query: 602 PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661
PL L A+G+ +L A++ IHRDV N+LL + VAK+ DFGL++
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 662 DRGYVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 703
D YV VKG+ ++ PE T +SDV+S+G++L+E+
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC 612
TE ++L RH L +L + V EY G HL ++ + ++R
Sbjct: 44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFY 100
Query: 613 ---IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
I SA L YLH+ + +++RD+K N++LD++ K+ DFGL K D + T
Sbjct: 101 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
G+ YL PE D + GVV++E++C R
Sbjct: 156 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 7/204 (3%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT-EIQMLSKLRHRHL 566
NF + +G G + VY G G VA+K + +E+G EI ++ +L+H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V L +++++LV+EYM + + L +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-- 118
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
++HRD+K N+L+++ K+ADFGL++A + S V + Y P+ +
Sbjct: 119 -NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 687 LTEKS-DVYSFGVVLFEVLCARPV 709
S D++S G ++ E++ RP+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 516 IGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
I G FGKVY+G ++ +K+ +K+ + ++ +++ Q E L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 572 FCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
+ + LV EY+ G + H+YG ++ K E+ A L YLH G
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV----ALALDYLHR---HG 124
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663
IIHRD+K N+L+ K+ DFGLSK ++R
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVT-LNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 44/131 (33%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGS-ARGLHYLHTGAAQGIIHRDV 635
S++ LV +YM+ G HL + + R + I L +LH I++RD+
Sbjct: 69 SDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHK---YDIVYRDL 122
Query: 636 KTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVY 694
K NILLD + DFGLSKA D +T G+ YL PE ++ T+ D +
Sbjct: 123 KPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLLDEKGYTKHVDFW 181
Query: 695 SFGVVLFEVLC 705
S GV++FE+ C
Sbjct: 182 SLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRH 563
++FD +++G G FG+V + + + +K+ +++ ++ F+ E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL------EICIGSAR 617
+ L ++ + LV EY G D L N+ + + + E+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVL---- 113
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677
+H +H G +HRD+K N+L+D K+ADFG + ++ S G+ Y+
Sbjct: 114 AIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 678 DPEYFRRQQLTEKS------DVYSFGVVLFEVLCAR 707
PE K D +S GV+ +E++ R
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 516 IGVGGFGKVYIGVLEDG---NKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
IG G FGKV +G + G +V +K R + ++ + +F E Q L+H +L+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCL 61
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQ-----PPLSWKQRLEICIGSARGLHYLHTG 625
G C E + +LV E+ G + +L + P + QR+ I A GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHK- 118
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG-SFGYLDPEYFRR 684
IH D+ N LL +L K+ D+GLS + YV+ ++ PE
Sbjct: 119 --NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 685 QQ-------LTEKSDVYSFGVVLFEVL 704
T++S+V+S GV ++E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 68/221 (30%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 503 LQNATQNFDENAVIGVGGFGKVYIGVLEDGNKV----------AIKRGNPGSEQGINEFQ 552
LQ +++D VIG G FG+V + + KV IKR + F
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF------FW 91
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
E +++ +V L FC Q + + +V EYM G + L P W +
Sbjct: 92 EERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAK--- 145
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR-GYV--S 667
+A + L + G+IHRDVK N+LLD++ K+ADFG MD G V
Sbjct: 146 --FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMVRCD 201
Query: 668 TAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 704
TAV G+ Y+ PE + Q + D +S GV LFE+L
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF-----RDHLYGTNQPPLSWKQ 607
TE ++L RH L +L + V EY G R+ ++ ++ +
Sbjct: 44 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 608 RLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667
I SA L YLH + + +++RD+K N++LD++ K+ DFGL K D +
Sbjct: 104 -----IVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154
Query: 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
T G+ YL PE D + GVV++E++C R
Sbjct: 155 TFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEI------QMLSKLRHRHLVS 568
+G G +G V + G KVAIK+ + FQ+EI + L+ L+H +
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 569 LIGFCDEQS---------EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
+IG D + + LV YM + L PLS + + GL
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLD 678
Y+H + GIIHRD+K N+ ++E+ K+ DFGL++ A + GYV T Y
Sbjct: 131 KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRA 182
Query: 679 PEY-FRRQQLTEKSDVYSFGVVLFEVLCARPVINPK 713
PE + D++S G ++ E+L + + K
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 549 NEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQR 608
N+ E+Q+L + ++V G E+ + E+M G L + P +Q
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQI 104
Query: 609 L-EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667
L ++ I +GL YL I+HRDVK +NIL++ K+ DFG+S +D ++
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MA 159
Query: 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
+ G+ Y+ PE + + +SD++S G+ L E+ R I P +E
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGIN-EFQTEIQMLSKLRHRHLVSLIGFC 573
+G G + V+ G + N VA+K E+G E+ +L L+H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 574 DEQSEMILVYEYMANG--PFRDH---LYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
+ + LV+EY+ + + D+ L + + Q L RGL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK---R 122
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
I+HRD+K N+L++E K+ADFGL++A + S V + Y P+ T
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS--T 179
Query: 689 EKS---DVYSFGVVLFEVLCARPVINPKLPREQVSL 721
E S D++ G +L+E+ RP+ +E++ L
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 10/104 (9%)
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS-- 673
A+G+ +L A++ IHRD+ NILL + K+ DFGL++ D YV VKG+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 674 --FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP 715
++ PE T +SDV+S+G++L+E+ P +P
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 61/200 (30%), Positives = 86/200 (43%), Gaps = 13/200 (6%)
Query: 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQ-----MLSKLRHRHLVS 568
VIG G FGKV + + DG A+K E Q I +L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L ++ V +++ G HL P + I SA G YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---I 115
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
I++RD+K NILLD + DFGL K + + +T G+ YL PE R+Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEG-IAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 689 EKSDVYSFGVVLFEVLCARP 708
D + G VL+E+L P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQ---TEIQMLSKLRHR 564
NF IG G F +VY L D VA+K+ Q EI +L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHL-YGTNQPPL-----SWKQRLEICIGSARG 618
+++ + E +E+ +V E G + Y Q L WK +++C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
+ ++H+ + ++HRD+K N+ + V K+ D GL + + V G+ Y+
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEV 703
PE KSD++S G +L+E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 509 NFDENAVIGVGGFGKVY-IGVLEDGNKVAIKR---GNPGSEQGINEFQTEIQMLSKLRHR 564
NF IG G F +VY L DG VA+K+ + + + EI +L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHL-YGTNQPPL-----SWKQRLEICIGSARG 618
+++ E +E+ +V E G + + Q L WK +++C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L ++H+ + ++HRD+K N+ + V K+ D GL + + + ++ G+ Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEV 703
PE KSD++S G +L+E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 39/124 (31%), Positives = 72/124 (58%), Gaps = 13/124 (10%)
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSK----AAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
++HRD+K+ NI L + K+ DFG SK + +D V+++ G+ YL PE + R+
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERK 246
Query: 686 QLTEKSDVYSFGVVLFEVLCA-RPVINPKLPRE---QVSLAEW-ALQCHRKGILEKIIDP 740
+ ++K+D++S GV+L+E+L RP P RE QV ++ C ++ ++DP
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPS-QREIMQQVLYGKYDPFPCPVSSGMKALLDP 305
Query: 741 VIAE 744
++++
Sbjct: 306 LLSK 309
|
Length = 478 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS-- 673
ARG+ +L A++ +HRD+ N+LL + + K+ DFGL++ D YVS KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 674 --FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
++ PE T SDV+S+G++L+E+
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 554 EIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS--WKQRLEI 611
EI++L + H ++V D E+ ++ E+M G ++ L+ +Q L
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA-DEQFLADVARQILS- 179
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTA 669
G+ YLH + I+HRD+K +N+L++ K+ADFG+S+ A MD S
Sbjct: 180 ------GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 670 VKGSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEVLCAR 707
G+ Y+ PE L D++S GV + E R
Sbjct: 230 --GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 52/243 (21%), Positives = 92/243 (37%), Gaps = 65/243 (26%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLED---GNKVAIKR------GNPGSEQGINEFQTEIQML 558
Q +D +IG GG G+VY+ D +VA+K+ NP + F E ++
Sbjct: 2 QRYDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLK---KRFLREAKIA 56
Query: 559 SKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF--------------------RDHLYGT 598
+ L H +V + C + VY M P+ ++ T
Sbjct: 57 ADLIHPGIVPVYSICSDGD---PVYYTM---PYIEGYTLKSLLKSVWQKESLSKELAEKT 110
Query: 599 NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
+ L I + Y+H+ +G++HRD+K NILL + D+G +
Sbjct: 111 SVGAF-----LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162
Query: 659 APM---DRGYVSTAVKGSF--------------GYLDPEYFRRQQLTEKSDVYSFGVVLF 701
+ D + + Y+ PE +E +D+Y+ GV+L+
Sbjct: 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILY 222
Query: 702 EVL 704
++L
Sbjct: 223 QML 225
|
Length = 932 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA---------PMDRGYVS 667
+ L Y+H+G +IHRD+K +NILL+ + K+ADFGL+++ P+ YV+
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 668 TAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPV 709
T Y PE + T+ D++S G +L E+L +P+
Sbjct: 175 TR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVY-IGVLEDGNKVAIKRGNPGSEQGINEFQT 553
G+ F + + ++ IG G +GKV+ + ++G+K A+K +P + E +
Sbjct: 5 GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEA 63
Query: 554 EIQMLSKLR-HRHLVSLIGFCDEQS-----EMILVYEYMANGPFRDHLYG-------TNQ 600
E +L L H ++V G ++ ++ LV E G D + G +
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123
Query: 601 PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660
P +++ I + GL +LH IHRDVK NILL K+ DFG+S
Sbjct: 124 PIIAY-----ILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 661 MDRGYVSTAVKGSFGYLDPEYFR-RQQL----TEKSDVYSFGVVLFEV 703
R +T+V F ++ PE QQL + DV+S G+ E+
Sbjct: 176 STRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 493 GLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGIN-E 550
G G+ T+ +L+ +G G + V+ G + N VA+K E+G
Sbjct: 1 GFGKMETYIKLEK----------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT 50
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
E+ +L L+H ++V+L + LV+EY+ KQ ++
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK---------------DLKQYMD 95
Query: 611 ICIGSA--------------RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
C G+ RGL Y H + ++HRD+K N+L++E K+ADFGL+
Sbjct: 96 DC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLA 151
Query: 657 KAAPMDRGYVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 709
+A + S V + Y P+ + + + D++ G + FE+ RP+
Sbjct: 152 RAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 60/200 (30%), Positives = 85/200 (42%), Gaps = 13/200 (6%)
Query: 515 VIGVGGFGKVYIGVLEDGN-----KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FGKV + + KV K+ ++ + +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC-IGSARGLHYLHTGAAQ 628
++ V +Y+ G HL + L + R I SA G YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALG--YLHS---L 115
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
I++RD+K NILLD + DFGL K G ST G+ YL PE +Q
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYD 174
Query: 689 EKSDVYSFGVVLFEVLCARP 708
D + G VL+E+L P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINE---FQTEIQMLSKLRH 563
++F+ VIG G FG+V + L++ +KV A+K N E F+ E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANG-------PFRDHLYGTNQPPLSWKQRLEICIGSA 616
+ + +L +++ + LV +Y G F D L + + I I S
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYLAEMVIAIDSV 118
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK-GSFG 675
LHY +HRD+K NIL+D N ++ADFG S M+ G V ++V G+
Sbjct: 119 HQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPD 168
Query: 676 YLDPEYFR-----RQQLTEKSDVYSFGVVLFEVL 704
Y+ PE + + + + D +S GV ++E+L
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 41/237 (17%)
Query: 516 IGVGGFGKVYIGVLEDGNKVA------IKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
IG G FGKV + + VA +K EQ NEF + L+H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL------YGTNQPPLSWKQRLEICIGSARGLHYLH 623
+G C E +LV+EY G + +L +Q L + EI A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTHMH 116
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG--YLDPEY 681
+H D+ N L +L KV D+G+ + Y+ T +L PE
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSR-YKEDYIETEDDKCVPLRWLAPEL 172
Query: 682 FRRQQ-------LTEKSDVYSFGVVLFEV----------LCARPVINPKLPREQVSL 721
T+ S+V++ GV L+E+ L R V+N + +QV L
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD--------------RG 664
L YLH GI+HRD+K N+L+ K+ DFGLSK M R
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
++ V G+ Y+ PE RQ + D ++ G++L+E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 516 IGVGGFGKVYIGVLEDGNK-VAIKRGNPGSE-QGINEFQT-EIQMLSKLRHRHLVSLIGF 572
IG G +G VY N+ +A+K+ E +G+ EI +L +++H ++V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGS-----ARGLHYLHTGAA 627
+ + LV+EY+ + + H+ + P + RL I + RG+ Y H+
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRL---IKTYLYQILRGIAYCHS--- 120
Query: 628 QGIIHRDVKTTNILLDENLVA-KVADFGLSKA--APMDRGYVSTAVKGSFGYLDPE-YFR 683
++HRD+K N+L+D A K+ADFGL++A P+ R + V + Y PE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVV--TLWYRAPEILLG 177
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARPV 709
+ + D++S G + E++ +P+
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 38/208 (18%)
Query: 515 VIGVG--GFGKVYIGVLEDGNK-VAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+IG V++ + N VA+K+ N S++ + Q EI +L+H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL-----YGTNQPPLSWKQRLEICI---GSARGLHY 621
+ SE+ +V MA G D L G + L I L Y
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE--------LAIAFILKDVLNALDY 116
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGS------- 673
+H+ +G IHR VK ++ILL + KV GL + M G V
Sbjct: 117 IHS---KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 674 FGYLDPEYFRRQQL---TEKSDVYSFGV 698
+L PE +Q L EKSD+YS G+
Sbjct: 172 LPWLSPEVL-QQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 489 FSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQG 547
F Q L + T E+ QN + +G G +G V + G +VA+K+ + +
Sbjct: 3 FYRQELNK--TIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 57
Query: 548 INEFQT--EIQMLSKLRHRHLVSLIG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS 604
I+ +T E+++L ++H +++ L+ F +S E + HL G + +
Sbjct: 58 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS-----LEEFNDVYLVTHLMGADLNNIV 112
Query: 605 WKQRLE------ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
Q+L + RGL Y+H+ IIHRD+K +N+ ++E+ K+ DFGL++
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 169
Query: 659 APMD-RGYVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCAR 707
+ GYV+T Y PE + D++S G ++ E+L R
Sbjct: 170 TDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV-AIK-------RGNPGSEQGINEFQTEIQMLSKLRHRHL 566
+IG GGFG+VY D K+ A+K + G +NE + + ++S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFI 59
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V + ++ + + M G HL + S K+ GL ++H
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
+ +++RD+K NILLDE+ +++D GL+ + + S G+ GY+ PE ++
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 687 LTEKS-DVYSFGVVLFEVL 704
+ S D +S G +LF++L
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 15/92 (16%)
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL----SKAAPMDRGYVSTAVKGS 673
GL ++H + +++RD+K NILLDE+ +++D GL SK P A G+
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-------ASVGT 158
Query: 674 FGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 704
GY+ PE ++ + S D +S G +LF++L
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIGF 572
+G G + VY G+ +G VA+K + +E+G+ F E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 573 CDEQSEMILVYEY--------MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
+ + V+EY M P H Y L Q L RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVR---LFMFQLL-------RGLAYIH- 120
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM-DRGYVSTAVKGSFGYLDPEYFR 683
Q I+HRD+K N+L+ K+ADFGL++A + + Y S V + Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 684 -RQQLTEKSDVYSFGVVLFEVLCARPV 709
+ D++ G + E+L +P
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 31/234 (13%)
Query: 510 FDENAVIGVGGFGKVYIGVLEDGNK-VAIKR--GNPGSEQGINEFQTEIQMLSKLRHRHL 566
F+ V+G G +G V ++ + VAIK+ + +E+ E++ML L+ ++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFR---DHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
V L + ++ LV+EY+ + G PP + + I + +H+ H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLI---KAIHWCH 117
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
I+HRD+K N+L+ N V K+ DFG ++ T + Y PE
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP----------------VINPKLPREQVSL 721
+ D++S G +L E+ +P V+ P LP EQ+ L
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-LPAEQMKL 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 58/241 (24%), Positives = 88/241 (36%), Gaps = 67/241 (27%)
Query: 515 VIGVGGFGKVYIGVLEDGNKV----------AIKRGNPGSEQGINEFQTEIQMLSKLRHR 564
++G G G+V++ L+ K+ IKR + TE ++L+ L H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK------VKRVLTEQEILATLDHP 61
Query: 565 HLVSLIGFCDEQSEM--ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR----- 617
L +L + Q+E LV +Y G L QP + L AR
Sbjct: 62 FLPTL--YASFQTETYLCLVMDYCPGGELFRLL--QRQP----GKCL--SEEVARFYAAE 111
Query: 618 ---GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK-AAPMDRGYVSTAVKGS 673
L YLH GI++RD+K NILL E+ ++DF LSK + KGS
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 674 FG---------------------------YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 706
Y+ PE D ++ G++L+E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 707 R 707
Sbjct: 229 T 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 40/122 (32%), Positives = 61/122 (50%), Gaps = 14/122 (11%)
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVST 668
I + +GL YL + I+HRDVK +N+L++ K+ DFG+S + + YV
Sbjct: 100 IAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-- 154
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWA-L 726
G+ Y+ PE +Q SDV+S G+ E+ R P P++ + Q SL L
Sbjct: 155 ---GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY--PQIQKNQGSLMPLQLL 209
Query: 727 QC 728
QC
Sbjct: 210 QC 211
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 35/160 (21%)
Query: 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIG 571
+G G + VY G + G VA+K E+G F E +L L+H ++V+L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA-------------RG 618
+ + LV+EY+ D KQ ++ C G RG
Sbjct: 71 IIHTKKTLTLVFEYLD----TD-----------LKQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
L Y H + ++HRD+K N+L+ E K+ADFGL++A
Sbjct: 116 LAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIGF 572
+G G +G V KVA+K+ + + I+ +T E+++L ++H +++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 573 ------CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE------ICIGSARGLH 620
+ +E+ LV M G + + Q+L + RGL
Sbjct: 83 FTPATSIENFNEVYLVTNLM----------GADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDP 679
Y+H+ GIIHRD+K +N+ ++E+ ++ DFGL++ A + GYV+T Y P
Sbjct: 133 YIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAP 184
Query: 680 E-YFRRQQLTEKSDVYSFGVVLFEVL 704
E + D++S G ++ E+L
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 69/347 (19%), Positives = 129/347 (37%), Gaps = 71/347 (20%)
Query: 510 FDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRHRH 565
F + +G+G FG+V + D + +++ + + + E +L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLH 623
+V L ++ + V +Y+ G L G L+ E+ + +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL-TCAVESVHKM- 120
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLS--------------------------- 656
G IHRD+K NIL+D + K+ DFGL
Sbjct: 121 -----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 657 -------------------KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 697
+AA + ++ ++ G+ Y+ PE R T+ D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 698 VVLFEVLCARPVINPKLPRE-QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVE 756
V+L+E+L +P + P E Q+ + W H + + P ++ I K
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIP--PQAKLSPEASDLII-----KLCR 288
Query: 757 AAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAST----QIDHPEDKS 799
E L + G D ++++ L++ S +I HP D S
Sbjct: 289 GPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTS 335
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/219 (23%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 512 ENAVIGVGGFGKVYIGVLEDG--NKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
E +G G +G VY +DG ++ + G+ ++ + EI +L +L+H +++SL
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISL 63
Query: 570 --IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GL 619
+ ++ L+++Y + + H+ ++ + K+ +++ G + G+
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 620 HYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKA--APMDRGYVSTAVKGS 673
HYLH A ++HRD+K NIL+ E K+AD G ++ +P+ V +
Sbjct: 122 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 674 FGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIN 711
F Y PE + T+ D+++ G + E+L + P+ +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 36/181 (19%)
Query: 535 VAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDH 594
V IK G G TE +L + H ++ L G L+ ++
Sbjct: 120 VVIKAGQRGGTA------TEAHILRAINHPSIIQLKGTFTYNKFTCLILPR-----YKTD 168
Query: 595 LYGTNQPPLSWKQRLEICIGSA------RGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648
LY L+ K+ + IC A R + YLH IIHRD+K NI ++
Sbjct: 169 LYCY----LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDV 221
Query: 649 KVADFGLSKAAPMD------RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 702
+ DFG + P+D G+ T + PE R D++S G+VLFE
Sbjct: 222 CLGDFG-AACFPVDINANKYYGWAGTIATNA-----PELLARDPYGPAVDIWSAGIVLFE 275
Query: 703 V 703
+
Sbjct: 276 M 276
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP---MDRGYVSTAVKGSF 674
G+ +LH + GIIHRD+K +NI++ + K+ DFGL++ A M YV T
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707
Y PE E D++S G ++ E++
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 30/219 (13%)
Query: 502 ELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKV----------AIKRGNPGSEQGINEF 551
+L+ ++++ VIG G FG+V + + KV IKR + F
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF------F 90
Query: 552 QTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ--RL 609
E +++ +V L + + +V EYM G + L P W +
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTA 149
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
E+ + + +H + G IHRDVK N+LLD++ K+ADFG +
Sbjct: 150 EVVL-ALDAIH------SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 670 VKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 704
G+ Y+ PE + Q + D +S GV L+E+L
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 554 EIQMLSKLRHRHLVSLIGF------CDEQSEMILVYEYM-ANGPFRDHLYGTNQPPLSWK 606
E+ +L + H++++SL+ +E ++ LV E M AN H+ + +S+
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-ELDHERMSYL 128
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP---MDR 663
+C G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A M
Sbjct: 129 LYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT 180
Query: 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
YV T Y PE E D++S G ++ E++
Sbjct: 181 PYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP---MDRGYVSTAVKGSF 674
G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A M YV T
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
Y PE E D++S G ++ E++
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 49/224 (21%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----------AIKRGNPGSEQGINEFQTEIQM 557
+F+ VIG G FG+V + +++ +V +KR F+ E +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDV 54
Query: 558 LSKLRHRHLVSL-IGFCDEQSEMILVYEYMANG-------PFRDHLYGTNQPPLSWK--- 606
L R + +L F DE + + LV +Y G F D L P +
Sbjct: 55 LVNGDRRWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRL-----PEDMARFYL 108
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666
+ + I S L Y +HRD+K N+LLD+N ++ADFG S + G V
Sbjct: 109 AEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTV 158
Query: 667 STAVK-GSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVL 704
+ V G+ Y+ PE + + + + D +S GV ++E+L
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 19/103 (18%)
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS--- 673
GL Y+H+ ++HRD+K N+L++ + K+ DFGL+ RG+ + +
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA------RGFSENPGENAGFM 166
Query: 674 FGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARPV 709
Y+ ++R Q T+ DV+S G +L E+L +PV
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 532 GNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589
G V ++ + +E+ + Q E+ + RH ++++ S + ++ +MA G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 590 PFRDHLYGTNQPP-LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---- 644
L T P +S I G+ RGL+YLH G IHR++K ++IL+
Sbjct: 85 SAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLV 140
Query: 645 ------NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL---TEKSDVYS 695
+L + V + +K D ST+V +L PE RQ L KSD+YS
Sbjct: 141 SLSGLSHLYSLVRNGQKAKVV-YDFPQFSTSV---LPWLSPELL-RQDLYGYNVKSDIYS 195
Query: 696 FGVVLFEVLCARPVINPKLPREQVSL 721
G+ E+ R V + R Q+ L
Sbjct: 196 VGITACELATGR-VPFQDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 20/169 (11%)
Query: 545 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLY--GTNQPP 602
E N+ E+ +L K ++V G + + + EYM G D LY G
Sbjct: 40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEG 98
Query: 603 LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662
+ I +GL +L IIHRDVK TN+L++ N K+ DFG+S
Sbjct: 99 IPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG----- 151
Query: 663 RGYVSTAVKGSFG---YLDPEYFR------RQQLTEKSDVYSFGVVLFE 702
V++ K + G Y+ PE + T +SDV+S G+ + E
Sbjct: 152 -NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 55/254 (21%), Positives = 104/254 (40%), Gaps = 55/254 (21%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRH 563
++F+ VIG G FG+V + +D V +++ + ++ + + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPF------RDHLYGTNQPPLSWKQRLEICIGSAR 617
+V + ++ + L+ E++ G +D L T + + + I S
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL--TEEETQFYIAETVLAIDS-- 116
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG----------------LSKAAPM 661
+H L G IHRD+K N+LLD K++DFG L+ + P
Sbjct: 117 -IHQL------GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 662 D------------------RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 703
D R ++ + G+ Y+ PE F + + D +S GV+++E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 704 LCARPVINPKLPRE 717
L P + P+E
Sbjct: 230 LIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 499 TFTELQNATQNFDENAVIGVGGFGKV---YIGVLEDGNKVAIKR-GNPGSEQG-INEFQT 553
TFT L+ QN IG G G V Y VL+ VAIK+ P Q
Sbjct: 12 TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR 65
Query: 554 EIQMLSKLRHRHLVSLIGF------CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ 607
E+ ++ + H++++SL+ +E ++ LV E M + + +S+
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125
Query: 608 RLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667
+C G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A ++
Sbjct: 126 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMM 175
Query: 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
T + Y PE E D++S G ++ E++
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-06
Identities = 41/121 (33%), Positives = 58/121 (47%), Gaps = 17/121 (14%)
Query: 591 FRDHLY---GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD--EN 645
+R LY G PL Q + + Y+H +GIIHRD+KT N+L++ E+
Sbjct: 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPED 298
Query: 646 LVAKVADFGLSKAAPMDRGYVSTAVK-GSFGYLD---PEYFRRQQLTEKSDVYSFGVVLF 701
+ + DFG AA RG ST G G +D PE T D++S G+V+F
Sbjct: 299 IC--LGDFG---AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
Query: 702 E 702
E
Sbjct: 354 E 354
|
Length = 461 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 51/218 (23%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 512 ENAVIGVGGFGKVYIGVLEDGN---KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
E +G G +G VY +DG + A+K+ G+ ++ + EI +L +L+H ++++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIA 62
Query: 569 L--IGFCDEQSEMILVYEYMANGPFR----DHLYGTNQPPLSWKQRL--EICIGSARGLH 620
L + ++ L+++Y + + N+ P+ + + + G+H
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 621 YLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKA--APMDRGYVSTAVKGSF 674
YLH A ++HRD+K NIL+ E K+AD G ++ +P+ V +F
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 675 GYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIN 711
Y PE + T+ D+++ G + E+L + P+ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQT--EIQMLSKLRHRHLVSLIGF 572
+G G + VY G + +G VA+K E+G F E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 573 CDEQSEMILVYEYMANG--PFRDHLYGTNQP---PLSWKQRLEICIGSARGLHYLHTGAA 627
+ + LV+EY+ + D G P L Q L RGL Y+H
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIHQ--- 121
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
+ I+HRD+K N+L+ + K+ADFGL++A
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 45/234 (19%)
Query: 516 IGVGGFGKVYIGVLEDGN-------------KVAIKRGNPGSEQGINEFQTEIQMLSKLR 562
+G G ++Y G+L + KV +K +P F M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
H+H+V L G C E I+V E++ GP D L+ + ++ A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSYL 121
Query: 623 HTGAAQGIIHRDVKTTNILLDENLV-------AKVADFG-----LSKAAPMDRGYVSTAV 670
+ ++H +V T NILL + K++D G LS+ ++R
Sbjct: 122 ED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------- 171
Query: 671 KGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723
++ PE + L+ +D +SFG L+E+ C N ++P + +LAE
Sbjct: 172 ---IPWIAPECVEDSKNLSIAADKWSFGTTLWEI-C----YNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 35/144 (24%), Positives = 58/144 (40%), Gaps = 11/144 (7%)
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
+ + + L +L+ +Y+ +G D L + LS + +I L+ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 623 HTGAAQGIIHRDVKTTNILLDENLV-AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
H IIH D+K N+L D + D+GL K G S G+ Y PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI----IGTPSC-YDGTLDYFSPEK 177
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLC 705
+ D ++ GV+ +E+L
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 37/126 (29%)
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSK--------------------------AAPMD 662
G IHRD+K N+LLD K++DFGL + PM
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 663 RGYVSTAVK-----------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIN 711
+ K G+ Y+ PE F + ++ D +S GV+++E+L P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 712 PKLPRE 717
P+E
Sbjct: 241 SDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 30/207 (14%)
Query: 516 IGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
IG G FGKV D ++ I++ + S + E +L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR----------GLHY 621
++ LV ++ G HL QR E +R L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----------QR-EGRFDLSRARFYTAELLCALEN 108
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
LH +I+RD+K NILLD + DFGL K D +T G+ YL PE
Sbjct: 109 LHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPEL 164
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARP 708
T+ D ++ GV+L+E+L P
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINE---FQTEIQMLSKLRH 563
+F+ VIG G FG+V + ++ ++ A+K N E F+ E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANG-------PFRDHLYGTNQPPLSWKQRLEICIGSA 616
+ + +L +++ + LV +Y G F D L + + + I S
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYIAEMVLAIHSI 118
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK-GSFG 675
LHY +HRD+K N+LLD N ++ADFG S G V ++V G+
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPD 168
Query: 676 YLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVL 704
Y+ PE + + + D +S GV ++E+L
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 28/180 (15%)
Query: 538 KRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL--IGFCDEQSEMIL------VYEYMANG 589
KR GS I + + EI L +L H +++ + I + + MI +Y +M +
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256
Query: 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAK 649
F PL + R I + Y+H + +IHRD+K NI L+ +
Sbjct: 257 AFD-----WKDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIV 307
Query: 650 VADFGL-----SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
+ DFG + D G+V T S PE E +D++S G++L ++L
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWVGTVATNS-----PEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 43/247 (17%)
Query: 509 NFDENAVIGVGGFGKVYIGVLED-GNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHR 564
+F+ VIG G FG+V + +D G+ A+K + + ++ + + E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
+V + ++ + L+ E++ G L + LS + + + +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFG----------------LSKAAPMD------ 662
G IHRD+K N+LLD K++DFG L+ P D
Sbjct: 120 ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 663 ------------RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI 710
R ++ + G+ Y+ PE F + + D +S GV+++E+L P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 711 NPKLPRE 717
+ P+E
Sbjct: 237 CSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 17/103 (16%)
Query: 602 PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661
PL+ ++ +C+ L LH A G NILL + + K+ K
Sbjct: 13 PLNEEEIWAVCLQCLGALRELHRQAKSG---------NILLTWDGLLKLDGSVAFKTPEQ 63
Query: 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
R F PE + Q TEK+D+YS G+ L+E L
Sbjct: 64 SR------PDPYFM--APEVIQGQSYTEKADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 58/220 (26%)
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGL---------SK-------------------AAP 660
G IHRD+K NIL+D + K+ DFGL SK +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 661 MDRGYVSTAVK--------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 706
+ G+ Y+ PE R T+ D +S GV+L+E+L
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 707 RPVINPKLPRE-QVSLAEWALQCH--RKGILEKIIDPVIAETICKESLRKYVEAAEKCLA 763
+P P E Q+ + W H + L + + + + AE L
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSR---------EASDLILRLCCGAEDRLG 291
Query: 764 EYGVDRPGMGDVLWNLEYAMQLQEAST----QIDHPEDKS 799
+ G D +++A ++ +I HP D S
Sbjct: 292 KNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTS 331
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 28/188 (14%), Positives = 66/188 (35%), Gaps = 36/188 (19%)
Query: 206 VSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVHYPDGGATPYIAPN 265
V +N GGP T + T+ +D ++ G A Y++
Sbjct: 1 VVLAINCGGPEHTDSDGI---TYEADT-------------------YFTGGSADYYVSDT 38
Query: 266 WVYASAQKMKEAQVMQ----PNFNLTWKMSVDPSFSYLIRFHFCDIV--SKSLNDLLFNV 319
+S + ++ Q + ++ + + +Y + HF +I L +F+V
Sbjct: 39 NGSSSIAGTTDPELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDV 98
Query: 320 YINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSSLP----- 374
Y+ + D+ + +K+++ T V + ++ + A +P
Sbjct: 99 YVQGKLVLKDFDIVAEAGGKGKTAHKEYI-PVT-VTDGTLEIHFYWAGKGTLLIPFRGVY 156
Query: 375 -NAILNGL 381
N ++ +
Sbjct: 157 GNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 68/227 (29%)
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGL--------------------------------- 655
G IHRD+K NIL+D + K+ DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 656 -------------SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 702
+A + ++ ++ G+ Y+ PE R+ T+ D +S GV+LFE
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 703 VLCARPVINPKLPRE-QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKC 761
+L +P P E Q+ + W H ++ + P + I K C
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK--LSPEAVDLITKLC----------C 288
Query: 762 LAEYGVDRPGMGDV-----LWNLEYAMQLQEAST----QIDHPEDKS 799
AE + R G D+ ++++ ++ +I HP D S
Sbjct: 289 SAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTS 335
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 38/171 (22%)
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF-----RDHLYGTNQPPLSW 605
F+T ++S++ H HL + G C SE I+V E++ +GP ++ + P++W
Sbjct: 64 FETA-SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAW 118
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA-------KVADFG---- 654
K + + SA L YL + ++H +V NILL +A K++D G
Sbjct: 119 KITVAQQLASA--LSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT 173
Query: 655 -LSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEV 703
LS+ ++R ++ PE L+ +D +SFG L E+
Sbjct: 174 ALSREERVER----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 35/143 (24%), Positives = 50/143 (34%), Gaps = 52/143 (36%)
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS--------------- 656
C+ + +H L G IHRD+K NIL+D K++DFGLS
Sbjct: 110 CVLAIEAVHKL------GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 657 ----KAAPMDRGYVSTAVK---------------------------GSFGYLDPEYFRRQ 685
S AV G+ Y+ PE F +Q
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 686 QLTEKSDVYSFGVVLFEVLCARP 708
++ D +S G ++FE L P
Sbjct: 224 GYGQECDWWSLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 41/238 (17%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR 562
++ +++ +IG G FG VY + ++ KVAIK+ Q E+ ++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLN 117
Query: 563 HRHLVSLIGF----CDEQSE----MILVYEYMANG--PFRDHLYGTNQ--PPLSWK-QRL 609
H +++ L + C +++E + +V E++ + H N P K
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPMDRGYVST 668
++C R L Y+H+ + I HRD+K N+L+D N K+ DFG +K
Sbjct: 178 QLC----RALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------L 222
Query: 669 AVKGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
A + S Y+ ++R +L T D++S G ++ E++ P+ + + +Q+
Sbjct: 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 74/310 (23%), Positives = 121/310 (39%), Gaps = 59/310 (19%)
Query: 98 PGPHW-VRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIG--NTTSLVFKEYLINIT- 153
P H+ VR+ F V + ++ +F V + + G + VF E L+ +T
Sbjct: 91 PKGHYSVRVFFGLVAEPNFD-SEPLFDVSVEG-TQISSLKSGWSSHDEQVFAEALVFLTD 148
Query: 154 GRLSIIFKPHKDSHA--FINAIEVVSAPGSIISDAASTVAP-----------RDTFTGLS 200
G SI F H H I +IE++ + D A P + G
Sbjct: 149 GSASICF--HSTGHGDPAILSIEILQ-----VDDKAYNFGPSWGQGVILRTAKRLSCGAG 201
Query: 201 NFAFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGS-EAVSVEPKNVHYPDGGAT 259
F+ Y + G R W + F GS +A+S E
Sbjct: 202 KSKFDEDYSGDHWGG---------DRFWNRMQT---FGSGSDQAISTENV---IKKASNA 246
Query: 260 PYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVS--KSLNDLLF 317
P P +Y SA + Q +L++ M VDP+ +Y + HF +I + + +F
Sbjct: 247 PNFYPESLYQSALVSTDTQP-----DLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVF 301
Query: 318 NVYINEFMAASSLDLSSLTNALSTAYYKDFVLNAT-AVKNDSITVQVGPASNAQSSLPNA 376
+V IN A +D+ ++ TA VLN T AV ++T+ + P +A
Sbjct: 302 DVLINGDTAFKDVDIVKMSGERYTA----LVLNKTVAVSGRTLTIVLQPKKG-----THA 352
Query: 377 ILNGLEVIKL 386
I+N +EV ++
Sbjct: 353 IINAIEVFEI 362
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 10/119 (8%)
Query: 67 AKSSPCPSAYP--LYRSARIFTG-ESRYRFFIS-QPGPHW-VRLHFYPVPHSSIKLTDAV 121
K+S P+ YP LY+SA + T + + + P ++ V LHF + +S V
Sbjct: 241 KKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRV 300
Query: 122 FTVQTDKFVLLHDFSIGNTTSLVFKEYLIN----ITGR-LSIIFKPHKDSHAFINAIEV 175
F V + D I + + ++N ++GR L+I+ +P K +HA INAIEV
Sbjct: 301 FDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHAIINAIEV 359
|
Length = 623 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 38/173 (21%), Positives = 61/173 (35%), Gaps = 28/173 (16%)
Query: 19 NYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPL 78
I+CG E T DG T+++D + S + + S + + P L
Sbjct: 2 VLAINCGGP--EHTD-SDGITYEADTYFTGG-SADYYVSDTNGSSSIAGTTDP-----EL 52
Query: 79 YRSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSI- 137
Y++ R Y + G + V LHF + L VF V ++L DF I
Sbjct: 53 YQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDFDIV 112
Query: 138 ----GNTTSLVFKEYLINIT-------------GRLSIIFKPHKDSHAFINAI 173
G + + + +T G L I F+ + I+AI
Sbjct: 113 AEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYGN-PKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 27/167 (16%), Positives = 57/167 (34%), Gaps = 16/167 (9%)
Query: 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS-- 568
++ G +VY+ L ++ + + NP E+G + + E+ +L L + L
Sbjct: 1 SSIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPK 57
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
++ + L+ E++ + E + L LH
Sbjct: 58 VLASGESDGWSYLLMEWIEGETL------DEVSEEEKEDIAEQ-LAEL--LAKLHQLPLL 108
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAP--MDRGYVSTAVKGS 673
+ H D+ NIL+D+ + + D+ + P D
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAALLFNLLE 155
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 29/171 (16%)
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
++V L + + + LV ++ G H+ P +R + A L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA--LDALHR 103
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFG-LSKAAPM-DRGYVSTAVKGSFGYLDPEYF 682
+GI+ RD+ NILLD+ ++ F S+ D V Y PE
Sbjct: 104 ---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733
+ TE D +S G +LFE+L + + ++CH GI
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTL----------------VECHPSGI 189
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 842 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| KOG3593 | 355 | consensus Predicted receptor-like serine/threonine | 98.43 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.04 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.29 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.77 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.48 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.3 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.21 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.12 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.04 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-56 Score=493.85 Aligned_cols=289 Identities=49% Similarity=0.829 Sum_probs=259.9
Q ss_pred CCccccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEee
Q 037607 494 LGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573 (842)
Q Consensus 494 ~~~~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~ 573 (842)
..+.|++.|++.||++|...++||+|+||.||+|.+++|..||||++.....+..++|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998876543146699999999999999999999999
Q ss_pred ccCC-eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 574 DEQS-EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 574 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
.+.+ +.+||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+.+...||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999876544899999999999999999999998888999999999999999999999999
Q ss_pred cccccccCC-CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 653 FGLSKAAPM-DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 653 FGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
||||+..+. .... .+...||.+|+|||++..+..++|+|||||||+|+||++|+++.+...+.....+++|+.....+
T Consensus 221 FGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999987765 3221 11118999999999999999999999999999999999999999987766677799999999999
Q ss_pred cccccccchhHH-hhhcH-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 732 GILEKIIDPVIA-ETICK-ESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 732 ~~l~~i~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+.+.+++|+.+. ..... +++.++..++.+|++.+|.+||+|.||+++|+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999987 55553 68899999999999999999999999999996543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-54 Score=509.40 Aligned_cols=329 Identities=21% Similarity=0.306 Sum_probs=265.6
Q ss_pred CCCCCceEEecCCCCCCccccCCCCccccCCCCCccccccccccccccccCccCCCCCCCCCccceeeeeeecc----cc
Q 037607 14 YSPRDNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPLYRSARIFTG----ES 89 (842)
Q Consensus 14 ~~p~~~~~i~cg~~~~~~~~~~~~r~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~tar~f~~----~~ 89 (842)
.+..|+|+||||++.+. .++.+||+|++|.. +.. + .. ...+.+ + .+ .++|+|||+|.. ++
T Consensus 20 ~~~~~~~~I~CGs~~~~-~~d~~~~~w~~D~~---~~~-~--~~-~~~~~~-----~-~~--~~~~~t~R~F~~~~g~~~ 83 (623)
T PLN03150 20 SPEPFTMRISCGARVNV-RTAPTNTLWYKDFA---YTG-G--IP-ANATRP-----S-FI--APPLKTLRYFPLSDGPEN 83 (623)
T ss_pred cCCCccEEEeCCCCCCc-ccCCCCCEEcCCcc---ccc-C--cc-ccccCc-----c-cc--cchhhccccCCccccccc
Confidence 33789999999998762 13468999999933 211 1 11 111111 1 11 256999999975 88
Q ss_pred eEEEeeccCcceEEEEeeccCCCCCCCccCcEEEEEeCc---eEEeccccCCCCCcceEEEEEEeecCc-eEEEEeeCCC
Q 037607 90 RYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDK---FVLLHDFSIGNTTSLVFKEYLINITGR-LSIIFKPHKD 165 (842)
Q Consensus 90 ~y~f~~~~~g~~~~rl~f~~~~~~~~~~~~~~f~v~~~~---~~~l~~f~~~~~~~~~~~e~~~~~~~~-~~i~f~p~~~ 165 (842)
||+||+.++|+|+|||||+|.+|++.+ +.+.|+|+++| ++|+++|+.. ..+++|||+++++++ +.|||+|..+
T Consensus 84 cY~~~~~~~g~ylVRl~F~~~~y~~~~-~~~~Fdv~~~~~~~~tv~~~~~~~--~~~v~~E~i~~~~~~~l~vcf~~~~~ 160 (623)
T PLN03150 84 CYNINRVPKGHYSVRVFFGLVAEPNFD-SEPLFDVSVEGTQISSLKSGWSSH--DEQVFAEALVFLTDGSASICFHSTGH 160 (623)
T ss_pred ceEeeecCCCcEEEEEEeecCCcCCCC-CCCceEEEECcEEEEEEecCcccC--CCcEEEEEEEEecCCcEEEEEecCCC
Confidence 999999889999999999999999999 88999999999 9999999864 468999999999976 9999999988
Q ss_pred CcceeeeeEEEecCCccccCcccccCCCCcccccccceeeEEEEEeeCCCccccCCCc----c--cccccCCCcccccCC
Q 037607 166 SHAFINAIEVVSAPGSIISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPLVTPKNDT----L--SRTWLSDEAYNAFPE 239 (842)
Q Consensus 166 ~~~fvn~ie~~~~p~~~~~~~~~~~~~~~~~~~~~~~a~~~~~rin~Gg~~~~~~~d~----~--~r~w~~d~~~~~~~~ 239 (842)
+.||||||||+|+|+++|.-. +. +-.+++|+++|||||||+++++.+|+ + +|.|.+|..|+...
T Consensus 161 ~~pFIs~iEv~~l~~~~y~~~-----~~----~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~- 230 (623)
T PLN03150 161 GDPAILSIEILQVDDKAYNFG-----PS----WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGS- 230 (623)
T ss_pred CCCceeEEEEEEcCccccccc-----cc----ccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCc-
Confidence 999999999999999888311 00 11267899999999999988765444 4 99999999886221
Q ss_pred CCcceecCCceeEeCCCCCCCCcCChHHHHHhhccccccCCCcceeeEEEEeeCCCCceEEEEeeecccc--ccCCcEEE
Q 037607 240 GSEAVSVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVS--KSLNDLLF 317 (842)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~Y~tar~~~~~~~~~~~~~lt~~~~v~~~~~y~vrlhF~ei~~--~~~~~r~F 317 (842)
....+....|.+. ..++|++|+.||+|||.+.... .++||.|+|+++++|+||||||||.. ...++|+|
T Consensus 231 --~~~~st~~~I~~~--~~~~~~~P~~VyqTA~~~~~~~-----~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F 301 (623)
T PLN03150 231 --DQAISTENVIKKA--SNAPNFYPESLYQSALVSTDTQ-----PDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVF 301 (623)
T ss_pred --ccccccccccccc--cCCCccChHHHhhhhccccCCC-----CceEEEeecCCCCCEEEEEEEEeccCccCCCceEEE
Confidence 1123344556655 3578999999999999998522 37999999999999999999999974 35689999
Q ss_pred EEEEcCccccCCCChhhhccccCceEEEEEEEEecccCCcceEEEeccCCCCCCCCccccccceeEeeccC
Q 037607 318 NVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSSLPNAILNGLEVIKLSN 388 (842)
Q Consensus 318 diyi~~~~~~~~~di~~~~~~~~~~~~~~~~v~~~~~~~~~l~i~~~p~~~~~~~i~~~~lnG~ei~~l~~ 388 (842)
||||||+.++++|||.+++++...++|++|.+.+. ++.|+|+|+|... ..+++||+||+++..
T Consensus 302 ~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~---~g~l~isl~p~~~-----s~pilNaiEI~~~~~ 364 (623)
T PLN03150 302 DVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVS---GRTLTIVLQPKKG-----THAIINAIEVFEIIT 364 (623)
T ss_pred EEEECCEEeecccChhhhcCCcccceEEEeEEeec---CCeEEEEEeeCCC-----Ccceeeeeeeeeccc
Confidence 99999999999999999999889999999999984 5899999999654 258999999999965
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=468.14 Aligned_cols=322 Identities=37% Similarity=0.630 Sum_probs=245.3
Q ss_pred EecCCCCCCccccCC---CCccccCCCCCccccccccccccccccCccCCCCCCCCCccceeeeeeec--ccceEEEeec
Q 037607 22 IDCGSGSSEQTSLDD---GRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPLYRSARIFT--GESRYRFFIS 96 (842)
Q Consensus 22 i~cg~~~~~~~~~~~---~r~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~tar~f~--~~~~y~f~~~ 96 (842)
||||++.+.+ ...| ||+|++|.. +..++. ..++... ..+..+...++|+|||+|. +++||+|++.
T Consensus 1 IdCG~~~~~s-~y~D~~tg~~~~~D~~---~~~~g~-----~~~i~~~-~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~ 70 (347)
T PF12819_consen 1 IDCGSSSNSS-SYVDDSTGRTWVSDDD---FIDTGK-----SGNISSQ-PDSSSSDSSPPYQTARIFPEGSRNCYTLPVT 70 (347)
T ss_pred CcCCCCCCCc-ccccCCCCcEEeCCCC---cccCCC-----ccccccc-cCCcCCccccccceEEEcCCCCccEEEeecc
Confidence 7999998854 1234 999999974 433222 1112101 1111122336799999997 7899999997
Q ss_pred cCc--ceEEEEeeccCCCCCCCccCcEEEE-E-eCceEEeccccCC------CC-CcceEEEEEEeec-Cc-eEEEEeeC
Q 037607 97 QPG--PHWVRLHFYPVPHSSIKLTDAVFTV-Q-TDKFVLLHDFSIG------NT-TSLVFKEYLINIT-GR-LSIIFKPH 163 (842)
Q Consensus 97 ~~g--~~~~rl~f~~~~~~~~~~~~~~f~v-~-~~~~~~l~~f~~~------~~-~~~~~~e~~~~~~-~~-~~i~f~p~ 163 (842)
++| +|||||||+|.+|++. .|+| + ...|.|+.+|+.. .. ..+++|||+|+|. ++ |.|||+|.
T Consensus 71 ~~~~~~yliRl~F~~gnyd~~-----~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~ 145 (347)
T PF12819_consen 71 PPGGGKYLIRLHFYYGNYDGL-----NFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPT 145 (347)
T ss_pred CCCCceEEEEEEecccccccc-----ccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeC
Confidence 544 9999999999998833 3454 2 2335566666652 11 2579999999999 45 99999999
Q ss_pred C-CCcceeeeeEEEecCCccccCcccccCCCCcccccccceeeEEEEEeeCCCc--cccCCCcccccccCCCcccccCCC
Q 037607 164 K-DSHAFINAIEVVSAPGSIISDAASTVAPRDTFTGLSNFAFEVSYRLNVGGPL--VTPKNDTLSRTWLSDEAYNAFPEG 240 (842)
Q Consensus 164 ~-~~~~fvn~ie~~~~p~~~~~~~~~~~~~~~~~~~~~~~a~~~~~rin~Gg~~--~~~~~d~~~r~w~~d~~~~~~~~~ 240 (842)
. +.+||||||||+|+|++++.+ ..+..++|||++||+||||.. +.+.+|+++|.|.+ |...+
T Consensus 146 ~~g~~pFIsaiEl~~lp~~ly~~----------~~~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~---~~~~~-- 210 (347)
T PF12819_consen 146 GSGTFPFISAIELRPLPDSLYPD----------TDANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQP---YSSSP-- 210 (347)
T ss_pred CCCCCCceeEEEEEECCccceec----------cccCCCceeEEEEeecCCCcccccCCCCCcceeeccc---cccCc--
Confidence 8 566999999999999999943 133578899999999999999 99999999999993 31111
Q ss_pred Ccce-ecCCceeEeCCCCCCCCcCChHHHHHhhccccccCCCcceeeEEEEeeCCCCceEEEEeeeccccc--cCCcEEE
Q 037607 241 SEAV-SVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSK--SLNDLLF 317 (842)
Q Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~p~~~Y~tar~~~~~~~~~~~~~lt~~~~v~~~~~y~vrlhF~ei~~~--~~~~r~F 317 (842)
.|. .+....+. .....+.|.+|..||+|||++..+. .+++|||.| ++++..|+||||||||+.. ..++|+|
T Consensus 211 -~~~~ist~~~i~-~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F 284 (347)
T PF12819_consen 211 -GWSNISTTSNIN-INSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREF 284 (347)
T ss_pred -cccccccceeee-cccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEE
Confidence 121 22233344 2346788999999999999999754 237999999 9999999999999999974 5568999
Q ss_pred EEEEcCccccCCCChhh-hccccCceEEEEEEEEecccCCcceEEEeccCCCCCCCCccccccceeEeec
Q 037607 318 NVYINEFMAASSLDLSS-LTNALSTAYYKDFVLNATAVKNDSITVQVGPASNAQSSLPNAILNGLEVIKL 386 (842)
Q Consensus 318 diyi~~~~~~~~~di~~-~~~~~~~~~~~~~~v~~~~~~~~~l~i~~~p~~~~~~~i~~~~lnG~ei~~l 386 (842)
||||||+++.+ |+.. +.+..+.|+|+||++.++ +.+.++|+|+|...+ .. +.+|||+||+++
T Consensus 285 ~IyiN~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~isL~~t~~S--~l-ppiLNalEIy~v 347 (347)
T PF12819_consen 285 DIYINGQTAYS--DVSPPYLGADTVPYYSDYVVNVP--DSGFLNISLGPTPDS--TL-PPILNALEIYKV 347 (347)
T ss_pred EEEECCeEccC--ccCcccccCcceEeecceEEEec--CCCEEEEEEEeCCCC--Cc-CceeEeeeeEeC
Confidence 99999999998 5444 567788999999999997 667999999998884 44 899999999986
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=408.14 Aligned_cols=256 Identities=35% Similarity=0.561 Sum_probs=213.5
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh--hHHHHHHHHHHHHhcCCCceeeEEEeeccCC-eEEEEEEecCCC
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ--GINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-EMILVYEYMANG 589 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~--~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-~~~lV~Ey~~~g 589 (842)
.+.||+|+||+||+|.++....||||++...... ..++|.+|+.+|++|+|||||+++|+|.+.. .++||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3459999999999999974445999998865322 2569999999999999999999999999887 799999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc-eEeccCCCCCEEEcCCC-ceEEeecccccccCCCCCcee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG-IIHRDVKTTNILLDENL-VAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~-ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|.+++++.....+++..+++|+.+||+||+|||+ ++ ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999977667899999999999999999999999 66 99999999999999997 99999999998765322 233
Q ss_pred eeeccCCCCCCccccc--ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 668 TAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~--~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
+...||+.|||||++. ...++.|+||||||++||||+||+.||..... .+ +...+.. .+ ....
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~--~~~~v~~---~~---------~Rp~ 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ--VASAVVV---GG---------LRPP 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH--HHHHHHh---cC---------CCCC
Confidence 4578999999999999 66999999999999999999999999987654 22 2222111 11 1112
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
+...+...+..++.+||+.+|.+||++.|++.+|+.+.....
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 233366778889999999999999999999999998866433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.97 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=206.4
Q ss_pred ccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC-eEEEEEEecC
Q 037607 511 DENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-EMILVYEYMA 587 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-~~~lV~Ey~~ 587 (842)
+..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+|||||.++|.|.... +..|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 33458999999999999986 6788999998544 4455688999999999999999999999998888 5999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|+|++++ +..+.+++...-+|+.++++||.|||+ .++||||||||+|||++..|++||||||.++..... ..
T Consensus 162 gGSLd~~~--k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 162 GGSLDDIL--KRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 99999998 344679999999999999999999995 389999999999999999999999999999876533 45
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCc--hhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP--REQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
....||..|||||.+.+..|+.++||||||++++|+.+|+-|+....+ .....+..+ +++... ..
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~~pp-P~ 301 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVDEPP-PR 301 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------HhcCCC-CC
Confidence 678899999999999999999999999999999999999999976521 111222222 222100 11
Q ss_pred hcH-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 746 ICK-ESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 746 ~~~-~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
++. ....++..++..||+.||.+||++.|+++.-
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 112 2456788899999999999999999998753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=388.15 Aligned_cols=254 Identities=32% Similarity=0.471 Sum_probs=212.4
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
...+.||+|-||.||.|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+|+|+|..++.++||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 34557999999999999998777999999887633 23679999999999999999999999999889999999999999
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeee
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 670 (842)
|.++|....+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||||+...++.-......
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 9999977677889999999999999999999999 9999999999999999999999999999996544443344455
Q ss_pred ccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 671 ~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
.-...|.|||.+....++.|+|||||||+||||+| |+.|+.+....+-+..+ .+| .++. -+..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-------e~G--yRlp-------~P~~ 428 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-------ERG--YRLP-------RPEG 428 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-------hcc--CcCC-------CCCC
Confidence 56779999999999999999999999999999998 77777766443322111 111 1111 1234
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 750 SLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
++..+.+++..||..+|++|||+..+...|+....
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 55677889999999999999999988888876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=388.58 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=213.9
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..|...++||+|||+.||+++. ..|+.||+|++.+. .....+...+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999997 88999999987663 3445678899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|+|++++|.+++ +.++++++.+++.++.||+.||.|||+ ++|||||||..|+||+++.++||+|||||.....+.
T Consensus 98 ELC~~~sL~el~--Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELL--KRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHH--HhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999988 578899999999999999999999999 999999999999999999999999999999886543
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
. .....+||+.|+|||++.+...+..+||||+|||||-||.|+|||+...-.+..+-+ +. .+-.
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I-------k~---~~Y~----- 236 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI-------KL---NEYS----- 236 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-------Hh---cCcc-----
Confidence 3 345689999999999999999999999999999999999999999866433221111 00 0000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
++........+|+.++|+.+|.+||++++|+..--.
T Consensus 237 --~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 --MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred --cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 112334456789999999999999999999975443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=371.78 Aligned_cols=204 Identities=31% Similarity=0.521 Sum_probs=183.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..+|...+.||+|+|++||+|+++ ++..||||.+... ..+..+.+..||.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999975 6899999988766 5666677899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC------CceEEeeccccc
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN------LVAKVADFGLSK 657 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~------~~~kl~DFGla~ 657 (842)
|||.||+|.++|+ ..+.+++..+..++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999994 45589999999999999999999999 999999999999999764 568999999999
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
.... +......+|++-|||||+++.++|+.|+|+||+|+||||+++|++||+.....+
T Consensus 164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 8763 334567899999999999999999999999999999999999999999776554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=397.94 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=216.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
+.+....+.||+|.||+||+|+.. +.+.||||.++..... ..++|++|+++|..|+|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344555668999999999999853 2457999999987555 789999999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccC--------C----CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 580 ILVYEYMANGPFRDHLYGT--------N----QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--------~----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
+||+|||..|+|.++|... . ..+|+..+.+.||.|||.||+||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 9999999999999999421 1 3348899999999999999999998 99999999999999999999
Q ss_pred eEEeecccccccCCCCCceee-eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 037607 648 AKVADFGLSKAAPMDRGYVST-AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~ 725 (842)
+||+||||++..-..+-+... ...-.++|||||.++.+++|.++|||||||||||+++ |+.|+.+....+ +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence 999999999876433333222 3345679999999999999999999999999999997 888887665443 3
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
..+.+.+.+-. .++.++.++.+|+..||+..|.+||+++||-..|+...+.
T Consensus 715 Ie~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 34444554422 2446677899999999999999999999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=367.23 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=208.4
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCCh-------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSE-------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS 577 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~-------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~ 577 (842)
..+.|.+.+.||+|+||.|-+|.- ++|+.||||.++...- .......+|+++|++|+|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345678888999999999999985 5799999998765311 11234579999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC---CceEEeecc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN---LVAKVADFG 654 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~---~~~kl~DFG 654 (842)
..|||||||+||.|.+.+ -.++.+.+.....++.|++.|+.|||+ +||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~v--v~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV--VANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHH--HhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999998 445567788889999999999999999 999999999999999654 899999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccC---CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
||+... ....+...+||+.|.|||++.+.. +..|+|+||+|||||-+|+|.+||....... .+.+. ..+
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ----I~~ 396 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ----ILK 396 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH----Hhc
Confidence 999875 344567899999999999998654 3358899999999999999999998654321 12211 112
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
|... +.| ....+..++.++++.+||..||++||++.|+++.-|..
T Consensus 397 G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 397 GRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred Cccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 2111 111 22345567788999999999999999999999876643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=349.34 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=213.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|+...++|+|+||+|||++.+ +|+.||||++....+ .-.+-.++||++|++|+|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46777889999999999999975 699999999876533 234557899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||+..=|.++- .....++...+.+++.|+++|+.|+|+ +++|||||||+||||+.++.+||||||+|+.... .+
T Consensus 82 ~~dhTvL~eLe--~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE--RYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHH--hccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99875555433 455678899999999999999999999 9999999999999999999999999999998763 33
Q ss_pred ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH--------h-hcccc-
Q 037607 665 YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ--------C-HRKGI- 733 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~--------~-~~~~~- 733 (842)
...+..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+.++...+..... . .....
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 34567788999999999988 8999999999999999999999999999887776654433221 1 11111
Q ss_pred ----cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 734 ----LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 734 ----l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.+.-++...+.--+....-+++++..|++.||.+|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22222222222222334557899999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=351.49 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=210.4
Q ss_pred cCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEE-eeccCCe-EEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIG-FCDEQSE-MILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g-~~~~~~~-~~lV 582 (842)
.+|.+.++||+|.||.|||+. +.+|..||.|.+.-. ..+..+....|+.+|++|+|||||++++ -+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999998 568999999987643 5566778999999999999999999998 4555555 8999
Q ss_pred EEecCCCCcccccc--cCCCCCCchHHHHHHHHHHHHHHHHHHhCCC-CceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 583 YEYMANGPFRDHLY--GTNQPPLSWKQRLEICIGSARGLHYLHTGAA-QGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~--~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
||||.+|+|...+. ++..+.++++.+++++.|+++||..+|..-. .-|+||||||.||+|+.+|.+||.||||++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999984 3566789999999999999999999997332 34999999999999999999999999999998
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
....+ -....+||+.||+||.+....|+.|+||||+||++|||+.-++||.+.+-. .+.+. ...+....+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~~K----I~qgd~~~~p- 249 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLCKK----IEQGDYPPLP- 249 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHHHH----HHcCCCCCCc-
Confidence 65433 345678999999999999999999999999999999999999999877321 12111 2222222111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++..|+..||+.||+...+++.+..
T Consensus 250 -------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 -------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 13456678889999999999999987666665554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=365.57 Aligned_cols=265 Identities=26% Similarity=0.343 Sum_probs=214.5
Q ss_pred cCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~lV 582 (842)
+.|+...+||+|.||.||||+ ..+|+.||+|++.... +.-..-..+||.||++|.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456777789999999999999 5689999999877654 33345567999999999999999999988765 789999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
+|||++ +|.-++. ...-.|++.++..++.|++.||+|+|. ++|+|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999986 5666552 345689999999999999999999999 99999999999999999999999999999988766
Q ss_pred CCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc------
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE------ 735 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~------ 735 (842)
.....+..+-|.+|+|||.+.+ ..|+.+.|+||.||||.||+.|++.+++..+.+|...+-.+..-..+..+.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 6656777788999999999987 689999999999999999999999999998877766543333222222122
Q ss_pred -cccc------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 -KIID------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 -~i~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.++. ..+.+. ........++|+..+|..||.+|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111 122222 23334667889999999999999999988863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=355.56 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=202.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.++||+|+||+||+++.+ +++.+|+|++++. .....+...+|..+|.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999864 6889999998764 234567789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
+||+.||.|..+| ++...+++..+.-++..|+.||.|||+ ++||||||||+|||||++|+++|+|||||+.....
T Consensus 104 ld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999 566789999999999999999999999 99999999999999999999999999999976433
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. .....++||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+... +.....+ +.+.
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~-~k~~------- 243 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILK-GKLP------- 243 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhc-CcCC-------
Confidence 2 23456899999999999999999999999999999999999999998764322 1111111 1100
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP 770 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 770 (842)
..+.-...+..+++.+.+..+|++|-
T Consensus 244 --~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 --LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 00111234577888999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=362.48 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=214.0
Q ss_pred HhcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHH--HHHHHHHHhcC-CCceeeEEEeeccCC-eEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEF--QTEIQMLSKLR-HRHLVSLIGFCDEQS-EMI 580 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f--~~Ei~il~~L~-HpnIv~l~g~~~~~~-~~~ 580 (842)
..++|...++||.|+||.||+|+ .+.|+.||||+++..-.. +++. ++|+.-|++|. |||||+|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678888899999999999999 567999999998875332 2333 68999999998 999999999998887 999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|||||+ .+|.+++.++ +..+++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+||||||...
T Consensus 87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 9999996 5899988655 7899999999999999999999999 999999999999999988999999999999875
Q ss_pred CCCCceeeeeccCCCCCCccccc-ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc--
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI-- 737 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i-- 737 (842)
... ..+..+.|.+|+|||++. ...|+.+.||||+|||++||.+-++.|.+..+.++..-+--+.....+..+.+.
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 443 346778899999999875 578999999999999999999999999988776654332222211111111110
Q ss_pred -----------cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 738 -----------IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 738 -----------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
+.+.-...+-.....+.++++.+|++.||.+|||+.|.+++-
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 001111122233567889999999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=362.63 Aligned_cols=271 Identities=26% Similarity=0.422 Sum_probs=217.7
Q ss_pred CccccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEe
Q 037607 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572 (842)
Q Consensus 495 ~~~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~ 572 (842)
+...+..++....+++.+...||+|+||+||+|.|. | .||||+++.. +.+..+.|++|+.++++-+|.||+-++||
T Consensus 379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cCCccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 334445666666677778889999999999999985 3 3999987764 55678899999999999999999999999
Q ss_pred eccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 573 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
|..... .||..+|+|-+|+.+||..+ .+|+..+.++|+.|||+||.|||. ++|||||||..||+|.+++++||.|
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEec
Confidence 988877 99999999999999997544 678999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC-CceeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 037607 653 FGLSKAAPMDR-GYVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 653 FGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
|||+.....-. ........|...|||||+++. .+|+..+||||||+|+|||++|..|+.... .++.- | +
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIi---f---m 604 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQII---F---M 604 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheE---E---E
Confidence 99987643211 112234457889999999874 578999999999999999999999998433 33210 1 1
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
...| ..+.|... ....+.++|.+|+..||..++++||.+.+|+.+|+....
T Consensus 605 VGrG--~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 VGRG--YLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred eccc--ccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1112 11222221 233456678889999999999999999999998887655
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=362.66 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=205.0
Q ss_pred hcCcccceEEeecCcEEEEEEEE------cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC-C
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ-S 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~------~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~-~ 577 (842)
.++|.+.++||+|+||.||+|.+ .+++.||||++.... ......+.+|+.+|.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999974 235679999987543 33456799999999999 899999999988754 4
Q ss_pred eEEEEEEecCCCCcccccccCC----------------------------------------------------------
Q 037607 578 EMILVYEYMANGPFRDHLYGTN---------------------------------------------------------- 599 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 599 (842)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5899999999999998885321
Q ss_pred --CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce-eeeeccCCCC
Q 037607 600 --QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGY 676 (842)
Q Consensus 600 --~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y 676 (842)
..++++.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++......... .....++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1357888999999999999999999 999999999999999999999999999998654332221 1233456789
Q ss_pred CCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHH
Q 037607 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYV 755 (842)
Q Consensus 677 ~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~ 755 (842)
+|||++.+..++.++|||||||+||||++ |..||......+. + ... ...+.... ........+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~~~-~~~~~~~~---------~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---CQR-LKDGTRMR---------APENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---HHH-HhcCCCCC---------CCCCCCHHHH
Confidence 99999999999999999999999999997 9999976543221 1 111 11111110 1112345678
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 756 EAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 756 ~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+++.+||+.+|.+||++.|++++|+.+.+
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=330.27 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=216.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChh-h-HHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQ-G-INEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~-~-~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...++||+|.||.||+|+. ++|+.||||+++..... + .....+||+.|+.++|+||+.|+++|...+.+-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 567778999999999999994 57999999998876432 1 34678999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|+. +|+..+. .....|+..++..++.++++||+|||+ +.|+||||||.|+|++++|.+||+||||++.+......
T Consensus 83 m~t-dLe~vIk-d~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MPT-DLEVVIK-DKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ccc-cHHHHhc-ccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 964 7887774 455688999999999999999999999 99999999999999999999999999999998754332
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc---ccchh
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK---IIDPV 741 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~---i~d~~ 741 (842)
.+..+-|..|+|||.+.+ +.|+..+||||.|||+.||+.|.|.|.+..+-+|...+--+.....+..+.+ +.|-.
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 223367999999999887 6899999999999999999999999999888887765544433333332222 11211
Q ss_pred H--------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 742 I--------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 742 l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
- ...+-..+....++++..++..+|.+|+++.|++++--
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 0 11122344566799999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.00 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=213.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
..+...+.++||+|-||.|..+....+.+||||.++..... ..++|.+||++|.+|+|||||+|+|+|..++.+++++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34566777899999999999999988899999999987544 45899999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||++|+|..+|.....+.+.-...+.||.|||.||+||.+ .++|||||.++|+|+|.++++||+|||+++..-....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999966544455667788899999999999999 9999999999999999999999999999996543333
Q ss_pred c-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHH--hCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 665 Y-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL--CARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 665 ~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELl--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
+ .....+-..+|||+|.+..++++.++|||+|||+|||++ |...|+.....++ .++-+..+.+.+.....+
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l--- 766 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVL--- 766 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceec---
Confidence 3 223445678999999999999999999999999999985 5777776543322 223233332222222111
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
..+.-++.++.+++.+||..+-++||+++++...|+.
T Consensus 767 ---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 767 ---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred ---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 1122345677899999999999999999999888764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.43 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=204.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--eEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS--EMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~--~~~lV~E 584 (842)
.++...+.||+|+||.||++... +|+..|||..........+.+.+|+.+|++|+|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34566778999999999999975 48999999876553333677899999999999999999999754444 6999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccccccCC--
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKAAPM-- 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~~~~-- 661 (842)
|+++|+|.+++.+... .|++..+..++.||++||+|||+ ++||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999965555 89999999999999999999998 99999999999999999 79999999999987653
Q ss_pred CCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
..........||+.|||||++..+ ....++|||||||++.||+||++||... .+ ..++...........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~---~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE---EAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc---hHHHHHHHhccCCCC-----
Confidence 122223457899999999999853 3446999999999999999999999864 11 112222211111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.++.....+..+++.+|++.+|.+|||+.|+++...-
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2233344567788999999999999999999986543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=345.71 Aligned_cols=247 Identities=21% Similarity=0.342 Sum_probs=199.9
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChh---hHHHHHHHHHHHHhcCCCceeeEEEeecc----CCeEEEEEEec
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ---GINEFQTEIQMLSKLRHRHLVSLIGFCDE----QSEMILVYEYM 586 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~---~~~~f~~Ei~il~~L~HpnIv~l~g~~~~----~~~~~lV~Ey~ 586 (842)
..||+|+++.||+|.+ +|+.||||++...... ..+.|.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 5889999998754322 25778899999999999999999999866 45789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.. ...+++...++++.+++.||.|||+ ..+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999943 4578999999999999999999997 2378899999999999999999999999988654221
Q ss_pred eeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 667 STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +..... ..+. . +
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~---~~~~-~----~---- 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLII---NKNN-S----L---- 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---hcCC-C----C----
Confidence 23457889999999976 689999999999999999999999998654322 111111 1110 0 0
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..+......+.+++.+||+.+|.+||++.|+++.|+...+
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111334568899999999999999999999999987543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=368.46 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=217.6
Q ss_pred CcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
...++++||.|.||.||+|.++- ...||||.++.. .+++..+|+.|..||.++.||||++|.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34667899999999999999752 347999999986 4566789999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|+.+|+... ..+++-++..++.+||.||+||-+ .++|||||..+|||++.+...|++||||++..+++.
T Consensus 710 EyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999996544 569999999999999999999998 999999999999999999999999999999887654
Q ss_pred Ccee--eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.... ..-+-..+|.|||.+..+++|.++||||||+||||.++ |.+|+-.....+-.+. ..++
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-------Ie~g-------- 850 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-------IEQG-------- 850 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-------HHhc--------
Confidence 3222 23334579999999999999999999999999999885 7777754432221111 1111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhcc
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAST 790 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~~ 790 (842)
.+-..+.+++..|.+|++.||+.|-.+||.+.+|+..|.+.........
T Consensus 851 -yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 851 -YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred -cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 1111234677889999999999999999999999999998877665543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.32 Aligned_cols=241 Identities=28% Similarity=0.487 Sum_probs=202.8
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
..+.||.|+-|.||+|+++ ++.||||+++.. -..+|+.|++|+||||+.+.|+|.....+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3458999999999999996 788999986532 24678999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+.| +...++......+|..+||.||+|||. ++|||||||+-||||..+..+||+|||-++..... .....++
T Consensus 200 ~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 200 YEVL--KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHH--hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 9999 566778889999999999999999999 99999999999999999999999999999877543 2234678
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
||..|||||++++.+.++|+|||||||||||||||..|+..-.... +-|. +-...|.-..+..++
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG-----------VGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG-----------VGSNSLHLPVPSTCP 337 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe-----------ccCCcccccCcccCc
Confidence 9999999999999999999999999999999999999986432211 0010 111111122344667
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
..|.-|+++||+..|..||++.+++..|+-+
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 7888899999999999999999999988754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=353.95 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=209.5
Q ss_pred cCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
..|....+||+|..|.||.+. ...++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 466667789999999999998 4578899999988765555567889999999999999999999998889999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.|.+. ...+++.++..||.++++||+|||. ++|+|||||.+||||+.++.+||+|||+|........ .
T Consensus 353 ~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999883 3348999999999999999999999 9999999999999999999999999999987754433 4
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....+||+.|||||+.....|++|.||||||++++||+-|.+||-...+-... |... ..| ..++-.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl----yLIa--~ng-~P~lk~------- 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIA--TNG-TPKLKN------- 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH----HHHh--hcC-CCCcCC-------
Confidence 45678999999999999999999999999999999999999999765443222 1111 111 111111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+.....|.+++.+||+.|+++||++.|+|+.
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 23345678889999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.89 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=210.0
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.+.|++...||.|..++||+|+. ..++.||||+++-. .....+.+.+|+..|+.++||||++++..|..+.++++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46789999999999999999984 56899999998754 33346889999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||.+|++.+.+...-...+++..+..|+.++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+..+-....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999977677789999999999999999999999 9999999999999999999999999998765543221
Q ss_pred c---eeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 665 Y---VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 665 ~---~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
. ......||++|||||+++. ..|+.|+||||||++.+||.+|..||....+-... ...+........ -
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~--t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLL--T 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcc--c
Confidence 1 1145689999999999654 67999999999999999999999999866443211 111111110000 0
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+..+-.+.....+.+++..||+.||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 01111112233447889999999999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.92 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=204.0
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.|...+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999986 478999999876432 2334567899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||++|+|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988865555678999999999999999999999 999999999999999999999999999998754322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... .. ....... .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~-~~~~~~~----------~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--VD-RRVKEDQ----------E 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--HH-HHhhccc----------c
Confidence 22345689999999999999999999999999999999999999986543221110 00 0000000 0
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWNL 779 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~L 779 (842)
.+.......+.+++.+||+.+|.+||+ ++|+++.-
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 112223456788999999999999997 78887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.12 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=206.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.. .......|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999863 3568999998765 33445679999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999988543 3578999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
..........++..|+|||.+.+..++.++|||||||++|||++ |++||......+ +.+.. ..+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~~~----- 227 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDGFRL----- 227 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCCC-----
Confidence 22222222345678999999999999999999999999999775 999997654322 11111 111100
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.........+.+++.+||+.+|.+||++.|+++.|...
T Consensus 228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223455688899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=358.94 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=209.1
Q ss_pred CcccceEEeecCcEEEEEEEEcC--C--cE-EEEEECCC---CChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLED--G--NK-VAIKRGNP---GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~--g--~~-VAvK~~~~---~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
+....++||+|.||.||+|.+.. + .. ||||..+. .......+|++|.++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445799999999999999753 2 23 89998874 35777899999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
||||+|.||+|.++|... ...++..+++.++.+.|+||+|||+ +++|||||..+|+|++.++.+||+||||++...
T Consensus 238 ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999999443 3369999999999999999999999 999999999999999999999999999988764
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .......-...|+|||.+....++.++|||||||++||+.+ |..|+.+....+ +..|+. ..+.-
T Consensus 314 ~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~---~~~~r----- 381 (474)
T KOG0194|consen 314 QYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV---KNGYR----- 381 (474)
T ss_pred cee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH---hcCcc-----
Confidence 111 11111235679999999999999999999999999999998 788887664332 222221 11111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
...+...+..+..+..+|+..+|++||+|.++.+.|+........
T Consensus 382 ----~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 ----MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111224455677788899999999999999999999987665543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=356.37 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=204.1
Q ss_pred hcCcccceEEeecCcEEEEEEEE------cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~------~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
.++|+..+.||+|+||.||+|++ +++..||||+++... ....+.+.+|+.+|+.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44688889999999999999974 235689999987542 33456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------------------------------------------------- 599 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (842)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998884321
Q ss_pred --------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 600 --------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 600 --------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1257889999999999999999999 99999999999999999999999999999866433221
Q ss_pred e-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 666 V-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 666 ~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
. .....++..|+|||++.+..++.++|||||||++|||++ |.+||....... .+..+.. .+... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~~--~~---- 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGYRM--LS---- 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCccC--CC----
Confidence 1 122335668999999999999999999999999999997 888886543221 1111111 11100 00
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
......++.+++.+||+.+|.+||++.||+++|++.
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=351.80 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=208.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC----Ch-hhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG----SE-QGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSE 578 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~----~~-~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~ 578 (842)
..++|...+.||+|+||+|+.|.. .+|+.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999985 47899999976653 12 23456678999999999 9999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeeccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSK 657 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGla~ 657 (842)
.++||||+.+|.|.+++.. ..++.+.++..++.|++.|++|||+ ++|+||||||+|||||.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999944 6789999999999999999999999 999999999999999999 999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccC-CC-CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s-~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +.. ...++...
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~----ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYR----KIRKGEFK 241 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHH----HHhcCCcc
Confidence 874 2223456788999999999999877 76 89999999999999999999998743221 111 11111100
Q ss_pred cccchhHHhhhcHHH-HHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKES-LRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
++... ..++..++.+|+..+|.+|+++.|+++.=+..
T Consensus 242 ----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 242 ----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 11111 45678899999999999999999999544443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=376.38 Aligned_cols=260 Identities=30% Similarity=0.463 Sum_probs=211.9
Q ss_pred cCcccceEEeecCcEEEEEEEEcC--Cc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED--GN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~--g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
.+....+.||+|.||.||+|...+ |. .||||.+... +.+...+|++|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345567789999999999999653 43 4899988875 5667789999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCC-----CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 581 LVYEYMANGPFRDHLYGTN-----QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
|++|||++|+|..+|++.+ ...|+..+.+.++.|||+|++||++ +++|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999996542 4568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeee-ccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 656 SKAAPMDRGYVSTAV-KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 656 a~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
|+..-...-+..... .-...|||||.++.+.++.|+|||||||+|||+++ |..|+......+-. ..| .+.+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~--~~~----~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL--LDV----LEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--HHH----HhCCc
Confidence 995433322222222 33568999999999999999999999999999998 78888765443311 111 22222
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
+. .+..++..+.+++.+||+.+|++||++..+++.++.+.+-.
T Consensus 923 L~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 923 LD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 21 13345567789999999999999999999999888776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.87 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=202.3
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-----------------CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-----------------GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-----------------g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l 569 (842)
++|...+.||+|+||.||+|.+++ +..||+|.+... ......+|.+|+++|++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999998542 336999998764 34445689999999999999999999
Q ss_pred EEeeccCCeEEEEEEecCCCCcccccccCC-----------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037607 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTN-----------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632 (842)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivH 632 (842)
++++.+.+..++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999998874321 1357888999999999999999999 89999
Q ss_pred ccCCCCCEEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh--CCCC
Q 037607 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPV 709 (842)
Q Consensus 633 rDIKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt--G~~p 709 (842)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865332211 1223345788999999998899999999999999999986 5566
Q ss_pred CCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 710 INPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 710 ~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+......+ ..+++.......... +. ......+...+.+++.+||+.+|.+||++.||.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQ-VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccc-cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66443221 222222211111000 00 0011223457889999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=337.17 Aligned_cols=265 Identities=20% Similarity=0.237 Sum_probs=204.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 5788999987643 23345678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|++++.|..+. .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99988776544 234578999999999999999999998 9999999999999999999999999999987643332
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHH---------HHhhcccccc
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWA---------LQCHRKGILE 735 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~l~ 735 (842)
.......|+..|+|||++.+..++.++|||||||++|||++|++||......+........ ..........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2333456899999999999989999999999999999999999999865433321111110 0000000000
Q ss_pred cccchh------HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 736 KIIDPV------IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 736 ~i~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
....+. ............+.+++.+||+.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 001111223456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=355.03 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=204.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
.++|++.+.||+|+||.||+|+.. ++..||+|++... .......+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888899999999999999842 2357999998754 333456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------------------------------------------------- 599 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (842)
.++|||||++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998874321
Q ss_pred ---------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce-eee
Q 037607 600 ---------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV-STA 669 (842)
Q Consensus 600 ---------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~ 669 (842)
..++++.++++|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1347888999999999999999999 999999999999999999999999999998654332211 122
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
..++..|||||++.+..++.++|||||||++|||++ |+.||........ +. .. ...+. .... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~-~~---~~~~~--~~~~-------~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY-KM---VKRGY--QMSR-------PD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH-HH---HHccc--CccC-------CC
Confidence 335668999999999999999999999999999997 9999975432221 11 00 01110 0000 01
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.....+.+++.+||+.+|.+||++.+++++|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12356788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=333.80 Aligned_cols=254 Identities=25% Similarity=0.446 Sum_probs=209.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|++.++||+|+||.||+|...++..||+|++..... ..+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56888899999999999999988888999998775433 35789999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999976666778999999999999999999998 8999999999999999999999999999987643322222
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ...+...... . + .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~---~-----~-----~ 225 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYR---M-----P-----R 225 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCC---C-----C-----C
Confidence 23345678999999998899999999999999999998 999997543222 1122111100 0 0 0
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+|+..+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.45 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=209.2
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
+.-.++|...+.||+|+|++|++|+. ..+..+|||++.+. .+...+-...|-+.|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44457899999999999999999984 46889999997754 122223466888999999 89999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
+|+|+||+++|.|.++| +..+.|++...+.++.+|+.||+|||+ +|||||||||+|||||+|+++||+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i--~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLI--KKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHH--HHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999999 455789999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCC----------cee--eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 037607 659 APMDRG----------YVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 659 ~~~~~~----------~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~ 726 (842)
+..... ... ..++||..|.+||+|.....+..+|+|+||||||+|+.|.+||...++.-.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-------- 295 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-------- 295 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--------
Confidence 753211 112 458899999999999999999999999999999999999999987754321
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.++|++ +.-++.+.......+|+.+.|..||.+|++..+|-+.
T Consensus 296 -------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 -------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111 1112233334667889999999999999999887653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=349.91 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=211.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|.+...||+|+||+||||+.+ +.+.||+|.+.+. .++.++.+.+|++++++|+|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777788999999999999854 6789999987653 45667889999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+.| +|..+| .....|+++.+..|+.++..||.|||+ .+|+|||+||.||||+..+.+|+||||+|+.... ..
T Consensus 82 ~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9977 999999 566789999999999999999999999 9999999999999999999999999999998764 44
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
...+...||+-|||||...+++|+..+|+||+||||||+..|+|||-.... ..+++.+ .. |+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~~Lv~~I---~~--------d~v--- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---TQLVKSI---LK--------DPV--- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---HHHHHHH---hc--------CCC---
Confidence 566788999999999999999999999999999999999999999964421 1122111 11 111
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+......+..++...+..||.+|.+..+++..
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1123556778999999999999999999998764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.19 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=208.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778889999987543 23567999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 99999999965555678999999999999999999998 899999999999999999999999999998765322111
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......+..|+|||++.+..++.++||||||+++|||++ |+.||....... +.... .... . . .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~-~-~-------~ 224 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQV----DQGY-R-M-------P 224 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC-C-C-------C
Confidence 122223458999999999999999999999999999999 999997553221 11111 0110 0 0 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=392.57 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=218.0
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
...+...++||+|+||.||+|+. .+|..||||++...... ...|++++++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999997 47899999998654322 23568899999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|++|+|.++++ .++|.++.+|+.|+++||+|||..+..+|+||||||+||+++.++.+++. ||+......+
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 99999999984 38999999999999999999997666899999999999999999988876 6665443211
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
....++..|||||++.+..++.|+|||||||++|||++|+.|++.... ....+.+|+...........++|+.+...
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence 223578999999999999999999999999999999999999965432 23457788876666556666677765432
Q ss_pred --hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 746 --ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 746 --~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
...++..++.+++.+||+.+|++||+|.|++++|+.+.+.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 3446677889999999999999999999999999877553
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.65 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=207.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.+|...+.||+|+||.||+|... .++.|++|++... .....++.+|++++++++||||++++++|...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778889999999999999965 5888999987754 334578999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+|||+++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999999865556678999999999999999999998 899999999999999999999999999998764332211
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+. .... ..+. ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~----~~~~---------~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----EKGY---------RME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCC---------CCC
Confidence 122334568999999999999999999999999999998 9999875432221 1111 1110 001
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+++.+|++.+|.+||++.+++++|+..
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1222345688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.98 Aligned_cols=251 Identities=31% Similarity=0.458 Sum_probs=204.0
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|+..+.||+|+||.||++.+.++..+|+|.+.... ....+|.+|+++|++++||||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577888999999999999998888899999876442 234678999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999988543 2468999999999999999999998 9999999999999999999999999999876543222222
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||++.+..++.++||||||+++|||++ |++||......+ ...+..... ....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~~------~~~~~------ 223 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRGF------RLYRP------ 223 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC------CCCCC------
Confidence 23345668999999998899999999999999999999 899987553322 222221110 01111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
......+.+++.+||+.+|.+||++.|+++.|
T Consensus 224 -~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 -KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.95 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=206.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++..++||||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 58899999976532 234567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999984 34578999999999999999999999 9999999999999999999999999999976533
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~l~~i~d~~l 742 (842)
......|++.|+|||++.+..++.++|||||||++|||++|++||......+... +..|.. .+.. +..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~~---~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------TLQR---PVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------cccC---CCC
Confidence 2234568999999999999999999999999999999999999998664433211 111110 0100 100
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
. .........+.+++.+||+.+|.+||++.|+++...
T Consensus 223 ~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 223 D-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred C-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 0 000123456788999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.32 Aligned_cols=249 Identities=36% Similarity=0.557 Sum_probs=196.3
Q ss_pred cceEEeecCcEEEEEEEEc-----CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 512 ENAVIGVGGFGKVYIGVLE-----DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~-----~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
..+.||.|.||.||+|.+. .+..|+||.++.. .....++|.+|++.+++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999987 2567999998664 344578999999999999999999999999988889999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC-
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG- 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~- 664 (842)
+++|+|.++|.......+++.+++.|+.|+++||.|||+ .+++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999977767789999999999999999999999 8999999999999999999999999999987632211
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ + .... .++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~---~~~~-~~~~~~~------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I---IEKL-KQGQRLP------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H---HHHH-HTTEETT-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---cccc-cccccce-------
Confidence 12233456779999999999999999999999999999999 778876553221 1 1111 1111111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
........+.+++.+||..+|++||++.++++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112345677899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.73 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=199.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc--CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhc---CCCceeeEEEeec-----c
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE--DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKL---RHRHLVSLIGFCD-----E 575 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~--~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L---~HpnIv~l~g~~~-----~ 575 (842)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46888999999999999999863 46789999876432 22234567788877766 6999999999884 3
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
....++||||+. ++|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 689888865555678999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HHHHHHHhhccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LAEWALQCHRKGIL 734 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~l 734 (842)
++..... .......|+..|+|||.+.+..++.++|||||||++|||++|++||......+... +.+.........+-
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9865432 22345568999999999998899999999999999999999999998765433221 11110000000000
Q ss_pred ------ccccch---hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 735 ------EKIIDP---VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 735 ------~~i~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.....+ .....+.......+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0011112233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.33 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=212.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
..+|...++||.|+||.||+|...++..+++|.+.........++.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688888999999999999998889999999988776656678999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++.+++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++....... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YL 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc-cc
Confidence 99999999976666778999999999999999999998 899999999999999999999999999997764322 12
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ...+... +.. ..
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~---------~~ 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA----GYR---------MP 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh----CCc---------CC
Confidence 223345678999999998899999999999999999998 899997654222 1111111 000 01
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112334567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.79 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=197.8
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
++||+|+||.||++... +|+.||||++... ......++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 6889999987653 2334567889999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 9998884 34578999999999999999999999 99999999999999999999999999998754322 122344
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... .+.. .+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~----~~~~----------~~p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL----MEEI----------RFPRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHH----cCCC----------CCCCC
Confidence 679999999999999999999999999999999999999997653222 111111 0000 01122
Q ss_pred HHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
....+.+++.+||+.+|.+|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 345678899999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.65 Aligned_cols=236 Identities=26% Similarity=0.386 Sum_probs=198.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||.|+||+|..++.+ +|..+|+|+++... .++.+...+|..+|+.+.||.+++|++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788889999999999999965 68889999988753 344567789999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||.+||.|..+| +..+++++..++-++.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~L--rk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL--RKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHH--HhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999 556789999999999999999999999 99999999999999999999999999999987432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.-+.+||+.|+|||.+..+.+...+|.|||||++|||++|.+||...++.. +. ++|+...+
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY------------~KI~~~~v- 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IY------------EKILEGKV- 258 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HH------------HHHHhCcc-
Confidence 457899999999999999999999999999999999999999998765522 11 11111111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCC
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDR 769 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~R 769 (842)
.++.-....+.+++...++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 0122223456677778888887777
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=341.11 Aligned_cols=266 Identities=26% Similarity=0.333 Sum_probs=198.9
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----CeEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SEMI 580 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~~~ 580 (842)
+|++.++||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999964 6899999987642 233446789999999999999999999988432 3589
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|||||. ++|.+++. ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68888873 34568999999999999999999999 999999999999999999999999999998653
Q ss_pred CCCC--ceeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 661 MDRG--YVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 661 ~~~~--~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
.... .......|+..|+|||++.+ ..++.++|||||||++|||++|++||.......................+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 11234568999999999876 6789999999999999999999999976543322211100000000000000
Q ss_pred ccc--------------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 737 IID--------------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 737 i~d--------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+.. +.......+.....+.+++.+||+.+|.+||+++|+++.-.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 000 00000001112345789999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=339.02 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=202.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 68899999876432 234567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999884 34578999999999999999999999 99999999999999999999999999998865422
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+. .+... .+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i~----~~~~--------- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKIL----AGKL--------- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCCc---------
Confidence 1235689999999999999999999999999999999999999976543221 11111 0100
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWNLE 780 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~Le 780 (842)
.+.......+.+++.+||+.||.+||+ +.|+++.-+
T Consensus 216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 011122345788999999999999995 777776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.73 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=205.8
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-C-----cEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-G-----NKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-g-----~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
++|++.+.||+|+||.||+|.... + ..|++|.+.... .....+|.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998643 2 579999887543 344567999999999999999999999999989999
Q ss_pred EEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC
Q 037607 581 LVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~ 646 (842)
++|||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 9999999999999885321 1568889999999999999999999 8999999999999999999
Q ss_pred ceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 037607 647 VAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEW 724 (842)
Q Consensus 647 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~ 724 (842)
.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ +.++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999976532221 12233456788999999998899999999999999999998 999987654322 2221
Q ss_pred HHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 725 ALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 725 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+. ++... ........++.+++.+||+.+|.+||++.||++.|+.
T Consensus 239 i~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IR----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11111 1122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.64 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=201.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 6889999987643 2234567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999884 34578899999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+. ...+...
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~----i~~~~~~-------- 233 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEK----ILAGRLK-------- 233 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHH----HhcCCcC--------
Confidence 123578999999999999999999999999999999999999997553321 1111 1111110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~ 778 (842)
+......++.+++.+||+.||.+||+ +.++++.
T Consensus 234 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 --FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112245678999999999999996 6777654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=340.42 Aligned_cols=268 Identities=23% Similarity=0.310 Sum_probs=206.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|+..+.||+|+||.||+++.. +|..+|+|.+... .....+++.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999975 6788999987754 33445679999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.+++. ....+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999984 34568899999999999999999997 236999999999999999999999999998765322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc-----------
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI----------- 733 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------- 733 (842)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+..............+.
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 12345689999999999999999999999999999999999999975443221110000000000000
Q ss_pred ----------------cccccchhHHh---h-hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 734 ----------------LEKIIDPVIAE---T-ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 734 ----------------l~~i~d~~l~~---~-~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
..++.+..... . .......++.+++.+||+.+|++||++.|+++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000000000 0 011234578999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=329.28 Aligned_cols=269 Identities=25% Similarity=0.310 Sum_probs=214.9
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECC--CCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-----
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE----- 575 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~--~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~----- 575 (842)
......|...+.||+|+||.|+.+... +|+.||||++. -......++..+|+.+|+.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 334556666778999999999999864 78999999987 3455667888999999999999999999998854
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
-...|+|+|+| ..+|...+ +.+..|+...+..+..|+++||+|+|+ .+|+||||||+|+|++.++.+||+||||
T Consensus 98 f~DvYiV~elM-etDL~~ii--k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQII--KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred cceeEEehhHH-hhHHHHHH--HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 45789999999 45788888 445569999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC-CCceeeeeccCCCCCCccccc-ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 656 SKAAPMD-RGYVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 656 a~~~~~~-~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
|+..... .....+..+.|..|+|||.+. ...|+...||||.|||+.||++|++.|.+.....+..+..-......+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987532 122346677899999999865 57899999999999999999999999999887777666543333333322
Q ss_pred cccccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 LEKIIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 l~~i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+..+-.... ...+-+......++++++||..||.+|+|++|.++.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 322221111 011122334567899999999999999999998864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.07 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=205.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~ 578 (842)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++|+++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888899999999999999853 13469999987543 334567999999999996 9999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------------------------------------------------- 599 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (842)
.+||||||++|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998874321
Q ss_pred -----------------------------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC
Q 037607 600 -----------------------------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644 (842)
Q Consensus 600 -----------------------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~ 644 (842)
...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1347888999999999999999998 99999999999999999
Q ss_pred CCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHH
Q 037607 645 NLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLA 722 (842)
Q Consensus 645 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~ 722 (842)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 999999999999865433222 1223346788999999999999999999999999999997 8888875432221 11
Q ss_pred HHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 723 EWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 723 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.. ...+... .........+.+++.+||+.+|++||++.+|+++|+...
T Consensus 351 ~~----~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NK----IKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH----HhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11 1111000 011233467889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.35 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=209.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
-|...+.||+|+-|.|-.|++ .+|+.+|||.+... +......+.+||-||+-|.||||++|++++++..++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466777899999999999996 58999999987665 22334568899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++|-|.+++ ...++|++.++.+.+.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||||.....+
T Consensus 93 yv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 93 YVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred ecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999999 556789999999999999999999999 99999999999999999999999999999875432
Q ss_pred ceeeeeccCCCCCCcccccccCCC-CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......||++.|+|||++++.+|. .++||||+|||||.||+|+.||+..+.. .+. ...+.|..+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LL----lKV~~G~f~-------- 230 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLL----LKVQRGVFE-------- 230 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHH----HHHHcCccc--------
Confidence 345678999999999999999886 7999999999999999999999854322 122 122223222
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
++.....+..+|+.+|+..||..|.|+.||++...
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 12334456778999999999999999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=332.44 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=200.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|...++||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999865 68899999876432 22345678999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++ +|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 974 88887743 23457899999999999999999999 9999999999999999999999999999976543221
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc--------
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK-------- 736 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~-------- 736 (842)
......++..|+|||++.+ ..++.++||||+||++|||++|++||......+................+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1233467899999999875 5689999999999999999999999987654433221111100000000000
Q ss_pred -ccchhHH----hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 737 -IIDPVIA----ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 737 -i~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
...+... .........++.+++.+||+.+|.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001000 0001112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.84 Aligned_cols=260 Identities=27% Similarity=0.369 Sum_probs=206.8
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--------------hhHHHHHHHHHHHHhcCCCceee
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--------------QGINEFQTEIQMLSKLRHRHLVS 568 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--------------~~~~~f~~Ei~il~~L~HpnIv~ 568 (842)
.+..|+|++...||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445688999999999999999999964 689999998765421 11357889999999999999999
Q ss_pred EEEeecc--CCeEEEEEEecCCCCcccccccCCCCC-CchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 569 LIGFCDE--QSEMILVYEYMANGPFRDHLYGTNQPP-LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 569 l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~-l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
|+.+..+ .+.+|||+|||..|.+...= ...+ |++.++++++.++..||+|||. ++||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 9999864 45799999999998776532 3344 9999999999999999999999 999999999999999999
Q ss_pred CceEEeecccccccCCCC----CceeeeeccCCCCCCcccccccC----CCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 646 LVAKVADFGLSKAAPMDR----GYVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 646 ~~~kl~DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
|++||+|||.+....... ........||+.|||||.+.++. .+.+.||||+||+||.|+.|+.||-.....+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 999999999998763211 11123467999999999987632 3578999999999999999999997654322
Q ss_pred hhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
...+|+...+.-...++...++.++++++|+.||++|.+..+|....+-...
T Consensus 327 ---------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 ---------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1122333223222334566788999999999999999999999877665433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=338.52 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=205.7
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
..++|+.+.+||+|+||.||.|+. .+|+.+|+|++++.. ....+..+.|-.+|....+|+||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999985 479999999998763 4456678899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||++||++..+| .+...|++..+...+.+++-|++-||+ .|+|||||||+|+|||..|++||+|||||.-...
T Consensus 219 iMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999 566789999999999999999999999 9999999999999999999999999999863311
Q ss_pred ----C-----------------CCce-------------------------eeeeccCCCCCCcccccccCCCCcccchh
Q 037607 662 ----D-----------------RGYV-------------------------STAVKGSFGYLDPEYFRRQQLTEKSDVYS 695 (842)
Q Consensus 662 ----~-----------------~~~~-------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDVwS 695 (842)
+ .... ....+||+.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 0000 01245999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhh-hhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC
Q 037607 696 FGVVLFEVLCARPVINPKLPREQ-VSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPG 771 (842)
Q Consensus 696 ~GvvL~ELltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 771 (842)
+||||||||.|.|||....+.+. ..+..|-..+..... .....+..+++.+|+. ||++|--
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999998876553 346666543332211 1122567789999999 9999975
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=337.04 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=203.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|+..+.||+|+||.||+|++. +++ .||+|+++.. .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 343 4899998754 344567899999999999999999999999764 5789
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
++||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999998543 3468899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
..... .....++..|+|||++.+..++.++|||||||++|||++ |++|+......+ +..+.. .+. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~--~~~~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGE--RLPQ 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----CCC--CCCC
Confidence 32221 122334678999999999999999999999999999997 999997653222 111111 110 0000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
...+...+.+++.+||+.+|.+||++.+++..|.....
T Consensus 233 -------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 -------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11123457889999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.42 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=206.5
Q ss_pred cCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|+..+.||+|+||.||+|.+.. ...||||.+... ......+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999999742 357999988754 344456899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++|+|+||||+|||+++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999998543 3478999999999999999999998 99999999999999999999999999999877522
Q ss_pred CC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 663 RG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 663 ~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +.++... +... +
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~~----~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVED----GYRL----P 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHc----CCCC----C
Confidence 22 22223345678999999999999999999999999999998 999986543221 1122111 1000 0
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+++.+|++.+|.+||++.||+++|+.+
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=326.02 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=205.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788889999999999999988888899999876433 3467999999999999999999999885 456899999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 9999999866555678999999999999999999999 8999999999999999999999999999987643322222
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||.+.+..++.++||||||+++|||++ |++||......+ ..++... ... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~---~~~----------~~~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVER---GYR----------MPC 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc---CCC----------CCC
Confidence 22345678999999988899999999999999999999 889987543222 1111110 000 011
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+|+..+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.38 Aligned_cols=240 Identities=23% Similarity=0.257 Sum_probs=194.6
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 5789999987642 334456788999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 998843 4568999999999999999999999 999999999999999999999999999998643222 2234467
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
||+.|+|||++.+..++.++|||||||++|||++|++||......+ ....... +.. .+.....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~~----------~~~~~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EPL----------RFPDGFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CCC----------CCCCcCC
Confidence 9999999999999999999999999999999999999997653221 1111111 100 0112233
Q ss_pred HHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPG---MGDVLWN 778 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPt---m~evl~~ 778 (842)
..+.+++.+||+.+|.+||+ +.|+++.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 56778999999999999985 5565543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.11 Aligned_cols=252 Identities=31% Similarity=0.413 Sum_probs=203.6
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|...+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|+.++++++||||++++++|......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577788999999999999998777779999877543 234679999999999999999999999999889999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999988543 3378999999999999999999998 9999999999999999999999999999886543322222
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +.+....... .. .
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~----~~---------~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLR----LY---------R 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCC----CC---------C
Confidence 23345678999999998889999999999999999998 999987554322 1111111100 00 0
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112457889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.28 Aligned_cols=255 Identities=30% Similarity=0.432 Sum_probs=206.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|.+.++||+|+||.||+|...+...||+|++.... ...++|.+|++++++++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35688999999999999999998777789999987532 234678999999999999999999998754 5689999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999965555678999999999999999999999 999999999999999999999999999998664332222
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. .....+. . ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~~-~--------~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY-R--------MP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcCC-C--------CC
Confidence 223446678999999998999999999999999999999 88888755332211 0000100 0 00
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
...+....+.+++.+|++.+|.+||++.++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=341.24 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=204.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeecc-CCe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE-QSE 578 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~-~~~ 578 (842)
++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+.+|++++.++ +|+||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999742 24689999987542 33456788999999999 89999999998854 456
Q ss_pred EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------------------------------------------------- 599 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (842)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999998874321
Q ss_pred CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce-eeeeccCCCCCC
Q 037607 600 QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGYLD 678 (842)
Q Consensus 600 ~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~A 678 (842)
...++|..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999998 999999999999999999999999999998764322211 223345678999
Q ss_pred cccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHH
Q 037607 679 PEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEA 757 (842)
Q Consensus 679 PE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l 757 (842)
||++.+..++.++|||||||+||||++ |..||......+. +... ..++... .........+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~----~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR----LKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH----HhccCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999997 9999876433221 1111 1111100 0111234568899
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 758 AEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 758 ~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+.+||+.+|++||++.|++++|+.+.+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=338.15 Aligned_cols=242 Identities=23% Similarity=0.317 Sum_probs=196.5
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+.||+|+||.||++... +|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999864 6899999987653 2334567789999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9988883 34578999999999999999999999 999999999999999999999999999987643221 12234
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........... . .. . .. .+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---~---~~-~---~~-------~~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---I---LM-E---EI-------RFPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---H---hc-C---CC-------CCCCC
Confidence 5689999999999999999999999999999999999999976543221110 0 00 0 00 01112
Q ss_pred HHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
....+.+++.+||+.+|.+|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 234677899999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.82 Aligned_cols=250 Identities=31% Similarity=0.441 Sum_probs=201.7
Q ss_pred CcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...+|.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677789999999999999987777899998765432 335788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999998543 2378999999999999999999999 89999999999999999999999999998765432222122
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...... .+. .. ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~-----~~----~~~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVS----AGY-----RL----YRP 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHH----cCC-----cC----CCC
Confidence 2234568999999999999999999999999999998 899987543322 111111 110 00 011
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
......+.+++.+||+.+|++||++.|++++|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=324.60 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=207.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.+.|++.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 457888999999999999999988899999998875433 3467999999999999999999999874 46789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999866666789999999999999999999998 899999999999999999999999999997765332222
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++....++.++|||||||++|||++ |++||......+. .+... .+... .
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~~~---------~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNLE----RGYRM---------P 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHH----cCCCC---------C
Confidence 233446778999999998899999999999999999998 9999976543221 11111 11000 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111223568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.41 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=207.6
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChh-h-HHHHHHHHHHHHhcCCCceeeEEEee--ccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQ-G-INEFQTEIQMLSKLRHRHLVSLIGFC--DEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~-~-~~~f~~Ei~il~~L~HpnIv~l~g~~--~~~~~~~lV~ 583 (842)
+|+..+.|++|+||.||+|+.+ +++.||+|+++...+. + --.-++||.+|.+++|||||.+..+. .+-+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666778999999999999964 7899999998875422 1 12458999999999999999998766 3456799999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++ +|..++.. ...++...++..+..|+++||+|||. +.|+|||||++|+|+...|.+||+|||||+.+....
T Consensus 157 e~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99986 67777743 34689999999999999999999999 999999999999999999999999999999987542
Q ss_pred CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc-----
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI----- 737 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i----- 737 (842)
...+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||++++|.|.+..+.++.+.+--......+..+...
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 23466677999999999887 67999999999999999999999999998877766544332222222211111
Q ss_pred ---------cchhHHhhhcHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 738 ---------IDPVIAETICKE-SLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 738 ---------~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
....+.+.+.-. ....-.+++..++..||.+|-|+.|.++.=.
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 111222222111 2245577888999999999999999886543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.01 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=199.1
Q ss_pred CcccceEEeecCcEEEEEEEE----cCCcEEEEEECCCC----ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPG----SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~----~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~ 579 (842)
+|++.+.||+|+||.||+++. .+++.||+|++... .....+.+..|+++++++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999985 35789999987542 223346688999999999 599999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999884 34568999999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
............||..|+|||++.+. .++.++|||||||++|||++|+.||.......... ........ .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-------~ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-------C 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------C
Confidence 43333333456799999999999865 47899999999999999999999997543222111 11111000 0
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
++. +.......+.+++.+||+.+|.+|| ++.++++.
T Consensus 227 ~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 1112234577899999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.75 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=204.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
.+++|+..+.||+|+||.||+|.+. .+..||+|++... ......+|.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999853 2467999987643 23445679999999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC--------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEE
Q 037607 579 MILVYEYMANGPFRDHLYGTN--------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl 650 (842)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999885321 2346788999999999999999998 89999999999999999999999
Q ss_pred eecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 037607 651 ADFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 651 ~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |.+||......+ ..++..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence 9999987654322111 112345678999999999999999999999999999998 788887553322 111111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
++.... ........+.+++.+|++.+|.+||++.|++++|+
T Consensus 236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111 11223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=329.00 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=203.0
Q ss_pred cCcccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.+|+..+.||+|+||.||+|.+ ..+..|++|.+... ..+...++.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999984 24578999998753 34445789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCC---------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC
Q 037607 582 VYEYMANGPFRDHLYGTN---------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~ 646 (842)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999884221 2357889999999999999999999 8999999999999999999
Q ss_pred ceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 037607 647 VAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEW 724 (842)
Q Consensus 647 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~ 724 (842)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |.+||......+ +.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986543221 11233345678999999998889999999999999999998 998886543221 1111
Q ss_pred HHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 725 ALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 725 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.. ...... .+.....++.+++.+|++.+|.+||++.+++++|.
T Consensus 239 ~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 VR----KRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HH----cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11 111110 11223456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=338.55 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=197.4
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
++||+|+||.||++... +|+.||+|++... ......++.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 6899999987653 2344567889999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9988883 34578999999999999999999999 999999999999999999999999999987643221 12234
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .... + . . .+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~---~---~~~~-~---~---~----~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E---LILM-E---D---I----KFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH---H---Hhcc-C---C---c----cCCCC
Confidence 56999999999999999999999999999999999999999765332211 1 0000 0 0 0 01112
Q ss_pred HHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
....+.+++.+||+.+|.+|| ++.|+++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 334678899999999999997 88988865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.90 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=204.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 68999999976431 234567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998543 678999999999999999999999 999999999999999999999999999998654332
Q ss_pred ----------------------------CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCc
Q 037607 664 ----------------------------GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP 715 (842)
Q Consensus 664 ----------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~ 715 (842)
........||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999986643
Q ss_pred hhhh-hHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHHHH
Q 037607 716 REQV-SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPG-MGDVLWNL 779 (842)
Q Consensus 716 ~~~~-~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-m~evl~~L 779 (842)
.+.. .+..|. ..+ ..+. .......+.+++.+|++ +|.+||+ +.|+++..
T Consensus 236 ~~~~~~i~~~~------~~~---~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 236 QETYNKIINWK------ESL---RFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHhccC------Ccc---cCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 2211 011110 000 0000 01124567788899997 9999999 99998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.71 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=194.5
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+|+..+.||+|+||.||+|+.. +|+.||||++... ......++.+|+++++.++|+||+++++++...+..++|||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445668999999999999965 6899999997654 3344567899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+.. .+.+..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....... .
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999986543 34567888999999999999999 9999999999999999999999999999987542211 1
Q ss_pred eeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 667 STAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||......+...+.... ....
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~~--------- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMSQ--------- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hccC---------
Confidence 234568999999998743 33456999999999999999999999743322211111100 0000
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..........++.+++.+||+.+|++||++.|+++.-.
T Consensus 293 -~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 293 -PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00011233456889999999999999999999997543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=354.43 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=216.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCC-cEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEee-c-----c-C
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDG-NKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFC-D-----E-Q 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g-~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~-~-----~-~ 576 (842)
...+.+++++|-+|||+.||.+....+ ..+|+|++....+.+++...+||++|++|+ |+|||.+++.. . . .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 346788899999999999999997765 999999988888999999999999999997 99999999932 1 1 2
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
-+.+|+||||.||.|-|++.......|++.++++|+.++++|+++||. +..+|||||||-+||||+.++..||||||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 478999999999999999966566669999999999999999999997 5677999999999999999999999999988
Q ss_pred cccCCCC-Cce-------eeeeccCCCCCCcccc---cccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 037607 657 KAAPMDR-GYV-------STAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 657 ~~~~~~~-~~~-------~~~~~gt~~Y~APE~l---~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~ 725 (842)
...-... ... .-...-|+.|+|||++ .+...++|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 6543221 110 0112358899999986 468899999999999999999999999986521
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
..|++....-...+....+|.+||..||+.+|.+||++.+|++.+-++...+...
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 1222222221223467889999999999999999999999999888876655433
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.97 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778889999999999999964 68899999876532 2233567889999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++|+|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999988865555679999999999999999999999 899999999999999999999999999988754322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ......... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~----------~~ 222 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKED----------QE 222 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhc----------cc
Confidence 1234468999999999999999999999999999999999999998654322111 111100000 00
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
.........+.+++.+|++.+|.+|| ++.++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11223445678899999999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=328.17 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=205.6
Q ss_pred cCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
++|.+.+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|+++|+.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 478999998765443 5678999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccC------------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 581 LVYEYMANGPFRDHLYGT------------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
+||||+++++|.+++... ....+++.++..++.|++.||.|||+ ++++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 999999999999998532 23458899999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~ 726 (842)
||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 99999998765322211 1223345778999999999999999999999999999998 999986553322 122211
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+.... ........+.+++.+||+.+|.+||++.||++.|+
T Consensus 239 ----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111 11123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=353.26 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=204.6
Q ss_pred CcccceEEeecCcEEEEEEEEc-C-CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-D-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~-g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++||||++++++|...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999854 3 6789999876666666677889999999999999999999999999999999999
Q ss_pred CCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 587 ANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 587 ~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
++|+|.+++.. ....++++.++..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988753 234578999999999999999999999 8999999999999999999999999999987643221
Q ss_pred -ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 -YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 -~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +..... .+... +
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~----~~~~~----~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVL----YGKYD----P--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCCC----C---
Confidence 12345569999999999999999999999999999999999999997543222 111110 01000 0
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........+.+++.+||+.+|.+||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11123356788999999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=340.97 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=200.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC--CcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED--GNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~--g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|.+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999998643 368999987542 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999984 34578999999999999999999999 9999999999999999999999999999986532
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. .....||+.|+|||++.+..++.++|||||||++|||++|++||........ . .....+...
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~----~~i~~~~~~------ 246 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---Y----QKILEGIIY------ 246 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---H----HHHhcCCCC------
Confidence 2 2345789999999999998899999999999999999999999976533211 1 111111100
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
++......+.+++.+|++.+|.+|+ +++|+++.
T Consensus 247 ----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111234567899999999999995 78888765
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.76 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=209.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.+|...+.||+|+||.||+|... ++..+++|++........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999843 345689999887766666789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 582 VYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999885321 2358999999999999999999998 99999999999999999999
Q ss_pred eEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 037607 648 AKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~ 725 (842)
+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |++||......+ ..+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999976543221 11223446788999999999999999999999999999998 999986554322 1111
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
...+..... .......+.+++.+||+.+|.+||++.+|+++|+.+..
T Consensus 238 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 11234568899999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.47 Aligned_cols=263 Identities=24% Similarity=0.421 Sum_probs=202.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-----CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-----DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-----~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~~ 580 (842)
+.|++.+.||+|+||.||++..+ ++..||+|++........+++.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999753 578999999887777777889999999999999999999998743 45689
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999998432 3468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCcee--eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 661 MDRGYVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 661 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
....... ....++..|+|||++.+..++.++|||||||++|||++|..++...... +......... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~ 231 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQ-GQMI 231 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccc-cccc
Confidence 4322111 1122345699999999889999999999999999999987765432110 1100000000 0000
Q ss_pred chhHH--------hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 739 DPVIA--------ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 739 d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
...+. ..........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000 001122345788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.86 Aligned_cols=243 Identities=27% Similarity=0.411 Sum_probs=207.1
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
....++|...++||+|.||+|+++.++ +++.+|||++++. ...+.+..+.|.+|+... +||.++.|+.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999975 5789999998875 455677889999999888 49999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
++.||||+.||++..+. ....+++..+.-++..++.||+|||+ ++||+||||.+|||||.+|.+||+||||++.
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999955444 45679999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
... .+..+..++||+.|||||++.+..|+..+|+|||||+|||||.|..||.+..+++..
T Consensus 518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------------------- 577 (694)
T KOG0694|consen 518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------------------- 577 (694)
T ss_pred cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------------------
Confidence 642 233567899999999999999999999999999999999999999999987655422
Q ss_pred chhHHh--hhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 739 DPVIAE--TICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 739 d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
|..+.. .++.-...+.+.++++++..+|++|--+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 221111 1223345667889999999999999977
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.85 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=205.0
Q ss_pred CcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
+|.+.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 23568899876543 3445789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccC----------------------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCC
Q 037607 582 VYEYMANGPFRDHLYGT----------------------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTN 639 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~----------------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~N 639 (842)
++||+.+++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999987431 12358899999999999999999998 999999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchh
Q 037607 640 ILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPRE 717 (842)
Q Consensus 640 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~ 717 (842)
||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865432221 1223345678999999988899999999999999999998 999997654322
Q ss_pred hhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+.++.. ++... .........+.+++.+|++.+|.+||++.|+++.|+.+..
T Consensus 238 ---~~~~~~----~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LFNLLK----TGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHHh----CCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112111 11000 0112233568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=337.06 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=195.3
Q ss_pred eEEeecCcEEEEEEEE----cCCcEEEEEECCCC----ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 514 AVIGVGGFGKVYIGVL----EDGNKVAIKRGNPG----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+.||+|+||.||++.. ..++.||+|++... .......+.+|+++|+.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 35788999987642 223345678999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++. ....+.+..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 99999999883 34568888999999999999999999 999999999999999999999999999987543222 1
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......|+..|+|||++.+..++.++|||||||++|||++|++||......... .... .+.. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~-~~~~----------~ 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKIL-KGKL----------N 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHH-cCCC----------C
Confidence 223456899999999999988999999999999999999999999765432211 1110 1110 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
+.......+.+++.+||+.+|++|| ++.++++.
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1112234678899999999999999 78877664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.96 Aligned_cols=266 Identities=26% Similarity=0.366 Sum_probs=203.0
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC-----eEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-----EMI 580 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-----~~~ 580 (842)
+|+..+.||+|+||.||++.. .+|+.||||++... .....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477888999999999999996 47899999987653 2334567899999999999999999999998766 789
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|+||+. ++|.+.+ .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKII--VSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5777776 334578999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh----------
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH---------- 729 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~---------- 729 (842)
...........++..|+|||++.+ ..++.++|||||||++|||++|++||......++...........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 333333344567899999999887 457999999999999999999999998765543322211100000
Q ss_pred --cccccccccc-hhHHh--hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 730 --RKGILEKIID-PVIAE--TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 730 --~~~~l~~i~d-~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......... +.... ....+....+.+++.+||+.||.+||++.|+++.-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000000000 00000 111222456789999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.64 Aligned_cols=266 Identities=27% Similarity=0.384 Sum_probs=201.0
Q ss_pred ccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEEE
Q 037607 511 DENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMILV 582 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~lV 582 (842)
...+.||+|+||+||++.. .+++.||+|.+.... ......|.+|+++|++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7778999999999988653 357789999887543 33456789999999999999999999988653 458999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ..+++.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999998843 358999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 663 RGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 663 ~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..+..+.........+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence 211 1122335667999999998899999999999999999999999986432210 0011110000000001111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.............+.+++.+|++.+|.+||++++++++|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111112234567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.00 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=208.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999852 245689999887766667889999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccC-----------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEE
Q 037607 582 VYEYMANGPFRDHLYGT-----------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl 650 (842)
||||+++++|.+++... ....+++.+++.++.|++.+|+|||+ ++++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 99999999999988532 12358999999999999999999998 99999999999999999999999
Q ss_pred eecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 037607 651 ADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 651 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
+|||+++....... .......++..|+|||++.+..++.++|||||||+++||++ |.+||......+ ..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence 99999986543221 11122335678999999999999999999999999999998 899987554322 11111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..+..... .......+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 236 -~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 -TQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111110 11123468899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.48 Aligned_cols=253 Identities=29% Similarity=0.426 Sum_probs=204.4
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|.+...||+|+||.||+|....+..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578888999999999999998777789999876543 23467899999999999999999999885 456899999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 9999999966555668999999999999999999998 8999999999999999999999999999976543222222
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..++... +... ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~~~---------~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER----GYRM---------PC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCCC---------CC
Confidence 23345678999999998899999999999999999999 899987653322 1112111 1000 01
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12334568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=343.20 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=200.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||+|... +|+.||||++... .......+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 6889999997643 2334566889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999843 4568999999999999999999999 999999999999999999999999999987543211
Q ss_pred Cc-------------------------------------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhC
Q 037607 664 GY-------------------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 706 (842)
Q Consensus 664 ~~-------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG 706 (842)
.. ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC---HHHHHHHH
Q 037607 707 RPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPG---MGDVLWNL 779 (842)
Q Consensus 707 ~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~evl~~L 779 (842)
++||......+. ....... ...+. .+ . .......+.+++.+|+. +|.+|++ +.|+++.-
T Consensus 236 ~~Pf~~~~~~~~---~~~i~~~--~~~~~---~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 236 YPPFCSDNPQET---YRKIINW--KETLQ---FP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCHHHH---HHHHHcC--CCccC---CC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 999986543221 1111110 00000 00 0 00123456678888886 9999998 88887753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.44 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=197.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.|...+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 6789999998653 23445678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++|+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999984 34568899999999999999999998 9999999999999999999999999999764311000
Q ss_pred ----------------------------------------------ceeeeeccCCCCCCcccccccCCCCcccchhHHH
Q 037607 665 ----------------------------------------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 698 (842)
Q Consensus 665 ----------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~Gv 698 (842)
.......||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHH--hhhhCCCCCCCHHHH
Q 037607 699 VLFEVLCARPVINPKLPREQV-SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEK--CLAEYGVDRPGMGDV 775 (842)
Q Consensus 699 vL~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPtm~ev 775 (842)
++|||++|++||......+.. .+..|. ..+. + + . ......++.+++.+ |+..++..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~-~--~---~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWE------NTLH-I--P---P--QVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccc------cccC-C--C---C--CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999865443211 111110 0000 0 0 0 00122345566666 556667779999999
Q ss_pred HHHH
Q 037607 776 LWNL 779 (842)
Q Consensus 776 l~~L 779 (842)
+..-
T Consensus 303 l~hp 306 (381)
T cd05626 303 KAHP 306 (381)
T ss_pred hcCc
Confidence 8753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=335.13 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=207.8
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.|.....||+|.||.||||.. ..++.||+|++... .+...++.++|+.+|.+++|+||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 455567899999999999995 46889999998765 3445688999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
.||++.+.| +....+++..+.-|+.+++.||.|||. ++.+|||||+.|||+.++|.+||+|||++-.........
T Consensus 94 ~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 94 GGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred cCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999 455566888899999999999999999 999999999999999999999999999998776543333
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
..++||+-|||||+++...|+.|+||||||++++||.+|.||+....+..-. -.+.+-.-|.+.+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------flIpk~~PP~L~~-- 233 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------FLIPKSAPPRLDG-- 233 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------EeccCCCCCcccc--
Confidence 6788999999999999989999999999999999999999999765442110 0122222233333
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.....+.+++..||..+|+.||++.++++
T Consensus 234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 --DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33456888999999999999999999976
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.00 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=205.8
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-Cc--EEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-GN--KVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-g~--~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998753 33 4788887743 344567899999999999 799999999999999999999
Q ss_pred EEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 583 YEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
+||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999985421 1358899999999999999999998 999999999999999999999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~ 727 (842)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+. .+ .
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~---~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE---K 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---H
Confidence 999999986432111 1111223557999999998899999999999999999997 9999976543221 11 1
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
. ..+... .........+.+++.+|++.+|.+||++.+++++|+.+.+..+.
T Consensus 231 ~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 L-PQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred H-hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1 111000 01112335678899999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.00 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=206.6
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...+.||+|++|.||+|... +++.|++|.+... ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999975 6889999987542 345567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 999999999976556689999999999999999999998 8999999999999999999999999999887643322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......|+..|+|||++.+..++.++|||||||+++||++|+.||......+ ...+. ..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~~--------- 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKI----IRGVFPP--------- 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCCCCC---------
Confidence 2234468889999999999999999999999999999999999997654221 11111 1111111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.......+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111334568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.92 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=198.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.+.||+|+||.||++... +++.||||++... .....+++.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 6889999987643 2334567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999884 34578899999999999999999999 999999999999999999999999999986331100
Q ss_pred C----------------------------------------------ceeeeeccCCCCCCcccccccCCCCcccchhHH
Q 037607 664 G----------------------------------------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 697 (842)
Q Consensus 664 ~----------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~G 697 (842)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhhh-HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCC---CCHH
Q 037607 698 VVLFEVLCARPVINPKLPREQVS-LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDR---PGMG 773 (842)
Q Consensus 698 vvL~ELltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ptm~ 773 (842)
|++|||++|++||......+... +..|. . .+.-+ . .......+.+++.+|++ +|.+| +++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~------~---~~~~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWR------E---TLYFP---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccC------C---ccCCC---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999997654332111 11110 0 00000 0 00123456788889997 66665 6999
Q ss_pred HHHHHHH
Q 037607 774 DVLWNLE 780 (842)
Q Consensus 774 evl~~Le 780 (842)
|+++.-.
T Consensus 301 ~~l~hp~ 307 (377)
T cd05629 301 EIKSHPF 307 (377)
T ss_pred HHhcCCC
Confidence 9887643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=340.18 Aligned_cols=262 Identities=21% Similarity=0.196 Sum_probs=198.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|.+.+.||+|+||.||++... .++.||+|+... ..+.+|+++|++|+||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999864 688999997432 3578999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+. ++|.+++. ....+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 95 68888773 34568999999999999999999999 89999999999999999999999999999754322222
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh-----hhhHHHHHHHhhc---c------
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE-----QVSLAEWALQCHR---K------ 731 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~-----~~~l~~~~~~~~~---~------ 731 (842)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+-...... ...+......... +
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3345679999999999999999999999999999999999998764332111 0001000000000 0
Q ss_pred ccccccc---------chhHH--hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 732 GILEKII---------DPVIA--ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 732 ~~l~~i~---------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+.++. .+... .....+....+.+++.+||+.+|.+|||+.|+++.-.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 0000000 00000 0001123457889999999999999999999997544
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.23 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=206.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
.++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888999999999999999742 34579999877543 33456789999999999 79999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+.+|+|.+++.......+++.+++.++.|++.||+|||+ ++|+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999865555558999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 659 APMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 659 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |.+|+......+. ...+.. .+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~~~- 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGYRM- 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCCcC-
Confidence 6433221 1122345678999999999999999999999999999998 9999875543221 111111 11000
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........++.+++.+|++.+|++||++.|+++.|+.+
T Consensus 264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=331.81 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=204.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|+..++||+|+||.||++... ++..+|+|.+... ......++.+|++++++++||||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367899999999999999999976 5788999987654 33445679999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++|+|.+++. ....+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999984 34568899999999999999999997 247999999999999999999999999998765322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc----------
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL---------- 734 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l---------- 734 (842)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+... .......+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL----MFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH----HhcCcccCCccccccCcccC
Confidence 1233468999999999999899999999999999999999999997543321110 0000000000
Q ss_pred -------------------ccccchhHHhh---hc-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 735 -------------------EKIIDPVIAET---IC-KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 735 -------------------~~i~d~~l~~~---~~-~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+.+...... .. .....++.+++.+||+.+|.+||++.|+++.-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 00000000000 00 012356889999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.91 Aligned_cols=260 Identities=25% Similarity=0.437 Sum_probs=207.5
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~ 576 (842)
...++|+..+.||+|+||.||++.... ...+|+|++... ..+...++.+|+++++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678888999999999999998642 357999987753 344556789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCccccccc--------------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYG--------------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~--------------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
+..+++|||+++|+|.+++.. .....+++..++.++.|++.||+|||+ ++|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 999999999999999998853 224568999999999999999999998 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..|+......+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF- 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-
Confidence 999999999999998764322111 122335678999999998999999999999999999997 88888755332211
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+. ...+... .........+.+++.+|+..+|.+||++.|+++.|+...
T Consensus 245 --~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 --KL----LKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HH----HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 1111000 011223456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=343.60 Aligned_cols=255 Identities=23% Similarity=0.272 Sum_probs=202.2
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
..++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999965 6889999987542 22334567899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998843 357888899999999999999999 9999999999999999999999999999987643
Q ss_pred CCCceeeeeccCCCCCCccccccc----CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
..........||+.|+|||++.+. .++.++|||||||++|||++|++||........ ...... .... +
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~--~~~~---~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIMD--HKNS---L 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHHHHc--CCCc---C
Confidence 322223456799999999998653 478999999999999999999999986543221 111100 0000 0
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVD--RPGMGDVLWNL 779 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~evl~~L 779 (842)
..+ ........+.+++.+||+.+|.+ ||++.|+++.-
T Consensus 267 ~~~-----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 267 TFP-----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCC-----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 000 01122456778999999988987 99999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.55 Aligned_cols=203 Identities=24% Similarity=0.419 Sum_probs=176.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||+||++... +++.||||++... .......+.+|+.++.+++||||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999864 5889999998643 2233467889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999984 34578999999999999999999999 999999999999999999999999999987543110
Q ss_pred C----------------------------------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCC
Q 037607 664 G----------------------------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709 (842)
Q Consensus 664 ~----------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p 709 (842)
. .......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 037607 710 INPKLP 715 (842)
Q Consensus 710 ~~~~~~ 715 (842)
|.....
T Consensus 236 f~~~~~ 241 (363)
T cd05628 236 FCSETP 241 (363)
T ss_pred CCCCCH
Confidence 986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.40 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=199.0
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCccc
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD 593 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (842)
+||+|+||.||+|...++..+|+|++.... ......+.+|++++++++||||++++++|...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 689999999999998888999999987654 3334578999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccC
Q 037607 594 HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS 673 (842)
Q Consensus 594 ~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 673 (842)
++... ...+++..++.++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||++...............++
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 82 FLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 88433 3468999999999999999999998 9999999999999999999999999999875432211111222345
Q ss_pred CCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHH
Q 037607 674 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLR 752 (842)
Q Consensus 674 ~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~ 752 (842)
..|+|||++.+..++.++|||||||++|||++ |..||........ .... ..+... ........
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~----~~~~~~---------~~~~~~~~ 221 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQV----EKGYRM---------SCPQKCPD 221 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHH----HcCCCC---------CCCCCCCH
Confidence 68999999998899999999999999999998 9999875533221 1111 111000 01122346
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 753 KYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 753 ~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+.+++.+|++.+|++||++.|++++|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.74 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=207.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCC---CChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNP---GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~---~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||.||+|+.. +++.||||.+.. ........+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999964 688999997653 23444567899999999999999999999999999999999
Q ss_pred EecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 584 EYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||+++++|.+++.. .....+++..++.++.|+++||.|||+ ++++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988742 234568899999999999999999998 9999999999999999999999999999887643
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..++.......+ .+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~------~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQCD------YPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhcCC------CCC
Confidence 221 122345888999999999888999999999999999999999998643221 111111111100 110
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
+ ........+.+++.+||+.+|.+||++.||++.|+..
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 1123346688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.62 Aligned_cols=255 Identities=31% Similarity=0.470 Sum_probs=208.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|.+.++||+|+||.||+|..+++..++||.+..... ..+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467889999999999999999988888999998875433 3467999999999999999999999999889999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++.+++.++.|++.||.|||+ ++++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 99999999976555679999999999999999999998 899999999999999999999999999988764322112
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++|||||||+++||++ |+.||....... ..+.... + .. . .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~----~-~~-~-------~ 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVER----G-YR-M-------P 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C-CC-C-------C
Confidence 223335668999999999899999999999999999998 999996543222 1111111 0 00 0 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+|++.+|.+||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111224568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=333.34 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=197.3
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
++||+|+||.||++... +++.||+|+++.. .......+..|+.++..+ +||||+++++++...+..++|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 6889999988653 233456688999999998 799999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 99988873 34579999999999999999999999 999999999999999999999999999987532211 1233
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh--hhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE--QVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
...||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....++........... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------I 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------C
Confidence 4678999999999999999999999999999999999999997432211 111222332222221111 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCC------HHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPG------MGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPt------m~evl~~ 778 (842)
+......+.+++.+||+.+|.+||+ +.++++.
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1122345788999999999999997 5676643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.82 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=211.8
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+++. ++++.-.+.+||+||+.|+||||+.++.+|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45678888999999999999984 67999999987653 566677889999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||..+|.|.|++ ..+..|++.++..++.||..|+.|+|. ++++|||||.+|||||.++++||+||||+..+...
T Consensus 132 MEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999 567789999999999999999999999 99999999999999999999999999999887544
Q ss_pred CCceeeeeccCCCCCCcccccccCCC-CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. ....++|++-|.+||.+.+.+|. +.+|-|||||+||.|+.|..||++..... ++ .+ ...|...+
T Consensus 207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lv---rQ-Is~GaYrE----- 272 (668)
T KOG0611|consen 207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LV---RQ-ISRGAYRE----- 272 (668)
T ss_pred c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HH---HH-hhcccccC-----
Confidence 3 34678999999999999999886 89999999999999999999999764322 21 11 11222221
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
++.+....-++++||-.+|++|-|+.+|...-+
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 122344566889999999999999999987644
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.89 Aligned_cols=250 Identities=29% Similarity=0.484 Sum_probs=206.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|+..+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788889999999999999875 78899999876544 5678999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999999865555579999999999999999999998 999999999999999999999999999998763221
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....+..|+|||++....++.++||||||++++||++ |+.||......+ +..... ++... .
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~---------~ 219 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVE----KGYRM---------E 219 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----cCCCC---------C
Confidence 12334668999999998899999999999999999997 999987553222 111111 11000 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+|+..+|.+||++.|++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.86 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=200.5
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
+....++|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999975 5788999987542 22334568899999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++|||||++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999998842 357889999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccCCCCCCccccccc----CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
.............||+.|+|||++.+. .++.++|||||||+||||++|++||......+.. .... .....+
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~--~~i~---~~~~~~ 266 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY--SKIM---DHKNSL 266 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH--HHHH---hCCccc
Confidence 643322223456799999999998764 3789999999999999999999999765432211 0000 000000
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD--RPGMGDVLWNLE 780 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~evl~~Le 780 (842)
. + + . .......+.+++..|++..+.+ ||++.|+++.-+
T Consensus 267 ~-~--p---~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 267 N-F--P---E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred C-C--C---C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 0 0 0 0 0122345667778888755543 889999887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.77 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=205.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CC---cEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DG---NKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g---~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|+..+.||+|+||.||+|... ++ ..+++|.+... .....+++.+|++++++++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356888899999999999999975 33 37999998765 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999988542 3578999999999999999999998 8999999999999999999999999999876643
Q ss_pred CCCcee--eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 662 DRGYVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 662 ~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||......+ + ..... .+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~---~~~i~-~~~--~~- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---V---MKAIN-DGF--RL- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHh-cCC--CC-
Confidence 222111 11223457999999998889999999999999999997 999997554322 1 11111 110 00
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
+ ...+....+.+++.+|++.+|.+||+|.+|++.|+++
T Consensus 230 -~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1112345678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.15 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=198.3
Q ss_pred ccceEEeecCcEEEEEEEEcC-Cc--EEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------CeE
Q 037607 511 DENAVIGVGGFGKVYIGVLED-GN--KVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------SEM 579 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~-g~--~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~~~ 579 (842)
.+.+.||+|+||.||+|.+.+ +. .+|+|.++.. +....+.+.+|+++++.++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999754 33 5899987653 345567899999999999999999999987432 246
Q ss_pred EEEEEecCCCCccccccc----CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 580 ILVYEYMANGPFRDHLYG----TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
+++||||++|+|.+++.. .....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999887732 233458999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 656 SKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 656 a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
++........ ......++..|+|||++.+..++.++|||||||++|||++ |++||......+ +.+. ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----LRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcCC
Confidence 9876432211 1122345678999999999999999999999999999999 888887543221 1111 11111
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
... ........+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 1112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.87 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=196.4
Q ss_pred EEeecCcEEEEEEEEc---CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLE---DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999876543 334578999999999999999999999985 45679999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee--
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS-- 667 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~-- 667 (842)
+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||.|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999884 33568999999999999999999998 9999999999999999999999999999987654332211
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||.+....++.++|||||||++|||++ |++||......+ +.+.. .++.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i----~~~~~~~---------~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMI----ESGERME---------C 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCCCC---------C
Confidence 12234578999999988889999999999999999997 999997654322 11111 1111111 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+|++.+|.+||++.+|.++|+.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.50 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=196.3
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+.||+|+||.||++... +|+.||+|++... ......++.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 6889999987643 2334567889999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 9998883 34578999999999999999999995 2689999999999999999999999999987543222 12234
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..||..|+|||++.+..++.++|||||||++|||++|+.||......+.... .. .... . +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---i~----~~~~------~----~p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---IL----MEEI------R----FPRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---Hh----cCCC------C----CCCC
Confidence 5699999999999999999999999999999999999999976543221111 10 0000 0 1112
Q ss_pred HHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
....+.+++.+||+.+|.+|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234577899999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=332.86 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=196.1
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||.||++... +++.+|+|++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 5789999987653 333456688899998877 799999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 99988873 34578999999999999999999999 999999999999999999999999999987543221 1223
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh--hhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE--QVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CC
Confidence 4678999999999999999999999999999999999999996322111 11122222222211111 01
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCC------HHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPG------MGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPt------m~evl~~ 778 (842)
+......+.+++.+||+.+|.+||+ +.++++.
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1223456788999999999999998 5666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.93 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=201.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|+..+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35677789999999999999964 344 47888876443 3345678889999999999999999998854 56789
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
++||+++|+|.+++.. ....+++..++.|+.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999853 33568999999999999999999998 8999999999999999999999999999986543
Q ss_pred CC-CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DR-GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.. ........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... +.++.. ++. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~~--~~~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLE----KGE--RLAQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCC--cCCC
Confidence 22 122334557789999999998899999999999999999998 999997654322 112211 111 0011
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+. .+...+.+++.+|+..+|.+||++.|+++.|+...+
T Consensus 233 ~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 122356778899999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.91 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=207.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc--------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS 577 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~ 577 (842)
++|.+.+.||+|+||.||++... ++..+|+|.+... ......++.+|+++++.+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56889999999999999999852 2346999998754 344567789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc
Q 037607 578 EMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD 643 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld 643 (842)
..++||||+++|+|.+++.... ...+++.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999985432 1358899999999999999999998 8999999999999999
Q ss_pred CCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhH
Q 037607 644 ENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSL 721 (842)
Q Consensus 644 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l 721 (842)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |.+||......+.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~--- 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---
Confidence 9999999999998765422111 1122234568999999998899999999999999999998 8888865432221
Q ss_pred HHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 722 AEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 722 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.... ..+... .........+.+++.+|+..+|.+||+|.|+++.|+.+.+..
T Consensus 252 ---~~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 252 ---FKLL-KEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ---HHHH-HcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 111100 111233457788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=319.25 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=202.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-----EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-----~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|...+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 68999999865432 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|+||+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999884 34568899999999999999999999 9999999999999999999999999999876542
Q ss_pred CCCcee--eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGYVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||......+.. .+.. .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~---~~~~~----- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIA---TQPTN----- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHh---ccCCC-----
Confidence 211111 2345788999999999988999999999999999999999998754322211 1110 00000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+.......+.+++.+||..+|.+||++.|+++.
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01122334567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=325.62 Aligned_cols=266 Identities=20% Similarity=0.264 Sum_probs=199.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 688999998765432 223467899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 577777643 34568899999999999999999999 999999999999999999999999999987643222
Q ss_pred ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhh-hhHHHHHHHhhccccc--------
Q 037607 665 YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ-VSLAEWALQCHRKGIL-------- 734 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~l-------- 734 (842)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||........ .....+..........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234567899999999865 4688999999999999999999999986533211 1111111000000000
Q ss_pred ------ccccchhHHhhhcH-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 ------EKIIDPVIAETICK-ESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ------~~i~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+...... .....+.+++.+||+.+|.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000001100000 112457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.93 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=202.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999964 6889999997753 2234567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999988432 3578999999999999999999999 999999999999999999999999999998765443
Q ss_pred CceeeeeccCCCCCCccccc------ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 664 GYVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
........||..|+|||++. ...++.++|||||||++|||++|+.||......... ............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~ 230 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFLKF 230 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCccCC
Confidence 33334457899999999986 456789999999999999999999999765432211 111100000000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+ ........+.+++.+|++ +|.+||++.++++.
T Consensus 231 --~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 --P-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred --C-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 011223457788889998 99999999998764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.79 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=207.6
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.+|++.+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999995 47899999976542 3344568899999999999999999999999999999999
Q ss_pred EecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 584 EYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||+++++|.+++.. .....+++..++.++.|+++||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998843 234568999999999999999999998 9999999999999999999999999999877643
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
... ......++..|+|||++.+..++.++||||||+++|||++|..||....... .++... +.....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~------~~~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK------IEQCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh------hhcCCCCC
Confidence 321 2234568899999999998889999999999999999999999986543211 111111 01111111
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
+ ........+.+++.+|++.+|.+||+|.+|++++++.
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 0112345788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.17 Aligned_cols=255 Identities=28% Similarity=0.413 Sum_probs=202.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
+++|.+.+.||+|+||.||+|.+.+ +..|++|...... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999753 5679999876543 44456799999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCC-----CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---ceEEe
Q 037607 580 ILVYEYMANGPFRDHLYGTN-----QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL---VAKVA 651 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~---~~kl~ 651 (842)
++||||+++++|.+++.... ...+++..+++++.||+.||+|||+ ++++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999885432 2358999999999999999999999 8999999999999998654 69999
Q ss_pred ecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+. .+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~~~--- 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEFVT--- 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH---
Confidence 999998763221111 112223568999999999999999999999999999997 9999976543221 11111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..... .........+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10000 011223456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.66 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=196.4
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCcc
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFR 592 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (842)
.||+|+||.||+|... +++.+|+|..... .......+.+|++++++++||||++++++|......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6899999999999964 6889999987643 3444567999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce-eeeec
Q 037607 593 DHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV-STAVK 671 (842)
Q Consensus 593 ~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 671 (842)
+++.. ....+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.......... .....
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 98843 23468999999999999999999998 899999999999999999999999999987643211100 01112
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKES 750 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~ 750 (842)
.+..|+|||.+.++.++.++|||||||++|||++ |.+|+......... .... ... . .......
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~---~~~~----~~~-~--------~~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR---EAIE----QGV-R--------LPCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH---HHHH----cCC-C--------CCCcccC
Confidence 3457999999999899999999999999999997 88888654322211 1110 000 0 0111223
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 751 LRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 751 ~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
...+.+++.+|++.+|.+||++.|++++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=308.52 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=211.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++++||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 457899999999999999999964 67889999976542 23346889999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
+||..+|.|...|.......+++.....+..|+|.||.|+|. ++||||||||+|+|++..+.+||+|||-+...+.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 999999999999987788889999999999999999999998 9999999999999999999999999998876542
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
......+||..|.+||+..+...+.++|+|++|++.||++.|.+||......+... ... -.++.+|
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk-------rI~---k~~~~~p-- 242 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK-------RIR---KVDLKFP-- 242 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-------HHH---HccccCC--
Confidence 23456889999999999999999999999999999999999999998765332110 000 0112222
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
........+++.+|+..+|.+|....|++..-
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 23345677899999999999999999988654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=323.99 Aligned_cols=261 Identities=26% Similarity=0.323 Sum_probs=202.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC---C--eEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ---S--EMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~---~--~~~l 581 (842)
-.|...+++|.|+||.||+|++. +++.||||+.....+ --.+|+++|+.+.|||||+|+-+|... + ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35677789999999999999964 578999999765533 225799999999999999999887422 2 3569
Q ss_pred EEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeecccccc
Q 037607 582 VYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKA 658 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGla~~ 658 (842)
|||||+. +|.+.++. ..+..++...+.-+..||++||.|||+ .+|+||||||.|+|+|.+ +.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999975 88888843 345678888889999999999999999 999999999999999976 9999999999998
Q ss_pred cCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc--
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE-- 735 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~-- 735 (842)
....... .....|.-|+|||.+.+ ..|+.+.||||.|||+.||+.|++.|.+....++..+.--+.....+..+.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 7544322 44557889999999887 689999999999999999999999999877666544332222222111111
Q ss_pred -----cccchhHHh-----hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 -----KIIDPVIAE-----TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 -----~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+...|.+.. -+......+.++++.++++.+|.+|.++.|++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111122211 1233455778999999999999999999998864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=341.19 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=194.1
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.|+..++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 67899999876532 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR- 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~- 663 (842)
||++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999998843 3568889999999999999999999 899999999999999999999999999975321000
Q ss_pred ---------------------------------------------CceeeeeccCCCCCCcccccccCCCCcccchhHHH
Q 037607 664 ---------------------------------------------GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 698 (842)
Q Consensus 664 ---------------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~Gv 698 (842)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC---HHH
Q 037607 699 VLFEVLCARPVINPKLPREQV-SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPG---MGD 774 (842)
Q Consensus 699 vL~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~e 774 (842)
+||||++|++||....+.+.. .+..|. ..+. .+. .........+++.+|+ .+|.+|++ +.|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~---~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQ------TSLH---IPP-----QAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccC------CCcC---CCC-----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999866443211 111110 0000 000 0111234555665654 49999997 777
Q ss_pred HHHH
Q 037607 775 VLWN 778 (842)
Q Consensus 775 vl~~ 778 (842)
+++.
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.28 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=201.5
Q ss_pred cccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe-----
Q 037607 510 FDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE----- 578 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~----- 578 (842)
|.+.+.||+|+||.||+|.+.. +..||+|+++.. ......++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998642 367999987643 34455789999999999999999999998866554
Q ss_pred -EEEEEEecCCCCcccccccC----CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 579 -MILVYEYMANGPFRDHLYGT----NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 579 -~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
.+++|||+++|+|..++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999887432 23468999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 654 GLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 654 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |.+||......+ +.++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence 999876433221 1122335678999999998999999999999999999999 888886543221 2222211
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
+... .........+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 01123445789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.08 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=196.8
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||.||++... +|+.+|+|++.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999876421 12234566799999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 998866666678999999999999999999999 999999999999999999999999999987664322 233456
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+....... ..... ......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~~~~~---------~~~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-DEVKF---------EHQNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-ccccc---------ccccCC
Confidence 89999999999998899999999999999999999999975432111 1111111100 00000 001224
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.++.+++.+||+.+|.+||++.|+++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 46789999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=336.05 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=216.8
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
...+....++||-|.||.||.|.|+. .-.||||.++.... ..++|+.|..+|+.++|||+|+|+|+|.....+|||.|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34455667899999999999999864 56799999886543 46899999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||..|+|.++|++.++..++---.+.++.||+.||+||.. +++|||||..+|+|+.++..+||+||||++++..+.-
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999988888788888899999999999999998 9999999999999999999999999999999875543
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.........+.|.|||-+....++.|+|||+|||+|||+.| |..|+.+-.-.+ +..+..++ .+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg---------yR 484 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG---------YR 484 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc---------cc
Confidence 33344455779999999999999999999999999999987 777776542211 12222222 11
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
-+-++.|+.++.+|++.||+++|.+||++.|+-+.+|...+
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 12245667788999999999999999999999998887643
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.54 Aligned_cols=244 Identities=26% Similarity=0.350 Sum_probs=193.4
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHH---HhcCCCceeeEEEeeccCCeEEEE
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQML---SKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il---~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
|.+.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999865 6889999997643 122345566776655 566899999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|...+. ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999988873 2468999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... +..
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~-~~~-------- 218 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVN-DEV-------- 218 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CCC--------
Confidence 1 1223467899999999999999999999999999999999999999765432211 11000 000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLW 777 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~ 777 (842)
.........+.+++.+||+.+|.+||+ +.++++
T Consensus 219 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011122355778999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=317.69 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=207.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|.+.+.||+|+||.||++...++..+++|.+.... .....+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45788899999999999999998778889999877543 345678999999999999999999999877 7789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 99999999966556678999999999999999999998 899999999999999999999999999987654322222
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++....++.++|||||||++||+++ |+.||....... +..+.. .+... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~~---------~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RGYRM---------P 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----CCCCC---------C
Confidence 223345678999999998889999999999999999998 899987543222 111111 11000 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.78 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=196.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|++++||||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 68899999876432 223466889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC-
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD- 662 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~- 662 (842)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|......
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999999843 4568889999999999999999999 99999999999999999999999999997532100
Q ss_pred -----------------------------------------CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHH
Q 037607 663 -----------------------------------------RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 701 (842)
Q Consensus 663 -----------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ 701 (842)
.........||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000112356999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCchhhhh-HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC---CHHHHHH
Q 037607 702 EVLCARPVINPKLPREQVS-LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP---GMGDVLW 777 (842)
Q Consensus 702 ELltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---tm~evl~ 777 (842)
||++|++||......+... +..|. . .. .+ + ........+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~-----~-~~-~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWE-----T-TL-HI--P-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccC-----c-cc-cC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999998665432211 11110 0 00 00 0 00112334566666765 5999999 8888886
Q ss_pred H
Q 037607 778 N 778 (842)
Q Consensus 778 ~ 778 (842)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.58 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=208.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+++.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7899999987532 2334578999999999999999999999999999999999
Q ss_pred EecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 584 EYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||+++++|.+++.. .....+++.+++.++.++++||.|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998843 334568999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+..... .+.++.... ..+....+.
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~~--- 229 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EKCDYPPLP--- 229 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhh-hcCCCCCCC---
Confidence 221 12345688899999999988999999999999999999999999864431 111111111 111111110
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.......+.+++.+||..+|.+||++.+|+++|+.+
T Consensus 230 -----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 -----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 113345678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=327.26 Aligned_cols=260 Identities=30% Similarity=0.448 Sum_probs=204.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCc--EEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGN--KVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~--~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|++.+.||+|+||.||+|.++ ++. .+++|++... ......++.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999964 454 4688876653 344557889999999999 89999999999999999999
Q ss_pred EEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 582 VYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
||||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 999999999999885422 2368899999999999999999998 99999999999999999999
Q ss_pred eEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 037607 648 AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~ 726 (842)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |.+||......+ ..+...
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP 237 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHHh
Confidence 999999998643211 11112234668999999988889999999999999999998 999997543322 111110
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
.+... .........+.+++.+|++.+|.+||++.+++++|+.+.+...
T Consensus 238 ----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 ----QGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00000 0011123467889999999999999999999999987765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.37 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=194.9
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCC-CceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRH-RHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~H-pnIv~l~g~~~~~~~~~lV~ 583 (842)
+|++.+.||+|+||.||+|... +++.||||++... .....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 5778999987643 23445678899999999976 46888999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998883 34568899999999999999999999 999999999999999999999999999987542221
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||..|+|||++.+..++.++|||||||++|||++|++||......+. ..... +...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~~~--------- 218 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EHNV--------- 218 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCCC---------
Confidence 223456799999999999999999999999999999999999999976543221 11111 0000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.+.......+.+++.+||+.+|.+|++.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111223467889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=305.67 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=210.5
Q ss_pred HhcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-----CCeE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-----QSEM 579 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-----~~~~ 579 (842)
..++|.+.+.||+|||+-||.++ +.++..+|+|++.-.+.++.+..++|++..++++||||+++++++.. ..+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35689999999999999999998 56788999999888777888999999999999999999999998843 3458
Q ss_pred EEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 580 ILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
||+++|...|+|.+.+.. .++..+++.+++.|+.++++||++||+. ..++.||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999854 2345799999999999999999999982 2349999999999999999999999999988
Q ss_pred ccCCCCC--c------eeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 037607 658 AAPMDRG--Y------VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 658 ~~~~~~~--~------~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~ 726 (842)
..+..-. . .......|..|+|||.+. +...++++|||||||+||+|+.|..||+...... .++
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSl----- 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSL----- 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeE-----
Confidence 7642211 0 112345789999999875 4567899999999999999999999997543211 111
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
...+..+.+.-.-.....+.+.+++.+|++.||.+||++.|++..++..
T Consensus 252 -------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111221111222567889999999999999999999999988653
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=340.39 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=204.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~ 578 (842)
.++|.+.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|+++|.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777789999999999999864 24579999987542 333457899999999997 9999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------------------------------------------------- 599 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (842)
.++||||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999885421
Q ss_pred -------------------------------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 600 -------------------------------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 600 -------------------------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
...+++..++.++.|++.||+|||+ .+++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 1246788899999999999999998 899999999999999
Q ss_pred cCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~- 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF- 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-
Confidence 99999999999999865332211 1123356788999999998889999999999999999998 88888654322211
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
......+. ... ........+.+++.+||+.+|.+||+++||++.|+.++
T Consensus 352 -----~~~~~~~~--~~~-------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 -----YNAIKRGY--RMA-------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHcCC--CCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111110 000 11123456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.59 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=208.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC-----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-CCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED-----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-QSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~-----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~~~ 579 (842)
.++|.+.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999765 678999987754 34456778999999999999999999998865 5678
Q ss_pred EEEEEecCCCCcccccccCCC------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 580 ILVYEYMANGPFRDHLYGTNQ------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999998854321 568999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 654 GLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 654 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
|+++........ ......++..|+|||++.+..++.++|||||||++||+++ |++||...... .+..+... .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~---~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLKD---G 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHHc---C
Confidence 999865432221 1123345778999999998899999999999999999998 99999765332 22222211 1
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..+.. .......+.+++.+||..+|++||++.|+++.|+....
T Consensus 236 ~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00000 11123467899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.39 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=201.4
Q ss_pred CcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
+|.+.+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35667789999999999998632 46899999876543 334678999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccC--------------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 582 VYEYMANGPFRDHLYGT--------------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
++||+.+++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999887421 12458889999999999999999998 89999999999999999999
Q ss_pred eEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 037607 648 AKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~ 725 (842)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |.+|+......+ +.+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 999999998865422211 1223345779999999988889999999999999999998 888886543221 11111
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.. +... .........+.+++.+|++.+|.+||++.||+..|+
T Consensus 240 ~~----~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 240 RN----RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred Hc----CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11 1110 112234556889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=331.01 Aligned_cols=239 Identities=26% Similarity=0.376 Sum_probs=190.6
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+||+|+||.||+|... +++.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999975 5788999987643 223345566777777654 8999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 82 DLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9998884 34578999999999999999999999 999999999999999999999999999997643222 22345
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..||..|+|||++.+..++.++|||||||++|||++|+.||......+.. ...... .+. +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~-------~~~----~~~~ 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSILND-------RPH----FPRW 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHcC-------CCC----CCCC
Confidence 67899999999999999999999999999999999999999865432211 111000 000 1111
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRPGMG-DVL 776 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RPtm~-evl 776 (842)
....+.+++.+||+.+|.+||++. +++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 234567889999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=350.60 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=206.1
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-- 577 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-- 577 (842)
.+...++|.+.+.||+|+||+||+|.. .+|+.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 334457999999999999999999985 47899999987543 4455677899999999999999999988764322
Q ss_pred ------eEEEEEEecCCCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceE
Q 037607 578 ------EMILVYEYMANGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAK 649 (842)
Q Consensus 578 ------~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~k 649 (842)
.+++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999988542 34578999999999999999999999 9999999999999999999999
Q ss_pred EeecccccccCCCC-CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 037607 650 VADFGLSKAAPMDR-GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 650 l~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
|+|||+++...... ........||+.|+|||++.+..++.++|||||||+||||++|++||......+ .....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH
Confidence 99999998754321 122345679999999999999999999999999999999999999997653222 11111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. .+... .+.......+.+++.+||+.+|.+||++.++++.
T Consensus 258 ~-~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L-AGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h-cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 11111 1122334568899999999999999999999864
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=318.83 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=204.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-C---CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-D---GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~---g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|.+.+.||+|+||.||+|.+. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 2 3379999887543 34456899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999998543 3468999999999999999999998 99999999999999999999999999999876543
Q ss_pred CCceee--eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 663 RGYVST--AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 663 ~~~~~~--~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
...... ...++..|+|||++.+..++.++|||||||++||+++ |+.||......+ ...+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~------~~-- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGY------RL-- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCC------cC--
Confidence 222211 1223568999999999899999999999999999886 999987654322 112211110 00
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
......+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.87 Aligned_cols=241 Identities=23% Similarity=0.353 Sum_probs=195.0
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+||+|+||.||+|+.. +++.||+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 6999999999999975 5789999987653 233456678899999876 7999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|...+. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 9998884 34568999999999999999999999 999999999999999999999999999987643222 22344
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..|+..|+|||++.+..++.++|||||||++|||++|++||......+. .+... ... ... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~i~---~~~----~~~-------p~~ 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FESIL---HDD----VLY-------PVW 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHHHH---cCC----CCC-------CCC
Confidence 5689999999999999999999999999999999999999986643221 11111 100 000 111
Q ss_pred HHHHHHHHHHHhhhhCCCCCC-------CHHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRP-------GMGDVLWN 778 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RP-------tm~evl~~ 778 (842)
....+.+++.+||+.+|.+|| ++.++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 234678899999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.78 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=194.8
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
+|...+.||+|+||.||+|... +++.||+|++... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 5789999987653 223345677888888877 5899999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+.+. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998883 34568999999999999999999998 999999999999999999999999999987543221
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||+.|+|||++.+..++.++|||||||++|||++|++||......+ +...... ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~----~~~--------- 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME----HNV--------- 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CCC---------
Confidence 12334678999999999999999999999999999999999999998654322 1111111 000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.++.....++.+++.+|++.+|.+|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0112234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.64 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=196.5
Q ss_pred EEeecCcEEEEEEEEc---CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 515 VIGVGGFGKVYIGVLE---DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
.||+|+||.||+|.+. .+..||+|++.... ....++|.+|+.++++++||||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 35579999987653 334567999999999999999999999985 457899999999999
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee--e
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS--T 668 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~--~ 668 (842)
|.+++.. ....+++.++++++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9998843 34578999999999999999999998 8999999999999999999999999999986543322211 1
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
...++..|+|||.+.+..++.++|||||||++|||++ |.+||......+ +...+. .+... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~---------~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIE----QGKRL---------DCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CCCCC---------CCC
Confidence 2223578999999988889999999999999999996 999997654322 111111 11100 111
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22345778899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=319.38 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=202.5
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999996 46889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++. ...++++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 99999999884 34578999999999999999999998 899999999999999999999999999998653221 1
Q ss_pred eeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 666 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
......++..|+|||.+. ...++.++|||||||++|||++|++|+....+.+.. ..+ .... ...+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~-----~~~~---~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM-----SKSN---FQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eee-----ecCC---CCCCCC
Confidence 123346888999999874 345788999999999999999999998644322111 000 0000 000101
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
. ........+.+++.+||+.+|++||+++++++.|
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0112335678999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=325.47 Aligned_cols=261 Identities=24% Similarity=0.421 Sum_probs=207.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEc--------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~ 576 (842)
..+|.+.+.||+|+||.||+|+.. ++..||+|..... .....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788889999999999999742 2457999988754 344567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
...++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999985421 2357889999999999999999999 899999999999999
Q ss_pred cCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|+......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 99999999999999876433221 1223345678999999998899999999999999999998 778876543222
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
+..... .+.... ........+.+++.+||+.+|.+||+|.|+++.|+++....
T Consensus 248 ---~~~~~~-~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 ---LFKLLK-EGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHHHH-cCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111111 110000 11123456788999999999999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=322.65 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=196.1
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||+||++... +|+.+|+|++.... ....+.+..|+++++.++|+||+++.+++......++|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 68899999876432 23346678999999999999999999999999999999999999999
Q ss_pred cccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 592 RDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 592 ~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
.+++.. .....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 887743 234578999999999999999999999 9999999999999999999999999999876543221 2234
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ .. + ..+...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~-~~-------~---~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRIL-ND-------S---VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhc-cc-------C---CCCccc
Confidence 56899999999999999999999999999999999999999754322110 00000000 00 0 011223
Q ss_pred HHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
....+.+++.+||+.+|.+|| +++++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 345678899999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.70 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=203.2
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 68899999876432 22335678899999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 999999998865555679999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||............... .. . ....
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~-----~-----~~~~ 223 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VK-----E-----VQEE 223 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hh-----h-----hhhh
Confidence 22346899999999999999999999999999999999999999764322111000000 00 0 0001
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~Le~ 781 (842)
........+.+++.+||+.+|.+||+ +.|+++.-..
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 11223345788999999999999999 8888875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.97 Aligned_cols=235 Identities=25% Similarity=0.382 Sum_probs=191.3
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+||+|+||.||+|... +++.||||++... .....+.+..|+.++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999975 5789999987643 233456778899999877 6999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 82 ~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (320)
T cd05590 82 DLMFHIQ--KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST 155 (320)
T ss_pred hHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence 9998884 34578999999999999999999999 99999999999999999999999999998764322 122344
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+... .+. .. ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~----~~~---~~-------~~~~ 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAIL----NDE---VV-------YPTW 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHh----cCC---CC-------CCCC
Confidence 5789999999999999999999999999999999999999986543221 11111 110 00 0111
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
....+.+++.+||+.+|.+||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 23467889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=329.31 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=194.0
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||+||++... +++.+|+|++... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 5788999998753 233456788999999888 699999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99988873 34579999999999999999999999 999999999999999999999999999987532221 1234
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...||+.|+|||++.+..++.++|||||||+||||++|+.||............++........... ++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CCC
Confidence 5679999999999999999999999999999999999999997543322222222322222111110 111
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.....+.+++.+||+.+|.+|+++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 223456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=318.54 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=204.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-C---cEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-G---NKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-g---~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
+.|++.+.||+|+||.||+|.+.. + ..||||.+... ......+|..|+.++++++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788899999999999999653 3 36999998764 455567899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++|+||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999988433 4568999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCce-ee-eec--cCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 663 RGYV-ST-AVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 663 ~~~~-~~-~~~--gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.... .. ... .+..|+|||++.+..++.++|||||||++|||++ |.+||...... ...+++..... +
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~~---~--- 230 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDYR---L--- 230 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCc---C---
Confidence 2111 11 111 2457999999999999999999999999999886 99998754332 22233221100 0
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
....+.+..+.+++.+||+.+|.+||++.+++.+|+.+
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01122345678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.70 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=214.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe-EEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE-MILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~-~~lV~ 583 (842)
++|...+++|+|+||.++..+++ ++..+++|.+... +....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888889999999999998865 5778999986543 34444578899999999999999999999999888 99999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
+||+||+|.+.+..++...++++.+..++.|++.|+.|||+ +.|+|||||+.||+++.+..+||.|||+|+....+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999977777889999999999999999999998 999999999999999999999999999999987654
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.. ...+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+... ++... .....
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki--------~~~~~----- 223 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKI--------NRGLY----- 223 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHH--------hhccC-----
Confidence 32 346789999999999999999999999999999999999999998765332 11111 11111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..++.....++..++..|+..+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12344556778899999999999999999999987
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.64 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=200.7
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
|+..+.||+|+||+||+|... +++.+|+|.+.... ......+.+|+++|++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999864 68899999876532 22335578899999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999998866555679999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||......... ..+.... ... .. .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~~-~~~--~~--------~ 223 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRRV-LET--EE--------V 223 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhh-hcc--cc--------c
Confidence 123456899999999999999999999999999999999999999765432211 1111110 000 00 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~ 778 (842)
+.......+.+++.+|++.+|++||+ +.+++..
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11223345678999999999999999 5565543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.50 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=201.0
Q ss_pred cCcccceEEeecCcEEEEEEEEcC---------------CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED---------------GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIG 571 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~---------------g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g 571 (842)
++|++.+.||+|+||.||++...+ ...||+|++... .......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987542 125899998764 3444567999999999999999999999
Q ss_pred eeccCCeEEEEEEecCCCCcccccccCC----------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEE
Q 037607 572 FCDEQSEMILVYEYMANGPFRDHLYGTN----------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 641 (842)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 641 (842)
++...+..++||||+++++|.+++.... ...+++..++.++.|+++||+|||+ .+++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999884321 1347889999999999999999998 99999999999999
Q ss_pred EcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh--CCCCCCCCCchhh
Q 037607 642 LDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVINPKLPREQ 718 (842)
Q Consensus 642 ld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt--G~~p~~~~~~~~~ 718 (842)
+++++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||+++||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 999999999999999765432211 1122345678999999998899999999999999999988 556766543222
Q ss_pred hhHHHHHHHhhcc-cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 719 VSLAEWALQCHRK-GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 719 ~~l~~~~~~~~~~-~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
........... +...... ........+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111 0000000 01112357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=316.19 Aligned_cols=248 Identities=29% Similarity=0.458 Sum_probs=201.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEee-ccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC-DEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~-~~~~~~~lV~Ey~ 586 (842)
.+|...+.||+|+||.||++... |..+++|...... ..+.+.+|+.++++++|+|++++++++ ...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999875 7889999876543 246789999999999999999999976 4556789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999865555568999999999999999999998 899999999999999999999999999987653221
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+......+ +..+... +.-. .
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~~---------~ 219 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK----GYKM---------D 219 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc----CCCC---------C
Confidence 22334568999999998899999999999999999997 998886543221 1111111 1000 1
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112234567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=320.11 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=205.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999998642 3679999977543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCC--------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 580 ILVYEYMANGPFRDHLYGTN--------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999885422 2357889999999999999999998 999999999999999999999999
Q ss_pred ecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |++|+......+ +.++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh---
Confidence 99998865433221 1223446788999999998899999999999999999998 999987544322 122211
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+..... .......+.+++.+||+.+|.+||++.|+++.|+
T Consensus 236 -~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 1122457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.14 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|+..++||+|+||+||+|.+. +|+ .||+|++... .....+++.+|+.+++.++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788889999999999999853 454 4899987654 34446788999999999999999999999975 45789
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999998532 3568999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |.+||+...... +..+...... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~---~~---- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGER---LP---- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCc---CC----
Confidence 3221 1122335678999999999999999999999999999998 899987543221 2222221100 00
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
........+.+++.+||+.+|.+||++.|+++.|+.....
T Consensus 232 ------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 ------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0112234678899999999999999999999988766443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.47 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=205.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcCC----cEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDG----NKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g----~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|.+.+.||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++++++||||++++++|.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577888999999999999986432 468999877654 4556789999999999999999999999875 557899
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++|+|.+++... ...+++..++.++.+++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999998432 3468999999999999999999998 99999999999999999999999999999876543
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.........++..|+|||.+....++.++|||||||+++||++ |++||......+. ..+... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~---~~~~------- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIEN---GERL------- 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc---CCcC-------
Confidence 3222223334568999999988889999999999999999986 9999976543221 111111 0000
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.........+.+++.+|+..+|.+||++.++++.|+....
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0112234568889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.73 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=204.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.+|.....||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677789999999999999742 356799999887777777889999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCC-------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 582 VYEYMANGPFRDHLYGTN-------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
+|||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 999999999999885422 1358899999999999999999998 999999999999999999999
Q ss_pred EEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~ 726 (842)
||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |++||......+.. ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHH-
Confidence 99999998765322211 1122335678999999999999999999999999999998 89998654332211 111
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+.... ........+.+++.+||+.+|.+||++.||++.|+
T Consensus 238 ---~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ---TQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0110000 01122345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.42 Aligned_cols=259 Identities=23% Similarity=0.397 Sum_probs=201.7
Q ss_pred cCcccceEEeecCcEEEEEEEE------cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeecc-CCe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE-QSE 578 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~------~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~-~~~ 578 (842)
++|.+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.+|.++ +||||++++++|.. ...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688899999999999999973 346789999987543 33456788999999999 68999999998854 456
Q ss_pred EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------------------------------------------------- 599 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 599 (842)
.++||||+++|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 899999999999998875321
Q ss_pred ------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc-eeeeecc
Q 037607 600 ------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKG 672 (842)
Q Consensus 600 ------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~g 672 (842)
...+++.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++........ ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1246888899999999999999998 99999999999999999999999999998765322211 1122345
Q ss_pred CCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 673 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 673 t~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
+..|+|||.+.+..++.++||||||+++|||++ |..|+........ +. ....++..... .....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~~~~---------~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTRMRA---------PDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCCCCC---------CCCCC
Confidence 678999999999999999999999999999996 8888865432211 11 11111111100 01122
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..+.+++.+||+.+|.+||++.|+++.|+.+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 457889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.86 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=205.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC-----------------CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceee
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED-----------------GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~-----------------g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~ 568 (842)
.++|++.+.||+|+||.||++...+ +..||+|++... .....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998642 245899987754 3445678999999999999999999
Q ss_pred EEEeeccCCeEEEEEEecCCCCcccccccCC---------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCC
Q 037607 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTN---------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTN 639 (842)
Q Consensus 569 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~N 639 (842)
++++|...+..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999885422 2368999999999999999999998 899999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh--CCCCCCCCCch
Q 037607 640 ILLDENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVINPKLPR 716 (842)
Q Consensus 640 ILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt--G~~p~~~~~~~ 716 (842)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533221 11223446778999999998899999999999999999998 66777644322
Q ss_pred hhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 717 EQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 717 ~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+ ................... .......++.+++.+|++.+|.+||++.|+++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 2222222211111111100 11123357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.55 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=200.6
Q ss_pred EEeecCcEEEEEEEEcC--C--cEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLED--G--NKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~--g--~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
.||+|++|.||+|.+.+ + ..||||.+..... ...+++.+|+.++++++||||+++++.+.. ...++||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999999743 3 3689999887655 567789999999999999999999999988 8899999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc--ee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VS 667 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~--~~ 667 (842)
+|.+++.......+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999865443578999999999999999999998 99999999999999999999999999999876543221 11
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||++.+..++.++|||||||++|||++ |++||......+. ...... .. .... .
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~--~~~~-------~ 222 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EG--ERLE-------R 222 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cC--CcCC-------C
Confidence 23456789999999999999999999999999999998 9999975533321 111111 00 0000 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+|++.+|.+||++.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1123456888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.85 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=196.5
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhc---CCCceeeEEEeecc-----CC
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKL---RHRHLVSLIGFCDE-----QS 577 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L---~HpnIv~l~g~~~~-----~~ 577 (842)
+|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 68899999876432 22224566777777665 69999999998854 34
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++||||+. ++|.+++.......+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999997 488888865555679999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HHHHHHHhhcccccc-
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LAEWALQCHRKGILE- 735 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~l~- 735 (842)
...... ......++..|+|||++.+..++.++|||||||++|||++|++||......+... +..+........+-.
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 654221 2234567899999999999899999999999999999999999997654332211 111110000000000
Q ss_pred -----cccc---hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 736 -----KIID---PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 736 -----~i~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.... +.......++....+.+++.+|++.||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00011122234456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=328.89 Aligned_cols=237 Identities=27% Similarity=0.342 Sum_probs=189.4
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQ-MLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~-il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||+||+|... +|+.||+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 68999999876431 222345556655 56789999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99999884 34578999999999999999999999 999999999999999999999999999987543221 2234
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...... +... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~-~~~~----------~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNILN-KPLR----------LKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHHc-CCCC----------CCC
Confidence 45689999999999999999999999999999999999999976533221 111110 1000 111
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMG 773 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~ 773 (842)
.....+.+++.+|++.+|.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.30 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=202.6
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHH--HHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGIN--EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~--~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
|+..+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999976 4668999998876544332 3456999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++. ....+++..++.++.|+++||++||+ .+|+|+||||+||++++++.++|+|||++.... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999995 45678999999999999999999999 999999999999999999999999999987642 22223
Q ss_pred eeeeccCCCCCCccccc-ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~-~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++. +...+.++||||+|+++++|++|+.|+......+.......... ..+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~------------~~~~~~ 222 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK------------RPLPSS 222 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH------------THHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc------------cccccc
Confidence 44567899999999998 88999999999999999999999999986632222211111100 000000
Q ss_pred h--cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 I--CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~--~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. .......+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00112688999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.71 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=192.5
Q ss_pred EEeecCcEEEEEEEEcC---CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 515 VIGVGGFGKVYIGVLED---GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~---g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
.||+|+||.||+|.+.+ +..+++|++.... .....++.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 3579999877543 3344578999999999999999999999999999999999999999
Q ss_pred cccccccCC---CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc-e
Q 037607 591 FRDHLYGTN---QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-V 666 (842)
Q Consensus 591 L~~~l~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~-~ 666 (842)
|.+++.... ....++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999985422 2356778888999999999999999 89999999999999999999999999998764332211 1
Q ss_pred eeeeccCCCCCCccccccc-------CCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 667 STAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~-------~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||......+.. .+.. .+....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~----~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTV----REQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHh----hcccCCCC
Confidence 2234567889999998642 35789999999999999996 99999755432211 1110 11111222
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
++.+.. .....+.+++.+|+ .+|++||++.||++.|+
T Consensus 232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222111 12335677888998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=322.54 Aligned_cols=258 Identities=22% Similarity=0.384 Sum_probs=204.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
..++|++.+.||+|+||.||+|..++ +..||+|.+.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45688999999999999999997532 4579999876543 3344578899999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC--------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEE
Q 037607 579 MILVYEYMANGPFRDHLYGTN--------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl 650 (842)
.++||||+++|+|.+++.... ...+++..+++++.|++.||.|||+ ++|+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999985321 2445778899999999999999998 99999999999999999999999
Q ss_pred eecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 037607 651 ADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 651 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |.+||......+ +.+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVM-- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH--
Confidence 999998865432211 1122335678999999999999999999999999999998 788886543222 111111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.+.... ........+.+++.+|++.+|.+||++.++++.|+..
T Consensus 236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 --DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 110000 1112245788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=336.15 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=203.7
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
+.++....++|++.+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556689999999999999999999975 6789999987542 22334568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
....++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998843 357888999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCccccccc----CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
++..............||+.|+|||++.+. .++.++|||||||+||||++|++||......... .. +. ...
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--~~-i~--~~~ 263 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--SK-IM--NHK 263 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH--HH-HH--cCC
Confidence 987643332233456799999999998754 3789999999999999999999999865432111 00 00 000
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD--RPGMGDVLWNLE 780 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~evl~~Le 780 (842)
..+ ...+ .......+.+++.+|+...+.+ ||++.|+++...
T Consensus 264 ~~~-~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 264 NSL-TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred Ccc-cCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 000 0000 1123455678888999844433 789999887654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.30 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=200.2
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc------C
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE------Q 576 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~------~ 576 (842)
.+++.|+..+.||+|+||.||+|... +++.||+|+..... ....++.+|+.+++++ +|+||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888889999999999999865 57889999876443 3346788999999998 79999999999864 2
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
...++||||+.+++|.+++.......+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 468999999999999999865555678999999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
........ ......|+..|+|||++. +..++.++|||||||++|||++|+.|+......... ... ..
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~-~~- 230 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLI-PR- 230 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHH-hc-
Confidence 76532221 223456889999999986 346888999999999999999999999654322111 000 00
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
....... .......+.+++.+||+.+|.+||++.|+++
T Consensus 231 ~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011111 1122346788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.97 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=192.9
Q ss_pred eEEeecCcEEEEEEEE----cCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 514 AVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|+++|++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999874 357899999876532 2234567889999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|+|.+++. ....+++..++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 999999883 34568999999999999999999999 999999999999999999999999999987654322 123
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+. .... . .... .+.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i---~-~~~~----------~~p 218 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMI---L-KAKL----------GMP 218 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHH---H-cCCC----------CCC
Confidence 346789999999999998899999999999999999999999976543221 1111 0 1100 011
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRPGMGD 774 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RPtm~e 774 (842)
......+.+++.+||+.+|.+||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 122345778999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.18 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=202.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999865 67889999876442 22334678999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++ +|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 78777643 23458899999999999999999999 9999999999999999999999999999876533221
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc-----
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID----- 739 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d----- 739 (842)
......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+................+..+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223457889999998865 5688999999999999999999999987654433222211110000000000000
Q ss_pred ----hhH----HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 740 ----PVI----AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 740 ----~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+.. ...........+.+++.+|++.+|.+|||+.|+++.-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 000 000111234567899999999999999999999875543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.40 Aligned_cols=251 Identities=33% Similarity=0.523 Sum_probs=202.8
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
.+|+..+.||+|+||.||++.+.++..+|+|.+..... ...+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46777889999999999999987788999998765432 34678999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++... ...+++..++.++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999988532 3468899999999999999999998 8999999999999999999999999999876543322122
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++.+|+|||++.++.++.++||||||+++|||++ |+.||......+ +.+. . .++ .....+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~---~-~~~--~~~~~~~----- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET---I-NAG--FRLYKPR----- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH---H-hCC--CCCCCCC-----
Confidence 23335678999999998899999999999999999998 999987543222 1111 1 111 0111111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.....+.+++.+||+.+|.+||++.|++++|
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235688899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.25 Aligned_cols=248 Identities=31% Similarity=0.473 Sum_probs=195.9
Q ss_pred EEeecCcEEEEEEEEcC-Cc--EEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLED-GN--KVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~-g~--~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+||+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999753 43 4788887753 344557899999999999 7999999999999999999999999999
Q ss_pred CcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 590 PFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 590 sL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999885422 2357899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+....... .......+..|+|||++....++.++|||||||++|||++ |..||......+ ... ... .+..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~~-~~~~ 229 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---KLP-QGYR 229 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---HHh-CCCC
Confidence 86432111 1112233567999999988899999999999999999996 999996543221 111 111 1100
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.+ ........+.+++.+|++.+|.+||++.|+++.|+.+.
T Consensus 230 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 01122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=329.11 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=195.3
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||+||++... +++.||||++... .......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 5789999987743 233456678899999888 699999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++.++..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 99998883 34579999999999999999999998 999999999999999999999999999987532222 1223
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +..... ... . .+..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i~---~~~-~----------~~~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSIL---EDE-V----------RYPR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHHH---cCC-C----------CCCC
Confidence 4568999999999999999999999999999999999999997554221 111111 000 0 0111
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCH-----HHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGM-----GDVLWN 778 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm-----~evl~~ 778 (842)
.....+.+++.+||+.+|.+||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 223567889999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.66 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=204.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCC-CChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNP-GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~-~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+|++.+.||+|+||.||++... +++.+|+|.+.. ......+++.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 688999998753 23445678899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.......+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999998865555678999999999999999999998 9999999999999999999999999999876643221 2
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||++.+..++.++||||||+++|+|++|++||........ .... ..+....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKV-CQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHH-hcCCCCCC---------
Confidence 2345688999999999998999999999999999999999999975432211 1111 11111111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.+|.+||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.51 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=192.3
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||+||+|... +++.||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 57899999876531 23345677788888764 899999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 99999884 34578899999999999999999999 999999999999999999999999999987542221 1234
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+. .+.+. .. .+.+ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~i~----~~------~~~~----~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQSIR----MD------NPCY----PR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hC------CCCC----Cc
Confidence 56789999999999999999999999999999999999999976543221 11111 00 0000 11
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMG-DVLW 777 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~-evl~ 777 (842)
.....+.+++.+||+.+|.+||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1234567889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.46 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=203.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|+..+.||+|+||.||++... ++..||+|++... ......++.+|+.++++++||||++++++|......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 3578999988754 344557799999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccC--------------------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCC
Q 037607 580 ILVYEYMANGPFRDHLYGT--------------------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTN 639 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--------------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~N 639 (842)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 9999999999999988532 12357888999999999999999998 899999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchh
Q 037607 640 ILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPRE 717 (842)
Q Consensus 640 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~ 717 (842)
||+++++.+||+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765322111 1122234667999999998999999999999999999997 888886543322
Q ss_pred hhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+... ..++.... .......++.+++.+|++.+|.+||++.|+++.|+
T Consensus 241 ------~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 ------VIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111 11111110 11123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.77 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=203.7
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455677777789999999999999964 577899999887766677889999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCC--chHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccccc
Q 037607 582 VYEYMANGPFRDHLYGTNQPPL--SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKA 658 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l--~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~ 658 (842)
|+||+++++|.+++.... ..+ ++..+..++.|+++||+|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999985432 334 788899999999999999998 99999999999999976 67999999999876
Q ss_pred cCCCCCceeeeeccCCCCCCccccccc--CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
...... ......++..|+|||++.+. .++.++||||||+++|||++|++|+........ ..|.......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~----- 229 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKI----- 229 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhcc-----
Confidence 532221 12234578999999998764 378999999999999999999999865432111 1111100000
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...++.....++.+++.+||+.+|.+||++.|+++.
T Consensus 230 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 ------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011122334567889999999999999999998863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.77 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=203.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
++|.....||+|+||.||+|+.+ +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788889999999999999964 2457999987765433 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCC-------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 581 LVYEYMANGPFRDHLYGTN-------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999985433 1268999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 654 GLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 654 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
|+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||....... +.... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~----~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL----QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH----HcC
Confidence 9987553322222233456778999999988889999999999999999998 778886432211 11111 111
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+... ........+.+++.+||+.+|.+||++.|+++.|+
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 11123356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.80 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=197.8
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--------C
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--------Q 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--------~ 576 (842)
...+|...++||+|+||.||+|... +++.||||++.... ....+|+.+|+.++||||+++++++.. .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 68899999875432 234579999999999999999987632 1
Q ss_pred CeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeec
Q 037607 577 SEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADF 653 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DF 653 (842)
..+++||||+++ +|.+++.. .....+++..++.++.||++||+|||+ ++|+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 67666532 345678999999999999999999999 9999999999999998664 7999999
Q ss_pred ccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 654 GLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 654 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
|+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|++||......+...............
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9998764322 2234568999999999876 468999999999999999999999998765433221111000000000
Q ss_pred ------------ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 733 ------------ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 733 ------------~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.+..+....+...++.....++.+++.+||+.+|.+||++.|+++.-..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 0001111112222222334678899999999999999999999876543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=339.24 Aligned_cols=270 Identities=21% Similarity=0.285 Sum_probs=199.9
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC------CceeeEEEee
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH------RHLVSLIGFC 573 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H------pnIv~l~g~~ 573 (842)
+++...+++|.+.++||+|+||+||+|... .++.||||+++... ...+++..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999864 57889999986432 233456778888887765 4588899988
Q ss_pred ccC-CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC------
Q 037607 574 DEQ-SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL------ 646 (842)
Q Consensus 574 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~------ 646 (842)
... ...++|||++ +++|.+++. ....+++..+..|+.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence 654 5789999988 778888874 34579999999999999999999996 14899999999999998665
Q ss_pred ----------ceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCch
Q 037607 647 ----------VAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPR 716 (842)
Q Consensus 647 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~ 716 (842)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|++||+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764321 234567999999999999999999999999999999999999999876554
Q ss_pred hhhhHHH---------HHHHhhc---------ccccccccchhHHhhh-------cHHHHHHHHHHHHHhhhhCCCCCCC
Q 037607 717 EQVSLAE---------WALQCHR---------KGILEKIIDPVIAETI-------CKESLRKYVEAAEKCLAEYGVDRPG 771 (842)
Q Consensus 717 ~~~~l~~---------~~~~~~~---------~~~l~~i~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt 771 (842)
+...+.. |...+.. .+.+....++.....+ .......+++++.+||+.||.+||+
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 4333221 1111000 0000001111100000 0011346789999999999999999
Q ss_pred HHHHHHHHH
Q 037607 772 MGDVLWNLE 780 (842)
Q Consensus 772 m~evl~~Le 780 (842)
++|+++.-.
T Consensus 432 a~e~L~Hp~ 440 (467)
T PTZ00284 432 ARQMTTHPY 440 (467)
T ss_pred HHHHhcCcc
Confidence 999997544
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.23 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=197.6
Q ss_pred eEEeecCcEEEEEEEEc--C--CcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE--D--GNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~--~--g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
++||+|+||.||+|++. + +..+|+|.+..... ...+++.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999853 2 26899999876543 34568999999999999999999999876 4568999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee-
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS- 667 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~- 667 (842)
++|.+++.. ...+++..++.++.|++.+|+|||. .+++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 999999943 3478999999999999999999998 8999999999999999999999999999987643322211
Q ss_pred -eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 668 -TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 668 -~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
....++..|+|||.+.+..++.++|||||||++|||++ |++||...... .+..+...... . .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~~---~-~--------- 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGER---L-P--------- 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCCc---C-C---------
Confidence 12223567999999998999999999999999999997 99999765432 22222221110 0 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+++.+|++.+|.+||++.++++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.29 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=201.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-----------------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceee
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-----------------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-----------------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~ 568 (842)
.++|++.+.||+|+||.||++... ++..+|+|++... ......+|.+|+++|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 2346899998754 3445578999999999999999999
Q ss_pred EEEeeccCCeEEEEEEecCCCCcccccccCC---------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCC
Q 037607 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTN---------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTN 639 (842)
Q Consensus 569 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~N 639 (842)
+++++...+..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999885422 1347788999999999999999999 899999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh--CCCCCCCCCch
Q 037607 640 ILLDENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVINPKLPR 716 (842)
Q Consensus 640 ILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt--G~~p~~~~~~~ 716 (842)
||++.++.++|+|||+++......... .....++..|+|||...++.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987653322111 122334678999999888899999999999999999998 66777654332
Q ss_pred hhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 717 EQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 717 ~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+.. ............. ...+ ....+...+.+++.+||+.+|.+||++.||++.|+
T Consensus 241 ~~~---~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVI---ENTGEFFRDQGRQ-VYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHHhhcccc-ccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 1111111110000 0000 01123357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.72 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=204.8
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
..+|+..+.||+|+||.||+|+. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999985 46889999988765555567889999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred cCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 999999998842 357899999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......++..|+|||.+.+..++.++|||||||++|||++|++||....+... +..+. ..+ ...+.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~----~~~-~~~~~------- 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA----TNG-TPELQ------- 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----cCC-CCCCC-------
Confidence 12334688899999999988899999999999999999999999975543221 11111 000 00000
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+|+..+|++||++.|+++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 112234567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=328.07 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=191.9
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
++||+|+||.||+|... +|+.||+|.++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999975 68899999876531 23345677888888765 899999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 99998884 34578899999999999999999999 999999999999999999999999999987532211 1234
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+ +.+... .. .+.+ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~----~~------~~~~----~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR----VD------TPHY----PR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCC----CC
Confidence 5679999999999999999999999999999999999999997654321 111110 00 0001 11
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMG-DVL 776 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~-evl 776 (842)
....++.+++.+||+.+|.+||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.02 Aligned_cols=236 Identities=26% Similarity=0.346 Sum_probs=188.0
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQ-MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~-il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
+||+|+||.||+|+.. +|+.||+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999975 68899999876432 222345556654 678899999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9988873 34568889999999999999999998 999999999999999999999999999987542222 12334
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..|++.|+|||++.+..++.++|||||||++|||++|++||....... +.+.+. ...+ .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~----~~~~----------~~~~~ 218 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNIL----HKPL----------QLPGG 218 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHh----cCCC----------CCCCC
Confidence 568999999999999999999999999999999999999997653221 111110 0000 01122
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRPGMG 773 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RPtm~ 773 (842)
....+.+++.+||+.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 345678899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.07 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=202.6
Q ss_pred cCcccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEM 579 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~ 579 (842)
+.|.+.+.||+|+||.||++.+ .++..||+|.+.... ......+.+|++++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999984 247789999987553 44456899999999999999999999998765 568
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999988432 3468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCch---------hhhhHHHHHHHh
Q 037607 660 PMDRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPR---------EQVSLAEWALQC 728 (842)
Q Consensus 660 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~---------~~~~l~~~~~~~ 728 (842)
...... ......++..|+|||++.+..++.++|||||||++|||++++.|....... .+.....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 112345677899999999889999999999999999999987654322110 001111111111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
..+.. ..........+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 240 -~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 -EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01100 001122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.73 Aligned_cols=258 Identities=23% Similarity=0.420 Sum_probs=204.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc--------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS 577 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~ 577 (842)
.+|.+.+.||+|+||.||++... ....+|+|++... ......++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 2456899987754 344567889999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc
Q 037607 578 EMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD 643 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld 643 (842)
..++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999885421 2458899999999999999999998 9999999999999999
Q ss_pred CCCceEEeecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhH
Q 037607 644 ENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSL 721 (842)
Q Consensus 644 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l 721 (842)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--- 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--- 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999998664322111 112234567999999999999999999999999999999 8888865433221
Q ss_pred HHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 722 AEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 722 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.+.. ..+.... ........+.+++.+|++.+|.+||++.|+++.|+....
T Consensus 246 ~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKLL----REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHH----HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 1111000 111234467789999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.65 Aligned_cols=248 Identities=31% Similarity=0.499 Sum_probs=203.1
Q ss_pred eEEeecCcEEEEEEEEcC----CcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLED----GNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||.||+|.... +..+++|.+...... ..+++.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999754 778999998765433 367899999999999999999999999999999999999999
Q ss_pred CCcccccccCC-------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 589 GPFRDHLYGTN-------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 589 gsL~~~l~~~~-------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
++|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999985432 4679999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .......++..|+|||.+....++.++|||||||+++||++ |+.||......+ +.+.... +.. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~--~-- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK----GYR--L-- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----CCC--C--
Confidence 321 12234557889999999988899999999999999999998 699997653221 1111111 100 0
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.........+.+++.+|++.+|.+||++.|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223467889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.72 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=196.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 5889999997642 2233466889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999998843 24568999999999999999999999 999999999999999999999999999987654333
Q ss_pred CceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. ............+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~~ 230 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQFP 230 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccCC
Confidence 323334569999999999863 4578899999999999999999999975533221 11111100000000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhh--CCCCCCCHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAE--YGVDRPGMGDVLWNL 779 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPtm~evl~~L 779 (842)
+ ........+.+++.+|+.. ++..||++.++++.-
T Consensus 231 -~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 231 -P-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred -C-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 0 0011234456667676654 344488999888763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.48 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=204.0
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888899999999999999764 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.. ....+++..++.++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 99999998843 34678999999999999999999998 8999999999999999999999999999887643321 2
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||++.+..++.++|||||||++|||++|++|+....+...... ........+. .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~-------~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKPPPTLS-------D 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCCCCCCC-------c
Confidence 2344578899999999999999999999999999999999999975533221100 0000000000 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.......+.+++.+|++.+|.+||++.|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1123356788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.72 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=206.3
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||.|+||.||.++. .+++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999985 46889999986543 345567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++.++..++.|++++|+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999865545678999999999999999999998 8999999999999999999999999999987643332
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+.. .... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-cCCCCCC--------
Confidence 223456889999999999888999999999999999999999999765432211 1111 1111110
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
......++.+++.+|++.+|.+||++.|+++.+
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 122345688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.31 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=199.1
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+|+..++||+|+||.||+|.. .+++.||+|++... .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999985 46889999987544 3444567999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 999986542 46788899999999999999999 99999999999999999999999999998765322 1
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV-SLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++.+..++.++|||||||++|||++|+.||......... ....+... ..... .+.+
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~--- 220 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDED-----PPVL--- 220 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccC-----CCCC---
Confidence 23456899999999999999999999999999999999999999754322211 00111110 00000 0000
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......++.+++.+|++.+|.+||++.|+++...
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 01112346788999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=330.37 Aligned_cols=240 Identities=26% Similarity=0.334 Sum_probs=190.3
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHH-HHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQ-MLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~-il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||+||+|+.. +|+.+|+|++... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999864 6899999987643 2233455666665 46779999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|..++. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 99988873 44578999999999999999999999 999999999999999999999999999987543221 1223
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...|+..|+|||++.+..++.++|||||||++|||++|++||......+. . ..... ..+ . ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~---~~~~~-~~~--~--------~~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---Y---DNILH-KPL--V--------LRP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---H---HHHHc-CCc--c--------CCC
Confidence 45689999999999999999999999999999999999999976533221 1 11111 000 0 011
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVL 776 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl 776 (842)
.....+.+++.+|++.+|.+||++.+.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2234577899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.60 Aligned_cols=238 Identities=24% Similarity=0.362 Sum_probs=189.3
Q ss_pred EEeecCcEEEEEEEEcC-------------------------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeE
Q 037607 515 VIGVGGFGKVYIGVLED-------------------------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~-------------------------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l 569 (842)
.||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998521 13589999876655556788999999999999999999
Q ss_pred EEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---
Q 037607 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL--- 646 (842)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~--- 646 (842)
+++|......++||||+++|+|..++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999888843 34578999999999999999999998 8999999999999997643
Q ss_pred ----ceEEeecccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHH-hCCCCCCCCCchhhhh
Q 037607 647 ----VAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVL-CARPVINPKLPREQVS 720 (842)
Q Consensus 647 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELl-tG~~p~~~~~~~~~~~ 720 (842)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+......+..
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 4799999987654321 12346788999998875 56899999999999999995 789988765433211
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.+... ... ........+.+++.+||+.+|.+||++.++++.|
T Consensus 232 --~~~~~---~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 --RFYEK---KHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHHHh---ccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11100 000 0011123578899999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.57 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=194.1
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~ 583 (842)
+|+..+.||+|+||.||+|... +|+.||+|++... .....+.+..|+.++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999864 6889999987643 2334466888999998885 577888999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999883 34568999999999999999999998 999999999999999999999999999987643221
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||..|+|||++.+..++.++|||||||++|||++|++||....... +...... ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~~~--------- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIME----HNV--------- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CCC---------
Confidence 12234568999999999999999999999999999999999999998654322 1111111 000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.........+.+++.+|++.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111223467889999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.10 Aligned_cols=237 Identities=25% Similarity=0.402 Sum_probs=189.8
Q ss_pred EEeecCcEEEEEEEEcCCc-----------EEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 515 VIGVGGFGKVYIGVLEDGN-----------KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~-----------~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999976433 5788876654433 6789999999999999999999999988 7889999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-------ceEEeecccc
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-------VAKVADFGLS 656 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-------~~kl~DFGla 656 (842)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999885432 278999999999999999999998 9999999999999999887 7999999998
Q ss_pred cccCCCCCceeeeeccCCCCCCccccccc--CCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
..... .....++..|+|||++.+. .++.++|||||||++|||++ |..|+......+.. .+. ....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~---~~~~- 223 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY---QDQH- 223 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH---hcCC-
Confidence 76543 1233467789999998876 78999999999999999999 57777654322111 111 0000
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.... .....+.+++.+|+..+|.+||++.|+++.|+
T Consensus 224 --~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 --RLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 01157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.87 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=197.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 5788999987642 2233456889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999853 23578899999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
........|++.|+|||++.+ ..++.++|||||||+||||++|+.||......+.. ....... ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~--~~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHE--ERFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCC--Cccc
Confidence 333344579999999999875 56789999999999999999999999765432211 1110000 0000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVD--RPGMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~evl~~ 778 (842)
-+ ........++.+++.+|++..+.+ |+++.++++.
T Consensus 229 ~p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FP----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CC----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 001122356777888888765543 4678887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=333.57 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=210.5
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-C-----CceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-H-----RHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-H-----pnIv~l~g~~~~~~~~~ 580 (842)
-+|++.++||+|+||+|-||.. .+++.||||+++.. ..-..+-..|+.+|..|+ | -|+|++++||...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3899999999999999999985 46999999998865 334567789999999997 5 38999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC--CCceEEeecccccc
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE--NLVAKVADFGLSKA 658 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~--~~~~kl~DFGla~~ 658 (842)
||+|.+. .+|.++|....-.+|+...++.|+.||+.||..||+ .+|||+||||+||||.+ ...+||+|||.|+.
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999994 699999987777889999999999999999999998 99999999999999964 34899999999987
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH--------HHHHhhc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE--------WALQCHR 730 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~--------~~~~~~~ 730 (842)
.... .. ...-+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.++...+- |+.....
T Consensus 341 ~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5321 22 4556788999999999999999999999999999999999999988777655332 1111110
Q ss_pred -------c--cccc-----c-----------------cc---ch----hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 731 -------K--GILE-----K-----------------II---DP----VIAETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 731 -------~--~~l~-----~-----------------i~---d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
+ +... . .. -| .+........-..+++++.+|+..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0 0000 0 00 00 00001112334678999999999999999999
Q ss_pred HHHHHHH
Q 037607 773 GDVLWNL 779 (842)
Q Consensus 773 ~evl~~L 779 (842)
.|+++.-
T Consensus 497 ~qal~Hp 503 (586)
T KOG0667|consen 497 AQALNHP 503 (586)
T ss_pred HHHhcCc
Confidence 9998754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=351.51 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=205.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.++||+|+||.||+|... +|+.||+|++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 5889999987643 2334567999999999999999999999999999999999
Q ss_pred EecCCCCcccccccC---------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 584 EYMANGPFRDHLYGT---------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~---------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
||+++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988431 12346778889999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCC-----------------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 655 LSKAAPMDRG-----------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 655 la~~~~~~~~-----------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
+++....... .......||+.|||||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123468999999999999999999999999999999999999997643221
Q ss_pred hhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHhh
Q 037607 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP-GMGDVLWNLEYAMQL 785 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~evl~~Le~~~~~ 785 (842)
.. +. ..+.++.-.. ...+....+.+++.+|++.+|.+|| ++.++++.|+...+.
T Consensus 239 i~----~~---------~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS----YR---------DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh----hh---------hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 00 0011110000 0112345678899999999999996 677788888776553
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.67 Aligned_cols=238 Identities=23% Similarity=0.370 Sum_probs=189.9
Q ss_pred EEeecCcEEEEEEEEcC-------------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 515 VIGVGGFGKVYIGVLED-------------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~-------------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.||+|+||.||+|++.. ...|++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 23589998877666666788999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc-------eEEeecc
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV-------AKVADFG 654 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~-------~kl~DFG 654 (842)
||||+++|+|..++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999888743 33568999999999999999999998 99999999999999987664 8999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCccccc-ccCCCCcccchhHHHHHHHHH-hCCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL-CARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwS~GvvL~ELl-tG~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+... . .. +
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~---~~-~ 224 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----F---YE-G 224 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----H---Hh-c
Confidence 98654322 2345778899999886 567899999999999999998 5888876543222110 0 00 0
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.. ... ......+.+++.+||+.+|.+||++.+|++.|
T Consensus 225 ~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 000 11234678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.29 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=201.3
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556678999999999999975 4778899998777777778899999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
++|..++.. ...++++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 999887743 34578999999999999999999999 899999999999999999999999999987653221 1223
Q ss_pred eeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 669 AVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
...++..|+|||++. +..++.++|||||||++|||++|++||......+. ...... . ....+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~----~-~~~~~~~---- 230 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK----S-EPPTLAQ---- 230 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhh----c-CCCCCCC----
Confidence 456889999999984 45678899999999999999999999875433221 111100 0 0001111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.......+.+++.+||+.+|.+||++.++++.-
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 231 ---PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 112235678899999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.60 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=198.4
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCccc
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD 593 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (842)
+||+|+||.||++...+++.|++|+...... ....++.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6899999999999987799999998776433 356789999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee-eeecc
Q 037607 594 HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS-TAVKG 672 (842)
Q Consensus 594 ~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~-~~~~g 672 (842)
++... ...+++..++.++.+++.+|+|||+ ++++||||||+|||++.++.+||+|||+++.......... .....
T Consensus 82 ~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 82 FLRKK-KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 98543 3468899999999999999999998 8999999999999999999999999999876542111111 11223
Q ss_pred CCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 673 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 673 t~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
+..|+|||.+.+..++.++|||||||++|||++ |..||........ ..... ... .. .......
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~~~----~~~--~~-------~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERIE----SGY--RM-------PAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHHHh----cCC--CC-------CCCccCC
Confidence 567999999998899999999999999999998 8888865533221 11111 000 00 0112234
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+.+++.+|++.+|.+||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 57889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=323.79 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=196.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.++||+|+||.||+++.. +++.+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 4678999987542 2223455889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999853 23568999999999999999999999 999999999999999999999999999987654333
Q ss_pred CceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 664 GYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ....... ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~--~~~~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHK--ERFQ 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCC--cccc
Confidence 33334457999999999986 346889999999999999999999999765332211 1111100 0000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCC--CCCCCHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYG--VDRPGMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP--~~RPtm~evl~~ 778 (842)
-+. ........+.+++.+|+..++ ..|+++.|+++.
T Consensus 229 ~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 011223456677777775544 447899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.29 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=189.5
Q ss_pred EEeecCcEEEEEEEEcC---CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 515 VIGVGGFGKVYIGVLED---GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~---g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
.||+|+||.||+|...+ ...+++|.+... ......+|.+|+++++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 347889987644 33445678999999999999999999999999999999999999999
Q ss_pred cccccccCC---CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce-
Q 037607 591 FRDHLYGTN---QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV- 666 (842)
Q Consensus 591 L~~~l~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~- 666 (842)
|.+++.... ....++...+.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999985432 2345678889999999999999999 899999999999999999999999999987643222111
Q ss_pred eeeeccCCCCCCcccccc-------cCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 667 STAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~-------~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.....++..|+|||++.. ..++.++|||||||++|||++ |.+||....+.+. + ... .... ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~-~~~---~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--L-KQV---VREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--H-HHH---hhcc-CccCC
Confidence 122345678999998743 456889999999999999998 7888865433221 1 111 1111 11111
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
++.+ .......+.+++..|+ .+|++||+++||+++|.
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2211 2223345566777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.50 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=204.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999865 5788999987654 334456789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ...+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 999999999843 3668999999999999999999996 258999999999999999999999999998765322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc-----------
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL----------- 734 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l----------- 734 (842)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+....... ...+..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 1234568899999999988889999999999999999999999986543221 11111000000000
Q ss_pred ---------ccccchhHH---hhhc-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 735 ---------EKIIDPVIA---ETIC-KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 735 ---------~~i~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.++.+.... ...+ ......+.+++.+||+.+|++||++.|+++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000000 0000 01234688999999999999999999999876653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=328.74 Aligned_cols=240 Identities=26% Similarity=0.337 Sum_probs=189.6
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQ-MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~-il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
.||+|+||+||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999975 56789999876432 222334455544 567889999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
+|.+++. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 82 ELFYHLQ--RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 9999884 34567888999999999999999999 999999999999999999999999999987543222 12345
Q ss_pred eccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHH
Q 037607 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~ 749 (842)
..||+.|+|||++.+..++.++|||||||++|||++|++||......+. .+.... . ... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~---~-~~~----------~~~~ 218 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILN---K-PLQ----------LKPN 218 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHHHh---C-CcC----------CCCC
Confidence 6799999999999999999999999999999999999999976543221 111111 0 000 1112
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 750 SLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 750 ~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
....+.+++.+|++.+|.+||++.+.+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 3456788999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.18 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=205.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcC--------CcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED--------GNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS 577 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~--------g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~ 577 (842)
.+|.+.+.||+|+||.||++.... +..||+|.+... .....+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997421 236899987754 344567899999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc
Q 037607 578 EMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD 643 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld 643 (842)
..+++|||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999885321 2357889999999999999999998 9999999999999999
Q ss_pred CCCceEEeecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhH
Q 037607 644 ENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSL 721 (842)
Q Consensus 644 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l 721 (842)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |.+||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 99999999999998654322111 122334567999999999999999999999999999998 888886543222
Q ss_pred HHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 722 AEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 722 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
+...... +.... ........+.+++.+|++.+|.+||++.|+++.|+.+...
T Consensus 245 --~~~~~~~-~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 --LFKLLKE-GHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred --HHHHHHc-CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111 11000 1112345688999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.15 Aligned_cols=270 Identities=27% Similarity=0.380 Sum_probs=200.9
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc--CCCceeeEEEeeccCC----eEEEEEEe
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL--RHRHLVSLIGFCDEQS----EMILVYEY 585 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L--~HpnIv~l~g~~~~~~----~~~lV~Ey 585 (842)
...+||+|+||.||||.+. ++.||||++.. +..+.|++|-+|.+.. +|+||+++++.-+... +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3457999999999999996 58999999774 4456788888888764 8999999999876555 89999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhC------CCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG------AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~------~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
.+.|+|.++| ....++|....+|+..+++||+|||+. .+.+|+|||||++||||.+|++..|+|||||..+
T Consensus 290 h~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999 345789999999999999999999975 3567999999999999999999999999999877
Q ss_pred CCC-CCceeeeeccCCCCCCcccccccC-CC-----CcccchhHHHHHHHHHhCCCCCCC-CCchhhhhHHHHHHHhhcc
Q 037607 660 PMD-RGYVSTAVKGSFGYLDPEYFRRQQ-LT-----EKSDVYSFGVVLFEVLCARPVINP-KLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 660 ~~~-~~~~~~~~~gt~~Y~APE~l~~~~-~s-----~ksDVwS~GvvL~ELltG~~p~~~-~~~~~~~~l~~~~~~~~~~ 731 (842)
... ........+||.+|||||++.+.- +. .+.||||+|.|||||++.....+. ..++-+.....-+.....-
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 532 222334578999999999997632 22 479999999999999987654431 1111111111000000000
Q ss_pred c-----ccccccchhHHhhh-cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 732 G-----ILEKIIDPVIAETI-CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 732 ~-----~l~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
+ .+++-..|.+...+ ....+..+.+.++.||..|++.|-|+.=+.+++.+.....+.
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 0 11111222222222 234577899999999999999999999888888776555443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.04 Aligned_cols=203 Identities=24% Similarity=0.417 Sum_probs=175.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 6889999987642 2334567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999984 34578999999999999999999999 999999999999999999999999999987542110
Q ss_pred C----------------------------------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCC
Q 037607 664 G----------------------------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709 (842)
Q Consensus 664 ~----------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p 709 (842)
. .......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235699999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 037607 710 INPKLP 715 (842)
Q Consensus 710 ~~~~~~ 715 (842)
|.....
T Consensus 236 f~~~~~ 241 (360)
T cd05627 236 FCSETP 241 (360)
T ss_pred CCCCCH
Confidence 986644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=327.01 Aligned_cols=266 Identities=21% Similarity=0.254 Sum_probs=199.4
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------ 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------ 576 (842)
..++|...+.||+|+||.||++... .|+.||+|++... ......++.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 6889999997643 334456788999999999999999999998543
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 357999999975 5655552 347889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHH---------H----
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLA---------E---- 723 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~---------~---- 723 (842)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+..... +
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 764322 1223456899999999999999999999999999999999999999865432211000 0
Q ss_pred ---HHHHhhcc-cc-----cccccchhHH---hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 724 ---WALQCHRK-GI-----LEKIIDPVIA---ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 724 ---~~~~~~~~-~~-----l~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........ .. +.+.....+. ..........+.+++.+||+.+|.+||++.|+++.-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 00000000 00 0000000000 00001123567899999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=313.79 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=198.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||+|++|.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999975 6889999987643 222346788999999999999999999999999999999999
Q ss_pred cCCCCcccccccCC-CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 586 MANGPFRDHLYGTN-QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
++ ++|.+++.... ...+++..++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888774432 3678999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh--hcccc--------
Q 037607 665 YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC--HRKGI-------- 733 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~--~~~~~-------- 733 (842)
.......++..|+|||.+.+ ..++.++|||||||+++||++|++||......... ....... .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhhH
Confidence 11223456889999998865 45789999999999999999999999865432211 0000000 00000
Q ss_pred -----cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 734 -----LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 734 -----l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........+. ........++.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.34 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=204.2
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCc-eeeEEEeeccCC------
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRH-LVSLIGFCDEQS------ 577 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~Hpn-Iv~l~g~~~~~~------ 577 (842)
..|...++||+|+||+||+|+. .+|+.||+|++.-..+ .......+|+.+|++|+|+| |++|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455566799999999999995 4789999998765533 23345689999999999999 999999998776
Q ss_pred eEEEEEEecCCCCcccccccCCC--CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQ--PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
.++||+||++ -+|..++..... ..++...+..++.||++||+|||+ ++|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 7899999995 478888744332 467778999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
|+....... ..+..++|..|+|||++.+. .|+...||||+|||+.||+++++.|.+..+.++...+--......+..+
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 997764322 24556789999999999885 7999999999999999999999999988765544322211111111111
Q ss_pred cccc---c----------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKII---D----------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~---d----------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+. + +.......+.......+++.+|++.+|.+|.+++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1110 1 110001111112467899999999999999999998875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.51 Aligned_cols=250 Identities=22% Similarity=0.434 Sum_probs=200.7
Q ss_pred CcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
+|...+.||+|+||.||+|...+|+.+|+|.+.... ......+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367778999999999999998889999999875432 23345688999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++. ...++++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999984 33568899999999999999999998 89999999999999999999999999998765321
Q ss_pred C-----CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 663 R-----GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 663 ~-----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||......+.. . ......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~---~~~~~~~~~~~- 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--F---YIGAHRGLMPR- 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--H---HhhhccCCCCC-
Confidence 1 11122345888999999999988999999999999999999999999754322211 0 00000011111
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........+.+++.+||+.+|.+||++.|+++
T Consensus 230 --------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 --------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12223456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.49 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=193.9
Q ss_pred EEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeec-cCCeEEEEEEecCC
Q 037607 515 VIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD-EQSEMILVYEYMAN 588 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~-~~~~~~lV~Ey~~~ 588 (842)
.||+|+||.||+|.+.+ ...+|+|++... .....+.+.+|+.+++.++||||++++++|. ..+..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 68999999999998632 357999987643 3445678899999999999999999999875 45568999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc---
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--- 665 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~--- 665 (842)
|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 82 GDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999998533 3456788889999999999999998 89999999999999999999999999999765322111
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......++..|+|||.+.+..++.++|||||||++|||++| .+|+...... .+..+... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~---~~~~~--------- 222 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQ---GRRLL--------- 222 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhc---CCCCC---------
Confidence 11233457789999999888999999999999999999995 5666543221 12222111 00000
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.....+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 223 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 -QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01112346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.58 Aligned_cols=250 Identities=32% Similarity=0.519 Sum_probs=202.5
Q ss_pred ccceEEeecCcEEEEEEEEcC-----CcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 511 DENAVIGVGGFGKVYIGVLED-----GNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~-----g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++.+.||.|+||.||+++..+ +..||+|++...... ..+.+..|+.+++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999753 378999998765433 56789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999855443338999999999999999999998 8999999999999999999999999999987654432
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......++..|+|||.+.+..++.++||||+|++++||++ |++|+....... +.+.... +....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~~~------- 224 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKK----GYRLP------- 224 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc----CCCCC-------
Confidence 22222346789999999988889999999999999999998 788887532221 1221111 11100
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
........+.+++.+|+..+|++||++.|+++.|
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0112345688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.62 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=203.6
Q ss_pred CcccceEEeecCcEEEEEEEEc-----CCcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-----DGNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEMI 580 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-----~g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~~ 580 (842)
.|...+.||+|+||.||++.+. .+..+|||++...... ..++|.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566779999999999999864 3678999998765443 56789999999999999999999999877 56799
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999998543 3369999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCce--eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh---------hHHHHHHHhh
Q 037607 661 MDRGYV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV---------SLAEWALQCH 729 (842)
Q Consensus 661 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~---------~l~~~~~~~~ 729 (842)
...... .....++..|+|||.+.+..++.++||||||++++||++|+.|+......... ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 332211 11233456799999999889999999999999999999999887653221100 0111111100
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
... .......+..++.+++.+|++.+|.+||+|.||+++|+.+
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 0001122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=308.55 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-CCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-QSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~~~~lV~E 584 (842)
+|++.+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 5788999987543 33445678999999999999999999998764 446799999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.+++.......+++.+++.++.+++.||++||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999865555678999999999999999999998 8999999999999999999999999999987643322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......++..|+|||++.+..++.++||||||++++||++|+.||....... +..... .+.+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~-~~~~~~-------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII-EGKLPP-------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCCCC--------
Confidence 2234568899999999999999999999999999999999999987543221 111111 111111
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+|++.+|.+||++.|+++.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112334568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=315.45 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=202.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+.|++.+.||.|+||.||+|... +++.+++|.+........+++.+|+.+++.++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888889999999999999975 58899999988777777788999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|..++.. ....+++..++.++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 99999887743 23568999999999999999999998 899999999999999999999999999987543221 12
Q ss_pred eeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 667 STAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.....++..|+|||++. ...++.++|||||||++|||++|++|+........ .. ... ......+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~-~~~~~~~~--- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIA-KSEPPTLS--- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----HHh-cCCCccCC---
Confidence 23456888999999985 34578899999999999999999999875432211 11 110 00000000
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......++.+++.+||+.+|++||++.|+++.
T Consensus 237 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 ----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011233467889999999999999999998763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=319.01 Aligned_cols=267 Identities=21% Similarity=0.316 Sum_probs=201.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999865 57899999876432 23345678999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
++ ++|.+++.. ....+++..+..++.|+++||+|||+ .+|+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 588887743 34468899999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc-----
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID----- 739 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d----- 739 (842)
......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+......-.........+..+.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1223456889999999875 4578899999999999999999999986654332211100000000001111000
Q ss_pred ----hhHH----hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 ----PVIA----ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ----~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+... ..........+.+++.+|++.+|.+|||+.|+++.-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 0111123456789999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.33 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=201.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|+....||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 58899999875432 2233568899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|..++. ....+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988887763 34468999999999999999999999 9999999999999999999999999999987643221
Q ss_pred ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH-HHHH-------hh-ccccc
Q 037607 665 YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE-WALQ-------CH-RKGIL 734 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~-~~~~-------~~-~~~~l 734 (842)
......++..|+|||++.+ ..++.++|||||||++|||++|++||......+...... .... .. .....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999999876 568899999999999999999999998655433211100 0000 00 00000
Q ss_pred ccccchhHH-----hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKIIDPVIA-----ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+..+... ..........+.+++.+|++.+|++||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000 00111224668899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.25 Aligned_cols=266 Identities=22% Similarity=0.296 Sum_probs=205.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|+..+.||+|+||.||+|... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 5789999987643 23345678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|++++.|..++ .....+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLE--ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987776555 234568999999999999999999999 8999999999999999999999999999887654433
Q ss_pred ceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH---------Hhhcccc-
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL---------QCHRKGI- 733 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~- 733 (842)
.......++..|+|||++.+. .++.++||||||+++|||++|++||......+......... .......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233445678899999999887 88999999999999999999999997654332211111100 0000000
Q ss_pred ----cccccchhH-HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 ----LEKIIDPVI-AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 ----l~~i~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.....++.. ..........++.+++++||..+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 011111111 111222236778999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=315.75 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=206.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|++.+.||+|+||+||++... +|+.||+|++... .....+++.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777789999999999999964 6888999986543 234457899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ...+++..+..++.+++.+|.|||+ ..+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 999999988843 4568999999999999999999996 2579999999999999999999999999986543221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh-----hhhHHHHHHHhhcccccccccch
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE-----QVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+ ...+.++........ .+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence 123468999999999988899999999999999999999999998654321 111222222111110 00
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.+. ..+....+.+++.+|++.+|.+||++.|++++....
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000 112345688999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.63 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=205.2
Q ss_pred ccHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeec-
Q 037607 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCD- 574 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~- 574 (842)
..++.+..+.++|++.+.||+|+||.||++... +++.+|+|++..... ...++.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566678899999999999999999999864 578999998765322 235688999999999 6999999999883
Q ss_pred ----cCCeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 575 ----EQSEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 575 ----~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
.++..++||||+++++|.+++.. .....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 44578999999999999988743 234568899999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~ 723 (842)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|++|+......... ..
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK 240 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence 999999987654322 12234468999999998753 45788999999999999999999998755332211 10
Q ss_pred HHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 724 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
+ . ......+.++ ......+.+++.+||+.+|++||++.|+++.+
T Consensus 241 ~----~-~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 I----P-RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c----c-ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0 0000011111 11234688899999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.84 Aligned_cols=247 Identities=29% Similarity=0.470 Sum_probs=196.6
Q ss_pred EEeecCcEEEEEEEEcC-------CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 515 VIGVGGFGKVYIGVLED-------GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~-------g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.||+|+||.||+|+..+ ++.+++|.+.... .....++.+|+++++.++||||++++++|...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998642 2578999876543 344678999999999999999999999999999999999999
Q ss_pred CCCCcccccccC-----CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-----ceEEeecccc
Q 037607 587 ANGPFRDHLYGT-----NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-----VAKVADFGLS 656 (842)
Q Consensus 587 ~~gsL~~~l~~~-----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-----~~kl~DFGla 656 (842)
++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.+. .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998542 23458899999999999999999998 8999999999999999877 8999999998
Q ss_pred cccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 657 KAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 657 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ...... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~---~~~~~ 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVT---AGGRL 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHh---cCCcc
Confidence 765322111 1122345678999999999999999999999999999998 999987543322 111111 11000
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 233 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 ----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 011223456789999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.22 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=200.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|.+.+.||+|+||.||++.. .++.||+|...... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588889999999999999985 57889999876543 236789999999999999999999998654 5799999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 9999999966555678999999999999999999998 999999999999999999999999999987643211
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....+..|+|||++.+..++.++|||||||++|||++ |++||......+. .+.. ..+.... .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~~---------~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KECV----EKGYRME---------P 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH----hCCCCCC---------C
Confidence 12234568999999998899999999999999999997 9999875543221 1111 1111000 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+|++.+|.+||+++++++.|++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 12234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=325.56 Aligned_cols=266 Identities=20% Similarity=0.254 Sum_probs=200.2
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ----- 576 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~----- 576 (842)
...++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35578999999999999999999864 5889999988653 334456788999999999999999999988543
Q ss_pred -CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 577 -SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 577 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5666552 357889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHH---------HH--
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLA---------EW-- 724 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~---------~~-- 724 (842)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865322 2223456899999999999999999999999999999999999999865432221100 00
Q ss_pred -----HHHhhcc-cccccccchhHH--------hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 725 -----ALQCHRK-GILEKIIDPVIA--------ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 725 -----~~~~~~~-~~l~~i~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
....... .....+..+... ..........+.+++.+|++.+|.+|||+.|+++.-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 0000000 000000000000 0011122356789999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.97 Aligned_cols=196 Identities=23% Similarity=0.362 Sum_probs=160.1
Q ss_pred ceEEeecCcEEEEEEEEc---CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeec--cCCeEEEEEEecC
Q 037607 513 NAVIGVGGFGKVYIGVLE---DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD--EQSEMILVYEYMA 587 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~--~~~~~~lV~Ey~~ 587 (842)
.++||+|+||.||+|... +++.+|+|++..... ...+.+|+++|++++||||+++++++. .....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 457899998765422 245789999999999999999999884 3456899999986
Q ss_pred CCCccccccc-------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE----cCCCceEEeecccc
Q 037607 588 NGPFRDHLYG-------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLS 656 (842)
Q Consensus 588 ~gsL~~~l~~-------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl----d~~~~~kl~DFGla 656 (842)
++|.+++.. .....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 477766532 122358899999999999999999999 999999999999999 45679999999999
Q ss_pred cccCCCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 037607 657 KAAPMDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKL 714 (842)
Q Consensus 657 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~ 714 (842)
+....... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 12234568999999999877 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=317.59 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=204.8
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46788899999999999999996 47899999988765555557789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999998832 457899999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......++..|+|||.+.+..++.++|||||||++|||++|++||....+...... ....+ .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~~~------- 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPELQ------- 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCCCC-------
Confidence 22344688899999999998999999999999999999999999976543221100 00000 00000
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.06 Aligned_cols=250 Identities=28% Similarity=0.375 Sum_probs=203.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|+..+.||.|+||.||+|+.. +++.|++|++.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999965 68899999876543 44456789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++... ++++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998432 78999999999999999999998 899999999999999999999999999998765332 1
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......++..|+|||++.+..++.++|||||||++|||++|++||....+... ... ........ +...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~~~~~~~-----~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-IPKNNPPS-----LEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-hhhcCCCC-----Cccc
Confidence 22345678899999999988899999999999999999999999975432211 000 11111111 1110
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.....+.+++.+||..+|++||+++++++.-
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 1334678899999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=315.12 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=201.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 58899999865432 2234678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.++.. ....+++.+++.++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999998887763 23458999999999999999999998 899999999999999999999999999988654332
Q ss_pred ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HHHHHHHhhcc-------c-c-
Q 037607 665 YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LAEWALQCHRK-------G-I- 733 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~~~~~~~~~~-------~-~- 733 (842)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||......+... +..+....... . .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22234457889999999875 457889999999999999999999997554322111 11110000000 0 0
Q ss_pred ----cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 734 ----LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 734 ----l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+...........+.....+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000001112234567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=310.72 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=199.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh---------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE---------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~---------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
+|.....||+|+||.||+|... +++.+|+|.+..... +..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 578999998754321 123568899999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999983 34578899999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCc-----eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 659 APMDRGY-----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 659 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ +. .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~-~~-- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IF----KI-GE-- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HH----HH-hc--
Confidence 6522111 11234578899999999988899999999999999999999999975432211 10 00 00
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
...+ .........+.+++.+||+.+|.+||++.|+++
T Consensus 227 ---~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111 112233456788999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=325.17 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=212.7
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh---hhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE---QGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~---~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~ 580 (842)
....|++.+.||.|.||.||+++.+ +|+.+|+|.+.+... .....+.+|+++|++|. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888889999999999999976 499999998776533 23468999999999998 999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC----CCceEEeecccc
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE----NLVAKVADFGLS 656 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~----~~~~kl~DFGla 656 (842)
+|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .+|+||||||+|+|+.. ++.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999655 39999999999999999999999 99999999999999953 358999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
..... +......+||+.|+|||++....|+..+||||+||++|.|++|.+||......+... ....+.+
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC--
Confidence 98765 445678899999999999999999999999999999999999999998776443221 1111111
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.......+.......+++..|+..||.+|+++.++++.-
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 112223344466778899999999999999999999853
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.45 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=200.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777789999999999999864 68899999887665555567889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++. ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999883 34578999999999999999999999 899999999999999999999999999987653221 12
Q ss_pred eeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 667 STAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....|+..|+|||++. ...++.++|||||||++|||++|++|+....+...... ....... .+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~~~~~~~----~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MTKSNFQ----PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------hhccCCC----CCccc
Confidence 23456899999999974 45688999999999999999999999865433221100 0000000 00000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.. ......+.+++.+|++.+|++||++.++++
T Consensus 233 ~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 012245778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.17 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=194.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEM 579 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~ 579 (842)
.+|...+.||+|+||.||+|... .+..|++|++... ..+....+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999864 5889999986532 22344678899999999999999999998865 4578
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999998843 3468899999999999999999998 89999999999999999999999999998765
Q ss_pred CCCC--CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 660 PMDR--GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 660 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.... ........++..|+|||++.+..++.++|||||||++|||++|++||......+.. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~----- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP----- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC-----
Confidence 3211 11122345788999999999988999999999999999999999999754322211 1111100
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+.+ .......+.+++ +|+..+|++||+++|+++
T Consensus 226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111 112223344454 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=317.37 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=205.6
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.+|+..+.||.|+||.||+|.. .+|+.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 478999999887655555678899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++. ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 9999999883 2358999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||.+.+..++.++|||||||++|||++|++||......+... +... . ....+. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~~~---~-~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIAT---N-GTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh---c-CCcccC-------C
Confidence 233468889999999998889999999999999999999999997664432211 1100 0 000000 0
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+||..+|.+||++.++++.=.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 1123346778999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=311.54 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=201.3
Q ss_pred CcccceEEeecCcEEEEEEEEcC--CcEEEEEECCCC----------ChhhHHHHHHHHHHHHh-cCCCceeeEEEeecc
Q 037607 509 NFDENAVIGVGGFGKVYIGVLED--GNKVAIKRGNPG----------SEQGINEFQTEIQMLSK-LRHRHLVSLIGFCDE 575 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~--g~~VAvK~~~~~----------~~~~~~~f~~Ei~il~~-L~HpnIv~l~g~~~~ 575 (842)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777899999999999999764 678999976432 23344667889998875 799999999999999
Q ss_pred CCeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 576 QSEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
.+..+++|||+++++|.+++.. .....+++..+++++.|++.||.|||+ ..+++|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 234578999999999999999999995 267999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 654 GLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 654 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
|++....... ......++..|+|||++.+..++.++||||||+++|||++|++||....... .. .... .+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~---~~~~-~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA---TKIV-EAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH---HHHh-hcc
Confidence 9998754332 2344568899999999998889999999999999999999999986543221 11 1111 111
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
...+. .......+.+++.+|++.+|.+||++.|+..+++
T Consensus 230 ~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11000 0122356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=314.05 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=205.3
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc-
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE- 575 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~- 575 (842)
++.++....+.|+..+.||+|+||.||+|.. .+++.+|+|...... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 5566667788999999999999999999996 467899999876543 3346788999999998 69999999999853
Q ss_pred -----CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEE
Q 037607 576 -----QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 576 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl 650 (842)
....+++|||+++|+|.+++.......+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEE
Confidence 4678999999999999998865555668899999999999999999999 89999999999999999999999
Q ss_pred eecccccccCCCCCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 037607 651 ADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 651 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~ 725 (842)
+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.......
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--- 238 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 238 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH---
Confidence 99999876532211 123456889999999876 356788999999999999999999999754332211100
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.....+.+ ........+.+++.+||+.+|.+||++.|+++
T Consensus 239 ---------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 ---------PRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------hhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000000 11123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=308.56 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=200.4
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-----EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-----~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
+|...+.||+|+||.||+|... +++.|++|.+.... .+..+++.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999976 78999999865432 33557899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999843 3468899999999999999999998 89999999999999999999999999998765433
Q ss_pred CCceeeeeccCCCCCCcccccccC-CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. ......++..|+|||.+.... ++.++|+|||||++|||++|++||......+. ...+ ........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~----~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKI----GRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHH----HhcccCCC-----
Confidence 2 223456888999999987766 89999999999999999999999976542111 1111 11011111
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.......+.+++.+||+.+|.+||++.++++
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11223456778999999999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.11 Aligned_cols=264 Identities=25% Similarity=0.296 Sum_probs=201.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc---CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE---DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..+|.+.+.||+|+||.||++... .+..|++|.+... ..+.+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3568999987643 23568999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|++. ++|.+++ .....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6788887 445679999999999999999999999 899999999999999999999999999997654332
Q ss_pred C-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc-----
Q 037607 664 G-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI----- 737 (842)
Q Consensus 664 ~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i----- 737 (842)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||.............-+............
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2 1223457999999999999999999999999999999999999999765432211111111111100000000
Q ss_pred ------------cchh--HHhhhc-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 738 ------------IDPV--IAETIC-KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 738 ------------~d~~--l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
..+. +...+. ......+.+++.+||..+|++||++.|++..-..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0000 000000 0123457788999999999999999999987544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.23 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=204.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.+|...+.||+|+||.||+|.+. +|+ .+|+|...... .....++.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45777889999999999999864 343 58999877553 3455789999999999999999999999987 78999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999998543 3458999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
..... .....++..|+|||.+....++.++|||||||++|||++ |+.||+.....+ +.+... .+. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~--~~~~ 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLE----KGE--RLPQ 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh----CCC--CCCC
Confidence 32211 122224568999999988899999999999999999998 999997654322 122111 110 0000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.......+.+++.+||..+|.+||++.++++.|+....
T Consensus 233 -------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 -------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122457788999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.25 Aligned_cols=238 Identities=23% Similarity=0.375 Sum_probs=189.7
Q ss_pred EEeecCcEEEEEEEEcC--------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 515 VIGVGGFGKVYIGVLED--------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~--------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.||+|+||.||+|.... ...+++|.+........+++.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 68999999999998642 2348888877655556678999999999999999999999999989999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc--------eEEeecccccc
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV--------AKVADFGLSKA 658 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~--------~kl~DFGla~~ 658 (842)
++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. ++++|||++..
T Consensus 82 ~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 82 KFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999998543 3468999999999999999999999 99999999999999987765 69999998865
Q ss_pred cCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|. +|+........... .....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~------~~~~~---- 222 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------YEDRH---- 222 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH------HHccc----
Confidence 4321 23457889999999986 45899999999999999999995 55543322211110 00000
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.++.....++.+++.+||+.+|++||+++++++.|
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 --------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11112234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.53 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=204.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|++.+.||+|+||.||+|... +|+.|++|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999964 68899999876543 33456899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+ +++|.+++.... ..+++.+++.++.|++++|+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999885433 679999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc------------
Q 037607 666 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG------------ 732 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------ 732 (842)
......++..|+|||++.+. .++.++||||+||+++||++|++++......+.. .+........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcc
Confidence 23345688999999998654 4689999999999999999998888765432211 1111110000
Q ss_pred cccccc----chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 ILEKII----DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 ~l~~i~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
....+. .+.......++....+.+++.+|++.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000111122334788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.45 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=204.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||+|+||.||++... +|+.+++|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999864 6889999987542 334456899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999998865455578999999999999999999998 8999999999999999999999999999976543221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......|+..|+|||++.+...+.++|||||||+++||++|+.|+......+. ..... .+... .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~---------~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKII-RGSYP---------P 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHh-cCCCC---------C
Confidence 12234578899999999998999999999999999999999999875433221 11111 11110 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+|++.+|.+||+|.||++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.69 Aligned_cols=192 Identities=26% Similarity=0.385 Sum_probs=165.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
...+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999975 5678999975433 23569999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+. ++|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred ccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 995 688887743 34578999999999999999999999 899999999999999999999999999987543221
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCC
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI 710 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~ 710 (842)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456899999999999999999999999999999999865444
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=318.63 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=201.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE---QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~---~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 489999998765432 24567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+.+++|.+++.......+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999865555789999999999999999999998 899999999999999999999999999987653221
Q ss_pred Cc----------------------------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCc
Q 037607 664 GY----------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP 715 (842)
Q Consensus 664 ~~----------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~ 715 (842)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11123578899999999998999999999999999999999999976543
Q ss_pred hhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 037607 716 REQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776 (842)
Q Consensus 716 ~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl 776 (842)
.... ........... ........+.+++.+|++.+|++||++...+
T Consensus 238 ~~~~-----~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 238 DETF-----SNILKKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred HHHH-----HHHhcCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 2211 00000000000 0111356788999999999999999944333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=323.57 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=198.5
Q ss_pred HHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ----- 576 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~----- 576 (842)
...++|...+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+++|++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999986 467899999986532 23346688999999999999999999887532
Q ss_pred -CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 577 -SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 577 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
...++++|++ +++|.+++. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 4579999988 778887763 3468999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--ccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH--RKG 732 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~--~~~ 732 (842)
++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..+..... ...
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCCHH
Confidence 9865432 234568999999999877 57899999999999999999999999765432211 11110000 000
Q ss_pred cccccc---------------chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 733 ILEKII---------------DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 733 ~l~~i~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+..+. ...+. .........+.+++.+|++.+|.+||++.|+++.-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000 00000 000111234678999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.97 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=195.7
Q ss_pred ceEEeec--CcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 513 NAVIGVG--GFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 513 ~~~LG~G--~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
..+||+| +|++||++.. .+|+.||+|++... .....+.+.+|+++++.++||||++++++|...+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 7899999986 47899999998754 23344567789999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc--
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-- 665 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~-- 665 (842)
+|+|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999855445568999999999999999999998 99999999999999999999999999865433211100
Q ss_pred ----eeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 666 ----VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 666 ----~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... +......+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-----~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLN-----GTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhc-----CCcccccc
Confidence 0112346678999999876 4689999999999999999999999975432110 000000 00000000
Q ss_pred h------------------------------------hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 P------------------------------------VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ~------------------------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
. .............+.+++.+||+.||++|||+.|+++.-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0 0000111223457889999999999999999999987544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=331.92 Aligned_cols=261 Identities=20% Similarity=0.220 Sum_probs=195.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|+++|++|+|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 447999999999999999999975 578899996432 3467899999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC-
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG- 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~- 664 (842)
+. ++|.+++.. ....++|.+++.|+.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 688887743 23479999999999999999999998 8999999999999999999999999999986543221
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCC-CCchh----hhhHHHHHHHhhcc-ccccccc
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINP-KLPRE----QVSLAEWALQCHRK-GILEKII 738 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~-~~~~~----~~~l~~~~~~~~~~-~~l~~i~ 738 (842)
.......||..|+|||++.+..++.++|||||||+||||++|..++-. ..... ...+...+...... .......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 122345699999999999999999999999999999999998765432 21111 01111111111000 0000000
Q ss_pred chhHHhh-----------------hc--HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 739 DPVIAET-----------------IC--KESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~-----------------~~--~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...+... +. ......+.+++.+||+.||.+||++.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 00 0112357889999999999999999999975
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.57 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=196.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEM 579 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~ 579 (842)
.+|.+.+.||+|+||.||+|... +|..|+||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999964 5889999986432 123456788999999999999999999988653 467
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
+++|||+++++|.+++. ....+++...++++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999884 33468889999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCC--ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 660 PMDRG--YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 660 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||........ +. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~----- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIATQP----- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHhcCC-----
Confidence 32111 112334588899999999888899999999999999999999999975422211 10 000000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+ .........+.+++.+|+. +|.+||+++|+++.
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011 1122334566778888885 99999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.91 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=201.4
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555667999999999999864 57889999876442 344567899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++. ...+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 9999999883 3468999999999999999999998 999999999999999999999999999987654322 11
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+....+.... .+ ...+. .+. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~~~~-----~~~----~ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IPKNS-----PPT----L 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hhcCC-----CCC----C
Confidence 22345788999999999989999999999999999999999998654322211 00 00110 111 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+|++.+|.+||+|.|+++.-.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 1233456889999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.15 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=205.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
++|+..+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999964 57889999887665556788999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.. ....+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 83 GGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 99999998743 23578999999999999999999998 899999999999999999999999999987654221 12
Q ss_pred eeeeccCCCCCCccccccc---CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 667 STAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~---~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....++..|+|||.+.+. .++.++|||||||++|||++|++|+.......... ... ..+ + ..+.+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~~----~~~-~---~~~~~~ 227 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LIS----KSN-F---PPPKLK 227 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH----hcc-C---CCcccc
Confidence 2345678899999998776 88999999999999999999999997654332211 100 000 0 000000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........+.+++.+|++.+|.+||++.+++.
T Consensus 228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 --DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.88 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=189.1
Q ss_pred EEeecCcEEEEEEEEcCC---cEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 515 VIGVGGFGKVYIGVLEDG---NKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g---~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985443 346677765432 3456789999999999999999999999999999999999999999
Q ss_pred cccccccCC--CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-Ccee
Q 037607 591 FRDHLYGTN--QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR-GYVS 667 (842)
Q Consensus 591 L~~~l~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~-~~~~ 667 (842)
|.+++.... ...+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999986432 2456777888999999999999998 899999999999999999999999999986432211 1112
Q ss_pred eeeccCCCCCCcccccc-------cCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 668 TAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~-------~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
....++..|+|||++.. ..++.++|||||||++|||++ |.+|+......+. ...+ .. +....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~---~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LNHV---IK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---Hh-hcccccCC
Confidence 34567889999998753 345789999999999999996 5677764432221 1111 11 11122223
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+.+.. ....++.+++..|+ .+|.+||++.||++.|.
T Consensus 232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 32221 12345677888899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.68 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=204.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666778999999999999975 5889999987643 3455678999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++. ..++++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 9999999884 2468899999999999999999998 899999999999999999999999999997654322 12
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||++.+..++.++|||||||++|||++|.+|+....+..... . ...+. ....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~~~~---------~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L-IPKNN---------PPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h-hhcCC---------CCCC
Confidence 233457889999999998889999999999999999999999997654322110 0 00000 0112
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+||+.+|.+||++.++++.-.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 2345567889999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=317.14 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=201.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|+..+.||+|+||.||+|.+. +|+ .+|+|.+.... .....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677789999999999999863 444 57899877543 33345789999999999999999999998654 5779
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999998843 23468899999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +.++... .... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~---~~ 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEK---GERL---PQ 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC---CCCC---CC
Confidence 2221 1223345678999999999999999999999999999997 888987543222 2222211 0000 00
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.......+.+++.+|+..+|++||++.|++++|+.+.+
T Consensus 233 -------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 233 -------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11123467889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.65 Aligned_cols=195 Identities=23% Similarity=0.368 Sum_probs=159.7
Q ss_pred eEEeecCcEEEEEEEEc---CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeec--cCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE---DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD--EQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~--~~~~~~lV~Ey~~~ 588 (842)
.+||+|+||.||+|+.. ++..||+|++..... ...+.+|++++++++||||+++++++. .....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999965 346899998765432 246789999999999999999999884 45678999999875
Q ss_pred CCccccccc-------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE----cCCCceEEeeccccc
Q 037607 589 GPFRDHLYG-------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSK 657 (842)
Q Consensus 589 gsL~~~l~~-------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl----d~~~~~kl~DFGla~ 657 (842)
+|.+++.. .....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 66666521 123358899999999999999999999 899999999999999 567799999999998
Q ss_pred ccCCCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 037607 658 AAPMDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKL 714 (842)
Q Consensus 658 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~ 714 (842)
....... .......+|..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 7643221 12234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.38 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=211.0
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhc-CCCceeeEE
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKL-RHRHLVSLI 570 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L-~HpnIv~l~ 570 (842)
.+-+...++|...+.||.|..+.|-++.++ +|...|+|++.... ....+.-..|+.||+++ .||||+.+.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 344556678899999999999999999865 67888888765421 12234567899999998 699999999
Q ss_pred EeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEE
Q 037607 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl 650 (842)
++++....+++|+|.|+.|.|.|+| ...-.++++...+|+.|+.+|++|||. ..||||||||+|||+|++.++||
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEE
Confidence 9999999999999999999999999 556789999999999999999999998 99999999999999999999999
Q ss_pred eecccccccCCCCCceeeeeccCCCCCCcccccc------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 037607 651 ADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW 724 (842)
Q Consensus 651 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~ 724 (842)
+|||+++..+. +......+||++|+|||.+.. ..|+..+|+|++|||||.||.|.+||.... ++-
T Consensus 165 sDFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---Qml---- 235 (411)
T KOG0599|consen 165 SDFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QML---- 235 (411)
T ss_pred eccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHH----
Confidence 99999987653 335567899999999999864 458889999999999999999999997542 211
Q ss_pred HHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 725 ALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 725 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+..+..+|..+ ...+-..+......+++.+||+.||.+|.|.+|++..-..
T Consensus 236 MLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 236 MLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 11222222211 0111123445677899999999999999999999976444
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.40 Aligned_cols=265 Identities=20% Similarity=0.266 Sum_probs=199.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------ 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------ 576 (842)
..++|...+.||+|+||.||++... .++.||||++... ......++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999864 5788999998653 234456788999999999999999999987543
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 6666652 347889999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHH---------HHHHH
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLA---------EWALQ 727 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~---------~~~~~ 727 (842)
+..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++...
T Consensus 174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 865322 1223456899999999999999999999999999999999999999765433221110 00000
Q ss_pred -------hh-ccccc-----ccccchhH---HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 728 -------CH-RKGIL-----EKIIDPVI---AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 728 -------~~-~~~~l-----~~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.. ..... .++....+ ...........+.+++.+|++.||.+|||+.|+++.-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00 00000 00000000 00011112346789999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.51 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=204.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|++.+.||.|+||.||++... ++..+|+|+.........+.|.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888889999999999999975 6889999998877666778899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 999999998843 23579999999999999999999999 8999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 666 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
......++..|+|||.+. ...++.++|||||||++|||++|++||........ +..+ . .+....+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~-~~~~~~~~~- 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI----L-KSEPPTLDQ- 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH----h-cCCCCCcCC-
Confidence 223456889999999975 34577899999999999999999999975532211 1111 1 110000000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.......+.+++.+||+.+|.+||++.++++.-
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 231 ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred ------cccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 112234677899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.82 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=197.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|+..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 688999998764322 2234577899999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+.+ +|.+++... ...+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 974 898887543 3478999999999999999999998 8999999999999999999999999999875432211
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhcccccc--------
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPR-EQVSLAEWALQCHRKGILE-------- 735 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~l~-------- 735 (842)
......++..|+|||++.+ ..++.++|||||||++|||++|++||...... ++.................
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346789999999875 55889999999999999999999999755421 1111111000000000000
Q ss_pred ------cccchhHHhhhc-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 736 ------KIIDPVIAETIC-KESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 736 ------~i~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
......+..... ......+.+++.+|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000111000 011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.94 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=206.0
Q ss_pred ccHHHHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc
Q 037607 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE 575 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~ 575 (842)
+.+.++..++++|...+.||+|+||.||++.. .+++.+|+|++..... ...++.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566777889999999999999999999996 4688999998865432 235678899999999 79999999999864
Q ss_pred C-----CeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 576 Q-----SEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 576 ~-----~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
. ...++||||+++++|.+++.. .....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998743 234578999999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCccccccc-----CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~ 723 (842)
||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|++|+......+. +..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK 244 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH
Confidence 9999999886543221 12334688899999997643 368999999999999999999999975533221 111
Q ss_pred HHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 724 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+. +.....+.+ ..+....+.+++.+|++.+|++||++.|+++.
T Consensus 245 ~~-----~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IP-----RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hh-----cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111111111 11233468899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.55 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=203.2
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|++...||+|.|+.||++.. ..|+.+|+|.++.. +..+.+++.+|+.|.+.|+|||||+|.+.+.+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677777899999999999985 47888998876542 3446788999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeecccccccC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~~~ 660 (842)
|+|.|+.|..-+- .+.-+++..+-..+.||+++|.|+|. ++|||||+||+|+||- ..--+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999977662 22456788888999999999999999 9999999999999993 45578999999999876
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.+.......||++|||||+++..+|+..+|||+.|||||-||.|++||.+.... .+.+-+ ..+...
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I----~~g~yd----- 230 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQI----KAGAYD----- 230 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH----hccccC-----
Confidence 444556788999999999999999999999999999999999999999875322 122111 111110
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......+...+...+++.+||..||.+|.|+.|.++.
T Consensus 231 -~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 -YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 0111122334556789999999999999999998753
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.01 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=201.7
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...+.||+|+||.||+|... +++.|++|.+..... ...+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778889999999999999864 688999998765433 4678899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ...+++..+..|+.++++||.|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999843 3458899999999999999999999 99999999999999999999999999998876543322
Q ss_pred ee---eeeccCCCCCCcccccccC---CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 666 VS---TAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 666 ~~---~~~~gt~~Y~APE~l~~~~---~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.. ....++..|+|||++.+.. .+.++||||||++++||++|+.||........ ....... +. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGA----GH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhc----CC-----C
Confidence 21 1356788999999998766 88999999999999999999999975432211 1111110 00 0
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.+.. .......+.+++.+|++.+|.+||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 1112455678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=311.76 Aligned_cols=274 Identities=24% Similarity=0.378 Sum_probs=208.4
Q ss_pred ccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHh--cCCCceeeEEEeecc
Q 037607 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSK--LRHRHLVSLIGFCDE 575 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~--L~HpnIv~l~g~~~~ 575 (842)
.++--.+...+.....+.||+|.||.||+|.|+ |+.||||++....+ +.+.+|.+++.. |+|+||+.+++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 344555666778888999999999999999997 88999999886654 456777777755 599999999987643
Q ss_pred C----CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHh-----CCCCceEeccCCCCCEEEcCCC
Q 037607 576 Q----SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT-----GAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 576 ~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~-----~~~~~ivHrDIKp~NILld~~~ 646 (842)
+ .+++||.+|.++|||.|+| ++..++.+..++++..+|.||++||. +.+..|.|||||+.|||+..++
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 3 3689999999999999999 33688999999999999999999995 3456799999999999999999
Q ss_pred ceEEeecccccccCCCCCc---eeeeeccCCCCCCccccccc------CCCCcccchhHHHHHHHHHhC----------C
Q 037607 647 VAKVADFGLSKAAPMDRGY---VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA----------R 707 (842)
Q Consensus 647 ~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwS~GvvL~ELltG----------~ 707 (842)
...|+|+|||.....+... .....+||.+|||||++... ..-..+||||||.|+||+... +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999876654322 23456799999999998642 122479999999999999752 3
Q ss_pred CCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh-hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 708 PVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE-TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 708 ~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+||....+.+.. ..+ +. +-...+-+.|.+.. ....+.+..+.++++.||..+|..|-|+-.+-+.|.+..+
T Consensus 434 ~Pyyd~Vp~DPs-~ee-Mr----kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 434 LPYYDVVPSDPS-FEE-MR----KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCcccCCCCCCC-HHH-Hh----cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 555543332211 111 11 11111112233222 2345788999999999999999999999888888776654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.88 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=201.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
+|+..+.||+|+||.||++.. .+++.+|+|++.... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 578899999876432 2235688999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAP 660 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~ 660 (842)
||||+++++|.+++. ...++++..++.++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999884 34578999999999999999999999 8999999999999998775 59999999987764
Q ss_pred CCCC---ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 661 MDRG---YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 661 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.... .......++..|+|||.+.+..++.++||||+|++++||++|+.||........... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~---- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATT---- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCC----
Confidence 3211 112234678899999999888899999999999999999999999965432221111 111000000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
...........+.+++.+|++.+|.+||++.|+++
T Consensus 229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01122334567888999999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.42 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=203.0
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 6788999987643 334467899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeecccccccCCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGla~~~~~~~~ 664 (842)
+++++|.+++.......+++..+++++.+++++|+|||+ ++++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999966556678999999999999999999999 999999999999999854 468999999998764322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+... +....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~----~~~~~-------- 220 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMS----GTFAP-------- 220 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHHh----cCCCC--------
Confidence 1223568889999999998889999999999999999999999997654322 1111110 00111
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.......+.+++.+||+.+|.+||++.|+++.
T Consensus 221 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 -ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.58 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=199.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC----------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS----------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS 577 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~----------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~ 577 (842)
+|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999854 68899999865321 112346889999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 99999999999999999843 3578999999999999999999998 899999999999999999999999999997
Q ss_pred ccCCCCC-ceeeeeccCCCCCCcccccccC--CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 658 AAPMDRG-YVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 658 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~--~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
....... .......++..|+|||.+.... ++.++||||||+++|||++|..|+......+. +.+ .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~~~~-~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----LGNK-RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----hhcc-cc
Confidence 6543211 1223456888999999987654 88999999999999999999999864322111 111 0000 00
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...+ ...........+.+++.+|++.+|.+||++.++++.
T Consensus 230 ~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 111222345678889999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.91 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=201.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 57889999876543 234567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999999843 4568999999999999999999998 899999999999999999999999999987421110
Q ss_pred --------------CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 037607 664 --------------GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 664 --------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
........++..|+|||.+.+..++.++|+|||||++|||++|+.||.+....+ +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 011123457889999999988899999999999999999999999997543221 111111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
. + ....+.. .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~-~---~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 S-D---DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred h-c---ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 0 0001110 01234567899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.41 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=205.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 67899999876432 33567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCC-CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 586 MANGPFRDHLYGTNQ-PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999855333 578999999999999999999998 9999999999999999999999999999877654322
Q ss_pred c---eeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 665 Y---VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 665 ~---~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
. ......|+..|+|||++... ..+.++|||||||++|||++|+.||....... .+.+.... ....+....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~--~~~~~~~~~-- 231 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN--DPPSLETGA-- 231 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC--CCCCcCCcc--
Confidence 2 22344688999999998876 78999999999999999999999997553321 11111110 000000000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........+.+++.+|++.+|.+||++.++++
T Consensus 232 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 -----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -----ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01233467889999999999999999999886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=322.57 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=216.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc---CCc--EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE---DGN--KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~---~g~--~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
.......++||+|-||.||+|+.. .|+ .||||..+.. .....+.|+.|..+|+.++|||||+|+|.|.+ ..++
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 344556678999999999999953 343 5899988874 44557889999999999999999999999976 4689
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
||||.++-|-|..+|. .+...|+......++.||+.+|+|||+ ..+|||||..+|||+....-+||+||||++...
T Consensus 467 ivmEL~~~GELr~yLq-~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQ-QNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEEecccchhHHHHHH-hccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999994 445678889999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.+.-+......-.+.|||||.+.-++++.++|||-|||++||++. |..||.+-...+ .+..+-.
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~iEn 607 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHIEN 607 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEecC
Confidence 877777776777889999999999999999999999999999875 999998754433 1111111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
. -+-..++.++..+..++.+||+.+|.+||...|+...|..+++...
T Consensus 608 G-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 608 G-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred C-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 1 0112345667778899999999999999999999999988877433
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.83 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=203.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeec--cCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD--EQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~--~~~~~~lV~ 583 (842)
+|++.+.||.|+||.||++... +++.+++|++... .....+++.+|++++++++||||+++++++. .....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778889999999999999864 6789999987643 3445577899999999999999999999875 345689999
Q ss_pred EecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCC--CCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 584 EYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGA--AQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 584 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~--~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
||+++++|.+++.. ....++++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999998843 23467899999999999999999999322 389999999999999999999999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
..... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... +.+.. ..+...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~---- 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI----KEGKFR---- 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH----hcCCCC----
Confidence 54332 1234568999999999998889999999999999999999999998654211 11111 111111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+.......+.+++.+|++.+|.+||++.+|+++
T Consensus 229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.64 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=201.0
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+|++.+.||+|+||.||++... +|..||+|.+... ......++.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778889999999999999975 6899999987653 3444578999999999999999999999999999999999999
Q ss_pred CCCCcccccccC-CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 587 ANGPFRDHLYGT-NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 587 ~~gsL~~~l~~~-~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
++++|..++... ....+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999998887432 23478999999999999999999996 258999999999999999999999999998765322
Q ss_pred eeeeeccCCCCCCccccccc------CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 666 VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||............ .....+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~---- 228 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL----SAIVDGDPP---- 228 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----HHHhhcCCC----
Confidence 12234578899999998543 3588999999999999999999999754322111100 000011000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.........+.+++.+|++.+|.+||++.+++..-+
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 112234456788999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.10 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=199.9
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||+|++|.||+|+.. +|+.|+||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788889999999999999865 68899999876432 22345789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+. ++|.+++.......+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 688888866566789999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCcccccccC-CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc-------------
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK------------- 731 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~------------- 731 (842)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||......+. +..........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHH
Confidence 122334688999999887644 68899999999999999999999976543221 11111100000
Q ss_pred --cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 732 --GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 732 --~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..........+ ....+.....+.+++.+|++.+|.+||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 01111223457789999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.89 Aligned_cols=247 Identities=22% Similarity=0.366 Sum_probs=199.5
Q ss_pred ceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 513 NAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
...||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 347999999999999864 6889999998766556667899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+++. ...+++.+++.++.||+.||+|||+ ++|+||||||+||++++++.++|+|||++........ ......
T Consensus 107 ~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 179 (292)
T cd06658 107 TDIVT---HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV 179 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence 99873 2358899999999999999999999 8999999999999999999999999999876543221 223456
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
++..|+|||.+.+..++.++|||||||++|||++|+.||........... . .. ...+.+.. .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~----~~-----~~~~~~~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---I----RD-----NLPPRVKD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H----Hh-----cCCCcccc--ccccC
Confidence 88999999999888899999999999999999999999975533221111 0 00 00110000 11123
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+.+++.+|+..+|.+||++.|+++.-.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 45778899999999999999999997533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.19 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=200.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChh-----hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQ-----GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~-----~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
+|+..+.||+|+||.||+|... +|+.|+||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 6899999987654322 335678899999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+ +++|.+++.... ..+++..+++++.|+++||.|||+ ++++|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999985433 479999999999999999999999 89999999999999999999999999999876533
Q ss_pred CCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc--c------cc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR--K------GI 733 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~--~------~~ 733 (842)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|.++|....+.+... ........ . ..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG--KIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH--HHHHHcCCCchhhhhhccc
Confidence 21 1223346788999998865 567899999999999999999988887654322111 00000000 0 00
Q ss_pred cccccc-----hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 LEKIID-----PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 l~~i~d-----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+..... +.............+.+++.+||+.+|.+||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 000011112335678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.41 Aligned_cols=264 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEEEEE
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMILVYE 584 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~lV~E 584 (842)
|++.+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999975 57899999987652 33346788999999999999999999999877 88999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++ +|.+++... ...+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 888877433 2578999999999999999999998 8999999999999999999999999999987654332
Q ss_pred ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc---------
Q 037607 665 YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL--------- 734 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l--------- 734 (842)
.......++..|+|||.+.+ ..++.++||||||+++|||++|++||........................
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22234456788999998765 46789999999999999999999999866543322111110000000000
Q ss_pred -----ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 -----EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 -----~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+...+...+...+.+++.+|++.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00011111111111225678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.11 Aligned_cols=240 Identities=24% Similarity=0.278 Sum_probs=187.3
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhc---CCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKL---RHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L---~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
||+|+||+||+|+.. +++.||||++.... .....++..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 68999999976431 22334556777777665 699999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 99998884 44578999999999999999999999 999999999999999999999999999987643222 1233
Q ss_pred eeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 669 AVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
...||..|+|||++.+. .++.++|||||||++|||++|+.||......+.. .. ...+.. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~-i~~~~~-~~~~-------- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RN-IAFGKV-RFPK-------- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HH-HHcCCC-CCCC--------
Confidence 46799999999998764 5899999999999999999999999765332211 00 111100 0000
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRP----GMGDVLW 777 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RP----tm~evl~ 777 (842)
......+.+++.+||+.+|.+|| ++.|+++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01234567899999999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.66 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=199.1
Q ss_pred cccceEEeecCcEEEEEEEEc----CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC------
Q 037607 510 FDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS------ 577 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~------ 577 (842)
|.+.+.||+|+||.||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999864 3678999987653 3445678999999999999999999999885432
Q ss_pred eEEEEEEecCCCCcccccccC----CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 578 EMILVYEYMANGPFRDHLYGT----NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
..++++||+.+|+|.+++... ....+++..+++++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998876432 22357889999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 654 GLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 654 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |++|+...... .+..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~--- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIKG--- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHcC---
Confidence 999866433211 1223345678999999998889999999999999999999 88888754322 222222111
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.... ........+.+++.+|++.+|.+||++.|+++.|+.+
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.76 Aligned_cols=254 Identities=27% Similarity=0.372 Sum_probs=200.9
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC-----
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS----- 577 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~----- 577 (842)
..+++|++.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999975 578899998775543 346799999999999 6999999999996544
Q ss_pred -eEEEEEEecCCCCcccccccCC--CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 578 -EMILVYEYMANGPFRDHLYGTN--QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999885433 5678999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
++....... .......++..|+|||++.. ..++.++|||||||+|+||++|++||........ +...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~----- 230 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI----- 230 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh-----
Confidence 987653222 12234558889999998753 3567899999999999999999999974432211 1110
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.+.....+.. .......+.+++.+||..+|.+||++.|+++
T Consensus 231 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0111111111 1123457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.02 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=207.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|+..+.||+|++|.||+++.. +++.|++|++..... ....++.+|++++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999976 589999999776543 4567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ...+++..++.++.|+++||+|||+ ..+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999843 3678999999999999999999995 278999999999999999999999999998876433221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+..+... .... .
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~---------~ 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPPP---------S 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CCCC---------C
Confidence 2345678899999999999999999999999999999999999976643222222222211 1000 0
Q ss_pred hcHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKE-SLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~-~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.... ....+.+++.+|+..+|.+||++.|+++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112 34678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=332.16 Aligned_cols=270 Identities=19% Similarity=0.260 Sum_probs=193.2
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEcC--CcEEEEE------------------ECCCCChhhHHHHHHHHHHHHhcCC
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLED--GNKVAIK------------------RGNPGSEQGINEFQTEIQMLSKLRH 563 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~~--g~~VAvK------------------~~~~~~~~~~~~f~~Ei~il~~L~H 563 (842)
....++|.+.+.||+|+||+||++.++. +...++| ++. .......++.+|+++|++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999987542 2222222 111 122334678899999999999
Q ss_pred CceeeEEEeeccCCeEEEEEEecCCCCcccccccCC---CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCE
Q 037607 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTN---QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNI 640 (842)
Q Consensus 564 pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NI 640 (842)
|||+++++++...+..++|+|++. ++|.+++.... .......+++.|+.|++.||+|||+ ++||||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHE
Confidence 999999999999999999999985 56766664321 2223456778899999999999999 9999999999999
Q ss_pred EEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCC-CCCCCCchhhh
Q 037607 641 LLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP-VINPKLPREQV 719 (842)
Q Consensus 641 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~-p~~~~~~~~~~ 719 (842)
||+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||+||||++|.. |+.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999998765443333345679999999999999999999999999999999999875 44333222222
Q ss_pred hHHHHHHHhh--cccc---------------cc---cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 720 SLAEWALQCH--RKGI---------------LE---KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 720 ~l~~~~~~~~--~~~~---------------l~---~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.+.+...... .+.. +. ..+.+.+.. ......+.+++.+||+.||.+||++.|+++.-
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 2222111100 0000 00 000000000 01124567788999999999999999999764
Q ss_pred HH
Q 037607 780 EY 781 (842)
Q Consensus 780 e~ 781 (842)
..
T Consensus 456 ~f 457 (501)
T PHA03210 456 LF 457 (501)
T ss_pred hh
Confidence 43
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.19 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=204.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
++|...+.||+|+||.||++... ++..|++|.+........+.+.+|+.++++++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999854 67889999986555555678899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.. ..+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999998843 357899999999999999999998 9999999999999999999999999999876543221 2
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......+.... ....+. +.. ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~------~~~--~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PEL--QN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC------CCC--CC
Confidence 2334688899999999888899999999999999999999999976543222110 000000 000 01
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+||+.+|.+||++.+++.+-.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 1123346778999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=305.65 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=200.7
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcC---CCceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.|+..+.||+|+||.||+|.. .+++.+++|.+... ......++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999996 46889999987654 3445577899999999997 999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999998833 378999999999999999999998 999999999999999999999999999998765332
Q ss_pred CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. ......|+..|+|||.+.+ ..++.++|||||||++|||++|++||........ ... +.....+.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~------~~~~~~~~~ 222 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML------IPKSKPPRL 222 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc------cccCCCCCC
Confidence 2 2234468889999999875 4578999999999999999999999975432211 100 000011111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.. ......+.+++.+|++.+|.+||++.|+++.-
T Consensus 223 ~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 223 ED---NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred Cc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 11 01345678899999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.44 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=203.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~~lV~ 583 (842)
++|+..+.||.|++|.||++... +++.+|+|.+... ......++.+|++++++++||||++++++|.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999974 5788999987654 23455779999999999999999999998854 44689999
Q ss_pred EecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 584 EYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||+++++|.+++.. .....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 234568899999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCc--hhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLP--REQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .....+..|....... .+.+
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 230 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP----ELKD 230 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch----hhcc
Confidence 21 1234578899999999999999999999999999999999999986532 1112233332221110 0000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
. . .........+.+++.+||..+|.+||++.|+++.-.
T Consensus 231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 0 000123456889999999999999999999987544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.02 Aligned_cols=250 Identities=29% Similarity=0.462 Sum_probs=205.5
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
+|+..+.||+|++|.||++... +++.+++|++.........++.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999887665566889999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++.... ..+++..+..++.|++.+|+|||+ .+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999884432 578999999999999999999998 9999999999999999999999999999887654322 3
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
....++..|+|||.+.+...+.++||||||++++||++|+.|+.......... .... .....+..+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-~~~~~~~~~------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIAT-NGPPGLRNP------- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHh-cCCCCcCcc-------
Confidence 34568899999999998889999999999999999999999987553222110 0000 111111110
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......+.+++.+|++.+|.+||++.|+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1114568889999999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.08 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=199.7
Q ss_pred cceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 512 ENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
....||+|+||.||++... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3447999999999999864 688999999866555555778999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeee
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 670 (842)
|.+++. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 105 L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 105 LTDIVS---QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred HHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 998773 2468999999999999999999998 899999999999999999999999999987654322 122345
Q ss_pred ccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHH
Q 037607 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKES 750 (842)
Q Consensus 671 ~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~ 750 (842)
.++..|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ....... ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~----~~~~~~~-------~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLR----DSPPPKL-------KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----ccCCCCc-------cccCCC
Confidence 6889999999999889999999999999999999999999755432221 1111 0000000 001122
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 751 LRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 751 ~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
...+.+++.+|++.+|.+||++.|+++.-
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 34577899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.38 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=203.6
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCcc
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFR 592 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (842)
-+||+|.||+||-|+.. +...+|||.+.....+..+-+..||.+-++|+|.|||+++|.|.+++.+-+.||-.+||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999965 45579999988777777788999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC--chHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCceEEeecccccccCCCCCceeee
Q 037607 593 DHLYGTNQPPL--SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTA 669 (842)
Q Consensus 593 ~~l~~~~~~~l--~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~ 669 (842)
++|..+ =++| ++.++-....||++||.|||+ +.|||||||-.|||++ -.|.+||+|||-++....-. .....
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET 735 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET 735 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence 999543 3455 678888899999999999999 9999999999999995 57899999999998764222 23456
Q ss_pred eccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 670 VKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 670 ~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
+.||..|||||++.. +.|+.++|||||||++.||.||+|||........ .+.+-|... ....++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK------vHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK------VHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee------cCCCCc
Confidence 779999999999976 4588999999999999999999999975533221 111222111 123455
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+...+...++.+|+.++|.+||+++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 6667788899999999999999999999864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=309.33 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=200.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|...+.||+|+||.||++... +++.+|+|++... .......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 6889999987643 2234567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 99999999999843 3678999999999999999999999 99999999999999999999999999998876433
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....++..|+|||.+.+...+.++||||||+++|||++|+.||....... ..... ..+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~--------- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKI----LEGKV--------- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcCCc---------
Confidence 234468899999999988889999999999999999999999997554211 11111 01110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLW 777 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~ 777 (842)
.+.......+.+++.+||+.+|.+|| +++|+++
T Consensus 216 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 -RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 01112245678899999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=344.60 Aligned_cols=258 Identities=20% Similarity=0.318 Sum_probs=200.4
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CC
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QS 577 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~ 577 (842)
.....++|.+.+.||+|+||+||++... .+..+|+|.+... .......|..|+.+|++|+|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445678999999999999999999965 5678899987643 33445779999999999999999999998843 45
Q ss_pred eEEEEEEecCCCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCC----CCceEeccCCCCCEEEcC-------
Q 037607 578 EMILVYEYMANGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGA----AQGIIHRDVKTTNILLDE------- 644 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~----~~~ivHrDIKp~NILld~------- 644 (842)
.++|||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.. .++||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999988542 2357999999999999999999999732 145999999999999964
Q ss_pred ----------CCceEEeecccccccCCCCCceeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCC
Q 037607 645 ----------NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINP 712 (842)
Q Consensus 645 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~ 712 (842)
...+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3358999999998764322 2234568999999999864 4588999999999999999999999975
Q ss_pred CCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 713 KLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 713 ~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...... ....... +. .+. .......+.+++..||+.+|.+||++.|++..
T Consensus 246 ~~~~~q-----li~~lk~-~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNFSQ-----LISELKR-GP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcHHH-----HHHHHhc-CC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 433221 1111111 10 000 01123567889999999999999999999853
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=306.01 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=194.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHH-HHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQM-LSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~i-l~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|++.+.||+|+||.||++... +|+.||+|++.... .....++..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 68999999876542 2333456667665 566789999999999999999999999
Q ss_pred ecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||+ |+|.+++.. .....+++..++.++.|++.||+|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 678777643 234578999999999999999999998 6 899999999999999999999999999886542
Q ss_pred CCCceeeeeccCCCCCCcccccc----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... ..+.... .+....+
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~-----~~~~~~~ 228 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVV-----EEPSPQL 228 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHH-----hcCCCCC
Confidence 21 1233457889999998864 457899999999999999999999986432111 1111110 0100110
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
. .......+.+++.+||..+|.+||++.++++.-.
T Consensus 229 ~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 229 P--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred C--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0 0112356888999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=324.02 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=206.6
Q ss_pred ceEEeecCcEEEEEEEEc--CCc--EEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 513 NAVIGVGGFGKVYIGVLE--DGN--KVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~--~g~--~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
.++||+|.||.|++|.|. +|+ .||||.+...... ...+|++|+.+|.+|+|||+++|+|+..+ ..+.||+|+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 347999999999999986 344 5899999877554 67899999999999999999999999877 77899999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC-ce
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-YV 666 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~-~~ 666 (842)
.|+|.+.|++.....|-......++.|||.||.||.. +++|||||..+|+||-....+||+||||.+.+....+ +.
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999988677788888999999999999999998 9999999999999999899999999999998875443 33
Q ss_pred ee-eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 667 ST-AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 667 ~~-~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
+. ...-.+.|.|||.++...++.++|||+|||+||||++ |..||.+-....... .+|..-.-
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~iD~~erL 334 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NIDAGERL 334 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hccccccC
Confidence 22 2335678999999999999999999999999999997 778887765433211 11110000
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.-.+.+.+++.+++..||..+|.+||++..|.+.+-.
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1245677889999999999999999999999865443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=307.00 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=195.7
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999975 68899999876432 22235678899999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
++ ++|.+++.. ....+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 97 577777643 24568999999999999999999999 9999999999999999999999999999986543221
Q ss_pred eeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc---c---cccccc
Q 037607 666 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK---G---ILEKII 738 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~---~---~l~~i~ 738 (842)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+......+. .+ +........ . .+..+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhcc
Confidence 12234578899999998764 478999999999999999999888644332211 00 100000000 0 000000
Q ss_pred ch--------h-HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 739 DP--------V-IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 739 d~--------~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+. . ......+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0 001111223467789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.84 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=198.9
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
|+..+.||+|++|.||+|... +|..|++|++.... ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 78999999876442 223457889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
+ ++|.+++.......+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 689988855444578999999999999999999998 8999999999999999999999999999876542211 1
Q ss_pred eeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc-------------
Q 037607 667 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG------------- 732 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------- 732 (842)
.....++..|+|||++.+. .++.++|||||||++|||++|++||........ +...........
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223468899999988764 578999999999999999999999976543221 111111000000
Q ss_pred --ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 --ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 --~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.. ..........+.+++.+|++.+|.+||++.|+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 11112233578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.82 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=207.4
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
+.|+..+.||.|.-|+||++.+++ +..+|+|++.+.. .+...+.+.|-+||+.+.||.+..|++.++.....||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346666789999999999999864 5889999988753 444567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC-
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD- 662 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~- 662 (842)
|||+||+|..+++++..+.+++..++-++..++-||+|||- .|||.|||||+||||.++|++.|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999988889999999999999999999999999 99999999999999999999999999987643210
Q ss_pred ---------------------------------C---------------------CceeeeeccCCCCCCcccccccCCC
Q 037607 663 ---------------------------------R---------------------GYVSTAVKGSFGYLDPEYFRRQQLT 688 (842)
Q Consensus 663 ---------------------------------~---------------------~~~~~~~~gt~~Y~APE~l~~~~~s 688 (842)
. +..+..++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0011234588899999999999999
Q ss_pred CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCC
Q 037607 689 EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD 768 (842)
Q Consensus 689 ~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 768 (842)
.++|+|+|||+|||||.|..||.+....+.. ..++-..+.-...++....+.+||++.|..||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999988765432 2222211111112244567889999999999999
Q ss_pred CCC----HHHHH
Q 037607 769 RPG----MGDVL 776 (842)
Q Consensus 769 RPt----m~evl 776 (842)
|-. +.||-
T Consensus 379 Rlg~~rGA~eIK 390 (459)
T KOG0610|consen 379 RLGSKRGAAEIK 390 (459)
T ss_pred hhccccchHHhh
Confidence 997 55554
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.60 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=197.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++++|...+.||+|+||.||+|... +|+.|++|++..... .....+.+|+++++.++|+||+++.+++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 688999998765432 22346789999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+. ++|.+.+.. ....+.+..+..++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 677666633 23467888899999999999999998 899999999999999999999999999987653322
Q ss_pred CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh-hcc----------
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC-HRK---------- 731 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~-~~~---------- 731 (842)
. ......++..|+|||++.+ ..++.++|||||||++|||++|++||.........-...|.... ...
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1 1233456889999999876 45788999999999999999999999765432111111111000 000
Q ss_pred ccccccc---chhHHhhhc--HHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 732 GILEKII---DPVIAETIC--KESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 732 ~~l~~i~---d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
....... .+....... ......+.+++.+|++.+|.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 000000000 011356778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.20 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=210.0
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.-|..++.||+|.|.+|-.|++ -.|++||||++.+.. .....++.+|++.|+-++|||||+|+.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4477778999999999999984 379999999987753 3334678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE-cCCCceEEeecccccccCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL-DENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl-d~~~~~kl~DFGla~~~~~~~ 663 (842)
+=.+|+|.|+|. +....+++....+++.||..|+.|+|+ ..+|||||||+||.. ..-|-+||.|||++..+..
T Consensus 98 LGD~GDl~DyIm-KHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIM-KHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHH-hhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 999999999994 345679999999999999999999999 999999999999877 5678999999999877643
Q ss_pred CceeeeeccCCCCCCcccccccCCC-CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
+...+..+|+..|-|||.+.+..|+ +++||||||||||-|+||++||+..++.+.. ..|+|...
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKY 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKY 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccc
Confidence 3355778999999999999998887 7899999999999999999999988776643 23333221
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+.....++.+++..||..||.+|-+.+||+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 123455677889999999999999999999875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.53 Aligned_cols=248 Identities=21% Similarity=0.384 Sum_probs=200.8
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 6889999988765555566789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
++|.+++.. ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........ ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 999998843 568999999999999999999999 9999999999999999999999999998876543221 223
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.+.. .... ... .+.+.. ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~~-~~~-----~~~~~~--~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRIR-DNL-----PPKLKN--LH 239 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHH-hcC-----CCCCcc--cc
Confidence 355889999999999888999999999999999999999998754332211 1111 010 000000 11
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.....+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 133568899999999999999999998863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.77 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=200.6
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+|+..+.||+|++|.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 688999998765432 23466789999999999999999999999999999999999
Q ss_pred CCCCcccccccCC-CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 587 ANGPFRDHLYGTN-QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 587 ~~gsL~~~l~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
++ +|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888774332 3568999999999999999999998 8999999999999999999999999999976543211
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH-HHHHH--------Hhhcc----
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL-AEWAL--------QCHRK---- 731 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l-~~~~~--------~~~~~---- 731 (842)
......++..|++||++.+ ..++.++|||||||++|||++|++||......+.... .+... .....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1223456889999998866 4578999999999999999999999986654332111 10000 00000
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.......+. ....+.+.....+.+++.+|++.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQ-DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChH-HHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 011122233567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=306.01 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=207.7
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..++.|+..+.||+|++|.||+|... ++..+++|++..... ..+++.+|++++++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35667888889999999999999976 688999999876544 5578899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999995432 479999999999999999999998 999999999999999999999999999987654322
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
. ......++..|+|||.+.+..++.++|||||||++|||++|+.|+....+.... ..+. .. ......+
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~----~~-~~~~~~~---- 238 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLIT----TK-GIPPLKN---- 238 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH----hc-CCCCCcc----
Confidence 1 223345788999999999888999999999999999999999998755332211 1110 00 1111111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+|++.+|.+||++.++++....
T Consensus 239 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 239 ---PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred ---hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 11134567889999999999999999999875443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=314.87 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=198.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----CeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~~ 579 (842)
+++|.+.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68999999986532 33456788999999999999999999887543 358
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++|+||+.+ +|.+.+. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999964 7776662 3468999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc--eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc---cc
Q 037607 660 PMDRGY--VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK---GI 733 (842)
Q Consensus 660 ~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 733 (842)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|++||......... .+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHH
Confidence 432211 1133568899999998754 56899999999999999999999999765332211 111110000 00
Q ss_pred cccccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 LEKIIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 l~~i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+..+.+... .....+....++.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111000 000111234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=301.71 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=202.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999975 5788999987543 223446788999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccCCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~~~~ 664 (842)
+++++|.+++.......+++..++.++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999865555578999999999999999999998 8999999999999998875 569999999877643221
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......|+..|+|||++.+..++.++|||||||+++||++|+.|+...... ++...... +....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~-------- 221 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYFAP-------- 221 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccCCC--------
Confidence 222345888999999998888999999999999999999999998754322 12222111 11111
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+|++.+|++||++.|+++.
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 -ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111223568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.53 Aligned_cols=265 Identities=21% Similarity=0.280 Sum_probs=198.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|+..+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999975 68899999875432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccccccCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~~~~~~ 663 (842)
|++ ++|.+++.......+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 578777754444456888899999999999999998 89999999999999985 5679999999997654322
Q ss_pred CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc-------
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE------- 735 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~------- 735 (842)
. ......++..|+|||++.+ ..++.++|||||||++|||++|++||......+.....-..........+.
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 1223456889999999876 457899999999999999999999997654332211100000000000000
Q ss_pred ------cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 ------KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 ------~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......+ ....+....++.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 01112234568899999999999999999999874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.94 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=197.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
+.|...+.||+|+||.||+|+.. +|+.||+|++... .....+++.+|+++++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788889999999999999965 6889999987533 2344567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 567666632 23468999999999999999999998 89999999999999999999999999998765422
Q ss_pred CceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
....++..|+|||++. ...++.++||||||+++|||++|++|+......... ... .... . +
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---~~~---~~~~-~-----~ 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI---AQND-S-----P 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---HHH---hcCC-C-----C
Confidence 2345788999999874 456889999999999999999999998755322211 000 0000 0 0
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+. .......+.+++.+||+.+|.+||++.+++....
T Consensus 233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 233 TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000 1123456889999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.89 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=200.5
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
-|...+.||+|+||.||+|... +++.+|+|...... ......+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3666778999999999999864 68899999876432 344567899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++. ...+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 9999999883 3468999999999999999999998 999999999999999999999999999987654321 11
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....++..|+|||.+.+...+.++|||||||++|||++|..|+........ . .... .... + ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~---~~~~-~~~~-----~----~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---L---FLIP-KNNP-----P----TL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---H---HHHh-cCCC-----C----CC
Confidence 2334578899999999888899999999999999999999999875432211 1 1110 0100 0 11
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12234567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=313.62 Aligned_cols=270 Identities=21% Similarity=0.303 Sum_probs=203.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeec----cCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCD----EQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~----~~~~~ 579 (842)
..+|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+|++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999964 68999999876542 234567889999999999999999998875 34568
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+. ++|.+++. ....+++..+..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 68888884 34569999999999999999999998 89999999999999999999999999999765
Q ss_pred CCCCCc---eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 660 PMDRGY---VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 660 ~~~~~~---~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||.............-.........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 1234468889999999865 568899999999999999999999997654433221111000000000000
Q ss_pred cccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 736 KIIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 736 ~i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.+....+ .....+.....+.+++.+|++.+|.+||++.+++...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0000000 0111223457789999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.24 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=199.7
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC----
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS---- 577 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~---- 577 (842)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 58899999876532 223356788999999999999999999986654
Q ss_pred ------eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 578 ------EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 578 ------~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
..++|+||+++ +|...+.. ....+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 66666633 24578999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 037607 652 DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730 (842)
Q Consensus 652 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~ 730 (842)
|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|++||......+......-......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998765433222233346778999998865 4578999999999999999999999976543322211111000000
Q ss_pred ccccccccc--------------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 731 KGILEKIID--------------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 731 ~~~l~~i~d--------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
......+.. ..+.. ........+.+++.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 00000 11122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=303.02 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=202.9
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+|+..+.||+|+||.||++... +++.+++|++.... .....++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999976 68899999876653 344567899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.... ..+++..+..++.|++.+|+|||+ ..+++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999884332 678999999999999999999996 46899999999999999999999999999876532211
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||.+.+..++.++||||||++++||++|+.|+....... ....+......... .+.+..
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~-- 226 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRLPS-- 226 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCCCh--
Confidence 12568889999999999999999999999999999999999987542111 11111111111110 001100
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
......+.+++.+|+..+|.+||++.|++..-
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred -hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence 01345678999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.73 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=199.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~lV 582 (842)
++|+..+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888889999999999999975 58899999876432 22234578899999999999999999998776 889999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+. ++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 4888877432 3468999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH-H---------HHHHH--h-
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL-A---------EWALQ--C- 728 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l-~---------~~~~~--~- 728 (842)
.. ......++..|+|||.+.+. .++.++|+||||+++|||++|++||......+.... . .|... .
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 21 12334578899999998764 468999999999999999999999986543221110 0 01000 0
Q ss_pred -hcccccccccchhHHhhhcHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 729 -HRKGILEKIIDPVIAETICKE-SLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 729 -~~~~~l~~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.......+.....+...+... ....+.+++.+||+.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000011111111112222221 3556788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.27 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=204.9
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~lV~ 583 (842)
+|...+.||+|++|.||+|... +++.|++|+..... ....+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 68899999876554 25567899999999999999999999999888 8899999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++... ..+++..++.++.|++++|+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999999998433 389999999999999999999999 999999999999999999999999999988765432
Q ss_pred Cc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.. ......++..|+|||.+.....+.++||||||++++||++|+.||........ -..........
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~-------- 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGSSGEP-------- 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhccccCCC--------
Confidence 11 12345688899999999988899999999999999999999999976541110 01111100011
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+.......+.+++.+|++.+|.+||++.|+++.
T Consensus 223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11222335678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=302.59 Aligned_cols=247 Identities=28% Similarity=0.360 Sum_probs=202.5
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
+|+..+.||.|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 58899999876432 2456789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+.+++|.+++.. ..++++..+..++.|+++||.|||+ ++++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 9999999999843 3678999999999999999999998 899999999999999999999999999987764332
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ++........ ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~----------~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETA----------DV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccc----------cc
Confidence 22345688899999999988899999999999999999999999986653211 1111111110 01
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCH--HHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGM--GDVL 776 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm--~evl 776 (842)
.........+.+++.+||+.+|.+||+. +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.99 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=198.3
Q ss_pred CcccceEEeecCcEEEEEEEEc---CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE---DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMI 580 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~ 580 (842)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999975 47899999987632 33346778999999999999999999999887 8899
Q ss_pred EEEEecCCCCccccccc---CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC----CCceEEeec
Q 037607 581 LVYEYMANGPFRDHLYG---TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE----NLVAKVADF 653 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~----~~~~kl~DF 653 (842)
+||||+++ +|.+.+.. .....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 56665522 122478999999999999999999998 89999999999999999 999999999
Q ss_pred ccccccCCCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchh-------hhhHHH
Q 037607 654 GLSKAAPMDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE-------QVSLAE 723 (842)
Q Consensus 654 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~-------~~~l~~ 723 (842)
|+++....... .......++..|+|||.+.+ ..++.++|||||||+++||++|++||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 12234567889999998876 457899999999999999999999997654332 011111
Q ss_pred HHHHhhccc-----------cccc--------ccc-hhHHhhhcH--HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 724 WALQCHRKG-----------ILEK--------IID-PVIAETICK--ESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 724 ~~~~~~~~~-----------~l~~--------i~d-~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
....+.... .... ... ..+...... ....++.+++.+|++.+|++||++.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110000 0000 000 011111111 234578899999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.01 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=202.0
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
|...+.||.|++|.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999964 688999998765432 34567889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++ +|.+++... ...+++..++.++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 888777442 3578999999999999999999999 999999999999999999999999999987765432 12
Q ss_pred eeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc------
Q 037607 667 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID------ 739 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d------ 739 (842)
.....++..|+|||.+.+. .++.++||||||+++|+|++|++||......+......-............+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334578899999998876 789999999999999999999999976654332111100000000000000000
Q ss_pred -------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 740 -------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 740 -------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+....++.+++.+||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000011223456788999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.89 Aligned_cols=267 Identities=23% Similarity=0.293 Sum_probs=201.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----Ce
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~ 578 (842)
.++|.+.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999864 6899999987653 233446778999999999999999999988543 35
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999996 68888773 34579999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|++||......+......-+........+..+
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 64332 12234457889999998865 56889999999999999999999999765432211111000000000000000
Q ss_pred cchhHH--------------hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 738 IDPVIA--------------ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 738 ~d~~l~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+.... ....+....++.+++.+||+.+|.+||++.|+++.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 000000 0111234567889999999999999999999998733
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.47 Aligned_cols=244 Identities=28% Similarity=0.408 Sum_probs=199.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
-|...+-||.|+||.||-++. .+.+.||||++.-. +.+.+++++.|+..|++|+|||++.+.|||......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355566799999999999985 57889999997653 44557889999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||- |+-.|++ ....++|-+.++..|+.+.+.||+|||+ .+.||||||..||||.+.|.+||+|||.|.....
T Consensus 107 YCl-GSAsDll-eVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YCL-GSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHh-ccHHHHH-HHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 994 5777766 2345688999999999999999999999 9999999999999999999999999999876542
Q ss_pred ceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 665 YVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
...++||+.|||||++. .++|+-|+||||||+++.||.-.+||+-..+.-. ....+ ..--.|.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---ALYHI---------AQNesPt 244 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI---------AQNESPT 244 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---HHHHH---------HhcCCCC
Confidence 34678999999999975 4789999999999999999999999875543221 11111 1111122
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+. ..+-...+.+++..||+.-|.+|||..++++
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 22 2344566888888999999999999988764
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.56 Aligned_cols=249 Identities=28% Similarity=0.380 Sum_probs=198.0
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.|...+.||+|+||.||+++.. +++.+|+|++... ......++.+|++++++++|||+++++++|......++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999964 6889999987643 23345678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+. |+|.+.+.. ...++++.++..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 997 577776632 34568999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 665 YVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
....++..|+|||++. .+.++.++|||||||++|||++|++|+........ +..+.. .+. ..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~----~~~-~~----- 243 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ----NES-PT----- 243 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHh----ccC-CC-----
Confidence 2345788999999974 46788999999999999999999999865432211 111111 000 00
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.........+.+++.+|++.+|.+||++.++++.+...
T Consensus 244 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 ---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00112345678899999999999999999999876554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.68 Aligned_cols=265 Identities=21% Similarity=0.291 Sum_probs=196.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCe-----
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSE----- 578 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~----- 578 (842)
++|+..+.||+|+||.||+|... +++.||||+..... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 68899999865432 223467889999999995 6999999999876655
Q ss_pred EEEEEEecCCCCcccccccCC---CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecc
Q 037607 579 MILVYEYMANGPFRDHLYGTN---QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFG 654 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFG 654 (842)
.++||||+++ +|.+++.... ...+++..++.++.||++||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888774422 3468999999999999999999998 89999999999999998 8999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhccc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV-SLAEWALQCHRKG 732 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~ 732 (842)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|.+||......+.. .+..... .....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TPTEQ 234 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CCChh
Confidence 9876533211 1123346788999998865 56789999999999999999999999765432211 0100000 00000
Q ss_pred ccccc---c--------chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 ILEKI---I--------DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 ~l~~i---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..... . .+.......+.....+.+++.+||+.+|.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0 0000111112345678899999999999999999998853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=330.58 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=205.4
Q ss_pred ceEEeecCcEEEEEEEE-cCCc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 513 NAVIGVGGFGKVYIGVL-EDGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~-~~g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++||.|+||+||||.+ ..|+ +||||++... ..+...++++|+-+|.+|+|||+++|+|+|.... +.||.+||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 45899999999999996 3454 6899987654 4556789999999999999999999999997765 89999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC-CCc
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGY 665 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~-~~~ 665 (842)
+.|+|.++++. .+.++-.+..+.|+.|||+||.|||+ +.++||||-.+|||+.+-..+||.|||+++....+ ..+
T Consensus 780 P~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 99999999954 55678889999999999999999998 99999999999999999999999999999988754 334
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
.....+-.+.|||-|.+....++.++|||||||.+|||+| |..|+++....+..++.+ ++ .++-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g--eRLs------ 920 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG--ERLS------ 920 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc--ccCC------
Confidence 4444555778999999999999999999999999999997 888888765544322221 11 0011
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
-++-+..++..++.+||..|+..||+++++...+.+.
T Consensus 921 -qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 921 -QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred -CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 1233456777889999999999999999998877654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.72 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=202.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCC--CChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNP--GSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~--~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~ 583 (842)
...|++.++||.||.+.||++...+.+.+|+|++.. ...+...-|.+||+.|.+|+ |.+||+|++|=..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456888889999999999999988888899887543 45667788999999999995 999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||= ..+|..+|..+......| .+..+..||+.++.++|+ .+|||.||||.|+|+- .|.+||+|||+|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 986 458888886555545556 788899999999999999 9999999999999995 4789999999999987665
Q ss_pred Cc-eeeeeccCCCCCCccccccc-----------CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 664 GY-VSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 664 ~~-~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
+. .....+||+.||+||.+... +.+.++||||+|||||+|+.|++||..-.. .|+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a------ 580 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA------ 580 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH------
Confidence 43 34678899999999998642 256799999999999999999999964311 111
Q ss_pred cccccccchhHHhhhcH-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 732 GILEKIIDPVIAETICK-ESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+..+.||.-.-+++. ....++++++..||+.||.+||+..|+|+.
T Consensus 581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2344555522111111 112238999999999999999999999863
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.98 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=199.9
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc--CCeE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE--QSEM 579 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~--~~~~ 579 (842)
..++|+..+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++++ +||||++++++|.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999975 5789999987542 233446678899999999 99999999999854 3468
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||++ ++|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5888887432 78899999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCC----ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc--
Q 037607 660 PMDRG----YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG-- 732 (842)
Q Consensus 660 ~~~~~----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 732 (842)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|++||......+...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43321 12234568899999998765 567899999999999999999999997654433211111100000000
Q ss_pred ----------ccccccch--hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 ----------ILEKIIDP--VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 ----------~l~~i~d~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+..+... .......+.....+.+++.+|++.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 00011112235678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.10 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=196.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS------ 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~------ 577 (842)
.++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999965 68899999875432 222345678999999999999999999986543
Q ss_pred --eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 578 --EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 578 --~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
..++||||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999964 77777633 33468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCC---ceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 656 SKAAPMDRG---YVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 656 a~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
+........ .......++..|+|||.+.+. .++.++||||||+++|||++|++||.....................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 986643221 111234578899999988764 4789999999999999999999999876544333222221111111
Q ss_pred cccccc---------cch-----hHHhhh-cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 732 GILEKI---------IDP-----VIAETI-CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 732 ~~l~~i---------~d~-----~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...... ..+ .....+ .......+.+++.+||+.+|.+||+++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 100000 000 000000 00112456789999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.14 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=195.8
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445568999999999999964 58899999876542 344567899999999996 99999999999999999999999
Q ss_pred cCCCCcccc---cccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 586 MANGPFRDH---LYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 586 ~~~gsL~~~---l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
+.. +|.++ +.......+++..+..++.+++.||+|||+ ..+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443 333344679999999999999999999996 248999999999999999999999999998765432
Q ss_pred CCceeeeeccCCCCCCccccccc---CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
. ......|+..|+|||++.+. .++.++|||||||++|||++|++||..... ..+-....... ..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~------~~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG------DP 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC------CC
Confidence 2 12334578899999998765 689999999999999999999999975431 11111111110 01
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
+.+...........+.+++.+|++.+|.+||++.||++.-
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111111123456788999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.98 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=197.6
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhc---CCCceeeEEEeeccCCe-----
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKL---RHRHLVSLIGFCDEQSE----- 578 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L---~HpnIv~l~g~~~~~~~----- 578 (842)
|++.+.||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999986 48999999876432 22234567788877766 59999999999987766
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.+++|||+. ++|.+++.......+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999997 478888755444579999999999999999999999 8999999999999999999999999999877
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc-----
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI----- 733 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 733 (842)
...... .....++..|+|||++.+..++.++|||||||++|||++|++||......+. +..+.........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcCC
Confidence 643321 1233478899999999999999999999999999999999999976543322 1111111100000
Q ss_pred --------cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 734 --------LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 734 --------l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........ .....++....+.+++.+||+.+|.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred Ccccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 11122334567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=299.04 Aligned_cols=258 Identities=24% Similarity=0.272 Sum_probs=194.7
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccC--CeEEEEEE
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQ--SEMILVYE 584 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~--~~~~lV~E 584 (842)
|++.+.||+|+||.||+|... +++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999964 68899999876532 222234567999999985 99999999999877 88999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|++ ++|.+.+... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 5787777432 3578999999999999999999999 89999999999999999 9999999999987643222
Q ss_pred ceeeeeccCCCCCCccccc-ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh-----------ccc
Q 037607 665 YVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH-----------RKG 732 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~~ 732 (842)
.....++..|+|||++. +..++.++|||||||++|||++|.+||......+. ..+..... ...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhccc
Confidence 12345788999999765 45678999999999999999999999976644321 11111110 000
Q ss_pred ccccccchhH----HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 ILEKIIDPVI----AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 ~l~~i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.. ...........+.+++.+||+.+|.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 011122346788999999999999999999998863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=311.02 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=200.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------ 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------ 576 (842)
..++|+..+.||+|+||.||+|... +|+.||+|++... ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 6899999987642 334456788999999999999999999988543
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999996 578777632 28899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH---------HHHHHH
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL---------AEWALQ 727 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l---------~~~~~~ 727 (842)
+...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........... .+|...
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8654321 22334578899999999999999999999999999999999999976543221100 000000
Q ss_pred -------hhccc------ccccccchhH----HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 728 -------CHRKG------ILEKIIDPVI----AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 728 -------~~~~~------~l~~i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..... .+.++....+ ...........+.+++.+||+.+|.+||++.|+++.-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 00000 0001110000 00001123456789999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=300.61 Aligned_cols=245 Identities=27% Similarity=0.365 Sum_probs=196.5
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE---QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~---~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||.||++... +|+.+++|++..... ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865433 4557789999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC-------
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG------- 664 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~------- 664 (842)
.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9988432 378999999999999999999998 9999999999999999999999999999876543321
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
.......++..|+|||.+.....+.++||||||++++||++|+.||......+. .... .. +.... +
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~---~~-~~~~~---~---- 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNI---LN-GKIEW---P---- 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---hc-CCcCC---C----
Confidence 122345578899999999888899999999999999999999999976543221 1111 10 10000 0
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
........+.+++.+|++.+|.+||++.++.+.|+
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00012456789999999999999999966555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.45 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=194.9
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||.||+++.. +++.+++|++.... ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 48899999876432 23456799999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+++.+ ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999843 3468999999999999999999998 999999999999999999999999999998765332 223346
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
++..|++||.+.+..++.++|+||||+++|||++|..|+....... . +....... +. . .........
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~---~~~~~~~~-~~-~-------~~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M---EIYNDILK-GN-G-------KLEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H---HHHHHHhc-cC-C-------CCCCCcccC
Confidence 7889999999988889999999999999999999999997654211 1 11111110 00 0 001111224
Q ss_pred HHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPG-----MGDVLW 777 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPt-----m~evl~ 777 (842)
..+.+++.+||+.+|.+||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 57889999999999999999 566655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.41 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=205.5
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...+.||.|+||.||++... +++.+++|++.... .....++.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999975 68899999977543 35567889999999999999999999999999999999999
Q ss_pred cCCCCcccccccCC--CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTN--QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885433 4789999999999999999999999 899999999999999999999999999998764432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......|+..|+|||.+.+..++.++||||+|+++++|++|+.|+......+ + ...... .....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~---~~~~~~-~~~~~------- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L---ALKILK-GQYPP------- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H---HHHHhc-CCCCC-------
Confidence 22334568889999999998899999999999999999999999997553221 1 111111 11111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.......+.+++.+||..+|.+||++.|+++.
T Consensus 223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111234567889999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.52 Aligned_cols=255 Identities=16% Similarity=0.195 Sum_probs=184.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCCChhhH-----------HHHHHHHHHHHhcCCCceeeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPGSEQGI-----------NEFQTEIQMLSKLRHRHLVSLIG 571 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~~~~~~-----------~~f~~Ei~il~~L~HpnIv~l~g 571 (842)
.++|.+.++||+|+||.||+|...+ +..+++|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999754 34567775433221111 11223444556678999999999
Q ss_pred eeccCC----eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 572 FCDEQS----EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 572 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
++.... ..++++|++. .++.+.+. .....++..++.|+.|+++||+|||+ ++|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFK--RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHH--hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 775443 3467777763 35555542 22345788899999999999999998 89999999999999999999
Q ss_pred eEEeecccccccCCCCC------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh-h
Q 037607 648 AKVADFGLSKAAPMDRG------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV-S 720 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~-~ 720 (842)
++|+|||+++....... .......||+.|+|||++.+..++.++|||||||+|+||++|++||......... .
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986642211 1112346999999999999999999999999999999999999999866332211 1
Q ss_pred H--HHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 721 L--AEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 721 l--~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
. .++. ..+..+.+. .......+.+++..|+..+|++||++.++++.|
T Consensus 245 ~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFI---------KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHH---------HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 1111 111111111 112346688999999999999999999999876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.93 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=204.7
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
|.+..+||+|+||.|||+.++ .|+.+|||++... .+++++..||.+|.++..|+||+++|.+.....+++|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556668999999999999965 7999999997754 4568999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+..+.++ .++++|++.++..|+...++||+|||. ..-||||||..||||+.+|.+||+|||.|-...+. -....
T Consensus 113 GSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRN 187 (502)
T KOG0574|consen 113 GSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRN 187 (502)
T ss_pred CcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhC
Confidence 99999884 567899999999999999999999998 88899999999999999999999999998665322 12335
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
.+.||+-|||||++..-.|+.++||||||+...||..|++|+..-.+-...- .+..-.-|.. ..++
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MIPT~PPPTF--~KPE 253 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MIPTKPPPTF--KKPE 253 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------eccCCCCCCC--CChH
Confidence 6789999999999999999999999999999999999999986432211000 0000000111 1133
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+-..++-++++.||-..|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 44567889999999999999999988765
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=296.94 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEM 579 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~ 579 (842)
.+|.+.+.||+|+||.||+|... +++.+++|.+... ..+....+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 6889999986422 234456889999999999999999999998653 568
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999998843 3458899999999999999999998 89999999999999999999999999999865
Q ss_pred CCC--CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 660 PMD--RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 660 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
... .........++..|+|||++.+..++.++|||||||+++||++|++||........ +... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~-~--- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKI----ATQP-T--- 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHH----HcCC-C---
Confidence 321 11112335588899999999988899999999999999999999999975432221 1110 0000 0
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
...++......+.+++.+|++ +|..||+..+++.
T Consensus 227 -----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 -----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011233344668889999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=305.59 Aligned_cols=268 Identities=26% Similarity=0.300 Sum_probs=198.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~l 581 (842)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999974 68999999875432 22223567899999999999999999998654 56899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+.+ +|.+++.. ....+++.+++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999974 78777743 23678999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc------
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL------ 734 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l------ 734 (842)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+......-..........
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 321 1223345788999999875 56789999999999999999999999866543322111100000000000
Q ss_pred --------ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 735 --------EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 735 --------~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+... .......+.+++.+|++.||++||++.|++..-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred cccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00000000000 01124567789999999999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.18 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=193.8
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||+||++... +|+.+++|.+.... ......+.+|+++|++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999876432 22345678899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+++.......+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 999866555679999999999999999999999 89999999999999999999999999998765432 1223345
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
++..|+|||++.+..++.++|||||||+++||++|+.||.......... . .... .... .........
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~~----~~~~------~~~~~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LKRR----TLEM------AVEYPDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HHhc----cccc------cccCCccCC
Confidence 7889999999988889999999999999999999999997654311110 0 0000 0000 001112224
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRP-----GMGDVLW 777 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RP-----tm~evl~ 777 (842)
..+.+++.+||+.+|.+|| +..++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 5678899999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.49 Aligned_cols=267 Identities=25% Similarity=0.327 Sum_probs=204.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC-----eEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-----EMI 580 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-----~~~ 580 (842)
+|.+.+.||.|++|.||+|+.. +++.++||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778889999999999999975 48999999887643 344568999999999999999999999987765 789
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+||||++ ++|.+++. ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888874 33489999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCC--ceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc--
Q 037607 661 MDRG--YVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE-- 735 (842)
Q Consensus 661 ~~~~--~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~-- 735 (842)
.... .......++..|+|||.+.+. .++.++||||||+++|||++|++||......+......-.........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 122344578899999999887 88999999999999999999999998765433211110000000000000
Q ss_pred ------cccc------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 736 ------KIID------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 736 ------~i~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
..+. +.-...........+.+++.+||+.+|.+||++.++++.-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 0000 000001112234668899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=292.90 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=202.8
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|+..+.||+|++|.||+++.. +++.+++|....... ....++.+|++++++++|||++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999865 678999998776543 4567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.. ...+++..+..++.|++.+|.|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 999999998843 3678999999999999999999998 89999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+...+.++||||+|++++||++|+.|+........ .|... . .... .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~--~-~~~~---------~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIV--Q-DDHP---------P 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh--c-cCCC---------C
Confidence 2345678899999999888889999999999999999999999875432111 11111 0 0000 1
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........+.+++.+|+..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11223456788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.87 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=203.6
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|++.+.||+|+||.||++... +++.+++|++... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999854 6789999987653 334456788999999999999999999999999999999999
Q ss_pred cCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
+++++|.+++.. .....+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998844 224578999999999999999999998 99999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......++..|++||.+.+..++.++|+||||+++|||++|+.||......+ +... ...+....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~~------- 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYK----VQRGKYPP------- 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HhcCCCCC-------
Confidence 2223457889999999999999999999999999999999999997654322 1111 11111111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.......++.+++.+|++.+|.+||++.|+++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 12234566899999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.32 Aligned_cols=244 Identities=21% Similarity=0.361 Sum_probs=198.0
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCcc
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFR 592 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (842)
.+||+|+||.||++... +|+.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999874 68999999987655555677999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeecc
Q 037607 593 DHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG 672 (842)
Q Consensus 593 ~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 672 (842)
+++. ...+++...+.++.|++.+|+|||+ .+++|+||||+||++++++.++|+|||++........ ......+
T Consensus 106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 8773 2358999999999999999999999 8999999999999999999999999999876543221 2234568
Q ss_pred CCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHH
Q 037607 673 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLR 752 (842)
Q Consensus 673 t~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~ 752 (842)
+..|+|||.+.+..++.++|||||||++|||++|.+||......+.... ...... ..+.. ......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~~~~~-~~~~~----------~~~~~~ 244 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNLP-PKLKN----------LHKVSP 244 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhhCC-cccCC----------cccCCH
Confidence 8999999999888899999999999999999999999976543322111 111000 00000 011234
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 753 KYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 753 ~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+.+++.+||+.+|.+||++.++++.
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 56788999999999999999998874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=305.38 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=196.8
Q ss_pred EEeec--CcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVG--GFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G--~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
.||+| +||+||++... +|+.||+|+.... .....+.+.+|+.+++.++||||++++++|..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999964 7899999987643 3344578899999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc---e
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY---V 666 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~---~ 666 (842)
+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.+......... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99998865545568999999999999999999998 89999999999999999999999999865433211100 0
Q ss_pred ---eeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh-------------
Q 037607 667 ---STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC------------- 728 (842)
Q Consensus 667 ---~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~------------- 728 (842)
.....++..|+|||++.+ ..++.++|||||||++|||++|++||........ +.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchh
Confidence 011224567999999876 3578999999999999999999999976543221 11100000
Q ss_pred -------------------hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 729 -------------------HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 729 -------------------~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+..+...........+.+++.+||+.+|.+|||+.|+++.-...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 000000011111111222334567889999999999999999999999765543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.14 Aligned_cols=274 Identities=21% Similarity=0.291 Sum_probs=205.0
Q ss_pred ccccHHHHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEe
Q 037607 496 RFFTFTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572 (842)
Q Consensus 496 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~ 572 (842)
+.....++..++++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445677888899999999999999999999985 47889999998653 23334678899999999999999999998
Q ss_pred eccC------CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC
Q 037607 573 CDEQ------SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 573 ~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~ 646 (842)
+... ...+++++++ +++|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence 8532 3468888887 788888773 2368999999999999999999999 9999999999999999999
Q ss_pred ceEEeecccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 037607 647 VAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 647 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~ 725 (842)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|++||...............
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999998765322 233467889999998876 56889999999999999999999999755432221111000
Q ss_pred HHhhcccccccccchhHH--------------hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 726 LQCHRKGILEKIIDPVIA--------------ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
...........+.+.... ..........+.+++.+|++.+|.+||++.+++..-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000001111100000 0000012346789999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=297.42 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=199.3
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEec
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
|.+.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+++++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 578899998765422 22234567999999999 999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
+|+|.+++.......+++.+++.++.|++.+|.|||+ ++++|+||||+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 8899998865555678999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH-H---------HHHHHhhcccccc
Q 037607 667 STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL-A---------EWALQCHRKGILE 735 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l-~---------~~~~~~~~~~~l~ 735 (842)
.....++..|+|||++.. ..++.++|+||||++++||++|++||......+.... . .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223457889999998754 5678999999999999999999999976644332110 0 0111110000010
Q ss_pred cc----cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 KI----IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 ~i----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.. ....+ ....+.....+.+++.+|++.+|.+||++.|++..
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 00001 11111224678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.65 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=196.4
Q ss_pred CcccceEEeecCcEEEEEEEE----cCCcEEEEEECCCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGS----EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~~----~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~ 579 (842)
+|++.+.||+|+||.||++.. .+|..||+|++.... ....+++.+|+++++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999986 368899999876532 22346788999999999 599999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 999999999999999843 4568899999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
............|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ...++........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE----- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC-----
Confidence 4332222334568899999999875 346789999999999999999999986432211 1111211111110
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLW 777 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~ 777 (842)
+ .........+.+++.+|++.+|.+|| +..+++.
T Consensus 229 --~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 01122345678899999999999997 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=298.54 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=188.0
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHh---cCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSK---LRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~---L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999875432 1222334455544443 479999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999998884 34569999999999999999999999 899999999999999999999999999987553221 2
Q ss_pred eeeccCCCCCCccccc-ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~-~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....|+..|+|||.+. +..++.++|||||||+++||++|+.||..........+.... .. .. ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----~~------~~----~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LT------VN----VEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----hc------CC----cCC
Confidence 2346899999999986 456899999999999999999999999754332211111110 00 00 111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~Le 780 (842)
+.....++.+++.+||+.+|.+|| +++|+++...
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 223345678899999999999999 5998887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.28 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=203.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
+.|..-++||+||||.||-+..+ +|+.+|.|++.++ ..++....++|-.||.+++.+.||.|--.|+..+.+|||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 67888889999999999999864 6889999977653 2344556789999999999999999988899999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
..|.||+|.-||++..++.+++..++-++.+|+.||++||+ .+||.|||||+|||||+.|+++|+|+|||..++...
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999998876443
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH-
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI- 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l- 742 (842)
.....+||.+|||||++.++.|+...|.||+||+||||+.|+.||........ | +-+|.++
T Consensus 342 --~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~-----------eEvdrr~~ 403 (591)
T KOG0986|consen 342 --PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----R-----------EEVDRRTL 403 (591)
T ss_pred --ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----H-----------HHHHHHHh
Confidence 23444899999999999999999999999999999999999999975432211 1 0011111
Q ss_pred --HhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 743 --AETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 743 --~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
..+++....++...+.+..|+.||.+|---
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 122334445567778888999999998643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=307.54 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=194.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------C
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------S 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~ 577 (842)
.++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 6899999987643 223345688999999999999999999988644 3
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46999999964 665544 2468899999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............+............
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 65322 123456888999999876 5688999999999999999999999986543222111111000000000000
Q ss_pred cc---------------chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 II---------------DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 i~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+. ...+.. ..+.....+.+++.+||+.+|.+||++.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred hcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 001223567899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=291.75 Aligned_cols=250 Identities=20% Similarity=0.252 Sum_probs=193.3
Q ss_pred HHHHHHHhcCcccceEE--eecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc
Q 037607 500 FTELQNATQNFDENAVI--GVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE 575 (842)
Q Consensus 500 ~~el~~at~~f~~~~~L--G~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~ 575 (842)
..+.....++|++.+.+ |+|+||.||++... ++..+|+|......... .|+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556677777666 99999999999964 67889999876432111 122222222 69999999999999
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFG 654 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFG 654 (842)
.+..++||||+++++|.+++.. ...+++.+++.++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999999843 3489999999999999999999999 8999999999999999988 99999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+++...... ...++..|+|||++.+..++.++|||||||+++||++|+.||..... +......|....... .
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~--~ 227 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQKK--L 227 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhccc--C
Confidence 987654322 23578899999999998999999999999999999999999984432 222223332221100 0
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPG-MGDVLW 777 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-m~evl~ 777 (842)
...+.....+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 ----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011133456788999999999999995 688874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.19 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=199.3
Q ss_pred CcccceEEeecCcEEEEEEEE----cCCcEEEEEECCCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeE
Q 037607 509 NFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGS----EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~~----~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~ 579 (842)
+|+..+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999984 256889999876431 22345788999999999 599999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999998843 3568899999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCCceeeeeccCCCCCCcccccccC--CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~------ 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS------ 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc------
Confidence 443322233456889999999987654 7889999999999999999999986432111 111111111110
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.+ .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 -~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 0111223457789999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.94 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=213.9
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCC-CChhhHHHHHHHHHHHHhcCCCceeeEEE
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNP-GSEQGINEFQTEIQMLSKLRHRHLVSLIG 571 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~-~~~~~~~~f~~Ei~il~~L~HpnIv~l~g 571 (842)
...++.....+++...++-+|.||.||+|.|.+ .+.|.+|.++. .+.-+...++.|..++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345666667778888899999999999998753 34577786554 45666788999999999999999999999
Q ss_pred eecc-CCeEEEEEEecCCCCccccccc------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC
Q 037607 572 FCDE-QSEMILVYEYMANGPFRDHLYG------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644 (842)
Q Consensus 572 ~~~~-~~~~~lV~Ey~~~gsL~~~l~~------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~ 644 (842)
.+.+ ....+++|.++.-|+|..+|.. +....++..+...++.|++.|++|||. ++|||.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehh
Confidence 9854 5567999999999999999952 233457778889999999999999999 99999999999999999
Q ss_pred CCceEEeeccccccc-CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHH
Q 037607 645 NLVAKVADFGLSKAA-PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLA 722 (842)
Q Consensus 645 ~~~~kl~DFGla~~~-~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~ 722 (842)
..++||+|=.|++.. +.+-............||+||.+.+..|+..+|||||||+||||++ |+.|+-.-.+.|..
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--- 508 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--- 508 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---
Confidence 999999999999865 4444445566667889999999999999999999999999999997 88887665554422
Q ss_pred HHHHHhhccc-ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 723 EWALQCHRKG-ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 723 ~~~~~~~~~~-~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.+.++| .+.+ +-.++.++..++.-||...|++||+.++++.-|.+-
T Consensus 509 ----~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 509 ----HYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----HHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111222 1221 224567889999999999999999999999887653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.63 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=195.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccC-------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------- 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------- 576 (842)
.++|++.+.||+|+||.||+|... +++.+++|++..... .....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 688999998754322 2234678999999999999999999887433
Q ss_pred -CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 577 -SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 577 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
..+++||||+.+ +|...+.. ....+++.++..++.|+++||+|||+ ++|+|+||||+|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999965 56665533 34579999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCC----------ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 037607 656 SKAAPMDRG----------YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW 724 (842)
Q Consensus 656 a~~~~~~~~----------~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~ 724 (842)
++....... ...+...++..|+|||.+.+ ..++.++|||||||++|||++|++||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976542211 11123456888999998765 4588999999999999999999999986654332221111
Q ss_pred HHHhhccc------ccc--------cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 725 ALQCHRKG------ILE--------KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 725 ~~~~~~~~------~l~--------~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
........ .+. ....+.+.. ........+.+++.+|++.+|.+||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 000 000111111 11122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.70 Aligned_cols=260 Identities=21% Similarity=0.211 Sum_probs=194.3
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCcc
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFR 592 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (842)
.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 445556666666655 6899999997654 4456678999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC------ce
Q 037607 593 DHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG------YV 666 (842)
Q Consensus 593 ~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~------~~ 666 (842)
+++.......+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||.+........ ..
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 99865555678999999999999999999999 8999999999999999999999999998875532111 11
Q ss_pred eeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc-----------ccc
Q 037607 667 STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR-----------KGI 733 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~~~ 733 (842)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||........ +.+....... ...
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCC
Confidence 123456778999999876 4588999999999999999999999975432211 1111000000 000
Q ss_pred ccc----ccchhH----HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 734 LEK----IIDPVI----AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 734 l~~----i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
... ..++.. ..........++.+++.+||+.+|.+||++.++++.-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 001100 00111223457888999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=293.57 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=188.7
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHH-HhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQML-SKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il-~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||.||+|... +|+.||+|++.... ......+..|..++ ..++|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68899999876542 22233445555544 455899999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
++|.+++. ....+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999884 34568899999999999999999999 8999999999999999999999999999876533 22
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...++..|+|||.+.+..++.++||||||+++|||++|.+||......... .. ...+... .. .....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~--~~----~~~~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF------DN-ILSRRIN--WP----EEVKE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHhcccC--CC----Ccccc
Confidence 345788999999998888999999999999999999999999765432211 00 0000000 00 00111
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.....+.+++.+||+.+|.+||++.++.+.|
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 2345688999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=297.30 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=201.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV 582 (842)
++|...+.||+|+||.||++... +|+.|++|++... .......+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 6899999987652 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++. ....+++..++.|+.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999984 34479999999999999999999998 99999999999999999999999999998866432
Q ss_pred CC-------------------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 037607 663 RG-------------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723 (842)
Q Consensus 663 ~~-------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~ 723 (842)
.. .......++..|+|||.+....++.++||||||++++||++|+.|+....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH
Confidence 21 12233457889999999988889999999999999999999999998654211 111
Q ss_pred HHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 037607 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGM----GDVLW 777 (842)
Q Consensus 724 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm----~evl~ 777 (842)
... .. ...+.......+.+++.+||+.+|.+||++ .++++
T Consensus 233 ~~~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KIL----KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH----hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 00 001112224568899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.44 Aligned_cols=266 Identities=25% Similarity=0.334 Sum_probs=200.1
Q ss_pred HHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-CC
Q 037607 502 ELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-QS 577 (842)
Q Consensus 502 el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~ 577 (842)
++..++++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++.++|.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999854 7899999986542 23344678899999999999999999998865 56
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++++||+ +++|.+++. ..++++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 568887773 3457888899999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH-HH--------HHHH
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL-AE--------WALQ 727 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l-~~--------~~~~ 727 (842)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|++||........... .+ |...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 123456889999998765 5789999999999999999999999976543221111 11 1110
Q ss_pred hhccccccc---cc--chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 728 CHRKGILEK---II--DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 728 ~~~~~~l~~---i~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......... +. .+.......+.....+.+++.+|++.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00 0000011112234678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.93 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=196.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCC---CChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNP---GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~---~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
+.|...+.||+|+||.||+|+.. +++.+++|.+.. ......+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666778999999999999964 678899998653 23344567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+. |+|.+.+.. ....+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 678776643 23568999999999999999999998 89999999999999999999999999998765322
Q ss_pred CceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+......+.. ..+. . +....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~----~-~~~~~---- 233 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA----Q-NESPA---- 233 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHh----h-cCCCC----
Confidence 2345788999999975 356788999999999999999999998654322211 1111 0 10000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
. ........+.+++.+||+.+|.+||++.++++.....
T Consensus 234 -~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 234 -L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred -c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0 0112345678899999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.21 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=195.0
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|+..+.||+|+||.||+|...+ ++.||||++.... .....++..|+.++.++. ||||++++++|......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888899999999999999864 8899999986542 334456777888777775 9999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+. ++|.+++.. ....+++..+..++.|+++||+|||+ ..+|+||||+|+||++++++.+||+|||++........
T Consensus 95 ~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 985 466665533 23478999999999999999999996 25899999999999999999999999999876543221
Q ss_pred ceeeeeccCCCCCCcccccccC----CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~----~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ....... ... ...+..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~---~~~-~~~~~~- 241 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKIL---QEE-PPSLPP- 241 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHHHh---cCC-CCCCCC-
Confidence 12335778999999987553 7899999999999999999999996532211 1111110 000 000000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
......++.+++.+||+.+|.+||++.++++...
T Consensus 242 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 242 ------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0123456888999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=302.68 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=197.9
Q ss_pred cCccc-ceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhh--------------HHHHHHHHHHHHhcCCCceeeEEE
Q 037607 508 QNFDE-NAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQG--------------INEFQTEIQMLSKLRHRHLVSLIG 571 (842)
Q Consensus 508 ~~f~~-~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~--------------~~~f~~Ei~il~~L~HpnIv~l~g 571 (842)
++|.. .+.||.|+||+||+|... +++.||||++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 457999999999999965 68899999875432211 125789999999999999999999
Q ss_pred eeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
++...+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 68888883 34568999999999999999999998 999999999999999999999999
Q ss_pred ecccccccCCCC-------------CceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 652 DFGLSKAAPMDR-------------GYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 652 DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
|||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|++||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999987654110 1111233467889999998764 46899999999999999999999998665433
Q ss_pred hhhHHHHHHHhhcc---cccc------------cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 718 QVSLAEWALQCHRK---GILE------------KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 718 ~~~l~~~~~~~~~~---~~l~------------~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
... .+...... ..+. ....+.. .........++.+++.+|++.+|++||++.|++..-..
T Consensus 242 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 242 QLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 211 11111100 0000 0000111 11112234668899999999999999999999975543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=311.26 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=200.6
Q ss_pred cceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------CeEEEEE
Q 037607 512 ENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------SEMILVY 583 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~~~~lV~ 583 (842)
....||+|+||.||+|+. ..|+.||||.++.. .....+...+|+++|++|+|+|||++++.=++. ....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 345799999999999995 57999999998764 334456678999999999999999999875443 3579999
Q ss_pred EecCCCCccccccc-CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE--cCCC--ceEEeecccccc
Q 037607 584 EYMANGPFRDHLYG-TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL--DENL--VAKVADFGLSKA 658 (842)
Q Consensus 584 Ey~~~gsL~~~l~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl--d~~~--~~kl~DFGla~~ 658 (842)
|||.+|+|+..|.. .+...|++.+.+.++.++..||.|||+ ++|+||||||.||++ .++| .-||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999965 345789999999999999999999999 999999999999999 3334 469999999998
Q ss_pred cCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
..++. ..+.+.||..|++||++.+ +.|+..+|.|||||++||..||..||.+........-..|...........-.
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 86544 6678899999999999985 88999999999999999999999999865433221122333222211111111
Q ss_pred cchhH------------HhhhcHHHHHHHHHHHHHhhhhCCCCCC--CHHHHHHHHHHH
Q 037607 738 IDPVI------------AETICKESLRKYVEAAEKCLAEYGVDRP--GMGDVLWNLEYA 782 (842)
Q Consensus 738 ~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--tm~evl~~Le~~ 782 (842)
..+.. ...++.....++-..+..++..+|++|. ...+....+..+
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111 1123344556666777778888888887 444444444433
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=311.79 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=201.7
Q ss_pred cccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 510 FDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
|.+..-||.|+||+||||..++ +-..|-|++...+.+.+++|+-||+||..+.||+||+|++.|...+.++|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455679999999999999764 344577888888899999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|-.+..+.. -...|.+.++.-+|.|++.||.|||+ +.|||||||..|||++-+|.++|+|||.+-..... .....
T Consensus 114 GAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD 188 (1187)
T ss_pred chHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence 988776643 45689999999999999999999999 99999999999999999999999999987543211 12335
Q ss_pred eeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 669 AVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.+.||+.|||||+.+ ..+|+.++||||||++|.||..+.||-...++.- -+. . ..+. --|.+.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--Vll----K-iaKS-----ePPTLl 256 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL----K-IAKS-----EPPTLL 256 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHH----H-Hhhc-----CCCccc
Confidence 678999999999875 4789999999999999999999998876543321 011 0 0010 011111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
. +......+.+++.+||..+|..||++.++++
T Consensus 257 q--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 Q--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred C--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 2234567889999999999999999999976
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=291.62 Aligned_cols=243 Identities=22% Similarity=0.290 Sum_probs=187.6
Q ss_pred EEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHH---HHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQ---MLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~---il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
+||+|+||.||++... +++.||+|.+.... ......+..|.. .++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999876532 121223444444 3444579999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++. ....+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 999998883 34579999999999999999999999 899999999999999999999999999987653221 1
Q ss_pred eeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||............ .. ... ..+ .+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~---~~~------~~~----~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RM---TLT------MAV----EL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HH---hhc------cCC----CC
Confidence 234689999999998754 6899999999999999999999999765322211110 00 000 001 11
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWNL 779 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~L 779 (842)
.......+.+++.+|+..+|.+|| ++.|+++.-
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 112245788899999999999999 999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.95 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=199.6
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
|+..+.||+|++|.||+|+.. +++.+++|+..... ....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999975 58999999877653 333467889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
+ ++|.+++.... ..+++..++.++.|+++||+|||+ .+|+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58999885432 478999999999999999999999 8999999999999999999999999999887643321 2
Q ss_pred eeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HHH---------HHHHhh---ccc
Q 037607 667 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LAE---------WALQCH---RKG 732 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~~---------~~~~~~---~~~ 732 (842)
.....++..|+|||.+.+. .++.++|||||||+++||++|++||......+... +.. |..... .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234457789999998776 88999999999999999999999997654322211 000 000000 000
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.......... ....+.....+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 0111122467899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=300.71 Aligned_cols=264 Identities=24% Similarity=0.297 Sum_probs=194.1
Q ss_pred CcccceEEeecCcEEEEEEEEc-C--CcEEEEEECCCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc----CCe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-D--GNKVAIKRGNPG--SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE----QSE 578 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~--g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~----~~~ 578 (842)
+|...+.||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999965 3 678999987642 222346788999999999 59999999987532 245
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++++||+. ++|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899886 68888873 45678999999999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCC---ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 659 APMDRG---YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 659 ~~~~~~---~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
...... .......|+..|+|||++.+ ..++.++|||||||++|||++|++||.......................+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 542211 11233468899999998765 56899999999999999999999999765432211110000000000000
Q ss_pred ccccchh--------------HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKIIDPV--------------IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~d~~--------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.++..+. ............+.+++.+|++.+|.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1100000 0001111124568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=297.25 Aligned_cols=244 Identities=26% Similarity=0.400 Sum_probs=193.3
Q ss_pred cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
|...+.||+|+||+||+|+.. +|+.|++|++... ......++.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555668999999999999964 6889999987643 233446788999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+. |+|.+.+.. ...++++.+++.++.|++.+|.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 577776633 34568999999999999999999998 8999999999999999999999999999865322
Q ss_pred eeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 666 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.....|+..|+|||++. ...++.++|||||||++|||++|.+|+......... .+. .... .....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~---~~~~-~~~~~---- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI---AQND-SPTLQ---- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHH---HhcC-CCCCC----
Confidence 12346888999999984 466889999999999999999999998765432211 111 1110 01100
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 ----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123457889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=304.95 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=196.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC---------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--------- 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--------- 576 (842)
..+|...+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367899999999999999999964 6889999988766556667889999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCceEE
Q 037607 577 -----SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKV 650 (842)
Q Consensus 577 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~kl 650 (842)
...++||||++ ++|.+++. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35799999997 58877763 2468899999999999999999998 8999999999999997 4567899
Q ss_pred eecccccccCCCCCc--eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 651 ADFGLSKAAPMDRGY--VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 651 ~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+..........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765322111 1123357889999998754 5688999999999999999999999976654332211100000
Q ss_pred hhccccccccc------------ch-hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 728 CHRKGILEKII------------DP-VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 728 ~~~~~~l~~i~------------d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.. .+ .......+....++.+++.+|++.+|.+||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000000000 00 00001111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=301.66 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=199.6
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-- 577 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-- 577 (842)
+....++|...+.||+|+||.||++.. .+|..||||++... .......+.+|+++|++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334567899999999999999999985 47899999987543 2333457889999999999999999999886543
Q ss_pred ----eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 578 ----EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 578 ----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
..++||||+ +++|.+++. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 468999999 778888773 3468999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HH--------H
Q 037607 654 GLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LA--------E 723 (842)
Q Consensus 654 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~--------~ 723 (842)
|++...... .....++..|+|||.+.+ ..++.++|||||||++++|++|++||.......... +. +
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998765322 123457889999999876 468899999999999999999999997654321110 00 0
Q ss_pred HHHHhhccc------ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 724 WALQCHRKG------ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 724 ~~~~~~~~~------~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
|........ .+.......+ ....+.....+.+++.+|++.+|.+||++.+++..-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 100000000 0000000000 111123345688999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=309.40 Aligned_cols=242 Identities=25% Similarity=0.432 Sum_probs=197.0
Q ss_pred EEeecCcEEEEEEEEc-CCcEEE---EEECC-CCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--eEEEEEEecC
Q 037607 515 VIGVGGFGKVYIGVLE-DGNKVA---IKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS--EMILVYEYMA 587 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~-~g~~VA---vK~~~-~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~--~~~lV~Ey~~ 587 (842)
+||+|.|-+||||... +|..|| ||.-+ ..+....++|..|+++|+.|+||||++++.++.+.. ...+|.|.|.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 7999999999999964 465565 33211 134556789999999999999999999999886554 4889999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCceEEeecccccccCCCCCce
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
.|+|..++ ++.+.++.+.+..||.||++||.|||+ ...+|||||||.+||+|+ ..|.+||+|+|||...... .
T Consensus 127 SGtLr~Y~--kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~ 200 (632)
T KOG0584|consen 127 SGTLREYR--KKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---H 200 (632)
T ss_pred CCcHHHHH--HHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---c
Confidence 99999998 555678889999999999999999998 456899999999999996 4689999999999987533 2
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
...+.||+.|||||++. ..|++.+||||||++|+||+|+.-|+..=... .++...+....+...+.++.||
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~kV~dP------ 271 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALSKVKDP------ 271 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhhccCCH------
Confidence 34478999999999987 88999999999999999999999988643322 2344445555555556665554
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
++.+++++|+.. ..+||++.|+|+.
T Consensus 272 ------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 ------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 456789999999 9999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=304.80 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=199.1
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe---
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE--- 578 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~--- 578 (842)
...++|...+.||+|+||.||+|... +++.||+|++... .....+++.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999975 5789999987643 23344678899999999999999999988765554
Q ss_pred ---EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 579 ---MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 579 ---~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6789888743 468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH-HHHHHHhhcccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL-AEWALQCHRKGI 733 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~ 733 (842)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... .+.. .......
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV-GTPDEEL 239 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCCHHH
Confidence 8865432 233457889999999865 4678999999999999999999999976543322110 0000 0000000
Q ss_pred cccccc---------------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 LEKIID---------------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 l~~i~d---------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+..+.. +... .........+.+++.+|++.+|.+||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 0000 0111225678899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=306.10 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=207.5
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.-...|.+...||+|.|++|..|++. .+..||||.+.+.. ....+.+.+|+++|+.|+|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567899999999999999999964 68899999988753 3344568999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+.+|.++++| .....+.+..+..+..|+.++++|||+ +.|||||||.+||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl--~~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYL--VKHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEEeccCchhHHHH--HhcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec-
Confidence 99999999999999 444556678899999999999999999 999999999999999999999999999998775
Q ss_pred CCCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
........+|++.|.|||++.+..| ++++|+||+|++||-|++|..||++..-.+ +-++
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence 3344567889999999999998766 489999999999999999999999764322 1111
Q ss_pred hHHhh--hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 741 VIAET--ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 741 ~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+.+. ++.-...++-+++++++-.+|.+|++++++.+.-+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 11111 11122345567888899999999999999876533
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=285.39 Aligned_cols=241 Identities=27% Similarity=0.357 Sum_probs=199.1
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|+..++||+|.||+|..++- ..|+.+|+|++++. .......-+.|-++|+..+||.+..|.-.|...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788899999999999999984 47889999998875 233445667899999999999999998888999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||..||.|.-+| .+...+++...+-....|..||.|||+ ++||.||||.+|.|||.+|++||+|||||+..- .
T Consensus 247 MeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K 320 (516)
T ss_pred EEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-c
Confidence 9999999999998 456778999999999999999999999 999999999999999999999999999998753 3
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.+.....++||+.|+|||++....|...+|.|.+|||||||+||+.||..........+ +. ..++.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL---Il-------~ed~k---- 386 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL---IL-------MEDLK---- 386 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH---HH-------hhhcc----
Confidence 34456789999999999999999999999999999999999999999986643322111 10 11111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP 770 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 770 (842)
++.....+...++...|..||.+|-
T Consensus 387 ---FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 ---FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---CCccCCHHHHHHHHHHhhcChHhhc
Confidence 1112223455677788999999996
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-34 Score=335.80 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=202.4
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECC--CCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~--~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
+...+-++.....||.|.||.||-|. .++|+..|+|-++ +..........+|+.++..|.|||+|+++|+=.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34456678888899999999999998 5689999999654 33455667889999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
+|.||||++|+|.+.+ .....+++.....+..|++.|+.|||+ +|||||||||.||||+.+|.+|+.|||.|...
T Consensus 1310 ~IFMEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999998 334456666677789999999999999 99999999999999999999999999999877
Q ss_pred CCCCC---ceeeeeccCCCCCCccccccc---CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh-hccc
Q 037607 660 PMDRG---YVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC-HRKG 732 (842)
Q Consensus 660 ~~~~~---~~~~~~~gt~~Y~APE~l~~~---~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~-~~~~ 732 (842)
..... .......||+.|||||++.+. .-..++||||+|||++||+||++||..... +|+.-. ..-|
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAG 1457 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhcc
Confidence 54321 122356799999999999763 355789999999999999999999986543 233321 1222
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.... ++.....+=.+++.+||+.||++|.++.|+++
T Consensus 1458 h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2222 22223445567889999999999988775553
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=318.75 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=207.9
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc----C----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE----D----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE 575 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~----~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~ 575 (842)
..++..+.+.||+|.||.|++|... . ...||||+++.. .....+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444455569999999999999843 1 346999998764 335668899999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCCcccccccCC------C--------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEE
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTN------Q--------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 641 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~------~--------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 641 (842)
.+..++|+||+..|+|.++|+..+ . ..|+..+.+.++.|||.|++||++ .++|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence 999999999999999999996544 0 238889999999999999999999 89999999999999
Q ss_pred EcCCCceEEeecccccccCCCCCceeeeecc--CCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhh
Q 037607 642 LDENLVAKVADFGLSKAAPMDRGYVSTAVKG--SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQ 718 (842)
Q Consensus 642 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~ 718 (842)
+.++..+||+|||+|+.......+......| ...|||||.+....++.|+|||||||+||||++ |..|+.+-...+.
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 9999999999999999766555444333332 457999999999999999999999999999997 7777765321221
Q ss_pred hhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 719 VSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 719 ~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+.+ ..++|.-.+ .+..+..++.++++.||+.+|++||+..|+++.++..+
T Consensus 531 --l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 --LLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --HHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 122 223332111 12234566779999999999999999999999999854
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=288.51 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=193.8
Q ss_pred CcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999998653 344555544321 222345677899999999999999999999999999999
Q ss_pred EEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 583 YEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
|||+++++|.+++.. .....+++.+++.++.|+++||.|||+ .+++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 334679999999999999999999998 99999999999999975 569999999987764
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... ...... .+. .+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~~-----~~ 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-EGP-----TP 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-cCC-----CC
Confidence 3221 2234557889999999988889999999999999999999999986442211 111110 111 11
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
. ........+.+++.+|+..+|++||++.|+++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 12234457888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=284.22 Aligned_cols=264 Identities=21% Similarity=0.362 Sum_probs=205.4
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccC
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQ 576 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~ 576 (842)
++.++.+.|.+ .||+|+|+.|--++ +.+|..+|||++.+.......+..+|++++.+.+ |+||+.|+++|+++
T Consensus 74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 46777777765 79999999999988 6789999999999887777889999999999995 99999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---ceEEeec
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL---VAKVADF 653 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~---~~kl~DF 653 (842)
..+|||||-|.||+|..+| ..+..+++.++.++..+|+.||.+||. ++|.||||||+|||..... -+|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI--~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHI--QKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHH--HHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999 456789999999999999999999999 9999999999999995443 5799999
Q ss_pred ccccccCCC------CCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh---
Q 037607 654 GLSKAAPMD------RGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV--- 719 (842)
Q Consensus 654 Gla~~~~~~------~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~--- 719 (842)
.|..-.... .+......+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+.-..+..
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 887543211 112234567899999999863 256889999999999999999999999876543311
Q ss_pred -----hHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 720 -----SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 720 -----~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...+....-.++|..+ . ..+-......+..+++...+..++.+|-++..+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYe-F-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYE-F-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccHHHHHHHHHHHhccCCc-C-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 0000111111122111 1 111122334556677778888999999999888763
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=283.80 Aligned_cols=236 Identities=28% Similarity=0.378 Sum_probs=192.8
Q ss_pred EeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 516 IGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 516 LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
||+|+||.||++... +++.+++|++.... ......+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 58899999876543 23456889999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
.+++. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLS--KEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99984 33468999999999999999999999 999999999999999999999999999987764322 1233456
Q ss_pred cCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
++..|++||.+.+...+.++|+||||+++|||++|+.||....... +...... ... .+.....
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~----~~~----------~~~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKILK----DPL----------RFPEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhc----CCC----------CCCCCCC
Confidence 7889999999998889999999999999999999999997553211 1111111 000 1111224
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGD 774 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~e 774 (842)
..+.+++.+|+..+|++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 56788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=319.86 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=191.4
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ----- 576 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~----- 576 (842)
....++|++..+||+||||.|||++.+ ||+.+|||++... +........+|+..|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678888999999999999999965 8999999997755 444556788999999999999999876321000
Q ss_pred --------------------------------------------------------------------------------
Q 037607 577 -------------------------------------------------------------------------------- 576 (842)
Q Consensus 577 -------------------------------------------------------------------------------- 576 (842)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHH
Q 037607 577 ----------------------------------SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622 (842)
Q Consensus 577 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yL 622 (842)
..+||-||||+..+|.+++....... .-...++++.+|++||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 12478888888877777773322111 3567899999999999999
Q ss_pred HhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC--------------C---CCCceeeeeccCCCCCCccccccc
Q 037607 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP--------------M---DRGYVSTAVKGSFGYLDPEYFRRQ 685 (842)
Q Consensus 623 H~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~--------------~---~~~~~~~~~~gt~~Y~APE~l~~~ 685 (842)
|+ ++||||||||.||+||++..+||.|||+|+... . ......+...||.-|+|||++.+.
T Consensus 714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99 999999999999999999999999999998721 0 011234677899999999999764
Q ss_pred ---CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhh
Q 037607 686 ---QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCL 762 (842)
Q Consensus 686 ---~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl 762 (842)
.|+.|+|+||+|||++||+. ||....++-. +....+++.+..- ..+..+....-..++++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~------iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS------ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHH------HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 59999999999999999994 4654433221 1111223333221 1122333445567899999
Q ss_pred hhCCCCCCCHHHHHH
Q 037607 763 AEYGVDRPGMGDVLW 777 (842)
Q Consensus 763 ~~dP~~RPtm~evl~ 777 (842)
+.||.+|||+.|+|+
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=318.56 Aligned_cols=145 Identities=30% Similarity=0.415 Sum_probs=130.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|.+.++||+|+||.||+|... +++.||||++... ......++..|+.+++.++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 6889999987643 2334567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
||+.+++|.+++.. ...+++..++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998843 3468889999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=276.73 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred HhcCcccc-eEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc----CCe
Q 037607 506 ATQNFDEN-AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE----QSE 578 (842)
Q Consensus 506 at~~f~~~-~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~----~~~ 578 (842)
.+++|.+. ++||-|-.|+|-.+..+ +|+++|+|++... ....+|+++--.. .|||||.+++++++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666554 47999999999999865 7899999998754 3346777654433 69999999998854 457
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeeccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGL 655 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGl 655 (842)
+++|||.|+||.|...+..+....++++++-+|..||+.|+.|||+ .+|.||||||+|+|.. .|..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 8999999999999999988888889999999999999999999999 9999999999999995 466899999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
|+..... ......+.|+.|.|||++...+|+..+|+||+||++|-||||.+||....... +..=+....+.|...
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCcc
Confidence 9986532 23345678999999999999999999999999999999999999997553211 100011111111110
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
...+-.....+...++++.+|..+|.+|-|+.|++..-
T Consensus 286 ------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 286 ------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred ------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 11112234566778899999999999999999988643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.90 Aligned_cols=275 Identities=19% Similarity=0.230 Sum_probs=214.5
Q ss_pred cccHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC--C----ceeeE
Q 037607 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH--R----HLVSL 569 (842)
Q Consensus 497 ~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H--p----nIv~l 569 (842)
.+-+......+++|.+...+|+|.||.|-++... .+..||||+++... .-.+..+-|+++|.+|.+ | -+|.+
T Consensus 78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 3444444556899999999999999999999854 47899999987543 223456789999999942 2 37888
Q ss_pred EEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc------
Q 037607 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD------ 643 (842)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld------ 643 (842)
.+||...++.|||+|.| |-|+.++|...+-.+++..++..|+.|+++++++||+ .+++|-||||+|||+.
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence 89999999999999998 5699999977777889999999999999999999999 9999999999999992
Q ss_pred --------------CCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCC
Q 037607 644 --------------ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709 (842)
Q Consensus 644 --------------~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p 709 (842)
.+..+||+|||.|...... ....+.|..|+|||++.+-.++.++||||+||||.||.+|...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1446899999998774322 2456789999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhHHHHHHHhhcccccccc-------------------------c---chhH-HhhhcHHHHHHHHHHHHH
Q 037607 710 INPKLPREQVSLAEWALQCHRKGILEKI-------------------------I---DPVI-AETICKESLRKYVEAAEK 760 (842)
Q Consensus 710 ~~~~~~~~~~~l~~~~~~~~~~~~l~~i-------------------------~---d~~l-~~~~~~~~~~~l~~l~~~ 760 (842)
|+.....+...+.+.+..-.....+.+. . .|.- ...-...+..+|.+|+++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 9987766655444433221111111111 1 1110 011123556789999999
Q ss_pred hhhhCCCCCCCHHHHHHHHH
Q 037607 761 CLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 761 Cl~~dP~~RPtm~evl~~Le 780 (842)
+|..||.+|+|+.|+++.--
T Consensus 389 mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPF 408 (415)
T ss_pred HHccCccccccHHHHhcCHH
Confidence 99999999999999987543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=275.64 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=193.2
Q ss_pred cceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEecCC
Q 037607 512 ENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
....||.|+.|+|+++..+ .|..+|||.+... +.+..+++++.+.++..-+ .|+||+.+|||.......+.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3446999999999999965 5889999987764 5556677888888776664 8999999999999999999999994
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
..++.+| ..-.+++++.-+-++...+.+||.||.+ .++|+|||+||+|||+|+.|++||||||++-..-+.. ..+
T Consensus 175 ~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 175 TCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred HHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 3455544 3345678888889999999999999998 6889999999999999999999999999987654332 234
Q ss_pred eeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 669 AVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
...|-+.|||||.+.- ..|+-++||||||+.|+||.||+-|+..-..+-. ....+.. +. -|.+.+.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkvln--------~e-PP~L~~~ 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKVLN--------EE-PPLLPGH 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHHHh--------cC-CCCCCcc
Confidence 5678889999999863 4688999999999999999999999986432211 1111111 00 0222111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......+++++..||+.|+.+||.+.++++.
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1135678999999999999999999988763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=299.47 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=210.0
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeec---
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCD--- 574 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~--- 574 (842)
++.+..-+..|++...||+|.+|.||+++. ++|+.+|+|++....+. .++...|.+||+.+ .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344444567889999999999999999994 57899999998876544 36778999999988 6999999999984
Q ss_pred --cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 575 --EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 575 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
.+++++||||||.+||.-|++.+.....+.|..+..|+..+++||.+||. ..++|||||-.||||+.++.+||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEee
Confidence 46789999999999999999977778889999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 653 FGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 653 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
||++........ ......||+.|||||++.. ..|+.++|+||||++..||..|.||+-...+.-.+ .
T Consensus 167 FGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F- 238 (953)
T KOG0587|consen 167 FGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------F- 238 (953)
T ss_pred eeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------c-
Confidence 999876643322 2345679999999999864 34678999999999999999999998655332110 0
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.+..-.-|.+. -++.-.+++.+++..||..|-++||++.++++
T Consensus 239 -----~IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 -----LIPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----cCCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00111111121 13455678999999999999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=272.10 Aligned_cols=205 Identities=24% Similarity=0.364 Sum_probs=170.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcC--C---cEEEEEECCCCChh--hHHHHHHHHHHHHhcCCCceeeEEEeecc-CC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLED--G---NKVAIKRGNPGSEQ--GINEFQTEIQMLSKLRHRHLVSLIGFCDE-QS 577 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~--g---~~VAvK~~~~~~~~--~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~ 577 (842)
....|+....||+|.||.||||.-.+ + ..+|||+++..... -....-+|+.+++.|+||||+.|+.++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568888999999999999997432 2 26899988754221 12456799999999999999999998876 77
Q ss_pred eEEEEEEecCCCCccccccc---CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC----CceEE
Q 037607 578 EMILVYEYMANGPFRDHLYG---TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN----LVAKV 650 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~----~~~kl 650 (842)
..+|++||.+. +|.+.|+- ...+.++...+..|+.||+.|++|||+ +=|+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEe
Confidence 89999999986 67776632 234578889999999999999999998 889999999999999776 99999
Q ss_pred eecccccccCCCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 037607 651 ADFGLSKAAPMDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKL 714 (842)
Q Consensus 651 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~ 714 (842)
+|||+++.+...-. .....++-|+.|+|||.+.+ ..||.+.|||+.|||..||++-.|.|.+..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999998864322 23456778999999999987 679999999999999999999999887643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=251.48 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=204.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+|...++||+|.||+||||+. +.++.||+|+..-. .+.-....++||.+|+.|+|.|||++++....+..+.||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455556899999999999994 56899999986543 333345689999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|. ..|..+. ...++.++.+.+..++.|+++||.++|+ +++.|||+||.|.||+.+|++|++|||+++........
T Consensus 83 cd-qdlkkyf-dslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CD-QDLKKYF-DSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hh-HHHHHHH-HhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 95 4566655 3456778999999999999999999999 99999999999999999999999999999988754322
Q ss_pred eeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHH-hCCCCCCCCCchhhhhHHHHHHHhhccccc---ccccch
Q 037607 666 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVL-CARPVINPKLPREQVSLAEWALQCHRKGIL---EKIIDP 740 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELl-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~l---~~i~d~ 740 (842)
.....-|..|++|.++.+. -|+...|+||-|||+.||. .|++.|.+....++..-+-|......+..+ .++.|-
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 2344568999999999874 5889999999999999997 588888887777766666666554444332 222221
Q ss_pred hHH---------hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 741 VIA---------ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 741 ~l~---------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
... ..+-+....+=.++.++.+.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111 1122222233456777788889999999887664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.79 Aligned_cols=238 Identities=29% Similarity=0.351 Sum_probs=193.9
Q ss_pred CcEEEEEEEEc-CCcEEEEEECCCCChhh-HHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCccccccc
Q 037607 520 GFGKVYIGVLE-DGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG 597 (842)
Q Consensus 520 ~fg~Vykg~~~-~g~~VAvK~~~~~~~~~-~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 597 (842)
+||.||+|+.. +|+.+++|+........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999988765544 68899999999999999999999999999999999999999999998843
Q ss_pred CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCC
Q 037607 598 TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677 (842)
Q Consensus 598 ~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 677 (842)
. ..+++..++.++.+++++|.|||+ .+++|+||+|+||++++++.++|+|||++....... ......++..|+
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 2 238999999999999999999999 899999999999999999999999999998765432 234456788999
Q ss_pred CcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHH
Q 037607 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEA 757 (842)
Q Consensus 678 APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l 757 (842)
+||.+.+..++.++||||||++++||++|..|+......+ .+.++... +..... ........++.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~----~~~~~~-------~~~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGK----PKPPFP-------PPEWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHhc----cCCCCc-------cccccCCHHHHHH
Confidence 9999998889999999999999999999999997632211 12222111 100000 0000034578889
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 037607 758 AEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 758 ~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.+|+..+|.+||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.99 Aligned_cols=221 Identities=19% Similarity=0.197 Sum_probs=176.8
Q ss_pred cCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCccccccc
Q 037607 519 GGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG 597 (842)
Q Consensus 519 G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 597 (842)
|.||.||++... +++.+|+|++.... ++..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999987543 234555566667899999999999999999999999999999998843
Q ss_pred CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCC
Q 037607 598 TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677 (842)
Q Consensus 598 ~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 677 (842)
...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.++++|||++...... .....++..|+
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 3468999999999999999999998 99999999999999999999999999987655321 12334567899
Q ss_pred CcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHH
Q 037607 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEA 757 (842)
Q Consensus 678 APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l 757 (842)
|||.+.+..++.++||||+||++|||++|+.|+........ ....+ .+.......+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~~~~~-------~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------THTTL-------NIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------ccccc-------CCcccCCHHHHHH
Confidence 99999888899999999999999999999987753311100 00000 0111223467889
Q ss_pred HHHhhhhCCCCCCCHHH
Q 037607 758 AEKCLAEYGVDRPGMGD 774 (842)
Q Consensus 758 ~~~Cl~~dP~~RPtm~e 774 (842)
+.+|++.+|.+||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=280.39 Aligned_cols=241 Identities=26% Similarity=0.377 Sum_probs=197.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~l 581 (842)
..+|....+||+|+||+|.+|..+ ..+.+|||++++. ...+.+--+.|-++|... +-|.+++|..++..-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888999999999999999865 4578999998865 233445567788888766 46899999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+.||+|--++ ++-+.+.+..+.-++..||-||-+||+ ++||.||||..|||||.+|++||+|||+++..-.
T Consensus 428 VMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999998888 455678888999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
+ +......+||+.|+|||.+..++|+..+|+|||||+|||||.|++||++..+.+... .+.+..
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~ehn 566 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIMEHN 566 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHHcc
Confidence 3 334567899999999999999999999999999999999999999999886654221 111110
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCC
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRP 770 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 770 (842)
-.+++....+...++...+...|.+|-
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112334455667788888999998885
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=269.90 Aligned_cols=269 Identities=23% Similarity=0.370 Sum_probs=203.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hh-hHHHHHHHHHHHHhcCCCceeeEEEeecc--------C
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDE--------Q 576 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--------~ 576 (842)
+.|+-..+||+|.||.||+|+.. .|++||+|+..... .. --....+|+.+|..|.|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555668999999999999965 57788998644322 11 22456899999999999999999998842 3
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
..++||+++|+. +|.-+| ......++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlL-sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLL-SNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHh-cCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 458999999976 566666 2334678999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCC---ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 657 KAAPMDRG---YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 657 ~~~~~~~~---~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
+....... ...+..+-|..|++||.+.+ +.|+++.|||.-||||.||+++.+-+++..+..+..++.-....+.++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87653221 22344556899999999886 689999999999999999999999998876665555554444333333
Q ss_pred ccccccchhHHhhh------------cHHHH------HHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 733 ILEKIIDPVIAETI------------CKESL------RKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 733 ~l~~i~d~~l~~~~------------~~~~~------~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.+..+..-.+...+ -++.+ ...++++.+++..||.+|+++++++....+
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 33332221111111 11222 256889999999999999999998865433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=286.24 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=197.9
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
++||.|-||+||-|+++ +|+.||||++.+. ..+...++.+|+.||..++||.||.|.-.|+..+..++|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 58999999999999965 7999999987753 3445578899999999999999999999999999999999999 567
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeecccccccCCCCCcee
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
..+.+...+.+.|++..-.-++.||+.||.|||. ++|+|+||||+||||. .-.++||||||.|+..+... -.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 7777767778899999999999999999999999 9999999999999994 34589999999999986432 23
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh-hhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE-QVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
..++||+.|+|||+++++.|...-|+||.|||+|--|.|.-||+...+.. +.+-+.+ +.-+. .
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF------------MyPp~----P 787 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF------------MYPPN----P 787 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc------------ccCCC----c
Confidence 56789999999999999999999999999999999999999998654322 1111111 11111 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+.....++++...|+..-.+|-+...-+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2333455677888888888888888776554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=301.43 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=172.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-C----CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEe------ec
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-D----GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGF------CD 574 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~----g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~------~~ 574 (842)
..++|...+.||+|+||.||+|.+. + +..||+|++...... +.+.+| .++...+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999975 4 689999987643221 111111 1222222222222211 34
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCC------------------CCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCC
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQP------------------PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~------------------~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIK 636 (842)
.....+|||||+.+++|.+++...... ...+..+..|+.|++.||+|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 667899999999999999988543210 11233456899999999999998 899999999
Q ss_pred CCCEEEcC-CCceEEeecccccccCCCCCceeeeeccCCCCCCccccccc----------------------CCCCcccc
Q 037607 637 TTNILLDE-NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ----------------------QLTEKSDV 693 (842)
Q Consensus 637 p~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------------------~~s~ksDV 693 (842)
|+|||+++ ++.+||+|||+++.......+......+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 67999999999987654444444566789999999965422 24457799
Q ss_pred hhHHHHHHHHHhCCCCCCCCCchh-------hhhHHHHHHHhhcccccccccchhHHhh--hcHHHHHHHHHHHHHhhhh
Q 037607 694 YSFGVVLFEVLCARPVINPKLPRE-------QVSLAEWALQCHRKGILEKIIDPVIAET--ICKESLRKYVEAAEKCLAE 764 (842)
Q Consensus 694 wS~GvvL~ELltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~l~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~ 764 (842)
|||||+||||+++..+.+.....- ...+..|....... ..+.+... +.........+++.+||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999765543211000 01112222111100 00000000 0011123455899999999
Q ss_pred CCCCCCCHHHHHHH
Q 037607 765 YGVDRPGMGDVLWN 778 (842)
Q Consensus 765 dP~~RPtm~evl~~ 778 (842)
||.+|||+.|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=309.56 Aligned_cols=210 Identities=25% Similarity=0.328 Sum_probs=185.1
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeec
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~ 574 (842)
...+++.-..+|.+.++||+|+||.|..++++ .++.+|+|++++. .......|..|-.+|..-..+-|+.|.-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34566666789999999999999999999975 5788999998762 2334567999999999989999999998899
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
+...+|||||||+||+|..++.+. .++++..++-++..|.-||.-||+ .|+|||||||+|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999998433 389999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCccccc----c-cCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFR----R-QQLTEKSDVYSFGVVLFEVLCARPVINPK 713 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~----~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~ 713 (842)
.|-.+..+..-.+...+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 99877666555666778999999999986 2 67999999999999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=293.36 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=183.1
Q ss_pred hcCcccceEEeecCcEEEEEEEE-----------------cCCcEEEEEECCCCChhhHHHH--------------HHHH
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-----------------EDGNKVAIKRGNPGSEQGINEF--------------QTEI 555 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-----------------~~g~~VAvK~~~~~~~~~~~~f--------------~~Ei 555 (842)
.++|++.++||+|+||.||+|.+ ..++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 67899999999999999999964 2356799999875443333333 4477
Q ss_pred HHHHhcCCCce-----eeEEEeecc--------CCeEEEEEEecCCCCcccccccCC----------------------C
Q 037607 556 QMLSKLRHRHL-----VSLIGFCDE--------QSEMILVYEYMANGPFRDHLYGTN----------------------Q 600 (842)
Q Consensus 556 ~il~~L~HpnI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~ 600 (842)
.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888876654 677888753 356899999999999999886421 1
Q ss_pred CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcc
Q 037607 601 PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680 (842)
Q Consensus 601 ~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE 680 (842)
..++|..++.++.|++.+|+|||+ .+|+||||||+|||++.++.+||+|||+++..............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 235678899999999999999998 89999999999999999999999999999765432222222233578999999
Q ss_pred cccccCC----------------------CCcccchhHHHHHHHHHhCCC-CCCCCCchh------hhhHHHHHHHhhcc
Q 037607 681 YFRRQQL----------------------TEKSDVYSFGVVLFEVLCARP-VINPKLPRE------QVSLAEWALQCHRK 731 (842)
Q Consensus 681 ~l~~~~~----------------------s~ksDVwS~GvvL~ELltG~~-p~~~~~~~~------~~~l~~~~~~~~~~ 731 (842)
.+..... ..+.||||+||+++||++|.. |+....... ...+..|... ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cc
Confidence 8754321 235799999999999999875 554321111 1112222211 00
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCC---CCCCCHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYG---VDRPGMGDVLWNL 779 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPtm~evl~~L 779 (842)
... +- ...........+++.+++..+| .+|++++|+++.-
T Consensus 459 ~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 459 QKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred cCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 000 00 0111234567788889998766 6899999998653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=289.35 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=196.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++.|.....+|.|+|+.|-++... +++..++|++.... .+-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3667888888999999999999854 67889999987652 2346778777666 6999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE-cCCCceEEeecccccccCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL-DENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl-d~~~~~kl~DFGla~~~~~~ 662 (842)
|++.++-|.+.+..+. .+. .++..|+.+|+.++.|||+ +++|||||||+|||+ +..++++|+|||.++....+
T Consensus 396 e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998888774322 222 7788899999999999999 999999999999999 68999999999999887544
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
....+-|..|.|||++....|++++|+||||++|||||+|+.|+...... .. +......+.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~--------- 530 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPK--------- 530 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCc---------
Confidence 23345688999999999999999999999999999999999999865432 11 111111111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+.........+++.+||+.+|.+||+|.++...-+.
T Consensus 531 ---~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ---FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 112334567789999999999999999999876554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=265.78 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=193.5
Q ss_pred ceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 513 NAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
...||.|.||+|+|-.++ .|+.+|||++.... +...++++.|.+...+- +.||||+++|.+..++..++.||+|. .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 346999999999999865 68999999987654 35667888888765544 78999999999999999999999995 4
Q ss_pred Ccccc---cccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 590 PFRDH---LYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 590 sL~~~---l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
||..+ ++......+++.-+-.|.....+||.||.+ ...||||||||+|||||..|.+||||||++-..... ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence 55443 344566788898889999999999999998 578999999999999999999999999998655321 22
Q ss_pred eeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 667 STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
.+...|-..|||||.+.. ..|+-++||||||++|+|+.||+-|+..-.. +.+.+.+..... -..+. ..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gd-pp~l~----~~ 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGD-PPILL----FD 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCC-CCeec----Cc
Confidence 344567788999999864 4588999999999999999999999875422 222222211111 11110 11
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.-+.+....+++++..|+..+-.+||...++.++-
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 12234456788899999999999999999987653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=272.71 Aligned_cols=256 Identities=24% Similarity=0.332 Sum_probs=194.4
Q ss_pred hcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECC--CCChh-----hHHHHHHHHHHHHhcCCCceeeEEEeec-cCC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN--PGSEQ-----GINEFQTEIQMLSKLRHRHLVSLIGFCD-EQS 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~--~~~~~-----~~~~f~~Ei~il~~L~HpnIv~l~g~~~-~~~ 577 (842)
.++|-..++||+|||+.|||+. +...+-||+|+-. +...+ -.+...+|..|-+.|.||.||++++|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567778899999999999998 4567789999733 22111 1245678999999999999999999995 567
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeecc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFG 654 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFG 654 (842)
.+|-|+|||+|.+|+-+| +..+.++++++..|+.||..+|.||.+ -..+|||-||||.|||| +..|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 799999999999999888 666789999999999999999999997 45789999999999999 457899999999
Q ss_pred cccccCCCCCc------eeeeeccCCCCCCcccccc----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 037607 655 LSKAAPMDRGY------VSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW 724 (842)
Q Consensus 655 la~~~~~~~~~------~~~~~~gt~~Y~APE~l~~----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~ 724 (842)
|++.+..+... ......||++|++||.+.- ...+.|+||||+|||+|..+.|+.||...... ..+.+.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhh
Confidence 99988644321 2345679999999998753 35788999999999999999999999865422 222211
Q ss_pred HHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 037607 725 ALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776 (842)
Q Consensus 725 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl 776 (842)
- .+...-+ ..-..-+....+...++++||+..-++|....++.
T Consensus 697 N-------TIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N-------TILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h-------chhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 1100000 00000112234566788999999999998766554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=277.40 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=204.6
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCc-EEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGN-KVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~-~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.+++....||-||||.|=........ .+|+|.+++. ...+.+....|-++|.+++.|.||+|+..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34445557999999999988875433 3788876653 4555677889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|-|-||.|...| ..++.++..+..-++..+.+|++|||+ ++||.|||||+|.+||.+|-+||.|||+|+.....
T Consensus 500 EaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 500 EACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred HhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 999999999999 556789999999999999999999999 99999999999999999999999999999987543
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
..+-.++||+.|.|||.+.++..+..+|.||||+++||||+|+|||.+.++...-+++ -+| +..
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------LkG-id~------- 637 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------LKG-IDK------- 637 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------Hhh-hhh-------
Confidence 3566899999999999999999999999999999999999999999987654322221 111 111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWNLEY 781 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~Le~ 781 (842)
-.++........+++++.+..+|.+|-- +.||-+..++
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 1223334455677888888999999975 4555554443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=256.05 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=197.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|...++||+|+|.+|..+.+. +.+.+|+|++++. ..+++.=.+.|-.+..+. +||.+|.|..+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 478999999999999999999865 5778999987653 344445567788887776 69999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|.||.+||+|--++ +++.+|+++.+.-....|.-+|.|||+ .|||.||||..|+|||..|.+||.|+|+++..-.
T Consensus 329 vieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999997776 667789999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCC-chhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKL-PREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
+ +-....++||+.|.|||.+++..|...+|.|++||+|+||+.|+.||+--. .....+-.++..+..-+..+.
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----- 477 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----- 477 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-----
Confidence 3 334567899999999999999999999999999999999999999998432 112223333333332221111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCC
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRP 770 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 770 (842)
++.....+...++..-|+.||.+|-
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1122233445567777888888774
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=260.52 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=203.6
Q ss_pred cccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----CeEEE
Q 037607 510 FDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SEMIL 581 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~~~l 581 (842)
.+..+.||-|.||.||.... ++|+.|++|++... +-...+.+.+|+++|..++|.|++..++..... .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44556899999999999985 58999999987653 333457889999999999999999998766433 35788
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
+.|.|. .+|+..+ .....|+-..+.-+..||++||+|||+ .+|.||||||.|.|++.+..+|||||||++....
T Consensus 135 ~TELmQ-SDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 999985 4788777 455678888999999999999999999 9999999999999999999999999999999877
Q ss_pred CCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------Hhhccc
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL--------QCHRKG 732 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~ 732 (842)
+....++..+-|..|+|||.+++ +.|+.+.||||.|||+.||+..+..|+...+.++..++.-.. ....+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 76666777778899999999997 679999999999999999999999999888877766543211 111122
Q ss_pred ccccccc-----hhHHh--hhc--HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 733 ILEKIID-----PVIAE--TIC--KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 733 ~l~~i~d-----~~l~~--~~~--~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.-..++. |.+.. .+. ...-.+-..+.++++..+|..|.+-.+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111 00000 000 11123456677788999999999988877543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=272.35 Aligned_cols=212 Identities=25% Similarity=0.411 Sum_probs=177.2
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.-|..++.||-|+||+|.++.. ++...+|+|.+.+.. +......+.|-.||.....+-||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4567778899999999999974 456678999877653 334456788999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC--C
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP--M 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~--~ 661 (842)
||++||++-.+|. +.+-+.+..++-++..+..|+++.|. .|+|||||||+|||||.+|++||.|||||.-+. .
T Consensus 709 dYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999884 34568888888899999999999998 999999999999999999999999999987431 0
Q ss_pred CC------C---------------------------------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHH
Q 037607 662 DR------G---------------------------------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 702 (842)
Q Consensus 662 ~~------~---------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~E 702 (842)
+. . ......+||..|+|||++....++.-+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00 0 01124569999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCchh-hhhHHHH
Q 037607 703 VLCARPVINPKLPRE-QVSLAEW 724 (842)
Q Consensus 703 LltG~~p~~~~~~~~-~~~l~~~ 724 (842)
|+.|++||....+.+ +..+..|
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeeh
Confidence 999999998766544 3344555
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=239.06 Aligned_cols=210 Identities=38% Similarity=0.609 Sum_probs=183.2
Q ss_pred EeecCcEEEEEEEEcC-CcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCccc
Q 037607 516 IGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRD 593 (842)
Q Consensus 516 LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (842)
||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998766443 45679999999999999999999999999899999999999999999
Q ss_pred ccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccccccCCCCCceeeeecc
Q 037607 594 HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKAAPMDRGYVSTAVKG 672 (842)
Q Consensus 594 ~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 672 (842)
++.... ..+++..++.++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 884322 468999999999999999999999 89999999999999999 89999999999887643321 1233557
Q ss_pred CCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHH
Q 037607 673 SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751 (842)
Q Consensus 673 t~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 751 (842)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 752 RKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 752 ~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457789999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=281.42 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=186.5
Q ss_pred cccceEEeecCcEE-EEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEecC
Q 037607 510 FDENAVIGVGGFGK-VYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 510 f~~~~~LG~G~fg~-Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
|...+++|.|+-|+ ||+|..+ |+.||||++..... .-..+||..|+.- +|||||++++.=.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44455789998876 7999995 88999999775432 3457999999887 69999999987788888999999995
Q ss_pred CCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-----CCceEEeecccccccC
Q 037607 588 NGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAAP 660 (842)
Q Consensus 588 ~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-----~~~~kl~DFGla~~~~ 660 (842)
.+|.+++... ......-...+.+..|++.||++||+ .+||||||||.||||+. ..+++|+|||+++...
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999552 11111214557889999999999999 99999999999999965 3588999999999886
Q ss_pred CCCCce--eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 661 MDRGYV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 661 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.+.... .....||-||+|||++....-+.++||+|+|||+|+.++| .+||......+ .++. ..+..+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl------~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL------TGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh------cCccceeee
Confidence 544322 3456799999999999998888999999999999999886 89997654332 1111 001111111
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
. + ..++ +..+++.+|++.+|..||++.+|+.
T Consensus 736 ~-~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 E-P------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c-c------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 0 1111 6778999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=238.39 Aligned_cols=199 Identities=34% Similarity=0.511 Sum_probs=173.4
Q ss_pred cccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 510 FDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
|...+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567789999999999999865 889999998876544 67889999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++..... .+++..+..++.+++++|.+||+ .+++|+||+|.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999998843321 28899999999999999999999 8999999999999999999999999999887754321122
Q ss_pred eeeccCCCCCCcccc-cccCCCCcccchhHHHHHHHHHhCCCCCCC
Q 037607 668 TAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPVINP 712 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l-~~~~~s~ksDVwS~GvvL~ELltG~~p~~~ 712 (842)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=233.89 Aligned_cols=200 Identities=22% Similarity=0.303 Sum_probs=163.8
Q ss_pred cccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEec
Q 037607 510 FDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
......||+|+||.|=+-++ .+|+..|+|++... ..+..++.++|+.+..+. .+|.+|.++|........++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 33445699999999988875 47999999998754 344556788899877665 7999999999999999999999999
Q ss_pred CCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 587 ANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 587 ~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
. .||..+-.+ +.+..+++.-+-+|+..+.+||.|||+ ...+||||+||+||||+.+|++|+||||.+-...+.-
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi- 203 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI- 203 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence 5 467655422 456778899999999999999999998 5789999999999999999999999999987654321
Q ss_pred ceeeeeccCCCCCCcccccc----cCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 037607 665 YVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVINPKL 714 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~ 714 (842)
..+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|++...
T Consensus 204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 1223457778999998753 478999999999999999999999997543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-27 Score=241.61 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=191.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------Ce
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------SE 578 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~~ 578 (842)
.+|.....+|.|.- .|.-+... .+++||+|++... .....++..+|...+..+.|+|+++++.++... .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555667777776 45445432 5789999986543 233446778999999999999999999998543 45
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.|+|||||. .+|...++ ..++.+++..|..|++.|++|||+ .+|+||||||+||++..++.+||.|||+++.
T Consensus 96 ~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence 799999995 58888774 456778999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH---------HHHHhh
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE---------WALQCH 729 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~---------~~~~~~ 729 (842)
...+ ...+....|.-|+|||++.+..+.+.+||||+||++.||++|+-.|.+....++..... +..++.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 6544 45567778999999999999889999999999999999999999888654433211110 000000
Q ss_pred ccc-------------cccc-ccchhHHh--hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 730 RKG-------------ILEK-IIDPVIAE--TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 730 ~~~-------------~l~~-i~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+ ...+ ..|..... +..+-......+++.+||..+|++|-+..++|+.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 0000 00100000 0111223456789999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=255.86 Aligned_cols=196 Identities=23% Similarity=0.422 Sum_probs=168.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhcC---CCceeeEEEeecc
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKLR---HRHLVSLIGFCDE 575 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~ 575 (842)
..|...+.||+|+||.|+.|+++ +...|+||.+.+.. ...+-..-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888899999999999999976 45678999876531 111223557999999997 9999999999999
Q ss_pred CCeEEEEEEec-CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 576 QSEMILVYEYM-ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 576 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
++.+||+||-. ++.+|.+++ ...+.+++.++..|..|++.|+++||+ ++|||||||-+|+.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 99999999976 567888888 566789999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCC
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIN 711 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~ 711 (842)
.+...... ....++||.+|.|||++.+.+| ...-|||++|++||.++....|+.
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765432 2456789999999999998776 567899999999999998887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=242.72 Aligned_cols=132 Identities=26% Similarity=0.397 Sum_probs=114.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-----C---CceeeEEEeec----
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-----H---RHLVSLIGFCD---- 574 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-----H---pnIv~l~g~~~---- 574 (842)
.+|.+.++||-|.|++||++... +.+-||+|+.+.. ..-.+..+.||++|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999854 5678999997754 233456789999999994 3 47999999995
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD 643 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld 643 (842)
.+.+.|||+|++ |.+|..+|.....+.++...+.+|+.||+.||.|||.. .+|||-||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 466899999999 77899999777888999999999999999999999994 5899999999999993
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=226.39 Aligned_cols=259 Identities=20% Similarity=0.312 Sum_probs=195.4
Q ss_pred hcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccC--CeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQ--SEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~--~~~~lV 582 (842)
.++|++.+++|+|.|+.||.|. ..+.++++||.+++... +.+.+|+.+|..|+ ||||+.|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4688999999999999999998 46789999999987543 56899999999997 99999999988654 457899
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccccccCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKAAPM 661 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~~~~ 661 (842)
+||..+.+...+. +.|+..++.....++++||.|+|+ +||.|||+||.|++||. ...++|+|+|||..+-.
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999887665543 567888899999999999999999 99999999999999985 55799999999998754
Q ss_pred CCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc------cc
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG------IL 734 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~l 734 (842)
... ....+.+..|.-||.+-. +.|+..-|+|||||+|.+|+..+.||-...... .+++..+.-+-.+. ..
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHHH
Confidence 332 233445677889998865 678899999999999999999998875443221 22332222111110 01
Q ss_pred ccccchhHHh-----------h-h---cHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 735 EKIIDPVIAE-----------T-I---CKE-SLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 735 ~~i~d~~l~~-----------~-~---~~~-~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.--+||.... . + ... ...+.++++.+.|.-|-.+|||++|....-
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 1113332211 0 0 001 125678999999999999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=227.72 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=187.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEe-eccCCeEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGF-CDEQSEMILV 582 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~-~~~~~~~~lV 582 (842)
..+.|.+.+.||+|.||.+.++.++ ..+.+++|-+... ....++|.+|..---.| .|.||+.-++. |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3457888889999999999999986 4567888876543 33458899999866566 58999987764 5677788999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE-c-CCCceEEeecccccccC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL-D-ENLVAKVADFGLSKAAP 660 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl-d-~~~~~kl~DFGla~~~~ 660 (842)
+||++.|+|..-+ ....+-+....+++.|++.||.|+|+ +++||||||.+|||| + +..++||||||+.+...
T Consensus 101 qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999877 33567888899999999999999999 999999999999999 3 34489999999987653
Q ss_pred CCCCceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
. .......+..|.+||.+.. -...+.+|||.||++++..|+|++||+.. ........+|..-..++ ..
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk--~~ 247 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRK--NP 247 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhccc--Cc
Confidence 2 2223445668999998753 24568899999999999999999999843 33334455554432222 22
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.+ |.....+. .++.++-++-+..++++|=...++-++.
T Consensus 248 ~~--P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 AL--PKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cC--chhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 21 22222232 3455666778899999995555554443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=248.14 Aligned_cols=273 Identities=21% Similarity=0.233 Sum_probs=207.5
Q ss_pred cccHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC------CCceeeE
Q 037607 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR------HRHLVSL 569 (842)
Q Consensus 497 ~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~------HpnIv~l 569 (842)
.+.+.-....-..|.+....|+|-|++|.+|... .|+.||||++... +...+.=+.|+++|++|+ --|+++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 4444455566788999999999999999999864 4789999998865 334455688999999995 2489999
Q ss_pred EEeeccCCeEEEEEEecCCCCcccccccC-CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-Cc
Q 037607 570 IGFCDEQSEMILVYEYMANGPFRDHLYGT-NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LV 647 (842)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~ 647 (842)
+-.|...+++|||+|-+ ..+|.+.|..- .+-.|....+..++.|+.-||..|.. .+|+|.||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 99999999999999987 46899988442 34578889999999999999999998 899999999999999875 57
Q ss_pred eEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-
Q 037607 648 AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL- 726 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~- 726 (842)
+||||||.|....... .+...-+.-|.|||.+.+.+|+...|+||.||+||||.||+-.|.+........+..-+.
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 8999999987764322 223334567999999999999999999999999999999999998876554433321111
Q ss_pred ----Hhhcccc---------------------------cccccch------hHHh--hh---cHHHHHHHHHHHHHhhhh
Q 037607 727 ----QCHRKGI---------------------------LEKIIDP------VIAE--TI---CKESLRKYVEAAEKCLAE 764 (842)
Q Consensus 727 ----~~~~~~~---------------------------l~~i~d~------~l~~--~~---~~~~~~~l~~l~~~Cl~~ 764 (842)
.+.+++. +...+.| .|.. .+ .......|.+|+.+|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 1111110 1111112 1111 01 123467889999999999
Q ss_pred CCCCCCCHHHHHH
Q 037607 765 YGVDRPGMGDVLW 777 (842)
Q Consensus 765 dP~~RPtm~evl~ 777 (842)
||++|.+..+.|+
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999988775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=257.46 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=202.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
...+|+....+|.|.||.|||++. ..++..|+|+++.....+..-.++||-+++..+||||+.++|-+...+.+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 346788889999999999999995 4789999999887777777788899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||.+|+|.+.-+ -..++++.++...+...++||+|||+ ++-+|||||-.|||+++.+.+|++|||.+-.+...-
T Consensus 93 ycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred ecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 999999999774 34689999999999999999999999 888999999999999999999999999876553211
Q ss_pred ceeeeeccCCCCCCcccc---cccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch-
Q 037607 665 YVSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP- 740 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l---~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~- 740 (842)
.....+.||+.|||||+. +.+.|.+++|||++|+...||---.+|.-...+-.. + .+..+. ..+|
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l-----~LmTkS----~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--L-----FLMTKS----GFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--H-----HHhhcc----CCCCC
Confidence 123467899999999985 357899999999999999999877776643322111 1 111111 1111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.+.. ...-...+-++++.|+..+|.+||++..+++
T Consensus 236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1122456778899999999999999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=236.05 Aligned_cols=201 Identities=26% Similarity=0.392 Sum_probs=167.7
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCC
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQS 577 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~ 577 (842)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+.. ....+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4456678999999999999999999854 3578999998876544 56899999999995 899999999999999
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLS 656 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla 656 (842)
..++|+||+++....+++ ..++..++...+..++.||+++|. +|||||||||+|+|.+. .+.-.|.|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 999999999998888877 346678899999999999999999 99999999999999974 567889999999
Q ss_pred cccCCCC---------------------------------Cc----------eeeeeccCCCCCCcccccc-cCCCCccc
Q 037607 657 KAAPMDR---------------------------------GY----------VSTAVKGSFGYLDPEYFRR-QQLTEKSD 692 (842)
Q Consensus 657 ~~~~~~~---------------------------------~~----------~~~~~~gt~~Y~APE~l~~-~~~s~ksD 692 (842)
....... ++ ......||+||+|||++.+ ...+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221000 00 0113359999999999875 67889999
Q ss_pred chhHHHHHHHHHhCCCCCCCC
Q 037607 693 VYSFGVVLFEVLCARPVINPK 713 (842)
Q Consensus 693 VwS~GvvL~ELltG~~p~~~~ 713 (842)
|||.|||++-+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=274.95 Aligned_cols=196 Identities=19% Similarity=0.247 Sum_probs=140.1
Q ss_pred hcCC-CceeeEEEee-------ccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceE
Q 037607 560 KLRH-RHLVSLIGFC-------DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631 (842)
Q Consensus 560 ~L~H-pnIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iv 631 (842)
.++| +||++++++| .....+++++||+ +++|.++|.. ....+++.+++.++.||++||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4556 6888888887 2334678889988 5699999953 34569999999999999999999998 9999
Q ss_pred eccCCCCCEEEcC-------------------CCceEEeecccccccCCCC---------------CceeeeeccCCCCC
Q 037607 632 HRDVKTTNILLDE-------------------NLVAKVADFGLSKAAPMDR---------------GYVSTAVKGSFGYL 677 (842)
Q Consensus 632 HrDIKp~NILld~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~Y~ 677 (842)
||||||+||||+. ++.+|++|||+++...... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4455666666665321100 00011235788899
Q ss_pred CcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHH
Q 037607 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEA 757 (842)
Q Consensus 678 APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l 757 (842)
|||++.+..++.++|||||||+||||++|.+|+..... .+..+.. ....+... ....+...+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~---------~~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH---------RVLPPQIL-----LNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH---------hhcChhhh-----hcCHHHHHH
Confidence 99999999999999999999999999999887642210 0111100 01111110 112345677
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 037607 758 AEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 758 ~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.+||+.+|.+||+|.|+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=211.74 Aligned_cols=259 Identities=19% Similarity=0.228 Sum_probs=208.9
Q ss_pred hcCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC-CceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH-RHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H-pnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.++||.|+||.+|.|. ..+|+.||||........ .++..|..+.+.|+| ..|..+.-|..+...-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999998 568999999987655433 567899999999986 556666677788889999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~~~~ 661 (842)
.+ |.+|++++ .-....++.++++-++-|++.-++|+|. +++|||||||+|+|.. ....+.++|||||+.+-+
T Consensus 92 LL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 78888876 4456778999999999999999999999 9999999999999994 456899999999998754
Q ss_pred CCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 662 DRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 662 ~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
..+. ......||.+|.+-..+.+...+.+.|+-|+|.+|.++..|..||++.......+-.+.+ .
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---------~ 237 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---------S 237 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---------H
Confidence 3221 234567999999999999999999999999999999999999999987655443332222 2
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+..-....+.+|+..+.++...+.-|-...-++-|...-+.+...-
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 2222233445677778888888999999999999998776665443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=226.67 Aligned_cols=262 Identities=21% Similarity=0.240 Sum_probs=199.3
Q ss_pred CcccceEEeecCcEEEEEEEEcCC--cEEEEEECCCCChhhHHHHHHHHHHHHhcCC----CceeeEEEee-ccCCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLEDG--NKVAIKRGNPGSEQGINEFQTEIQMLSKLRH----RHLVSLIGFC-DEQSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~g--~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H----pnIv~l~g~~-~~~~~~~l 581 (842)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 4789998665433322368889999999973 6899999888 57778999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-----CceEEeecccc
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-----LVAKVADFGLS 656 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-----~~~kl~DFGla 656 (842)
||+.+ |.+|.++........++..+.+.|+.|++.+|++||+ .|++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 8899997754446789999999999999999999999 999999999999999754 46999999999
Q ss_pred c--ccCCCCCc------e-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 657 K--AAPMDRGY------V-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 657 ~--~~~~~~~~------~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
+ ........ . .....||..|+++.++.+...+.+.|+||++.++.||+.|..||........... ...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HHH
Confidence 8 43222211 1 2345699999999999999999999999999999999999999976543221110 000
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
...+..... ........+.++...+-..+..++|....+...|+......
T Consensus 252 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred Hhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000000000 11223345666666667789999999999999988776554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=208.34 Aligned_cols=168 Identities=22% Similarity=0.250 Sum_probs=126.3
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
|+|.+++.. ...+++|.+++.|+.|+++||+|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 688888843 34579999999999999999999998 44 999999999999999 99988754322
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
..|++.|||||++.+..++.++|||||||++|||++|++||....... ..+..+......... . +. ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~-~---~~----~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPADDP-R---DR----SNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccCCc-c---cc----ccHH
Confidence 258899999999999999999999999999999999999986543211 111111111111100 0 00 0011
Q ss_pred HHH--HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 749 ESL--RKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 749 ~~~--~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
... ..+.+++.+|++.+|.+||++.|+++.+....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 111 36899999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=210.19 Aligned_cols=265 Identities=18% Similarity=0.225 Sum_probs=210.0
Q ss_pred cCcccceEEeecCcEEEEEEE-EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~-~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
-.|.+.++||+|.||+.+.|+ +-+++.||||.....++. .++..|.+.++.|. .++|...+-+..++.+..||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368899999999999999998 558999999986655543 56889999999985 58888888677788889999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-----CCceEEeecccccccC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAAP 660 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-----~~~~kl~DFGla~~~~ 660 (842)
+ |.||+|++ .-+...++.+++..||+|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||||+.+.
T Consensus 106 L-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 78898876 4567789999999999999999999999 99999999999999953 3468999999999886
Q ss_pred CCCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 661 MDRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 661 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+..+. ......||.+||+-..+.++..+.+.|+-|+|-++++.|-|..||++........-.+ .+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe---------KI 251 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE---------KI 251 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---------Hh
Confidence 54432 2345679999999999999999999999999999999999999999865432111111 12
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
.+-........+|...+.++..-+.-.-..+-++-|..+-+...+...+.....
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 222222334456666667777777777788999999998877777666554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=224.56 Aligned_cols=167 Identities=21% Similarity=0.196 Sum_probs=130.8
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEc--CCcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLE--DGNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~--~g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
......+|...+.||+|+||+||+|.+. +++.+|||++... .....+.|.+|+++|++|+|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3455678999999999999999999864 5778899986533 223356799999999999999998533222
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccC-CCCCEEEcCCCceEEeecc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV-KTTNILLDENLVAKVADFG 654 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDI-Kp~NILld~~~~~kl~DFG 654 (842)
+..+|||||+++++|.... .. . ...++.+++++|.|||+ ++|+|||| ||+|||++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~--~~-~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR--PH-G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC--cc-c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4689999999999996321 11 1 14678899999999999 99999999 9999999999999999999
Q ss_pred cccccCCCCCc-------eeeeeccCCCCCCcccccc
Q 037607 655 LSKAAPMDRGY-------VSTAVKGSFGYLDPEYFRR 684 (842)
Q Consensus 655 la~~~~~~~~~-------~~~~~~gt~~Y~APE~l~~ 684 (842)
+|+........ ..+...+++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99976532211 1135668889999999864
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-24 Score=211.35 Aligned_cols=152 Identities=18% Similarity=0.332 Sum_probs=100.5
Q ss_pred EEEEEeeCCCccccCCCcccccccCCCcccccCCCCcceecCCce--e-EeCCCCCCCCcCChHHHHHhhccccccCCCc
Q 037607 206 VSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKN--V-HYPDGGATPYIAPNWVYASAQKMKEAQVMQP 282 (842)
Q Consensus 206 ~~~rin~Gg~~~~~~~d~~~r~w~~d~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~p~~~Y~tar~~~~~~~~~~ 282 (842)
++|||||||+.. .|.....|.+|..|.-... .+..+.+ . ..........+.++.||+|+|....
T Consensus 1 ~~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~~----~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~------ 67 (174)
T PF11721_consen 1 VVLRINAGGPAY---TDSSGIVWEADQYYTGGSW----GYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS------ 67 (174)
T ss_dssp EEEEEEETSSSE---EETTTEEE-SSSSSTTSS---------------SSTTS--TTS-HHHHHTTT-----SS------
T ss_pred CEEEEECCCCcc---cCCCCCEEcCCCCCCCCCc----ccccccccccccccccccccCCCchhhhHhhcCCCC------
Confidence 479999999999 6678889999998732222 1111100 0 0111123345566779999999765
Q ss_pred ceeeEEEEeeCCCCceEEEEeeecccccc------CCcEEEEEEEcCccccCCCChhhhccccCceEEEEE-EEEecccC
Q 037607 283 NFNLTWKMSVDPSFSYLIRFHFCDIVSKS------LNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDF-VLNATAVK 355 (842)
Q Consensus 283 ~~~lt~~~~v~~~~~y~vrlhF~ei~~~~------~~~r~Fdiyi~~~~~~~~~di~~~~~~~~~~~~~~~-~v~~~~~~ 355 (842)
+++|.+||.++|.|.|+|||||+++.. .|+|+|||+|||++++++|||.+++|+..+|+++.| .|.+ +
T Consensus 68 --~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v---~ 142 (174)
T PF11721_consen 68 --SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTV---T 142 (174)
T ss_dssp --SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEE---E
T ss_pred --ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEE---e
Confidence 699999999999999999999999888 999999999999999999999999999998888777 8888 6
Q ss_pred CcceEEEeccCCCCCCCCcc
Q 037607 356 NDSITVQVGPASNAQSSLPN 375 (842)
Q Consensus 356 ~~~l~i~~~p~~~~~~~i~~ 375 (842)
++.|+|+|.|..++...|+.
T Consensus 143 dg~L~i~f~~~~~~~~~i~~ 162 (174)
T PF11721_consen 143 DGTLNIQFVWAGKGTLCIPF 162 (174)
T ss_dssp TTEEETTEEEE--SEEEEEE
T ss_pred CCcEEEEEEecCCCcEEeec
Confidence 89999999998886655543
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=209.73 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=191.5
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
.+|.+...|..|+|+++ |..++.|+++.. ...-.++|..|.-.|+-+.||||++++|.|.....+.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 36888999999999997 445666766543 333347899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeec
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 671 (842)
...||+...--.+..++.++++++|+|++|||+. ..-|..--|.+..+++|++.+++|+- +-.+. ..+.....
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~gr~ 347 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEVGRA 347 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eeeccccc
Confidence 9999988777788899999999999999999982 22244456999999999999988752 11111 11222334
Q ss_pred cCCCCCCcccccccCCC---CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 672 GSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 672 gt~~Y~APE~l~~~~~s---~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
..+.||+||.++..+-+ ..+|+|||.++||||.|..-||....+-+.. .++.-..++-.+++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~ipp 412 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVHIPP 412 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccccCCC
Confidence 57899999999876544 5899999999999999999999765544321 11111123334555
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.....+.+++.-|++.||.+||.+..|+-.||+.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 6667788889999999999999999999988864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=202.91 Aligned_cols=259 Identities=30% Similarity=0.438 Sum_probs=196.9
Q ss_pred cccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh---hHHHHHHHHHHHHhcCCC-ceeeEEEeeccCCeEEEEEEe
Q 037607 510 FDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ---GINEFQTEIQMLSKLRHR-HLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~---~~~~f~~Ei~il~~L~Hp-nIv~l~g~~~~~~~~~lV~Ey 585 (842)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999976 78899987765332 367899999999999988 799999999777778999999
Q ss_pred cCCCCcccccccCCC-CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQ-PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~~~ 663 (842)
+.+++|.+.+..... ..+.......+..|++.++.|+|+ .+++||||||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966532211 378889999999999999999999 8899999999999999988 79999999998654332
Q ss_pred Cc-----eeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhccccc
Q 037607 664 GY-----VSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPR-EQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 664 ~~-----~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~l 734 (842)
.. ......|+..|+|||.+.+ .......|+||+|+++++++.|..|+...... ......+........ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 21 2456779999999999987 68889999999999999999999997655431 011111111111111 00
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...... .........+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 0001223567788899999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=227.17 Aligned_cols=255 Identities=21% Similarity=0.234 Sum_probs=191.2
Q ss_pred cceEEeecCcEEEEEEEEc-CCcEEEEEECC----CC-Chh-hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 512 ENAVIGVGGFGKVYIGVLE-DGNKVAIKRGN----PG-SEQ-GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~----~~-~~~-~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
...++|.|.+|.|+..... ..+..+.|... .. ... ....+..|+.+=..|+|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3458999999977777632 33334444322 21 111 12225677888888899999988888877777777799
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||++ +|...+ .....+...++..+..|+..|++|||+ .+|.|||||++|+++..++.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~--~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLV--MSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHH--hcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999888 333578889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ---ceeeeeccCCCCCCcccccccCCCC-cccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 665 ---YVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 665 ---~~~~~~~gt~~Y~APE~l~~~~~s~-ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......++.. ............
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~--- 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIF--- 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccc---
Confidence 4557788999999999999998885 6899999999999999999998765544321 000000111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.-...+......+...++.++|+.+|.+|-+|++|++.=+
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 0112233455667788999999999999999999987654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=191.99 Aligned_cols=172 Identities=17% Similarity=0.175 Sum_probs=135.3
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh---hHHH------HHHHHHHHHhcCCCceeeEEEeecc
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ---GINE------FQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~---~~~~------f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
...++|...++||.|+||.||.... ++..+|||.+.+.... .... +.+|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3568999999999999999999655 5778999998754322 2222 6899999999999999999888643
Q ss_pred C--------CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 576 Q--------SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 576 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
. ...+|||||++|.+|.++. .++. ....+++.+|..||+ .+++||||||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 2 3589999999999998764 1222 345689999999999 9999999999999999988
Q ss_pred eEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHH
Q 037607 648 AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELl 704 (842)
++|+|||.......+... ..+...+.+..++|+|+|||.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987655322111 11445566778999999999998765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.3e-20 Score=187.43 Aligned_cols=139 Identities=19% Similarity=0.211 Sum_probs=108.1
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh--h-------HHH-----------------HHHHHHHHHhcCCCce
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ--G-------INE-----------------FQTEIQMLSKLRHRHL 566 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~--~-------~~~-----------------f~~Ei~il~~L~HpnI 566 (842)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.|.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999987654211 0 112 2359999999988776
Q ss_pred eeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHH-HhCCCCceEeccCCCCCEEEcCC
Q 037607 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL-HTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yL-H~~~~~~ivHrDIKp~NILld~~ 645 (842)
.....+.. ...+|||||+++++|...+. ...++++.+.++++.|++.+|.|| |+ .+|+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 43332221 23489999999887765432 235788999999999999999999 67 8999999999999998 4
Q ss_pred CceEEeeccccccc
Q 037607 646 LVAKVADFGLSKAA 659 (842)
Q Consensus 646 ~~~kl~DFGla~~~ 659 (842)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-21 Score=223.36 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=183.6
Q ss_pred CcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC-ChhhHHHHHHHHHHH--HhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG-SEQGINEFQTEIQML--SKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il--~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++...+.||.+.|=+|.+|+.++|. |+||++-+. ..-.++.|.++++-+ ..++|||++++..+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777788999999999999998888 888985543 344455555555444 445899999998887777778889899
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc--CCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA--PMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~--~~~~ 663 (842)
..+ +|.|.| ..++-|..-+...|+.|++.||..+|. .+|+|||||.+||||+...-+.|+||...+.. +.++
T Consensus 103 vkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 854 899988 567778888999999999999999999 99999999999999999999999999977654 2232
Q ss_pred Ccee----eeeccCCCCCCcccccc----------cC-CCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 037607 664 GYVS----TAVKGSFGYLDPEYFRR----------QQ-LTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 664 ~~~~----~~~~gt~~Y~APE~l~~----------~~-~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~ 727 (842)
.... .....-.+|+|||.+.. .. ++++.||||+||++.||++ |+|+|.-. ++..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY--- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY--- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH---
Confidence 2222 22233458999997643 12 6789999999999999987 68888632 11111
Q ss_pred hhcccccccccchh-HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 728 CHRKGILEKIIDPV-IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 728 ~~~~~~l~~i~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+.+. -.++. +.+.+.. ..+.+++..|++.||.+|-++++.|+.-.
T Consensus 248 --r~~~---~~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 --RSGN---ADDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --hccC---ccCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1110 01111 1111221 25678889999999999999999998743
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=202.79 Aligned_cols=216 Identities=25% Similarity=0.386 Sum_probs=165.7
Q ss_pred HHhcCCCceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCce-EeccCC
Q 037607 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI-IHRDVK 636 (842)
Q Consensus 558 l~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i-vHrDIK 636 (842)
|+.+.|.|+.+++|.+.++..+++|.+||..|+|.|.+.. ....++|.....+..+|+.||+|||. .+| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence 4678999999999999999999999999999999999954 46689999999999999999999998 343 999999
Q ss_pred CCCEEEcCCCceEEeecccccccCCC-CCceeeeeccCCCCCCccccccc-------CCCCcccchhHHHHHHHHHhCCC
Q 037607 637 TTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLCARP 708 (842)
Q Consensus 637 p~NILld~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~-------~~s~ksDVwS~GvvL~ELltG~~ 708 (842)
++|+++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776421 11112223345679999998763 25778999999999999999999
Q ss_pred CCCCCCchhh-hhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 709 VINPKLPREQ-VSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 709 p~~~~~~~~~-~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
||+.....+. ..++.++.. .....+.|.+.... +....+..++..||..+|.+||+++.|-..++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9986543322 122222222 11222333333211 334478999999999999999999999877766544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=177.56 Aligned_cols=141 Identities=18% Similarity=0.203 Sum_probs=110.9
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh--------------------------hHHHHHHHHHHHHhcCCCce
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ--------------------------GINEFQTEIQMLSKLRHRHL 566 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~--------------------------~~~~f~~Ei~il~~L~HpnI 566 (842)
...||+|+||.||+|...+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3589999999999999878999999987654210 01224679999999999987
Q ss_pred eeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC
Q 037607 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~ 646 (842)
.....+... ..+|||||++++++..... ....++..+...++.|++.+|.+||+ ..+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 544433322 2489999999886544321 23467788999999999999999996 37999999999999999 78
Q ss_pred ceEEeecccccccC
Q 037607 647 VAKVADFGLSKAAP 660 (842)
Q Consensus 647 ~~kl~DFGla~~~~ 660 (842)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=205.71 Aligned_cols=200 Identities=24% Similarity=0.289 Sum_probs=162.2
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC---CCceeeEEEeeccC
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQ 576 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~ 576 (842)
..++..-...|.+.+.||+|+||+||+|...+|+.||||+-++.+... |---.+++.+|+ -+-|..+...+.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 344555667899999999999999999998889999999988765432 222223344444 12333344444566
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-------CCCceE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-------ENLVAK 649 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-------~~~~~k 649 (842)
+..+||+||.+.|+|.+++ ...+.++|..+.-++.|+++.++.||. .+|||+||||+|+||. +..-++
T Consensus 767 ~~S~lv~ey~~~Gtlld~~--N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLI--NTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CcceeeeeccccccHHHhh--ccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 7889999999999999999 477789999999999999999999999 9999999999999993 345789
Q ss_pred EeecccccccC-CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCC
Q 037607 650 VADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707 (842)
Q Consensus 650 l~DFGla~~~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~ 707 (842)
|+|||.+..+. -..+......++|-.+-.+|+..++.++...|.|.++.+++-||.|+
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99999887654 23344567788999999999999999999999999999999999996
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.3e-18 Score=170.87 Aligned_cols=186 Identities=17% Similarity=0.139 Sum_probs=139.6
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh----hHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEe
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ----GINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~----~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.+...|+.|+||+||.+.- .+.+++.+.+.....- ....|.+|+++|++|. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456899999999997765 6788888876654331 1235889999999995 5889999886 457999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccC-CCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV-KTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDI-Kp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
+.|.+|...+.. ....++.|++++|+++|+ ++|+|||| ||+|||+++++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654311 124578899999999999 99999999 79999999999999999999985442221
Q ss_pred c----e--------eeeeccCCCCCCccccccc-CCC-CcccchhHHHHHHHHHhCCCCCCCC
Q 037607 665 Y----V--------STAVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLFEVLCARPVINPK 713 (842)
Q Consensus 665 ~----~--------~~~~~gt~~Y~APE~l~~~-~~s-~ksDVwS~GvvL~ELltG~~p~~~~ 713 (842)
. . ......++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+.-..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 1122357788888754321 223 5679999999999999998776543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=170.51 Aligned_cols=135 Identities=18% Similarity=0.222 Sum_probs=105.5
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-----CCCceeeEEEeeccCC---e-EEE
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-----RHRHLVSLIGFCDEQS---E-MIL 581 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-----~HpnIv~l~g~~~~~~---~-~~l 581 (842)
.....||+|+||.||. .-.++.. +||++........+++.+|+.+++.+ .||||++++|++++.. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999996 3334454 69987765444567899999999999 5799999999998763 3 347
Q ss_pred EEEe--cCCCCcccccccCCCCCCchHHHHHHHHHHHHHH-HHHHhCCCCceEeccCCCCCEEEcC----CCceEEeecc
Q 037607 582 VYEY--MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL-HYLHTGAAQGIIHRDVKTTNILLDE----NLVAKVADFG 654 (842)
Q Consensus 582 V~Ey--~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL-~yLH~~~~~~ivHrDIKp~NILld~----~~~~kl~DFG 654 (842)
|+|| +.+|+|.+++.+ ..+++. ..++.+++.++ +|||+ ++|+||||||+|||++. +..++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 567999999933 235554 35677888777 99999 99999999999999963 3489999954
Q ss_pred c
Q 037607 655 L 655 (842)
Q Consensus 655 l 655 (842)
-
T Consensus 155 G 155 (210)
T PRK10345 155 G 155 (210)
T ss_pred C
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=174.62 Aligned_cols=232 Identities=22% Similarity=0.323 Sum_probs=149.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCC---CChhhHHHHHHHHHHHHhcCC-----------CceeeEEEe-
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNP---GSEQGINEFQTEIQMLSKLRH-----------RHLVSLIGF- 572 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~---~~~~~~~~f~~Ei~il~~L~H-----------pnIv~l~g~- 572 (842)
.+.....||.|+++.||.+++. +|+.+|||+... ......+++++|.-....+.+ .-++++--.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999975 589999997432 233456777777765555432 112222111
Q ss_pred -------eccC---C-----eEEEEEEecCCCCcccccc---c--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037607 573 -------CDEQ---S-----EMILVYEYMANGPFRDHLY---G--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632 (842)
Q Consensus 573 -------~~~~---~-----~~~lV~Ey~~~gsL~~~l~---~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivH 632 (842)
.... . ..+++|+-+ .++|.+++. . .....+....++.+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 1111 1 236788877 467877652 1 122334556678888999999999999 99999
Q ss_pred ccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccc--------cCCCCcccchhHHHHHHHHH
Q 037607 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLFEVL 704 (842)
Q Consensus 633 rDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDVwS~GvvL~ELl 704 (842)
+||||+|+|++.+|.++|+||+....... .......+..|.+||.... ..++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987665432 1111334578999997644 35788999999999999999
Q ss_pred hCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCC
Q 037607 705 CARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDR 769 (842)
Q Consensus 705 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 769 (842)
||+.||....+..... | .-..|.+.++.+..++..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~---~------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE---W------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG---G------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc---c------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999998653322110 0 111244777888999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-18 Score=193.98 Aligned_cols=186 Identities=26% Similarity=0.349 Sum_probs=156.3
Q ss_pred EEeecCcEEEEEEE----EcCCcEEEEEECCCCChh--hHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEecC
Q 037607 515 VIGVGGFGKVYIGV----LEDGNKVAIKRGNPGSEQ--GINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 515 ~LG~G~fg~Vykg~----~~~g~~VAvK~~~~~~~~--~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|+|.||.|+.+. .+.|..+|+|.+++.... .......|-.++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999665 335677888877664321 1125567888888887 9999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|.|...+ .....+++.........++-+++++|+ .+|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 99998888 455667777777788888999999999 9999999999999999999999999999987643321
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCC
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINP 712 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~ 712 (842)
.+||..|||||.+. .....+|.||||++++||++|..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 567899999999999999999999976
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=169.16 Aligned_cols=142 Identities=18% Similarity=0.190 Sum_probs=111.9
Q ss_pred CcccceEEeecCcEEEEEEE--EcCCcEEEEEECCCCChh------------------------hHHHHHHHHHHHHhcC
Q 037607 509 NFDENAVIGVGGFGKVYIGV--LEDGNKVAIKRGNPGSEQ------------------------GINEFQTEIQMLSKLR 562 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~--~~~g~~VAvK~~~~~~~~------------------------~~~~f~~Ei~il~~L~ 562 (842)
-|.+...||+|+||.||+|. ..+|+.||||+....... ....+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 568999999987643210 1123568999999997
Q ss_pred CC--ceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc-eEeccCCCCC
Q 037607 563 HR--HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG-IIHRDVKTTN 639 (842)
Q Consensus 563 Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~-ivHrDIKp~N 639 (842)
+. .+.+++++ ...++||||+++++|..... ....+...+...++.|++.+|++||+ .+ |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 53 34444443 23589999999988877652 23345666778999999999999999 88 9999999999
Q ss_pred EEEcCCCceEEeecccccccC
Q 037607 640 ILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 640 ILld~~~~~kl~DFGla~~~~ 660 (842)
|+++ ++.++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=165.56 Aligned_cols=134 Identities=26% Similarity=0.405 Sum_probs=113.2
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE--------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~--------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
+.||+|++|.||+|.+ .|..+++|+...... .....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999988 677899997654321 1124678999999999999988877777777889999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
++|++|.+++... .+ .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988321 12 788999999999999999 9999999999999999 78999999998765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=161.58 Aligned_cols=145 Identities=23% Similarity=0.219 Sum_probs=113.8
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCCh----------------------hhHHHHHHHHHHH
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE----------------------QGINEFQTEIQML 558 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~----------------------~~~~~f~~Ei~il 558 (842)
.++......|...+.||+|+||.||++...+|+.||||+...... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445778889999999999999988899999997553220 0112367899999
Q ss_pred HhcCCC--ceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCC
Q 037607 559 SKLRHR--HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636 (842)
Q Consensus 559 ~~L~Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIK 636 (842)
..+.|+ .+...++. ...++||||+++++|.+.... .....++.+++.++.++|+ .+|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence 999887 45555543 345899999999998775420 3456789999999999999 999999999
Q ss_pred CCCEEEcCCCceEEeecccccccC
Q 037607 637 TTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 637 p~NILld~~~~~kl~DFGla~~~~ 660 (842)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.2e-16 Score=186.12 Aligned_cols=139 Identities=22% Similarity=0.308 Sum_probs=113.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCCcEEEEEE-CCCC-C------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKR-GNPG-S------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS 577 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~-~~~~-~------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~ 577 (842)
....|...+.||+|+||.||+|.+.+.. +++|+ .... . ....+++.+|++++++++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445566789999999999999876443 44443 2211 1 112356889999999999999998888887777
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++||||+++++|.+++. ....++.+++++|.+||+ .+++||||||+|||+ +++.++|+|||+++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 8899999999999998873 467899999999999999 999999999999999 67899999999987
Q ss_pred cc
Q 037607 658 AA 659 (842)
Q Consensus 658 ~~ 659 (842)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 63
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=160.37 Aligned_cols=130 Identities=28% Similarity=0.401 Sum_probs=106.1
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.||+|+||.||+|.+ +|..+++|+..... .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999996 57889999855421 112356789999999999887655555555666789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
+|++|.+.+.... ..++.+++++|.+||+ .+++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773211 0889999999999999 9999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6e-17 Score=179.64 Aligned_cols=172 Identities=27% Similarity=0.425 Sum_probs=129.0
Q ss_pred CeEEEEEEecCCCCccccccc-CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 577 SEMILVYEYMANGPFRDHLYG-TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
..+++.|++|+..+|.++|.+ ......++...+.++.|++.|++| ++.+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 357999999999999999963 345567888999999999999999 6799999999999999999999999999
Q ss_pred ccccCCCC-----CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 037607 656 SKAAPMDR-----GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730 (842)
Q Consensus 656 a~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~ 730 (842)
........ ....+...||..||+||.+.+..|+.|+||||||++|+||+.- |.... + +
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~--e------------r 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQF--E------------R 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHH--H------------H
Confidence 87765443 2345677899999999999999999999999999999999961 11111 1 0
Q ss_pred ccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 731 KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 731 ~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.+.+.++-|..+.+.+..+ ..+=..++++++.+.|.+||+.
T Consensus 466 ~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchH
Confidence 0111222222111111111 1223467889999999999943
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.8e-16 Score=182.38 Aligned_cols=207 Identities=25% Similarity=0.349 Sum_probs=144.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.+|+.++.|..|+||.||..+++ ..+++|+|. ++.... .++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee-------------------
Confidence 57888899999999999999876 467788843 322111 011 33333444444
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC---
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--- 663 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~--- 663 (842)
|+-...+ +..++++... +.+++|||+ .+|+|||+||+|.||..-|++|+.|||+++...+..
T Consensus 136 --gDc~tll--k~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLL--KNIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhc--ccCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 2223333 2223333222 678999999 999999999999999999999999999988653211
Q ss_pred -----------CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 664 -----------GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 664 -----------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
......++||+.|+|||++..+.|...+|+|++|+|+||.+-|+-||.+..+++....+- ....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi-----sd~i 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-----SDDI 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh-----hhhc
Confidence 122346789999999999999999999999999999999999999999887665322110 0000
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP 770 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 770 (842)
.+. +-......+..+++.+.|+.+|..|-
T Consensus 276 ~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWP---------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccc---------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 000 11223345667888899999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-15 Score=160.74 Aligned_cols=194 Identities=20% Similarity=0.207 Sum_probs=134.8
Q ss_pred CCCceeeEEEeecc---------------------------CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHH
Q 037607 562 RHRHLVSLIGFCDE---------------------------QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG 614 (842)
Q Consensus 562 ~HpnIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ 614 (842)
+|||||++.+.|.+ ...+|+||.-++ .+|++++.. ...+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence 59999999876632 245789998875 478888732 34566677889999
Q ss_pred HHHHHHHHHhCCCCceEeccCCCCCEEE--cC--CCceEEeecccccccCCC---CCce--eeeeccCCCCCCccccccc
Q 037607 615 SARGLHYLHTGAAQGIIHRDVKTTNILL--DE--NLVAKVADFGLSKAAPMD---RGYV--STAVKGSFGYLDPEYFRRQ 685 (842)
Q Consensus 615 ia~gL~yLH~~~~~~ivHrDIKp~NILl--d~--~~~~kl~DFGla~~~~~~---~~~~--~~~~~gt~~Y~APE~l~~~ 685 (842)
+++|+.|||+ ++|.|||+|++|||| |+ -..+.|+|||+|-..... -.+. .....|...-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999 999999999999999 33 346789999988654321 1111 1234477789999987642
Q ss_pred C------CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHH
Q 037607 686 Q------LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAE 759 (842)
Q Consensus 686 ~------~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~ 759 (842)
+ --.|+|.|+.|.+.||++....||....+ -..+... .++..+.. ++..+...+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----Yqe~qLPa---------lp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----YQESQLPA---------LPSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----hhhhhCCC---------CcccCChHHHHHHH
Confidence 2 12699999999999999999999976311 1111111 11111111 22334455677888
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 037607 760 KCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 760 ~Cl~~dP~~RPtm~evl~ 777 (842)
..|+.+|.+|++..-...
T Consensus 492 ~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHhcCCccccCCccHHHh
Confidence 899999999998754433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-14 Score=140.44 Aligned_cols=135 Identities=17% Similarity=0.204 Sum_probs=115.9
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC--CceeeEEEeeccCCeEEEEEEecCCCC
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH--RHLVSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
.+.||+|.++.||++...+ ..+++|....... ..++.+|+.+++.++| .++.++++++...+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999854 7899999766543 4678999999999977 589999999888889999999999877
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||++...
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 55677889999999999999855568999999999999999899999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.9e-15 Score=175.17 Aligned_cols=157 Identities=24% Similarity=0.327 Sum_probs=114.5
Q ss_pred ceEEecCCCCCCcccc----CC--CCccccCCCCCccccccccccccccccCccC-CCCCCCCCccceeeeeeecc---c
Q 037607 19 NYLIDCGSGSSEQTSL----DD--GRTFKSDHESSSYLSTKEDIETSVDSIPVKA-KSSPCPSAYPLYRSARIFTG---E 88 (842)
Q Consensus 19 ~~~i~cg~~~~~~~~~----~~--~r~~~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~y~tar~f~~---~ 88 (842)
-|.||||+.......+ .. .|+|.+|.. ++......+++...|..+. .+.-+|. .+|+|||++.. +
T Consensus 193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~---~~~~~~~~~st~~~I~~~~~~~~~~P~--~VyqTA~~~~~~~~~ 267 (623)
T PLN03150 193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQT---FGSGSDQAISTENVIKKASNAPNFYPE--SLYQSALVSTDTQPD 267 (623)
T ss_pred EEEEEecCcccccccCCCCCcccCccccCcCcc---cCCCcccccccccccccccCCCccChH--HHhhhhccccCCCCc
Confidence 4789999864311111 11 799999944 2221111222233333221 1122343 69999999975 7
Q ss_pred ceEEEeeccCcceEEEEeeccCCCCCCCccCcEEEEEeCceEEeccccCCC----CCcceEEEEEEeecCc-eEEEEeeC
Q 037607 89 SRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIGN----TTSLVFKEYLINITGR-LSIIFKPH 163 (842)
Q Consensus 89 ~~y~f~~~~~g~~~~rl~f~~~~~~~~~~~~~~f~v~~~~~~~l~~f~~~~----~~~~~~~e~~~~~~~~-~~i~f~p~ 163 (842)
.+|+|++.+.|.|+|||||.+...+......+.|+|.+||.+++.+|++.. ...+++++|.+++++. |+|+|.|.
T Consensus 268 lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~ 347 (623)
T PLN03150 268 LSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPK 347 (623)
T ss_pred eEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeC
Confidence 899999977789999999999976655667788999999999999999732 2378999999999965 99999999
Q ss_pred CCCcceeeeeEEEecCC
Q 037607 164 KDSHAFINAIEVVSAPG 180 (842)
Q Consensus 164 ~~~~~fvn~ie~~~~p~ 180 (842)
+++.||||||||+.+-.
T Consensus 348 ~~s~pilNaiEI~~~~~ 364 (623)
T PLN03150 348 KGTHAIINAIEVFEIIT 364 (623)
T ss_pred CCCcceeeeeeeeeccc
Confidence 98889999999999654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=144.92 Aligned_cols=137 Identities=21% Similarity=0.273 Sum_probs=98.8
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCCh--hhHHH----------------------HHHHHHHHHhcCCC--ce
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE--QGINE----------------------FQTEIQMLSKLRHR--HL 566 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~--~~~~~----------------------f~~Ei~il~~L~Hp--nI 566 (842)
.+.||+|+||+||+|...+|+.||||+...... ..... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999988899999998665321 11111 13566666666443 24
Q ss_pred eeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC
Q 037607 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~ 646 (842)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. ..+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 444443 245899999999654322111110 11 6678999999999999996 37899999999999999 89
Q ss_pred ceEEeeccccccc
Q 037607 647 VAKVADFGLSKAA 659 (842)
Q Consensus 647 ~~kl~DFGla~~~ 659 (842)
.++|+|||++...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-14 Score=143.74 Aligned_cols=147 Identities=22% Similarity=0.294 Sum_probs=87.4
Q ss_pred ceEEecCCCCCCccccCCCCccccCCCC--Ccc--ccc-cccccccccccCccCCCCCCCCCccceeeeeeecccceEEE
Q 037607 19 NYLIDCGSGSSEQTSLDDGRTFKSDHES--SSY--LST-KEDIETSVDSIPVKAKSSPCPSAYPLYRSARIFTGESRYRF 93 (842)
Q Consensus 19 ~~~i~cg~~~~~~~~~~~~r~~~~d~~~--~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~y~tar~f~~~~~y~f 93 (842)
.|.||||+... ++.+|..|.+|..- ++. ... ...... .....+.+.....+||+|+|.-..+++|+|
T Consensus 2 ~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~-----~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~i 73 (174)
T PF11721_consen 2 VLRINAGGPAY---TDSSGIVWEADQYYTGGSWGYYVSSDNNGST-----SSTNSSIPGTTDDPLYQTERYGPSSFSYDI 73 (174)
T ss_dssp EEEEEETSSSE---EETTTEEE-SSSSSTTSS-----------SS-----TTS--TTS-HHHHHTTT-----SSSEEEEE
T ss_pred EEEEECCCCcc---cCCCCCEEcCCCCCCCCCccccccccccccc-----ccccccccCCCchhhhHhhcCCCCceEEEE
Confidence 47899999766 77899999999552 111 110 000000 001111111223489999998666899999
Q ss_pred eeccCcceEEEEeeccCCCCC----CCccCcEEEEEeCceEEeccccCCCCC----cceEEEE-EEeecC-ceEEEEee-
Q 037607 94 FISQPGPHWVRLHFYPVPHSS----IKLTDAVFTVQTDKFVLLHDFSIGNTT----SLVFKEY-LINITG-RLSIIFKP- 162 (842)
Q Consensus 94 ~~~~~g~~~~rl~f~~~~~~~----~~~~~~~f~v~~~~~~~l~~f~~~~~~----~~~~~e~-~~~~~~-~~~i~f~p- 162 (842)
|+.++|.|-|||||....... .....+.|+|.++|.+||.||++...+ .+++++| .+.|+. .|+|+|.+
T Consensus 74 p~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~ 153 (174)
T PF11721_consen 74 PVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWA 153 (174)
T ss_dssp E--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE
T ss_pred ecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEec
Confidence 977999999999999998665 455678899999999999999984332 3688888 888865 49999995
Q ss_pred ----------CCCCcceeeee
Q 037607 163 ----------HKDSHAFINAI 173 (842)
Q Consensus 163 ----------~~~~~~fvn~i 173 (842)
..-..|.||||
T Consensus 154 ~~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 154 GKGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp --SEEEEEEESSSSSSSEEEE
T ss_pred CCCcEEeeccccCCCcEEeeC
Confidence 33345667776
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.5e-14 Score=146.61 Aligned_cols=135 Identities=20% Similarity=0.224 Sum_probs=104.4
Q ss_pred eEEe-ecCcEEEEEEEEcCCcEEEEEECCCCC-------------hhhHHHHHHHHHHHHhcCCCce--eeEEEeeccCC
Q 037607 514 AVIG-VGGFGKVYIGVLEDGNKVAIKRGNPGS-------------EQGINEFQTEIQMLSKLRHRHL--VSLIGFCDEQS 577 (842)
Q Consensus 514 ~~LG-~G~fg~Vykg~~~~g~~VAvK~~~~~~-------------~~~~~~f~~Ei~il~~L~HpnI--v~l~g~~~~~~ 577 (842)
..|| .||.|+||+.... +..++||+..... ......+.+|++++.+|+|+++ ++.++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4788 8999999999885 6788998764321 1223567899999999998774 67777654322
Q ss_pred ----eEEEEEEecCC-CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 578 ----EMILVYEYMAN-GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 578 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
..++||||+++ .+|.+++.. ..++.. .+.+++++|.+||+ .||+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 688887732 234443 35688999999999 9999999999999999988999999
Q ss_pred ccccccc
Q 037607 653 FGLSKAA 659 (842)
Q Consensus 653 FGla~~~ 659 (842)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.6e-15 Score=172.37 Aligned_cols=255 Identities=23% Similarity=0.277 Sum_probs=189.7
Q ss_pred CcccceEEeecCcEEEEEEEEcC--CcEEEEEECCCCC--hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLED--GNKVAIKRGNPGS--EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~--g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35555669999999998877533 3456777655432 333344556777777776 999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHH-hCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH-TGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPM 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH-~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~ 661 (842)
+|..++++.+-+........+....-....|+..++.|+| . .++.||||||+|.+++..+ ..+++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999998884333335666777888999999999999 6 8999999999999999999 999999999988765
Q ss_pred --CCCceeeeecc-CCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 662 --DRGYVSTAVKG-SFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 662 --~~~~~~~~~~g-t~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...... .....|.... +..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~--- 250 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GRF--- 250 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---ccc---
Confidence 23334455667 999999999888 456789999999999999999999998664433 1222222211 000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.. ...........++..+++..+|..|.+.+++...
T Consensus 251 -~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 -TQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -cc----CccccCChhhhhcccccccCCchhcccccccccc
Confidence 00 0112223455677788888999999998876543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.6e-13 Score=152.11 Aligned_cols=140 Identities=24% Similarity=0.300 Sum_probs=101.4
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHH----------------------------------------HHHH
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN----------------------------------------EFQT 553 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~----------------------------------------~f~~ 553 (842)
+.||.|++|+||+|++.+|+.||||+.++....... +|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 579999999999999999999999998775322110 2555
Q ss_pred HHHHHHhcC-----CCceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHH-HHHHHHhCCC
Q 037607 554 EIQMLSKLR-----HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR-GLHYLHTGAA 627 (842)
Q Consensus 554 Ei~il~~L~-----HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~-gL~yLH~~~~ 627 (842)
|.+.+.+++ ++++.-..-+.......+|||||++|++|.+....... .+ .+.+++..+++ .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh---
Confidence 666666652 33332222222334567999999999999887632111 12 34566666666 4678887
Q ss_pred CceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 628 ~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
.+++|+|+||.||+++++++++++|||++....
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.8e-12 Score=134.55 Aligned_cols=200 Identities=23% Similarity=0.336 Sum_probs=139.3
Q ss_pred HHHHhcCCCceeeEEEeec-----cCCeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCC
Q 037607 556 QMLSKLRHRHLVSLIGFCD-----EQSEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628 (842)
Q Consensus 556 ~il~~L~HpnIv~l~g~~~-----~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~ 628 (842)
.-|-++.|.|||+++.|+. +..+..++.|||..|+|..+|.+ +++..+......+|+.||..||.|||+ |..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 4455677999999999874 34567999999999999999964 345678888899999999999999998 778
Q ss_pred ceEeccCCCCCEEEcCCCceEEeecccccccCC---CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh
Q 037607 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPM---DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705 (842)
Q Consensus 629 ~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~---~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt 705 (842)
.|+|+++..+-|++..++-+|+.--.-...... ..........+-++|.+||+-.....+-.+|||+||...+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 899999999999999988887742211100000 00111122346789999999887788889999999999999987
Q ss_pred CCCCCCCCC-ch-hhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 706 ARPVINPKL-PR-EQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 706 G~~p~~~~~-~~-~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.--..... .. .+.++.. .+.-+-+ ..-...+.+|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~---------~i~~len------------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN---------VIIGLEN------------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhh---------heeeccC------------ccccCcCcccccCCCCCCcchhhhhc
Confidence 753211111 00 0000000 0000000 11134677899999999999998864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.9e-11 Score=119.15 Aligned_cols=130 Identities=18% Similarity=0.115 Sum_probs=96.6
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCcee-eEEEeeccCCeEEEEEEecCCCCcc
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV-SLIGFCDEQSEMILVYEYMANGPFR 592 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (842)
+.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 46889999999999875 77899998765432 123568899999998765554 4444432 3458999999998876
Q ss_pred cccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC--CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 593 DHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA--AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 593 ~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~--~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
+.. .....+..+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 531 112346678999999999832 22369999999999999 66899999998654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-11 Score=143.36 Aligned_cols=146 Identities=20% Similarity=0.220 Sum_probs=93.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChhh----------------------------------HH--
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQG----------------------------------IN-- 549 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~~----------------------------------~~-- 549 (842)
...|+. +.||.|++|+||+|++++ |+.||||+..+...+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 689999999999999987 9999999988653211 01
Q ss_pred ----HHHHHHHHHHhcC----CCceeeEEEee-ccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHH-HH
Q 037607 550 ----EFQTEIQMLSKLR----HRHLVSLIGFC-DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR-GL 619 (842)
Q Consensus 550 ----~f~~Ei~il~~L~----HpnIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~-gL 619 (842)
+|.+|...+.+++ +.+.+.+-..+ .-....+|||||++|++|.+.-.-. ....+. ..++...++ -+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~---~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDM---KLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCH---HHHHHHHHHHHH
Confidence 2444555555542 33333322222 2245678999999999997742111 111111 122222111 12
Q ss_pred HHHHhCCCCceEeccCCCCCEEEcCCC----ceEEeecccccccC
Q 037607 620 HYLHTGAAQGIIHRDVKTTNILLDENL----VAKVADFGLSKAAP 660 (842)
Q Consensus 620 ~yLH~~~~~~ivHrDIKp~NILld~~~----~~kl~DFGla~~~~ 660 (842)
..++. .+++|+|+||.||+++.++ +++++|||+.....
T Consensus 274 ~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 22333 8999999999999999888 99999999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3e-11 Score=137.15 Aligned_cols=247 Identities=19% Similarity=0.187 Sum_probs=178.4
Q ss_pred CcccceEEee--cCcEEEEEEEE---cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEE
Q 037607 509 NFDENAVIGV--GGFGKVYIGVL---EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 509 ~f~~~~~LG~--G~fg~Vykg~~---~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~ 580 (842)
.|.....+|. |.+|.||++.. .++..+|+|+-+.. .......=.+|+..-+.+ .|+|.++....++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555667999 99999999986 36788999984332 223333345677666666 4999999888889999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHH----HHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeeccc
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR----GLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGL 655 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~----gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGl 655 (842)
+-.|++. .+|..+.+. ....++...++.+..+..+ ||.++|. .+++|-|+||.||++..+ ...++.|||+
T Consensus 195 iqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 9999985 677777643 2334666777777777777 9999998 999999999999999988 8899999999
Q ss_pred ccccCCCCC----ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 656 SKAAPMDRG----YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 656 a~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
........- .......|...|++||.+. .-++.+.|+|++|.+.+|..++..+........ |..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~----- 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ----- 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc-----
Confidence 887754321 1122335778899999876 456889999999999999999876655432111 111
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+..+. +..+++.....++...+.++++.+|..|++..++..
T Consensus 338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 223344344445555888899999999998776643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-10 Score=115.29 Aligned_cols=142 Identities=23% Similarity=0.376 Sum_probs=112.8
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCC--CceeeEEEeeccCC---eEEEEEEecC
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRH--RHLVSLIGFCDEQS---EMILVYEYMA 587 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~~~~---~~~lV~Ey~~ 587 (842)
+.|+.|..+.||++...+|+.+++|....... ....++..|+++++.+++ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999998765432 134678999999999976 44677787776543 5689999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA----------------------------------------- 626 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~----------------------------------------- 626 (842)
|.+|.+.+.. ..++..++..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876621 45778888899999999999999521
Q ss_pred ------------CCceEeccCCCCCEEEcC--CCceEEeecccccc
Q 037607 627 ------------AQGIIHRDVKTTNILLDE--NLVAKVADFGLSKA 658 (842)
Q Consensus 627 ------------~~~ivHrDIKp~NILld~--~~~~kl~DFGla~~ 658 (842)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-09 Score=110.17 Aligned_cols=137 Identities=13% Similarity=0.119 Sum_probs=98.0
Q ss_pred eEEeecCcEEEEEEEEcC-------CcEEEEEECCCCC------------h----------hhHHHHH----HHHHHHHh
Q 037607 514 AVIGVGGFGKVYIGVLED-------GNKVAIKRGNPGS------------E----------QGINEFQ----TEIQMLSK 560 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~-------g~~VAvK~~~~~~------------~----------~~~~~f~----~Ei~il~~ 560 (842)
..||.|.-+.||.|...+ +..+|||..+... . ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998543 4789999633210 0 0112233 89999999
Q ss_pred cCC--CceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHH-HhCCCCceEeccCCC
Q 037607 561 LRH--RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL-HTGAAQGIIHRDVKT 637 (842)
Q Consensus 561 L~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yL-H~~~~~~ivHrDIKp 637 (842)
+.. -++...+++ ...+|||||+.+..+.... .....++..+...+..+++.+|..| |+ .+|||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~--Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK--LKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh--hhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 456666654 5679999999765442211 1122345566778889999999999 77 8999999999
Q ss_pred CCEEEcCCCceEEeecccccccC
Q 037607 638 TNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 638 ~NILld~~~~~kl~DFGla~~~~ 660 (842)
.|||++ ++.+.|+|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.1e-09 Score=121.97 Aligned_cols=166 Identities=17% Similarity=0.217 Sum_probs=122.8
Q ss_pred EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHH
Q 037607 529 LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQR 608 (842)
Q Consensus 529 ~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~ 608 (842)
..++.+|.|...+...........+-++.|+.||||||++++...+..+..|||+|-+. .|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 34677777777665554444567788899999999999999999999999999999873 46555522 224556
Q ss_pred HHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCC
Q 037607 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688 (842)
Q Consensus 609 ~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s 688 (842)
...+.||+.||.+||+ ..+++|++|.-.-|++++.|.-||.+|.++.....-.. ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 6678999999999996 47799999999999999999999999998765432111 001111122455666543222
Q ss_pred CcccchhHHHHHHHHHhC
Q 037607 689 EKSDVYSFGVVLFEVLCA 706 (842)
Q Consensus 689 ~ksDVwS~GvvL~ELltG 706 (842)
-..|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.4e-10 Score=129.88 Aligned_cols=249 Identities=17% Similarity=0.170 Sum_probs=176.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc--CCcEEEEEECCCCChhhHHH--HHHHHHHHHhc-CCCceeeEEEeeccCCeEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE--DGNKVAIKRGNPGSEQGINE--FQTEIQMLSKL-RHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~--~g~~VAvK~~~~~~~~~~~~--f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~ 580 (842)
.+.+|.....||.|.|+.|++...+ ++..+++|.+.........+ -+.|+-+...+ .|.++++...-+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888889999999999998754 67789999876543222211 24566666555 5888888877777778888
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeeccccccc
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAA 659 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGla~~~ 659 (842)
+--|||+++++...+ .....+++..++++..|++.++.++|+ +.++|+|+||+||++..+ +.-++.|||+....
T Consensus 343 ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999887766 444567888899999999999999998 999999999999999775 78899999988642
Q ss_pred CCCCCceeeeeccCCCC-CCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGY-LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y-~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.-. .......+..| .+++......+..+.|++|||.-+.|.+++...-.... .|. ..+.+.+..
T Consensus 418 ~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~~p~-- 482 (524)
T KOG0601|consen 418 AFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGDTPN-- 482 (524)
T ss_pred cee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeecccccC--
Confidence 211 11111123334 35556666788899999999999999999975443221 111 011111111
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
+ . .....+..++..+...++..||.+.++..+.+..
T Consensus 483 ---~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 ---L----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---C----C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1 1 1125566777888999999999988877665543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.9e-09 Score=102.96 Aligned_cols=131 Identities=24% Similarity=0.330 Sum_probs=100.3
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEE-CCCC-Chh------hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKR-GNPG-SEQ------GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~-~~~~-~~~------~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.+++|+-+.+|.+.+. |.++++|. +.+. ... ...+-.+|..+|++++--.|..-+=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999874 44577774 3322 111 1245678999999987655555555667788899999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
+|..|.+.+... ...++..+-+-+.-||. .+|+|+||.++||++..+. +.++||||+...
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998888332 35677777788889998 9999999999999997764 999999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.9e-08 Score=112.12 Aligned_cols=167 Identities=17% Similarity=0.267 Sum_probs=128.1
Q ss_pred EEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeec----cCCeEEEEEEecCC-CCccccc
Q 037607 522 GKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD----EQSEMILVYEYMAN-GPFRDHL 595 (842)
Q Consensus 522 g~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~l 595 (842)
.+.||+.. .+|..+++||++-...+.......-+++++++.|+|||++..++. .+..+++||+|+++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788884 489999999994333222233456688999999999999998875 34568999999975 5666644
Q ss_pred cc-------------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 596 YG-------------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 596 ~~-------------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
+. ..+.+.++..++.++.|+..||.++|+ .|+.-+-|.+.+||++.+.+++|+.+|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 32 123456789999999999999999999 89888999999999999999999999987766543
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCC
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p 709 (842)
.. |.+. --.+-|.=.||.+++-|.||+..
T Consensus 447 ~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 31 1111 12467888999999999999743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.7e-09 Score=101.24 Aligned_cols=143 Identities=22% Similarity=0.228 Sum_probs=105.8
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEE-CCCCC-------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKR-GNPGS-------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~-~~~~~-------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
....|-+|+-+.|+++.+. |+..+||. ..+.- .-..++..+|++.|.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3457899999999999985 88877874 32221 112356788999999987544444444566667778999
Q ss_pred EecCC-CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---ceEEeecccccc
Q 037607 584 EYMAN-GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL---VAKVADFGLSKA 658 (842)
Q Consensus 584 Ey~~~-gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~---~~kl~DFGla~~ 658 (842)
||+++ .++.+++...............++..|-+.+.-||. .+|||+||..+||+|..++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 477777755444444444447889999999999998 9999999999999995443 558999999764
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.8e-09 Score=116.79 Aligned_cols=153 Identities=22% Similarity=0.358 Sum_probs=104.4
Q ss_pred EeeCCCcccc--CCCcccccccCCCcccccCCCCcceecCCceeEeCCCCCCCCcCChHHHHHhhccccccCCCcceeeE
Q 037607 210 LNVGGPLVTP--KNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPNFNLT 287 (842)
Q Consensus 210 in~Gg~~~~~--~~d~~~r~w~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~Y~tar~~~~~~~~~~~~~lt 287 (842)
||||+..-.. .+|.-.|+|.+|..|.-...+ .++.-. ....--.+..+|+|||..+... .-.
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~--------~~i~~~--~~~~~~~~~~~y~taR~F~~g~------r~c 64 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKS--------GNISSQ--PDSSSSDSSPPYQTARIFPEGS------RNC 64 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCc--------cccccc--cCCcCCccccccceEEEcCCCC------ccE
Confidence 7999995543 344578999999988542221 222100 0001123345999999998432 589
Q ss_pred EEEeeC--CCCceEEEEeeeccccccC------CcEEEEEEEcCccccCCCChhhhccccCceEEEEEEEEecccCCcce
Q 037607 288 WKMSVD--PSFSYLIRFHFCDIVSKSL------NDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSI 359 (842)
Q Consensus 288 ~~~~v~--~~~~y~vrlhF~ei~~~~~------~~r~Fdiyi~~~~~~~~~di~~~~~~~~~~~~~~~~v~~~~~~~~~l 359 (842)
|.||+. +|++|+|||||.-...... ..-.||++++...-.. .++. .....+++++|.+.+. .++.|
T Consensus 65 Y~l~~~~~~~~~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~t-V~~~---~~~~~~~~~E~ii~v~--~~~~l 138 (347)
T PF12819_consen 65 YTLPVTPPGGGKYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWST-VNLS---NSPSSPVVKEFIINVT--WSDTL 138 (347)
T ss_pred EEeeccCCCCceEEEEEEeccccccccccccccCCcceEEEECCceeEE-EEec---CCCcceEEEEEEEEEc--CCCcE
Confidence 999998 5779999999997654422 2347999999754321 2221 1122689999999995 57999
Q ss_pred EEEeccCCCCCCCCccccccceeEeeccC
Q 037607 360 TVQVGPASNAQSSLPNAILNGLEVIKLSN 388 (842)
Q Consensus 360 ~i~~~p~~~~~~~i~~~~lnG~ei~~l~~ 388 (842)
.|.|.|.+. + ..+++||+|+..|..
T Consensus 139 ~vclv~~~~--g--~~pFIsaiEl~~lp~ 163 (347)
T PF12819_consen 139 SVCLVPTGS--G--TFPFISAIELRPLPD 163 (347)
T ss_pred EEEEEeCCC--C--CCCceeEEEEEECCc
Confidence 999999986 1 137899999999955
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.1e-08 Score=103.91 Aligned_cols=140 Identities=16% Similarity=0.123 Sum_probs=101.8
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCCChh-hHH----------HHHHHHHHHHhcCC--CceeeEEEeecc-----C
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ-GIN----------EFQTEIQMLSKLRH--RHLVSLIGFCDE-----Q 576 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~-~~~----------~f~~Ei~il~~L~H--pnIv~l~g~~~~-----~ 576 (842)
.+-+.....|++..+ +|+.+.||+....... ..+ .+.+|...+.+|.. -.+.+.+++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 455555556777766 5788999976543321 112 37899999988843 334445555532 3
Q ss_pred CeEEEEEEecCCC-CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-------CCce
Q 037607 577 SEMILVYEYMANG-PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-------NLVA 648 (842)
Q Consensus 577 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-------~~~~ 648 (842)
...+||+|++++. +|.+++........+...+..++.++++.+.-||+ .||+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999876 78888732223345566778999999999999999 99999999999999975 5789
Q ss_pred EEeecccccc
Q 037607 649 KVADFGLSKA 658 (842)
Q Consensus 649 kl~DFGla~~ 658 (842)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-09 Score=128.76 Aligned_cols=247 Identities=21% Similarity=0.231 Sum_probs=160.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..+.+.+-+-.|.++.+..+.-. .|...++|..... ...+.+....+-.++-..+||-++...--+......+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34555556778888888776532 2333333322211 1112223333333333345566665554455677889999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC--
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM-- 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~-- 661 (842)
+|+.+++|...|+... .++..-.......+...++|||. ..+.|+|++|.|+|...++..++.|||+......
T Consensus 884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999998885543 45555555566667789999998 6689999999999999999999999984332210
Q ss_pred ---CC-------------------------CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 037607 662 ---DR-------------------------GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPK 713 (842)
Q Consensus 662 ---~~-------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~ 713 (842)
+. ........+|+.|.+||.+.+......+|+|++|++++|.++|.+||+..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00 01123456899999999999999999999999999999999999999876
Q ss_pred CchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHH
Q 037607 714 LPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMG 773 (842)
Q Consensus 714 ~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~ 773 (842)
.+.... + .+.....+.. ....+......+++.+.+..+|.+|-.|.
T Consensus 1039 tpq~~f-----------~-ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF-----------E-NILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhh-----------h-ccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 543211 0 0000001110 11122334455667778888999987765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=95.98 Aligned_cols=126 Identities=25% Similarity=0.328 Sum_probs=83.2
Q ss_pred EEEEEEEcCCcEEEEEECCCCC--------------h------------hhHHHHHHHHHHHHhcCCC--ceeeEEEeec
Q 037607 523 KVYIGVLEDGNKVAIKRGNPGS--------------E------------QGINEFQTEIQMLSKLRHR--HLVSLIGFCD 574 (842)
Q Consensus 523 ~Vykg~~~~g~~VAvK~~~~~~--------------~------------~~~~~f~~Ei~il~~L~Hp--nIv~l~g~~~ 574 (842)
.||.|...+|..+|||..+... . .......+|.+.|.++..- ++.+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999643211 0 0112467899999999755 456666542
Q ss_pred cCCeEEEEEEecC--CCCcccccccCCCCCCchHHHHHHHHHHHHHHHH-HHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 575 EQSEMILVYEYMA--NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY-LHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 575 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~y-LH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
..+|||||++ |..+..+. . ..++......++.++++.+.. +|. .+|+|+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~---~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-D---VDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-H---CGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHH-h---ccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 4589999998 65554433 1 112245567788888885555 567 899999999999999887 99999
Q ss_pred ecccccccC
Q 037607 652 DFGLSKAAP 660 (842)
Q Consensus 652 DFGla~~~~ 660 (842)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=91.84 Aligned_cols=136 Identities=24% Similarity=0.227 Sum_probs=97.3
Q ss_pred cccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC--------------------h--hhHHHHHHHHHHHHhcCCC--c
Q 037607 510 FDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS--------------------E--QGINEFQTEIQMLSKLRHR--H 565 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~--------------------~--~~~~~f~~Ei~il~~L~Hp--n 565 (842)
..+...||.|.-+.||.|....|.++|||.-+... . ......++|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34556899999999999999999999999422110 0 0112357899999988644 5
Q ss_pred eeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 566 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
|.+.++ .+...+||||++|-.|...- ++....-.|+..|++-+..+-. .||||+|+.+-||+++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 555554 35679999999986665532 1233344455555555555545 899999999999999999
Q ss_pred CceEEeeccccccc
Q 037607 646 LVAKVADFGLSKAA 659 (842)
Q Consensus 646 ~~~kl~DFGla~~~ 659 (842)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999865543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=9.3e-07 Score=102.48 Aligned_cols=146 Identities=21% Similarity=0.315 Sum_probs=97.5
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHH--------------------------------------
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN-------------------------------------- 549 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~-------------------------------------- 549 (842)
.+|+. ..|+.++-|+||+|++++|+.||||+..+.-.+..+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 478999999999999999999999998876432211
Q ss_pred --HHHHHHHHHHhcC-----CCceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHH
Q 037607 550 --EFQTEIQMLSKLR-----HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622 (842)
Q Consensus 550 --~f~~Ei~il~~L~-----HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yL 622 (842)
++.+|...+.+++ .+++.--.=|.+-.....|+|||++|..+.+....+. ..++.+.+.+...++. +..+
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~ 281 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQL 281 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHH
Confidence 1345555555552 2333222223344567899999999999988752222 3444333332222221 2222
Q ss_pred HhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 623 H~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
-. .++.|.|..|.||+++.++++.+.|||+.....
T Consensus 282 ~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 LR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred Hh---cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22 689999999999999999999999999876654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.7e-06 Score=90.00 Aligned_cols=260 Identities=15% Similarity=0.141 Sum_probs=153.1
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEee------cc-CCeEEEEE
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFC------DE-QSEMILVY 583 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~------~~-~~~~~lV~ 583 (842)
....||+|+-+.+|----- +..| -|+......... .+.+++|... .||-+..-+.+= -+ +...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchh-heeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3457999999999854311 2223 344333222211 1223334333 566444322211 12 22256777
Q ss_pred EecCCCCcccccc-----cCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 584 EYMANGPFRDHLY-----GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 584 Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
..+.+.-=-..++ ++.....+|...++.+..+|.+.+-||+ .|.+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 7776542212222 1234568999999999999999999999 8999999999999999999999998543322
Q ss_pred cCCCCCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhC-CCCCCCCCchh--hhhHH-HHHHHh-
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPRE--QVSLA-EWALQC- 728 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG-~~p~~~~~~~~--~~~l~-~~~~~~- 728 (842)
. ..+......+|...|.+||... +..-+...|.|.+||++++||.| ++||.+-.... ...+. +.+...
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2 3444555667899999999765 44567889999999999999876 99997532111 00000 000000
Q ss_pred --hcccccccccchhHHhhhc-HHHHHHHHHHHHHhhhhC--CCCCCCHHHHHHHHHHHHh
Q 037607 729 --HRKGILEKIIDPVIAETIC-KESLRKYVEAAEKCLAEY--GVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 729 --~~~~~l~~i~d~~l~~~~~-~~~~~~l~~l~~~Cl~~d--P~~RPtm~evl~~Le~~~~ 784 (842)
..+..... .+.. ..++ .-....+..+-.+|+... +.-||+.+.++..|..+.+
T Consensus 245 ~ya~~~~~g~--~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 245 AYASDQRRGL--KPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eechhccCCC--CCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 00000000 0000 0111 111233444556777653 5689999999888776544
|
|
| >KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.6e-07 Score=96.81 Aligned_cols=124 Identities=15% Similarity=0.167 Sum_probs=89.4
Q ss_pred eEEEEEeeCCCccccCCCcccccccCCCcccccCCCC-cceecCCceeEeCCCCCCCCcCChHHHHHhhccccccCCCcc
Q 037607 205 EVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGS-EAVSVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQPN 283 (842)
Q Consensus 205 ~~~~rin~Gg~~~~~~~d~~~r~w~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~Y~tar~~~~~~~~~~~ 283 (842)
.++|.|||||.+.+ | .....|..++... +.++.++-...+- -..+.--..+|+|+|....
T Consensus 59 svI~aVncGgdaav---d------~ygI~f~aD~~~~VGrasd~G~~l~i~---~raeeed~ily~ter~nee------- 119 (355)
T KOG3593|consen 59 SVIPAVNCGGDAAV---D------NYGIRFAADPLEGVGRASDYGMVLGIG---CRAEEEDIILYQTERYNEE------- 119 (355)
T ss_pred hhhheeccCChhhh---c------ccceEeeccccccccccCCccceeecc---ccCChhhhhhhhhcccchh-------
Confidence 37899999999884 2 2223333333332 2233332222221 1112233449999999876
Q ss_pred eeeEEEEeeCCCCceEEEEeeeccccccCCcEEEEEEEc-CccccCCCChhhhccccCce--EEEEEE
Q 037607 284 FNLTWKMSVDPSFSYLIRFHFCDIVSKSLNDLLFNVYIN-EFMAASSLDLSSLTNALSTA--YYKDFV 348 (842)
Q Consensus 284 ~~lt~~~~v~~~~~y~vrlhF~ei~~~~~~~r~Fdiyi~-~~~~~~~~di~~~~~~~~~~--~~~~~~ 348 (842)
.+.|..|.+..|.|-+-|.|||.+|...++.+|||-+| +..+.+++||..+.|+-|+| .+..+.
T Consensus 120 -tFgyd~pik~dgdyalvlkfaevyF~~~q~kvfdvrln~sh~vVk~ldi~~~vg~rg~AhDe~i~~~ 186 (355)
T KOG3593|consen 120 -TFGYDVPIKEDGDYALVLKFAEVYFKTCQHKVFDVRLNCSHCVVKALDIFDQVGDRGKAHDEIIPCL 186 (355)
T ss_pred -hhcccccccCCCceehhhhHHHHHHHhhhhhheeeeeccceeEEeccchhhhcCCCcccccceEEEE
Confidence 68899999999999999999999999999999999999 99999999999999977765 444443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.6e-07 Score=91.27 Aligned_cols=106 Identities=25% Similarity=0.287 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhcC--CCceeeEEEeeccC----CeEEEEEEecCCC-CcccccccCCCCCCchHHHHHHHHHHHHHHHH
Q 037607 549 NEFQTEIQMLSKLR--HRHLVSLIGFCDEQ----SEMILVYEYMANG-PFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621 (842)
Q Consensus 549 ~~f~~Ei~il~~L~--HpnIv~l~g~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~y 621 (842)
....+|...+.+|. .-.+.+.+++.+.. ...+||+|++++. +|.+++..... ++......++.++++.+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 46788888888885 33455566665442 2458999999874 78888843222 5667788999999999999
Q ss_pred HHhCCCCceEeccCCCCCEEEcCCC---ceEEeeccccccc
Q 037607 622 LHTGAAQGIIHRDVKTTNILLDENL---VAKVADFGLSKAA 659 (842)
Q Consensus 622 LH~~~~~~ivHrDIKp~NILld~~~---~~kl~DFGla~~~ 659 (842)
||+ .+|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999 9999999999999998877 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.6e-06 Score=85.44 Aligned_cols=139 Identities=19% Similarity=0.169 Sum_probs=104.5
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCC---C---hhhHHHHHHHHHHHHhcCC--CceeeEEEeec-c----CCeEEE
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPG---S---EQGINEFQTEIQMLSKLRH--RHLVSLIGFCD-E----QSEMIL 581 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~---~---~~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~-~----~~~~~l 581 (842)
--|+||.+-|++-.++ |+.+-+|+-... + ..+...|.+|+..|.+|.. -.+.+.+ ++. . .-+-+|
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3477999999998775 557999985521 1 2345789999999999953 2344444 332 1 224689
Q ss_pred EEEecCC-CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc--eEEeecccccc
Q 037607 582 VYEYMAN-GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV--AKVADFGLSKA 658 (842)
Q Consensus 582 V~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~--~kl~DFGla~~ 658 (842)
|+|-+.+ -+|.+++......+.+...+..+..++++.+.-||+ .++.|+|+-+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997753 577777744444566778889999999999999999 99999999999999986666 99999986654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.9e-07 Score=107.87 Aligned_cols=151 Identities=22% Similarity=0.293 Sum_probs=103.3
Q ss_pred HHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce--------eeeeccCCCCCCccccc
Q 037607 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV--------STAVKGSFGYLDPEYFR 683 (842)
Q Consensus 612 ~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~Y~APE~l~ 683 (842)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+.+........+. ..-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445589999998 5789999999999999999999999999876654321110 01112345799999999
Q ss_pred ccCCCCcccchhHHHHHHHHH-hCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhh
Q 037607 684 RQQLTEKSDVYSFGVVLFEVL-CARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCL 762 (842)
Q Consensus 684 ~~~~s~ksDVwS~GvvL~ELl-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl 762 (842)
+...+.++|++|+||++|.+. .|+.-+........... ....+..-......+.+.++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHh
Confidence 989999999999999999999 55544443321110000 0000000001112345667788888899
Q ss_pred hhCCCCCCCHHHHHH
Q 037607 763 AEYGVDRPGMGDVLW 777 (842)
Q Consensus 763 ~~dP~~RPtm~evl~ 777 (842)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.2e-05 Score=84.43 Aligned_cols=133 Identities=18% Similarity=0.177 Sum_probs=85.5
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEeeccCCeEEEEEEecCCCC-
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH--LVSLIGFCDEQSEMILVYEYMANGP- 590 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~gs- 590 (842)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 37899999999984 25567888876543 2245688999999986433 4666777777777889999999863
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHH---------------------------------------HHHHHhC-CCCce
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARG---------------------------------------LHYLHTG-AAQGI 630 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~g---------------------------------------L~yLH~~-~~~~i 630 (842)
+.+.+. .+......++..+++. ..+|... ....+
T Consensus 82 ~~~~~~------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 82 FSRIIS------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhhhhc------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 211110 0001111111111111 2222211 23457
Q ss_pred EeccCCCCCEEEcCCCceEEeecccccc
Q 037607 631 IHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 631 vHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999997654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.8e-05 Score=80.04 Aligned_cols=138 Identities=18% Similarity=0.202 Sum_probs=93.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHH---------HHHHHHHHhcCC---CceeeEEEe-
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEF---------QTEIQMLSKLRH---RHLVSLIGF- 572 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f---------~~Ei~il~~L~H---pnIv~l~g~- 572 (842)
..++|...+++-......|.+-.. +|..+++|..........+.| .+++..+.+++. -..+.++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457888888887777666666665 578899998776543333332 344554545532 222222222
Q ss_pred ----eccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 573 ----CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 573 ----~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
+......+|+|||++|..|.+.. .++. .++..+.+.+.-||+ .|+.|+|+.|.|++++++ .+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cE
Confidence 22335567999999998887754 1222 355667788999999 999999999999999865 49
Q ss_pred EEeecccccc
Q 037607 649 KVADFGLSKA 658 (842)
Q Consensus 649 kl~DFGla~~ 658 (842)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=3e-05 Score=80.50 Aligned_cols=142 Identities=20% Similarity=0.205 Sum_probs=85.6
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCC--ceeeEEEeec---cCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR--HLVSLIGFCD---EQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hp--nIv~l~g~~~---~~~~~~lV~Ey~~~ 588 (842)
+.|+.|..+.||+....+ ..+++|..... ....++.+|..+++.|... .+.+++.++. .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 579999999999999876 68999986654 4556788999999888533 3456665442 23347999999999
Q ss_pred CCccc----------------cc---ccC--CCCCCchHH---------HHHH------------HHHHHH-HHHHHHh-
Q 037607 589 GPFRD----------------HL---YGT--NQPPLSWKQ---------RLEI------------CIGSAR-GLHYLHT- 624 (842)
Q Consensus 589 gsL~~----------------~l---~~~--~~~~l~~~~---------~~~I------------~~~ia~-gL~yLH~- 624 (842)
..+.. .+ +.. ...++.+.. .... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 11 111 111111100 0000 111222 2333332
Q ss_pred ---CCCCceEeccCCCCCEEEc-CCCceEEeecccccc
Q 037607 625 ---GAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKA 658 (842)
Q Consensus 625 ---~~~~~ivHrDIKp~NILld-~~~~~kl~DFGla~~ 658 (842)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2346799999999999999 666668999997643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-05 Score=93.20 Aligned_cols=139 Identities=22% Similarity=0.301 Sum_probs=93.1
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHH-------------------------------------HHHHHHH
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN-------------------------------------EFQTEIQ 556 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~-------------------------------------~f~~Ei~ 556 (842)
+.||.-+.|+||+|++++|+.||||+-++.-++... +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 379999999999999999999999998776332210 2555655
Q ss_pred HHHhc----CCCc------eeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC
Q 037607 557 MLSKL----RHRH------LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626 (842)
Q Consensus 557 il~~L----~Hpn------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~ 626 (842)
-..+. .|-+ |.++ |..-.....|+||||+|..+.|.-.- ....++...+..-+.+ + |+++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~V--y~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~---~--~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKV--YWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVE---A--YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCee--hhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHH---H--HHHHHH
Confidence 54444 3444 2222 22334578999999999998886522 2233444433333332 2 333333
Q ss_pred CCceEeccCCCCCEEEcC----CCceEEeecccccccC
Q 037607 627 AQGIIHRDVKTTNILLDE----NLVAKVADFGLSKAAP 660 (842)
Q Consensus 627 ~~~ivHrDIKp~NILld~----~~~~kl~DFGla~~~~ 660 (842)
..|++|+|=.|.||+++. ++.+.+.|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 378999999999999983 6789999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.9e-05 Score=80.42 Aligned_cols=139 Identities=17% Similarity=0.154 Sum_probs=85.3
Q ss_pred EeecCc-EEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEecCCCCccc
Q 037607 516 IGVGGF-GKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYMANGPFRD 593 (842)
Q Consensus 516 LG~G~f-g~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 593 (842)
|-.|.. ..||+...+ +..+.||+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344444 788999765 4788999876543 345678999998884 4445567777766667899999999987764
Q ss_pred cc-------------------ccCCC--CCCch--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 037607 594 HL-------------------YGTNQ--PPLSW--KQRLEICI--------------------GSARGLHYLHT----GA 626 (842)
Q Consensus 594 ~l-------------------~~~~~--~~l~~--~~~~~I~~--------------------~ia~gL~yLH~----~~ 626 (842)
.. |.... .++.. ...+.... .+.+.+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11110 01110 00010000 01111222211 11
Q ss_pred CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 627 ~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
...++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 24589999999999999987788999997643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00016 Score=75.40 Aligned_cols=152 Identities=19% Similarity=0.237 Sum_probs=99.0
Q ss_pred ccHHHHHHHhcCcccceE---EeecCcEEEEEEEEcCCcEEEEEECCCCChhhH---------HH---------------
Q 037607 498 FTFTELQNATQNFDENAV---IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGI---------NE--------------- 550 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~---LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~---------~~--------------- 550 (842)
.++..+....+...+... |..|.-+.||+|.-.++..+|||+......... ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 456666666666655544 557888899999987899999998654321110 01
Q ss_pred HHHHHHHHHhcC--CCceeeEEEeeccCCeEEEEEEecCCCCc-ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCC
Q 037607 551 FQTEIQMLSKLR--HRHLVSLIGFCDEQSEMILVYEYMANGPF-RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627 (842)
Q Consensus 551 f~~Ei~il~~L~--HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~ 627 (842)
...|+..|+++. +-.+.+-+++. ...|||||+...-+ .-.| ...++...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHH--h
Confidence 235666676663 33344444433 45899999954311 1111 11122233566777777777777764 3
Q ss_pred CceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 628 ~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
.++||+||..-|||+. ++.+.|+|+|-|...
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 7899999999999999 889999999977654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.5e-06 Score=99.34 Aligned_cols=180 Identities=18% Similarity=0.121 Sum_probs=130.9
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEeeccCCeEEEEEEecCCC-Ccc
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH-LVSLIGFCDEQSEMILVYEYMANG-PFR 592 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn-Iv~l~g~~~~~~~~~lV~Ey~~~g-sL~ 592 (842)
-.++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.++ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 36889999999988533333334443322 44567899999999999 777777778888899999999877 222
Q ss_pred cccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeecc
Q 037607 593 DHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG 672 (842)
Q Consensus 593 ~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 672 (842)
... ......+...+...++..-++++++||+ ..=+|+| |||..+ ...|..||+....+... .......+
T Consensus 324 ~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--~~~~t~~~ 392 (829)
T KOG0576|consen 324 LEM-TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--MKPRTAIG 392 (829)
T ss_pred ccC-ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc--cccccCCC
Confidence 111 0111223444556677778889999998 4458898 887766 67899999987765432 23455678
Q ss_pred CCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCC
Q 037607 673 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI 710 (842)
Q Consensus 673 t~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~ 710 (842)
+..|+|||+.....+..+.|+|++|+-..++--|-+|-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99999999999999999999999999777777676554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00015 Score=90.23 Aligned_cols=80 Identities=19% Similarity=0.404 Sum_probs=59.1
Q ss_pred ceEEeecCcEEEEEEEEcCC---cEEEEEECCCCC-hhhHHHHHHHHHHHHhcC-CCce--eeEEEeeccC---CeEEEE
Q 037607 513 NAVIGVGGFGKVYIGVLEDG---NKVAIKRGNPGS-EQGINEFQTEIQMLSKLR-HRHL--VSLIGFCDEQ---SEMILV 582 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g---~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~-HpnI--v~l~g~~~~~---~~~~lV 582 (842)
...|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.|. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45788999999999887654 467888765432 123357889999999995 6664 7788888664 467899
Q ss_pred EEecCCCCcc
Q 037607 583 YEYMANGPFR 592 (842)
Q Consensus 583 ~Ey~~~gsL~ 592 (842)
|||++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999986543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.6e-05 Score=76.88 Aligned_cols=104 Identities=21% Similarity=0.256 Sum_probs=83.8
Q ss_pred HHHHHHHHhcCC-CceeeEEEeeccCCeEEEEEEecCCCCccccccc-CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc
Q 037607 552 QTEIQMLSKLRH-RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG-TNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629 (842)
Q Consensus 552 ~~Ei~il~~L~H-pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ 629 (842)
.+|.-+|..+++ +++.+++|+|- .++|.||...+++...-.. ..-..-+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 69999999994 3789999987766532100 11124689999999999999999999866666
Q ss_pred eEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 630 IIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 630 ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
+.-.|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999865543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00027 Score=74.42 Aligned_cols=75 Identities=12% Similarity=0.193 Sum_probs=47.2
Q ss_pred eEEeecCcEE-EEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCC---ceeeEEEeeccC---CeEEEEEEec
Q 037607 514 AVIGVGGFGK-VYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR---HLVSLIGFCDEQ---SEMILVYEYM 586 (842)
Q Consensus 514 ~~LG~G~fg~-Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hp---nIv~l~g~~~~~---~~~~lV~Ey~ 586 (842)
..|+.|+... ||+. +..+++|..... ....++.+|.++|..|... -+.+.++.+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3577777664 8875 235777865442 2235788999999888532 234444444332 2348899999
Q ss_pred CCCCcccc
Q 037607 587 ANGPFRDH 594 (842)
Q Consensus 587 ~~gsL~~~ 594 (842)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99887543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0007 Score=74.08 Aligned_cols=78 Identities=14% Similarity=0.069 Sum_probs=57.8
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC---CceeeEEEeecc---CCeEEEEEE
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH---RHLVSLIGFCDE---QSEMILVYE 584 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H---pnIv~l~g~~~~---~~~~~lV~E 584 (842)
...+.||+|..+.||+....++ ++.+|..+... ....|..|.+.|+.|.. -.+.+++++|.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3345799999999999986655 46667643311 22578999999999853 367888888754 366899999
Q ss_pred ecCCCCc
Q 037607 585 YMANGPF 591 (842)
Q Consensus 585 y~~~gsL 591 (842)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998766
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00064 Score=71.34 Aligned_cols=140 Identities=16% Similarity=0.195 Sum_probs=81.8
Q ss_pred eEEeecCcEEEEEEEEcC--CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEEEecCCCC
Q 037607 514 AVIGVGGFGKVYIGVLED--GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~--g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
+.|..|-...+|+....+ +..+++|........ ..+-.+|+.+++.+....+ .++++.+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999998664 678999976543222 1233578989988854333 34444332 248999999877
Q ss_pred cccc-----------------cccCCC---------CCC-chHHHHHHHH----------------------HHHHHHHH
Q 037607 591 FRDH-----------------LYGTNQ---------PPL-SWKQRLEICI----------------------GSARGLHY 621 (842)
Q Consensus 591 L~~~-----------------l~~~~~---------~~l-~~~~~~~I~~----------------------~ia~gL~y 621 (842)
+... +|.... ... -+..+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6422 011110 011 1122111111 11111111
Q ss_pred ----HHh-CCCCceEeccCCCCCEEEcC-CCceEEeecccccc
Q 037607 622 ----LHT-GAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKA 658 (842)
Q Consensus 622 ----LH~-~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~ 658 (842)
+.. .....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111 12356999999999999997 57899999997654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00087 Score=68.67 Aligned_cols=128 Identities=22% Similarity=0.317 Sum_probs=89.1
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCC----------------hhhHHHHHHHHHHHHhcC------CCceeeEE
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS----------------EQGINEFQTEIQMLSKLR------HRHLVSLI 570 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~----------------~~~~~~f~~Ei~il~~L~------HpnIv~l~ 570 (842)
...||+|+.-.||.- .+.....||+..+.. ....+++.+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 457999999988864 345557788776654 223466777887777666 78999999
Q ss_pred EeeccCCeEEEEEEecCC--C----CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC
Q 037607 571 GFCDEQSEMILVYEYMAN--G----PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644 (842)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~ 644 (842)
|+.++.-..-+|+|.+.+ | +|.+++. ...++. ...+. +-+-.+||-+ ..|+.+|++|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence 999999999999998743 3 4555552 223444 33333 3344567766 88999999999999943
Q ss_pred C---C-ceEEee
Q 037607 645 N---L-VAKVAD 652 (842)
Q Consensus 645 ~---~-~~kl~D 652 (842)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 567777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00046 Score=73.68 Aligned_cols=137 Identities=18% Similarity=0.143 Sum_probs=79.1
Q ss_pred EeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEEEecCCCCcccc
Q 037607 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVYEYMANGPFRDH 594 (842)
Q Consensus 516 LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 594 (842)
+..|-...+|+... ++..+++|..........-...+|.++++.+....+ .+++..+. -.+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45577778998874 577888987554322211235789999998864333 33444332 3689999998776532
Q ss_pred -----------------cccCC--CCCCchHHH-HHHHH---------HHHHHHHHHHhC-----CCCceEeccCCCCCE
Q 037607 595 -----------------LYGTN--QPPLSWKQR-LEICI---------GSARGLHYLHTG-----AAQGIIHRDVKTTNI 640 (842)
Q Consensus 595 -----------------l~~~~--~~~l~~~~~-~~I~~---------~ia~gL~yLH~~-----~~~~ivHrDIKp~NI 640 (842)
||... ..+++.... ..... .+.+.++.+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12111 112222111 11110 111112222111 124589999999999
Q ss_pred EEcCCCceEEeecccccc
Q 037607 641 LLDENLVAKVADFGLSKA 658 (842)
Q Consensus 641 Lld~~~~~kl~DFGla~~ 658 (842)
++++++ +.|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999997654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0024 Score=72.32 Aligned_cols=75 Identities=16% Similarity=0.215 Sum_probs=54.3
Q ss_pred eEEeecCcEEEEEEEEcCC-cEEEEEECCCCC-------hhhHHHHHHHHHHHHhcC---CCceeeEEEeeccCCeEEEE
Q 037607 514 AVIGVGGFGKVYIGVLEDG-NKVAIKRGNPGS-------EQGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g-~~VAvK~~~~~~-------~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~~~~~lV 582 (842)
+.||.|.+..||+....+| +.|+||...+.. .-..+++..|.+.|+.+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998877 489999854221 124567788888888863 2456667665 33557899
Q ss_pred EEecCCCC
Q 037607 583 YEYMANGP 590 (842)
Q Consensus 583 ~Ey~~~gs 590 (842)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00048 Score=68.20 Aligned_cols=128 Identities=20% Similarity=0.245 Sum_probs=86.4
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeE-EEeeccCCeEEEEEEecCCCC
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL-IGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l-~g~~~~~~~~~lV~Ey~~~gs 590 (842)
..+.|++|++|.||+|.+. |..+|+|+-...+.. ..+..|.++|..+.-.++.+= +.|- +-.+.|||+.|-+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3457999999999999997 457888886655443 678899999999886665543 3332 2344599999888
Q ss_pred cccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCC-CCCEEEcCCCceEEeecccccc
Q 037607 591 FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK-TTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 591 L~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIK-p~NILld~~~~~kl~DFGla~~ 658 (842)
|.+..... +-++. ..+++.---|.. .||-|+.|. |..++|-.+..+.|+||.-|+.
T Consensus 99 L~~~~~~~-----~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-----DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-----cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87655221 22233 333444333444 788898886 4444554555999999998874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00094 Score=72.74 Aligned_cols=142 Identities=18% Similarity=0.179 Sum_probs=85.6
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCC--ceeeEEEee------ccCCeEEEEEE
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR--HLVSLIGFC------DEQSEMILVYE 584 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hp--nIv~l~g~~------~~~~~~~lV~E 584 (842)
...|..|....+|+....+ ..+++|+.... ...+...|++++..|.+. .+.+++... ...+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3456677778999987654 46888987642 234567788888888533 244444321 22345689999
Q ss_pred ecCCCCcccc----c----------ccC----CC-----CCCchHHHH----------HHHHHHHHHHHHHHh----CCC
Q 037607 585 YMANGPFRDH----L----------YGT----NQ-----PPLSWKQRL----------EICIGSARGLHYLHT----GAA 627 (842)
Q Consensus 585 y~~~gsL~~~----l----------~~~----~~-----~~l~~~~~~----------~I~~~ia~gL~yLH~----~~~ 627 (842)
|++|..+... + |.. .. ....|.... .....+...+.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776431 0 110 00 111221110 011122334444442 234
Q ss_pred CceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 628 ~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.+++|+|+.|.|||++++....|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999987778999997654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0022 Score=65.47 Aligned_cols=125 Identities=26% Similarity=0.353 Sum_probs=89.1
Q ss_pred cCcccceEEeecCc-EEEEEEEEcCCcEEEEEECCC---CCh------------------hhHHHHHHHHHHHHhcC---
Q 037607 508 QNFDENAVIGVGGF-GKVYIGVLEDGNKVAIKRGNP---GSE------------------QGINEFQTEIQMLSKLR--- 562 (842)
Q Consensus 508 ~~f~~~~~LG~G~f-g~Vykg~~~~g~~VAvK~~~~---~~~------------------~~~~~f~~Ei~il~~L~--- 562 (842)
.+++..+.||.|.- |.|||+.+. |+.+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 999999995 78999998221 100 11235888999888885
Q ss_pred CCce--eeEEEeeccC------------------CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHH
Q 037607 563 HRHL--VSLIGFCDEQ------------------SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622 (842)
Q Consensus 563 HpnI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yL 622 (842)
+.++ |+.+||..-. ..+.||.||.+... .+.. +-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 4566 8999987211 12467888775432 2222 3344556667889
Q ss_pred HhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 623 H~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
|. .+|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 98 99999999999976 3589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0041 Score=68.62 Aligned_cols=156 Identities=14% Similarity=0.166 Sum_probs=84.6
Q ss_pred cHHHHHHHhcCccc-----ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCC--ceeeEEE
Q 037607 499 TFTELQNATQNFDE-----NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR--HLVSLIG 571 (842)
Q Consensus 499 ~~~el~~at~~f~~-----~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hp--nIv~l~g 571 (842)
+..++......|.. .+.|+.|....+|+....+| .+++|+...... .+...|+.++..|... .+.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCccee
Confidence 34455544455543 23466677778999887655 688898652222 3344556666665321 1333332
Q ss_pred e------eccCCeEEEEEEecCCCCcccc--------------cccCC---------CCCCch-HHHHHH----------
Q 037607 572 F------CDEQSEMILVYEYMANGPFRDH--------------LYGTN---------QPPLSW-KQRLEI---------- 611 (842)
Q Consensus 572 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~---------~~~l~~-~~~~~I---------- 611 (842)
. ....+..++++||++|..+... +|... ...+.| .....-
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1 1234567899999998755321 01110 011112 111111
Q ss_pred --H-HHHHHHHHHHHh----CCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 612 --C-IGSARGLHYLHT----GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 612 --~-~~ia~gL~yLH~----~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
. ..+...++.+.. ....++||+|+.+.|||++.+...-|+||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1 111112233321 1346899999999999999766568999997654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0041 Score=68.30 Aligned_cols=155 Identities=16% Similarity=0.198 Sum_probs=89.1
Q ss_pred HHHHHHhcCccc-----ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCC--ceeeEEEee
Q 037607 501 TELQNATQNFDE-----NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR--HLVSLIGFC 573 (842)
Q Consensus 501 ~el~~at~~f~~-----~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hp--nIv~l~g~~ 573 (842)
+++....+.|.+ .+.++.|--..+|+....+| .+++|+...... ..+...|++++..|... .+.+.+...
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 445444445543 33466666688999876555 577887654321 23456677777777432 244444322
Q ss_pred ------ccCCeEEEEEEecCCCCcccc--------------cccCCC---C-------CCchHHHH------------HH
Q 037607 574 ------DEQSEMILVYEYMANGPFRDH--------------LYGTNQ---P-------PLSWKQRL------------EI 611 (842)
Q Consensus 574 ------~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~~---~-------~l~~~~~~------------~I 611 (842)
...+..++++||++|..+... +|.... . .-.|.... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 224567899999998654321 111000 0 01121110 00
Q ss_pred HHHHHHHHHHHHh----CCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 612 CIGSARGLHYLHT----GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 612 ~~~ia~gL~yLH~----~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
...+.+.++++.. ....++||+|+.+.||++++++...|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123334555542 2357899999999999999887778999997643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00068 Score=83.16 Aligned_cols=199 Identities=19% Similarity=0.211 Sum_probs=135.4
Q ss_pred HHHHHHHHHHHHhcCCCceeeEEEeeccCCeE----EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHH
Q 037607 548 INEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM----ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623 (842)
Q Consensus 548 ~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH 623 (842)
......|++.+..+.|+|++.++.|-.+.... .+..|++..-++...+ ..-...+..+.+.+..++.+||+|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34456678888889999999999887554333 3445777777777777 33456777889999999999999999
Q ss_pred hCCCCceEeccCCCC---CEEEcCCCceEEe--ecccccccCCCCCceeeeeccCCCCCCcccccccCCCC--cccchhH
Q 037607 624 TGAAQGIIHRDVKTT---NILLDENLVAKVA--DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE--KSDVYSF 696 (842)
Q Consensus 624 ~~~~~~ivHrDIKp~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~--ksDVwS~ 696 (842)
+ ....|.-+..+ +-..+..+...++ ||+..+....... .....-+..|.++|......+.. ..|+|.+
T Consensus 304 ~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 S---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred H---hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHH
Confidence 8 55555544444 4444566677777 8888777654322 12233455677888877665554 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 037607 697 GVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776 (842)
Q Consensus 697 GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl 776 (842)
|..+..+..|..+-..... ...+.+ ......+.+...+|+..++++|+...+++
T Consensus 379 gll~~~~~~~~~i~~~~~~------------------~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV------------------PVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccc------------------hhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999988654332110 001111 11111456777899999999999999988
Q ss_pred HHH
Q 037607 777 WNL 779 (842)
Q Consensus 777 ~~L 779 (842)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0026 Score=69.53 Aligned_cols=139 Identities=24% Similarity=0.298 Sum_probs=83.3
Q ss_pred EEeecCcEEEEEEEEcC-------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEEEec
Q 037607 515 VIGVGGFGKVYIGVLED-------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~-------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~ 586 (842)
.|..|-...+|+....+ ++.+++|+...... ...+..+|.+++..+....+ .++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45566667899888654 57899998655432 22455788888888854333 345555532 3689999
Q ss_pred CCCCcccc-----------------cccCCCC---------CCchHHHHH--------------------------HHHH
Q 037607 587 ANGPFRDH-----------------LYGTNQP---------PLSWKQRLE--------------------------ICIG 614 (842)
Q Consensus 587 ~~gsL~~~-----------------l~~~~~~---------~l~~~~~~~--------------------------I~~~ 614 (842)
+|..+... +|..... +.-|....+ +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98776531 1111111 001111111 1112
Q ss_pred HHHHHHHHHh------CCCCceEeccCCCCCEEEcCC----CceEEeecccccc
Q 037607 615 SARGLHYLHT------GAAQGIIHRDVKTTNILLDEN----LVAKVADFGLSKA 658 (842)
Q Consensus 615 ia~gL~yLH~------~~~~~ivHrDIKp~NILld~~----~~~kl~DFGla~~ 658 (842)
+.+-+..|.. .....++|+|+.+.|||++++ +.++++||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222334431 245679999999999999875 8899999997654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0009 Score=71.96 Aligned_cols=135 Identities=21% Similarity=0.211 Sum_probs=92.2
Q ss_pred cccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--C------------------hhhH--HHHHHHHHHHHhcC-CCc-
Q 037607 510 FDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--S------------------EQGI--NEFQTEIQMLSKLR-HRH- 565 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~------------------~~~~--~~f~~Ei~il~~L~-Hpn- 565 (842)
+...+.||-|.-+.||.+...+|++.++|.-... + ...+ -...+|...|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4667889999999999999999999998842111 0 0001 12457888888874 322
Q ss_pred eeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 566 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
|.+.++ .+..++|||++.+-+|...-+-. +.. .+...+..-+.-|.. +|+||+|..-=||+++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d~~---~ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHVE-----DPP---TLYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeecC-----ChH---HHHHHHHHHHHHHHH---cCceecccchheeEEecC
Confidence 333333 34678999999988887654222 112 333333344455555 899999999999999999
Q ss_pred CceEEeeccccccc
Q 037607 646 LVAKVADFGLSKAA 659 (842)
Q Consensus 646 ~~~kl~DFGla~~~ 659 (842)
+.++++||--+...
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999865444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.015 Score=64.92 Aligned_cols=139 Identities=17% Similarity=0.206 Sum_probs=81.9
Q ss_pred EEeecCcEEEEEEEEcC-----CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCcee-eEEEeeccCCeEEEEEEecCC
Q 037607 515 VIGVGGFGKVYIGVLED-----GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV-SLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~-----g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv-~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
.|-.|-.-.+|+..+.+ ++.+++|........... -.+|..+++.+..-++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45457777899987542 367999987665433323 37889999888544433 445555332 58999987
Q ss_pred CCcccc-----------------cccCCC---C-CCchHHHHHHHHH-----------------HHHHHHHHH----h-C
Q 037607 589 GPFRDH-----------------LYGTNQ---P-PLSWKQRLEICIG-----------------SARGLHYLH----T-G 625 (842)
Q Consensus 589 gsL~~~-----------------l~~~~~---~-~l~~~~~~~I~~~-----------------ia~gL~yLH----~-~ 625 (842)
.+|... +|.... . ...|.++.++..+ +...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 122110 1 1123333232211 111122222 1 2
Q ss_pred CCCceEeccCCCCCEEEcC-CCceEEeecccccc
Q 037607 626 AAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKA 658 (842)
Q Consensus 626 ~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~ 658 (842)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999976 47899999997654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.031 Score=60.49 Aligned_cols=71 Identities=13% Similarity=0.033 Sum_probs=42.2
Q ss_pred EeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC--Cc-eeeEEEeeccCCeEEEEEEecCCCCcc
Q 037607 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH--RH-LVSLIGFCDEQSEMILVYEYMANGPFR 592 (842)
Q Consensus 516 LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H--pn-Iv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (842)
.++|--..|+.....+|..+++|+-... .......+|.++|+.|.. +- +.+++..+ .-+++|+++.|..+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~~----~~~~~y~~i~G~p~~ 92 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRVHT----PELIAYPKLPGVPAA 92 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceeeec----CceEEEeccCCCccc
Confidence 3444455666654456889999986532 234567899999998852 21 12222221 225678888776553
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.04 Score=60.52 Aligned_cols=121 Identities=17% Similarity=0.245 Sum_probs=78.1
Q ss_pred CcEEEEEECC-CCChhhHHHHHHHHHHHHhcCC--CceeeEEEeeccCC--eEEEEEEecCCCCcccccccCCCCCCchH
Q 037607 532 GNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRH--RHLVSLIGFCDEQS--EMILVYEYMANGPFRDHLYGTNQPPLSWK 606 (842)
Q Consensus 532 g~~VAvK~~~-~~~~~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~ 606 (842)
++++++.+-. ...........+|.++|+.+.- --+...+++|.++. ..+.||+|++|..+.+.+..... .
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~-----~ 122 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL-----G 122 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc-----h
Confidence 7788888221 1222334556788888887743 23445577787666 77999999998655444321110 1
Q ss_pred HHHHHH-HHHHHHHHHHHhC-------------------------------------------------------CCCce
Q 037607 607 QRLEIC-IGSARGLHYLHTG-------------------------------------------------------AAQGI 630 (842)
Q Consensus 607 ~~~~I~-~~ia~gL~yLH~~-------------------------------------------------------~~~~i 630 (842)
.+.+ ..+++.|+-||+. ....+
T Consensus 123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l 200 (321)
T COG3173 123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL 200 (321)
T ss_pred --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence 1222 2555555555541 23459
Q ss_pred EeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 631 IHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 631 vHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
+|+|+.+.||+++.+..+=|.||+++...
T Consensus 201 vHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 201 VHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 99999999999999888999999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.019 Score=62.45 Aligned_cols=75 Identities=20% Similarity=0.323 Sum_probs=48.8
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC---CCceeeEEEeeccCCeEEEEEEecC
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
+....|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344578889999999987 568889999855 333457899999999884 3457788888877777799999998
Q ss_pred CC
Q 037607 588 NG 589 (842)
Q Consensus 588 ~g 589 (842)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0033 Score=71.30 Aligned_cols=162 Identities=22% Similarity=0.291 Sum_probs=91.4
Q ss_pred HHHHHHHHHHHhcCCCceeeEEEeeccCC-eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCC
Q 037607 549 NEFQTEIQMLSKLRHRHLVSLIGFCDEQS-EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627 (842)
Q Consensus 549 ~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~ 627 (842)
.+.+-...+++.++|+|+...+.+..... ...+|+|++ +.||++.+.... +-.. .++ -
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~----------s~~--~----- 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE----------SLL--A----- 85 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh----------hhc--c-----
Confidence 45677788999999999999998875433 478899998 568888773221 1110 001 1
Q ss_pred CceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCC
Q 037607 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 707 (842)
Q Consensus 628 ~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~ 707 (842)
+++.|-.+ .+.+| -++.. | |- ...+|+|||++|.++.|+..|.
T Consensus 86 ~~~~~~~~------------~~~td-~~~t~-----------------~--~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 86 HGVLHLNI------------IYITD-HFLTK-----------------Y--PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred cccceehh------------hhccc-ccccc-----------------C--CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 33333322 22233 11000 0 10 1114999999999999999998
Q ss_pred CCCCCCCchhhhhHHHHHHHhh-cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHH
Q 037607 708 PVINPKLPREQVSLAEWALQCH-RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGD 774 (842)
Q Consensus 708 ~p~~~~~~~~~~~l~~~~~~~~-~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~e 774 (842)
..+......+.... ..... ..+....+. ....+..++..+++++..+|+...|..||...+
T Consensus 129 ~l~~~~~~s~~l~~---i~k~~~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 129 SLEAELTESEYLEI---LLKYYTDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHHH---HHHhccCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 66554333222111 11111 011000000 111334566778899999999999998885543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.096 Score=57.57 Aligned_cols=32 Identities=16% Similarity=0.231 Sum_probs=28.8
Q ss_pred CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 627 ~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
..++||+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.00098 Score=83.28 Aligned_cols=160 Identities=14% Similarity=0.014 Sum_probs=113.7
Q ss_pred HHHHHHHHHHhcCCCceeeEEEee--ccCCeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhC
Q 037607 550 EFQTEIQMLSKLRHRHLVSLIGFC--DEQSEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTG 625 (842)
Q Consensus 550 ~f~~Ei~il~~L~HpnIv~l~g~~--~~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~ 625 (842)
....|...++...|+++.....-. .+..+.+.+++|+..|.+.+.|.+ ++...++..-+...-.+......-+|..
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 344555566667898887665443 234567899999999999998854 2334455544444444434445555542
Q ss_pred C--CCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHH
Q 037607 626 A--AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 703 (842)
Q Consensus 626 ~--~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~EL 703 (842)
. ..-.+|+++|+.|.+|..+.++|+.++||.+....... ......+++-|+.|+......++.++|+|..|+.+|++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2 23478999999999999999999999999984332221 12234567789999998888999999999999999999
Q ss_pred HhCCCCC
Q 037607 704 LCARPVI 710 (842)
Q Consensus 704 ltG~~p~ 710 (842)
..|.+++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.055 Score=60.28 Aligned_cols=73 Identities=21% Similarity=0.254 Sum_probs=48.3
Q ss_pred EEeecCcEEEEEEEEcCC-cEEEEEECCCC-------ChhhHHHHHHHHHHHHhcC--CCceeeEEEeeccCCeEEEEEE
Q 037607 515 VIGVGGFGKVYIGVLEDG-NKVAIKRGNPG-------SEQGINEFQTEIQMLSKLR--HRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g-~~VAvK~~~~~-------~~~~~~~f~~Ei~il~~L~--HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.||.|...-||++...+| +.|+||.-.+. -+-...+..-|.+.|+... -|..++-+ |+.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence 378999999999997654 58999964321 1233456667888887663 35434332 2345566789999
Q ss_pred ecCC
Q 037607 585 YMAN 588 (842)
Q Consensus 585 y~~~ 588 (842)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.13 Score=58.38 Aligned_cols=73 Identities=21% Similarity=0.221 Sum_probs=50.2
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCC----h---hhHHHHHHHHHHHHhcC---CCceeeEEEeeccCCeEEEE
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS----E---QGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~----~---~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~~~~~lV 582 (842)
.+.||.|....||+.... +..++||+-.+.. . ....+-..|.+.|+.+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 346899999999998764 5579999855211 1 13344455677776653 247778888887 456888
Q ss_pred EEecCC
Q 037607 583 YEYMAN 588 (842)
Q Consensus 583 ~Ey~~~ 588 (842)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.069 Score=59.37 Aligned_cols=139 Identities=15% Similarity=0.201 Sum_probs=78.8
Q ss_pred EEeecCcEEEEEEEEcC----CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCcee-eEEEeeccCCeEEEEEEecCCC
Q 037607 515 VIGVGGFGKVYIGVLED----GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV-SLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv-~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
.|..|-.-.+|+....+ +..|++|+........ -.-.+|..+++.+..-++. ++++++.. + +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence 44446667788887543 2378899866544322 2336889999988655443 45555532 2 589999877
Q ss_pred Ccccc-----------------cccCC---CC-CCchHHHHHHHHH----------------------HHHHHHHHHh--
Q 037607 590 PFRDH-----------------LYGTN---QP-PLSWKQRLEICIG----------------------SARGLHYLHT-- 624 (842)
Q Consensus 590 sL~~~-----------------l~~~~---~~-~l~~~~~~~I~~~----------------------ia~gL~yLH~-- 624 (842)
.|... +|... .. +--|..+.++..+ +.+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 11111 01 1112222222211 1111222211
Q ss_pred ---CCCCceEeccCCCCCEEEcC-CCceEEeecccccc
Q 037607 625 ---GAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKA 658 (842)
Q Consensus 625 ---~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~ 658 (842)
....-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234899999999999974 57899999997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.07 Score=58.77 Aligned_cols=140 Identities=20% Similarity=0.218 Sum_probs=90.6
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECCCCC-------------------------hhhHH-HHHHHHHHHHhcCCCc
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS-------------------------EQGIN-EFQTEIQMLSKLRHRH 565 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~-------------------------~~~~~-~f~~Ei~il~~L~Hpn 565 (842)
+..+|..|.-+.||.+.-.+|..+|||+.+... ....+ =...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788999999999999999999999644210 00000 0235677777775432
Q ss_pred eeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 566 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
|..---. .-....|||+|+-...-..-. .....++...+..+-.++++-|.-|.+. .++||.||.--|+|+- +
T Consensus 228 IP~PePI--lLk~hVLVM~FlGrdgw~aPk--LKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 228 IPCPEPI--LLKNHVLVMEFLGRDGWAAPK--LKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCce--eeecceEeeeeccCCCCcCcc--cccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence 2110000 012357999998422111100 1234566677888888888888888874 5699999999999995 5
Q ss_pred CceEEeecccccc
Q 037607 646 LVAKVADFGLSKA 658 (842)
Q Consensus 646 ~~~kl~DFGla~~ 658 (842)
|.+.|+|-+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 7899999886544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.052 Score=56.04 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=22.0
Q ss_pred CceEeccCCCCCEEE-cCCCceEEeecccccc
Q 037607 628 QGIIHRDVKTTNILL-DENLVAKVADFGLSKA 658 (842)
Q Consensus 628 ~~ivHrDIKp~NILl-d~~~~~kl~DFGla~~ 658 (842)
.-++|+|+.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458999999999999 8899999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.13 Score=56.17 Aligned_cols=31 Identities=32% Similarity=0.448 Sum_probs=26.3
Q ss_pred CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 627 ~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 467999999999999987 6789999996543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.23 Score=55.07 Aligned_cols=136 Identities=21% Similarity=0.236 Sum_probs=81.0
Q ss_pred CcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC---CCceee---EEEee--ccC--CeEEEEEEecCCC
Q 037607 520 GFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR---HRHLVS---LIGFC--DEQ--SEMILVYEYMANG 589 (842)
Q Consensus 520 ~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~---HpnIv~---l~g~~--~~~--~~~~lV~Ey~~~g 589 (842)
.-..+|+...++|.. ++|...+. ....+...|+..|..|. .+=.++ +=|-. .-. ...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445789988877776 88887765 23356677788887773 222222 11111 112 3788999999998
Q ss_pred Cccc-cc--------------cc--CC-----C---CCCchH-------------HHHHHHHHHHHHHHHHHhC----CC
Q 037607 590 PFRD-HL--------------YG--TN-----Q---PPLSWK-------------QRLEICIGSARGLHYLHTG----AA 627 (842)
Q Consensus 590 sL~~-~l--------------~~--~~-----~---~~l~~~-------------~~~~I~~~ia~gL~yLH~~----~~ 627 (842)
.+.. .- |. +. . ....|. .......++...++.+.+. ..
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 00 10 0 122333 0111233334444444431 22
Q ss_pred Cc---eEeccCCCCCEEEcCCCc-eEEeecccccc
Q 037607 628 QG---IIHRDVKTTNILLDENLV-AKVADFGLSKA 658 (842)
Q Consensus 628 ~~---ivHrDIKp~NILld~~~~-~kl~DFGla~~ 658 (842)
.. +||+|+.|.|||++.+.. ..++||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 999999999999998875 88999997643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.26 Score=62.92 Aligned_cols=140 Identities=18% Similarity=0.269 Sum_probs=79.7
Q ss_pred EEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-------CCceeeEE-E----eecc-CC--eE
Q 037607 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-------HRHLVSLI-G----FCDE-QS--EM 579 (842)
Q Consensus 515 ~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-------HpnIv~l~-g----~~~~-~~--~~ 579 (842)
.|+ |..-.+|+....+|..+++|+.+..... .....|.+.|..|. -|.+++-. | .... .+ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 453 4557789888878889999998865332 33444555665552 23333321 1 1111 22 46
Q ss_pred EEEEEecCCCCccccc-----------------cc--------CCCCCCchHH-----------------HHHHHHHHHH
Q 037607 580 ILVYEYMANGPFRDHL-----------------YG--------TNQPPLSWKQ-----------------RLEICIGSAR 617 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l-----------------~~--------~~~~~l~~~~-----------------~~~I~~~ia~ 617 (842)
+-+++|++|..|.+.. +. .....+.|.. ...++.++.+
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 7789999998776511 00 0112233321 1122223332
Q ss_pred HHH-----HHHhCCCCceEeccCCCCCEEEcCCC--ceE-Eeecccccc
Q 037607 618 GLH-----YLHTGAAQGIIHRDVKTTNILLDENL--VAK-VADFGLSKA 658 (842)
Q Consensus 618 gL~-----yLH~~~~~~ivHrDIKp~NILld~~~--~~k-l~DFGla~~ 658 (842)
.++ .|. ....++||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 222 122 2456799999999999998875 555 999997654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 842 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-98 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-97 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-37 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-23 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-23 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-20 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 556 bits (1435), Expect = 0.0
Identities = 187/323 (57%), Positives = 229/323 (70%), Gaps = 8/323 (2%)
Query: 469 SSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV 528
S+ S + S + +L+ AT NFD +IG G FGKVY GV
Sbjct: 2 GSKYSK--ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV 59
Query: 529 LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588
L DG KVA+KR P S QGI EF+TEI+ LS RH HLVSLIGFCDE++EMIL+Y+YM N
Sbjct: 60 LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 589 GPFRDHLYGTNQP--PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646
G + HLYG++ P +SW+QRLEICIG+ARGLHYLHT A IIHRDVK+ NILLDEN
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176
Query: 647 VAKVADFGLSKAAP-MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
V K+ DFG+SK +D+ ++ST VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEVLC
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 706 ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEY 765
AR I LPRE V+LAEWA++ H G LE+I+DP +A+ I ESLRK+ + A KCLA
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 766 GVDRPGMGDVLWNLEYAMQLQEA 788
DRP MGDVLW LEYA++LQE+
Sbjct: 297 SEDRPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-123
Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 21/299 (7%)
Query: 496 RFFTFTELQNATQNFDENA------VIGVGGFGKVYIGVLEDGNKVAIKR----GNPGSE 545
F+F EL+N T NFDE +G GGFG VY G + + VA+K+ + +E
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 546 QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG-TNQPPLS 604
+ +F EI++++K +H +LV L+GF + ++ LVY YM NG D L PPLS
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 605 WKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM-DR 663
W R +I G+A G+++LH IHRD+K+ NILLDE AK++DFGL++A+ +
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723
+++ + G+ Y+ PE R ++T KSD+YSFGVVL E++ P ++ RE L +
Sbjct: 189 TVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLD 245
Query: 724 WALQCHR-KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781
+ + +E ID + + S+ A +CL E RP + V L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-122
Identities = 117/293 (39%), Positives = 165/293 (56%), Gaps = 5/293 (1%)
Query: 493 GLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGIN-EF 551
G + F+ ELQ A+ NF ++G GGFGKVY G L DG VA+KR QG +F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 552 QTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGT--NQPPLSWKQRL 609
QTE++M+S HR+L+ L GFC +E +LVY YMANG L +QPPL W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
I +GSARGL YLH IIHRDVK NILLDE A V DFGL+K +V+TA
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ--VSLAEWALQ 727
V+G+ G++ PEY + +EK+DV+ +GV+L E++ + + V L +W
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
++ LE ++D + E + + ++ A C ++RP M +V+ LE
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 1e-78
Identities = 69/309 (22%), Positives = 116/309 (37%), Gaps = 28/309 (9%)
Query: 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTE 554
G L + V G FG V+ L VA+K +Q + + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYE 68
Query: 555 IQMLSKLRHRHLVSLIGFCDE----QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
+ L ++H +++ IG ++ L+ + G D L +SW +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCH 125
Query: 611 ICIGSARGLHYLHTGAAQ-------GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663
I ARGL YLH I HRD+K+ N+LL NL A +ADFGL+ +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 664 GYV-STAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717
+ G+ Y+ PE ++ + D+Y+ G+VL+E+ + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 718 QVSLAEWALQCH-----RKGILEKIIDPVIAETICK-ESLRKYVEAAEKCLAEYGVDRPG 771
+ E Q ++ ++ K PV+ + K + E E+C R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 772 MGDVLWNLE 780
G V +
Sbjct: 306 AGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 21/269 (7%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FG V+ G+ VA+K + +NEF E+ ++ +LRH ++V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQ-PPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
+ + +V EY++ G L+ + L ++RL + A+G++YLH I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
HR++K+ N+L+D+ KV DFGLS+ S + G+ ++ PE R + EKS
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 692 DVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751
DVYSFGV+L+E+ + P ++ A+ + K I +
Sbjct: 221 DVYSFGVILWELATL------QQPWGNLNPAQVVA-----AVGFKCKRLEIPRN-LNPQV 268
Query: 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ E C RP ++ L
Sbjct: 269 AAII---EGCWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 28/289 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
V+G G FG V VAIK+ SE F E++ LS++ H ++V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPP-LSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ LV EY G + L+G P + + C+ ++G+ YLH+ + +IHR
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 634 DVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
D+K N+LL V K+ DFG + D T KGS ++ PE F +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 693 VYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751
V+S+G++L+EV+ R P P ++ A R P + + + +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VHNGTR---------PPLIKN-LPKPI 233
Query: 752 RKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ-LQEASTQIDHPEDKS 799
+ +C ++ RP M +++ + + M+ A + +P S
Sbjct: 234 ESLM---TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-60
Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 34/278 (12%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ----GINEFQTEIQMLSKLRHRHLVSLI 570
+IG+GGFGKVY G++VA+K ++ I + E ++ + L+H ++++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
G C ++ + LV E+ GP L G + + + ARG++YLH A I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 631 IHRDVKTTNILLDE--------NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
IHRD+K++NIL+ + N + K+ DFGL++ R +A G++ ++ PE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA-GAYAWMAPEVI 186
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742
R ++ SDV+S+GV+L+E+L ++P + A G+ + I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAY-----GVAMNKLALPI 235
Query: 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
T C E K + E C RP ++L L
Sbjct: 236 PST-CPEPFAKLM---EDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-60
Identities = 51/282 (18%), Positives = 116/282 (41%), Gaps = 37/282 (13%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
+ G+++ G GN + +K S + +F E L H +++ ++G
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 573 CDE--QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630
C L+ +M G + L+ + Q ++ + ARG+ +LHT I
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134
Query: 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL--- 687
+ + ++++DE++ A+++ + + S + ++ PE +++
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI---IDPVIAE 744
+D++SF V+L+E++ ++P +S E ++ +G+ I I P +++
Sbjct: 189 RRSADMWSFAVLLWELVTR------EVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786
+ + C+ E RP ++ LE MQ +
Sbjct: 243 LM------------KICMNEDPAKRPKFDMIVPILE-KMQDK 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 9e-60
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 46/307 (14%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
+IG G FG+VY G +VAI+ + +E + F+ E+ + RH ++V +G
Sbjct: 40 LIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
C + ++ + L + +I +G+ YLH A+GI+H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 633 RDVKTTNILLDENLVAKVADFGLSK----AAPMDRGYVSTAVKGSFGYLDPEYFRRQQL- 687
+D+K+ N+ D V + DFGL R G +L PE R+
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 688 --------TEKSDVYSFGVVLFEVLCARPVINP--KLPREQVSLAEWALQCHRKGILEKI 737
++ SDV++ G + +E+ P P E + W + K
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW---PFKTQPAEAII---WQMGTGMK------ 260
Query: 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPED 797
P +++ + + + C A +RP ++ LE +L + + ++ HP
Sbjct: 261 --PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE---KLPKRNRRLSHPGH 312
Query: 798 --KSANL 802
KSA L
Sbjct: 313 FWKSAEL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 72/330 (21%), Positives = 124/330 (37%), Gaps = 41/330 (12%)
Query: 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQG-INEFQTEIQ 556
+E N +IG G +G VY G L D VA+K + + Q INE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE--KNIY 59
Query: 557 MLSKLRHRHLVSLIGFC-----DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEI 611
+ + H ++ I D + E +LV EY NG +L + W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116
Query: 612 CIGSARGLHYLHTGAAQG------IIHRDVKTTNILLDENLVAKVADFGLSK-------A 658
RGL YLHT +G I HRD+ + N+L+ + ++DFGLS
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 659 APMDRGYVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVIN 711
P + + + G+ Y+ PE + ++ D+Y+ G++ +E+ +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 712 PKLPREQVSLA-EWALQCH------RKGILEKIIDPVIAETICKES--LRKYVEAAEKCL 762
P + +A + + H + + + P E + S +R E E C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 763 AEYGVDRPGMGDVLWNLEYAMQLQEASTQI 792
+ R + M + E + +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-58
Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 24/271 (8%)
Query: 516 IGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG VY G VA+K N + Q + F+ E+ +L K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
I V ++ HL+ ++ K+ ++I +ARG+ YLH A+ IIHR
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 634 DVKTTNILLDENLVAKVADFGLSKA-APMDRGYVSTAVKGSFGYLDPEYFRRQQL---TE 689
D+K+ NI L E+ K+ DFGL+ + + + GS ++ PE R Q +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 690 KSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKE 749
+SDVY+FG+VL+E++ + LP ++ + ++ +G L + V + C +
Sbjct: 205 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSPDLSKVRSN--CPK 256
Query: 750 SLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+++ + +CL + +RP +L +E
Sbjct: 257 RMKRLM---AECLKKKRDERPSFPRILAEIE 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 36/281 (12%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKR-------GNPGSEQGINEFQTEIQMLSKLRHRHL 566
IG GGFG V+ G ++D + VAIK G + EFQ E+ ++S L H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V L G +V E++ G L P+ W +L + + A G+ Y+
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 627 AQGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
I+HRD+++ NI L + AKVADFGLS+ + + + G+F ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPET 197
Query: 682 FRRQQL--TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739
++ TEK+D YSF ++L+ +L + P ++ S + I E+ +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTG------EGPFDEYSYGKIKFI---NMIREEGLR 248
Query: 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
P I E C LR + E C + RP ++ L
Sbjct: 249 PTIPED-CPPRLRNVI---ELCWSGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 33/296 (11%)
Query: 515 VIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
V+G G FG+ E G + +K E+ F E++++ L H +++ IG
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ + + EY+ G R + + W QR+ A G+ YLH + IIHR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 634 DVKTTNILLDENLVAKVADFGLS-------------KAAPMDRGYVSTAVKGSFGYLDPE 680
D+ + N L+ EN VADFGL+ ++ V G+ ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740
+ EK DV+SFG+VL E++ LPR + +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR-TMDFGLNVRGFLDRYCPPN---- 247
Query: 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPE 796
C S +C RP + LE +++ A P+
Sbjct: 248 ------CPPSFF---PITVRCCDLDPEKRPSFVKLEHWLE-TLRMHLAGHLPLGPQ 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-53
Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 28/289 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC- 573
IG G +G+V++G G KVA+K E +TEI +RH +++ I
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAADI 101
Query: 574 ---DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-- 628
+++ L+ +Y NG D+L L K L++ S GL +LHT
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 629 ---GIIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGYVSTAVKGSFGYLDPE-- 680
I HRD+K+ NIL+ +N +AD GL+ + + G+ Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 681 ----YFRRQQLTEKSDVYSFGVVLFEVLC----ARPVINPKLPREQVSLAEWALQCHRKG 732
Q +D+YSFG++L+EV V +LP + ++ + + R+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 733 ILEKIIDPVIAETICKES-LRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ K + P + LR+ + +C A R V L
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 30/290 (10%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G +G+V+ G G VA+K + E+ E TE+ LRH +++ I
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASD 71
Query: 574 ----DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ- 628
+++ L+ Y G D+L L L I + A GL +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 629 ----GIIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGYVSTAVKGSFGYLDPE- 680
I HRD+K+ NIL+ +N +AD GL+ + + G+ Y+ PE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 681 -----YFRRQQLTEKSDVYSFGVVLFEVLC----ARPVINPKLPREQVSLAEWALQCHRK 731
++ D+++FG+VL+EV V + K P V + + + RK
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 732 GILEKIIDPVIAETICKES-LRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ P I + L + ++C + R + L
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 9e-50
Identities = 70/290 (24%), Positives = 130/290 (44%), Gaps = 30/290 (10%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG+V+ G G +VA+K + E+ E EI LRH +++ I
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105
Query: 574 ----DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ- 628
+++ LV +Y +G D+L N+ ++ + +++ + +A GL +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 629 ----GIIHRDVKTTNILLDENLVAKVADFGLSK---AAPMDRGYVSTAVKGSFGYLDPE- 680
I HRD+K+ NIL+ +N +AD GL+ +A G+ Y+ PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 681 -----YFRRQQLTEKSDVYSFGVVLFEVL--CARPVINP--KLPREQVSLAEWALQCHRK 731
+ + +++D+Y+ G+V +E+ C+ I+ +LP + ++ +++ RK
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 732 GILEKIIDPVIAETI-CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ E+ + P I E+LR + +C G R + L
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-46
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 515 VIGVGGFGKVYIGVLEDGN-KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G FG+V+ G L N VA+K +F E ++L + H ++V LIG
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
C ++ + +V E + G F L T L K L++ +A G+ YL ++ IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY--LDPEYFRRQQLTEK 690
RD+ N L+ E V K++DFG+S+ D Y ++ PE + + +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 691 SDVYSFGVVLFEVL 704
SDV+SFG++L+E
Sbjct: 296 SDVWSFGILLWETF 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-44
Identities = 70/205 (34%), Positives = 100/205 (48%), Gaps = 5/205 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FG+V++G +VAIK PG+ F E Q++ KLRH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
E+ I V EYM+ G D L G L Q +++ A G+ Y+ +HRD
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 694
++ NIL+ ENLV KVADFGL++ + K + PE + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 695 SFGVVLFEVLCARPVINPKLPREQV 719
SFG++L E+ V P + +V
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREV 390
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FG+V++G KVA+K GS + F E ++ +L+H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
++ I + EYM NG D L + L+ + L++ A G+ ++ + IHRD
Sbjct: 79 QEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 694
++ NIL+ + L K+ADFGL++ + K + PE T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 695 SFGVVLFEVL 704
SFG++L E++
Sbjct: 195 SFGILLTEIV 204
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 515 VIGVGGFGKVYIGVLE-----DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FG V + + G VA+K+ +E+ + +F+ EI++L L+H ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 570 IGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
G C + L+ EY+ G RD+L ++ + + L+ +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLG---T 132
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRRQ 685
+ IHRD+ T NIL++ K+ DFGL+K P D+ + G + PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 686 QLTEKSDVYSFGVVLFEVL 704
+ + SDV+SFGVVL+E+
Sbjct: 193 KFSVASDVWSFGVVLYELF 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 491 NQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNK-----VAIKRGNPG-S 544
NQ L R TE + V+G G FG VY G+ + VAIK S
Sbjct: 5 NQALLRILKETEFKKIK-------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 545 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS 604
+ E E +++ + + H+ L+G C + + + + M G D++ ++ +
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR-EHKDNIG 115
Query: 605 WKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664
+ L C+ A+G++YL + ++HRD+ N+L+ K+ DFGL+K +
Sbjct: 116 SQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 665 YVSTA-----VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 704
+K ++ E + T +SDV+S+GV ++E++
Sbjct: 173 EYHAEGGKVPIK----WMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-43
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 5/190 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FG+V++ KVA+K PGS F E ++ L+H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
++ I + E+MA G D L + ++ A G+ ++ + IHRD
Sbjct: 254 KEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 694
++ NIL+ +LV K+ADFGL++ + K + PE T KSDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 695 SFGVVLFEVL 704
SFG++L E++
Sbjct: 370 SFGILLMEIV 379
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 5/190 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
IG G FG V++G + +KVAIK G+ +F E +++ KL H LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
EQ+ + LV E+M +G D+L T + + + L +C+ G+ YL +IHRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 694
+ N L+ EN V KV+DFG+++ D+ ST K + PE F + + KSDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 695 SFGVVLFEVL 704
SFGV+++EV
Sbjct: 190 SFGVLMWEVF 199
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-43
Identities = 70/205 (34%), Positives = 100/205 (48%), Gaps = 5/205 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FG+V++G +VAIK PG+ F E Q++ KLRH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
E+ I V EYM+ G D L G L Q +++ A G+ Y+ +HRD
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 694
++ NIL+ ENLV KVADFGL++ + K + PE + T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 695 SFGVVLFEVLCARPVINPKLPREQV 719
SFG++L E+ V P + +V
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREV 473
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 515 VIGVGGFGKVYIGVLE-----DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FG V + + G VA+K+ +E+ + +F+ EI++L L+H ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 570 IGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
G C + L+ EY+ G RD+L ++ + + L+ +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---GT 163
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRRQ 685
+ IHRD+ T NIL++ K+ DFGL+K P D+ Y G + PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 686 QLTEKSDVYSFGVVLFEVL 704
+ + SDV+SFGVVL+E+
Sbjct: 224 KFSVASDVWSFGVVLYELF 242
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 516 IGVGGFGKVYIGVLEDGNK---VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+G G FG V GV K VAIK G + E E Q++ +L + ++V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631
C ++ M+ V E GP L G + + E+ + G+ YL + +
Sbjct: 78 VCQAEALML-VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL---EEKNFV 132
Query: 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRRQQLTE 689
HRD+ N+LL AK++DFGLSKA D Y + G + + PE ++ +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 690 KSDVYSFGVVLFEVL 704
+SDV+S+GV ++E L
Sbjct: 193 RSDVWSYGVTMWEAL 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 512 ENAVIGVGGFGKVYIGVLEDGN---KVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHL 566
E+ +G G FG V G + VA+K + +E E ++ +L + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V +IG C+ +S M+ V E GP +L + K +E+ + G+ YL
Sbjct: 81 VRMIGICEAESWML-VMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRR 684
+HRD+ N+LL AK++DFGLSKA D Y G + + PE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 685 QQLTEKSDVYSFGVVLFEVL 704
+ + KSDV+SFGV+++E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 515 VIGVGGFGKVYIGVLEDGN----KVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+G G FG V G + + VA+K + +++F E+ + L HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L G + V E G D L +Q + A G+ YL +
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY--LDPEYFRRQ 685
+ IHRD+ N+LL + K+ DFGL +A P + + + PE + +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 686 QLTEKSDVYSFGVVLFEVL 704
+ SD + FGV L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FGKV + + VA+K P I + + EI++L L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 569 LIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
G C E + L+ E++ +G +++L N+ ++ KQ+L+ + +G+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF--GYLDPEYFRR 684
++ +HRD+ N+L++ K+ DFGL+KA D+ Y + + PE +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 685 QQLTEKSDVYSFGVVLFEVL 704
+ SDV+SFGV L E+L
Sbjct: 204 SKFYIASDVWSFGVTLHELL 223
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FG V G VAIK GS +EF E +++ L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
+Q + ++ EYMANG ++L + +Q LE+C + YL ++ +HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVS---------TAVKGSFGYLDPEYFRRQ 685
+ N L+++ V KV+DFGLS+ D S + PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------PEVLMYS 196
Query: 686 QLTEKSDVYSFGVVLFEVL 704
+ + KSD+++FGV+++E+
Sbjct: 197 KFSSKSDIWAFGVLMWEIY 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 38/213 (17%)
Query: 515 VIGVGGFGKVYIGVLEDGN--------KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL 566
+G G F K++ GV + +V +K + F M+SKL H+HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V G C E ILV E++ G +L N+ ++ +LE+ A +H+L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 627 AQGIIHRDVKTTNILLD--------ENLVAKVADFGLSKAAPMDRGYVS----TAVKGSF 674
+IH +V NILL K++D G+S
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP----- 185
Query: 675 GYLDPE---YFRRQQLTEKSDVYSFGVVLFEVL 704
PE + L +D +SFG L+E+
Sbjct: 186 ----PECIENPKN--LNLATDKWSFGTTLWEIC 212
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 62/190 (32%), Positives = 99/190 (52%), Gaps = 5/190 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
+G G FG V +G + VA+K GS +EF E Q + KL H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 634
++ + +V EY++NG ++L ++ L Q LE+C G+ +L + IHRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 635 VKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 694
+ N L+D +L KV+DFG+++ D+ S K + PE F + + KSDV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 695 SFGVVLFEVL 704
+FG++++EV
Sbjct: 190 AFGILMWEVF 199
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 515 VIGVGGFGKVYIGVL-----EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FG V + G VA+K+ +FQ EIQ+L L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 570 IGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
G + LV EY+ +G RD L ++ L + L +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG---S 145
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSFGYLDPEYFRRQ 685
+ +HRD+ NIL++ K+ADFGL+K P+D+ Y V + + PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 686 QLTEKSDVYSFGVVLFEV--LCARP 708
+ +SDV+SFGVVL+E+ C +
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-42
Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 515 VIGVGGFGKVYIGVLEDGN-KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G +G+VY GV + + VA+K + + + EF E ++ +++H +LV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ ++ E+M G D+L N+ +S L + + + YL + IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 342
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
++ N L+ EN + KVADFGLS+ D K + PE + + KSDV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 694 YSFGVVLFEVL 704
++FGV+L+E+
Sbjct: 403 WAFGVLLWEIA 413
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
++G G FG+VY GV + VA+K + +F +E ++ L H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
IG +E+ I + E G +L N+ L + + + + YL +
Sbjct: 79 IGIIEEEPTWI-IMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL---ESIN 133
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+HRD+ NIL+ K+ DFGLS+ + Y ++ + ++ PE ++ T
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 690 KSDVYSFGVVLFEVL 704
SDV+ F V ++E+L
Sbjct: 194 ASDVWMFAVCMWEIL 208
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-42
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 27/288 (9%)
Query: 437 QRRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGR 496
H +R S ++ +L + +SL+ S++ Y + +
Sbjct: 10 HHHHHG-RRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL 68
Query: 497 FFTFTELQNATQNFDE---------NAVIGVGGFGKVYIGVLEDGNK----VAIKRGNPG 543
EL A Q+ N VIG G FG VY G L D + A+K N
Sbjct: 69 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 544 -SEQGINEFQTEIQMLSKLRHRHLVSLIGFC-DEQSEMILVYEYMANGPFRDHLYGTNQP 601
+++F TE ++ H +++SL+G C + ++V YM +G R+ +
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETH 187
Query: 602 PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661
+ K + + A+G+ +L A++ +HRD+ N +LDE KVADFGL++
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-Y 243
Query: 662 DRGYVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
D+ + S + L E + Q+ T KSDV+SFGV+L+E++
Sbjct: 244 DKEFDSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 31/201 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
IG G FG V +G GNKVA+K + F E ++++LRH +LV L+G
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 575 EQSEMI-LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
E+ + +V EYMA G D+L + L L+ + + YL +HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS----------TAVKGSFGYLDPEYFR 683
D+ N+L+ E+ VAKV+DFGL+K A + TA PE R
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTA---------PEALR 187
Query: 684 RQQLTEKSDVYSFGVVLFEVL 704
++ + KSDV+SFG++L+E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-42
Identities = 65/191 (34%), Positives = 99/191 (51%), Gaps = 11/191 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
IG G FG V +G GNKVA+K + F E ++++LRH +LV L+G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 575 EQSEMI-LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
E+ + +V EYMA G D+L + L L+ + + YL +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 313
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDV 693
D+ N+L+ E+ VAKV+DFGL+K A + VK + PE R ++ + KSDV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSDV 369
Query: 694 YSFGVVLFEVL 704
+SFG++L+E+
Sbjct: 370 WSFGILLWEIY 380
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
+IG G G+V G L + VAIK G +E+ +F +E ++ + H +++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
G ++V EYM NG L T+ + Q + + G G+ YL + G
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL--DPEYFRRQQL 687
+HRD+ N+L+D NLV KV+DFGLS+ D T G PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 688 TEKSDVYSFGVVLFEVL 704
+ SDV+SFGVV++EVL
Sbjct: 232 SSASDVWSFGVVMWEVL 248
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
V+G G FG V+ GV + V IK G + + + L H H+V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAIGSLDHAHIV 78
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L+G C S + V +Y+ G DH+ ++ L + L + A+G++YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EE 133
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-----VKGSFGYLDPEYF 682
G++HR++ N+LL +VADFG++ P D + + +K ++ E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALESI 189
Query: 683 RRQQLTEKSDVYSFGVVLFEVL 704
+ T +SDV+S+GV ++E++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELM 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FG VY G L D + A+K N +++F TE ++ H +++SL
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 570 IGFC-DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
+G C + ++V YM +G R+ + + K + + A+G+ YL A++
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL-----DPEYFR 683
+HRD+ N +LDE KVADFGL++ M + + L E +
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 684 RQQLTEKSDVYSFGVVLFEVL 704
Q+ T KSDV+SFGV+L+E++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELM 226
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 15/196 (7%)
Query: 515 VIGVGGFGKVYIGVLEDGN-KVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G +G+VY GV + + VA+K + + + EF E ++ +++H +LV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ ++ E+M G D+L N+ +S L + + + YL + IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-----VKGSFGYLDPEYFRRQQLT 688
D+ N L+ EN + KVADFGLS+ D Y + A +K + PE + +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK----WTAPESLAYNKFS 190
Query: 689 EKSDVYSFGVVLFEVL 704
KSDV++FGV+L+E+
Sbjct: 191 IKSDVWAFGVLLWEIA 206
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
V+G G FG+V G L+ +K VAIK G +E+ +F E ++ + H +++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
G + +++V EYM NG L + + Q + + G A G+ YL + G
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL--DPEYFRRQQL 687
+HRD+ NIL++ NLV KV+DFGL + D T G PE ++
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 688 TEKSDVYSFGVVLFEVL 704
T SDV+S+G+VL+EV+
Sbjct: 228 TSASDVWSYGIVLWEVM 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 10/195 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
IG G FG V+ G+ VAIK S+ +F E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
IG E I + E G R L + L + + L YL ++
Sbjct: 82 IGVITENPVWI-IMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+HRD+ N+L+ N K+ DFGLS+ Y ++ K ++ PE ++ T
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 690 KSDVYSFGVVLFEVL 704
SDV+ FGV ++E+L
Sbjct: 197 ASDVWMFGVCMWEIL 211
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 67/198 (33%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 515 VIGVGGFGKVYIGVLEDGN-----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
VIG G FG+VY G+L+ + VAIK G +E+ +F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L G + M+++ EYM NG L S Q + + G A G+ YL A
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY--LDPEYFRRQQ 686
+HRD+ NIL++ NLV KV+DFGLS+ D T G PE ++
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 687 LTEKSDVYSFGVVLFEVL 704
T SDV+SFG+V++EV+
Sbjct: 227 FTSASDVWSFGIVMWEVM 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-41
Identities = 48/201 (23%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVS 568
V+G G FG VY G+ + VAIK + + E E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L+G C + + + + M G D++ ++ + + L C+ A+G++YL +
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA-----VKGSFGYLDPEYFR 683
++HRD+ N+L+ K+ DFGL+K + +K ++ E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 684 RQQLTEKSDVYSFGVVLFEVL 704
+ T +SDV+S+GV ++E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 515 VIGVGGFGKVYIGVLEDGNK-----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FGKV + + N VA+K Q + ++ EI +L L H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 569 LIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
G C++ + LV EY+ G RD+L + + Q L G+ YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH--- 151
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSFGYLDPEYFRR 684
AQ IHRD+ N+LLD + + K+ DFGL+KA P Y V + PE +
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 685 QQLTEKSDVYSFGVVLFEV--LCARPVINPK-------LPREQVSLAE 723
+ SDV+SFGV L+E+ C P + + Q+++
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 515 VIGVGGFGKVYIGVLEDGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
VIG G FG VY G D + AIK + Q + F E ++ L H ++++L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 570 IGFCDEQSEMIL-VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
IG + + YM +G + + Q + K + + ARG+ YL A Q
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL-----DPEYFR 683
+HRD+ N +LDE+ KVADFGL++ +DR Y S + L E +
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QHRHARLPVKWTALESLQ 201
Query: 684 RQQLTEKSDVYSFGVVLFEVL 704
+ T KSDV+SFGV+L+E+L
Sbjct: 202 TYRFTTKSDVWSFGVLLWELL 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-40
Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 10/195 (5%)
Query: 515 VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSL 569
IG G FG V+ G+ VAIK S+ +F E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
IG E I + E G R L + L + + L YL ++
Sbjct: 457 IGVITENPVWI-IMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL---ESKR 511
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+HRD+ N+L+ N K+ DFGLS+ Y ++ K ++ PE ++ T
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 690 KSDVYSFGVVLFEVL 704
SDV+ FGV ++E+L
Sbjct: 572 ASDVWMFGVCMWEIL 586
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-40
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 513 NAVIGVGGFGKVYIGVLEDGNK---VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVS 568
+ +G G FG V GV K VAIK G + E E Q++ +L + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
LIG C ++ M+ V E GP L + + E+ + G+ YL +
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY--LDPEYFRRQQ 686
+HR++ N+LL AK++DFGLSKA D Y + G + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 687 LTEKSDVYSFGVVLFEVL 704
+ +SDV+S+GV ++E L
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 35/231 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
+G G FGKV++ + VA+K SE +FQ E ++L+ L+H+H+V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHL-------------YGTNQPPLSWKQRLEICIGS 615
G C E +++V+EYM +G L PL Q L +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
A G+ YL A +HRD+ T N L+ + LV K+ DFG+S+ Y G
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGRT 220
Query: 676 YL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
L PE ++ T +SDV+SFGVVL+E+ +P +L +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSNTEA 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 516 IGVGGFGKVYIGVLEDGNK------VAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G G FGKV++ + + VA+K + +FQ E ++L+ L+H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLEICIGS 615
G C + +I+V+EYM +G L + L Q L I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
A G+ YL A+Q +HRD+ T N L+ NL+ K+ DFG+S+ Y G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYR---VGGHT 195
Query: 676 YL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
L PE ++ T +SDV+SFGV+L+E+ +P +L +V
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW--FQLSNTEV 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGN---KVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSL 569
VIG G FG+V ++ AIKR S+ +F E+++L KL H ++++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLEICIGS 615
+G C+ + + L EY +G D L + LS +Q L
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
ARG+ YL + + IHRD+ NIL+ EN VAK+ADFGLS+ + VK + G
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEV---YVKKTMG 201
Query: 676 YL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
L E T SDV+S+GV+L+E+
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 515 VIGVGGFGKVYIGVLEDGN----KVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
++G G FG V L+ + KVA+K + + + I EF E + + H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 569 LIGFC------DEQSEMILVYEYMANGPFRDHL----YGTNQPPLSWKQRLEICIGSARG 618
L+G +++ +M +G L G N L + + + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL- 677
+ YL +++ IHRD+ N +L E++ VADFGLS+ Y +G L
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDY---YRQGCASKLP 202
Query: 678 ----DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
E T SDV++FGV ++E++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 515 VIGVGGFGKVYIGVLEDGN----KVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
++G G FG V G L+ + KVA+K + + S++ I EF +E + H +++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 569 LIGFC------DEQSEMILVYEYMANGPFRDHL----YGTNQPPLSWKQRLEICIGSARG 618
L+G C M+++ +M G +L T + + L+ + A G
Sbjct: 101 LLGVCIEMSSQGIPKPMVIL-PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL- 677
+ YL + + +HRD+ N +L +++ VADFGLSK Y +G +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 678 ----DPEYFRRQQLTEKSDVYSFGVVLFEVL 704
E + T KSDV++FGV ++E+
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 59/249 (23%), Positives = 96/249 (38%), Gaps = 26/249 (10%)
Query: 478 SRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVA 536
S SG + G +++ +G GGF V + L DG+ A
Sbjct: 4 SHHHHHHSSGRENLYFQGHMVIIDN-----KHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58
Query: 537 IKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS----EMILVYEYMANGPFR 592
+KR +Q E Q E M H +++ L+ +C + E L+ + G
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 593 DHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650
+ + L+ Q L + +G RGL +H +G HRD+K TNILL + +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVL 175
Query: 651 ADFGLSKAAPMDRGYVSTAVK--------GSFGYLDPEYF---RRQQLTEKSDVYSFGVV 699
D G A + A+ + Y PE F + E++DV+S G V
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 700 LFEVLCARP 708
L+ ++
Sbjct: 236 LYAMMFGEG 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
+G G FG VY GV + K VAIK N S + EF E ++ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL--------YGTNQPPLSWKQRLEICIGSARGL 619
L+G + +++ E M G + +L P S + +++ A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL-- 677
YL A +HRD+ N ++ E+ K+ DFG+++ + Y KG G L
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY---YRKGGKGLLPV 204
Query: 678 ---DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 708
PE + T SDV+SFGVVL+E+ L +P
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
+G FGKVY G L VAIK EF+ E + ++L+H ++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLEICI 613
L+G + + +++ Y ++G + L T + L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGS 673
A G+ YL ++ ++H+D+ T N+L+ + L K++D GL + +
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLG 188
Query: 674 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 708
L PE + + SD++S+GVVL+EV +P
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 515 VIGVGGFGKVYIGVLEDGNK--------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHR 564
+G G FG+V + +K VA+K +E+ +++ +E++M+ + +H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLE 610
++++L+G C + + ++ EY + G R++L + +++K +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
ARG+ YL A+Q IHRD+ N+L+ EN V K+ADFGL++ Y
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----K 214
Query: 671 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
K + G L PE + T +SDV+SFGV+++E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 63/216 (29%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
+G G FG+VY G + VA+K SEQ +F E ++SK H+++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL-----YGTNQPPLSWKQRLEICIGSARGLHYL 622
IG + ++ E MA G + L + L+ L + A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 623 HTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL-- 677
IHRD+ N LL VAK+ DFG+++ Y KG L
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYR---KGGCAMLPV 209
Query: 678 ---DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 708
PE F T K+D +SFGV+L+E+ L P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 10/207 (4%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR---GNPGSEQGINEFQTEIQMLSKLRH 563
NF IG G F +VY L DG VA+K+ + + + EI +L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHY 621
+++ E +E+ +V E G + + + + + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
+H ++ ++HRD+K N+ + V K+ D GL + + V G+ Y+ PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARP 708
KSD++S G +L+E+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 41/223 (18%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
+G G FGKV VA+K S + + +E +L ++ H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL----------------------YGTNQPPLSW 605
L G C + ++L+ EY G R L ++ L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
+ ++G+ YL A ++HRD+ NIL+ E K++DFGLS+ + Y
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 666 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
VK S G + E T +SDV+SFGV+L+E+
Sbjct: 207 ----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 7/204 (3%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHR 564
+ + IG G FGK + EDG + IK N S + E + E+ +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
++V +E + +V +Y G + Q L+ + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ I+HRD+K+ NI L ++ ++ DFG+++ + G+ YL PE
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 685 QQLTEKSDVYSFGVVLFEVLCARP 708
+ KSD+++ G VL+E+ +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKH 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 47/286 (16%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL 566
+F E +IG GGFG+V+ DG IKR +E+ E ++ L+KL H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 567 VSLIGFCDEQSEMI----------------LVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
V G D + E+ G + L LE
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
+ +G+ Y+H+ + +I+RD+K +NI L + K+ DFGL + + T
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDGKRTRS 181
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730
KG+ Y+ PE Q ++ D+Y+ G++L E+L E
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-----CDTAFE------------T 224
Query: 731 KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ D +I++ K+ + + +K L++ DRP ++L
Sbjct: 225 SKFFTDLRDGIISDIFDKK-EKTLL---QKLLSKKPEDRPNTSEIL 266
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHR 564
++++ IG G +G+ DG + K + G +E +E+ +L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 565 HLVSLIG-FCDEQSEMI-LVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLH 620
++V D + + +V EY G + + L + L + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 621 YLHT--GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
H ++HRD+K N+ LD K+ DFGL++ D + T V G+ Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE R EKSD++S G +L+E+ P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 515 VIGVGGFGKVYIGVLEDGNK--------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHR 564
+G G FG+V + +K VA+K +E+ +++ +E++M+ + +H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLE 610
++++L+G C + + ++ EY + G R++L + +++K +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
ARG+ YL A+Q IHRD+ N+L+ EN V K+ADFGL++ Y
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----K 260
Query: 671 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
K + G L PE + T +SDV+SFGV+++E+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHL 566
+G G FGKV K VA+K +E++++S L +H ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHL------------YGTNQPPLSWKQRLEICIG 614
V+L+G C ++++ EY G + L + S + L
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
A+G+ +L A++ IHRDV N+LL VAK+ DFGL++ D Y +
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGN 225
Query: 675 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
L PE T +SDV+S+G++L+E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHL 566
+G G FG+V +K VA+K G + +E+++L + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 567 VSLIGFC-DEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLEI 611
V+L+G C ++++ E+ G +L + L+ + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671
A+G+ +L A++ IHRD+ NILL E V K+ DFGL++ D Y V+
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VR 206
Query: 672 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
L PE + T +SDV+SFGV+L+E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
+G G FG+VY G + VA+K SEQ +F E ++SK H+++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL-----YGTNQPPLSWKQRLEICIGSARGLHYL 622
IG + ++ E MA G + L + L+ L + A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 623 HTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL-- 677
IHRD+ N LL VAK+ DFG+++ Y KG L
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLPV 250
Query: 678 ---DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQV 719
PE F T K+D +SFGV+L+E+ L P P ++V
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 36/218 (16%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHL 566
+G G FGKV K VA+K P +E+++LS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHL----------------YGTNQPPLSWKQRLE 610
V+L+G C +++ EY G + L ++ L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
A+G+ +L A++ IHRD+ NILL + K+ DFGL++ D Y V
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----V 202
Query: 671 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
L PE T +SDV+S+G+ L+E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 45/241 (18%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLV 567
IG G FG+V+ VA+K S +FQ E ++++ + ++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHL----------------------YGTNQPPLSW 605
L+G C M L++EYMA G + L PPLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
++L I A G+ YL + + +HRD+ T N L+ EN+V K+ADFGLS+ +
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYS 226
Query: 666 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPVINPKLPREQ 718
+ PE + T +SDV+++GVVL+E+ +P + E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--YGMAHEE 284
Query: 719 V 719
V
Sbjct: 285 V 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRH--RHLVSLI 570
IG GG KV+ + E AIK N Q ++ ++ EI L+KL+ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 571 GFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLS---WKQRLEICIGSARGLHYLHTG 625
+ + +V E N L + P WK LE +H +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH-- 144
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPE---- 680
GI+H D+K N L+ + ++ K+ DFG++ D V + G+ Y+ PE
Sbjct: 145 -QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 681 -------YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ +++ KSDV+S G +L+ + +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 60/266 (22%), Positives = 93/266 (34%), Gaps = 26/266 (9%)
Query: 450 SSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQN 509
S + L + F S R F S++ S + FF Q+
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQ--------QS 58
Query: 510 FDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKL-RHRH 565
F + +G G +G+V+ EDG A+KR + E+ K+ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQP---PLSWKQRLEICIGSARGLHYL 622
V L +E + L E + H W + L +L
Sbjct: 119 CVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL----LALAHL 173
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
H+ QG++H DVK NI L K+ DFGL + +G Y+ PE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQEGDPRYMAPELL 228
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARP 708
+ +DV+S G+ + EV C
Sbjct: 229 -QGSYGTAADVFSLGLTILEVACNME 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 515 VIGVGGFGKVYIGVLEDGNK------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHL 566
V+G G FGKV +K VA+K +E++M+++L H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHL---------------------YGTNQPPLSW 605
V+L+G C + L++EY G ++L + L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
+ L A+G+ +L + +HRD+ N+L+ V K+ DFGL++ D Y
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 666 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
V L PE T KSDV+S+G++L+E+
Sbjct: 229 ----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-36
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRH--RHLVSLI 570
IG GG KV+ + E AIK N Q ++ ++ EI L+KL+ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 571 GFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLS---WKQRLEICIGSARGLHYLHTG 625
+ + +V E N L + P WK LE +H +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH-- 125
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPE---- 680
GI+H D+K N L+ + ++ K+ DFG++ D V + G+ Y+ PE
Sbjct: 126 -QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 681 -------YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ +++ KSDV+S G +L+ + +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-36
Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 515 VIGVGGFGKVYIGVLEDGNK--------VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHR 564
+G G FG+V + +K VA+K +E+ +++ +E++M+ + +H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHL--------------YGTNQPPLSWKQRLE 610
++++L+G C + + ++ EY + G R++L + LS K +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
ARG+ YL A++ IHRD+ N+L+ E+ V K+ADFGL++ Y
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----K 248
Query: 671 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 703
K + G L PE + T +SDV+SFGV+L+E+
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-35
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRH--RHLVSLI 570
IG GG KV+ + E AIK N Q ++ ++ EI L+KL+ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 571 GFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLS---WKQRLEICIGSARGLHYLHTG 625
+ + +V E N L + P WK LE +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH-- 172
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPE---- 680
GI+H D+K N L+ + ++ K+ DFG++ D V + G+ Y+ PE
Sbjct: 173 -QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 681 -------YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ +++ KSDV+S G +L+ + +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH 565
+F+E AV+G G FG+V D AIK+ +E+ ++ +E+ +L+ L H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 566 LVSLIG-FCDEQSEMI------------LVYEYMANGPFRDHL---YGTNQPPLSWKQRL 609
+V + + ++ + + EY NG D + Q W+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK------------ 657
+I L Y+H +QGIIHRD+K NI +DE+ K+ DFGL+K
Sbjct: 124 QIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 658 --AAPMDRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLC 705
P +++A+ G+ Y+ E EK D+YS G++ FE++
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQ 552
GR+ T +F+ +G GGFG V+ D AIKR P E +
Sbjct: 1 GRYLT---------DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM 51
Query: 553 TEIQMLSKLRHRHLVSLIG-FCDEQSEM--------ILVY---EYMANGPFRDHLYGTNQ 600
E++ L+KL H +V + ++ + + +Y + +D + G
Sbjct: 52 REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT 111
Query: 601 -PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA- 658
L I + A + +LH ++G++HRD+K +NI + V KV DFGL A
Sbjct: 112 IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 659 ----------APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 706
PM T G+ Y+ PE + K D++S G++LFE+L
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 26/224 (11%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKL 561
+ + + ++G G V+ G + G+ AIK N + ++ E ++L KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 562 RHRHLVSLIGFCDEQS--EMILVYEYMANGPFRDHLY-GTNQPPLSWKQRLEI--CIGSA 616
H+++V L +E + +L+ E+ G L +N L + L + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKAAPMDRGYVSTAVKG 672
+++L GI+HR++K NI+ D V K+ DFG ++ ++ ++ G
Sbjct: 125 --MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYG 177
Query: 673 SFGYLDPEYFRRQQL--------TEKSDVYSFGVVLFEVLCARP 708
+ YL P+ + R L D++S GV +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 514 AVIGVGGFGKVYIGVLED---GNKVAIK--RGNPGSEQG-INEFQTEIQMLSKLRHRHLV 567
+G GG VY+ ED KVAIK P ++ + F+ E+ S+L H+++V
Sbjct: 17 DKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
S+I +E LV EY+ +++ + PLS + G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
I+HRD+K NIL+D N K+ DFG++KA + V G+ Y PE + +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
E +D+YS G+VL+E+L P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-34
Identities = 69/224 (30%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIK----RGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+G GGFG V + + G +VAIK +P + + EIQ++ KL H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSA 77
Query: 570 IGFCDEQSEM------ILVYEYMANGPFRDHLYG-TNQPPLSWKQRLEI--CIGSARGLH 620
D ++ +L EY G R +L N L + I SA L
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LR 135
Query: 621 YLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677
YLH IIHRD+K NI+L + L+ K+ D G +K +D+G + T G+ YL
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFVGTLQYL 190
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
PE +++ T D +SFG + FE + P LP Q
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR---PFLPNWQPVQ 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 46/221 (20%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIK-----------------RGNPGSEQGINEFQTEIQM 557
+ G F K+ + +D A+K + ++F+ E+Q+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR 617
++ +++ + ++ G E+ ++YEYM N L I I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVIK 154
Query: 618 --------GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
Y+H + I HRDVK +NIL+D+N K++DFG S+ + + +
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKGS 210
Query: 670 VKGSFGYLDPEYFRRQQLT--EKSDVYSFGVVLFEVLCARP 708
G++ ++ PE+F + K D++S G+ L+ +
Sbjct: 211 R-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 513 NAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
+ IG G F VY G+ E +VA + ++ F+ E +ML L+H ++V
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 570 IG----FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+ ++LV E M +G + +L + K C +GL +LHT
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 626 AAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
IIHRD+K NI + K+ D GL+ + AV G+ ++ PE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMY-E 203
Query: 685 QQLTEKSDVYSFGVVLFEVLCARP 708
++ E DVY+FG+ + E+ +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEY 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIKRGNP---GSEQGINEFQTEIQMLSKLRHRHLVSL 569
++G GG +V++ L D VA+K F+ E Q + L H +V++
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 570 --IGFCDEQSEMI--LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
G + + + +V EY+ RD + + P++ K+ +E+ + + L++ H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV--STAVKGSFGYLDPEYFR 683
GIIHRDVK NI++ KV DFG+++A V + AV G+ YL PE R
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP 708
+ +SDVYS G VL+EVL P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 15/202 (7%)
Query: 514 AVIGVGGFGKVYIGVLED---GNKVAIK--RGNPGSEQGINE-FQTEIQMLSKLRHRHLV 567
++G GG G VY ED VA+K S+ Q E + +L+ H+V
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
+ F + ++ + + L Q PL+ + + I L H A
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---A 152
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST-AVKGSFGYLDPEYFRRQQ 686
G HRDVK NIL+ + A + DFG++ A D G+ Y+ PE F
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 687 LTEKSDVYSFGVVLFEVLCARP 708
T ++D+Y+ VL+E L P
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 26/224 (11%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKL 561
+ + + ++G G V+ G + G+ AIK N + ++ E ++L KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 562 RHRHLVSLIGFCDEQS--EMILVYEYMANGPFRDHLYG-TNQPPLSWKQRLEI--CIGSA 616
H+++V L +E + +L+ E+ G L +N L + L + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKAAPMDRGYVSTAVKG 672
+++L GI+HR++K NI+ D V K+ DFG ++ ++ ++ G
Sbjct: 125 --MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYG 177
Query: 673 SFGYLDPEYFRRQQL--------TEKSDVYSFGVVLFEVLCARP 708
+ YL P+ + R L D++S GV +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 45/260 (17%), Positives = 84/260 (32%), Gaps = 25/260 (9%)
Query: 471 RRSSLFGSRKSKSGYSGLFSNQG-LGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV- 528
L G K S Y F Q L TE Q ++ + ++G G F +VY
Sbjct: 27 IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQ 86
Query: 529 -----LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583
++ K +K P + ++ L + Q+ +LV
Sbjct: 87 GDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146
Query: 584 EYMANGPFRDHL---YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNI 640
E + G + + T + + + + + +H IIH D+K N
Sbjct: 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNF 203
Query: 641 LL-----------DENLVAKVADFGLSKAAPM-DRGYVSTAVKGSFGYLDPEYFRRQQLT 688
+L D + + D G S + +G + TA + G+ E +
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263
Query: 689 EKSDVYSFGVVLFEVLCARP 708
+ D + ++ +L
Sbjct: 264 YQIDYFGVAATVYCMLFGTY 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+G GGF K + + A K + + EI + L H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 572 FCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
F ++ + +V E + P + +I G YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 135
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+IHRD+K N+ L+E+L K+ DFGL+ D G+ Y+ PE ++ +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 194
Query: 690 KSDVYSFGVVLFEVLCARP 708
+ DV+S G +++ +L +P
Sbjct: 195 EVDVWSIGCIMYTLLVGKP 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+G GGF K + + A K + + EI + L H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 572 FCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG 629
F ++ + +V E + P + +I G YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 161
Query: 630 IIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+IHRD+K N+ L+E+L K+ DFGL+ D G+ Y+ PE ++ +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 220
Query: 690 KSDVYSFGVVLFEVLCARP 708
+ DV+S G +++ +L +P
Sbjct: 221 EVDVWSIGCIMYTLLVGKP 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 24/204 (11%)
Query: 514 AVIGVGGFGKVYIGV--LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
I GG G +Y+ + +G V +K + G + E Q L+++ H +V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 570 IGFCDEQSEMI-----LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
F + +V EY+ + L + + + L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH- 199
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ G+++ D+K NI+L E + K+ D G + ++ + G+ G+ PE R
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGA--VSRINS---FGYLYGTPGFQAPEIVRT 251
Query: 685 QQLTEKSDVYSFGVVLFEVLCARP 708
T +D+Y+ G L + P
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 55/253 (21%), Positives = 94/253 (37%), Gaps = 30/253 (11%)
Query: 480 KSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK 538
S G SG + +G ++ V+ GGF VY + G + A+K
Sbjct: 5 GSLGGASGRDQSDFVG-----QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK 59
Query: 539 RGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFC--------DEQSEMILVYEYMANG 589
R E+ E+ + KL H ++V Q+E +L+ E
Sbjct: 60 RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ 119
Query: 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAK 649
++ PLS L+I + R + ++H IIHRD+K N+LL K
Sbjct: 120 LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIK 178
Query: 650 VADFGLSKAAPMDRGYVSTAVK-----------GSFGYLDPE---YFRRQQLTEKSDVYS 695
+ DFG + Y +A + + Y PE + + EK D+++
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238
Query: 696 FGVVLFEVLCARP 708
G +L+ + +
Sbjct: 239 LGCILYLLCFRQH 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRH 563
++F+ +G G FG VY+ + +A+K + ++ + E+++ S LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHY 621
+++ L G+ + + + L+ EY G L + E+ L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSY 124
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
H ++ +IHRD+K N+LL K+ADFG S AP R G+ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DLC-GTLDYLPPEM 178
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ EK D++S GV+ +E L +P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHR 564
+FD +G G FG VY+ ++ +A+K + E ++ + EI++ S LRH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYL 622
+++ + + ++ + L+ E+ G L +G S E+ A LHY
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALHYC 130
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
H + +IHRD+K N+L+ K+ADFG S AP R T G+ YL PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRTMC-GTLDYLPPEMI 184
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARP 708
+ EK D++ GV+ +E L P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
V+G G +G VY G L + ++AIK + EI + L+H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 574 DEQSEMILVYEYMANGPFRD---HLYGTNQPPLSW-----KQRLEICIGSARGLHYLHTG 625
E + + E + G +G + KQ LE GL YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH-- 139
Query: 626 AAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
I+HRD+K N+L++ + V K++DFG SK T G+ Y+ PE +
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDK 197
Query: 685 QQL--TEKSDVYSFGVVLFEVLCARP 708
+ +D++S G + E+ +P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-30
Identities = 25/248 (10%), Positives = 55/248 (22%), Gaps = 43/248 (17%)
Query: 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQ 552
+ L + + VG V++ +E A+K G S +
Sbjct: 51 TTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLH 110
Query: 553 TEIQMLSKLRHRHLVSLIGFC--------------------------DEQSEMILVYEYM 586
++L + +L+
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170
Query: 587 A----NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642
+ + + R L ++G++H N+ +
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFI 227
Query: 643 DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVL 700
+ + D G A Y E+ T + + G+ +
Sbjct: 228 MPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 701 FEVLCARP 708
+ V C
Sbjct: 284 YRVWCLFL 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 69/326 (21%), Positives = 124/326 (38%), Gaps = 40/326 (12%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLV 567
+F V+G G G + + D VA+KR P E+Q+L + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
++ + E A ++ + + + + GL +LH +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLH---S 136
Query: 628 QGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAAPMDRGYVS--TAVKGSFGYLDPE 680
I+HRD+K NIL+ + A ++DFGL K + R S + V G+ G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 681 YFRR---QQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPREQVSLAEWALQCHRKGILEK 736
+ T D++S G V + V+ L R+ A L+
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSLDC 249
Query: 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL-----WNLEYAMQ-LQEAST 790
+ + I +E + K +A RP VL W+LE +Q Q+ S
Sbjct: 250 LHPEKHEDVIARELIE-------KMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSD 302
Query: 791 QIDHPEDKSANLIALDKPCENLSRED 816
+I+ + L++ + + D
Sbjct: 303 RIEKESLDGPIVKQLERGGRAVVKMD 328
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK------RGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
+G G F VY + G +VAIK G Q + Q E+++ +L+H ++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRV---QNEVKIHCQLKHPSILE 75
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQP---PLSWKQRLEICIGSARGLHYLHTG 625
L + ++ + + LV E NG +L +P + +I G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLH-- 129
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
+ GI+HRD+ +N+LL N+ K+ADFGL+ M T G+ Y+ PE R
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 686 QLTEKSDVYSFGVVLFEVLCARP 708
+SDV+S G + + +L RP
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRP 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 5/151 (3%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH 565
+ ++ +G G FGKVY E G A K SE+ + ++ EI++L+ H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+V L+G ++ ++ E+ G + L+ Q +C L++LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH-- 134
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
++ IIHRD+K N+L+ ++ADFG+S
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 8/212 (3%)
Query: 492 QGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINE 550
+ L + + + + FD +G G +G VY + E G VAIK+ E + E
Sbjct: 13 RQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQE 70
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE 610
EI ++ + H+V G + +++ +V EY G D + L+ +
Sbjct: 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT 129
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I + +GL YLH IHRD+K NILL+ AK+ADFG++ +T +
Sbjct: 130 ILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 702
G+ ++ PE + +D++S G+ E
Sbjct: 187 -GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 47/228 (20%), Positives = 78/228 (34%), Gaps = 34/228 (14%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKL-R 562
T F E IG G FG V+ V DG AIKR E+ + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLH 620
H H+V E M++ EY G D + + ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 621 YLHTGAAQGIIHRDVKTTNILLDEN-------------------LVAKVADFGLSKAAPM 661
Y+H + ++H D+K +NI + ++ K+ D G
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 662 DRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 708
+G +L E + K+D+++ + + A P
Sbjct: 187 -----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 31/235 (13%), Positives = 65/235 (27%), Gaps = 43/235 (18%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLR------- 562
V+G E G + I + + E+ L LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 563 ---------------HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL---------YGT 598
+I ++ +M ++ + + +L + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 599 NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
L RL++ + R L LH G++H ++ +I+LD+ + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVLCARP 708
Q +T D ++ G+ ++ + CA
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 8/213 (3%)
Query: 491 NQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGIN 549
+ L + + + + + + IG G G VY + + G +VAI++ N +
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 550 EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
EI ++ + ++ ++V+ + E+ +V EY+A G D + T + Q
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIA 119
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
+C + L +LH + +IHRD+K+ NILL + K+ DFG ++ ST
Sbjct: 120 AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 702
V G+ ++ PE R+ K D++S G++ E
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 34/230 (14%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-R 562
Q+ ++G G G V G VA+KR EI++L++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDD 67
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPF----RDHLYGTNQPPLSWKQRLEICIGSARG 618
H +++ + + E ++ N + + A G
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLD-------------ENLVAKVADFGLSKAAPMDRGY 665
+ +LH + IIHRD+K NIL+ ENL ++DFGL K +
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 666 VSTAVK---GSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLC 705
T + G+ G+ PE +++LT D++S G V + +L
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 44/280 (15%), Positives = 79/280 (28%), Gaps = 57/280 (20%)
Query: 478 SRKSKSGYSGLFSNQGL--GRFFTF-TELQNATQNFDENAVIGVGGFGKVYIGV-LEDGN 533
S +S L S G+ F +EL + V+G E G
Sbjct: 40 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 99
Query: 534 KVAIK---RGNPGSEQGINEFQTEIQMLSKLR-------------------------HRH 565
+ I + + E+ L LR +
Sbjct: 100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159
Query: 566 LVSLIG-FCDEQSEMILVYEYMANGPFRDHL-----YGTNQPPLSWKQRLEICIGSARGL 619
++ + D + + + L RL++ + R L
Sbjct: 160 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 219
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDP 679
LH G++H ++ +I+LD+ + F R S G+ P
Sbjct: 220 ASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPP 271
Query: 680 EYF-----------RRQQLTEKSDVYSFGVVLFEVLCARP 708
E RR +T D ++ G+V++ + CA
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 503 LQNATQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTE 554
+Q++T F + V+G G FG+V + G + A+K + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 555 IQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG 614
+Q+L +L H +++ L F +++ LV E G D + ++ S I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 134
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVK 671
G+ Y+H I+HRD+K N+LL ++ ++ DFGLS +
Sbjct: 135 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKI 189
Query: 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ Y+ PE EK DV+S GV+L+ +L P
Sbjct: 190 GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+GVG FGKV IG G+KVA+K R S + + + EIQ L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYLH 623
++ +V EY++ G D++ R+E AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEE--MEARRLFQQILSAVDYCH 128
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
++HRD+K N+LLD ++ AK+ADFGLS D ++ T+ GS Y PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPEVIS 183
Query: 684 RQQLT-EKSDVYSFGVVLFEVLC 705
+ + D++S GV+L+ +LC
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLC 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 33/205 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK-----RGNPGSEQGINEFQTEIQMLSKLRHRHLVSL 569
IG G F KV + + G +VAIK + NP S Q + E++++ L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 570 IGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL---EIC-----IGSARGLHY 621
+ + + L+ EY + G D+L R+ E I SA + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL--------VAHGRMKEKEARSKFRQIVSA--VQY 129
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
H + I+HRD+K N+LLD ++ K+ADFG S G + G+ Y PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-NEFTVGGKLDAFC-GAPPYAAPEL 184
Query: 682 FRRQQLT-EKSDVYSFGVVLFEVLC 705
F+ ++ + DV+S GV+L+ ++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 8/227 (3%)
Query: 477 GSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKV 535
G+ + Q + + D IG G G V + G +V
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQV 73
Query: 536 AIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL 595
A+K + +Q E+ ++ +H ++V + E+ ++ E++ G D +
Sbjct: 74 AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 133
Query: 596 YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655
L+ +Q +C + L YLH AQG+IHRD+K+ +ILL + K++DFG
Sbjct: 134 SQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 702
D + V G+ ++ PE R + D++S G+++ E
Sbjct: 188 CAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 27/195 (13%), Positives = 62/195 (31%), Gaps = 31/195 (15%)
Query: 203 AFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVHYPDGGATPYI 262
A +V + +N GG D + D S+ P P
Sbjct: 3 ADKVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNP-------- 51
Query: 263 APNWVYASAQKMKEAQVMQPNFNLTWKMSVDPSFSYLIRFHFCDIVSKSLNDLLFNVYIN 322
+Y + + + + + + Y++ F ++ +F+V +N
Sbjct: 52 EDQVLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVN 103
Query: 323 EFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVGPASNA--------QSSLP 374
LD+ STA+ + ++ +K ++VQ ++ +
Sbjct: 104 GHTVVKDLDIFDRVGH-STAHDEIIPIS---IKKGKLSVQGEVSTFTGKLSVEFVKGYYD 159
Query: 375 NAILNGLEVIKLSNE 389
N + L ++K + +
Sbjct: 160 NPKVCALFIMKGTAD 174
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 27/178 (15%), Positives = 53/178 (29%), Gaps = 29/178 (16%)
Query: 20 YLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPLY 79
+ ++ G G S G ++ D + P LY
Sbjct: 8 WAVNAG-GESHVDV--HGIHYRKDPLEGRVGRASDYGMKLPILRSN-------PEDQVLY 57
Query: 80 RSARIFTGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIGN 139
++ R Y I + G + + L F V + VF V+ + ++ D I +
Sbjct: 58 QTERYNEDSFGYDIPIKEEGEYVLVLKFAEV--YFAQSQQKVFDVRVNGHTVVKDLDIFD 115
Query: 140 TT-----------------SLVFKEYLINITGRLSIIFKPHKDSHAFINAIEVVSAPG 180
L + + TG+LS+ F + + A+ ++
Sbjct: 116 RVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGTA 173
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 42/215 (19%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIK-------RGNPGSEQGINEFQTEIQMLSKLRHRHL 566
++G G +GKV + E + A+K R P E + + EIQ+L +LRH+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV---KKEIQLLRRLRHKNV 68
Query: 567 VSL--IGFCDEQSEMILVYEYMANGPFR--DHLYGTNQPPLSWKQRLEICIGSAR----- 617
+ L + + +E+ +M +V EY G D + ++R +C A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVC--QAHGYFCQ 117
Query: 618 ---GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--GYVSTAVKG 672
GL YLH +QGI+H+D+K N+LL K++ G+++A T+ G
Sbjct: 118 LIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-G 173
Query: 673 SFGYLDPEYFRRQQLTE--KSDVYSFGVVLFEVLC 705
S + PE K D++S GV L+ +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
V+G G F +V++ G A+K + + EI +L K++H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 574 DEQSEMILVYEYMANGPFRDHL-----YGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
+ + LV + ++ G D + Y L +Q L + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVKYLH---EN 125
Query: 629 GIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
GI+HRD+K N+L +EN + DFGLSK G +STA G+ GY+ PE ++
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC-GTPGYVAPEVLAQK 182
Query: 686 QLTEKSDVYSFGVVLFEVLCARP 708
++ D +S GV+ + +LC P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYP 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 500 FTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQML 558
+ L++ F+ ++G G +G+VY G ++ G AIK + + E + EI ML
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINML 74
Query: 559 SKL-RHRHLVSLIG------FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEI 611
K HR++ + G ++ LV E+ G D + T L + I
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
C RGL +LH +IHRD+K N+LL EN K+ DFG+S
Sbjct: 135 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTE 554
F ++ + ++ + +G G +G+V + + AIK R S ++ E
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEE 86
Query: 555 IQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG 614
+ +L L H +++ L F +++ LV E G D + ++ + I
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQ 144
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVK 671
G+ YLH I+HRD+K N+LL +++ + K+ DFGLS +
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL 199
Query: 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ Y+ PE R+ + EK DV+S GV+LF +L P
Sbjct: 200 GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 54/263 (20%), Positives = 91/263 (34%), Gaps = 30/263 (11%)
Query: 458 STKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIG 517
+ + L+ SS + L G+ + L E + +G
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKL--KPVDYEYREEVHWMTHQPRVG 67
Query: 518 VGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEF-QTEIQMLSKLRHRHLVSLIGFCDE 575
G FG+V+ + G + A+K + + F E+ + L +V L G E
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 576 QSEMILVYEYMANGPFRDHL--YGTNQPPLSW---KQRLEICIGSARGLHYLHTGAAQGI 630
+ + E + G + G + Q LE GL YLH + I
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH---TRRI 171
Query: 631 IHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKGSF-G---YLDPEYFRRQ 685
+H DVK N+LL + A + DFG + D S G ++ PE +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 686 QLTEKSDVYSFGVVLFEVLCARP 708
K D++S ++ +L
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 20/202 (9%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK--------RGNPGSEQGINEFQTEIQMLSKLRHRHL 566
+G G FG V+ V E +V +K + + + EI +LS++ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 567 VSLIGFCDEQSEMILVYEYMANGP--FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
+ ++ + Q LV E +G F + P L I + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLF-AFI--DRHPRLDEPLASYIFRQLVSAVGYLR- 147
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ IIHRD+K NI++ E+ K+ DFG + A T G+ Y PE
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFC-GTIEYCAPEVLMG 203
Query: 685 QQLT-EKSDVYSFGVVLFEVLC 705
+ +++S GV L+ ++
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVF 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+G G FGKV + + KVA+K R + EI L LRH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYLH 623
+++++V EY A G D++ K+R+ R + Y H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYI--------VEKKRMTE--DEGRRFFQQIICAIEYCH 125
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
I+HRD+K N+LLD+NL K+ADFGLS D ++ T+ GS Y PE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVIN 180
Query: 684 RQQLT-EKSDVYSFGVVLFEVLCAR 707
+ + DV+S G+VL+ +L R
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 503 LQNATQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIK-------------RGNPGS 544
++ E+ +G G +G+V + ++ AIK N
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 545 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS 604
E+ E EI +L L H +++ L +++ LV E+ G + + N+
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFD 144
Query: 605 WKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPM 661
I G+ YLH I+HRD+K NILL + L K+ DFGLS
Sbjct: 145 ECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--F 199
Query: 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ Y G+ Y+ PE ++ + EK DV+S GV+++ +LC P
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKR------GNPGSEQGINEFQTEIQMLSKLR----H 563
++G GGFG V+ G L D +VAIK E+ +L K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGP--FRDHLYGTNQPPLSWKQRL-EICIGSAR--- 617
++ L+ + + Q +LV E F D++ + K L E G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLF-DYI--------TEKGPLGE---GPSRCFF 145
Query: 618 -----GLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVK 671
+ + H+ +G++HRD+K NIL+D AK+ DFG A + +
Sbjct: 146 GQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD- 199
Query: 672 GSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 705
G+ Y PE+ R Q + V+S G++L++++C
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 9/201 (4%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKL 561
+ + F + IG G FG+V+ G+ VAIK + +E I + Q EI +LS+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
++ G + +++ ++ EY+ G D L PL Q I +GL Y
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDY 134
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
LH+ + IHRD+K N+LL E+ K+ADFG++ + +T V G+ ++ PE
Sbjct: 135 LHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 190
Query: 682 FRRQQLTEKSDVYSFGVVLFE 702
++ K+D++S G+ E
Sbjct: 191 IKQSAYDSKADIWSLGITAIE 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK----RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
+G G +G+V + V VA+K + + I + EI + L H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFY 71
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYL 622
G E + L EY + G D + + A+ G+ YL
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI--------EPDIGMPE--PDAQRFFHQLMAGVVYL 121
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--GYVSTAVKGSFGYLDPE 680
H GI HRD+K N+LLDE K++DFGL+ + ++ G+ Y+ PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 681 YFRRQQLT-EKSDVYSFGVVLFEVLC 705
+R++ E DV+S G+VL +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 46/210 (21%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 505 NATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH 563
+ +D +G G FG V+ V G K N + EI ++++L H
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGP-F-----RDHLYGTNQPPLSWKQRLEICIGSAR 617
L++L +++ EM+L+ E+++ G F D+ + +Q E
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE------- 160
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILL--DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFG 675
GL ++H I+H D+K NI+ + K+ DFGL+ ++ + +
Sbjct: 161 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAE 215
Query: 676 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
+ PE R+ + +D+++ GV+ + +L
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 28/203 (13%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
+GVG FGKV +G G+KVA+K R S + + + EIQ L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYLH 623
S++ +V EY++ G D++ RL+ +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDE--KESRRLFQQILSGVDYCH 133
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
++HRD+K N+LLD ++ AK+ADFGLS D ++ T+ GS Y PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPEVIS 188
Query: 684 RQQLT-EKSDVYSFGVVLFEVLC 705
+ + D++S GV+L+ +LC
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLC 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 41/262 (15%)
Query: 465 SSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKV 524
SS SS R S L E + + ++G GGFG V
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPG---KEKEPLESQYQVGPLLGSGGFGSV 59
Query: 525 YIGV-LEDGNKVAIKR------GNPGSEQGINEFQTEIQMLSKLRHR--HLVSLIGFCDE 575
Y G+ + D VAIK + G E+ +L K+ ++ L+ + +
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 576 QSEMILVYEYMANGP--FRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYLHTG 625
+L+ E F D + T + L + AR + + H
Sbjct: 120 PDSFVLILERPEPVQDLF-DFI--TERGALQEEL--------ARSFFWQVLEAVRHCH-- 166
Query: 626 AAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
G++HRD+K NIL+D N K+ DFG A + + G+ Y PE+ R
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYSPPEWIRY 222
Query: 685 QQLT-EKSDVYSFGVVLFEVLC 705
+ + V+S G++L++++C
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVC 244
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 42/198 (21%), Positives = 75/198 (37%), Gaps = 16/198 (8%)
Query: 517 GVGGFGKVYIGV-LEDGNKVAIKRGN--PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
G V + G V ++R N S + + Q E+ + H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+E+ +V +MA G +D + ++ I G + L Y+H G +HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHR 152
Query: 634 DVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY-------LDPEYFRRQQ 686
VK ++IL+ + ++ + + + G V Y L PE ++
Sbjct: 153 SVKASHILISVDGKVYLSGLRSN-LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 687 L--TEKSDVYSFGVVLFE 702
KSD+YS G+ E
Sbjct: 212 QGYDAKSDIYSVGITACE 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 15/205 (7%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIK-----RGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
VIG G F V + E G + A+K + + + E + L+H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
L+ + +V+E+M + S L Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--- 147
Query: 627 AQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
IIHRDVK +LL + + K+ FG++ V G+ ++ PE +
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP 708
R+ + DV+ GV+LF +L
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCL 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR---GNPGSEQGINEFQTEIQMLS 559
+ + F + IG G FG VY + + VAIK+ S + + E++ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
KLRH + + G + LV EY G D L ++ PL + + G+ +GL
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656
YLH+ +IHRDVK NILL E + K+ DFG +
Sbjct: 168 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK----RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLI 570
+G G +G+V + V VA+K + + I + EI + L H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFY 71
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYL 622
G E + L EY + G D + + A+ G+ YL
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI--------EPDIGMPE--PDAQRFFHQLMAGVVYL 121
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR--GYVSTAVKGSFGYLDPE 680
H GI HRD+K N+LLDE K++DFGL+ + ++ G+ Y+ PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 681 YFRRQQLT-EKSDVYSFGVVLFEVLC 705
+R++ E DV+S G+VL +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
VIG G V KVAIKR N + ++E EIQ +S+ H ++VS
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLE------ICIGSARGLHYLHTGA 626
+ E+ LV + ++ G D + L+ I GL YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF-G---YLDPEYF 682
G IHRDVK NILL E+ ++ADFG+S V+ +F G ++ PE
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 683 RRQQL-TEKSDVYSFGVVLFE 702
+ + K+D++SFG+ E
Sbjct: 199 EQVRGYDFKADIWSFGITAIE 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 14/225 (6%)
Query: 490 SNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQ 546
+ + ++ ++G G FG+V + A+K +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 547 GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWK 606
+ E+++L KL H +++ L ++ S +V E G D + + S
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEH 121
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDR 663
I G+ Y+H I+HRD+K NILL +++ K+ DFGLS +
Sbjct: 122 DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQ 176
Query: 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ Y+ PE R EK DV+S GV+L+ +L P
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIK--------RGNPGSEQGINEFQTEIQMLSKLRHRH 565
+G G G+V + + KVAI+ G+ +TEI++L KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
++ + F D + +V E M G D + L + YLH
Sbjct: 202 IIKIKNFFDAED-YYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE- 257
Query: 626 AAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE-- 680
GIIHRD+K N+LL +E+ + K+ DFG SK + + + G+ YL PE
Sbjct: 258 --NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVL 313
Query: 681 -YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
D +S GV+LF L P
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 44/198 (22%), Positives = 83/198 (41%), Gaps = 12/198 (6%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G +G+V I V + A K+ + ++ F+ EI+++ L H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
++ +++ LV E G + + ++ I + Y H + HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHR 130
Query: 634 DVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
D+K N L + K+ DFGL+ G + G+ Y+ P+ +
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVSPQVLEG-LYGPE 187
Query: 691 SDVYSFGVVLFEVLCARP 708
D +S GV+++ +LC P
Sbjct: 188 CDEWSAGVMMYVLLCGYP 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 55/232 (23%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---------------RGNPGSEQGINEFQT------ 553
IG G +G V + D A+K R P +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 554 -----EIQMLSKLRHRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWK 606
EI +L KL H ++V L+ D+ +E + +V+E + GP + PLS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSED 137
Query: 607 QRLEICIGSAR--------GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
Q AR G+ YLH Q IIHRD+K +N+L+ E+ K+ADFG+S
Sbjct: 138 Q--------ARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCAR 707
+S V G+ ++ PE + + DV++ GV L+ + +
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 54/264 (20%), Positives = 93/264 (35%), Gaps = 56/264 (21%)
Query: 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK-----RGNPGSEQGINE 550
+F L + + IG G +G V + + + AIK + + + +
Sbjct: 15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER 74
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG------PFRDHLYGTNQPPLS 604
+TE++++ KL H ++ L +++ + LV E G
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 605 WKQRLEICIGSAR--------------------------------GLHYLHTGAAQGIIH 632
K ++ C LHYLH QGI H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICH 191
Query: 633 RDVKTTNILL--DENLVAKVADFGLSK----AAPMDRGYVSTAVKGSFGYLDPEYFR--R 684
RD+K N L +++ K+ DFGLSK + ++T G+ ++ PE
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTN 250
Query: 685 QQLTEKSDVYSFGVVLFEVLCARP 708
+ K D +S GV+L +L
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 504 QNATQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIK---------RGNPGSEQGIN 549
++T F EN ++G G V + + A+K ++
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 550 EFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQR 608
E+ +L K+ H +++ L + + LV++ M G D+L T + LS K+
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKET 126
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
+I + LH I+HRD+K NILLD+++ K+ DFG S +D G
Sbjct: 127 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR 181
Query: 669 AVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
V G+ YL PE ++ D++S GV+++ +L P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 507 TQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIKRGN--PGSEQGINEFQTEIQMLS 559
+ F +N +G G F V V G + A K N S + + + E ++
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
KL+H ++V L E+S LV++ + G + + + S +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESI 118
Query: 620 HYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
Y H + GI+HR++K N+LL + K+ADFGL+ ++ G+ GY
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFAGTPGY 173
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
L PE ++ ++ D+++ GV+L+ +L P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 24/288 (8%)
Query: 438 RRPHDWDKRKSFSSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGL-GR 496
RR + + S + S + + + K + F + G
Sbjct: 23 RREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--------RGNPGSEQG 547
+ + Q +D VIG G V V G++ A+K E+
Sbjct: 83 LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 548 INEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWK 606
+ E +L ++ H H+++LI + S M LV++ M G D+L T + LS K
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEK 200
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666
+ I + +LH A I+HRD+K NILLD+N+ +++DFG S ++ G
Sbjct: 201 ETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255
Query: 667 STAVKGSFGYLDPEYFRRQQL------TEKSDVYSFGVVLFEVLCARP 708
+ G+ GYL PE + ++ D+++ GV+LF +L P
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/209 (27%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIK-------RGNPGSEQGINE-FQTEIQMLSKLRHRH 565
+G G G+V + + KVAIK E +TEI++L KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
++ + F D + +V E M G D + L + YLH
Sbjct: 77 IIKIKNFFDAED-YYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH-- 131
Query: 626 AAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE-- 680
GIIHRD+K N+LL +E+ + K+ DFG SK + + + G+ YL PE
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVL 188
Query: 681 -YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
D +S GV+LF L P
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 13/226 (5%)
Query: 490 SNQGLGRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQG 547
+ F +G G FG V++ G + IK N S+
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63
Query: 548 INEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPP--LSW 605
+ + + EI++L L H +++ + ++ M +V E G + + LS
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMD 662
E+ L Y H +Q ++H+D+K NIL + K+ DFGL++
Sbjct: 124 GYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FK 178
Query: 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
ST G+ Y+ PE F+R +T K D++S GVV++ +L
Sbjct: 179 SDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 56/207 (27%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIG 571
IG G FG + VA+K RG E Q EI LRH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR--------GLHYLH 623
+ + ++ EY + G + + R AR G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI--------CNAGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 624 TGAAQGIIHRDVKTTNILLDENLVA--KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
+ I HRD+K N LLD + K+ DFG SK++ + + V G+ Y+ PE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEV 188
Query: 682 FRRQQLT-EKSDVYSFGVVLFEVLCAR 707
RQ+ + +DV+S GV L+ +L
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+ ++G G FG+V+ G K+A K + E + EI ++++L H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 568 SLIGFCDEQSEMILVYEYMANGP-F-----RDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
L + +++++LV EY+ G F + L KQ E G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIRH 202
Query: 622 LHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
+H I+H D+K NIL D + K+ DFGL++ G+ +L
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARR--YKPREKLKVNFGTPEFLA 256
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLC 705
PE ++ +D++S GV+ + +L
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRH 563
+ ++ ++G G FG+V + A+K + + E+++L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
+++ L ++ S +V E G D + + S I G+ Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 624 TGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
I+HRD+K NILL +++ K+ DFGLS + G+ Y+ PE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPE 193
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
R EK DV+S GV+L+ +L P
Sbjct: 194 VLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK------RGNPGSEQGINEFQTEIQ 556
Q +D +G G F V G + A K E + E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS-------WKQRL 609
+L ++ H ++++L + +++++L+ E ++ G D L + LS KQ L
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKAAPMDRGY 665
+ G++YLH + I H D+K NI+L K+ DFGL+ ++ G
Sbjct: 126 D-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGV 173
Query: 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
+ G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 19/233 (8%)
Query: 486 SGLFSNQGLGRFFTFTELQNATQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIKRG 540
+ + Q +GR F + NA+ F +N +G G F V V G + A K
Sbjct: 5 ASMTGGQQMGRGSEF--MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 541 N--PGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGT 598
N S + + + E ++ KL+H ++V L E+S LV++ + G + +
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--V 120
Query: 599 NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGL 655
+ S + Y H + GI+HR++K N+LL + K+ADFGL
Sbjct: 121 AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ ++ G+ GYL PE ++ ++ D+++ GV+L+ +L P
Sbjct: 178 AIE--VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 16/212 (7%)
Query: 507 TQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLS 559
F E +G G F V V + G + A S + + + E ++
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
L+H ++V L E+ L+++ + G + + + S +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCIQQILEAV 123
Query: 620 HYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
+ H G++HR++K N+LL + K+ADFGL+ ++ G+ GY
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGY 179
Query: 677 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
L PE R+ + D+++ GV+L+ +L P
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 25/271 (9%)
Query: 450 SSWLLPLHSTKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNA--T 507
++ +L + + + G S Y + + E+++
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL 566
++D + +G G FG V+ GN A K E + EIQ +S LRH L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHL------YGTNQPPLSWKQRLEICIGSARGLH 620
V+L ++ +EM+++YE+M+ G + + ++ +Q + GL
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------GLC 269
Query: 621 YLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677
++H +H D+K NI+ N + K+ DFGL+ +D G+ +
Sbjct: 270 HMHE---NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAH--LDPKQSVKVTTGTAEFA 323
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE + + +D++S GV+ + +L
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 52/219 (23%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 505 NATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK----RGNPGSEQG--INEFQTEIQM 557
+++ +G G F V G + A K R S +G E + E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS-------WKQRLE 610
L ++RH ++++L + +++++L+ E ++ G D L + L+ KQ L+
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILD 119
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKAAPMDRGYV 666
G+HYLH+ + I H D+K NI+L N K+ DFG++ ++ G
Sbjct: 120 -------GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNE 167
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
+ G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 498 FTFTELQNAT-QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIK---RGNPGSEQGINEFQ 552
+ + E Q F + V+G GGFG+V+ ++ K+ A K + +G
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 553 TEIQMLSKLRHRHLVSLIGFCDE-QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL-- 609
E ++L+K+ R +VSL + E ++++ LV M G R H+Y ++ +++
Sbjct: 234 VEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 610 ----EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
+I G L +LH + II+RD+K N+LLD++ +++D GL+ +
Sbjct: 293 FYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ G++ PE ++ D ++ GV L+E++ AR
Sbjct: 346 TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 14/199 (7%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGF 572
+G G F V + A+K + E Q EI L H ++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+Q LV E + G + + + S + I + ++H G++H
Sbjct: 75 FHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVH 129
Query: 633 RDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
RD+K N+L ++NL K+ DFG ++ P D + T + Y PE + E
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDE 188
Query: 690 KSDVYSFGVVLFEVLCARP 708
D++S GV+L+ +L +
Sbjct: 189 SCDLWSLGVILYTMLSGQV 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 47/219 (21%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK------RGNPGSEQGINEFQTEIQ 556
Q +D +G G F V G + A K E + E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG------PFRDHLYGTNQPPLSWKQRLE 610
+L ++ H ++++L + +++++L+ E ++ G ++ + KQ L+
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILD 126
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKAAPMDRGYV 666
G++YLHT + I H D+K NI+L K+ DFGL+ ++ G
Sbjct: 127 -------GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVE 174
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
+ G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK----RGNPGSEQG--INEFQTEIQ 556
+N +D +G G F V G + A K R S +G + + E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGP-F-----RDHLYGTNQPPLSWKQRLE 610
+L +++H ++++L + ++++IL+ E +A G F ++ + KQ L
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILN 125
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKAAPMDRGYV 666
G++YLH+ I H D+K NI+L K+ DFGL+ +D G
Sbjct: 126 -------GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE 173
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ G+ ++ PE + L ++D++S GV+ + +L
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 23/240 (9%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGF 572
V+G G +V + L + A+K + E++ML + + HR+++ LI F
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+E+ LV+E M G H+ + + + + A L +LH +GI H
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHN---KGIAH 134
Query: 633 RDVKTTNILL---DENLVAKVADFGLSK-------AAPMDRGYVSTAVKGSFGYLDPEYF 682
RD+K NIL ++ K+ DF L +P+ + T GS Y+ PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVV 193
Query: 683 RRQQLTEKS-----DVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737
D++S GV+L+ +L P + + A + + E I
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 38/214 (17%), Positives = 82/214 (38%), Gaps = 22/214 (10%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR 562
+ + + +G G FG V+ V K + EI +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIAR 59
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGP-F-----RDHLYGTNQPPLSWKQRLEICIGSA 616
HR+++ L + E+++++E+++ F + Q E
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------ 113
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILL--DENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
L +LH + I H D++ NI+ + K+ +FG ++ + G + +
Sbjct: 114 -ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTAP 167
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
Y PE + ++ +D++S G +++ +L
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGIN---EFQTEIQMLSKL-RHRHLVSL 569
V+G+G GKV G K A+K + + + E+ + H+V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKL--------LYDSPKARQEVDHHWQASGGPHIVCI 87
Query: 570 IGFCDEQSEMI----LVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC--IGSARGLHYLH 623
+ + ++ E M G + + ++ EI IG+A + +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA--IQFLH 145
Query: 624 TGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
+ I HRDVK N+L +++ V K+ DFG +K + + T + Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPC-YTPYYVAPE 199
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
++ + D++S GV+++ +LC P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 26/205 (12%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHR-HLVSLI 570
+G G F V + G + A K + + E EI +L + +++L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLS-------WKQRLEICIGSARGLHYLH 623
+ SE+IL+ EY A G +S KQ LE G++YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLH 148
Query: 624 TGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
I+H D+K NILL K+ DFG+S+ + + G+ YL PE
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIMGTPEYLAPE 203
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLC 705
+T +D+++ G++ + +L
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLT 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G VY A+K +TEI +L +L H +++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ +E+ LV E + G D + + S + + + YLH GI+HR
Sbjct: 118 ETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLH---ENGIVHR 172
Query: 634 DVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEK 690
D+K N+L + K+ADFGLSK ++ + V G+ GY PE R +
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 691 SDVYSFGVVLFEVLCARP 708
D++S G++ + +LC
Sbjct: 231 VDMWSVGIITYILLCGFE 248
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGF 572
IGVG + + + A+K + EI++L + +H ++++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
D+ + +V E M G D + Q S ++ + + + YLH AQG++H
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 633 RDVKTTNILL----DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
RD+K +NIL ++ DFG +K + G + T + ++ PE RQ
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYD 198
Query: 689 EKSDVYSFGVVLFEVLCARP 708
D++S GV+L+ +L
Sbjct: 199 AACDIWSLGVLLYTMLTGYT 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 15/174 (8%)
Query: 544 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHL-YGTNQPP 602
S ++ +I+ + ++ V + + + + + +D + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 603 LSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA---- 658
L I I A + +LH ++G++HRD+K +NI + V KV DFGL A
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 659 -------APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705
PM T G+ Y+ PE + K D++S G++LFE+L
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 22/81 (27%), Positives = 31/81 (38%), Gaps = 2/81 (2%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGN-PGSEQGINEFQTEIQMLSKLRHRH 565
+F+ +G GGFG V+ D AIKR P E + E++ L+KL H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 566 LVSLIGFCDEQSEMILVYEYM 586
+V E E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMD 86
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 498 FTFTELQNAT-QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIK---RGNPGSEQGINEFQ 552
+ + E Q T F + V+G GGFG+V + K+ A K + +G
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL--- 609
E Q+L K+ R +VSL + + + LV M G + H+Y Q + +
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 610 -EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
EIC G L LH + I++RD+K NILLD++ +++D GL+ + G
Sbjct: 293 AEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIK 343
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ GY+ PE + ++ T D ++ G +L+E++ +
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 11/221 (4%)
Query: 510 FDENAVIGVGGFGKVYIGVLEDGNKV-AIK--RGNPGSEQGINEFQTEIQMLSKLRHRHL 566
F++ + +G G G V+ + V A K N+ E+Q+L + ++
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYI 93
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V G E+ + E+M G D + + + ++ I +GL YL
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE-- 149
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
I+HRDVK +NIL++ K+ DFG+S + ++ V G+ Y+ PE +
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-GTRSYMSPERLQGTH 206
Query: 687 LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727
+ +SD++S G+ L E+ R I P +E + ++
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 38/220 (17%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIK---RGNPGSEQGINEFQTEIQMLSKLRH 563
+F+ IG G FGKV I D K+ A+K + + E+Q++ L H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 564 RHLVSLIG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEI----------- 611
LV+L F DE +M +V + + G R HL Q+
Sbjct: 75 PFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLFIC 122
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671
+ A L YL Q IIHRD+K NILLDE+ + DF ++ P + + A
Sbjct: 123 ELVMA--LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-- 175
Query: 672 GSFGYLDPEYFRRQQLTEKS---DVYSFGVVLFEVLCARP 708
G+ Y+ PE F ++ S D +S GV +E+L R
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGF 572
V+G+G GKV K A+K Q + + E+++ + + H+V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 573 CDEQSEMI----LVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC--IGSARGLHYLHTGA 626
+ +V E + G + + ++ EI IG A + YLH+
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS-- 179
Query: 627 AQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
I HRDVK N+L N + K+ DFG +K +T + Y+ PE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TTPC-YTPYYVAPEVLG 236
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP 708
++ + D++S GV+++ +LC P
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 14/207 (6%)
Query: 510 FDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNP-GSEQGINEFQTEIQMLSKL-RHRHL 566
+ +G G G+V+ V A+K+ G+++ ++ ++ K ++
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V G +++ + E M + L Q P+ + ++ + + L+YL
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALYYLKE-- 142
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
G+IHRDVK +NILLDE K+ DFG+S + G Y+ PE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 687 LTE-----KSDVYSFGVVLFEVLCARP 708
T+ ++DV+S G+ L E+ +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQF 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 64/217 (29%), Positives = 93/217 (42%), Gaps = 46/217 (21%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQT----EIQMLSKLRHRHLVSLI 570
VIG G FG V+ L + ++VAIK+ + + + E+Q++ ++H ++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKK--------VLQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 571 GFCDEQSEMI------LVYEYMANGP-----FRDHLYGTNQ--PPLSWK----QRLEICI 613
F + LV EY+ P H Q P L K Q L
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKLYMYQLL---- 151
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKG 672
R L Y+H+ GI HRD+K N+LLD V K+ DFG +K VS
Sbjct: 152 ---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-- 203
Query: 673 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
S Y PE F T D++S G V+ E++ +P
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIK---RGNPGSEQGINEFQTEIQMLSKL-- 561
+F + +IG GGFG+VY D K+ A+K + +QG E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 562 -RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----EICIGSA 616
+V + ++ + + M G HL S EI +G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILG-- 304
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
L ++H + +++RD+K NILLDE+ +++D GL+ + +V G+ GY
Sbjct: 305 --LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASV-GTHGY 356
Query: 677 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARP 708
+ PE ++ + S D +S G +LF++L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 48/223 (21%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKR--GNPGSEQGINEFQT---------EIQMLSKLRH 563
I G +G V GV +G VAIKR + +N EI++L+ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 564 RHLVSLI-----GFCDEQSEMILVYEYMANGPFRD--HLYGTNQPPLSWK-------QRL 609
+++ L ++ LV E M D + + +S + L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR---GYV 666
GLH LH G++HRD+ NILL +N + DF L++ D YV
Sbjct: 145 -------LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 667 STAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ Y PE + + T+ D++S G V+ E+ +
Sbjct: 195 THRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 20/201 (9%), Positives = 53/201 (26%), Gaps = 43/201 (21%)
Query: 514 AVIGVGGFGKVYIGVLED---GNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
G + + + D +VA+ + + E + LS++ +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
++ ++ ++V E++ G ++ S + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAH---R 147
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
G+ + + + + +A +
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA------- 179
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
+ D+ G L+ +L R
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNP-GSEQGINEFQTEIQ-MLSKLRHR 564
++ + IG G +G V V G +A+KR E+ + ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 565 HLVSLIGFCDEQSEMILVYEYMANG--PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
++V G + + + E M+ F ++Y + + +I + + + L++L
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE-- 680
IIHRD+K +NILLD + K+ DFG+S + T G Y+ PE
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERI 197
Query: 681 --YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
RQ +SDV+S G+ L+E+ R
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 76/274 (27%), Positives = 113/274 (41%), Gaps = 52/274 (18%)
Query: 461 TSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIGVGG 520
TSF S ++ S FGS K G + + ++ + VIG G
Sbjct: 8 TSFAESCKPVQQPSAFGSMKVSRDKDG-SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGS 66
Query: 521 FGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQT----EIQMLSKLRHRHLVSLIGFCDE 575
FG VY L + G VAIK+ + + + E+Q++ KL H ++V L F
Sbjct: 67 FGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYS 118
Query: 576 QSEMI------LVYEYMANGPFR--DHLYGTNQP-PLSWKQRL--EICIGSARGLHYLHT 624
E LV +Y+ +R H Q P+ + + ++ R L Y+H+
Sbjct: 119 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF----RSLAYIHS 174
Query: 625 GAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAA----PMDRGYVST----AVKGSFG 675
GI HRD+K N+LLD + V K+ DFG +K P Y+ + A
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRA------ 224
Query: 676 YLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE F T DV+S G VL E+L +P
Sbjct: 225 ---PELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 42/222 (18%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINEFQ-----TEIQMLSKL 561
++F ++G G F V + ++ AIK I E + E ++S+L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 87
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL-----------E 610
H V L + ++ Y NG ++ K E
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---------KIGSFDETCTRFYTAE 138
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I L YLH +GIIHRD+K NILL+E++ ++ DFG +K +
Sbjct: 139 IVSA----LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-- 189
Query: 671 KGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
SF G Y+ PE + + SD+++ G ++++++ P
Sbjct: 190 -NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---EIQMLSKLRHRHLVSLIG 571
+G G + VY G+ G VA+K SE+G T EI ++ +L+H ++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYD 70
Query: 572 FCDEQSEMILVYEYMAN---GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
++++ LV+E+M N G L +GL + H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---EN 127
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKA 658
I+HRD+K N+L+++ K+ DFGL++A
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARA 157
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-20
Identities = 52/224 (23%), Positives = 79/224 (35%), Gaps = 39/224 (17%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINE---FQTEIQMLSKLRH 563
+F+ VIG G F +V + ++ +V A+K N E F+ E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 564 RHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR---- 617
R + L Q E + LV EY G L + I +
Sbjct: 121 RWITQL--HFAFQDENYLYLVMEYYVGGDLLTLL-----------SKFGERIPAEMARFY 167
Query: 618 ------GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671
+ +H G +HRD+K NILLD ++ADFG D S
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 672 GSFGYLDPEYFRRQQLTEKSDVY-------SFGVVLFEVLCARP 708
G+ YL PE + + Y + GV +E+ +
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 26/216 (12%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNP-GSEQGINEFQTEIQM-LSKLRHR 564
+ + +G G +G V + G +A+KR + Q ++ + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLY---GTNQPPLSWKQRLEICIGSARGLHY 621
V+ G + ++ + E M D Y + +I + + L +
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSL--DKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSF----GY 676
LH+ +IHRDVK +N+L++ K+ DFG+S GY V K Y
Sbjct: 125 LHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDDVAKDIDAGCKPY 175
Query: 677 LDPE----YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ PE ++ + KSD++S G+ + E+ R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 24/166 (14%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLRHRHLVSLI 570
IG G +G V+ + G VAIK+ + I + EI+ML +L+H +LV+L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIALREIRMLKQLKHPNLVNLL 68
Query: 571 GFCDEQSEMILVYEYMANGPFRDH-LYG---TNQPPLSWKQRLEICIGSARGLHYLHTGA 626
+ + LV+EY DH + Q + I + + +++ H
Sbjct: 69 EVFRRKRRLHLVFEYC------DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH--- 119
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKA--APMDR--GYVST 668
IHRDVK NIL+ ++ V K+ DFG ++ P D V+T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLR 562
+NF + IG G +G VY G VA+K+ +E G+ T EI +L +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELN 60
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDH-----LYGTNQPPLSWKQRLEICIGSAR 617
H ++V L+ ++++ LV+E++ + + + +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL------HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
GL + H + ++HRD+K N+L++ K+ADFGL++A
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINE---FQTEIQMLSKLRH 563
++F+ VIG G FG+V + L++ +KV A+K N E F+ E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 564 RHLVSLIG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR----- 617
+ + +L F D+ + + LV +Y G L + E +
Sbjct: 134 KWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLL-----------SKFEDRLPEEMARFYL 181
Query: 618 -----GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG 672
+ +H +HRD+K NIL+D N ++ADFG D S+ G
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 673 SFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 708
+ Y+ PE + + + D +S GV ++E+L
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 550 EFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
+ + + + R L S+ S + + +++ + + L+ + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
A+G+ +L A++ IHRD+ NILL E V K+ DFGL++ D Y
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 249
Query: 670 VKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLFEV 703
V+ L PE + T +SDV+SFGV+L+E+
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 28/152 (18%), Positives = 55/152 (36%), Gaps = 18/152 (11%)
Query: 515 VIGVGGFGKVYIGVL------EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHL 566
+G G FG+V VA+K G + +E+++L + H ++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 567 VSLIGFC-DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
V+L+G C ++++ E+ G +L +R E +G +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGK 139
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
G I D+K + + + + F K
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLS 559
Q + + + +G G +G VY G VA+KR +E GI T EI +L
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP--STAIREISLLK 74
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDH----LYGTNQPPLSWKQRLEICIGS 615
+L H ++VSLI + + LV+E+M + + N+ L Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFM------EKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 616 ARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
RG+ + H I+HRD+K N+L++ + K+ADFGL++A
Sbjct: 129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 38/173 (21%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLRHRHLVSLI 570
+G G +G V + G VAIK+ + + + EI++L +LRH +LV+L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQLRHENLVNLL 90
Query: 571 GFCDEQSEMILVYEYMANGPFRDH-LYG---TNQPPLSW-------KQRLEICIGSARGL 619
C ++ LV+E++ DH + L + Q + G+
Sbjct: 91 EVCKKKKRWYLVFEFV------DHTILDDLELFPNGLDYQVVQKYLFQII-------NGI 137
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA--APMDR--GYVST 668
+ H + IIHRD+K NIL+ ++ V K+ DFG ++ AP + V+T
Sbjct: 138 GFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRH 563
F+ ++G G FGKV + + + +K+ ++ + TE ++L RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 564 RHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL-----------E 610
L +L Q+ + V EY G HL ++R+ E
Sbjct: 208 PFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLS---------RERVFSEDRARFYGAE 256
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
I L YLH + + +++RD+K N++LD++ K+ DFGL K + G
Sbjct: 257 IVSA----LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTF 309
Query: 671 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ YL PE D + GVV++E++C R
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLRH 563
+ + IG G +G VY G A+K+ E GI T EI +L +L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKH 59
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDH----LYGTNQPPLSWKQRLEICIGSARGL 619
++V L + ++LV+E++ D L + L + G+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
Y H + ++HRD+K N+L++ K+ADFGL++A
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARA 149
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLR 562
Q +++ IG G +G V+ E VA+KR + G+ + EI +L +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELK 59
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDH----LYGTNQPPLSWKQRLEICIGSARG 618
H+++V L ++ LV+E+ D + + L + +G
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
L + H ++ ++HRD+K N+L++ N K+A+FGL++A
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA 150
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 508 QNFDENAVIGVGGFGKVYIG-VLEDGNKVAIKRGNPGSEQGINEFQT---EIQMLSKLRH 563
+ + + +G G + VY G N VA+K E+G T E+ +L L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDH----LYGTNQPPLSWKQRLEICIGSARGL 619
++V+L + + LV+EY+ D ++ RGL
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
Y H Q ++HRD+K N+L++E K+ADFGL++A
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA 149
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 23/220 (10%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR 562
+ F + G G FG V +G G VAIK+ E Q +Q L+ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 563 HRHLVSLIGFCDEQSE-------MILVYEYMANGPFR--DHLYGTNQP-PLSWKQRL--E 610
H ++V L + E + +V EY+ + R + Y P + +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTA 669
+ R + LH + + HRD+K N+L++ + K+ DFG +K V+
Sbjct: 138 LI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 670 VKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 708
S Y PE F Q T D++S G + E++ P
Sbjct: 193 C--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINE---FQTEIQMLSKLRH 563
++++ VIG G FG+V + + KV A+K + ++ F E +++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 564 RHLVSLIG-FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL----------EIC 612
+V L F D+ + +V EYM G + + + E+
Sbjct: 129 PWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLMS---------NYDVPEKWARFYTAEVV 178
Query: 613 IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKG 672
+ L +H + G IHRDVK N+LLD++ K+ADFG + G
Sbjct: 179 LA----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 673 SFGYLDPEYFRRQQLTEK----SDVYSFGVVLFEVLCARP 708
+ Y+ PE + Q D +S GV L+E+L
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 23/155 (14%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKR----GNPGSEQGINEFQT---EIQMLSKLRHRHLV 567
+G G F VY VAIK+ ++ GIN +T EI++L +L H +++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNII 75
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDH----LYGTNQPPLSWKQRLEICIGSARGLHYLH 623
L+ +S + LV+++M + + N L+ + + +GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFM------ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
I+HRD+K N+LLDEN V K+ADFGL+K+
Sbjct: 130 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 44/247 (17%)
Query: 485 YSGLFSNQGLGRFFTFTELQNA---TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR- 539
+ + ++ +F++ + + + IG G G V VAIK+
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL 95
Query: 540 GNPGSEQGINEFQT---------EIQMLSKLRHRHLVSLI------GFCDEQSEMILVYE 584
P FQ E+ ++ + H++++SL+ +E ++ LV E
Sbjct: 96 SRP--------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644
M +L Q L ++ + G+ +LH+ GIIHRD+K +NI++
Sbjct: 148 LMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 199
Query: 645 NLVAKVADFGLSKAAPMDR---GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 701
+ K+ DFGL++ A YV T Y PE E D++S G ++
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 702 EVLCARP 708
E++ +
Sbjct: 255 EMVRHKI 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 34/217 (15%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSKLRH 563
+FD ++G G FGKV + + + +++ ++ + TE ++L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL----------EI 611
L +L Q+ + V EY G HL S ++ EI
Sbjct: 65 PFLTAL--KYAFQTHDRLCFVMEYANGGELFFHL--------SRERVFTEERARFYGAEI 114
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK 671
L YLH ++ +++RD+K N++LD++ K+ DFGL K + G
Sbjct: 115 VSA----LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFC 166
Query: 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ YL PE D + GVV++E++C R
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 69/238 (28%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---------EIQ 556
+ + IG G +G V + +VAIK+ I+ F+ EI+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 557 MLSKLRHRHLVSLI-----GFCDEQSEMILVYEYM---------ANGPFRDH----LYGT 598
+L + RH +++ + ++ ++ +V + M DH LY
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-- 135
Query: 599 NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
Q L RGL Y+H+ ++HRD+K +N+LL+ K+ DFGL++
Sbjct: 136 --------QIL-------RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 659 APMDR-------GYVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 708
A D YV+T Y PE + T+ D++S G +L E+L RP
Sbjct: 178 ADPDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 52/235 (22%), Positives = 92/235 (39%), Gaps = 41/235 (17%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQT---------EI 555
+ + IG G G V VAIK+ P FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--------FQNQTHAKRAYREL 75
Query: 556 QMLSKLRHRHLVSLI------GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL 609
++ + H++++ L+ +E ++ +V E M + L Q L ++
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQMELDHERMS 130
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR---GYV 666
+ G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A YV
Sbjct: 131 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
T Y PE E D++S G ++ E++ + +Q +
Sbjct: 188 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 54/228 (23%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQT---------EI 555
+ + +G G +G V + G KVAIK+ P FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--------FQSEIFAKRAYREL 74
Query: 556 QMLSKLRHRHLVSLI------GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWK--- 606
+L ++H +++ L+ + LV +M D L S +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQ 129
Query: 607 ----QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662
Q L +GL Y+H+ G++HRD+K N+ ++E+ K+ DFGL++ A +
Sbjct: 130 YLVYQML-------KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 663 R-GYVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
GYV T Y PE + D++S G ++ E+L +
Sbjct: 180 MTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLR 562
+ +G G +G+VY + VAIKR E+ G+ T E+ +L +L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP--GTAIREVSLLKELQ 91
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDH---LYGTNQPPLSWKQRLEICIGSARGL 619
HR+++ L + L++EY ++ Y P +S + G+
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYA------ENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVA-----KVADFGLSKA 658
++ H+ + +HRD+K N+LL + + K+ DFGL++A
Sbjct: 146 NFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 508 QNFDENAVIGVGGFGKVYI---GVLEDGNKV-AIK--RGNPGSEQGINEFQTEIQMLSKL 561
F+ V+G G FGKV++ D ++ A+K + + + E +L ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 562 RHRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL---------- 609
H +V L Q+E + L+ +++ G L K+ +
Sbjct: 84 NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLS---------KEVMFTEEDVKFYL 132
Query: 610 -EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
E+ + L +LH + GII+RD+K NILLDE K+ DFGLSK + +D +
Sbjct: 133 AELALA----LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAY 184
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ G+ Y+ PE R+ T+ +D +SFGV++FE+L
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 4e-17
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
+F+ V+G G FGKV + + +++ +K+ + + E ++L+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQ--RLEICIGSARG 618
L L Q+ + V EY+ G H+ + EI IG
Sbjct: 401 PPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG---- 454
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +L ++GII+RD+K N++LD K+ADFG+ K + G + G+ Y+
Sbjct: 455 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIA 510
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE Q + D ++FGV+L+E+L +
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 28/167 (16%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKLRH 563
+++ A IG G FG+V+ + G KVA+K+ +E+ G T EI++L L+H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLKH 75
Query: 564 RHLVSLIGFCDEQSEMI--------LVYEYMANGPFRDH----LYGTNQPPLSWKQRLEI 611
++V+LI C ++ LV+++ +H L + + +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRV 129
Query: 612 CIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
GL+Y+H I+HRD+K N+L+ + V K+ADFGL++A
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 173
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
Q+FD VIG G + KV + L+ +++ +K+ ++ I+ QTE + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL----------- 609
H LV L Q+E + V EY+ G H+ +QR
Sbjct: 69 HPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSA 117
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
EI + L+YLH +GII+RD+K N+LLD K+ D+G+ K + G ++
Sbjct: 118 EISLA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTST 169
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ Y+ PE R + D ++ GV++FE++ R
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-17
Identities = 49/267 (18%), Positives = 91/267 (34%), Gaps = 62/267 (23%)
Query: 458 STKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNATQNFDENAVIG 517
S + + +S + ++ GS++ S++ ++ +IG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 518 VGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---------EIQMLSKLRHRHLV 567
G +G V + VAIK+ F+ EI +L++L H H+V
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 568 SLI-----GFCDEQSEMILVYEYM---------ANGPFRD-H----LYGTNQPPLSWKQR 608
++ ++ E+ +V E + H LY
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----------NL 165
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS------KAAPMD 662
L G+ Y+H+ GI+HRD+K N L++++ KV DFGL+ +
Sbjct: 166 L-------VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 663 RGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+ ++QLT
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 63/233 (27%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---------EIQ 556
+ + + +G G +G V + G +VA+K+ + FQ+ E++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 557 MLSKLRHRHLVSLI------GFCDEQSEMILVYEYM---------ANGPFRDH----LYG 597
+L ++H +++ L+ +E +++ LV M DH +Y
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY- 139
Query: 598 TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657
Q L RGL Y+H+ IIHRD+K +N+ ++E+ K+ DFGL++
Sbjct: 140 ---------QIL-------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 658 -AAPMDRGYVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
A GYV+T Y PE + D++S G ++ E+L R
Sbjct: 181 HTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
Q+FD VIG G + KV + L+ +++ +K+ ++ I+ QTE + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL----------- 609
H LV L Q+E + V EY+ G H+ +QR
Sbjct: 112 HPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSA 160
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
EI + L+YLH +GII+RD+K N+LLD K+ D+G+ K + G ++
Sbjct: 161 EISLA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTST 212
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ Y+ PE R + D ++ GV++FE++ R
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 28/169 (16%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQ-GINEF-QT---EI---QMLS 559
++ A IGVG +G VY G+ VA+K + G + E+ + L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 560 KLRHRHLVSLI-----GFCDEQSEMILVYEYMANGPFRDH-----LYGTNQPPLSWKQRL 609
H ++V L+ D + ++ LV+E++ D L P L +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLDKAPPPGLPAETIK 123
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
++ RGL +LH A I+HRD+K NIL+ K+ADFGL++
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 508 QNFDENAVIGVGGFGKVYI---GVLEDGNKV-AIKRGNPGS-EQGINEF---QTEIQMLS 559
+ F+ V+G GG+GKV+ + K+ A+K + + + E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 560 KLRHRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL-------- 609
+++H +V L Q+ + L+ EY++ G L ++ +
Sbjct: 77 EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLE---------REGIFMEDTACF 125
Query: 610 ---EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666
EI + L +LH +GII+RD+K NI+L+ K+ DFGL K + + G V
Sbjct: 126 YLAEISMA----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTV 177
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ G+ Y+ PE R D +S G +++++L P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 55/229 (24%)
Query: 507 TQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQT---------EI 555
+ + +G G +G V V G KVAIK+ P FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--------FQSELFAKRAYREL 75
Query: 556 QMLSKLRHRHLVSLI------GFCDEQSEMILVYEYMANGPFRD-HLYGTNQPPLSWK-- 606
++L +RH +++ L+ D+ ++ LV +M D ++ L
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEK-LGEDRI 130
Query: 607 -----QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661
Q L +GL Y+H GIIHRD+K N+ ++E+ K+ DFGL++ A
Sbjct: 131 QFLVYQML-------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
Query: 662 DR-GYVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ GYV T Y PE + T+ D++S G ++ E++ +
Sbjct: 181 EMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 53/232 (22%), Positives = 86/232 (37%), Gaps = 66/232 (28%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---------EIQMLSKLRHR 564
++G G +G V G VAIK+ I F EI++L +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIKILKHFKHE 69
Query: 565 HLVSLI-----GFCDEQSEMILVYEYM--------ANGPFRD-H----LYGTNQPPLSWK 606
+++++ + +E+ ++ E M + D H +Y
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------- 119
Query: 607 QRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666
Q L R + LH +IHRD+K +N+L++ N KV DFGL++
Sbjct: 120 QTL-------RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 667 STAVKGSFG---------YLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 708
S G Y PE + + DV+S G +L E+ RP
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 48/207 (23%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGF 572
V+G+G GKV K A+K Q + + E+++ + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 573 CDEQSEMI----LVYEYMANGPFRDHLYGTNQPPLSWKQRLEIC--IGSARGLHYLHTGA 626
+ +V E + G + + ++ EI IG A + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLH--- 134
Query: 627 AQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAP--MDRGYVSTAVKGSFGYLDPEY 681
+ I HRDVK N+L N + K+ DFG A Y
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKETTGEKY---------------- 175
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ D++S GV+++ +LC P
Sbjct: 176 ------DKSCDMWSLGVIMYILLCGYP 196
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINEFQ-----TEIQMLSKL 561
FD +G G FG+V + ++ A+K + ++ + Q E ++L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEHTLNEKRILQAV 98
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
LV L + S + +V EY+A G HL + + I Y
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEY 156
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF-G---YL 677
LH + +I+RD+K N+L+D+ +V DFG +K R + + G L
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTW-------TLCGTPEAL 205
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE + + D ++ GV+++E+ P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
+F+ V+G G FGKV + + +++ +K+ + + E ++L+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQ--RLEICIGSARG 618
L L Q+ + V EY+ G H+ + EI IG
Sbjct: 80 PPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG---- 133
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +L ++GII+RD+K N++LD K+ADFG+ K + G + G+ Y+
Sbjct: 134 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIA 189
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE Q + D ++FGV+L+E+L +
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 45/223 (20%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
++F + ++G G FGKV++ + N+ A+K+ + + E ++LS
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL----------- 609
H L + FC Q++ + V EY+ G H+
Sbjct: 77 HPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ---------SCHKFDLSRATFYAA 125
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
EI +G L +LH ++GI++RD+K NILLD++ K+ADFG+ K + +T
Sbjct: 126 EIILG----LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT- 177
Query: 670 VKGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
F G Y+ PE Q+ D +SFGV+L+E+L +
Sbjct: 178 ----FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 47/222 (21%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV-AIKRGNPGSEQGINEFQ-----TEIQMLSKL 561
Q+F +G G FG+V++ + A+K E + Q E MLS +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLSIV 63
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRL-----------E 610
H ++ + G + ++ ++ +Y+ G L K + E
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---------KSQRFPNPVAKFYAAE 114
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
+C+ L YLH ++ II+RD+K NILLD+N K+ DFG +K P D Y
Sbjct: 115 VCLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY----- 161
Query: 671 KGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ G Y+ PE + + D +SFG++++E+L
Sbjct: 162 --TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
NF+ V+G G FGKV + +++ + +K+ + + TE ++LS
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQ--RLEICIGSARG 618
H L L FC Q+ + V E++ G H+ + + + + EI
Sbjct: 83 HPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA---- 136
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +LH +GII+RD+K N+LLD K+ADFG+ K + G + G+ Y+
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG-ICNGVTTATFCGTPDYIA 192
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
PE + D ++ GV+L+E+LC
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 45/261 (17%), Positives = 94/261 (36%), Gaps = 77/261 (29%)
Query: 503 LQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT----EIQM 557
L+ +++ + +G G FG V +E G + A+K+ + + E+ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDI 53
Query: 558 LSKLRHRHLVSLIGFCDEQSEMI------------------------------------- 580
+ L H +++ L+ + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 581 -LVYEYMANGPFRDHLYGTNQPPLSWKQRLE----------ICIGSARGLHYLHTGAAQG 629
++ EY+ D L+ + + + + + R + ++H+ G
Sbjct: 114 NVIMEYVP-----DTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHS---LG 161
Query: 630 IIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE-YFRRQQL 687
I HRD+K N+L++ ++ K+ DFG +K V+ S Y PE +
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEY 219
Query: 688 TEKSDVYSFGVVLFEVLCARP 708
T D++S G V E++ +P
Sbjct: 220 TPSIDLWSIGCVFGELILGKP 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKV----AIKRGNPGSEQGINEFQTEIQMLSK-LR 562
+F VIG G FGKV + + +++ ++ +E +L K ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 563 HRHLVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL----------- 609
H LV L Q+ + V +Y+ G HL ++R
Sbjct: 98 HPFLVGL--HFSFQTADKLYFVLDYINGGELFYHLQ---------RERCFLEPRARFYAA 146
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
EI L YLH + I++RD+K NILLD + DFGL K ++ ++
Sbjct: 147 EIASA----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNSTTST 198
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
G+ YL PE +Q D + G VL+E+L P
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 46/226 (20%), Positives = 80/226 (35%), Gaps = 59/226 (26%)
Query: 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQ 552
+F + + N+ +IG G +G VY+ VAIK+ F+
Sbjct: 13 NLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FE 64
Query: 553 T---------EIQMLSKLRHRHLVSLI-----GFCDEQSEMILVYEYM---------ANG 589
EI +L++L+ +++ L + E+ +V E
Sbjct: 65 DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI 124
Query: 590 PFRD-H----LYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644
+ H LY L G +++H GIIHRD+K N LL++
Sbjct: 125 FLTEEHIKTILY----------NLL-------LGENFIHES---GIIHRDLKPANCLLNQ 164
Query: 645 NLVAKVADFGLS-KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
+ KV DFGL+ + ++ + ++QLT
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 38/174 (21%)
Query: 508 QNFDENAVIGVGGFGKVYIG--VLEDGNKVAIKRGNPGSEQ-GINEFQT---EIQMLSKL 561
Q ++ A IG G +GKV+ + G VA+KR + + G+ + E+ +L L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHL 68
Query: 562 R---HRHLVSLI-----GFCDEQSEMILVYEYMANGPFRDH-----LYGTNQPPLSWKQR 608
H ++V L D ++++ LV+E++ D L +P + +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVPTETI 122
Query: 609 ----LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658
++ RGL +LH + ++HRD+K NIL+ + K+ADFGL++
Sbjct: 123 KDMMFQLL----RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 39/205 (19%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIG-F 572
+G G + +V+ + + + KV +K P ++ I EI++L LR ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNIITLADIV 100
Query: 573 CDEQSEM-ILVYEYMANGPFRDHLYGTNQPPLS-------WKQRLEICIGSARGLHYLHT 624
D S LV+E++ N F+ L+ + L + L Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL-------KALDYCHS 148
Query: 625 GAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDR---GYVSTAVKGSFGYLDPE 680
GI+HRDVK N+++D E+ ++ D+GL++ + V++ + PE
Sbjct: 149 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE 200
Query: 681 YFRRQQLTEKS-DVYSFGVVLFEVL 704
Q+ + S D++S G +L ++
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 40/172 (23%)
Query: 512 ENAVIGVGGFGKVYIGV---LEDGNKVAIKR----GNPGSEQGINEFQTEIQMLSKLRHR 564
E +G G +G VY +D A+K+ G S EI +L +L+H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78
Query: 565 HLVSLIGFCDEQSEMI--LVYEYMANGPFRDH-LYG---TNQPPLSWKQRLEICIGSA-- 616
+++SL ++ L+++Y +H L+ ++ + K+ +++ G
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 617 ------RGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKA 658
G+HYLH A ++HRD+K NIL+ E K+AD G ++
Sbjct: 133 LLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 55/202 (27%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKR-GNPGSEQGINEFQT---------EIQMLSKLR- 562
+G G +G V+ + G VA+K+ + FQ EI +L++L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFREIMILTELSG 67
Query: 563 HRHLVSL--IGFCDEQSEMILVYEYM---------ANGPFRDH----LYGTNQPPLSWKQ 607
H ++V+L + D ++ LV++YM AN H +Y Q
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----------Q 117
Query: 608 RLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667
+ + + YLH+G G++HRD+K +NILL+ KVADFGLS++ R +
Sbjct: 118 LI-------KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 668 TAVKGSFGYLDPEYFRRQQLTE 689
+ + LT+
Sbjct: 168 NIPLSINENTENFDDDQPILTD 189
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 52/240 (21%), Positives = 89/240 (37%), Gaps = 80/240 (33%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQT---------EIQMLSKLRHR 564
+G GG G V+ V + +VAIK+ I EI+++ +L H
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKK--------IV-LTDPQSVKHALREIKIIRRLDHD 68
Query: 565 HLVSLI--------------GFCDEQSEMILVYEYM---------ANGPFRDH----LYG 597
++V + G E + + +V EYM +H +Y
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY- 127
Query: 598 TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLS 656
Q L RGL Y+H+ ++HRD+K N+ ++ E+LV K+ DFGL+
Sbjct: 128 ---------QLL-------RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 657 KAAPMDR-------GYVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+ + T Y P T+ D+++ G + E+L +
Sbjct: 169 RIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 52/230 (22%)
Query: 508 QNFDENAVIGVGGFGKVYI---GVLEDGNKV-AIK---------RGNPGSEQGINEFQTE 554
+NF+ V+G G +GKV++ D K+ A+K + +TE
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-----TTEHTRTE 108
Query: 555 IQMLSKLRHRH-LVSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRL-- 609
Q+L +R LV+L Q+E + L+ +Y+ G HL ++
Sbjct: 109 RQVLEHIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLS---------QRERFT 157
Query: 610 ---------EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660
EI + L +LH GII+RD+K NILLD N + DFGLSK
Sbjct: 158 EHEVQIYVGEIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210
Query: 661 MDRGYVSTAVKGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLFEVLCARP 708
D + G+ Y+ P+ R + D +S GV+++E+L
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 7e-11
Identities = 34/205 (16%), Positives = 59/205 (28%), Gaps = 48/205 (23%)
Query: 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIK--------RGNPGSEQGIN 549
F+ T+ IG G FG+V+ + D VAIK N ++
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 550 EFQTEIQMLSKL---------RHRHLVSLIGFCDEQ----SEMILVYEYMANG----PFR 592
E EI + +L R + L Q ++ +++ + R
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 593 DHLYGTNQPPL-------------------SWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ +Q + S I L HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 634 DVKTTNILLDENLVAKVADFGLSKA 658
D+ N+LL + + K+ K+
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKS 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH-RHLVSLIGFC 573
IG G FG +Y+G + G +VAIK ++ E ++ ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
E ++V E + GP + L+ S K L + + Y+H ++ IHR
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 634 DVKTTNILL----DENLVAKVADFGLSK 657
DVK N L+ NLV + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYII-DFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 35/150 (23%), Positives = 60/150 (40%), Gaps = 16/150 (10%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH-RHLVSLIGFC 573
IG G FG ++ G L + +VAIK S+ E + L + ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
E +LV + + GP + L S K + +H + +++R
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 130
Query: 634 DVKTTNILL------DENLVAKVADFGLSK 657
D+K N L+ + N++ V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIY-VVDFGMVK 159
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 43/221 (19%), Positives = 86/221 (38%), Gaps = 38/221 (17%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIK--RGNP-GSEQGINEFQTEIQMLSKLR------- 562
+G G F V++ + + VA+K RG+ +E + EI++L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKE 80
Query: 563 ----HRHLVSLIG---FCDEQSE-MILVYEYMANGP-FRDHLYGTNQPPLSWKQRLEICI 613
H++ L+ +++V+E + G + + +I
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL--GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 614 GSARGLHYLHTGAAQGIIHRDVKTTNILLDE------NLVAKVADFGLSKAAPMDRGYVS 667
GL Y+H GIIH D+K N+L++ + K+AD G A + +
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG---NACWYDEHYT 193
Query: 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
+++ Y PE +D++S ++FE++
Sbjct: 194 NSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 24/209 (11%)
Query: 513 NAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPG-SEQGINEFQTEIQMLSKLRHR---- 564
+++IG G FG+V + VAIK + Q Q E+++L +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEM 114
Query: 565 --HLVSLIGFCDEQSEMILVYEYMA-NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
++V L ++ + LV+E ++ N D L TN +S + L +
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 622 LHTGAAQGIIHRDVKTTNILL--DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDP 679
L T IIH D+K NILL + K+ DFG ++ + ++ F Y P
Sbjct: 173 LATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRF-YRSP 227
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 708
E D++S G +L E+ P
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 6e-10
Identities = 66/468 (14%), Positives = 130/468 (27%), Gaps = 182/468 (38%)
Query: 451 SWLL-PLH--STKTSFLSSKSSSRRSSLFGSRKSKSGYSGLFSNQGLGRFFTFTELQNAT 507
+L+ P+ + S ++ +R L+ + +F+ + R + +L+ A
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ-------VFAKYNVSRLQPYLKLRQAL 144
Query: 508 QNFDENAVI---GVGGFGK--VYIGVLED-------GNKVA-IKRGNPGSEQGINEFQTE 554
+ GV G GK V + V K+ + N S + +
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV------ 198
Query: 555 IQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG 614
++ML KL ++ + D + +N R H S + L +
Sbjct: 199 LEMLQKLLYQIDPNWTSRSD----------HSSNIKLRIH---------SIQAELRRLLK 239
Query: 615 SARGLHYLHTGAAQGIIHRDVK----------------TT---------------NILLD 643
S + L ++ +V+ TT +I LD
Sbjct: 240 SKPYENCL-------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292
Query: 644 EN-----------LVAKVAD---------------FGLSKAAPMDRGY------------ 665
+ L+ K D LS A R
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 666 --VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINP---KLPREQVS 720
++T ++ S L+P +R+ +F+ L + P +P +
Sbjct: 353 DKLTTIIESSLNVLEPAEYRK---------------MFDRL----SVFPPSAHIP-TILL 392
Query: 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
W + K V+ + K SL EK E
Sbjct: 393 SLIW-------FDVIKSDVMVVVNKLHKYSL------VEK----------------QPKE 423
Query: 781 YAMQL----QEASTQIDHPEDKSANLIALDKPCENLSREDLAVAVSDN 824
+ + E ++++ +++ + +DL D
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 26/202 (12%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPG-SEQGINEFQTEIQMLSKLRHR----- 564
VIG G FG+V + VA+K R Q EI++L LR +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNT 158
Query: 565 -HLVSLIGFCDEQSEMILVYEYMA-NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
+++ ++ ++ + + +E ++ N + + S + + L L
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVA--KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
H IIH D+K NILL + + KV DFG S + V T ++ F Y PE
Sbjct: 217 HK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQSRF-YRAPE 269
Query: 681 YFRRQQLTEKSDVYSFGVVLFE 702
+ D++S G +L E
Sbjct: 270 VILGARYGMPIDMWSLGCILAE 291
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 16/150 (10%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH-RHLVSLIGFC 573
IG G FG++ +G L VAIK S E + +L + + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+V E + GP + L+ S K L I I + Y+H+ + +I+R
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYR 129
Query: 634 DVKTTNILL------DENLVAKVADFGLSK 657
DVK N L+ + ++ + DF L+K
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFC 573
IG G FG++Y+G ++ +VAIK N ++ + E ++ L+ + ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
E +LV + + GP + L+ LS K L + + ++H+ + +HR
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
Query: 634 DVKTTNILLDENLVAK---VADFGLSK 657
D+K N L+ A + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 27/165 (16%), Positives = 54/165 (32%), Gaps = 28/165 (16%)
Query: 516 IGVGGFGKVYIGV---------LEDGNKVAIK----RGNPGSEQGINEFQTEIQMLSKLR 562
G +Y K ++K G +EQ + + ++K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 563 HRHLVSLIGF-------CDEQSEMILVYEYMANGP-FRDHLYGTNQPPLSWKQRLEICIG 614
+ L+ + LV + G + L + + LS + L++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV--ADFGLSK 657
L +LH +H +V NI +D ++V A +G +
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 31/165 (18%), Positives = 60/165 (36%), Gaps = 28/165 (16%)
Query: 516 IGVGGFGKVYIGVLEDGN------KVAIKRGNPGSEQGINEFQT-----EIQMLSKLRHR 564
IG GGFG +Y+ + +K + E + + + + K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 565 HLVSLIGFC----------DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG 614
+ +G + +S ++ + G +Y N S K L++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV--ADFGLSK 657
L Y+H +H D+K +N+LL+ +V D+GL+
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 47/226 (20%), Positives = 78/226 (34%), Gaps = 52/226 (23%)
Query: 514 AVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPG-SEQGINEFQTEIQMLSKLRHR----- 564
+G G FG+V + +++ A+K R + + E +L K+++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNN 96
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGP-FRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
++V G M L++E + GP + + N + CI + L+YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL--GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV---STAVK----GSFGY 676
+ H D+K NILLD+ K ST +K G +
Sbjct: 155 K---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 677 LD--------------PE------YFRRQQLTEKSDVYSFGVVLFE 702
PE + SD++SFG VL E
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 43/225 (19%), Positives = 79/225 (35%), Gaps = 54/225 (24%)
Query: 514 AVIGVGGFGKVY--IGVLEDGNKVAIK--RGNPG-SEQGINEFQTEIQMLSKLRHR---- 564
+G G FGKV + ++VA+K R E + EI +L K++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80
Query: 565 --HLVSLIGFCDEQSEMILVYEYMANGP-FRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
V + + + M + +E + G + L N P + L +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELL--GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK----GSFGYL 677
LH + H D+K NIL + + + + ++ +T+++ GS +
Sbjct: 139 LHE---NQLTHTDLKPENILFVNSEFETLYN---EHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 678 D--------------PE------YFRRQQLTEKSDVYSFGVVLFE 702
PE + + DV+S G +LFE
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 46/225 (20%), Positives = 83/225 (36%), Gaps = 54/225 (24%)
Query: 514 AVIGVGGFGKVY--IGVLEDGNKVAIK--RGNPG-SEQGINEFQTEIQMLSKLRHR---- 564
+G G FGKV I G VA+K + E ++EIQ+L L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75
Query: 565 --HLVSLIGFCDEQSEMILVYEYMANGP-FRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
V ++ + + + +V+E + G D + P ++ + +++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL--GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVK----GSFGYL 677
LH+ + H D+K NIL ++ + + K +R ++ +K GS Y
Sbjct: 134 LHS---NKLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSATYD 187
Query: 678 D--------------PE------YFRRQQLTEKSDVYSFGVVLFE 702
D PE + ++ DV+S G +L E
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 37/163 (22%), Positives = 60/163 (36%), Gaps = 27/163 (16%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVA---IKRGNPGSEQGINEFQTEIQM-----LSKLRHRHL 566
IG GGFG +Y+ K A +K + +E + ++ + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 567 VSLIGF----------CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA 616
+ +G +S +V E + G + G N L++ I
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN-GTFKKSTVLQLGIRML 161
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV--ADFGLSK 657
L Y+H +H D+K N+LL +V AD+GLS
Sbjct: 162 DVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 49/268 (18%), Positives = 80/268 (29%), Gaps = 78/268 (29%)
Query: 516 IGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLR--------H 563
+G G F V++ ++ VA+K +E ++E I++L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDE----IRLLKSVRNSDPNDPNR 100
Query: 564 RHLVSLIGFCDEQSE----MILVYEYMANGP-FRDHLYGTNQPPLSWKQRLEICIGSARG 618
+V L+ + +V+E + G + +N L +I +G
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 619 LHYLHTGAAQGIIHRDVKTTNILL------------------------------------ 642
L YLHT IIH D+K NILL
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 643 -------------DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTE 689
E L K+AD G + Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR----QYRSLEVLIGSGYNT 272
Query: 690 KSDVYSFGVVLFEVLCARPVINPKLPRE 717
+D++S + FE+ + P E
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEE 300
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 842 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.49 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.0 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.18 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.28 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=457.40 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=210.5
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778889999999999999864 478899999998888888899999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCC-------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 582 VYEYMANGPFRDHLYGTN-------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
|||||++|+|.++|+... ..+++|.+++.|+.|||+||+|||+ ++||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999985432 3469999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCC-CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 037607 649 KVADFGLSKAAPMDR-GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 649 kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~ 726 (842)
||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |++||......+ +...+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHHH
Confidence 999999998764332 223345679999999999999999999999999999999998 899998654332 222221
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
. +.- . ..+..+..++.+++.+||+.+|++||||.||+++|+.+.+.
T Consensus 275 ~----g~~--~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 Q----GRE--L-------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H----TCC--C-------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred c----CCC--C-------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 110 0 01123345688999999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=453.73 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=215.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|.+.+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999864 467899999988888888899999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccC-----------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEE
Q 037607 582 VYEYMANGPFRDHLYGT-----------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl 650 (842)
|||||++|+|.++|+.. ....++|.+++.|+.|||+||+|||+ ++||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 24579999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 037607 651 ADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 651 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
+|||+|+........ ......||+.|||||++.++.++.|+|||||||+||||+| |++||......+ +...+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~-- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECIT-- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence 999999876433222 2234568999999999999999999999999999999998 899998664332 222221
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.+.... .+..+..++.+++.+||+.+|.+||+|.||++.|+...+
T Consensus 245 --~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 --QGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111 122334568899999999999999999999999987644
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=450.73 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=210.0
Q ss_pred CcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
+++..+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.+|++|+|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566788999999999999963 46789999987643 3446789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 582 VYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
|||||++|+|.++|+... ...++|.++++|+.|||+||+|||+ ++||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 999999999999995432 2468999999999999999999999 99999999999999999999
Q ss_pred eEEeecccccccCCCC-CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 037607 648 AKVADFGLSKAAPMDR-GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~ 725 (842)
+||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |++||......+ +.+.+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence 9999999998764322 223345679999999999999999999999999999999998 899998664332 22222
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
. .+.... .+.+++..+.+++.+||+.+|.+||+|.||++.|+.
T Consensus 261 ~----~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 261 R----NRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp H----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H----cCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 221111 122345678899999999999999999999999973
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=441.97 Aligned_cols=259 Identities=26% Similarity=0.461 Sum_probs=205.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.+++.+.++||+|+||+||+|++.+ .||||+++.. ..+..++|.+|+++|++++|||||+++|+|.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567888999999999999998753 5999988643 45667889999999999999999999999865 56899999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR- 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~- 663 (842)
||++|+|.++|+. ....++|.+++.|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999954 34579999999999999999999999 999999999999999999999999999998765322
Q ss_pred CceeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.......+||+.|||||++.+ ..|+.|+|||||||+||||++|++||......... ...+ ..+. ..|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~----~~~~----~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMV----GRGY----ASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHH----HTTC----CCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHH----hcCC----CCC
Confidence 223456789999999999864 46899999999999999999999999865443221 1111 1111 111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.+ ......+...+.+++.+||+.+|.+||||.||++.|+...
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 1122334567889999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=444.59 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=207.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....++|.+|+++|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 6899999987643 45556789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||+||+|.++|.......+++.+++.|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999976667778999999999999999999999 999999999999999999999999999998764211
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+. ...+. .+....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~----~~~~~~-------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VLKII----SGSFPP-------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH----HTCCCC--------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHH----cCCCCC--------
Confidence 123456799999999999999999999999999999999999999987643321 11111 111111
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
........+.+++.+||+.||.+||++.|+++.-+
T Consensus 245 -~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 245 -VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 11223456788999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=441.28 Aligned_cols=268 Identities=22% Similarity=0.363 Sum_probs=218.1
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCC-CceeeEEE
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRH-RHLVSLIG 571 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~H-pnIv~l~g 571 (842)
..++....++|++.+.||+|+||+||+|.+.. ++.||||++.... ....++|.+|+++|++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34445556889999999999999999998653 3579999987653 4456789999999999965 89999999
Q ss_pred eecc-CCeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCC
Q 037607 572 FCDE-QSEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636 (842)
Q Consensus 572 ~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIK 636 (842)
+|.+ .+.++||||||++|+|.++|+... ...++|.+++.++.|||+||+|||+ ++|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccC
Confidence 9965 456899999999999999996422 3468999999999999999999999 999999999
Q ss_pred CCCEEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 037607 637 TTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKL 714 (842)
Q Consensus 637 p~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~ 714 (842)
|+||||++++.+||+|||+|+....+... ......||+.|||||++.++.|+.++|||||||+||||++ |++||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999977544333 3345679999999999999999999999999999999998 999998654
Q ss_pred chhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 715 PREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 715 ~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
..+. +.. ...++.... .+..+..++.+++.+||+.||.+|||+.||++.|+.+++.
T Consensus 293 ~~~~--~~~----~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 IDEE--FCR----RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSHH--HHH----HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH--HHH----HHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 3321 111 111111111 1122345678899999999999999999999999988764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=435.10 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=203.7
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC----eEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS----EMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~----~~~lV~ 583 (842)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577888999999999999998 5899999998754322 223345666677899999999999997653 689999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhC-----CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG-----AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-----~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
|||++|+|.++|+. .+++|..+++|+.|+++||+|||+. +..+||||||||+||||+.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999954 4699999999999999999999973 134899999999999999999999999999987
Q ss_pred cCCCCCc---eeeeeccCCCCCCccccccc------CCCCcccchhHHHHHHHHHhCCCCCCCCCchhh---------hh
Q 037607 659 APMDRGY---VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ---------VS 720 (842)
Q Consensus 659 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~---------~~ 720 (842)
....... .....+||+.|||||++.+. .++.|+|||||||+||||++|++|+......+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543322 22346799999999998754 478899999999999999999887754322110 01
Q ss_pred HHHHHHHhhcccccccccchhHHhh-hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAET-ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
..++ .... .....+|.+... ...+....+.+++.+||+.||.+||||.||+++|+++.+.
T Consensus 238 ~~~~-~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEM-RKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHH-HHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHH-HHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 1111 111222222221 2335677889999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=434.99 Aligned_cols=257 Identities=20% Similarity=0.187 Sum_probs=209.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.+.|...++||+|+||+||+|+.. +|+.||||+++.... +.+|+.+|++|+|||||++++++.+.+.++|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888889999999999999975 689999999865422 25799999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccCCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~~~~ 664 (842)
|+||+|.++|.. ...+++.+++.++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+....+..
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999943 4579999999999999999999999 9999999999999999987 699999999987653321
Q ss_pred ----ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 665 ----YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 665 ----~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+.. ....
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~~--~~~~------- 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIAS--EPPP------- 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHHH--SCCG-------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHc--CCCC-------
Confidence 1223467999999999999999999999999999999999999999865443321 11111 0000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
...+++.....+.+++.+||+.||.+|||+.|+++.|..+++...
T Consensus 275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 012233445668889999999999999999999999988876544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=435.56 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=209.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++|+|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 69999999986554444567899999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 99999998843 469999999999999999999999 999999999999999999999999999998765332 23
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+. .+....+. .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~----~~~~~~~~-------~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----DNLPPRLK-------N 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSSCCCCS-------C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----cCCCCCCC-------c
Confidence 45678999999999999999999999999999999999999999866443321 1111 11100110 0
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11233567889999999999999999998864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=423.39 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=197.4
Q ss_pred ccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc----CCeEEEEE
Q 037607 511 DENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE----QSEMILVY 583 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~----~~~~~lV~ 583 (842)
...+.||+|+||+||+|.+. ++..||+|++... .....++|.+|+++|++|+|||||+++++|.. ...++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45668999999999999975 6889999987543 44556789999999999999999999999854 45689999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEc-CCCceEEeecccccccC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLD-ENLVAKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld-~~~~~kl~DFGla~~~~ 660 (842)
|||++|+|.+++. ....+++..++.|+.||+.||+|||+ ++ ||||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999994 34579999999999999999999998 66 99999999999997 47999999999998643
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.. .....+||+.|||||++.+ .|+.++|||||||+||||++|++||........ +.. ....+.. .+
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~----~i~~~~~----~~ 249 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RVTSGVK----PA 249 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HHTTTCC----CG
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH----HHHcCCC----CC
Confidence 22 3456789999999998865 699999999999999999999999975433221 111 1111110 01
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. +......++.+++.+||+.||.+|||+.|+++.
T Consensus 250 ~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 111223457889999999999999999998863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=428.55 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=208.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++|+|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999964 6899999998643 2234577999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||+||+|.+++. ....+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999994 34579999999999999999999999 999999999999999999999999999999765332
Q ss_pred -CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 -GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.......+||+.|||||++.+..|+.++||||+||+||||++|++||......+ +...+. ++...
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~----~~~~~------- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKII----KLEYD------- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC-------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCCC-------
Confidence 233456789999999999999999999999999999999999999998654332 111111 11110
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
++.....++.+++.+||+.||.+||++.|++.
T Consensus 253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11122345788999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=437.62 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=210.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++|+|||||+++++|.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 6899999998765555556789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|+||+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 999999998843 469999999999999999999999 999999999999999999999999999998765332 2
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+. .+....+.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~----~~~~~~~~------- 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----DNLPPRLK------- 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSCCCCCS-------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----cCCCCCCc-------
Confidence 345678999999999999999999999999999999999999999865443321 1111 11100110
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+||+.||.+||++.|+++.
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011223467889999999999999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=413.97 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=193.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999964 6899999987643 2334567999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||| +|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 6899998843 4579999999999999999999999 999999999999999999999999999998754322
Q ss_pred CceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.....+||+.|||||++.+..+ +.++||||+||+||||++|++||......+ +..-+ .++...
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i----~~~~~~------- 230 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNI----SNGVYT------- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCCC-------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCCC-------
Confidence 2345789999999999998876 579999999999999999999998654322 11111 111110
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
++......+.+++.+||+.||.+|||+.|+++.-+.
T Consensus 231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 111223457789999999999999999999986554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=421.83 Aligned_cols=242 Identities=26% Similarity=0.327 Sum_probs=193.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|++.+.||+|+||+||+|+.. .++.||||+++... .....++.+|+++|++|+|||||++++++.+.+.++|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999852 46789999876532 2233468899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|||||+||+|.+++. ....+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999994 34579999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+. ++...
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i~----~~~~~------ 244 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMIL----KAKLG------ 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCCC------
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---HHHH----cCCCC------
Confidence 22 2234578999999999999999999999999999999999999999876443321 1111 11110
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
++.....++.+++.+||+.||.+||++
T Consensus 245 ----~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 ----MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111223467889999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=406.62 Aligned_cols=288 Identities=63% Similarity=1.046 Sum_probs=254.7
Q ss_pred cccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC
Q 037607 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ 576 (842)
Q Consensus 497 ~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~ 576 (842)
.+++.++..++++|+..+.||+|+||.||+|.+.+|+.||||++........+++.+|++++++++||||++++++|...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34555666788999999999999999999999888999999998877777778999999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCC--CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999996543 3468999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC-CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 655 LSKAAPMD-RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 655 la~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
+++..... .........||..|+|||++.+..++.++|||||||++|||++|+.||....+.+...+.+|.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865422 22233455689999999999999999999999999999999999999998877777778888887777777
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
+..++++.+......+....+.+++.+||+.+|.+||++.|+++.|+.+.+.++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 888888777777778889999999999999999999999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=407.01 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=187.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--------
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-------- 577 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-------- 577 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 6899999987643 3445578999999999999999999999986543
Q ss_pred ----eEEEEEEecCCCCcccccccCCC-CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 578 ----EMILVYEYMANGPFRDHLYGTNQ-PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 578 ----~~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
.++||||||++|+|.+++..... ....+..++.|+.||++||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999954332 234566789999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCC-----------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH
Q 037607 653 FGLSKAAPMDRG-----------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721 (842)
Q Consensus 653 FGla~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l 721 (842)
||+|+....... ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||... .+....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 999987653221 12234679999999999999999999999999999999996 56422 111111
Q ss_pred HHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 722 AEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 722 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.. . ..... .|.. .......+.+++.+||+.||.+||++.|+++
T Consensus 237 ~~---~-~~~~~-----~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LT---D-VRNLK-----FPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH---H-HHTTC-----CCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH---H-HhcCC-----CCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 0 11111 1111 1222344577999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=409.54 Aligned_cols=267 Identities=22% Similarity=0.330 Sum_probs=206.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc------CC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE------QS 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~------~~ 577 (842)
.++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999974 7999999998654 34455788999999999999999999998753 46
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
.+|||||||+ |+|.+++. ....+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999996 67999883 45689999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCC---CCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 658 AAPMD---RGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 658 ~~~~~---~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
..... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....++.....-.........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 76432 12234567899999999998875 569999999999999999999999988765544332211111111000
Q ss_pred cccccc--------------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 734 LEKIID--------------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 734 l~~i~d--------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
...+.. +.......+.....+.+++.+||+.||.+|||+.|+++.-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 000000 0000011112235678999999999999999999988653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=397.15 Aligned_cols=288 Identities=40% Similarity=0.666 Sum_probs=249.7
Q ss_pred CccccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEee
Q 037607 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE-QGINEFQTEIQMLSKLRHRHLVSLIGFC 573 (842)
Q Consensus 495 ~~~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~-~~~~~f~~Ei~il~~L~HpnIv~l~g~~ 573 (842)
...+++.++....++|...+.||+|+||.||+|...+|+.||||++..... ....++.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356889999999999999999999999999999988899999999876432 2234689999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 574 DEQSEMILVYEYMANGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
...+..++||||+++|+|.+++... ....+++..++.|+.|++.||+|||+.+..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 9999999999999999999999653 34469999999999999999999999333399999999999999999999999
Q ss_pred ecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCC--chhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKL--PREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~--~~~~~~l~~~~~~~~ 729 (842)
|||+++..............||+.|+|||++.+..++.++|||||||++|||++|++||+... ......+.+|.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998776555555556679999999999999999999999999999999999999996321 223345677887777
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
....+..+.+..+......+....+.+++.+||+.+|.+||++.||+++|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 77778888888777778888899999999999999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=395.57 Aligned_cols=200 Identities=24% Similarity=0.385 Sum_probs=172.2
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~ 579 (842)
...+.|++.+.||+|+||+||+|+.+ .++.||||++..... ..++.+|+++|+.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45688999999999999999999853 467899998876533 35688999999998 699999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeecccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKA 658 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGla~~ 658 (842)
+||||||++|+|.+++ ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999988 258999999999999999999999 999999999999999876 7999999999986
Q ss_pred cCCCCC---------------------------ceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCC
Q 037607 659 APMDRG---------------------------YVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVI 710 (842)
Q Consensus 659 ~~~~~~---------------------------~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~ 710 (842)
...... ......+||+.|||||++.+. .++.++||||+||++|||++|++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 532210 112345799999999999875 5899999999999999999999999
Q ss_pred CCCC
Q 037607 711 NPKL 714 (842)
Q Consensus 711 ~~~~ 714 (842)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=415.04 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=211.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+++|+.|+|||||++++++.+...++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 6899999998877666778899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC--CceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN--LVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~--~~~kl~DFGla~~~~~~~ 663 (842)
|+||+|.++|.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 236 ~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 999999998843 34579999999999999999999999 999999999999999754 89999999999886433
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+.. ..+. ..... +....
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---~~i~----~~~~~--~~~~~- 379 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNVK----SCDWN--MDDSA- 379 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----TTCCC--CCSGG-
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----hCCCC--CCccc-
Confidence 2345668999999999999999999999999999999999999999876543321 1111 11000 01111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.||.+||++.|+++.
T Consensus 380 ---~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223457789999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=374.04 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=216.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|...++||+|+||+||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999975 6899999998877777888999999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++|+|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999854 24579999999999999999999999 99999999999999999999999999999876432211
Q ss_pred e-------------eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 666 V-------------STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 666 ~-------------~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
. .....||+.|+|||++.+..++.++|||||||++|||++|..|+.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------------- 231 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------------- 231 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-------------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-------------
Confidence 1 11457999999999999999999999999999999999999998754432211
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
........+...........+.+++.+||+.+|.+||++.|+++.|+......
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 232 -FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000111111122233456888999999999999999999999998876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=406.87 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=200.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC------ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG------SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~------~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
++|++.++||+|+||+||+|+.. +|+.||||++... ......+...++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999975 6899999987542 1222223344567777889999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
||||||+||+|.++|. ....+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999994 34579999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... ....+||+.|||||++.+ ..|+.++|||||||+||||++|++||......+...+...... ...
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~~~----- 411 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAV----- 411 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----CCC-----
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----CCC-----
Confidence 332 345689999999999974 5799999999999999999999999975433222212111111 000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWN 778 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~ 778 (842)
.++.....++.+++.+||+.||.+|++ +.||++.
T Consensus 412 -----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011122345788999999999999998 6777654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=379.79 Aligned_cols=262 Identities=23% Similarity=0.407 Sum_probs=214.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc--------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~ 576 (842)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. .....+++.+|+++|+++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999863 3457999998765 344567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
+..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999985432 2458999999999999999999999 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999986643322 12234457889999999999999999999999999999999 9999986543321
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
..... .+... ..+......+.+++.+||+.+|.+||++.|+++.|+.+..+..
T Consensus 315 -~~~~~----~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 315 -FKLLK----EGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -HHHHH----TTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -HHHHh----cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11111 11100 1112334568889999999999999999999999999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.93 Aligned_cols=280 Identities=36% Similarity=0.630 Sum_probs=227.7
Q ss_pred ccccHHHHHHHhcCcccc------eEEeecCcEEEEEEEEcCCcEEEEEECCCC----ChhhHHHHHHHHHHHHhcCCCc
Q 037607 496 RFFTFTELQNATQNFDEN------AVIGVGGFGKVYIGVLEDGNKVAIKRGNPG----SEQGINEFQTEIQMLSKLRHRH 565 (842)
Q Consensus 496 ~~~~~~el~~at~~f~~~------~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~----~~~~~~~f~~Ei~il~~L~Hpn 565 (842)
..|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 568999999999999888 8999999999999987 5889999987643 2344678999999999999999
Q ss_pred eeeEEEeeccCCeEEEEEEecCCCCcccccccC-CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC
Q 037607 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGT-NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644 (842)
Q Consensus 566 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~ 644 (842)
|+++++++...+..++||||+++++|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999988542 34579999999999999999999999 99999999999999999
Q ss_pred CCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 037607 645 NLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE 723 (842)
Q Consensus 645 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~ 723 (842)
++.+||+|||+++........ ......|+..|+|||.+.+ .++.++||||||+++|||++|++||........ +..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999876533222 2234568999999998865 588999999999999999999999986543321 112
Q ss_pred HHHHhhc-ccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 724 WALQCHR-KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 724 ~~~~~~~-~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+...... ...+...+++.+ ..........+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2221111 112223333222 1234566778999999999999999999999999998763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=372.30 Aligned_cols=264 Identities=27% Similarity=0.445 Sum_probs=206.2
Q ss_pred HHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 502 ELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 502 el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
++....++|++.+.||+|+||+||+|.. +|+.||||++... .....+++.+|+++|++++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334467899999999999999999987 5889999997654 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCC-CCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEcCCCceEEeecccc
Q 037607 580 ILVYEYMANGPFRDHLYGTN-QPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999995432 2348999999999999999999998 78 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ......... .
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~---~- 258 (309)
T 3p86_A 187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKCKR---L- 258 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHHSCCC---C-
T ss_pred ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCCC---C-
Confidence 8653321 2234567999999999999999999999999999999999999999866433221 111111100 0
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.....
T Consensus 259 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 --------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01122334678899999999999999999999999877543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=372.15 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=212.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|.+.+.||+|+||.||+|.+. .+..||||++... .....++|.+|+++|++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999974 3456999998765 45556789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ....+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999843 34579999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 662 DRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 662 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+. .+...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~----~~~~~--- 273 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISSVE----EGYRL--- 273 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHH----TTCCC---
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHH----cCCCC---
Confidence 3221 2233456778999999999999999999999999999999 9999976543321 11111 11000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+.+..+
T Consensus 274 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 274 ------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0112234568889999999999999999999999998865433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=374.03 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=210.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC----eEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS----EMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~----~~~lV 582 (842)
.++|++.++||+|+||+||+|++. ++.||||++.... ....++..|+.+|++++||||+++++++.... .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999875 7899999986543 33456677999999999999999999997643 47999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC----------ceEeccCCCCCEEEcCCCceEEee
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ----------GIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~----------~ivHrDIKp~NILld~~~~~kl~D 652 (842)
|||+++|+|.+++.. ..+++..++.++.|+++||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999944 359999999999999999999998 6 999999999999999999999999
Q ss_pred cccccccCCCCC-ceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHH----
Q 037607 653 FGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLA---- 722 (842)
Q Consensus 653 FGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~---- 722 (842)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987653322 12334579999999999986 46677899999999999999999999865443222111
Q ss_pred ------HHHHHhhcccccccccchhHHhh-hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 723 ------EWALQCHRKGILEKIIDPVIAET-ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 723 ------~~~~~~~~~~~l~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
++........ ..+.+... ........+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111 11111111 12245667999999999999999999999999999876653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=378.88 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=203.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|.+.+.||+|+||.||+|++. ++..||||+++.. .....++|.+|+.+|++++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999865 4678999998765 44556789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999953 34579999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 662 DRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 662 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.... ......++..|+|||++.+..++.++|||||||++|||++ |++||......+ +...+. .+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~----~~~~~--- 269 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVD----EGYRL--- 269 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHH----TTEEC---
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCCC---
Confidence 3221 1223345778999999999999999999999999999998 999997654322 111111 11000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
.........+.+++.+||+.+|.+||++.|++++|+.+.+....
T Consensus 270 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 270 ------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred ------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 01122345688999999999999999999999999998765443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.39 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=212.3
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57889999999999999999998899999999876533 34679999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+++|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 9999999843 34568999999999999999999999 9999999999999999999999999999987643322222
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....++..|+|||.+.+..++.++||||||+++|||++ |++||......+. ..... .+. ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~~~~~----~~~--~~~~------- 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDIS----TGF--RLYK------- 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH----TTC--CCCC-------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHh----cCc--cCCC-------
Confidence 34456778999999999999999999999999999999 9999986543321 11111 110 0001
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.......+.+++.+||+.+|.+||++.|+++.|+.+.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11123457889999999999999999999999998765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=363.26 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=208.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCC---CChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNP---GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~---~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 688999998643 2345567899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ..++++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999843 3579999999999999999999999 99999999999999999999999999999876544
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.........||+.|+|||.+.+..++.++|||||||++|||++|++||......+. ........ . +..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~-----~~~ 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-V-----PNV 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-C-----CCH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-C-----CCc
Confidence 33334456799999999999999999999999999999999999999986643221 11111110 0 111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHh
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP-GMGDVLWNLEYAMQ 784 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~evl~~Le~~~~ 784 (842)
...........+.+++.+|++.+|.+|| ++.++.+.|+....
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1222334456788999999999999999 89999988876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=363.05 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=208.5
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999985 47899999997655445567789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++|+|.+++.. ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999999843 358999999999999999999999 8999999999999999999999999999987653322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+ ......
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~-~~~~~~------ 238 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNG-TPELQN------ 238 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHC-SCCCSC------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC-CCCCCC------
Confidence 23456799999999999999999999999999999999999999976543322111 00000 001101
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.+|.+||++.|+++.
T Consensus 239 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 -PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234567889999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.93 Aligned_cols=271 Identities=21% Similarity=0.357 Sum_probs=217.4
Q ss_pred ccHHHHHHHhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeE
Q 037607 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSL 569 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l 569 (842)
+...++....++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445566667889999999999999999999842 3578999998764 344567899999999999 79999999
Q ss_pred EEeeccCC-eEEEEEEecCCCCcccccccCCC------------------------------------------------
Q 037607 570 IGFCDEQS-EMILVYEYMANGPFRDHLYGTNQ------------------------------------------------ 600 (842)
Q Consensus 570 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 600 (842)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997755 48999999999999999865332
Q ss_pred ----------------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 601 ----------------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 601 ----------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 228999999999999999999999 8999999999999999999999999999987643322
Q ss_pred -ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 665 -YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 665 -~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.......||..|+|||++.+..++.++|||||||++|||++ |++||......+.. .... ..+....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~----~~~~~~~------ 316 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL----KEGTRMR------ 316 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHH----HHTCCCC------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHH----HcCCCCC------
Confidence 23345668899999999999999999999999999999998 99999765433211 1111 1111000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
........+.+++.+||+.+|.+||++.|++++|+.+++..
T Consensus 317 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 317 ---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11122346788999999999999999999999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=363.35 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=216.9
Q ss_pred cccHHHHHHHhcC----------cccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc
Q 037607 497 FFTFTELQNATQN----------FDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH 565 (842)
Q Consensus 497 ~~~~~el~~at~~----------f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn 565 (842)
.+++++++.+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788888888865 777789999999999999976 79999999987766666788999999999999999
Q ss_pred eeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 566 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
|+++++++...+..++||||+++++|.+++. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999884 3469999999999999999999999 899999999999999999
Q ss_pred CceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 037607 646 LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWA 725 (842)
Q Consensus 646 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~ 725 (842)
+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+. ....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~~~ 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRL 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 9999999999987643322 23456799999999999999999999999999999999999999976543221 1111
Q ss_pred HHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 726 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.... ...+.. .......+.+++.+||+.+|.+||++.|+++..
T Consensus 254 ~~~~----~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 254 RDSP----PPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHSS----CCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hcCC----CCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1110 001000 112234578899999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=369.08 Aligned_cols=265 Identities=24% Similarity=0.404 Sum_probs=207.8
Q ss_pred hcCcccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~ 579 (842)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+++.+|++++++++||||++++++|.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999985 2578999999988777778899999999999999999999999854 4568
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999998543 3458999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh---------hhhHHHHHHHh
Q 037607 660 PMDRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE---------QVSLAEWALQC 728 (842)
Q Consensus 660 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~---------~~~l~~~~~~~ 728 (842)
...... ......++..|+|||.+.+..++.++|||||||++|||++|..|+....... ......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 533221 2233456778999999999999999999999999999999999886432110 00000011111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
...+.. ..........+.+++.+||+.+|.+||++.|+++.|+.+.+
T Consensus 245 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 245 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111100 01122334678899999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=356.50 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=212.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|.+.+.||+|+||.||+|...++..||+|++..... ..+++.+|++++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467899999999999999999998888999999876533 3467999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 99999999843 23468999999999999999999999 999999999999999999999999999998765443333
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .... .+. ....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~-~~~--~~~~~----- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVS-QGH--RLYRP----- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHH-TTC--CCCCC-----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHH-cCC--CCCCC-----
Confidence 344556778999999999999999999999999999998 99999765433211 1111 110 01111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
......+.+++.+||+.+|.+||++.|+++.|+...+
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 --HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1123457889999999999999999999999987644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.15 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=204.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHh--cCCCceeeEEEeecc----CCeEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSK--LRHRHLVSLIGFCDE----QSEMI 580 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~--L~HpnIv~l~g~~~~----~~~~~ 580 (842)
.++|.+.+.||+|+||+||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998643 34566777777776 799999999998643 45689
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHH--------hCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH--------TGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH--------~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
+||||+++|+|.+++. ...+++..++.++.|+++||+||| + ++|+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 9999999999999993 347999999999999999999999 6 8999999999999999999999999
Q ss_pred cccccccCCCCCce---eeeeccCCCCCCccccccc------CCCCcccchhHHHHHHHHHhC----------CCCCCCC
Q 037607 653 FGLSKAAPMDRGYV---STAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA----------RPVINPK 713 (842)
Q Consensus 653 FGla~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~------~~s~ksDVwS~GvvL~ELltG----------~~p~~~~ 713 (842)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| ++||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998764333221 2234799999999999876 566799999999999999999 7887654
Q ss_pred CchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 714 LPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 714 ~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
...... ................+ ............+.+++.+||+.+|.+||++.|+++.|+.+
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS-FEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC-HHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc-hhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 332211 11111111111111111 11123345677899999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=379.16 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=210.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. .....++|.+|+++|++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467889999999999999999986 7899999998764 33445678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||++|+|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999853 23468999999999999999999999 9999999999999999999999999999986532211
Q ss_pred ce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 665 YV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 665 ~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..+.+. .+.. +.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~~~--~~---- 335 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVE----KGGR--LP---- 335 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHH----TTCC--CC----
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC--CC----
Confidence 10 112235678999999999999999999999999999998 999997654322 111111 1110 00
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.+..+...+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 336 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 ---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112345678899999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=362.59 Aligned_cols=265 Identities=17% Similarity=0.173 Sum_probs=213.9
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+++.+|++++++| +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 5789999998765432 24688999999999 99999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc-----eEEeeccccccc
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV-----AKVADFGLSKAA 659 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~-----~kl~DFGla~~~ 659 (842)
|+ +++|.+++... ...+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999998543 4579999999999999999999999 89999999999999998887 999999999876
Q ss_pred CCCCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 660 PMDRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 660 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~- 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT- 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-
Confidence 433221 1245679999999999999999999999999999999999999998764433222221111110000
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
.....+...+ .+.+++.+|++.+|.+||++.+|++.|+...+....
T Consensus 240 --------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 240 --------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp --------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred --------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0011112223 789999999999999999999999999987765543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=366.94 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=205.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 78999999876443 2334678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR- 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~- 663 (842)
|+++|+|.+++. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999993 44569999999999999999999999 999999999999999999999999999998654221
Q ss_pred CceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|.... . ...+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~---~----~~~~-- 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK---T----YLNP-- 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTC---T----TSTT--
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccc---c----cCCc--
Confidence 122345679999999999988765 7899999999999999999999986543321 122221110 0 0000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+||+.+|.+||++.|+++.-+
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 1122345678999999999999999999987544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=360.21 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=210.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|...+.||+|+||.||+|.+.++..||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 467899999999999999999998888999999876533 2467999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 99999999843 24569999999999999999999999 999999999999999999999999999998764332222
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .... .+. . ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~~-~-~~~------ 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIA----QGL-R-LYR------ 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHH----TTC-C-CCC------
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---HHHh----ccc-C-CCC------
Confidence 234456788999999999999999999999999999998 99999865433211 1111 110 0 000
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.......+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111234678899999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=390.12 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=214.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|.+.+.||+|+||.||+|.+.. +..||||+++.... ..++|.+|+.+|++++||||++++++|......+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568889999999999999999864 88999999876533 467899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|++|+|.+++.......+++..++.|+.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999999999976666779999999999999999999999 99999999999999999999999999999876543222
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......++..|+|||++.+..++.++|||||||+||||++ |+.||......+ +.+.+.. +...
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~~~--------- 438 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEK----DYRM--------- 438 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT----TCCC---------
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCCC---------
Confidence 2234456789999999999999999999999999999999 999998654332 1111111 1000
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.....+...+.+++.+||+.+|.+||++.|+++.|+...
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111233456888999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.26 Aligned_cols=261 Identities=24% Similarity=0.375 Sum_probs=214.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3568999999999999999999862 3578999998764 45556789999999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCC----------------------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCC
Q 037607 579 MILVYEYMANGPFRDHLYGTNQ----------------------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIK 636 (842)
.++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999854322 348899999999999999999999 999999999
Q ss_pred CCCEEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 037607 637 TTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKL 714 (842)
Q Consensus 637 p~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~ 714 (842)
|+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876433222 2234457788999999999999999999999999999999 999998665
Q ss_pred chhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 715 PREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 715 ~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
..+. ..... .+.... ........+.+++.+||+.+|.+||++.|+++.|+.+.+.
T Consensus 258 ~~~~---~~~~~----~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERL---FNLLK----TGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGH---HHHHH----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH---HHHhh----cCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 4321 11111 111010 1122345688999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=368.88 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=207.4
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++|+.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 57999999987543 4455678999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999843 3568999999999999999999999 999999999999999999999999999998764332
Q ss_pred CceeeeeccCCCCCCcccccccCCC-CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.....+||+.|+|||++.+..+. .++|||||||++|||++|++||......+.. +.+. .+...
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~----~~~~~------- 232 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR---ERVL----RGKYR------- 232 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCCC-------
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCC-------
Confidence 23456799999999999987765 7999999999999999999999876433211 1111 11100
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
++......+.+++.+||+.+|.+|||+.|+++.-
T Consensus 233 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 233 ---IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ---CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 1111234577899999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=388.06 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=211.7
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
..++|.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 356789999999999999999999888999999988654 34678999999999999999999999986 5678999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|++|+|.+++.......+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999999999965444578899999999999999999999 89999999999999999999999999999876432111
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......++..|+|||++....++.++|||||||+||||++ |+.||......+. ...+.. +. .+.
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~----~~--~~~------ 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALER----GY--RMP------ 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHH----TC--CCC------
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc----CC--CCC------
Confidence 1233446788999999999999999999999999999999 9999986543321 111111 10 000
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
....+...+.+++.+||+.+|.+||++.+|+++|+...
T Consensus 406 -~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11223456889999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.74 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=215.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc--------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~ 576 (842)
.++|.+.+.||+|+||.||+|... .+..||||++... .....+++.+|+++++++ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999863 2357999998764 445567899999999999 999999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
+..++||||+++|+|.+++.... ...+++.+++.|+.|+++||+|||+ ++|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999985433 2469999999999999999999999 899999999999999
Q ss_pred cCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987653322 22334557889999999999999999999999999999999 999997654322
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
+.+.+. .+.... ........+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus 302 ~~~~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 LFKLLK----EGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHH----TTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHH----cCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111111 111100 111234568889999999999999999999999999876544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=353.30 Aligned_cols=265 Identities=15% Similarity=0.149 Sum_probs=214.2
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+++.+|+.+++++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 5789999998764432 24688999999999 79999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc-----eEEeeccccccc
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV-----AKVADFGLSKAA 659 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~-----~kl~DFGla~~~ 659 (842)
|+ +++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999543 3469999999999999999999998 99999999999999987766 999999999876
Q ss_pred CCCCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 660 PMDRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 660 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 23456799999999999999999999999999999999999999987543332222211111110000
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
...........+.+++.+||+.+|.+||++.+|++.|+.+.+...
T Consensus 242 ---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 ---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp ---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 111122345678899999999999999999999999998876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=357.15 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=205.8
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..++|++.+.||+|+||+||+|...+|+.||+|++.... ......+.+|++++++++||||+++++++......++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999976542 233467899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++ +|.+.+.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99984 77777743 34569999999999999999999999 999999999999999999999999999998764322
Q ss_pred CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc------
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK------ 736 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~------ 736 (842)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+......-.........+..
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 22344568999999999876 5689999999999999999999999987654443221111000000000000
Q ss_pred -------ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 -------IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 -------i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+........+....++.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001111111222234567899999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.21 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=213.9
Q ss_pred hcCcccceEEeecCcEEEEEEEE------cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~------~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
.++|...+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999985 246789999987653 34567899999999999 99999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCC----------------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 579 MILVYEYMANGPFRDHLYGTNQ----------------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
.++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999864332 258999999999999999999999 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCCce-eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRGYV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 999999999999998765443322 234457889999999999999999999999999999998 9999976543321
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
+...... + .... ........+.+++.+||+.+|.+||++.|+++.|+...+.
T Consensus 257 ~~~~~~~----~-~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 FYKMIKE----G-FRML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHHH----T-CCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcc----C-CCCC--------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111 1 0000 1112345678899999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.70 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=203.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|+..++||+|+||+||+|.+. +++ +||+|++... .....++|.+|+.++++++||||++++++|... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56899999999999999999964 344 4688987653 345567899999999999999999999999875 4789
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|+||+.+|+|.+++... ...+++..++.|+.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999998543 4579999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .......+|..|+|||++.+..++.++|||||||++|||++ |++||......+. ...... +.. .
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~----~~~--~-- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEK----GER--L-- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHT----TCC--C--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHHHHc----CCC--C--
Confidence 322 22334557889999999999999999999999999999999 9999986644332 111111 100 0
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.........+.+++.+||+.+|.+||++.|+++.|+......
T Consensus 239 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 239 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 011223456888999999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=374.34 Aligned_cols=264 Identities=27% Similarity=0.366 Sum_probs=213.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|.+.+.||+|+||+||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999953 4668999998754 455567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccC-----CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---ceEEe
Q 037607 580 ILVYEYMANGPFRDHLYGT-----NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL---VAKVA 651 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~-----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~---~~kl~ 651 (842)
++||||+++|+|.+++... ....+++.+++.++.||++||+|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999998542 22468999999999999999999999 9999999999999998544 59999
Q ss_pred ecccccccCCC-CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMD-RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
|||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |++||......+ +.+.+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~~-- 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTS-- 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc--
Confidence 99999754321 1122234567899999999999999999999999999999998 999997654332 1111111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
+.... ........+.+++.+||+.+|.+||++.||++.|+.+.+.....
T Consensus 302 --~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 302 --GGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp --TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred --CCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 11000 11223446788999999999999999999999999987766543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.84 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=200.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|++.+.||+|+||.||+|.... +..||+|+.... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4679999999999999999998642 457999998764 3445678999999999999999999999984 467899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999998533 4468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
..........+++.|+|||.+.+..++.++|||||||++|||++ |++||......+. ...+.. +...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~----~~~~----- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN----GERL----- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHT----TCCC-----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHc----CCCC-----
Confidence 33333344557789999999999999999999999999999996 9999986644332 111111 1000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 011223456788999999999999999999999999887654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.31 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=220.8
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
..++|.+.+.||+|+||.||+|.+. ++..||+|++.... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999976 48889999987543 345789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999976667789999999999999999999999 8999999999999999999999999999987765444
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......++..|+|||.+.+..++.++||||||+++|||++ |++||........ .+....... .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~~~~----~-------- 231 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYR----M-------- 231 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCC----C--------
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhccCC----C--------
Confidence 44455667889999999999999999999999999999999 9999976543321 111111000 0
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
.........+.+++.+|++.+|.+||++.|+++.|+...+....
T Consensus 232 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 232 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 01122345688999999999999999999999999988775544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=365.78 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=207.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
..+.|.+.+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|+.+|++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999975 689999998765322 135789999999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC----ceEEeecc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL----VAKVADFG 654 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~----~~kl~DFG 654 (842)
.++||||+++|+|.+++ .....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l--~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHH--TTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999 345679999999999999999999999 9999999999999998776 79999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+.. ..+ ..+..
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~~i----~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANI----TAVSY 235 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHH----HTTCC
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhcCC
Confidence 998764332 234567999999999999999999999999999999999999999865433211 111 11100
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
-.++.. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 236 --~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 --DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011111 11233567889999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=365.94 Aligned_cols=265 Identities=27% Similarity=0.416 Sum_probs=214.6
Q ss_pred HHHHHhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeec
Q 037607 502 ELQNATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574 (842)
Q Consensus 502 el~~at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~ 574 (842)
.+....++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33445688999999999999999999975 3478999998765 3445678999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCcccccccCC----------------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTN----------------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivH 632 (842)
..+..++||||+++|+|.+++.... ...+++.+++.|+.||++||+|||+ ++|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 9999999999999999999985432 2578999999999999999999999 99999
Q ss_pred ccCCCCCEEEcCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCC
Q 037607 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVI 710 (842)
Q Consensus 633 rDIKp~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~ 710 (842)
|||||+|||++.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976532211 12234567889999999999999999999999999999999 99999
Q ss_pred CCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 711 NPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 711 ~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
......+ +... ...+.... .+......+.+++.+||+.+|.+||++.|+++.|+.+.+.
T Consensus 278 ~~~~~~~---~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAHEE---VIYY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCHHH---HHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCChHH---HHHH----HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 7654322 1111 11111111 1122345688899999999999999999999999987543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.59 Aligned_cols=252 Identities=18% Similarity=0.290 Sum_probs=207.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~~lV 582 (842)
.++|...+.||+|+||.||+|+++ ++.||||++... .....++|.+|+.++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357889999999999999999985 889999997754 345567899999999999999999999999876 788999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
|||+++|+|.+++.......+++.+++.++.|+++||+|||+ ++ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999976655679999999999999999999998 77 9999999999999999999999999876533
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCC---cccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTE---KSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~---ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
. ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||......+.. ......+...
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~-- 230 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEGLRP-- 230 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSCCCC--
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcCCCC--
Confidence 2 2346899999999998765554 799999999999999999999765432211 1111111111
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 -------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111223456888999999999999999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=378.48 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=209.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC-eEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS-EMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~-~~~lV~Ey 585 (842)
.++|.+.+.||+|+||.||+|.+. |+.||||+++... ..++|.+|+++|++++||||++++++|.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467889999999999999999985 7899999987654 3478999999999999999999999986654 79999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|++|+|.+++.......+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999976555568999999999999999999999 99999999999999999999999999999864322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
.....++..|+|||.+.+..++.++|||||||+||||++ |+.||......+. ...+ ..+...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i----~~~~~~--------- 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKGYKM--------- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHH----HTTCCC---------
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCCC---------
Confidence 122357889999999999999999999999999999998 9999986543321 1111 111100
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
..+..+...+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11223345788899999999999999999999999887543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=365.03 Aligned_cols=262 Identities=23% Similarity=0.373 Sum_probs=209.7
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS 577 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~ 577 (842)
..++|...+.||+|+||.||+|... ++..||||++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999962 3567999998754 233457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCCC---------------------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCC
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQ---------------------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVK 636 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIK 636 (842)
..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+ ++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 99999999999999999965332 348999999999999999999999 999999999
Q ss_pred CCCEEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 037607 637 TTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKL 714 (842)
Q Consensus 637 p~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~ 714 (842)
|+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |++||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876543322 2334567889999999999999999999999999999998 999997664
Q ss_pred chhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 715 PREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 715 ~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.... +..... .+... .........+.+++.+||+.+|.+||++.|+++.|+.....
T Consensus 280 ~~~~--~~~~~~----~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDAN--FYKLIQ----NGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHH--HHHHHH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHH--HHHHHh----cCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 3321 111111 11000 01112245688899999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=360.41 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=206.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.+.|...+.||+|+||.||+|... +|+.||+|++..... ...+++.+|+.+|++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999975 689999998754321 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC----ceEEeeccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL----VAKVADFGL 655 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~----~~kl~DFGl 655 (842)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999983 45679999999999999999999999 9999999999999998877 899999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+... .... ...
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~----~~~- 234 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVSA----VNY- 234 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHH----TCC-
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHh----cCC-
Confidence 98764322 2334579999999999999999999999999999999999999997654332111 0100 000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.... .........+.+++.+||+.+|.+||++.|+++.
T Consensus 235 -~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -EFED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CcCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011 1111234567889999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.32 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=212.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
..++|.+.+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 356899999999999999999999888899999987543 235789999999999999999999999864 568999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999999954333479999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..+... .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~--~------ 230 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNL----ERGYRM--V------ 230 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTTCCC--C------
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHH----hcccCC--C------
Confidence 2234456789999999998999999999999999999999 9999976543221 1111 111000 0
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
........+.+++.+|++.+|.+||++.++++.|+.....
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1112345688999999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=383.69 Aligned_cols=256 Identities=30% Similarity=0.432 Sum_probs=206.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|.+.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 467888999999999999999998888899999886542 35689999999999999999999999976 6789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999965444678999999999999999999999 999999999999999999999999999998765332222
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++|||||||+||||++ |+.||......+. .+.+ ..+... .
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i----~~~~~~---------~ 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV----ERGYRM---------P 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTTCCC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCCC---------C
Confidence 334557889999999999999999999999999999999 9999976543321 1111 111000 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
....+...+.+++.+||+.+|.+||++.++++.|+...
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11233456888999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.01 Aligned_cols=250 Identities=27% Similarity=0.494 Sum_probs=195.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS----EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~----~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|+..+.||+|+||.||+|.+. |+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999975 8899999976542 23357789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc---eEeccCCCCCEEEcC--------CCceEEe
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG---IIHRDVKTTNILLDE--------NLVAKVA 651 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~---ivHrDIKp~NILld~--------~~~~kl~ 651 (842)
|||+++++|.+++. ...+++..++.++.|+++||+|||+ ++ |+||||||+|||++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999999883 3578999999999999999999999 66 999999999999986 7789999
Q ss_pred ecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 652 DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 652 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
|||+++...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ......
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVAMN 229 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHTS
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HhhhcC
Confidence 999998654322 22456899999999999999999999999999999999999999865432211 111111
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.... .........+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 230 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 KLAL---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1000 1112234568899999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=359.42 Aligned_cols=256 Identities=16% Similarity=0.228 Sum_probs=210.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 58899999887543 3456789999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC--CCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE--NLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~--~~~~kl~DFGla~~~~~~~ 663 (842)
+++|+|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 999999999843 33579999999999999999999999 99999999999999987 789999999999876433
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...+.. +... .++..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~----~~~~--~~~~~- 226 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMN----AEYT--FDEEA- 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH----TCCC--CCHHH-
T ss_pred -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHc----CCCC--CChhh-
Confidence 234556799999999999998899999999999999999999999986543321 111111 0000 11111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.......+.+++.+||+.+|.+||++.|+++.-+..
T Consensus 227 ---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 227 ---FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ---hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 112345678999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.72 Aligned_cols=271 Identities=19% Similarity=0.282 Sum_probs=213.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--eEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS--EMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~--~~~lV~ 583 (842)
++|.+.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57899999999999999999976 58999999987543 334577899999999999999999999987654 789999
Q ss_pred EecCCCCcccccccCC-CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE----cCCCceEEeecccccc
Q 037607 584 EYMANGPFRDHLYGTN-QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSKA 658 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl----d~~~~~kl~DFGla~~ 658 (842)
||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999995432 3349999999999999999999999 999999999999999 8888899999999987
Q ss_pred cCCCCCceeeeeccCCCCCCccccc--------ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhh-hhHHHHHHHhh
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFR--------RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ-VSLAEWALQCH 729 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~-~~l~~~~~~~~ 729 (842)
..... ......||..|+|||++. +..++.++|||||||++|||++|+.||........ ..+..-.....
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 65433 223456999999999986 57889999999999999999999999975443221 11211111111
Q ss_pred cccccccccc-----------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 730 RKGILEKIID-----------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 730 ~~~~l~~i~d-----------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
....+..+.. -.....+.......+.+++.+||+.||.+||++.|+++......
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111111100 00111334566778899999999999999999999999887653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=355.09 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=197.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--------------------------hhHHHHHHHHHHHH
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--------------------------QGINEFQTEIQMLS 559 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--------------------------~~~~~f~~Ei~il~ 559 (842)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+++.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999964 688999998754321 12356899999999
Q ss_pred hcCCCceeeEEEeecc--CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCC
Q 037607 560 KLRHRHLVSLIGFCDE--QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKT 637 (842)
Q Consensus 560 ~L~HpnIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 637 (842)
+++||||+++++++.. ....++||||+++++|.+++ ....+++.+++.++.|+++||+|||+ ++|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence 9999999999999976 66899999999999999876 23579999999999999999999999 8999999999
Q ss_pred CCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccC---CCCcccchhHHHHHHHHHhCCCCCCCCC
Q 037607 638 TNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVINPKL 714 (842)
Q Consensus 638 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~s~ksDVwS~GvvL~ELltG~~p~~~~~ 714 (842)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|++||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999998764332 2234567999999999998755 4789999999999999999999997653
Q ss_pred chhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 715 PREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 715 ~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
... +..... ...... + ........+.+++.+||+.+|.+||++.|+++.
T Consensus 245 ~~~---~~~~~~----~~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMC---LHSKIK----SQALEF---P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHH---HHHHHH----HCCCCC---C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHH---HHHHHh----cccCCC---C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 221 111111 111100 0 011223567889999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=359.83 Aligned_cols=263 Identities=24% Similarity=0.429 Sum_probs=213.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc--------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~ 576 (842)
.++|.+.+.||+|+||.||+|... ++..||||++... .....+++.+|+++++++ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 4678999998765 445567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 99999999999999999985433 2348999999999999999999999 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 99999999999999876533221 1233457789999999999999999999999999999999 999997654322
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
+...... +.... ........+.+++.+||+.+|.+||++.|+++.|+.+......
T Consensus 268 ~~~~~~~----~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 LFKLLKE----GHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHH----TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhc----CCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111111 11000 1112345678899999999999999999999999998776543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.33 Aligned_cols=257 Identities=30% Similarity=0.453 Sum_probs=211.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357889999999999999999998889999999876543 3467999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++++|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999854 34568999999999999999999999 999999999999999999999999999998764322112
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||.+.+..++.++||||||+++|||++ |++||......+. .+... .+.. ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~i~----~~~~--~~~------ 226 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDIS----TGFR--LYK------ 226 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH----TTCC--CCC------
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHHHh----cCCc--CCC------
Confidence 233456788999999999999999999999999999999 8999976543221 11111 1100 000
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.......+.+++.+||+.+|.+||++.|+++.|+.+.+
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123467889999999999999999999999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=365.30 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=213.6
Q ss_pred cccHHHHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-----CCceeeEE
Q 037607 497 FFTFTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-----HRHLVSLI 570 (842)
Q Consensus 497 ~~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-----HpnIv~l~ 570 (842)
.+++.+.....++|.+.++||+|+||.||+|.. .+++.||||++... ....+.+..|+++++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 445555666778999999999999999999997 46889999998743 444567889999999996 99999999
Q ss_pred EeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC------
Q 037607 571 GFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE------ 644 (842)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~------ 644 (842)
+++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 9999999976666679999999999999999999999 99999999999999975
Q ss_pred -------------------CCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh
Q 037607 645 -------------------NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 705 (842)
Q Consensus 645 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt 705 (842)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999865432 234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhHHHHHHHhhccccc--------ccccc--------hh----------HHh---hhcHHHHHHHHH
Q 037607 706 ARPVINPKLPREQVSLAEWALQCHRKGIL--------EKIID--------PV----------IAE---TICKESLRKYVE 756 (842)
Q Consensus 706 G~~p~~~~~~~~~~~l~~~~~~~~~~~~l--------~~i~d--------~~----------l~~---~~~~~~~~~l~~ 756 (842)
|++||......+................+ ....+ +. +.. .........+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 99999876544332222111100000000 00000 00 000 000011256789
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 037607 757 AAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 757 l~~~Cl~~dP~~RPtm~evl~ 777 (842)
++.+||+.||.+||++.|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999885
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=364.24 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=206.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|+..+.||+|+||+||+|... +|+.||||++... .......+.+|+.+|+.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999975 6899999997643 223456789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998843 4578999999999999999999999 99999999999999999999999999999864322
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. ......+||+.|+|||++.+..++.++|||||||++|||++|++||......+. .+.... +...
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~----~~~~------- 223 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILM----EEIR------- 223 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----CCCC-------
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HHHHHc----CCCC-------
Confidence 2 233456799999999999999999999999999999999999999976543221 111110 1000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWNL 779 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~L 779 (842)
++......+.+++.+||+.+|.+|| ++.|+++.-
T Consensus 224 ---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1112234678899999999999999 899988653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=360.82 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=198.1
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEcC-C---cEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLED-G---NKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~~-g---~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
...++|.+.+.||+|+||.||+|.... + ..||||++... .....+++.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999653 3 27999998764 34556889999999999999999999999977665
Q ss_pred E------EEEEEecCCCCcccccccC----CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 579 M------ILVYEYMANGPFRDHLYGT----NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 579 ~------~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
. ++||||+++|+|.+++... ....+++.+++.|+.|+++||+|||+ ++|+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 5 9999999999999988432 23368999999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 037607 649 KVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 649 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~ 726 (842)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |++||......+.. ....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~ 253 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---NYLI 253 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---HHHh
Confidence 9999999987643322 12234557789999999999999999999999999999999 99999866443321 1111
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
. .... .........+.+++.+||+.+|.+||++.|+++.|+.+++.....
T Consensus 254 ~---~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 254 G---GNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp T---TCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred c---CCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 1 0000 011223456889999999999999999999999999987755443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=379.46 Aligned_cols=265 Identities=19% Similarity=0.249 Sum_probs=212.1
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeec
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~ 574 (842)
.+.+++...++|++.++||+|+||+||+|++. +++.||+|++.... ......+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44566667789999999999999999999976 47889999876421 111234889999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
+.+..+||||||++|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999954 24579999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh-HHHHHHHh
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS-LAEWALQC 728 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~-l~~~~~~~ 728 (842)
+++.............+||+.|+|||++. ...++.++|||||||+||||++|++||......+... +..+....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 99876554444445578999999999987 5678999999999999999999999998764433211 11110000
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD--RPGMGDVLWNLE 780 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~evl~~Le 780 (842)
.+.. ........+.+++.+||+.+|.+ ||++.|+++.-.
T Consensus 301 ----~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 301 ----QFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp ----CCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred ----cCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 0000 00112345778899999888877 999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.10 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=202.0
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|.+.+.||+|+||.||+|...+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999998899999999765432 2346788999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++ +|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 975 88888743 34578999999999999999999999 999999999999999999999999999998764322 1
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc---cccc-----
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG---ILEK----- 736 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~l~~----- 736 (842)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+... . ........ ....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--R-IFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHHCCCChhhchhhhccc
Confidence 2234568999999999876 468999999999999999999999998764433221 1 11110000 0000
Q ss_pred ccc-------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 IID-------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 i~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+ +.............+.+++.+||+.||.+||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000111122334567899999999999999999998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=365.02 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=208.7
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
...++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44678999999999999999999975 6899999987643 44556789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC---CceEEeecccccc
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN---LVAKVADFGLSKA 658 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~---~~~kl~DFGla~~ 658 (842)
||||+++|+|.+++. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999884 44578999999999999999999999 899999999999999764 4599999999987
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
..... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+ +..... .+... ..
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~----~~~~~-~~ 250 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK----AGAYD-YP 250 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC-CC
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----hCCCC-CC
Confidence 65332 2345679999999999999999999999999999999999999997654322 111111 11110 00
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+ ........+.+++.+||+.+|.+||++.|+++.-+
T Consensus 251 ~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 251 SP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp TT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred cc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00 01122356788999999999999999999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.77 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=208.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|.+.+.||+|+||.||+|.+.+ +..||+|++... .....+++.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4679999999999999999998643 235999998765 44556789999999999999999999999865 45689
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++++|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999843 33568999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ....... . ..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~~~~---~-~~---- 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLEKGD---R-LP---- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHHHTC---C-CC----
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHhcCC---C-CC----
Confidence 43333344567889999999999999999999999999999998 99999765433321 1111100 0 00
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
........+.+++.+||+.+|.+||++.|+++.|+.+.+....
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 235 -----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 0111234678899999999999999999999999998776543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.78 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=201.8
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.|.+|+++|++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 57888999999999999999985 7889999987543 45789999999999999999999999874 4899999999
Q ss_pred CCCcccccccCCC-CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc-eEEeecccccccCCCCCc
Q 037607 588 NGPFRDHLYGTNQ-PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV-AKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 588 ~gsL~~~l~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~-~kl~DFGla~~~~~~~~~ 665 (842)
+|+|.+++..... ..+++..++.++.|+++||+|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999965432 35788999999999999999999855578999999999999988886 799999999765322
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ . ..|.... +....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~~---~~~~~--------- 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWAVHN---GTRPP--------- 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHHHHT---TCCCC---------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHHHhc---CCCCC---------
Confidence 2344689999999999999999999999999999999999999975433221 1 1111111 11111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
........+.+++.+||+.+|.+||++.|+++.|+...+...
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223467889999999999999999999999998765443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=356.42 Aligned_cols=270 Identities=22% Similarity=0.364 Sum_probs=216.3
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEE------cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEE
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLI 570 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~------~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~ 570 (842)
...++....++|.+.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678999999999999999999985 24678999998764 344557899999999999 799999999
Q ss_pred EeeccCC-eEEEEEEecCCCCcccccccCCC--------------CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccC
Q 037607 571 GFCDEQS-EMILVYEYMANGPFRDHLYGTNQ--------------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 635 (842)
Q Consensus 571 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDI 635 (842)
+++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+ ++|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9987654 58999999999999999955332 238999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 037607 636 KTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPK 713 (842)
Q Consensus 636 Kp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~ 713 (842)
||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876543322 2334567889999999999999999999999999999998 99999765
Q ss_pred CchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 714 LPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 714 ~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
...+. +..... .+.... ........+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus 255 ~~~~~--~~~~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEE--FCRRLK----EGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHH--HHHHHH----HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHH--HHHHhc----cCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 43321 111111 111000 11122346788999999999999999999999999887643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=358.91 Aligned_cols=246 Identities=23% Similarity=0.281 Sum_probs=195.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|+..++||+|+||+||+|... +|+.||||++... ......++..|+..+.++ +||||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999976 7899999987543 334445566777666665 899999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+ +++|.+++... ...++|..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 67898887443 4579999999999999999999999 89999999999999999999999999998876432
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..++..... |.. ... ....+.+
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~~--~~~----~~~~~~~ 273 (311)
T 3p1a_A 211 G--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQQ--LRQ----GYLPPEF 273 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HHH--HTT----TCCCHHH
T ss_pred C--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHH--Hhc----cCCCccc
Confidence 2 2344569999999999876 789999999999999999999776643211 110 011 1111111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.+|.+||++.|+++.
T Consensus 274 ----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 ----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 22334668899999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=365.22 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=209.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+++|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 6889999998876666667899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC--CCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE--NLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~--~~~~kl~DFGla~~~~~~~ 663 (842)
|++|+|.+++.. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999998843 34579999999999999999999999 99999999999999974 5789999999998765332
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...+... ... .++.
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~~----~~~--~~~~-- 272 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRC----DWE--FDED-- 272 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHC----CCC--CCSS--
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhC----CCC--CCcc--
Confidence 23455799999999999999999999999999999999999999986543221 1111111 000 0110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+||+.+|.+||++.|+++.
T Consensus 273 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 --AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111234567899999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.96 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=205.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcE----EEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNK----VAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~----VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|...+.||+|+||.||+|.+. +++. ||+|.+.... ....+++.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57889999999999999999964 4443 8888765432 333456789999999999999999999986 567899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999998543 4578999999999999999999999 8999999999999999999999999999988754
Q ss_pred CCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. +.... +. ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~----~~--~~~~ 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---DLLEK----GE--RLAQ 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---HHHHT----TC--BCCC
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---HHHHc----CC--CCCC
Confidence 332 23345668889999999999999999999999999999999 99999865443321 11111 10 0000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.......+.+++.+||+.+|.+||++.|+++.|+......
T Consensus 239 -------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 239 -------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1112235678999999999999999999999998875543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.32 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=203.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhh-------HHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQG-------INEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~-------~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
.++|...+.||+|+||.||+|... +++.||+|++....... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367999999999999999999974 78999999986543211 167899999999999999999999997665
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEcCCCc-----eEEe
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLDENLV-----AKVA 651 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld~~~~-----~kl~ 651 (842)
++||||+++|+|.+.+.. ....+++..++.++.|++.||+|||+ ++ |+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999888854 34579999999999999999999998 78 999999999999988776 9999
Q ss_pred ecccccccCCCCCceeeeeccCCCCCCcccc--cccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||........ ........
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~-- 244 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIRE-- 244 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHH--
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhc--
Confidence 9999975432 23456799999999998 456678999999999999999999999986543321 11111111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.+... .........+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 245 -~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 -EGLRP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -SCCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -cCCCC---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11101 1112334568899999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=363.49 Aligned_cols=275 Identities=25% Similarity=0.356 Sum_probs=210.7
Q ss_pred cCcccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeec--cCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD--EQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~--~~~~~~ 580 (842)
++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999984 357899999998877777788999999999999999999999885 556789
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+||||+++++|.+++... ...+++..++.|+.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999999998432 3468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 661 MDRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 661 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.|+......... ...+.........+.+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHHh
Confidence 43322 223445788899999999999999999999999999999999998643211000 000000000000000000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
...............+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0000011122344678899999999999999999999999988755433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=352.28 Aligned_cols=277 Identities=25% Similarity=0.333 Sum_probs=208.2
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc--CCCceeeEEEeeccC
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL--RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L--~HpnIv~l~g~~~~~ 576 (842)
.........++|.+.+.||+|+||.||+|+.. |+.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34444556688999999999999999999985 899999997543 234456666666555 899999999999776
Q ss_pred ----CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC-----CCceEeccCCCCCEEEcCCCc
Q 037607 577 ----SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA-----AQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 577 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~-----~~~ivHrDIKp~NILld~~~~ 647 (842)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 789999999999999999943 36899999999999999999999810 129999999999999999999
Q ss_pred eEEeecccccccCCCCCc---eeeeeccCCCCCCcccccccCCCCc------ccchhHHHHHHHHHhC----------CC
Q 037607 648 AKVADFGLSKAAPMDRGY---VSTAVKGSFGYLDPEYFRRQQLTEK------SDVYSFGVVLFEVLCA----------RP 708 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~k------sDVwS~GvvL~ELltG----------~~ 708 (842)
+||+|||+++........ ......||+.|+|||++.+...+.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999766433221 1124579999999999988776665 9999999999999999 56
Q ss_pred CCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 709 VINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 709 p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
||........ ....+.... .......... ......++...+.+++.+||+.+|.+||++.|+++.|+.+.+.++
T Consensus 261 p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 261 PYHDLVPSDP-SYEDMREIV-CIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTTTSCSSC-CHHHHHHHH-TTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cHhhhcCCCC-chhhhHHHH-hhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 6654332221 111111111 1111111111 111123567789999999999999999999999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=358.50 Aligned_cols=271 Identities=26% Similarity=0.391 Sum_probs=208.4
Q ss_pred cccceEEeecCcEEEEEEEEc-----CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeEEE
Q 037607 510 FDENAVIGVGGFGKVYIGVLE-----DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEMIL 581 (842)
Q Consensus 510 f~~~~~LG~G~fg~Vykg~~~-----~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~~l 581 (842)
|.+.+.||+|+||+||++.+. +++.||||++... .....+.+.+|+++|++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 5789999998765 34556789999999999999999999999976 467899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999943 348999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .....+.........+.+.++
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence 3321 2234557888999999999999999999999999999999999986432110 000000000000000000000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
..............+.+++.+||+.+|.+||++.|+++.|+.+.+...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 000011122344678899999999999999999999999998766544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=363.22 Aligned_cols=268 Identities=19% Similarity=0.246 Sum_probs=206.9
Q ss_pred hcCcccceEEeec--CcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVG--GFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G--~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|++.++||+| +||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999976 6899999987643 34556788899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|||||++|+|.+++.......+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999976666779999999999999999999999 9999999999999999999999999998865421
Q ss_pred CC------CceeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh----
Q 037607 662 DR------GYVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH---- 729 (842)
Q Consensus 662 ~~------~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~---- 729 (842)
.. ........||..|+|||++.+ ..++.++|||||||++|||++|++||......+.... .+.....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCcccc
Confidence 11 011123468899999999987 6799999999999999999999999986543332100 0000000
Q ss_pred -----cc------------cccccccc---hh------HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 730 -----RK------------GILEKIID---PV------IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 730 -----~~------------~~l~~i~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+ ..+..... +. ............+.+++.+||+.||.+||++.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000000 00 0001122234568899999999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=362.09 Aligned_cols=272 Identities=15% Similarity=0.170 Sum_probs=208.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcC------CcEEEEEECCCCChhhH-----------HHHHHHHHHHHhcCCCceee
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLED------GNKVAIKRGNPGSEQGI-----------NEFQTEIQMLSKLRHRHLVS 568 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~------g~~VAvK~~~~~~~~~~-----------~~f~~Ei~il~~L~HpnIv~ 568 (842)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999764 47899999776543211 12345666777788999999
Q ss_pred EEEeeccC----CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-
Q 037607 569 LIGFCDEQ----SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD- 643 (842)
Q Consensus 569 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld- 643 (842)
+++++... ...+|||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+ ++|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 99998654 4589999999 9999999854 34679999999999999999999999 8999999999999998
Q ss_pred -CCCceEEeecccccccCCCCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCch
Q 037607 644 -ENLVAKVADFGLSKAAPMDRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPR 716 (842)
Q Consensus 644 -~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~ 716 (842)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876422111 113455999999999999999999999999999999999999999854322
Q ss_pred hhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 717 EQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 717 ~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
.. ...+...... ..+..++++.+.. ......+.+++.+||+.+|.+||++.++++.|+.+.+....
T Consensus 268 ~~--~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 268 PK--YVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HH--HHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH--HHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 21 1111111111 1122222221110 12345788999999999999999999999999998775543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=359.94 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=213.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEcC-C-----cEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLED-G-----NKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS 577 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~~-g-----~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~ 577 (842)
..++|...+.||+|+||.||+|.... + ..||+|++... .....+.+.+|+.+++++ +||||++++++|...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999999642 2 47999998765 344567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcccccccC------------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 578 EMILVYEYMANGPFRDHLYGT------------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999998532 13468999999999999999999999 899999999999999999
Q ss_pred CceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 037607 646 LVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAE 723 (842)
Q Consensus 646 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~ 723 (842)
+.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |++||........ +..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHH
Confidence 99999999999866433322 2234557889999999999999999999999999999998 9999976543321 111
Q ss_pred HHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 724 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
.... +... . ........+.+++.+||+.+|.+||++.|+++.|+...+...
T Consensus 279 ~~~~----~~~~--~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 279 LVKD----GYQM--A-------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHH----TCCC--C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhc----CCCC--C-------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 1111 1000 0 011123567889999999999999999999999998766543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.28 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=212.4
Q ss_pred cCcccce-EEeecCcEEEEEEEEc---CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENA-VIGVGGFGKVYIGVLE---DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~-~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|.+.. .||+|+||.||+|... ++..||||++... .....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999853 5778999998764 445667899999999999999999999999 55679999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 999999999999843 34569999999999999999999999 99999999999999999999999999999876533
Q ss_pred CCce--eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 663 RGYV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 663 ~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... .....+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +...+.. +...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~----~~~~---- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----GKRM---- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----TCCC----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhc----CCcC----
Confidence 3221 123446889999999998899999999999999999998 999997654332 1111111 1100
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+.......
T Consensus 233 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 111233457888999999999999999999999999987765544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.38 Aligned_cols=267 Identities=20% Similarity=0.259 Sum_probs=208.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEee-ccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC-DEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~-~~~~~~~lV~ 583 (842)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... .++.+|+++++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 57889999985543222 3588999999999988877777666 6677889999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeecccccccC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~~ 660 (842)
||+ +++|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999998843 24569999999999999999999999 999999999999999 789999999999998765
Q ss_pred CCCC------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 661 MDRG------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 661 ~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-
Confidence 4322 122356789999999999999999999999999999999999999987544332222211111100000
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
...........+.+++.+||+.+|.+||++.|+++.|+...+....
T Consensus 239 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 --------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp --------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred --------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0111122345788999999999999999999999999988776543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=345.38 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=211.7
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEee-ccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC-DEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~-~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... +++.+|+.+++.++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56899999999999999999996 57899999987654332 4689999999999998877766665 56677899999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~~~ 661 (842)
|+ +++|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 9999999843 34579999999999999999999999 999999999999999 5889999999999987654
Q ss_pred CCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 662 DRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 662 ~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
.... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--
Confidence 3321 12456799999999999999999999999999999999999999986543332222111111100000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
....+......+.+++.+||+.+|.+||++.|+++.|+...+....
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0111223346788999999999999999999999999988776544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=356.24 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=206.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcC-----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED-----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~-----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
++|...+.||+|+||.||+|.... +..||||++... ......++.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567788999999999999998653 235999998764 34456689999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 9999999999999854 34579999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCC--ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 662 DRG--YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 662 ~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +...+ ..+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~----~~~~~~--- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAI----NDGFRL--- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HTTCCC---
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HCCCcC---
Confidence 321 12223446788999999999999999999999999999998 999997654322 11111 111000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+.......
T Consensus 270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 011123456788999999999999999999999999887655543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.79 Aligned_cols=267 Identities=24% Similarity=0.303 Sum_probs=203.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC-----hhhHHHHHHHHHHHHhcC---CCceeeEEEeeccC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS-----EQGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQ 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~-----~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~ 576 (842)
..++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 468999999875321 112245677887777765 99999999999765
Q ss_pred C-----eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 577 S-----EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 577 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
. ..++||||+. ++|.+++.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999997 599999976666679999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 652 DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 652 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+..............
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999998764322 234567899999999999999999999999999999999999999876544332211111100111
Q ss_pred cccccc----------cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 732 GILEKI----------IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 732 ~~l~~i----------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+... ..+.......++....+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 00000111222344678899999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=374.72 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=209.8
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
+.+++...++|.+.++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444556689999999999999999999976 58899999875421 1122458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
....+||||||++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999998843 358999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccC----CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
++.............+||+.|+|||++.+.. ++.++|||||||+||||++|++||......+... .+.....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i~~~~~- 290 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KIMNHKN- 290 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHHH-
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH---HHHhccc-
Confidence 9876544333344678999999999998755 8899999999999999999999998664332111 1100000
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVD--RPGMGDVLWNLEY 781 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~evl~~Le~ 781 (842)
.+.-| ........+.+++.+||+.+|.+ ||++.||++.-..
T Consensus 291 ----~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 291 ----SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp ----HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ----cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 00000 00122356788999999999988 9999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=357.43 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=197.2
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe----
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE---- 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~---- 578 (842)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 57889999998754 33445688999999999999999999999865543
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 4999999999999999843 3578999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCC--ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 659 APMDRG--YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 659 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~--- 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP--- 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC---
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC---
Confidence 643221 122345689999999999999999999999999999999999999976543321 111111110
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
..+ ..........+.+++.+||+.+|.+||+..+++..-
T Consensus 237 -~~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 275 (311)
T 3ork_A 237 -IPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275 (311)
T ss_dssp -CCH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred -CCc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence 011 111122345688999999999999999777666543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.90 Aligned_cols=262 Identities=25% Similarity=0.437 Sum_probs=205.5
Q ss_pred cCcccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC--CeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ--SEM 579 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~--~~~ 579 (842)
+.|+..+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999984 36889999998754 334457899999999999999999999999776 668
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999843 23568999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCch---------hhhhHHHHHHHh
Q 037607 660 PMDRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPR---------EQVSLAEWALQC 728 (842)
Q Consensus 660 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~---------~~~~l~~~~~~~ 728 (842)
...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT- 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-
Confidence 544321 223456788899999999999999999999999999999999876422100 00000000000
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
...+. ...........+.+++.+||+.+|.+||++.|+++.|+..+
T Consensus 256 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000 00112233457889999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=365.76 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=200.9
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~ 580 (842)
..++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|..+|+.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999975 6899999998643 233456788999999998 6999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|||||++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999843 3569999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.. +.+. .+. ..
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i~----~~~---~~-- 242 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---EAIL----NDE---VV-- 242 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCC---CC--
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---HHHH----cCC---CC--
Confidence 22 22344567999999999999999999999999999999999999999866443211 1111 010 00
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH------HHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGM------GDVLWN 778 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm------~evl~~ 778 (842)
+.......+.+++.+||+.+|.+||++ .|+++.
T Consensus 243 -----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 -----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111123457789999999999999998 677653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.39 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=197.5
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC------
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS------ 577 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~------ 577 (842)
..++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999986 7899999997643 3345678999999999999999999999985433
Q ss_pred ---------------------------------------------------eEEEEEEecCCCCcccccccCC-CCCCch
Q 037607 578 ---------------------------------------------------EMILVYEYMANGPFRDHLYGTN-QPPLSW 605 (842)
Q Consensus 578 ---------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~ 605 (842)
..++|||||++++|.+++.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3899999999999999995433 234566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC-----------ceeeeeccCC
Q 037607 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-----------YVSTAVKGSF 674 (842)
Q Consensus 606 ~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~ 674 (842)
..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6789999999999999999 9999999999999999999999999999987654321 1223456999
Q ss_pred CCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHH
Q 037607 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKY 754 (842)
Q Consensus 675 ~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l 754 (842)
.|+|||++.+..++.++|||||||++|||++|..|+. +....... .... ..+.. .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~----~~~~-----~~~~~----~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITD----VRNL-----KFPLL----FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHH----HHTT-----CCCHH----HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHH----hhcc-----CCCcc----cccCChhH
Confidence 9999999999999999999999999999999875532 11111110 1111 11111 12334566
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 755 VEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 755 ~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+++.+||+.+|.+||++.|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.12 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=200.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|++.+.||+|+||+||+|... +|+.||||++... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 6889999987543 33445788999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++ +|.+.+. .....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9976 5555543 234679999999999999999999999 899999999999999999999999999998764332
Q ss_pred ceeeeeccCCCCCCcccccccC-CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--cccccccc---c
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH--RKGILEKI---I 738 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~l~~i---~ 738 (842)
.......||..|+|||++.+.. ++.++|||||||++|||++|..|+-....... .+........ .......+ .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhcccc
Confidence 2234456899999999998765 89999999999999999988877543332221 1111111100 00000000 0
Q ss_pred c---------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 739 D---------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 739 d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+ ........+.....+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000001112234567899999999999999999998864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=370.61 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=206.4
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
...++|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999864 68899999876543 3445778999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeecccccc
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKA 658 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~ 658 (842)
|||||++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998843 4569999999999999999999999 9999999999999998 467899999999987
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+. .... ..+... ..
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~i----~~~~~~-~~ 233 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQI----KAGAYD-FP 233 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH----HHTCCC-CC
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHHH----HhCCCC-CC
Confidence 65332 223456799999999999999999999999999999999999999976543221 1111 111110 00
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+ ........+.+++.+||+.||.+||++.|+++.
T Consensus 234 ~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 011223567889999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=357.25 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=205.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
.+.|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999975 6899999987532 1123578999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc---eEEeeccc
Q 037607 581 LVYEYMANGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV---AKVADFGL 655 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~---~kl~DFGl 655 (842)
+|||||++++|.+.+... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877432 34468999999999999999999999 99999999999999976554 99999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|++||..... .+..... .+...
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~----~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGII----KGKYK 250 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHH----HTCCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHH----cCCCC
Confidence 98765332 223456799999999999999999999999999999999999999976421 1111111 11100
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+... ......+.+++.+||+.+|.+||++.|+++.-.
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 111111 122456788999999999999999999987543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=387.34 Aligned_cols=255 Identities=30% Similarity=0.431 Sum_probs=209.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|.+.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++|+||||++++++|.+ +..+||||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 467888999999999999999998888899999876542 35689999999999999999999999976 6789999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.++|.......+++.+++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999965444568999999999999999999999 999999999999999999999999999998764321111
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||......+. .+.+ ..+... .
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i----~~~~~~---------~ 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV----ERGYRM---------P 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHH----HTTCCC---------C
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCCC---------C
Confidence 223456788999999999999999999999999999999 9999976543321 1111 111100 0
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
....+...+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1123345678899999999999999999999999865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=351.54 Aligned_cols=268 Identities=20% Similarity=0.305 Sum_probs=193.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999864 68999999876543 2334678999999999999999999999999999999999
Q ss_pred ecCCCCccccccc----CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 585 YMANGPFRDHLYG----TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 585 y~~~gsL~~~l~~----~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
|++ |+|.+++.. .....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 589888743 223568999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc--
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI-- 737 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i-- 737 (842)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+......-.........+..+
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3221 2234568999999999876 46899999999999999999999999876544332211110000000000000
Q ss_pred ---------------cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 738 ---------------IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 738 ---------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
+...+...........+.+++.+||+.||.+||++.|+++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 000011111112345788999999999999999999988643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=361.62 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=200.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCC--CceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRH--RHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|++++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4569999999999999999999888999999987543 45556789999999999986 9999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|| +.+++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 568899999954 4578999999999999999999999 8999999999999997 578999999999876533
Q ss_pred CCc-eeeeeccCCCCCCcccccc-----------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 037607 663 RGY-VSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730 (842)
Q Consensus 663 ~~~-~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~ 730 (842)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||........ ....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~--- 232 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHA--- 232 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHH---
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHH---
Confidence 222 2345679999999999865 6789999999999999999999999975432110 0111
Q ss_pred ccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 731 KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 731 ~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
++++.....+.......+.+++.+||+.+|.+||++.|+++..+..
T Consensus 233 ------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 233 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 1111111111111234678899999999999999999999877654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.94 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=203.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
.++|++.++||+|+||.||+|.+. +++ +|++|.+... .....+++.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999964 444 3688876543 3445678999999999999999999999998754 88
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|+||+.+|+|.+++... ...+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999998543 4568999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 661 MDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 661 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.... .......+|..|+|||.+.+..++.++|||||||++|||++ |++||......+.. ..... +...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~----~~~~--- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK----GERL--- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT----TCCC---
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc----CCCC---
Confidence 3322 22334456889999999999999999999999999999999 99999876543321 11111 1000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.......
T Consensus 239 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 239 ------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 0111233467889999999999999999999999998875443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=349.39 Aligned_cols=266 Identities=24% Similarity=0.293 Sum_probs=202.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 58999999875543 334567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988873 34568999999999999999999999 999999999999999999999999999998764322
Q ss_pred CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH---------Hhhcccc
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL---------QCHRKGI 733 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~ 733 (842)
. ......||..|+|||++.+ ..++.++|||||||++|||++|++||......+......... .......
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2234568999999999876 678999999999999999999999998765544332211110 0000000
Q ss_pred ccc--ccchhH---HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 LEK--IIDPVI---AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 l~~--i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
... +.++.. .....+.....+.+++.+||+.+|.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000000 000112234568899999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.87 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=207.9
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
..++|.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999975 467899998876545556789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~~~ 661 (842)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999998843 4568999999999999999999999 999999999999999 7889999999999987643
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+.. .. ...+... .+
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~----~~~~~~~---~~- 227 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---LK----IREGTFT---FP- 227 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HHHCCCC---CC-
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---HH----HHhCCCC---CC-
Confidence 32 23445689999999998754 899999999999999999999999865432211 10 1111100 00
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
..........+.+++.+||+.+|.+||++.|+++.-...
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 228 --EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp --HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred --chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 000112245678899999999999999999998765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.70 Aligned_cols=263 Identities=24% Similarity=0.273 Sum_probs=204.1
Q ss_pred HHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 502 ELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-----SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 502 el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-----~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
++....++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35667789999999999999999999974 6789999986532 33456789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcccccccC--------------------------------------CCCCCchHHHHHHHHHHHH
Q 037607 576 QSEMILVYEYMANGPFRDHLYGT--------------------------------------NQPPLSWKQRLEICIGSAR 617 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~I~~~ia~ 617 (842)
.+..++||||+++|+|.+++... ....+++..++.|+.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988410 0123467788999999999
Q ss_pred HHHHHHhCCCCceEeccCCCCCEEEcCCC--ceEEeecccccccCCC---CCceeeeeccCCCCCCcccccc--cCCCCc
Q 037607 618 GLHYLHTGAAQGIIHRDVKTTNILLDENL--VAKVADFGLSKAAPMD---RGYVSTAVKGSFGYLDPEYFRR--QQLTEK 690 (842)
Q Consensus 618 gL~yLH~~~~~~ivHrDIKp~NILld~~~--~~kl~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~~--~~~s~k 690 (842)
||+|||+ ++|+||||||+|||++.++ .+||+|||+++..... .........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998766 8999999999865322 1122345679999999999875 678999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC
Q 037607 691 SDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP 770 (842)
Q Consensus 691 sDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 770 (842)
+|||||||++|||++|+.||......+.. ........ ....+ ........+.+++.+||+.+|.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999866443221 11111110 00011 1112235678899999999999999
Q ss_pred CHHHHHHHHH
Q 037607 771 GMGDVLWNLE 780 (842)
Q Consensus 771 tm~evl~~Le 780 (842)
++.|+++.-.
T Consensus 324 s~~~~l~hp~ 333 (345)
T 3hko_A 324 DAMRALQHPW 333 (345)
T ss_dssp CHHHHHHSHH
T ss_pred CHHHHhcChh
Confidence 9999987544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=364.52 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=199.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|++.++||+|+||+||+|+.. +++.||+|+++.. .....+.+.+|..+|.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999975 5788999987643 233345688999999887 89999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|||||++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999998843 4579999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhh--hhHHHHHHHhhcccccccccc
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ--VSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~l~~i~d 739 (842)
. .......+||+.|+|||++.+..++.++|||||||++|||++|++||......+. ....++.........+
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 2 2234567899999999999999999999999999999999999999975432211 1111111111111111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.++......+.+++.+||+.+|.+||++
T Consensus 280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0112233567889999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=359.35 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=214.0
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEee
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~ 573 (842)
+++....++|.+.+.||+|+||.||+|... .++.||||++... ......++.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456788999999999999999999864 3678999998754 344556799999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCCcccccccC--------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC
Q 037607 574 DEQSEMILVYEYMANGPFRDHLYGT--------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN 645 (842)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~ 645 (842)
...+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence 9999999999999999999998532 12567899999999999999999999 899999999999999999
Q ss_pred CceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 037607 646 LVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAE 723 (842)
Q Consensus 646 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~ 723 (842)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |++||......+ +..
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 251 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR 251 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HHH
Confidence 99999999999865422211 1223456889999999999999999999999999999999 889987654322 111
Q ss_pred HHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 724 WALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 724 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
... .+.... ........+.+++.+||+.+|.+||++.|+++.|+..+.
T Consensus 252 ~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVM----EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHH----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111 111111 112234567889999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.81 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=203.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CC-------cEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DG-------NKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g-------~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
.++|.+.+.||+|+||.||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357889999999999999999864 33 4699999877666777889999999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc--------eEE
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV--------AKV 650 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~--------~kl 650 (842)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999542 3348999999999999999999999 99999999999999998887 999
Q ss_pred eecccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHh
Q 037607 651 ADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 651 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~-~p~~~~~~~~~~~l~~~~~~~ 728 (842)
+|||++..... .....++..|+|||++.+ ..++.++|||||||++|||++|. +|+......... ...
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~~~--- 231 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---QFY--- 231 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHH---
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH---HHh---
Confidence 99999875432 233558899999999987 77999999999999999999965 444433221111 110
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.....+. ......+.+++.+||+.+|.+||++.|+++.|+....
T Consensus 232 ~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111111 1112357789999999999999999999999986544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=372.17 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=209.6
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeec
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~ 574 (842)
.+.+++...++|+..++||+|+||+||+++.. +|+.||||++.... ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555566789999999999999999999975 68999999986421 122345889999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
+.+..+||||||++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999999532 3478999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCccccc-------ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
+++.............+||+.|+|||++. ...++.++|||||||++|||++|++||......+... .+..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~~ 284 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVH 284 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHT
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH---HHHh
Confidence 99876544333344568999999999987 3578999999999999999999999998764332211 0100
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCC---CCHHHHHHHH
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDR---PGMGDVLWNL 779 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ptm~evl~~L 779 (842)
... .+..|.+ .......+.+++.+||+ +|.+| |++.|+++.-
T Consensus 285 ~~~-----~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 285 YKE-----HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHH-----HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred ccc-----CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 000 0000111 11234567889999999 99988 5888887643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.77 Aligned_cols=273 Identities=23% Similarity=0.358 Sum_probs=215.3
Q ss_pred ccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHh--cCCCceeeEEEeecc
Q 037607 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSK--LRHRHLVSLIGFCDE 575 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~--L~HpnIv~l~g~~~~ 575 (842)
.++.......++|.+.+.||+|+||.||+|+. +|+.||||++... ....+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 44555566778999999999999999999998 4899999998643 34678889999988 789999999999977
Q ss_pred CC----eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHH--------hCCCCceEeccCCCCCEEEc
Q 037607 576 QS----EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH--------TGAAQGIIHRDVKTTNILLD 643 (842)
Q Consensus 576 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH--------~~~~~~ivHrDIKp~NILld 643 (842)
.. ..++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| + .+|+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEEC
Confidence 65 79999999999999999943 36899999999999999999999 6 8999999999999999
Q ss_pred CCCceEEeecccccccCCCCCc---eeeeeccCCCCCCccccccc------CCCCcccchhHHHHHHHHHhC--------
Q 037607 644 ENLVAKVADFGLSKAAPMDRGY---VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA-------- 706 (842)
Q Consensus 644 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwS~GvvL~ELltG-------- 706 (842)
.++.+||+|||+++........ ......||..|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999876543322 12345689999999998765 344789999999999999999
Q ss_pred --CCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh-hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 707 --RPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET-ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 707 --~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+.||....... .....+........ ..+.+... ...+....+.+++.+||+.+|.+||++.||++.|+.+.
T Consensus 262 ~~~~p~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSD-PSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSS-CCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCc-ccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 66776543221 11222222111111 11111111 23356778999999999999999999999999999886
Q ss_pred hhh
Q 037607 784 QLQ 786 (842)
Q Consensus 784 ~~~ 786 (842)
+..
T Consensus 336 ~~~ 338 (342)
T 1b6c_B 336 QQE 338 (342)
T ss_dssp HTT
T ss_pred HHh
Confidence 643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=362.59 Aligned_cols=267 Identities=23% Similarity=0.346 Sum_probs=195.9
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccC--Ce
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQ--SE 578 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~--~~ 578 (842)
...++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+|+++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999964 6899999987543 4555678899999999997 99999999999643 47
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++|||||+ ++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 688888843 468999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCC--------------------CCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 659 APMD--------------------RGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 659 ~~~~--------------------~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
.... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1112344679999999999886 679999999999999999999999998765444
Q ss_pred hhhHHHHHHHhhcccccccccch-------------------------hHHh-----hhcHHHHHHHHHHHHHhhhhCCC
Q 037607 718 QVSLAEWALQCHRKGILEKIIDP-------------------------VIAE-----TICKESLRKYVEAAEKCLAEYGV 767 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~-------------------------~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~ 767 (842)
+.....-.........+..+..+ .... .........+.+++.+||+.||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 32221100000000000000000 0000 00002245688999999999999
Q ss_pred CCCCHHHHHHH
Q 037607 768 DRPGMGDVLWN 778 (842)
Q Consensus 768 ~RPtm~evl~~ 778 (842)
+|||+.|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999998865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.98 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=206.5
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--------
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-------- 575 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-------- 575 (842)
...++|+..+.||+|+||.||+|... +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34567999999999999999999986 78999999987654 346789999999999999999998854
Q ss_pred --------CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc
Q 037607 576 --------QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV 647 (842)
Q Consensus 576 --------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~ 647 (842)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence 4558999999999999999965555689999999999999999999999 89999999999999999999
Q ss_pred eEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 648 AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
+||+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+... . .+...
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~---~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S---KFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---HHHHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---HHHHH
Confidence 9999999998765432 223456899999999999999999999999999999999998776311 1 11111
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
...+.+.. .....+.+++.+||+.+|.+||++.|+++.|+.....
T Consensus 231 -~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 -LRDGIISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHTTCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -hhcccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111111 1224567899999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.00 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=195.0
Q ss_pred hcCcccceEEeecCcEEEEEEEE----cCCcEEEEEECCCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGS----EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~~----~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~ 578 (842)
.++|++.+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999997 478999999987542 2344668899999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999843 3568899999999999999999999 8999999999999999999999999999876
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...+.. ...
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~----~~~---- 238 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKILK----CKL---- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH----TCC----
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHh----CCC----
Confidence 43222 123345799999999999999999999999999999999999999986543221 111111 000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
.+.......+.+++.+||+.+|.+|| ++.|+++.
T Consensus 239 ------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01112235678899999999999999 77777764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.91 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=204.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999975 68999999876431 23456788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999943 4568999999999999999999998 99999999999999999999999999999875432
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
....+||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...+.. +.+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~----~~~~------- 221 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILN----AELR------- 221 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH----CCCC-------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----CCCC-------
Confidence 2346799999999999999999999999999999999999999976543221 111110 1000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
+.......+.+++.+||+.+|.+|| ++.|+++.
T Consensus 222 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1112234678899999999999999 88888754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=362.70 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=200.9
Q ss_pred ccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCCC
Q 037607 511 DENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANG 589 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 589 (842)
...+.||+|+||.||+|... +|+.||+|++........+++.+|+++|++++||||++++++|...+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33568999999999999964 68999999988777677788999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE--cCCCceEEeecccccccCCCCCcee
Q 037607 590 PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL--DENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 590 sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl--d~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|.+++.. ....+++..++.++.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 99998853 33468999999999999999999999 999999999999999 677899999999998764332 22
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhc
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~ 747 (842)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ... . .... ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~-~~~----~-~~~~-----~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNIL-ACR----W-DLED-----EEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHH-HTC----C-CSCS-----GGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-hcc----C-CCCh-----hhh
Confidence 3456999999999999999999999999999999999999999876433211 1111 100 0 0000 011
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 748 ~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
......+.+++.+||+.+|.+||++.|+++.-.
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 123456788999999999999999999998543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=345.46 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=205.2
Q ss_pred CcccceEEeecCcEEEEEEEEc-CC---cEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE-EEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DG---NKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM-ILV 582 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g---~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~-~lV 582 (842)
.|...++||+|+||.||+|.+. ++ ..+|+|++... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566689999999999999864 23 27999987754 445567899999999999999999999999766655 999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999854 45678999999999999999999999 89999999999999999999999999999865332
Q ss_pred C---CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 663 R---GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 663 ~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
. ........++..|+|||.+.+..++.++|||||||++|||++|. +|+......+ +..........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~------- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGRRL------- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTCCC-------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCCCC-------
Confidence 1 11223456788999999999999999999999999999999955 4454333222 22221111100
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.........+.+++.+||+.+|.+||++.|++++|+.+....
T Consensus 248 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 ------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 001122346788999999999999999999999999886653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=361.15 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=204.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++|+.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999975 5889999987543 123456789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+.+|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999984 35679999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCceeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.......||+.|+|||++.. ..++.++|||||||++|||++|++||..........+...... ...
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~----- 237 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVV----- 237 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCC-----
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----ccc-----
Confidence 23355679999999999874 4589999999999999999999999976543332222211111 000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPG-MGDVLW 777 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-m~evl~ 777 (842)
.++......+.+++.+||+.+|.+||+ +.++++
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011123456889999999999999998 666654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.21 Aligned_cols=259 Identities=27% Similarity=0.465 Sum_probs=197.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||+|... ..||+|+++.. .....+.|.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 35999987643 455667899999999999999999999976 4567899999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC-C
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-R 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~-~ 663 (842)
|+++++|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999998843 34679999999999999999999999 99999999999999999999999999999865432 1
Q ss_pred CceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
........||+.|+|||.+. +..++.++|||||||++|||++|+.||......+. +.+..........+.
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~----- 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLSPDLS----- 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSCCCCTT-----
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccccCcchh-----
Confidence 22234567999999999986 56788999999999999999999999986544332 112111111111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.........+.+++.+||+.+|.+||++.|++++|+.+.
T Consensus 249 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 ----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 112233467889999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=347.24 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=209.2
Q ss_pred hcCcccce-EEeecCcEEEEEEEEc---CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 507 TQNFDENA-VIGVGGFGKVYIGVLE---DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 507 t~~f~~~~-~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
.++|.+.. .||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788877 9999999999999653 46789999987542 33457899999999999999999999999 567789
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999954 4568999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcee--eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 661 MDRGYVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 661 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +..... .+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~~- 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KGERMG- 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTCCCC-
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCCCC-
Confidence 4433221 23346788999999999899999999999999999999 999998654332 111111 111010
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
........+.+++.+||+.+|.+||++.|+++.|+.........
T Consensus 241 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 241 --------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 11223456889999999999999999999999999887655443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=358.76 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=191.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
..++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+++|++++||||++++++|...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4678999999999999999999976 57899999987543 34678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~DFGla~~~~~ 661 (842)
|+++|+|.+++. ....+++.+++.++.|+++||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999984 44568999999999999999999999 89999999999999975 88999999999987543
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +.... ...... ...
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i----~~~~~~-~~~-- 272 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRI----LNCEYY-FIS-- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHH----HTTCCC-CCT--
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHH----HhCCCc-cCC--
Confidence 2 123456789999999999999999999999999999999999999976543321 11111 111000 000
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
....+....+.+++.+||+.+|.+||++.|+++.
T Consensus 273 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 ---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234567899999999999999999998864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=354.74 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=200.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999975 5889999987643 344567789999999988 899999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999998843 3568999999999999999999999 99999999999999999999999999999864322
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh--hHHHHHHHhhcccccccccch
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV--SLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~l~~i~d~ 740 (842)
. ......+||+.|+|||++.+..++.++|||||||++|||++|++||......... ...+...........
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 2334567999999999999999999999999999999999999999753221110 011111111111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.++......+.+++.+||+.+|.+||++
T Consensus 237 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0112234567889999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.59 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=206.3
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|+.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999997 578999999875421 12235789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+ +|+|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 7889888843 3569999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+.. ..+....
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~~ 224 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSCV 224 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSSC
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcCC
Confidence 2 2345679999999999988776 68999999999999999999999765432211 1110000
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
...+......+.+++.+||+.||.+|||+.|+++.-+....
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00111223457889999999999999999999988766543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=350.49 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=206.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999975 689999998754321 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC----ceEEeeccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL----VAKVADFGL 655 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~----~~kl~DFGl 655 (842)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999984 34578999999999999999999999 9999999999999999887 799999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... ....
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i-~~~~-- 234 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANI-TSVS-- 234 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHH-HTTC--
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-Hhcc--
Confidence 98765332 224456899999999999999999999999999999999999999765432211 110 0100
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...++.. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 235 ~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111111 11233567889999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=363.59 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=200.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcC--CCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLR--HRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~--HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.+|.+.+.||+|+||.||+|...+++.||||++... .....+++.+|+.+|++|+ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999987543 4556688999999999996 599999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
| +.+++|.+++.. ...+++.+++.++.||++||+|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 568899999854 3478899999999999999999999 8999999999999996 5799999999998765332
Q ss_pred C-ceeeeeccCCCCCCcccccc-----------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 664 G-YVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 664 ~-~~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
. .......||+.|+|||++.+ ..++.++|||||||+||||++|++||........ ....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~---- 279 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHA---- 279 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHH----
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHH----
Confidence 2 12345679999999999875 4688999999999999999999999975432111 1111
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
++++.....+.......+.+++.+||+.+|.+||++.|+++..+..
T Consensus 280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 1111100011111134678899999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=380.92 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=205.0
Q ss_pred Ccccce-EEeecCcEEEEEEEEc---CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 509 NFDENA-VIGVGGFGKVYIGVLE---DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 509 ~f~~~~-~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++.+.. .||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||++++++|.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999874 45679999988653 3456889999999999999999999999976 5699999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|.+++.. ....+++.+++.|+.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 99999999999854 35579999999999999999999999 999999999999999999999999999998765332
Q ss_pred Cce--eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||......+ +.+.+. .+...
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~~~~----- 558 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QGKRM----- 558 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHH----TTCCC-----
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCCCC-----
Confidence 211 123345689999999999999999999999999999998 999998765433 111111 11111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.....+...+.+++.+||+.+|.+||++.+|++.|+......
T Consensus 559 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 559 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111234467889999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.13 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=180.4
Q ss_pred eEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 514 AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
+.||+|+||.||+|... +|+.||||++... ....+.+|+.+++.++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999975 6899999998643 3467889999999997 99999999999999999999999999999
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---ceEEeecccccccCCCCCceee
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL---VAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~---~~kl~DFGla~~~~~~~~~~~~ 668 (842)
.+++.. ...+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++...... ....
T Consensus 94 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 94 FERIKK--KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp HHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 999944 4679999999999999999999999 9999999999999997655 89999999998664332 2234
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcH
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~ 748 (842)
...||+.|+|||++.+..++.++|||||||++|||++|++||.....................+... .. .....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~----~~~~~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FE----GEAWK 241 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CC----SHHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CC----ccccc
Confidence 5568999999999999999999999999999999999999998654322111111111112222111 00 11112
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 749 ~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.....+.+++.+||+.+|.+||++.|+++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 234568899999999999999999988754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=347.86 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=202.0
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ......++.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999996 47899999987652 345567899999999999999999999999999999999
Q ss_pred EEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 583 YEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
|||+++++|.+++.. .....+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999998843 245678999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+..... ........
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~~~~~~~-- 259 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE----QCDYPPLP-- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHH----TTCSCCCC--
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhh----cccCCCCc--
Confidence 322 12234568999999999999999999999999999999999999997543221 11111111 11111110
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
.......+.+++.+||+.+|.+||++.|+++.|+........
T Consensus 260 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 260 ------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 012234678899999999999999999999999887665543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=357.94 Aligned_cols=267 Identities=15% Similarity=0.169 Sum_probs=209.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC---------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceee---------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED---------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS--------- 568 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~---------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~--------- 568 (842)
.++|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999753 789999997654 35889999999999999998
Q ss_pred ------EEEeecc-CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEE
Q 037607 569 ------LIGFCDE-QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 641 (842)
Q Consensus 569 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 641 (842)
+++++.. ....++||||+ +++|.+++.......+++.+++.|+.||+.||+|||+ ++|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5667655 77899999999 9999999965545789999999999999999999999 89999999999999
Q ss_pred EcCCC--ceEEeecccccccCCCCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 037607 642 LDENL--VAKVADFGLSKAAPMDRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPK 713 (842)
Q Consensus 642 ld~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~ 713 (842)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876432111 123447999999999999999999999999999999999999999865
Q ss_pred CchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhh
Q 037607 714 LPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788 (842)
Q Consensus 714 ~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~ 788 (842)
..... .+..+...... ....+.+.... .......+.+++.+||+.+|.+||++.|++++|+.+.+....
T Consensus 272 ~~~~~-~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 272 LPNTE-DIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TTCHH-HHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CcCHH-HHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 42221 11111111111 01111111000 011235688899999999999999999999999998776553
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=358.66 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=210.6
Q ss_pred hcCcccceEEeecCcEEEEEEEE-----cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--eE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-----EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS--EM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-----~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~--~~ 579 (842)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++........+++.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999984 368899999988777777789999999999999999999999986544 78
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999998543 3468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCce--eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh---------hhhHHHHHHHh
Q 037607 660 PMDRGYV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE---------QVSLAEWALQC 728 (842)
Q Consensus 660 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~---------~~~l~~~~~~~ 728 (842)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......- ...........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5433221 123456778999999999899999999999999999999998875321100 00000001111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
...+.. ..........+.+++.+||+.+|.+||++.|+++.|+.+.+.
T Consensus 276 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 276 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111000 011223346788999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=350.83 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=200.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 6889999998654 233457899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999843 3568999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.........|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .+... .... ...+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~----~~~~----~~~~-- 254 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAH----INQA----IPRP-- 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHH----HHSC----CCCG--
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHH----hccC----CCCc--
Confidence 333334567899999999999999999999999999999999999999764321 11111 1110 0000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHhh
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP-GMGDVLWNLEYAMQL 785 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~evl~~Le~~~~~ 785 (842)
..........+.+++.+||+.+|.+|| ++.++++.|+.+...
T Consensus 255 -~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 -STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011223345678899999999999999 999999999876443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=345.52 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=204.4
Q ss_pred cCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEee-ccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFC-DEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~-~~~~~~~l 581 (842)
.+|...++||+|+||.||+|.+.+ ...+|+|.+... .....+++.+|+.++++++||||++++++| ...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998642 235899987754 445567899999999999999999999986 45567899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999953 44578999999999999999999999 9999999999999999999999999999986643
Q ss_pred CCC---ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 662 DRG---YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 662 ~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......+. ...... +. ..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~----~~--~~ 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQ----GR--RL 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHT----TC--CC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhc----CC--CC
Confidence 221 12334567889999999999999999999999999999999 5666655433221 111111 10 00
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.. .......+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus 252 ~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 111234688899999999999999999999999987653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=360.58 Aligned_cols=274 Identities=20% Similarity=0.287 Sum_probs=214.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC--eEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS--EMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~--~~~lV 582 (842)
.++|.+.++||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357899999999999999999976 58999999987532 334577889999999999999999999987654 78999
Q ss_pred EEecCCCCcccccccCC-CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE----cCCCceEEeeccccc
Q 037607 583 YEYMANGPFRDHLYGTN-QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKVADFGLSK 657 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl----d~~~~~kl~DFGla~ 657 (842)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999995432 2349999999999999999999999 999999999999999 788889999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc--------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhh-hhHHHHHHHh
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ-VSLAEWALQC 728 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~-~~l~~~~~~~ 728 (842)
...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .....-....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 764332 2234569999999999875 5778899999999999999999999975433221 1111111111
Q ss_pred hccccccccc-----------chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 729 HRKGILEKII-----------DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 729 ~~~~~l~~i~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.....+..+. +......+.......+.+++.+||+.||++||++.|+++.++.+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111111100 00011233456777889999999999999999999999999888764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.20 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=205.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999975 6899999987543 23445789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR- 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~- 663 (842)
|+++++|.+++. ....+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999984 34578999999999999999999999 999999999999999999999999999997654221
Q ss_pred CceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ .+..|... .... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~---~~~~----~--- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK---KTYL----N--- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT---CTTS----T---
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc---cccc----C---
Confidence 112344568999999999987665 7899999999999999999999986543321 12222111 0000 0
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+||+.+|.+||++.|+++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 011223467789999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.23 Aligned_cols=253 Identities=29% Similarity=0.431 Sum_probs=200.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-CCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-QSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~~~~lV~Ey 585 (842)
.++|++.+.||+|+||.||+|... |+.||||++.... ..+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467999999999999999999874 8899999987653 34789999999999999999999998754 4578999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++++|.+++.......+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999854433448899999999999999999999 99999999999999999999999999998765422
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
.....++..|+|||.+.+..++.++||||||+++|||++ |++||......+. .... ..+...
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~~--------- 233 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKGYKM--------- 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTTCCC---------
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcCCCC---------
Confidence 123457889999999999999999999999999999998 9999976543221 1111 111100
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11122345688899999999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=348.36 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=203.4
Q ss_pred HHHHHhcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 502 ELQNATQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 502 el~~at~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
++....++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+++.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33345678999999999999999999864 2457999998754 44556789999999999999999999999976
Q ss_pred CC-----eEEEEEEecCCCCccccccc----CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC
Q 037607 576 QS-----EMILVYEYMANGPFRDHLYG----TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL 646 (842)
Q Consensus 576 ~~-----~~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~ 646 (842)
.. ..++||||+++|+|.+++.. .....+++..++.++.|+++||.|||+ ++|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 54 35999999999999998842 344679999999999999999999998 8999999999999999999
Q ss_pred ceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 037607 647 VAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEW 724 (842)
Q Consensus 647 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~ 724 (842)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |++||......+. ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH
Confidence 999999999987643321 12234557889999999999999999999999999999999 8899976543321 111
Q ss_pred HHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 725 ALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 725 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
... +... .........+.+++.+||+.+|.+||++.|+++.|+...+.
T Consensus 262 ~~~----~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LLH----GHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHT----TCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHc----CCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1000 01122345688999999999999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.79 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=188.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeec-----cCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD-----EQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~-----~~~~ 578 (842)
.++|.+.++||+|+||+||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999865 6899999987653 3455678999999999999999999999994 3467
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+ +++|.+++. ....+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999998 578988883 34579999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCC--------------------------ceeeeeccCCCCCCcccc-cccCCCCcccchhHHHHHHHHHh------
Q 037607 659 APMDRG--------------------------YVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLC------ 705 (842)
Q Consensus 659 ~~~~~~--------------------------~~~~~~~gt~~Y~APE~l-~~~~~s~ksDVwS~GvvL~ELlt------ 705 (842)
...... ...+..+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 642211 123456789999999986 56779999999999999999999
Q ss_pred -----CCCCCCCCCchh-----------------hhhHHHHHHHhhcc---cccccccchhH--------------Hhhh
Q 037607 706 -----ARPVINPKLPRE-----------------QVSLAEWALQCHRK---GILEKIIDPVI--------------AETI 746 (842)
Q Consensus 706 -----G~~p~~~~~~~~-----------------~~~l~~~~~~~~~~---~~l~~i~d~~l--------------~~~~ 746 (842)
|+++|.+..... .......+...... ..+..+..... ....
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 666665543100 00000000000000 00000000000 0001
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+.....+.+++.+||+.||.+|||+.|+++.-.
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 1223456889999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.49 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=204.2
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
....++|.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 68899999986431 23456788999999887 89999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999843 3568999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|++||......+. ...+.. ....
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~--~~~~----- 236 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRM--DNPF----- 236 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH--CCCC-----
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHh--CCCC-----
Confidence 43222 223456799999999999999999999999999999999999999986543221 111110 0000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMG-DVLW 777 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~-evl~ 777 (842)
+.......+.+++.+||+.+|.+||++. |+++
T Consensus 237 -------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1111234678899999999999999997 6654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=359.79 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=195.6
Q ss_pred hcCcccc-eEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHh-cCCCceeeEEEeecc----CCeE
Q 037607 507 TQNFDEN-AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSK-LRHRHLVSLIGFCDE----QSEM 579 (842)
Q Consensus 507 t~~f~~~-~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~-L~HpnIv~l~g~~~~----~~~~ 579 (842)
.++|.+. ++||+|+||+||+|... +|+.||||++... ..+.+|++++.+ ++||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567665 68999999999999975 6889999998632 457788988744 589999999998865 6678
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEeecccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVADFGLS 656 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~DFGla 656 (842)
+||||||++|+|.+++.......+++.+++.|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999976556679999999999999999999999 99999999999999987 789999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcccccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV-SLAEWALQCHRKGILE 735 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~l~ 735 (842)
+...... .....+||+.|+|||++.+..++.++|||||||+||||++|++||......... .+..... .+...
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~ 285 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYE 285 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCC
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCccc
Confidence 8754322 234567899999999999999999999999999999999999999765432211 0111111 01000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
...+ ........+.+++.+||+.+|.+||++.|+++.-+..
T Consensus 286 -~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 286 -FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp -CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 0000 0112345678999999999999999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.46 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=204.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|+..+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999975 68999999976432 234567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999843 3468999999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....||+.|+|||++.+..++.++|||||||++|||++|++||......+. .+.+. .+...
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~----~~~~~-------- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIV----SGKVR-------- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCCC--------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HHHHH----cCCCC--------
Confidence 2345799999999999999999999999999999999999999986543221 11111 11110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWNL 779 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~L 779 (842)
++......+.+++.+||+.+|.+||+ +.|+++.-
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 11122356788999999999999998 78887643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.54 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=207.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999975 5889999987543 4455678899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc---eEEeecccccccC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV---AKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~---~kl~DFGla~~~~ 660 (842)
||+++++|.+.+.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999888843 3568999999999999999999999 99999999999999976655 9999999997764
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .... .+... ...+
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~----~~~~~-~~~~ 229 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIK----AGAYD-YPSP 229 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCCC-CCTT
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---HHHH----hcccc-CCch
Confidence 332 223467899999999999999999999999999999999999999765432211 1111 11100 0000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+||+.+|.+||++.|+++.-..
T Consensus 230 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 230 -----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp -----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred -----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 011223467889999999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=360.38 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=195.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999976 789999999865432 235688999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc--eEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV--AKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~--~kl~DFGla~~~~~~~ 663 (842)
+++|+|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999998843 3469999999999999999999999 99999999999999987765 9999999997543221
Q ss_pred CceeeeeccCCCCCCcccccccCCCCc-ccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
......||+.|+|||++.+..++.+ +|||||||++|||++|++||......... ........... . ...
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~-~-~~~---- 242 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVK-Y-SIP---- 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTC-C-CCC----
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCC-C-CCC----
Confidence 2234569999999999988887655 89999999999999999999865432211 11111111000 0 000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+++.+||+.+|.+||++.|+++.-+..
T Consensus 243 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 243 ---DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp ---TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred ---CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 0001234678899999999999999999999876654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=360.41 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=197.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc--CC--cEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeec-cCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE--DG--NKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD-EQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~--~g--~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~-~~~~~~l 581 (842)
..|...++||+|+||.||+|.+. ++ ..||+|.+... .....++|.+|+.++++++||||++++++|. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677789999999999999864 22 36899998754 3455688999999999999999999999875 4567899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999843 44568999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCC---ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 662 DRG---YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 662 ~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
... .......++..|+|||.+.+..++.++|||||||++|||++ |.+||......+ +...... +. ..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~----~~--~~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----GR--RL 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHT----TC--CC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHc----CC--CC
Confidence 221 12234557889999999999999999999999999999999 777887554332 1111111 10 01
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
.. .......+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus 316 ~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 112234678899999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=357.10 Aligned_cols=263 Identities=16% Similarity=0.166 Sum_probs=198.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCCChhh-----------HHHHHHHHHHHHhcCCCceeeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPGSEQG-----------INEFQTEIQMLSKLRHRHLVSLIG 571 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~~~~~-----------~~~f~~Ei~il~~L~HpnIv~l~g 571 (842)
.++|.+.+.||+|+||.||+|... .+..+|||+........ ...+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 57789999876543221 134678889999999999999999
Q ss_pred eecc----CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-
Q 037607 572 FCDE----QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL- 646 (842)
Q Consensus 572 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~- 646 (842)
++.. ....++||||+ +++|.+++... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 9977 77899999999 99999998433 379999999999999999999999 8999999999999998877
Q ss_pred -ceEEeecccccccCCCCC------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh
Q 037607 647 -VAKVADFGLSKAAPMDRG------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719 (842)
Q Consensus 647 -~~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~ 719 (842)
.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987642211 1123457999999999999999999999999999999999999999643222111
Q ss_pred hHHHHHHHhhcccccccccchhHHhhh-cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 720 SLAEWALQCHRKGILEKIIDPVIAETI-CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 720 ~l~~~~~~~~~~~~l~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
+. ...... ... +...+.... .......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 270 -~~-~~~~~~----~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 -VQ-TAKTNL----LDE-LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HH-HHHHHH----HHT-TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HH-HHHHhh----ccc-ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11 111000 001 111111100 013345788999999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=351.99 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=191.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEee--------ccC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFC--------DEQ 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~--------~~~ 576 (842)
..+|.+.++||+|+||.||+|... +|+.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999964 68999999987766777788999999999996 99999999998 445
Q ss_pred CeEEEEEEecCCCCccccccc-CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEcCCCceEEeec
Q 037607 577 SEMILVYEYMANGPFRDHLYG-TNQPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld~~~~~kl~DF 653 (842)
...++||||+. |+|.+++.. .....+++.+++.|+.|++.||+|||+ ++ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999996 789888843 234579999999999999999999998 77 999999999999999999999999
Q ss_pred ccccccCCCCCc-----------eeeeeccCCCCCCcccc---cccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh
Q 037607 654 GLSKAAPMDRGY-----------VSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719 (842)
Q Consensus 654 Gla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l---~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~ 719 (842)
|+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 999876533221 11244589999999998 567789999999999999999999999975432110
Q ss_pred hHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 720 SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 720 ~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
. .. .... .........+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus 262 --~---~~-----~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 262 --V---NG-----KYSI--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------CCC--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --h---cC-----cccC--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 00 0000 0001112346789999999999999999999999998766433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.05 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=206.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcE--EEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNK--VAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~--VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|.+.+.||+|+||.||+|... +|.. +|+|++... .....+++.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999964 5654 499987643 334456799999999999 899999999999999999999
Q ss_pred EEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 583 YEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
|||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999985432 3579999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~ 727 (842)
||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEK 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HHH
Confidence 99999998754321 11233456889999999999999999999999999999998 9999976543221 111
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
...+... .........+.+++.+||+.+|.+||++.|+++.|+...+...
T Consensus 254 -~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 254 -LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -GGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -hhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111000 0111223568899999999999999999999999998876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=351.89 Aligned_cols=264 Identities=27% Similarity=0.374 Sum_probs=209.7
Q ss_pred hcCcccceEEeecCcEEEEEEEE------cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~------~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|.+.+.||+|+||.||+|.+ .+++.||||++... ......++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999984 24678999998754 455667899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCCC-----CCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEe
Q 037607 580 ILVYEYMANGPFRDHLYGTNQ-----PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVA 651 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~ 651 (842)
++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++ .+..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999964322 458999999999999999999999 8999999999999998 45569999
Q ss_pred ecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +.++...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~-- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTS-- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHHhc--
Confidence 9999976532221 12234567889999999999999999999999999999998 999997654322 1222111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhhhc
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~~~ 789 (842)
+.... ........+.+++.+||+.+|.+||++.|+++.|+...+.....
T Consensus 261 --~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 261 --GGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp --TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred --CCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 10000 11123356788999999999999999999999999887765543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=364.58 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=199.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------C
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------S 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~ 577 (842)
.++|++.+.||+|+||+||+|... +|+.||||++... .....+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 6889999998653 445567889999999999999999999998544 4
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..+||||||+++ |.+.+. ..+++..+..++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 679999999764 655552 248999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH----------
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ---------- 727 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~---------- 727 (842)
..... ...+...||+.|+|||++.+..++.++|||||||+||||++|++||.+....++.....-...
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 76432 233556799999999999999999999999999999999999999987654433221100000
Q ss_pred ------hhcc-cccccccchhHH--------hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 728 ------CHRK-GILEKIIDPVIA--------ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 728 ------~~~~-~~l~~i~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.... .......-+... ..........+.+++.+||+.||.+|||+.|+++.-.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0000 000000000000 0111223567899999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.26 Aligned_cols=254 Identities=17% Similarity=0.205 Sum_probs=206.5
Q ss_pred HHhcCcccceEEeecCcEEEEEEE------EcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC---CCceeeEEEeecc
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGV------LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR---HRHLVSLIGFCDE 575 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~------~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~ 575 (842)
...++|.+.++||+|+||+||+|. ..+++.||||++..... .++..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 44688999999876543 56788888888886 9999999999999
Q ss_pred CCeEEEEEEecCCCCccccccc---CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC--------
Q 037607 576 QSEMILVYEYMANGPFRDHLYG---TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-------- 644 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-------- 644 (842)
.+..+||||||++|+|.+++.. .....+++..++.|+.||++||+|||+ ++|+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999953 135679999999999999999999999 89999999999999998
Q ss_pred ---CCceEEeecccccccCC-CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh
Q 037607 645 ---NLVAKVADFGLSKAAPM-DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS 720 (842)
Q Consensus 645 ---~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~ 720 (842)
++.+||+|||+++.... ..........||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 89999999999976532 223344567799999999999999999999999999999999999999854322110
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDR-PGMGDVLWNLEYAMQL 785 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ptm~evl~~Le~~~~~ 785 (842)
.+...+. ... ....+.+++..|++.+|.+| |++.++.+.|+...+.
T Consensus 294 ------------~~~~~~~----~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ------------KPEGLFR----RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------------EECSCCT----TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------eechhcc----ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0111111 001 12345678889999999998 5888888888877654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.61 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=203.9
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~ 580 (842)
..++|+..++||+|+||+||+|... +|+.||||++... .....+.+..|..+|..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999976 4789999987643 123456788999999988 7999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999843 3468999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||......+ +.+.+.. +...
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~----~~~~----- 239 (353)
T 2i0e_A 173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME----HNVA----- 239 (353)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CCCC-----
T ss_pred cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHHh----CCCC-----
Confidence 22 223345679999999999999999999999999999999999999998654322 1111111 1000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWN 778 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~ 778 (842)
++......+.+++.+||+.+|.+||+ +.|+++.
T Consensus 240 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 -----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11123356788999999999999995 4666653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=351.64 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=199.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhh-HHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~-~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|.+.+.||+|+||.||+|... +++.||||++....... ...+.+|+++|++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 78999999886543221 22456899999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
++ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 97 588888743 34568999999999999999999999 999999999999999999999999999998654322 2
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH--
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI-- 742 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l-- 742 (842)
......||..|+|||++.+ ..++.++|||||||++|||++|++||......+................+........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2334568999999999876 6789999999999999999999999987655443322211111111111111111000
Q ss_pred -----------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 743 -----------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 743 -----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
...........+.+++.+||+.||.+|||+.|+++.-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00111123456789999999999999999999987544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=358.20 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=202.4
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.+.|...+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++|++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588999999999999999996 57899999987643 233456799999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+. |+|.+.+.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 99997 678777742 34578999999999999999999999 89999999999999999999999999999875422
Q ss_pred CCceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
....||+.|+|||++. ...++.++|||||||++|||++|++||......+.. ....... .....
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~-~~~~~- 274 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-SPALQ- 274 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-CCCCC-
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-CCCCC-
Confidence 2456899999999985 567899999999999999999999999765432211 1111111 00000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.......+.+++.+||+.+|.+||++.|+++....
T Consensus 275 -------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 275 -------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 11123457789999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=351.83 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=198.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHH--HHhcCCCceeeEEEee-----ccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQM--LSKLRHRHLVSLIGFC-----DEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~i--l~~L~HpnIv~l~g~~-----~~~~~~ 579 (842)
.++|.+.+.||+|+||.||+|+. +++.||||++.... ..++..|.++ +..++||||+++++.+ ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46799999999999999999987 68999999986433 3445555554 4458999999999854 234467
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC---------ceEeccCCCCCEEEcCCCceEE
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ---------GIIHRDVKTTNILLDENLVAKV 650 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~---------~ivHrDIKp~NILld~~~~~kl 650 (842)
++||||+++|+|.+++.. ..+++..++.|+.|+++||+|||+ . +|+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 999999999999999943 345889999999999999999998 6 9999999999999999999999
Q ss_pred eecccccccCCCC-------CceeeeeccCCCCCCcccccc-------cCCCCcccchhHHHHHHHHHhCCCCCCCCCch
Q 037607 651 ADFGLSKAAPMDR-------GYVSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPR 716 (842)
Q Consensus 651 ~DFGla~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~-------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~ 716 (842)
+|||+++...... ........||..|+|||++.+ ..++.++|||||||++|||++|+.|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764321 112234569999999999986 56778999999999999999997665433221
Q ss_pred hhhh------------HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 717 EQVS------------LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 717 ~~~~------------l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.... ..++............+.+ .. .........+.+++.+||+.+|.+||++.|+++.|+.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-cc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1100 0011111111110000000 00 0112355679999999999999999999999999999876
Q ss_pred hhh
Q 037607 785 LQE 787 (842)
Q Consensus 785 ~~~ 787 (842)
...
T Consensus 319 ~~~ 321 (336)
T 3g2f_A 319 IWE 321 (336)
T ss_dssp CCC
T ss_pred HHH
Confidence 544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=351.46 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=197.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE--QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~--~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
..++|.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999864 788999999875432 2346788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE-----cCCCceEEeeccccc
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL-----DENLVAKVADFGLSK 657 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl-----d~~~~~kl~DFGla~ 657 (842)
|||++ |+|.+++.. ...+++..++.|+.||+.||+|||+ ++|+||||||+|||+ ++++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 589998843 4468999999999999999999999 899999999999999 455669999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc----
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG---- 732 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 732 (842)
...... .......||..|+|||++.+. .++.++|||||||++|||++|++||......+......-........
T Consensus 186 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 186 AFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 764322 123445689999999999874 58999999999999999999999998765433221111000000000
Q ss_pred ---------ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 ---------ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 ---------~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...+.....+...+.......+.+++.+||+.||.+||++.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0011111111222222234567899999999999999999998863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.07 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=207.6
Q ss_pred HHHHHHHhcCcccc-eEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcC-CCceeeEEEeec
Q 037607 500 FTELQNATQNFDEN-AVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLR-HRHLVSLIGFCD 574 (842)
Q Consensus 500 ~~el~~at~~f~~~-~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~ 574 (842)
+.......+.|.+. +.||+|+||.||+|... +|+.||+|++... ......++.+|+.++++++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445666778877 88999999999999975 6899999987653 2334678999999999995 699999999999
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEe
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVA 651 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~ 651 (842)
..+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999999976666789999999999999999999999 89999999999999987 7899999
Q ss_pred ecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 652 DFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 652 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ..... .
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~-~ 250 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN---ISQVN-V 250 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHTC-C
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---HHhcc-c
Confidence 999998764322 22345799999999999999999999999999999999999999976543322110 11100 0
Q ss_pred cccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 732 ~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. . ...........+.+++.+||+.+|.+||++.|+++.
T Consensus 251 ~-~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 D-Y--------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-C--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-c--------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 001112234567889999999999999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=351.91 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=204.7
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeec----cCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD----EQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~----~~~~~~l 581 (842)
.++|.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999997 578999999887666777788999999999999999999999986 4457899
Q ss_pred EEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 582 VYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
||||+++|+|.+++.. .....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999998854 245679999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCCCc--------eeeeeccCCCCCCcccccccC---CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 037607 660 PMDRGY--------VSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 660 ~~~~~~--------~~~~~~gt~~Y~APE~l~~~~---~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
...... ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||........ .+.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~-- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQ-- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhh--
Confidence 321100 012345799999999987543 78999999999999999999999853211110 1111100
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.. .. . .........+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 262 --~~-~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 262 --NQ-LS-I-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp --CC----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --cc-CC-C-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 00 00 0 00112345688999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.60 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=198.5
Q ss_pred cCcccc-eEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDEN-AVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~-~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
+.|.+. ++||+|+||.||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467764 6899999999999995 47899999998766555667899999999985 79999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc---eEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV---AKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~---~kl~DFGla~~~~~ 661 (842)
|+++|+|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999843 3568999999999999999999999 89999999999999988766 99999999876542
Q ss_pred CCC------ceeeeeccCCCCCCcccccc-----cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhH--------H
Q 037607 662 DRG------YVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL--------A 722 (842)
Q Consensus 662 ~~~------~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l--------~ 722 (842)
... .......||..|+|||++.+ ..++.++|||||||++|||++|++||......+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11224459999999999875 5689999999999999999999999986543221000 0
Q ss_pred HHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 723 EWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 723 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.........+... . + ..........+.+++.+||+.||.+||++.|+++.
T Consensus 247 ~~~~~~i~~~~~~-~--~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYE-F--P---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCC-C--C---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcc-c--C---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000111111100 0 0 00011224568899999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.21 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=203.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+++.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999976 68999999865432 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC----ceEEeeccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL----VAKVADFGL 655 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~----~~kl~DFGl 655 (842)
++||||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999843 4578999999999999999999999 9999999999999998877 899999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+.. .. . ....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~-~----~~~~-- 227 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL--TN-I----SAVN-- 227 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HH-H----HTTC--
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH--HH-h----Hhcc--
Confidence 98764322 223456899999999999999999999999999999999999999865432211 00 0 0000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
....+. ........+.+++.+||+.+|.+||++.|+++.-
T Consensus 228 ~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 228 YDFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred cCCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 001111 1122345678899999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=359.99 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=167.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----Ce
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~ 578 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 5789999998653 344567899999999999999999999999765 57
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++|||||. ++|.+++. ....+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999996 59999884 34679999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCC---------------------ceeeeeccCCCCCCcccc-cccCCCCcccchhHHHHHHHHHhCCCCC
Q 037607 659 APMDRG---------------------YVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPVI 710 (842)
Q Consensus 659 ~~~~~~---------------------~~~~~~~gt~~Y~APE~l-~~~~~s~ksDVwS~GvvL~ELltG~~p~ 710 (842)
...... ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 643221 123566799999999986 5667999999999999999999854433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.80 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=183.9
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999997 478999999976432 12246789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999998853 34578999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|++||......+... .. ..... .
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~----~~~~~---~- 230 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KV----VLADY---E- 230 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----CSSCC---C-
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HH----hhccc---C-
Confidence 21 2234568999999999999999999999999999999999999997654322110 00 00000 0
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+||+.+|.+||++.|+++.
T Consensus 231 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 231 ---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 111223467889999999999999999998863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=341.53 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=203.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 567999999999999999999875 57789999875432 22346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999998843 3568999999999999999999998 99999999999999999999999999998654322
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... ...
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~--~~~---------- 224 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---ISR--VEF---------- 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHH--TCC----------
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH---HHh--CCC----------
Confidence 22345789999999999999999999999999999999999999986543221110 000 000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.........+.+++.+||+.+|.+||++.|+++.-...
T Consensus 225 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred --CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 01112234577899999999999999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=366.61 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=207.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+|+.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999975 78999999976432 12346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999994 45679999999999999999999998 99999999999999999999999999999876432
Q ss_pred CCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. .....+||+.|+|||++.+..+ +.++|||||||++|||++|++||........ ...+ ..+...
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~i----~~~~~~------ 234 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FKKI----CDGIFY------ 234 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HHHH----HTTCCC------
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HHHH----hcCCcC------
Confidence 2 2345679999999999988765 6899999999999999999999986543221 1111 111100
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+||+.+|.+||++.|+++.-..
T Consensus 235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 011123457889999999999999999999986544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=364.59 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=211.4
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC-CceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH-RHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H-pnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.++||+|+||.||+|.. .+++.||||++...... .++.+|+++++.|+| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 56899999986654332 358899999999987 556666666678888999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~~~ 661 (842)
|+ +++|.+++.. ....+++.+++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999843 34579999999999999999999999 999999999999999 6889999999999987654
Q ss_pred CCCc------eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 662 DRGY------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 662 ~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-- 236 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-- 236 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC--
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc--
Confidence 3321 12356799999999999999999999999999999999999999987654433222222211111111
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
...++.....++.+++.+||+.+|.+||++.+|+++|+.+....
T Consensus 237 -------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 -------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11122233567899999999999999999999999999886644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=352.71 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=198.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------C
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------S 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~ 577 (842)
.++|...+.||+|+||.||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999974 6899999998543 344567889999999999999999999999765 3
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++||||| +++|.+++.. ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8899998843 468999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
..... .....+|..|+|||++.+ ..++.++|||||||+++||++|++||.+....++.....-.........+..
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 75432 234578999999999887 7899999999999999999999999987654433221110000000000000
Q ss_pred ccchh--------------HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 IIDPV--------------IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 i~d~~--------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.... -...........+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000 0001112234568899999999999999999998874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=345.44 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=198.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc--CCc--EEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE--DGN--KVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~--~g~--~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|++.+.||+|+||.||+|.+. +++ .||||++... .....+++.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999864 333 6899987754 3345678999999999999999999999997754 8
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999988532 3568999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 660 PMDRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 660 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~~~~~~~~~- 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LH---KIDKEGERL- 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHTSCCCC-
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HH---HHHccCCCC-
Confidence 543322 1234457889999999999899999999999999999999 9999976643221 11 111111000
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.........+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 245 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 011223456889999999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=371.57 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=208.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|...++||+|+||.||+|... +|+.||||++... .......+.+|+++|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 6899999997643 123346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++|+|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999976666679999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV-SLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. ......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+........
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------------ 405 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------------ 405 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------------
Confidence 2 234457999999999999999999999999999999999999999865432211 1111111100
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
..+.......+.+++.+||+.+|.+|| ++.|+++.
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 001122335678899999999999999 77888764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=359.87 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=194.0
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999965 67899999865421 1223358899999999999999999999854
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC---CceEEee
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN---LVAKVAD 652 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~---~~~kl~D 652 (842)
+..++|||||++|+|.+++. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.+ +.+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence 55899999999999999884 45679999999999999999999999 899999999999999654 4599999
Q ss_pred cccccccCCCCCceeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 037607 653 FGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 653 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .+.+...
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~--- 358 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT--- 358 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH---
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh---
Confidence 9999876432 23345679999999999863 678899999999999999999999997653322 1111111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+... ..+.. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 359 -~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 -SGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -TTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -cCCCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111 01111 11234568899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.15 Aligned_cols=269 Identities=23% Similarity=0.282 Sum_probs=201.0
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChh-----hHHHHHHHHHHHHhcCCCceeeEEEeeccCC
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQ-----GINEFQTEIQMLSKLRHRHLVSLIGFCDEQS 577 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~-----~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~ 577 (842)
....++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344678999999999999999999975 5899999998753221 1246889999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++||||+++ +|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999985 78887743 34578999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--ccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH--RKGIL 734 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~l 734 (842)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||......+... ....... ....+
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTTS
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHcCCCChhhh
Confidence 764322 22345678999999999876 458999999999999999999999998765433221 1111100 00000
Q ss_pred ccc---cc--------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 735 EKI---ID--------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 735 ~~i---~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..+ .+ ..............+.+++.+||+.+|.+||++.|+++.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 000 00 00001111233467899999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.16 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=204.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..++|++.+.||+|+||.||+|... +|+.||||++..... .+.+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999975 688999999865432 245788888888 7999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC----CceEEeeccccccc
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN----LVAKVADFGLSKAA 659 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~----~~~kl~DFGla~~~ 659 (842)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999843 4579999999999999999999999 999999999999998433 35999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
..... ......||+.|+|||++.+..++.++|||||||++|||++|++||..........+..... .+....
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~~--- 242 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFSL--- 242 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCCC---
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCccc---
Confidence 54322 2345678999999999998889999999999999999999999998643222222221111 111110
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
...........+.+++.+||+.||.+||++.|+++.-+.
T Consensus 243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 001112234567889999999999999999999986554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.83 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=198.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||++... ++..+|+|++... .....+.+.+|+++|++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357899999999999999999974 6889999987653 23346789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeeccccccc
Q 037607 585 YMANGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAA 659 (842)
Q Consensus 585 y~~~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~ 659 (842)
|+++|+|.+.+... ....+++..++.|+.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988432 34679999999999999999999999 999999999999999 45688999999999865
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......|+..|+|||.+. ..++.++|||||||++|||++|+.||......+.. ..... ........
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~~--~~~~~~~~-- 247 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKATY--KEPNYAVE-- 247 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH--CCCCCCC---
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhcc--CCcccccc--
Confidence 4322 234566899999999886 56899999999999999999999999865433211 11110 00000000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.+|.+||++.|+++.
T Consensus 248 -------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 -------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00123467789999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=351.75 Aligned_cols=271 Identities=21% Similarity=0.247 Sum_probs=204.4
Q ss_pred ccHHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC-----------hhhHHHHHHHHHHHHhcCCCce
Q 037607 498 FTFTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS-----------EQGINEFQTEIQMLSKLRHRHL 566 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~-----------~~~~~~f~~Ei~il~~L~HpnI 566 (842)
..+.++....++|.+.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678889999999999999999999999998889999999875421 2224789999999999999999
Q ss_pred eeEEEeec-----cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEE
Q 037607 567 VSLIGFCD-----EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 641 (842)
Q Consensus 567 v~l~g~~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 641 (842)
+++++++. .....++||||++ |+|.+.+.. ....+++..++.++.|++.||+|||+ ++|+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 99999983 3446899999998 688887753 34579999999999999999999999 89999999999999
Q ss_pred EcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh
Q 037607 642 LDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS 720 (842)
Q Consensus 642 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~ 720 (842)
++.++.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||++|++||......+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999997543322 2344578999999999877 779999999999999999999999998765433221
Q ss_pred HHHHHHHhhccc-------------------ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 721 LAEWALQCHRKG-------------------ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 721 l~~~~~~~~~~~-------------------~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.. ....... ....... .............+.+++.+||+.+|.+||++.|+++.-
T Consensus 245 ~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 245 KI---VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HH---HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HH---HHHcCCCChHHhhhccchhhhHHHHhhcccCCh-hhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 11 0000000 0000000 001112223345688999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=381.56 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=200.1
Q ss_pred eEEeecCcEEEEEEEEc---CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLE---DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
+.||+|+||.||+|.+. .++.||||+++.. .....++|.+|+++|++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 4578999998754 33446889999999999999999999999964 568999999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc--e
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--V 666 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~--~ 666 (842)
|+|.+++. ....+++.+++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++........ .
T Consensus 454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999994 34578999999999999999999999 99999999999999999999999999999876543221 2
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....+|..|+|||++.+..++.++|||||||+||||++ |+.||......+. .+.+ ..+....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i----~~~~~~~--------- 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAML----EKGERMG--------- 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTTCCCC---------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCCCC---------
Confidence 234457789999999999999999999999999999998 9999987654321 1111 1111111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
....+...+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112334568899999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.36 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=200.2
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~l 581 (842)
..++|.+.+.||+|+||.||+|... +++.||||++... ......++.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999975 7899999987653 344567889999999999 99999999999999999999
Q ss_pred EEEecCCCCcccccccCC--CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---------------
Q 037607 582 VYEYMANGPFRDHLYGTN--QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE--------------- 644 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~--------------- 644 (842)
||||+++++|.+++.... ...+++.+++.|+.|+++||+|||+ ++|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999985422 3678999999999999999999999 99999999999999984
Q ss_pred ----CCceEEeecccccccCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh
Q 037607 645 ----NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719 (842)
Q Consensus 645 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~ 719 (842)
...+||+|||++....... ...||..|+|||.+.+. .++.++|||||||++|||++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4489999999998765322 23589999999999865 667899999999999999999987643311
Q ss_pred hHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 720 SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 720 ~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
|. ....+....+ .......+.+++.+||+.+|.+||++.|+++.
T Consensus 237 ----~~--~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ----WH--EIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HH--HHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HH--HHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 10 0111111111 11223567889999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=351.61 Aligned_cols=263 Identities=22% Similarity=0.254 Sum_probs=205.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC--------CCceeeEEEeec---
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR--------HRHLVSLIGFCD--- 574 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~--------HpnIv~l~g~~~--- 574 (842)
.++|.+.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+++|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 6889999998754 445678899999999996 788999999987
Q ss_pred -cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEcCCC------
Q 037607 575 -EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLDENL------ 646 (842)
Q Consensus 575 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld~~~------ 646 (842)
.....++||||+ +++|.+.+.......+++..++.|+.||+.||+|||+ + +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 667899999999 6677777755555679999999999999999999999 7 999999999999998775
Q ss_pred -------------------------------------------ceEEeecccccccCCCCCceeeeeccCCCCCCccccc
Q 037607 647 -------------------------------------------VAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683 (842)
Q Consensus 647 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 683 (842)
.+||+|||+++..... .....||..|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 8999999999876432 23456899999999999
Q ss_pred ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh---HHHHHHHhhcc-------------------cccccccc--
Q 037607 684 RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS---LAEWALQCHRK-------------------GILEKIID-- 739 (842)
Q Consensus 684 ~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~---l~~~~~~~~~~-------------------~~l~~i~d-- 739 (842)
+..++.++|||||||+||||++|++||......+... ........... +.+..+.+
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999998655332111 11111110000 00000000
Q ss_pred -----hhHH--hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 740 -----PVIA--ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 740 -----~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..+. .....+....+.+++.+||+.+|.+||++.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 11245667789999999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=369.57 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=196.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.++||+|+||.||+|... +|+.||||++... ......++.+|+.+|+.++||||++++++|...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 6899999987642 333456788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++|+|.+++.. ...+++..+..++.||++||+|||+ .++|+||||||+||||+.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999998843 4578999999999999999999995 268999999999999999999999999999864322
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. .......||+.|+|||++.+..++.++|||||||+||||++|++||......... +.... ....
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i~~--~~~~--------- 367 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELILM--EEIR--------- 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH--CCCC---------
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---HHHHh--CCCC---------
Confidence 2 2334567999999999999999999999999999999999999999765433211 11110 0000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWNL 779 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~L 779 (842)
++......+.+++.+||+.||.+|| ++.|+++.-
T Consensus 368 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 368 ---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 1112235678899999999999999 999988643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.81 Aligned_cols=269 Identities=22% Similarity=0.330 Sum_probs=204.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||++++++|...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 457999999999999999999975 5899999986543 3344567889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988763 34569999999999999999999999 999999999999999999999999999997654322
Q ss_pred CceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH---------HHHhhccc-
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW---------ALQCHRKG- 732 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~- 732 (842)
.......|+..|+|||++.+. .++.++|||||||++|||++|++||......+....... ........
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345689999999999875 789999999999999999999999987654332211100 00000000
Q ss_pred ----ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 733 ----ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 733 ----~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
.+.++..........+.....+.+++.+||+.+|.+||++.|+++.-..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 1111111111111222345678999999999999999999999875443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=356.53 Aligned_cols=257 Identities=24% Similarity=0.319 Sum_probs=204.9
Q ss_pred hcCcccceEEeecCcEEEEEEEE----cCCcEEEEEECCCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGS----EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQS 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~----~~g~~VAvK~~~~~~----~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~ 577 (842)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|+++|+++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999997 368999999876432 22345678899999999 6999999999999999
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..+|||||+++|+|.+++.. ...+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999843 3468999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
..............||+.|+|||++.+ ..++.++|||||||+||||++|+.||......... ...........
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC---
Confidence 764333333445679999999999985 45789999999999999999999999755332211 11111111000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWNLEY 781 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~Le~ 781 (842)
..........+.+++.+||+.+|.+|| ++.|+++....
T Consensus 283 --------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 283 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred --------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 011222345678899999999999999 99999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.85 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=198.3
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc----CCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE----QSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~----~~~~~l 581 (842)
.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999974 6788999987643 45556789999999999999999999998854 456899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEc-CCCceEEeecccccc
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLD-ENLVAKVADFGLSKA 658 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld-~~~~~kl~DFGla~~ 658 (842)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++ +++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999943 3568999999999999999999998 77 99999999999997 789999999999976
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.... ......|++.|+|||.+. +.++.++|||||||++|||++|+.||......... ... ...+...
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~-~~~~~~~--- 248 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRR-VTSGVKP--- 248 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHH-HTTTCCC---
T ss_pred cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHH-HhccCCc---
Confidence 5332 234556999999999886 45899999999999999999999999765432211 111 1111000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. .........+.+++.+||+.+|.+||++.|+++.
T Consensus 249 -~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 -A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -c----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 1111223468899999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=357.46 Aligned_cols=202 Identities=22% Similarity=0.262 Sum_probs=177.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc------CCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL------RHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L------~HpnIv~l~g~~~~~~~~ 579 (842)
..+|++.++||+|+||.||+|... +++.||||++... ....+++.+|+++++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999865 5889999998754 34456788899999888 567999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc--eEEeeccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV--AKVADFGLSK 657 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~--~kl~DFGla~ 657 (842)
++||||+. ++|.+++.......+++..++.|+.||++||+|||+ ++|+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 689998876666679999999999999999999999 89999999999999999887 9999999997
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
..... .....||+.|+|||++.+..++.++|||||||+||||++|++||......+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 65422 234578999999999999999999999999999999999999998765443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=351.11 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=208.6
Q ss_pred cHHHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhc-CCCceee
Q 037607 499 TFTELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKL-RHRHLVS 568 (842)
Q Consensus 499 ~~~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L-~HpnIv~ 568 (842)
.+.......++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455666788999999999999999999985 79999999876542 11245688999999999 7999999
Q ss_pred EEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 569 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
+++++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999843 3568999999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccc------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLA 722 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~ 722 (842)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||........ .
T Consensus 240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~ 314 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---L 314 (365)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H
T ss_pred EEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---H
Confidence 999999998764332 2345679999999999864 3688999999999999999999999976533221 1
Q ss_pred HHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 723 EWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 723 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..... +... ...+. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 315 ~~i~~----~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RMIME----GQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHH----TCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHh----CCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 1100 00000 01223568889999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.45 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=208.0
Q ss_pred hcCcccceEEeecCcEEEEEEEE--cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc------eeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL--EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH------LVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~--~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn------Iv~l~g~~~~~~~ 578 (842)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 36889999998754 344578899999999997765 9999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC--------------
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-------------- 644 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-------------- 644 (842)
.++||||+ +++|.+++......++++..++.++.|+++||+|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 8999999976666689999999999999999999999 99999999999999987
Q ss_pred -----CCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh
Q 037607 645 -----NLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719 (842)
Q Consensus 645 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~ 719 (842)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|++||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999875432 23456899999999999999999999999999999999999999876544432
Q ss_pred hHHHHHHHhhccccccc--------------------------ccchhHH-hhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 720 SLAEWALQCHRKGILEK--------------------------IIDPVIA-ETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 720 ~l~~~~~~~~~~~~l~~--------------------------i~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
..............+.. ...+... ..........+.+++.+||+.||.+||++
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 22211110000000000 0000000 00123446788999999999999999999
Q ss_pred HHHHHH
Q 037607 773 GDVLWN 778 (842)
Q Consensus 773 ~evl~~ 778 (842)
.|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.01 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=205.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
..++|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567999999999999999999975 689999999876554455678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeecccccccCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~~~ 661 (842)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998843 3468999999999999999999999 899999999999999 7889999999999876432
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. ......|++.|+|||.+.+..++.++|||||||++|||++|++||......+ +.+... ++... . .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~----~~~~~-~-~-- 227 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIK----EGYYE-F-E-- 227 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HCCCC-C-C--
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----cCCCC-C-C--
Confidence 2 1234568999999999999999999999999999999999999997654322 111111 11100 0 0
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
..........+.+++.+||+.+|.+||++.|+++.-.
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 228 --SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp --TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred --ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 0111223456889999999999999999999987544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.90 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=203.1
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeecc--------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-------- 575 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-------- 575 (842)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 478999999876542 2234578899999999999999999999876
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
.+..++||||+++ +|.+.+.. ....+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999975 67676633 34569999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC---CceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 656 SKAAPMDR---GYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 656 a~~~~~~~---~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+..............
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98764221 122345568999999999876 56899999999999999999999999876544433222211111111
Q ss_pred cccccccc--------------hhHHhhhc-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 732 GILEKIID--------------PVIAETIC-KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 732 ~~l~~i~d--------------~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.....+.. ..+...+. ......+.+++.+||+.||.+||++.|+++.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 11111000 00000000 01124578999999999999999999998743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=341.84 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=204.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEee--ccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFC--DEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~--~~~~~~~l 581 (842)
.++|++.+.||+|+||.||++... +|+.||+|++... .....+.+.+|++++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999975 6899999987643 345567899999999999999999999987 45678999
Q ss_pred EEEecCCCCcccccccC--CCCCCchHHHHHHHHHHHHHHHHHHhCCCCc-----eEeccCCCCCEEEcCCCceEEeecc
Q 037607 582 VYEYMANGPFRDHLYGT--NQPPLSWKQRLEICIGSARGLHYLHTGAAQG-----IIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~-----ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
||||+++++|.+++... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998542 34569999999999999999999999 66 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+++....... ......|+..|+|||.+.+..++.++||||||+++|||++|++||......+ +.+... .+..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~----~~~~ 233 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIR----EGKF 233 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHh----hccc
Confidence 9987643221 1234568999999999999999999999999999999999999998654321 111111 1111
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.. +.......+.+++.+||+.+|.+||++.|+++.++
T Consensus 234 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 234 RR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11 11123456888999999999999999999998664
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.55 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=188.4
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC------C
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ------S 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~------~ 577 (842)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999986 46899999998653 344567889999999999999999999998643 5
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 7899998843 579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|++||.+....++.....-.........+..
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 75422 344678999999999887 7899999999999999999999999987654433222111110000001111
Q ss_pred ccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 737 IIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 737 i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
+..... ...........+.+++.+||+.||.+||++.|+++.-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 111000 0001112235678999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.51 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=199.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
+|....+||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566999999999999996 4688999999877666666889999999999999999999999999999999999999
Q ss_pred CCCcccccccCC-CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeecccccccCCCCCc
Q 037607 588 NGPFRDHLYGTN-QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 588 ~gsL~~~l~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGla~~~~~~~~~ 665 (842)
+++|.+++.... ...+++..+..++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999986542 3467789999999999999999999 89999999999999987 8999999999998764322 1
Q ss_pred eeeeeccCCCCCCcccccccC--CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~--~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......|+..|+|||++.+.. ++.++||||||+++|||++|+.||......... .. ..... . ..+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~--~~~~~--~-----~~~--- 245 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MF--KVGMF--K-----VHP--- 245 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HH--HHHHH--C-----CCC---
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HH--hhccc--c-----ccc---
Confidence 223456899999999997643 889999999999999999999999654322111 10 00000 0 000
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+.......+.+++.+||+.+|.+||++.|+++.
T Consensus 246 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 -EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112234567889999999999999999998863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=352.70 Aligned_cols=245 Identities=21% Similarity=0.308 Sum_probs=202.8
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEeeccC
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSE--------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~--------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~ 576 (842)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++|++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999996 4688999998765421 1334678899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 577 SEMILVYEYMANG-PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 577 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
+..++||||+.+| +|.+++. ....+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9998884 44569999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------- 237 (335)
T 3dls_A 177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------------- 237 (335)
T ss_dssp CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------
T ss_pred ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------
Confidence 98765332 2345679999999999988776 789999999999999999999996421110
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.....+ .......+.+++.+||+.+|.+||++.|+++.-+
T Consensus 238 ~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 238 EAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp TTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred hhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 000000 0112345788999999999999999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.60 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=208.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.+.|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999864 68899999876542 3456789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.+++. ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 999999999883 3578999999999999999999999 899999999999999999999999999997764322
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHh
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~ 744 (842)
.......|+..|+|||.+.+..++.++||||||+++|||++|++||........ ...... +....
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~----~~~~~-------- 238 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLIPK----NNPPT-------- 238 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH----SCCCC--------
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHhhc----CCCCC--------
Confidence 123445689999999999999999999999999999999999999976543221 111111 11000
Q ss_pred hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 745 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+++.+||+.+|.+||++.|+++.....
T Consensus 239 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 239 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp -CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred -CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 1112234578899999999999999999999866543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.28 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=207.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999976 5788999986543 344567889999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999873 33578999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.. .... .....
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~------- 233 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIK-KNEYS------- 233 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TTCCC-------
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHh-hccCC-------
Confidence 2 2233456899999999999999999999999999999999999999765432211 1111 11000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+.......+.+++.+||+.+|.+||++.|+++.-..
T Consensus 234 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 234 ---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ---CccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 111223457789999999999999999999886544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=360.44 Aligned_cols=242 Identities=17% Similarity=0.208 Sum_probs=190.8
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCC---CChhhHHHHHHHH---HHHHhcCCCceeeEE-------Ee
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNP---GSEQGINEFQTEI---QMLSKLRHRHLVSLI-------GF 572 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~---~~~~~~~~f~~Ei---~il~~L~HpnIv~l~-------g~ 572 (842)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.. ......+.+.+|+ ++|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 5699999999763 3344567899999 555556899999998 55
Q ss_pred eccCC-----------------eEEEEEEecCCCCcccccccC-----CCCCCchHHHHHHHHHHHHHHHHHHhCCCCce
Q 037607 573 CDEQS-----------------EMILVYEYMANGPFRDHLYGT-----NQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630 (842)
Q Consensus 573 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~-----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i 630 (842)
+...+ ..+|||||+ +|+|.+++... ....+++..++.|+.||++||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 278999999 68999998532 12345568899999999999999999 899
Q ss_pred EeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCccccccc-----------CCCCcccchhHHHH
Q 037607 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVV 699 (842)
Q Consensus 631 vHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDVwS~Gvv 699 (842)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 3345567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 700 LFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 700 L~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
||||++|+.||......... ..+.. ........+.+++.+||+.+|.+||++.|+++.
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999755332211 11111 001223567889999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.06 Aligned_cols=263 Identities=26% Similarity=0.357 Sum_probs=188.7
Q ss_pred HhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 357899999999999999999985 468999999886543 344577899999999999999999999999999999999
Q ss_pred EecCCCCccccccc------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 584 EYMANGPFRDHLYG------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 584 Ey~~~gsL~~~l~~------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
||+++++|.+++.. .....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999998843 234568999999999999999999999 899999999999999999999999999997
Q ss_pred ccCCCCC----ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccc
Q 037607 658 AAPMDRG----YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732 (842)
Q Consensus 658 ~~~~~~~----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 732 (842)
....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~----~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQ----N 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHT----S
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhc----c
Confidence 6543211 12234568999999999876 57899999999999999999999999866443211 11111 0
Q ss_pred ccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 733 ~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.....................+.+++.+||+.+|.+||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000000000111112233567889999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=359.15 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=193.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHH-HHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQM-LSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~i-l~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999975 57889999876432 2334566777776 577899999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999843 4568899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|++||......+. .+.+.. +.+.
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~----~~~~------ 257 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILN----KPLQ------ 257 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HHHHHH----SCCC------
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHh----cccC------
Confidence 22 233456799999999999999999999999999999999999999976543221 111110 1000
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.......+.+++.+||+.+|.+||++.+.++
T Consensus 258 ----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 258 ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp ----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 11122345788999999999999999864433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.14 Aligned_cols=267 Identities=24% Similarity=0.304 Sum_probs=205.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----CeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~~ 579 (842)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++|++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999965 6889999998754 344457899999999999999999999998654 468
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+. |+|.+++.. ..+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 589888843 468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 660 PMDRGY--VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 660 ~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+................+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 432211 1234579999999998764 5589999999999999999999999987655443221110000000000000
Q ss_pred ccchh--------------HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 737 IIDPV--------------IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 737 i~d~~--------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+.+.. ............+.+++.+||+.+|.+||++.|+++.-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00000 001111223456889999999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=338.91 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=202.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEee--ccCCe
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS----EQGINEFQTEIQMLSKLRHRHLVSLIGFC--DEQSE 578 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~----~~~~~~f~~Ei~il~~L~HpnIv~l~g~~--~~~~~ 578 (842)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999964 68899999987532 23457899999999999999999999998 45668
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||||++++ |.+++.......+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 99999999876 7777755556789999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCC-CCceeeeeccCCCCCCcccccccC--CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 659 APMD-RGYVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 659 ~~~~-~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
.... .........|+..|+|||++.+.. .+.++||||||+++|||++|+.||......+. .+ . ..++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~-i~~~~~~ 231 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---FE---N-IGKGSYA 231 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---H-HHHCCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HH---H-HhcCCCC
Confidence 6432 222334556899999999987643 47899999999999999999999986532221 11 1 1111100
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+.......+.+++.+||+.+|.+||++.|+++.-..
T Consensus 232 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 232 ----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp ----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred ----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 111233567789999999999999999999986554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=338.11 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=205.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999975 57889999875431 12346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998843 3468999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
......|+..|+|||.+.+..++.++||||||+++|||++|++||......+.. .... ....
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~~~~-------- 229 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIV-NVDL-------- 229 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TTCC--------
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHh-cccc--------
Confidence 123456899999999999999999999999999999999999999765432211 0000 0000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.+.......+.+++.+||+.+|.+||++.|+++.-...
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 01112234678899999999999999999999865443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=346.46 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=207.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999975 5788999986543 345567899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999998843 3578999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ....
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~~~~------- 259 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKK-NEYS------- 259 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-TCCC-------
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhc-CCCC-------
Confidence 2 2234456899999999999999999999999999999999999999765432211 11100 0000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+.......+.+++.+||+.+|.+||++.|+++.-..
T Consensus 260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 260 ---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 011123457789999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.53 Aligned_cols=268 Identities=22% Similarity=0.317 Sum_probs=207.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999975 6889999987754 44556789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999843 3468999999999999999999998 5 8999999999999999999999999998754321
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH-------------------
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW------------------- 724 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~------------------- 724 (842)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 12345789999999999999999999999999999999999999986543321111000
Q ss_pred ----HHHhhcccccccccchhHHhh----hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 725 ----ALQCHRKGILEKIIDPVIAET----ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 725 ----~~~~~~~~~l~~i~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
...........+..+...... ........+.+++.+||+.+|.+|||+.|+++.-...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 000000000000111000000 0011234688999999999999999999999865543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=351.33 Aligned_cols=263 Identities=18% Similarity=0.251 Sum_probs=199.8
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-------
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE------- 575 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~------- 575 (842)
....++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999986 4789999998765432 23479999999999999999999843
Q ss_pred -------------------------------CCeEEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHH
Q 037607 576 -------------------------------QSEMILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYL 622 (842)
Q Consensus 576 -------------------------------~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yL 622 (842)
....++||||++ |+|.+.+.. .....+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 577777643 3456799999999999999999999
Q ss_pred HhCCCCceEeccCCCCCEEEc-CCCceEEeecccccccCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHH
Q 037607 623 HTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVL 700 (842)
Q Consensus 623 H~~~~~~ivHrDIKp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL 700 (842)
|+ .+|+||||||+|||++ .++.+||+|||+++...... ......||..|+|||.+.+. .++.++|||||||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 98 9999999999999997 68899999999998764332 23345689999999998774 589999999999999
Q ss_pred HHHHhCCCCCCCCCchhhhhHHHHHHHhhc--------------ccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCC
Q 037607 701 FEVLCARPVINPKLPREQVSLAEWALQCHR--------------KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYG 766 (842)
Q Consensus 701 ~ELltG~~p~~~~~~~~~~~l~~~~~~~~~--------------~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP 766 (842)
|||++|++||......+... ..+..... ......+........+.......+.+++.+||+.+|
T Consensus 233 ~ell~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999998765443321 11110000 000011111111222233345668899999999999
Q ss_pred CCCCCHHHHHHH
Q 037607 767 VDRPGMGDVLWN 778 (842)
Q Consensus 767 ~~RPtm~evl~~ 778 (842)
.+|||+.|+++.
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=361.31 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=201.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
..+.|.+.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+|+.++||||++++++|......++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 68899999876532 33356789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEeeccccccc
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVADFGLSKAA 659 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~DFGla~~~ 659 (842)
||||++|+|.+.+.. ...+++..++.|+.||++||+|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 115 ~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 115 MECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999998843 3568999999999999999999999 99999999999999976 455999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......||+.|+|||++. ..++.++|||||||++|||++|++||......+.. ..+. .+... ...
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~~-~~~ 258 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL---RKVE----KGKYT-FDS 258 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCCC-CCS
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCC-CCc
Confidence 5332 234567999999999886 56999999999999999999999999876443221 1111 11110 000
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
+ ........+.+++.+||+.+|.+||++.|+++.-+
T Consensus 259 ~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 259 P-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp G-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred h-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 1 01123356788999999999999999999997644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=364.33 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=202.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|...++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++......++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888999999999999999975 68999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCC--CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 584 EYMANGPFRDHLYGTN--QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|||++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999885533 4579999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhh-hhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ-VSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... .....+||+.|+|||++.+..++.++|||||||++|||++|++||........ ..+..... ....
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~----~~~~------ 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL----EQAV------ 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH----HCCC------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh----hccc------
Confidence 322 23345799999999999999999999999999999999999999986532211 11111111 0000
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.++......+.+++.+||+.+|.+||++
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0112234567889999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.43 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=201.1
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc---
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE--- 575 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~--- 575 (842)
.++....++|.+.+.||+|+||.||+|... +|+.||||++.... ...+++.+|+.+++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344456788999999999999999999974 78999999876543 2346789999999999 79999999999965
Q ss_pred ---CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 576 ---QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 576 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
....++||||+++++|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEee
Confidence 5679999999999999999966555679999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 653 FGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 653 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
||++........ ......|+..|+|||++. +..++.++|||||||++|||++|++||......... .....
T Consensus 173 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~ 248 (326)
T 2x7f_A 173 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPR 248 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH
T ss_pred CcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHhhc
Confidence 999876542211 223456899999999987 567899999999999999999999999765432211 11111
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
....... .......+.+++.+||..+|.+||++.|+++.-
T Consensus 249 ----~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 249 ----NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp ----SCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred ----CccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 0011110 111234678899999999999999999998743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.58 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=198.7
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhcCCCceeeEEEeecc
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKLRHRHLVSLIGFCDE 575 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~ 575 (842)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34568999999999999999999975 57899999876432 1223458899999999999999999999876
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc---eEEee
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV---AKVAD 652 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~---~kl~D 652 (842)
.. .++||||+++++|.+++. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++. +||+|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred Cc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 54 899999999999999884 45679999999999999999999999 99999999999999987654 99999
Q ss_pred cccccccCCCCCceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 037607 653 FGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 653 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
||+++..... .......||..|+|||++. ...++.++|||||||++|||++|++||........ +......
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~-- 234 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS-- 234 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH--
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh--
Confidence 9999876422 1223456899999999974 46789999999999999999999999976543221 2111111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+... ..+.. .......+.+++.+||+.+|.+||++.|+++
T Consensus 235 --~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1110 01111 1223456889999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=362.79 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=207.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|...++||+|+||.||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999975 7899999987543 234567899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE---cCCCceEEeeccccccc
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAA 659 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---d~~~~~kl~DFGla~~~ 659 (842)
|||+.+|+|.+++. ....+++..++.|+.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999884 34579999999999999999999999 899999999999999 56789999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||......+. ...+. .+.... ..
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~----~~~~~~-~~ 248 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKKVE----KGKYTF-EL 248 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCCCC-CS
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHH----cCCCCC-CC
Confidence 4332 2344569999999999876 689999999999999999999999987644322 11111 111110 00
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+ ........+.+++.+||+.+|.+||++.|+++.-+.
T Consensus 249 ~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 249 P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 0 111234567899999999999999999999986554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=361.91 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=204.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-------------hhHHHHHHHHHHHHhcCCCceeeEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-------------QGINEFQTEIQMLSKLRHRHLVSLIG 571 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-------------~~~~~f~~Ei~il~~L~HpnIv~l~g 571 (842)
..++|.+.++||+|+||+||+|... +++.||||++..... ...+++.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999975 578999998764321 33567899999999999999999999
Q ss_pred eeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC---ce
Q 037607 572 FCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL---VA 648 (842)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~---~~ 648 (842)
+|.+....++|||||++|+|.+++.. ...+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999998843 3569999999999999999999999 9999999999999998765 69
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++|++||......+.. ..+
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i--- 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII---KKV--- 259 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH---
Confidence 999999998765332 234567999999999987 46899999999999999999999999876443211 111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
..+... .+... .......+.+++.+||+.+|.+|||+.|+++.-+.
T Consensus 260 -~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 260 -EKGKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp -HHCCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -HcCCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 111110 01001 11223568899999999999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=340.82 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=199.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeec-----------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD----------- 574 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~----------- 574 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999976 48999999988777777889999999999999999999999873
Q ss_pred ---cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCceEE
Q 037607 575 ---EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKV 650 (842)
Q Consensus 575 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~kl 650 (842)
+....++||||++ |+|.+++. ..++++..++.++.|+++||+|||+ ++|+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 69999883 3568999999999999999999999 9999999999999997 5779999
Q ss_pred eecccccccCCCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 651 ADFGLSKAAPMDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 651 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+..... ...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~--~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI--LES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHh
Confidence 99999987643211 12234457899999998865 78899999999999999999999999876543321111 100
Q ss_pred hhc--cccccc---ccchhH----------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 728 CHR--KGILEK---IIDPVI----------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 728 ~~~--~~~l~~---i~d~~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
... .....+ .+...+ ...........+.+++.+||+.+|.+||++.|+++.-..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 000 000000 000000 001112335678899999999999999999999875443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.92 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=206.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChh-----------------hHHHHHHHHHHHHhcCCCceeeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQ-----------------GINEFQTEIQMLSKLRHRHLVSL 569 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~-----------------~~~~f~~Ei~il~~L~HpnIv~l 569 (842)
.++|.+.+.||+|+||.||+|.. +|+.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999987543211 12789999999999999999999
Q ss_pred EEeeccCCeEEEEEEecCCCCcccc------cccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc
Q 037607 570 IGFCDEQSEMILVYEYMANGPFRDH------LYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD 643 (842)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld 643 (842)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ .++|+||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 644446789999999999999999999996 37899999999999999
Q ss_pred CCCceEEeecccccccCCCCCceeeeeccCCCCCCccccccc-CCCC-cccchhHHHHHHHHHhCCCCCCCCCchhhhhH
Q 037607 644 ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTE-KSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721 (842)
Q Consensus 644 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~-ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l 721 (842)
.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||++|||++|++||....... .+
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--EL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH
Confidence 9999999999999875432 33456789999999999877 6666 9999999999999999999998654421 11
Q ss_pred HHHHHHhhcccc--cccccchh---HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 722 AEWALQCHRKGI--LEKIIDPV---IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 722 ~~~~~~~~~~~~--l~~i~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..........-. ......+. ............+.+++.+||+.+|.+||++.|+++.
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111000000 00000000 0000112234578899999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.23 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=204.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---------hhhHHHHHHHHHHHHhcC-CCceeeEEEeec
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---------EQGINEFQTEIQMLSKLR-HRHLVSLIGFCD 574 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---------~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~ 574 (842)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999975 68899999876432 123467889999999996 999999999999
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
.....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999843 4578999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCccccc------ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
++....... ......|+..|+|||++. ...++.++||||||+++|||++|+.||......+. ......
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~- 243 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIMS- 243 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH-
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HHHHhc-
Confidence 998764322 234456899999999985 45688999999999999999999999976543221 111111
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+... ...+ ........+.+++.+||+.+|.+||++.|+++
T Consensus 244 ---~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 ---GNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---TCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---CCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1100 0000 11223456889999999999999999999886
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=337.59 Aligned_cols=256 Identities=19% Similarity=0.274 Sum_probs=189.8
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-Chhh-HHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQG-INEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~-~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .... .+.+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999997 47899999998754 2222 233445555688889999999999999999999999
Q ss_pred EecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 584 EYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
||++ |+|.+++.. .....+++..++.|+.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777643 245679999999999999999999998 7 99999999999999999999999999998764
Q ss_pred CCCCceeeeeccCCCCCCcccc----cccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||........ .+.... .... ..
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~-~~ 233 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV----EEPS-PQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH----HSCC-CC
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh----ccCC-CC
Confidence 332 22334689999999996 567789999999999999999999999975432211 111111 1110 00
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
.. .......+.+++.+||+.+|.+||++.|+++.-...
T Consensus 234 ~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 234 LP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp CC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred cc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 00 112234678899999999999999999999865443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=342.81 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=203.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEE--cCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhc---CCCceeeEEEeec----
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVL--EDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKL---RHRHLVSLIGFCD---- 574 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~--~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L---~HpnIv~l~g~~~---- 574 (842)
+.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 467899999999999999999997 467899999865321 12223567788777776 8999999999986
Q ss_pred -cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeec
Q 037607 575 -EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADF 653 (842)
Q Consensus 575 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DF 653 (842)
.....++||||+. |+|.+++.......+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5677899999998 699999876666679999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc---
Q 037607 654 GLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR--- 730 (842)
Q Consensus 654 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~--- 730 (842)
|+++..... .......|+..|+|||++.+..++.++|||||||++|||++|++||......+... .......
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~ 239 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPG 239 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCC
Confidence 999765422 12344568999999999999999999999999999999999999998765433221 1111100
Q ss_pred cccccc-cc---------chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 731 KGILEK-II---------DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 731 ~~~l~~-i~---------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
...+.. .. .......+.......+.+++.+||+.+|.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00 000011122234466789999999999999999999885
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=341.22 Aligned_cols=265 Identities=20% Similarity=0.261 Sum_probs=196.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS------ 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~------ 577 (842)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 6889999987643 3445678899999999999999999999997654
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999974 7877773 358899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHH---------HHH---
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLA---------EWA--- 725 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~---------~~~--- 725 (842)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ++.
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 65422 1234567899999999999999999999999999999999999999876543221100 000
Q ss_pred ----HHhhcc-c-----ccccccchhHH---hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 726 ----LQCHRK-G-----ILEKIIDPVIA---ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 726 ----~~~~~~-~-----~l~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
...... . .+.+....... ..........+.+++.+||+.||.+|||+.|+++.-..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 000000 0 00000000000 01112335678999999999999999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=333.40 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=197.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999976 78999999876432 22346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999843 3468999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... +.+.. ..+.. .
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~~~-~----- 229 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKI----RGGVF-Y----- 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCCC-C-----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh----hcCcc-c-----
Confidence 2 2234568999999999987765 689999999999999999999997653221 11111 11100 0
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
........+.+++.+||+.+|.+||++.|+++.-..
T Consensus 230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 011123457889999999999999999999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=360.86 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=204.3
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
..++|.+.++||+|+||+||+|... +++.||||++... .......+.+|+++|++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999975 7899999987532 123457789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeeccccccc
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAA 659 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~~ 659 (842)
||||++|+|.+.+.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999998843 3568999999999999999999999 9999999999999994 5668999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||......+.. ..+. .+.... ..
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~~~-~~ 243 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRVE----TGKYAF-DL 243 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCCCS-CS
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCCC-CC
Confidence 4332 2345579999999999875 5899999999999999999999999876443211 1111 111100 00
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+ ........+.+++.+||+.+|.+||++.|+++.-+.
T Consensus 244 ~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 244 P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 0 011223567899999999999999999999986443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=373.59 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=208.7
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
...++|.+.+.||+|+||.||+|.+.. +..||||++... .....+.|.+|+.+|++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345789999999999999999999742 457999998764 4445578999999999999999999999985 4568
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+++|+|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999853 34468999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
............+++.|+|||++.+..++.++|||||||++|||++ |++||......+ +...... +...
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~----~~~~--- 611 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----GERL--- 611 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH----TCCC---
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc----CCCC---
Confidence 5443333344567889999999999999999999999999999997 999998654332 1111111 1000
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.........+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus 612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 011223456788999999999999999999999999887643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=335.11 Aligned_cols=257 Identities=19% Similarity=0.260 Sum_probs=200.4
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeecc--CCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDE--QSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~--~~~~~lV~ 583 (842)
++|++.+.||+|+||.||+|.. .+++.||||++.... .+.+.+|+++|++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 478999999987544 367899999999997 9999999999987 67789999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPMD 662 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~~ 662 (842)
||+++++|.+++. .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999883 48899999999999999999999 9999999999999999776 8999999999876433
Q ss_pred CCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc------cc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI------LE 735 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------l~ 735 (842)
. ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+............ ..
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTT
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHhc
Confidence 2 2234568999999999877 6799999999999999999999999965433211 11111110000000 00
Q ss_pred cccchhH----------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 736 KIIDPVI----------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 736 ~i~d~~l----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...++.. ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 001111234678899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=343.87 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=200.4
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE---
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM--- 579 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~--- 579 (842)
..++|...+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3568999999999999999999965 6899999998753 344467889999999999999999999999876654
Q ss_pred ---EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 580 ---ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 580 ---~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
++||||+. ++|.+.+ ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 6787776 2348999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+......-...........
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 865322 234568999999999887 789999999999999999999999998765433221110000000000000
Q ss_pred cccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 736 KIIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 736 ~i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+.+... ...........+.+++.+||+.+|.+||++.|+++.-.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0000000 00111223467889999999999999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.00 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=202.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccC-----CeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQ-----SEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~-----~~~ 579 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 6889999998754 344456789999999999999999999988654 678
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
++||||+. ++|.+++.. ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 689888843 468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc---------eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 037607 660 PMDRGY---------VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 660 ~~~~~~---------~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
...... ......||..|+|||++.+ ..++.++|||||||++|||++|++||......+......-.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432111 1223468999999998765 778999999999999999999999998765433221110000000
Q ss_pred c-ccccccccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 730 R-KGILEKIIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 730 ~-~~~l~~i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
. ......+..+.. ...........+.+++.+||+.||.+||++.|+++.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0 000000000000 0111123346788999999999999999999998743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=340.37 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=199.5
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
..++|++.+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999976 588999999887766677889999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999988743 23568999999999999999999999 899999999999999999999999999875432110
Q ss_pred ceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 665 YVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
.......|+..|+|||++. ...++.++||||||+++|||++|++|+........ + ...... .......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~-~~~~~~~ 244 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAKS-DPPTLLT 244 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHHS-CCCCCSS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H----HHHhcc-CCcccCC
Confidence 1123456899999999984 56789999999999999999999999986543221 1 111111 0011111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.......+.+++.+||+.+|.+||++.|+++
T Consensus 245 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 -------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122346788999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=342.56 Aligned_cols=207 Identities=25% Similarity=0.299 Sum_probs=177.7
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CC-----ceeeEEEeeccC
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HR-----HLVSLIGFCDEQ 576 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-Hp-----nIv~l~g~~~~~ 576 (842)
....++|.+.+.||+|+||+||+|... +++.||||++... .....++..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 334678999999999999999999965 6789999998753 344577888999998885 44 499999999999
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc--CCCceEEeecc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD--ENLVAKVADFG 654 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld--~~~~~kl~DFG 654 (842)
+..+|||||+. ++|.+++.......+++..++.++.|++.||.|||. ...+|+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999996 599999976666679999999999999999999994 237899999999999994 57889999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99876432 234578999999999999999999999999999999999999998765443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=352.73 Aligned_cols=261 Identities=25% Similarity=0.269 Sum_probs=196.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc------CCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE------QSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~------~~~~~ 580 (842)
.+|...++||+|+||.||+|++. +|+.||||++..... .+.+|+++|++++||||++++++|.. ...++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 689999998765422 23579999999999999999998843 22367
Q ss_pred EEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-CceEEeeccccc
Q 037607 581 LVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-LVAKVADFGLSK 657 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-~~~kl~DFGla~ 657 (842)
+||||+++ +|.+.+.. .....+++..++.++.||++||+|||+ ++|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 56555432 345679999999999999999999998 999999999999999965 678999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc------
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR------ 730 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~------ 730 (842)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||......++. .+.......
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHH
Confidence 764332 22345789999999998764 7999999999999999999999999876543322 221111000
Q ss_pred ---ccccccccch-----hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 731 ---KGILEKIIDP-----VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 731 ---~~~l~~i~d~-----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.....+...+ .....+.......+.+++.+||+.+|.+||++.|+++.-.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 0000111001 0111122233467889999999999999999999987544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.28 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=201.8
Q ss_pred HHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 505 NATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 505 ~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
...++|++.+.||+|+||.||+|... +|+.||||++.... ..+++.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999975 58999999876543 3467899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++.......
T Consensus 104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998842 34578999999999999999999999 999999999999999999999999999997764322
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ........
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~----~~~~~~~~---- 247 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---FMIPT----NPPPTFRK---- 247 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----SCCCCCSS----
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHhc----CCCcccCC----
Confidence 1233456899999999999999999999999999999999999999765432211 00000 00000100
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.......+.+++.+||+.+|.+||++.|+++.-.
T Consensus 248 ---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 248 ---PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp ---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 1112346788999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=351.65 Aligned_cols=256 Identities=11% Similarity=0.057 Sum_probs=184.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhc--CCCceeeEE-------Eee
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKL--RHRHLVSLI-------GFC 573 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L--~HpnIv~l~-------g~~ 573 (842)
..+|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999965 78999999987643 24456778886555555 699988755 333
Q ss_pred ccC-----------------CeEEEEEEecCCCCcccccccCCCCCCchHHH------HHHHHHHHHHHHHHHhCCCCce
Q 037607 574 DEQ-----------------SEMILVYEYMANGPFRDHLYGTNQPPLSWKQR------LEICIGSARGLHYLHTGAAQGI 630 (842)
Q Consensus 574 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~I~~~ia~gL~yLH~~~~~~i 630 (842)
... ...+||||||+ |+|.+++... ...+.+..+ +.++.||++||+|||+ ++|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence 222 34899999998 8999999543 223456666 7888999999999999 999
Q ss_pred EeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCC
Q 037607 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARP 708 (842)
Q Consensus 631 vHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~ 708 (842)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987532 1224567799999999987 789999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 709 VINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 709 p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
||........... ............+...........+.+++.+||+.+|.+||++.|+++.-
T Consensus 292 Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 292 PFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp STTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 9986643221100 00000000000000111123345788999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.29 Aligned_cols=271 Identities=21% Similarity=0.252 Sum_probs=194.0
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe-
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE- 578 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~- 578 (842)
.+.....++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445667789999999999999999999975 68999999875432 223456788899999999999999999865333
Q ss_pred ------EEEEEEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHH--hCCCCceEeccCCCCCEEEcC-CCc
Q 037607 579 ------MILVYEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLH--TGAAQGIIHRDVKTTNILLDE-NLV 647 (842)
Q Consensus 579 ------~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH--~~~~~~ivHrDIKp~NILld~-~~~ 647 (842)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 8899999986 44443322 45567899999999999999999999 7 99999999999999996 899
Q ss_pred eEEeecccccccCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 037607 648 AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~ 726 (842)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||......+... ....
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HHHH
Confidence 9999999998765332 22345689999999998764 48999999999999999999999998765433221 1111
Q ss_pred Hhhc--cccccc---------ccc------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 727 QCHR--KGILEK---------IID------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 727 ~~~~--~~~l~~---------i~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.... ...+.. ..+ ..............+.+++.+||+.+|.+||++.|+++.-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 1000 000000 000 00011111224567899999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=337.48 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=205.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CC-cEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc------eeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DG-NKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH------LVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g-~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn------Iv~l~g~~~~~~~ 578 (842)
.++|.+.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999974 34 68999998754 344577899999999998766 9999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE----------------
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL---------------- 642 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl---------------- 642 (842)
.++||||+ +++|.+.+.......+++.+++.++.||++||+|||+ ++|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 6677777766555679999999999999999999998 899999999999999
Q ss_pred ---cCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh
Q 037607 643 ---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719 (842)
Q Consensus 643 ---d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~ 719 (842)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 67889999999999865432 23457899999999999999999999999999999999999999876544332
Q ss_pred hHHHHHHHhhcccccccc------------cc-----hhHH----------hhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 720 SLAEWALQCHRKGILEKI------------ID-----PVIA----------ETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 720 ~l~~~~~~~~~~~~l~~i------------~d-----~~l~----------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
..............+... .+ .... ..........+.+++.+||+.||.+||++
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 222111100000000000 00 0000 00112335678999999999999999999
Q ss_pred HHHHHH
Q 037607 773 GDVLWN 778 (842)
Q Consensus 773 ~evl~~ 778 (842)
.|+++.
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.73 Aligned_cols=268 Identities=20% Similarity=0.266 Sum_probs=184.8
Q ss_pred cCccc-ceEEeecCcEEEEEEEEc---CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEee--ccCCeEEE
Q 037607 508 QNFDE-NAVIGVGGFGKVYIGVLE---DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC--DEQSEMIL 581 (842)
Q Consensus 508 ~~f~~-~~~LG~G~fg~Vykg~~~---~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~--~~~~~~~l 581 (842)
+.|.+ .++||+|+||.||+|++. +++.||||++..... ...+.+|+++|++|+||||+++++++ ......+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44555 447999999999999975 478899999875432 24688999999999999999999999 45778999
Q ss_pred EEEecCCCCccccccc-------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE----cCCCceEE
Q 037607 582 VYEYMANGPFRDHLYG-------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL----DENLVAKV 650 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~-------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl----d~~~~~kl 650 (842)
||||+. ++|.+++.. .....+++..++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 577777631 123358999999999999999999999 999999999999999 77899999
Q ss_pred eecccccccCCCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchh-------hhh
Q 037607 651 ADFGLSKAAPMDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPRE-------QVS 720 (842)
Q Consensus 651 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~-------~~~ 720 (842)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||+||||++|++||....... ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643211 22345678999999999987 458999999999999999999999997654321 011
Q ss_pred HHHHHHHh--hcccccccc---cch-hHHh-----------------hhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 721 LAEWALQC--HRKGILEKI---IDP-VIAE-----------------TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 721 l~~~~~~~--~~~~~l~~i---~d~-~l~~-----------------~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+......+ .....+..+ .+. .+.. .........+.+++.+||+.||.+|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111100 000001100 000 0000 000011346789999999999999999999987
Q ss_pred HHHH
Q 037607 778 NLEY 781 (842)
Q Consensus 778 ~Le~ 781 (842)
.-..
T Consensus 334 hp~f 337 (405)
T 3rgf_A 334 DPYF 337 (405)
T ss_dssp SGGG
T ss_pred Chhh
Confidence 6543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=339.06 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=199.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe-----
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE----- 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~----- 578 (842)
.++|...+.||+|+||.||+|... +|+.||||++... .....+++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999975 6899999997653 34445788999999999999999999999976654
Q ss_pred -EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 579 -MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 579 -~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
.++||||+. ++|.+++. ..+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 68888772 348999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++|++||......+......-............
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65322 234568999999999887 7889999999999999999999999987654332111100000000000111
Q ss_pred ccchhH--------------HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 737 IIDPVI--------------AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 737 i~d~~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
+.+... ...........+.+++.+||+.+|.+||++.|+++.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 111000 0011123356788999999999999999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=348.84 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=197.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC------eEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS------EMI 580 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~------~~~ 580 (842)
..+|...++||+|+||+||+|+...+..+|+|++..... ...+|+++|+.++||||++++++|.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346999999999999999999987777799998754322 1247999999999999999999985433 378
Q ss_pred EEEEecCCCCcccccc-cCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCceEEeecccccc
Q 037607 581 LVYEYMANGPFRDHLY-GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKA 658 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~kl~DFGla~~ 658 (842)
+||||++++.+..... ......+++..++.++.||++||+|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998754433321 2335679999999999999999999999 9999999999999999 799999999999987
Q ss_pred cCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--------
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH-------- 729 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~-------- 729 (842)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|++||......+... +......
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHH
Confidence 64332 22345689999999998764 58999999999999999999999998765443221 1111000
Q ss_pred ------cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 730 ------RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 730 ------~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
....+..+....+...+.......+.+++.+||+.+|.+||++.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000111111111112222344678999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.99 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=200.1
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcC--CCceeeEEEeeccCCe
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLR--HRHLVSLIGFCDEQSE 578 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~--HpnIv~l~g~~~~~~~ 578 (842)
+....++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 33445789999999999999999999888999999987543 4556688999999999997 4999999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.++||| +.+++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||+++ +.+||+|||+++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999999 668899999853 3578999999999999999999999 89999999999999964 8999999999987
Q ss_pred cCCCCC-ceeeeeccCCCCCCcccccc-----------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 037607 659 APMDRG-YVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726 (842)
Q Consensus 659 ~~~~~~-~~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~ 726 (842)
...... .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----HHH
Confidence 643322 12234568999999999875 4788899999999999999999999975432211 111
Q ss_pred HhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 727 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
....... ...+.......+.+++.+||+.+|.+||++.|+++....
T Consensus 251 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 251 AIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHhccc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 1111110 001111123467889999999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=374.71 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=204.7
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~ 580 (842)
..++|++.++||+|+||.||+|... +++.||||+++.. .....+.+..|..+|..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3578999999999999999999975 5788999997642 223346788999999988 7999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
|||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999953 3569999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... .......||+.|+|||++.+..++.++|||||||+||||++|++||......+.. +.+ .++.+
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~---~~i----~~~~~------ 559 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSI----MEHNV------ 559 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HSSCC------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH---HHH----HhCCC------
Confidence 222 2345678999999999999999999999999999999999999999876433211 111 11110
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGM-----GDVLW 777 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm-----~evl~ 777 (842)
.++.....++.+++.+||+.+|.+||++ .||++
T Consensus 560 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0112234567889999999999999997 56654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.69 Aligned_cols=261 Identities=22% Similarity=0.369 Sum_probs=200.8
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
....++|.+.+.||+|+||.||+|...+ .+|+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3346789999999999999999998753 4999987653 23334568899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
||||+++++|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++ ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp ECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999843 34578999999999999999999999 8999999999999998 67999999999876532
Q ss_pred C----CCceeeeeccCCCCCCcccccc---------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 037607 662 D----RGYVSTAVKGSFGYLDPEYFRR---------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQC 728 (842)
Q Consensus 662 ~----~~~~~~~~~gt~~Y~APE~l~~---------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~ 728 (842)
. .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... + ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~--~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----W--QM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----H--HH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----H--Hh
Confidence 1 1112234458999999999874 45788999999999999999999999765432211 1 11
Q ss_pred hcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 729 HRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 729 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
..+....... ......+.+++.+||+.+|.+||++.|++++|+......
T Consensus 256 -~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 -GTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -HTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -ccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111100 012345788999999999999999999999998765543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.13 Aligned_cols=264 Identities=19% Similarity=0.282 Sum_probs=202.4
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-----------CCceeeEEEeec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-----------HRHLVSLIGFCD 574 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-----------HpnIv~l~g~~~ 574 (842)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999996 46889999998753 344577899999999886 899999999987
Q ss_pred cCC----eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEc------
Q 037607 575 EQS----EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLD------ 643 (842)
Q Consensus 575 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld------ 643 (842)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 544 789999999 8999999976666679999999999999999999999 7 999999999999994
Q ss_pred CCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhh----h
Q 037607 644 ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ----V 719 (842)
Q Consensus 644 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~----~ 719 (842)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999876432 2345689999999999999999999999999999999999999986542211 1
Q ss_pred hHHHHHHHhh------------------ccccccccc-------chhHH--hhhcHHHHHHHHHHHHHhhhhCCCCCCCH
Q 037607 720 SLAEWALQCH------------------RKGILEKII-------DPVIA--ETICKESLRKYVEAAEKCLAEYGVDRPGM 772 (842)
Q Consensus 720 ~l~~~~~~~~------------------~~~~l~~i~-------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 772 (842)
.+........ ..+.+..+. ...+. ..+.......+.+++.+||+.||.+||++
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111110000 000000000 00011 12345667889999999999999999999
Q ss_pred HHHHHHH
Q 037607 773 GDVLWNL 779 (842)
Q Consensus 773 ~evl~~L 779 (842)
.|+++.-
T Consensus 329 ~ell~hp 335 (373)
T 1q8y_A 329 GGLVNHP 335 (373)
T ss_dssp HHHHTCG
T ss_pred HHHhhCh
Confidence 9998743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.29 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=193.6
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc---------
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--------- 575 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--------- 575 (842)
..++|++.+.||+|+||.||+|+.. +|+.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999974 789999999854 34456789999999999999999999998754
Q ss_pred ----CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 576 ----QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 576 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
....++||||+++|+|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 4678999999999999999954 33567889999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCC-------------CceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchh
Q 037607 652 DFGLSKAAPMDR-------------GYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPRE 717 (842)
Q Consensus 652 DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~ 717 (842)
|||+++...... ........|+..|+|||++.+. .++.++|||||||++|||++ |+... .+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence 999998654221 1122345689999999999864 78999999999999999998 44321 11
Q ss_pred hhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......... . .. ..+...+.......+.+++.+||+.+|.+||++.|+++.
T Consensus 234 ~~~~~~~~~---~-~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLR---S-VS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHH---S-TT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcc---c-cc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111 0 00 001112223344567899999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.88 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=204.2
Q ss_pred HHHhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 504 QNATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 504 ~~at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
....++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999975 6899999987543 2334678999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC---CceEEeeccccc
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN---LVAKVADFGLSK 657 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~---~~~kl~DFGla~ 657 (842)
+||||+++++|.+.+.. ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999988843 3468999999999999999999999 899999999999999654 479999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
...... ......|+..|+|||.+.+ .++.++||||||+++|||++|++||......+ +..... .+.....
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~~ 242 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE----TGKYAFD 242 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCCCCCC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCCCCC
Confidence 764332 1233458899999999875 48999999999999999999999998654322 111111 1111000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
.+ ........+.+++.+||+.+|.+||++.|+++.-
T Consensus 243 -~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 243 -LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp -SG-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -ch-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 00 0112235678899999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.36 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=176.7
Q ss_pred HhcCcccce-EEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHH-HHHHhcCCCceeeEEEeecc----CCe
Q 037607 506 ATQNFDENA-VIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEI-QMLSKLRHRHLVSLIGFCDE----QSE 578 (842)
Q Consensus 506 at~~f~~~~-~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei-~il~~L~HpnIv~l~g~~~~----~~~ 578 (842)
..++|.+.+ +||+|+||.||+|... +|+.||||++... .. ..+|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356888854 6999999999999976 6899999998653 22 22333 34566799999999999865 556
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEeeccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVADFGL 655 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~DFGl 655 (842)
.++||||+++|+|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 8999999999999999976666789999999999999999999999 89999999999999976 45699999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|++||........... .......+..
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQY- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcccc-
Confidence 9865422 22345689999999999989999999999999999999999999976543221000 0000000000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
. ............+.+++.+||+.+|.+||++.|+++.-..
T Consensus 251 --~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 251 --G---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp --C---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred --c---cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0 0000112234567889999999999999999999986654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=334.39 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=181.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHH-HHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQ-MLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~-il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|...+.||+|+||.||+|... +|+.||||++... ......++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888999999999999999975 6899999988654 3344556677776 677789999999999999999999999
Q ss_pred EecCCCCcccccc---cCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEcCCCceEEeeccccccc
Q 037607 584 EYMANGPFRDHLY---GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 584 Ey~~~gsL~~~l~---~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
||+++ +|.+++. ......+++..+..++.|+++||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 7777663 2335678999999999999999999998 7 9999999999999999999999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccc----cccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
.... ......||..|+|||++ .+..++.++|||||||++|||++|+.||........ .... ...+..
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~- 247 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGDP- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC-
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCCC-
Confidence 4322 22334689999999998 466789999999999999999999999975432110 0000 000000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+.+...........+.+++.+||+.+|.+||++.|+++.-..
T Consensus 248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 011111111234568899999999999999999999875443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=344.21 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=188.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++|+++ +||||+++++++.+.+..++|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998776668999999987643 235678999999887 8999999999999999999999999
Q ss_pred CCCCcccccccCCCC-----CCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCC-------------Cce
Q 037607 587 ANGPFRDHLYGTNQP-----PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDEN-------------LVA 648 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~-----~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~-------------~~~ 648 (842)
. |+|.+++...... ..++..++.|+.||+.||+|||+ ++|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999998543321 12445678899999999999999 999999999999999654 589
Q ss_pred EEeecccccccCCCCCc---eeeeeccCCCCCCcccccc-------cCCCCcccchhHHHHHHHHHh-CCCCCCCCCchh
Q 037607 649 KVADFGLSKAAPMDRGY---VSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPRE 717 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~-------~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~ 717 (842)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |++||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 1234579999999999875 678999999999999999998 999997554322
Q ss_pred hhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 718 QVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 718 ~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
. ............. ..........+.+++.+||+.+|.+||++.|+++
T Consensus 248 ~----~i~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S----NIIRGIFSLDEMK--------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----HHHHTCCCCCCCT--------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HHhcCCCCccccc--------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1111111100011 1112344567889999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=332.43 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=191.6
Q ss_pred HHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCCh------hhHHHHHHHHHHHHhc----CCCceeeEE
Q 037607 502 ELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSE------QGINEFQTEIQMLSKL----RHRHLVSLI 570 (842)
Q Consensus 502 el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~------~~~~~f~~Ei~il~~L----~HpnIv~l~ 570 (842)
+.....++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445568899999999999999999986 4688999999865432 1233466899999999 899999999
Q ss_pred EeeccCCeEEEEEEe-cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCce
Q 037607 571 GFCDEQSEMILVYEY-MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVA 648 (842)
Q Consensus 571 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~ 648 (842)
+++...+..++|||| +.+++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 789999999843 3468999999999999999999999 8999999999999999 88999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccccCCC-CcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
||+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||..... . . .
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~---~-~ 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I---L-E 247 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H---H-H
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H---h-h
Confidence 999999998764322 2345689999999999876664 599999999999999999999964210 0 0 0
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
... .+.......+.+++.+||+.+|.+||++.|+++.-
T Consensus 248 ----~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 248 ----AEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp ----TCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ----hcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 01112234678899999999999999999998743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.45 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=180.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhH-HHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGI-NEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~-~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
.++|...+.||+|+||.||+|... +|+.||||++.... .... +.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999975 68999999986543 2222 33445556788889999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCC-ceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ-GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||+ ++.+ +.+.......+++..++.++.|+++||+|||+ + +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEH-HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcH-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 4444 44433335678999999999999999999998 5 8999999999999999999999999999765432
Q ss_pred CCceeeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
. ......|+..|+|||++. ...++.++|||||||++|||++|+.||........ ....... .. ...+
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~---~~-~~~~ 250 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKVLQ---EE-PPLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHH---SC-CCCC
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHHhc---cC-CCCC
Confidence 2 223456899999999984 56788999999999999999999999976432211 1111111 10 0000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.. .......+.+++.+||+.+|.+||++.|+++.-.
T Consensus 251 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 251 PG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred Cc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 00 0112346788999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.82 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=198.9
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCCh------hhHHHHHHHHHHHHhcC--CCceeeEE
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSE------QGINEFQTEIQMLSKLR--HRHLVSLI 570 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~------~~~~~f~~Ei~il~~L~--HpnIv~l~ 570 (842)
..+.....++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++++++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344455678899999999999999999986 4688999998754321 12245778999999996 59999999
Q ss_pred EeeccCCeEEEEEEecCC-CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc-CCCce
Q 037607 571 GFCDEQSEMILVYEYMAN-GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD-ENLVA 648 (842)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld-~~~~~ 648 (842)
+++...+..++||||+.+ ++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++ +++.+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999999976 899998843 4578999999999999999999999 9999999999999999 78999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~ 727 (842)
||+|||+++..... ......||..|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 190 kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~-- 256 (320)
T 3a99_A 190 KLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II-- 256 (320)
T ss_dssp EECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH--
T ss_pred EEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hh--
Confidence 99999999876432 2234568999999999987665 6889999999999999999999964310 00
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. +.. . ........+.+++.+||+.+|.+||++.|+++.
T Consensus 257 --~-~~~--~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 --R-GQV--F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --H-CCC--C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --c-ccc--c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0 011123467889999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=339.93 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=188.3
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
..+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++|+++ +||||+++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456888999999999996655556799999999876433 2357899999999 799999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-----CCceEEeecccccccC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAAP 660 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-----~~~~kl~DFGla~~~~ 660 (842)
|. |+|.+++... ...+.+..++.++.||++||+|||+ ++|+||||||+|||++. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 6999988543 3345566778999999999999999 99999999999999943 3468899999998765
Q ss_pred CCCC--ceeeeeccCCCCCCccccc---ccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 661 MDRG--YVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 661 ~~~~--~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
.... .......||+.|+|||++. ...++.++|||||||++|||++ |++||......... ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCCc
Confidence 3321 2234567999999999997 4677889999999999999999 99998654322110 01111111
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.. ..+ .......+.+++.+||+.+|.+||++.|+++
T Consensus 248 ~~-~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DC-LHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TT-SCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-cCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11 110 1123445788999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=354.71 Aligned_cols=240 Identities=20% Similarity=0.302 Sum_probs=194.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc--CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCe-----
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE--DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSE----- 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~--~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~----- 578 (842)
.++|.+.++||+|+||.||+|.+. +|+.||||++... .......+.+|+++|++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 5899999998654 44556789999999999999999999999977655
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.+||||||++++|.+++.. .+++.+++.|+.||++||+|||+ ++|+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987732 79999999999999999999999 999999999999999986 899999999987
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
.... ....||+.|+|||++.+.. +.++|||||||+||||++|.+|+....... +.
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~~ 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------LP 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------CC
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------cc
Confidence 6432 3456999999999987654 899999999999999999998876431110 00
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPG-MGDVLWNLEYAM 783 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-m~evl~~Le~~~ 783 (842)
... ........+.+++.+||+.+|.+||+ +.++...|....
T Consensus 286 ~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 EDD----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TTC----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccc----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 01122356788999999999999995 666666666553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.24 Aligned_cols=234 Identities=12% Similarity=0.101 Sum_probs=187.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999975 48999999987643 34457899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
|||+++++|.+++.. . ....++.+|+.|++.||+|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999832 2 3556789999999999999999 999999999999999999999997443
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
|++| ++.++|||||||++|||++|+.||......+..... ..........
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~--- 224 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIE--- 224 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCC---
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCC---
Confidence 3433 688999999999999999999999876543211000 0000000111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
...........+.+++.+||+.||.+| ++.|+++.|+.+....
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 112223344668899999999999999 9999999999876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=349.77 Aligned_cols=269 Identities=25% Similarity=0.337 Sum_probs=205.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc------CCeE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE------QSEM 579 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~------~~~~ 579 (842)
++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999964 6899999998764 45556789999999999999999999999865 6778
Q ss_pred EEEEEecCCCCcccccccC-CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCc---eEEeeccc
Q 037607 580 ILVYEYMANGPFRDHLYGT-NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLV---AKVADFGL 655 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~---~kl~DFGl 655 (842)
++|||||++|+|.+++... ....+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999998653 23469999999999999999999999 99999999999999987664 99999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||....... .|...........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC------
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccchh
Confidence 98764332 2345679999999999999999999999999999999999999997643211 1111110000000
Q ss_pred ccc----c------h--hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHHHhhh
Q 037607 736 KII----D------P--VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGD-----VLWNLEYAMQLQ 786 (842)
Q Consensus 736 ~i~----d------~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~e-----vl~~Le~~~~~~ 786 (842)
... . . .....+.......+.+++.+||..||.+||++.| +.+.++.+.+..
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000 0 0 0011223345678899999999999999999988 456666655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.61 Aligned_cols=233 Identities=20% Similarity=0.323 Sum_probs=183.0
Q ss_pred hcCcccc-eEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHH-HhcCCCceeeEEEeecc----CCeE
Q 037607 507 TQNFDEN-AVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQML-SKLRHRHLVSLIGFCDE----QSEM 579 (842)
Q Consensus 507 t~~f~~~-~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il-~~L~HpnIv~l~g~~~~----~~~~ 579 (842)
.++|.+. ++||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7899999999999997 46899999998642 4578899888 55699999999999876 6789
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEeecccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVADFGLS 656 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~DFGla 656 (842)
++||||+++|+|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999976666689999999999999999999999 99999999999999988 789999999998
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
+... +..++.++|||||||++|||++|++||......... ......
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~ 213 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR 213 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence 6532 245678999999999999999999999755322110 000000
Q ss_pred ccch--hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 037607 737 IIDP--VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781 (842)
Q Consensus 737 i~d~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~ 781 (842)
+... .............+.+++.+||+.+|.+||++.|+++.-..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 0000 00000112234568899999999999999999999986554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=333.67 Aligned_cols=242 Identities=17% Similarity=0.194 Sum_probs=183.2
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCC-Ccee----------e---
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRH-RHLV----------S--- 568 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~H-pnIv----------~--- 568 (842)
+.+|...++||+|+||+||+|.+ .+|+.||||++.... ....+.|.+|+.+++.++| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44577888999999999999995 478999999977432 2335789999999999987 2211 1
Q ss_pred --------EEEeecc-----CCeEEEEEEecCCCCcccccc-----cCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCce
Q 037607 569 --------LIGFCDE-----QSEMILVYEYMANGPFRDHLY-----GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGI 630 (842)
Q Consensus 569 --------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i 630 (842)
++.++.. ....+++|+++ +++|.+++. ......+++..++.|+.|+++||+|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 1111111 22457777765 689998883 3345678899999999999999999999 999
Q ss_pred EeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccc----------cccCCCCcccchhHHHHH
Q 037607 631 IHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF----------RRQQLTEKSDVYSFGVVL 700 (842)
Q Consensus 631 vHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~s~ksDVwS~GvvL 700 (842)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998865322 344567 999999999 556788999999999999
Q ss_pred HHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 701 FEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 701 ~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
|||++|+.||......+.. ..++.. +......+.+++.+||+.+|.+||++.|+++.
T Consensus 308 ~elltg~~Pf~~~~~~~~~---------------~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS---------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS---------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhhhH---------------HHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999765432211 111110 01223568899999999999999999888653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=320.40 Aligned_cols=242 Identities=19% Similarity=0.164 Sum_probs=183.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC--------hhhHHHHHHHHHHHHhcC---------CCceeeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS--------EQGINEFQTEIQMLSKLR---------HRHLVSL 569 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~--------~~~~~~f~~Ei~il~~L~---------HpnIv~l 569 (842)
.++|.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+|++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788899999999999999998 68999999876432 233478899999999986 6666666
Q ss_pred EEe-----------------ecc-------------CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHH
Q 037607 570 IGF-----------------CDE-------------QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619 (842)
Q Consensus 570 ~g~-----------------~~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL 619 (842)
.+. +.. .+..+||||||++|+|.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 554 332 6789999999999988777732 5689999999999999999
Q ss_pred HHHH-hCCCCceEeccCCCCCEEEcCCC--------------------ceEEeecccccccCCCCCceeeeeccCCCCCC
Q 037607 620 HYLH-TGAAQGIIHRDVKTTNILLDENL--------------------VAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678 (842)
Q Consensus 620 ~yLH-~~~~~~ivHrDIKp~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~A 678 (842)
+||| + ++|+||||||+||||+.++ .+||+|||+|+.... ....||+.|+|
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTC
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccC
Confidence 9999 8 8999999999999999887 999999999987642 23479999999
Q ss_pred cccccccCCCCcccchhHHHH-HHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHH
Q 037607 679 PEYFRRQQLTEKSDVYSFGVV-LFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEA 757 (842)
Q Consensus 679 PE~l~~~~~s~ksDVwS~Gvv-L~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l 757 (842)
||++.+.. +.++||||++++ .++++.|..||...... ..+.+.. ......... ...........++.++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~---~~~~~~~~~----~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKM---LKQMTFKTK----CNTPAMKQIKRKIQEF 315 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHH---HHTCCCSSC----CCSHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhh---hhhhccCcc----cchhhhhhcCHHHHHH
Confidence 99998766 899999998777 77788898887421000 0011111 100001110 0111234566789999
Q ss_pred HHHhhhhCCCCCCCHHHHH
Q 037607 758 AEKCLAEYGVDRPGMGDVL 776 (842)
Q Consensus 758 ~~~Cl~~dP~~RPtm~evl 776 (842)
+.+||+.+ |+.|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999965 888887
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-33 Score=275.67 Aligned_cols=159 Identities=14% Similarity=0.172 Sum_probs=129.4
Q ss_pred eeeEEEEEeeCCCccccCCCcccccccCCCcccccCCCCcceecCCceeEeCCCCCCCCcCChHHHHHhhccccccCCCc
Q 037607 203 AFEVSYRLNVGGPLVTPKNDTLSRTWLSDEAYNAFPEGSEAVSVEPKNVHYPDGGATPYIAPNWVYASAQKMKEAQVMQP 282 (842)
Q Consensus 203 a~~~~~rin~Gg~~~~~~~d~~~r~w~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~Y~tar~~~~~~~~~~ 282 (842)
+-|++|||||||+.++ |.++|+|.+|..|......+ .+...+.+ ...+++|+.||+|||.++.
T Consensus 3 ~~~~~~~INcGg~~~~---d~~gr~w~~D~~~~~~g~~~----~~~~~~~~----~~~~~~~~~lY~TaR~~~~------ 65 (174)
T 2jwp_A 3 ADKVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRAS----DYGMKLPI----LRSNPEDQVLYQTERYNED------ 65 (174)
T ss_dssp HHHEEEEEEETSSSEE---ETTTEEECSSCSSTTCCCCC----CCCTTSCC----SSSCHHHHHTTTCCCCCCS------
T ss_pred CccEEEEEECCCCCcc---CCCCCEEcCCcCcccCCccc----ccccceEe----cccCCCCchhhhhhccCCC------
Confidence 3478999999999975 67999999998764222111 11111211 2347789999999999986
Q ss_pred ceeeEEEEeeCCCCceEEEEeeeccccccCCcEEEEEEEcCccccCCCChhhhccccCceEEEEEEEEecc---------
Q 037607 283 NFNLTWKMSVDPSFSYLIRFHFCDIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATA--------- 353 (842)
Q Consensus 283 ~~~lt~~~~v~~~~~y~vrlhF~ei~~~~~~~r~Fdiyi~~~~~~~~~di~~~~~~~~~~~~~~~~v~~~~--------- 353 (842)
++||+|||+++|+|+|||||||+.+...|+|+|||||||+++++||||.+++|+ ++|++++|.+.+..
T Consensus 66 --~~tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~ 142 (174)
T 2jwp_A 66 --SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEV 142 (174)
T ss_dssp --CEEEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEE
T ss_pred --CeEEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeee
Confidence 899999999999999999999999999999999999999999999999999987 89999999998621
Q ss_pred -cCCcceEEEeccCCCCCCCCccccccceeEeec
Q 037607 354 -VKNDSITVQVGPASNAQSSLPNAILNGLEVIKL 386 (842)
Q Consensus 354 -~~~~~l~i~~~p~~~~~~~i~~~~lnG~ei~~l 386 (842)
.+++.|+|+|+|.. ..++++||+||++-
T Consensus 143 ~~~~g~L~I~f~p~~-----~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 143 STFTGKLSVEFVKGY-----YDNPKVCALFIMKG 171 (174)
T ss_dssp EECCSEEEEEEECSS-----SCSSSEEEEEEESS
T ss_pred cccCCeEEEEEeccC-----CCCcEEEEEEEEeC
Confidence 04678999999852 34899999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-29 Score=295.31 Aligned_cols=183 Identities=21% Similarity=0.140 Sum_probs=129.8
Q ss_pred EeecCcEEEEEEE-EcCCcEEEEEECCCC----------ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEEE
Q 037607 516 IGVGGFGKVYIGV-LEDGNKVAIKRGNPG----------SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 516 LG~G~fg~Vykg~-~~~g~~VAvK~~~~~----------~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++.|+.|.+.+++ .--|+.+++|++... .+...++|.+|+++|+++ .|+||+++++++++.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566777666554 235888999987543 133456799999999999 7999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||++|++|.+.|. ...+++.. +|+.||+.||+|||+ ++||||||||+||||++++++||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999994 34556553 589999999999999 999999999999999999999999999998765432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCC
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 708 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~ 708 (842)
......+||++|||||++.+ .+..++|+||+|+++++|.++..
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 23345789999999999876 46778999999999988766543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=226.87 Aligned_cols=151 Identities=19% Similarity=0.221 Sum_probs=114.5
Q ss_pred CceEEecCCCCCCccccCCCCccccCCCCCccccccccccccccccCccCCCCCCCCCccceeeeeeecccceEEEeecc
Q 037607 18 DNYLIDCGSGSSEQTSLDDGRTFKSDHESSSYLSTKEDIETSVDSIPVKAKSSPCPSAYPLYRSARIFTGESRYRFFISQ 97 (842)
Q Consensus 18 ~~~~i~cg~~~~~~~~~~~~r~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~tar~f~~~~~y~f~~~~ 97 (842)
.+|+||||+... ++.++|+|.+|.. ++..+.... ...++.... .+..| ++||+|||+|..+++|.||+.+
T Consensus 6 ~~~~INcGg~~~---~d~~gr~w~~D~~---~~~~g~~~~-~~~~~~~~~-~~~~~--~~lY~TaR~~~~~~tY~f~v~~ 75 (174)
T 2jwp_A 6 VIWAVNAGGESH---VDVHGIHYRKDPL---EGRVGRASD-YGMKLPILR-SNPED--QVLYQTERYNEDSFGYDIPIKE 75 (174)
T ss_dssp EEEEEEETSSSE---EETTTEEECSSCS---STTCCCCCC-CCTTSCCSS-SCHHH--HHTTTCCCCCCSCEEEEEECCS
T ss_pred EEEEEECCCCCc---cCCCCCEEcCCcC---cccCCcccc-cccceEecc-cCCCC--chhhhhhccCCCCeEEEEEeCC
Confidence 579999999765 5678999999954 211110000 011111111 11122 4789999999999999999988
Q ss_pred CcceEEEEeeccCCCCCCCccCcEEEEEeCceEEeccccCCCC---CcceEEEEEEee--------------cCceEEEE
Q 037607 98 PGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIGNT---TSLVFKEYLINI--------------TGRLSIIF 160 (842)
Q Consensus 98 ~g~~~~rl~f~~~~~~~~~~~~~~f~v~~~~~~~l~~f~~~~~---~~~~~~e~~~~~--------------~~~~~i~f 160 (842)
+|+|+|||||+|..++. +..+.|+|.+||.++|+||++... ..++.|+|.++| ++.|+|+|
T Consensus 76 ~G~Y~VrLhF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f 153 (174)
T 2jwp_A 76 EGEYVLVLKFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEF 153 (174)
T ss_dssp CEEEEEEEEEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEE
T ss_pred CeEEEEEEEEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEE
Confidence 89999999999998765 688999999999999999998433 358899999985 24599999
Q ss_pred eeCCCCcceeeeeEEEecCC
Q 037607 161 KPHKDSHAFINAIEVVSAPG 180 (842)
Q Consensus 161 ~p~~~~~~fvn~ie~~~~p~ 180 (842)
.|.....||||||||++.+-
T Consensus 154 ~p~~~~~a~inaIEI~~~~~ 173 (174)
T 2jwp_A 154 VKGYYDNPKVCALFIMKGTA 173 (174)
T ss_dssp ECSSSCSSSEEEEEEESSCC
T ss_pred eccCCCCcEEEEEEEEeCcc
Confidence 99878889999999998753
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-25 Score=262.94 Aligned_cols=184 Identities=18% Similarity=0.195 Sum_probs=145.4
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE--------QGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~--------~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
...++||+|+||.||+|.. .++.+++|+...... ...+++.+|+++|++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 578889987543221 1134589999999999999999666666677778999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++++|.+++.. ++.++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999843 66899999999999999 99999999999999998 9999999999987532
Q ss_pred CCce------eeeeccCCCCCCcccccc--cCCCCcccchhHHHHHHHHHhCCCCC
Q 037607 663 RGYV------STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVI 710 (842)
Q Consensus 663 ~~~~------~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS~GvvL~ELltG~~p~ 710 (842)
.... .....||+.|||||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2111 235679999999999987 67888999999999999988777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=217.94 Aligned_cols=165 Identities=16% Similarity=0.133 Sum_probs=130.4
Q ss_pred HHHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCCh------------------hhHHHHHHHHHHHHhc
Q 037607 500 FTELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSE------------------QGINEFQTEIQMLSKL 561 (842)
Q Consensus 500 ~~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~------------------~~~~~f~~Ei~il~~L 561 (842)
+..+......|.+.+.||+|+||.||+|...+|+.||||.+..... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344455567778899999999999999997799999999864321 1346789999999999
Q ss_pred CCCceeeEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEE
Q 037607 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 641 (842)
Q Consensus 562 ~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 641 (842)
+ | +++.+++. .+..++|||||++++|.+ +. ......++.|+++||+|||+ ++|+||||||+|||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 9 4 56665543 356799999999999998 51 13456799999999999999 99999999999999
Q ss_pred EcCCCceEEeecccccccCCCCCceeeeeccCCCCCCcccccc----------cCCCCcccchh
Q 037607 642 LDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR----------QQLTEKSDVYS 695 (842)
Q Consensus 642 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----------~~~s~ksDVwS 695 (842)
++ ++.+||+|||+++. +..++|||++.+ ..+...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 99999999999864 335789998864 44556666654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=183.63 Aligned_cols=137 Identities=15% Similarity=0.142 Sum_probs=107.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcE--EEEEECCCCChh------------------------hHHHHHHHHHHHHhc
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNK--VAIKRGNPGSEQ------------------------GINEFQTEIQMLSKL 561 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~--VAvK~~~~~~~~------------------------~~~~f~~Ei~il~~L 561 (842)
-|.+.+.||+|+||.||+|.. .+|+. ||||+.+..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999997 68988 999986543111 123688999999999
Q ss_pred CCCce--eeEEEeeccCCeEEEEEEecCC-C----CcccccccCCCCCCchHHHHHHHHHHHHHHHHHH-hCCCCceEec
Q 037607 562 RHRHL--VSLIGFCDEQSEMILVYEYMAN-G----PFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH-TGAAQGIIHR 633 (842)
Q Consensus 562 ~HpnI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH-~~~~~~ivHr 633 (842)
+|+++ ..++++ ...+|||||+.+ | +|.+... ..++..+..++.|++.+|.||| + .+|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 88754 344432 357899999942 4 4444431 1345678899999999999999 8 899999
Q ss_pred cCCCCCEEEcCCCceEEeeccccccc
Q 037607 634 DVKTTNILLDENLVAKVADFGLSKAA 659 (842)
Q Consensus 634 DIKp~NILld~~~~~kl~DFGla~~~ 659 (842)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5.5e-16 Score=172.19 Aligned_cols=135 Identities=19% Similarity=0.240 Sum_probs=98.6
Q ss_pred CcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC--------------hhhHHHH--------HHHHHHHHhcCCCce
Q 037607 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS--------------EQGINEF--------QTEIQMLSKLRHRHL 566 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~--------------~~~~~~f--------~~Ei~il~~L~HpnI 566 (842)
-|.+.++||+|+||.||+|...+|+.||||+++... ....... ..|...|.+|.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 489999999999999999999899999999754321 0011122 245555555544332
Q ss_pred e--eEEEeeccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC
Q 037607 567 V--SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE 644 (842)
Q Consensus 567 v--~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~ 644 (842)
. ..+++ ...+|||||+++++|.++.. ......++.|++.+|.|||+ .+||||||||.||||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 2 12221 22379999999998877542 12446788999999999999 89999999999999987
Q ss_pred CC----------ceEEeecccccc
Q 037607 645 NL----------VAKVADFGLSKA 658 (842)
Q Consensus 645 ~~----------~~kl~DFGla~~ 658 (842)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999996654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-11 Score=128.41 Aligned_cols=148 Identities=16% Similarity=0.098 Sum_probs=115.7
Q ss_pred HHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEE
Q 037607 503 LQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 503 l~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~l 581 (842)
+......|.....++.|+.+.||+.... ++.+++|+...........+.+|+++|+.|. |..+.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567888888898999999999754 6889999976421122245889999999995 6778889999988889999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA----------------------------------- 626 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~----------------------------------- 626 (842)
||||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999877541 12334578899999999999811
Q ss_pred ---------------------CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 627 ---------------------AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 627 ---------------------~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14599999999999998766667999997643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=4.8e-11 Score=124.74 Aligned_cols=138 Identities=18% Similarity=0.115 Sum_probs=101.8
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH--LVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn--Iv~l~g~~~~~~~~~lV~Ey 585 (842)
..+....+.+.|..+.||+....+|..+++|..... ....+..|+++++.+.+.+ +.++++++...+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333355569999998777888999986654 2245789999999996544 45588888887889999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA--------------------------------------- 626 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~--------------------------------------- 626 (842)
++|.+|. .. . . ....++.++++.|..||+..
T Consensus 97 i~G~~l~--~~-~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SS-H----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TS-C----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cC-c----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 21 1 1 22367788888888888732
Q ss_pred ----------------CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 627 ----------------AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 627 ----------------~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
...++|+|++|.|||++++..+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776677999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.6e-09 Score=116.79 Aligned_cols=143 Identities=16% Similarity=0.257 Sum_probs=108.9
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECC--CCC-hhhHHHHHHHHHHHHhcC--CCceeeEEEeeccC---CeEEEEE
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGN--PGS-EQGINEFQTEIQMLSKLR--HRHLVSLIGFCDEQ---SEMILVY 583 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~--~~~-~~~~~~f~~Ei~il~~L~--HpnIv~l~g~~~~~---~~~~lV~ 583 (842)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999875 4678889876 332 122356889999999997 45688899988766 4589999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA------------------------------------- 626 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~------------------------------------- 626 (842)
||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998886532 234678889999999999999999731
Q ss_pred ------------------CCceEeccCCCCCEEEcCCCc--eEEeeccccccc
Q 037607 627 ------------------AQGIIHRDVKTTNILLDENLV--AKVADFGLSKAA 659 (842)
Q Consensus 627 ------------------~~~ivHrDIKp~NILld~~~~--~kl~DFGla~~~ 659 (842)
...++|+|+++.|||+++++. +.|+||+++...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999987653 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=1.9e-09 Score=116.28 Aligned_cols=186 Identities=17% Similarity=0.207 Sum_probs=122.6
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCc--eeeEEEeeccCC---eEEEEEEec
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRH--LVSLIGFCDEQS---EMILVYEYM 586 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-Hpn--Iv~l~g~~~~~~---~~~lV~Ey~ 586 (842)
...++.|....||+.. ..+++|+... ......+.+|.++|+.+. +.. +.+.+..+.... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3468999999999863 5688998543 234567899999999884 322 344555544333 348899999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA---------------------------------------- 626 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~---------------------------------------- 626 (842)
+|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875332 34677778888899999998888611
Q ss_pred ---------------CCceEeccCCCCCEEEcC--CCceEEeecccccccCCCCCc--eee-----------eeccCCCC
Q 037607 627 ---------------AQGIIHRDVKTTNILLDE--NLVAKVADFGLSKAAPMDRGY--VST-----------AVKGSFGY 676 (842)
Q Consensus 627 ---------------~~~ivHrDIKp~NILld~--~~~~kl~DFGla~~~~~~~~~--~~~-----------~~~gt~~Y 676 (842)
...++|+|++|.||++++ ...+.|+||+.+......... ... .....++.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999988 556789999988654211000 000 00001111
Q ss_pred CC-cccccccCCCCcccchhHHHHHHHHHhCCCCC
Q 037607 677 LD-PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI 710 (842)
Q Consensus 677 ~A-PE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~ 710 (842)
.. |+..... ....+.|+++.++|++.+|.+++
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12358999999999999997544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=5.1e-06 Score=89.55 Aligned_cols=136 Identities=16% Similarity=0.171 Sum_probs=96.5
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCC---ceeeEEEeec-cCCeEEEEEEecCC
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR---HLVSLIGFCD-EQSEMILVYEYMAN 588 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hp---nIv~l~g~~~-~~~~~~lV~Ey~~~ 588 (842)
...++.|....||+. |..+++|+.. .......+.+|.++|+.|.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346888998999988 5678888842 334456789999999999752 3556666663 45567899999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG------------------------------------------- 625 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~------------------------------------------- 625 (842)
.+|.+... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88866321 1234455566666666666666642
Q ss_pred --------------CCCceEeccCCCCCEEEcC---CCc-eEEeecccccc
Q 037607 626 --------------AAQGIIHRDVKTTNILLDE---NLV-AKVADFGLSKA 658 (842)
Q Consensus 626 --------------~~~~ivHrDIKp~NILld~---~~~-~kl~DFGla~~ 658 (842)
....++|+|+++.|||++. ++. ..|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=4.1e-06 Score=88.03 Aligned_cols=135 Identities=19% Similarity=0.157 Sum_probs=97.3
Q ss_pred EEeecCcE-EEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 515 VIGVGGFG-KVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 515 ~LG~G~fg-~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
.+..|..+ .||+.... ++..+++|+.... ...++.+|..+|+.|. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987754 4667999985433 3457889999999884 33466788889888899999999999887
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG---------------------------------------------- 625 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~---------------------------------------------- 625 (842)
.+.... .......++.++++.|.-||..
T Consensus 108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 665411 1233445666777777777742
Q ss_pred ---------CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 626 ---------AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 626 ---------~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012389999999999999877777999997654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=3.4e-06 Score=92.61 Aligned_cols=146 Identities=8% Similarity=0.064 Sum_probs=91.9
Q ss_pred ceEE-eecCcEEEEEEEEc-------CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCC---CceeeEEEeeccC--
Q 037607 513 NAVI-GVGGFGKVYIGVLE-------DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRH---RHLVSLIGFCDEQ-- 576 (842)
Q Consensus 513 ~~~L-G~G~fg~Vykg~~~-------~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~H---pnIv~l~g~~~~~-- 576 (842)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+|+.|.. -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3467 78888999998764 26789999865432 0012457889999988853 3567788887655
Q ss_pred -CeEEEEEEecCCCCccccccc----CCCCCCchHHHHHHHHHHHHHH--------------------------------
Q 037607 577 -SEMILVYEYMANGPFRDHLYG----TNQPPLSWKQRLEICIGSARGL-------------------------------- 619 (842)
Q Consensus 577 -~~~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~I~~~ia~gL-------------------------------- 619 (842)
+..++||||++|.+|.+.+.. .....++..++..++.++++.|
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW 184 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence 356899999999887653200 0000122222222233333333
Q ss_pred ----------------------HHHHhC-------CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 620 ----------------------HYLHTG-------AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 620 ----------------------~yLH~~-------~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
++|.+. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 333221 135799999999999999654578999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=5.1e-05 Score=84.58 Aligned_cols=75 Identities=17% Similarity=0.144 Sum_probs=49.6
Q ss_pred ceEEeecCcEEEEEEEEc-CCcEEEEEECCCCCh-------hhHHHHHHHHHHHHhcCC--Cc-eeeEEEeeccCCeEEE
Q 037607 513 NAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSE-------QGINEFQTEIQMLSKLRH--RH-LVSLIGFCDEQSEMIL 581 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~-------~~~~~f~~Ei~il~~L~H--pn-Iv~l~g~~~~~~~~~l 581 (842)
.+.||.|..+.||++... +++.++||...+... ....++..|.++|+.+.. +. +.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457899999999999754 468899997554221 123456789999988742 33 44555443 345689
Q ss_pred EEEecCCC
Q 037607 582 VYEYMANG 589 (842)
Q Consensus 582 V~Ey~~~g 589 (842)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00019 Score=77.65 Aligned_cols=140 Identities=20% Similarity=0.191 Sum_probs=80.5
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC--CceeeEEEe------eccCCeEEEEEEe
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH--RHLVSLIGF------CDEQSEMILVYEY 585 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H--pnIv~l~g~------~~~~~~~~lV~Ey 585 (842)
..|+.|..+.||+....+| .+++|+.... . .++..|..+++.|.. -.+.+++.. ....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987655 4899987752 2 334456666665531 123333321 1235678999999
Q ss_pred cCCCCccc--------------cccc--C-C--C-------CCCchHHH-------------------------------
Q 037607 586 MANGPFRD--------------HLYG--T-N--Q-------PPLSWKQR------------------------------- 608 (842)
Q Consensus 586 ~~~gsL~~--------------~l~~--~-~--~-------~~l~~~~~------------------------------- 608 (842)
++|..+.. .+|. . . . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 1111 0 0 0 00122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 609 LEICIGSARGLHYLHT----------GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 609 ~~I~~~ia~gL~yLH~----------~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
..+...+.+++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111123345666653 1247899999999999998888999999997643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.0002 Score=76.03 Aligned_cols=80 Identities=19% Similarity=0.155 Sum_probs=59.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC---CceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH---RHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H---pnIv~l~g~~~~~~~~~lV~E 584 (842)
.+......+|.|..+.||+..+.+|+.+++|+...........|..|...|+.|.- --+.+.+++. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34556678999999999999999999999998665443333568899999998842 1244555543 3478999
Q ss_pred ecCCCCc
Q 037607 585 YMANGPF 591 (842)
Q Consensus 585 y~~~gsL 591 (842)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00065 Score=73.32 Aligned_cols=138 Identities=14% Similarity=0.164 Sum_probs=92.1
Q ss_pred cceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC---CCceeeEEEeeccCCeEEEEEEecCC
Q 037607 512 ENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR---HRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 512 ~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~---HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
....|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+.++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345789999999999886 4678889985432 3567889999999884 35688888888878889999999998
Q ss_pred CCccc-----------ccccCCC-C-------------------CCchHHH-----HHHHHH--------------HHH-
Q 037607 589 GPFRD-----------HLYGTNQ-P-------------------PLSWKQR-----LEICIG--------------SAR- 617 (842)
Q Consensus 589 gsL~~-----------~l~~~~~-~-------------------~l~~~~~-----~~I~~~--------------ia~- 617 (842)
..+.. .||.... . .-+|... +.-..+ +.+
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 87632 1122111 1 0134322 111111 111
Q ss_pred HHHHHHh-CCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 618 GLHYLHT-GAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 618 gL~yLH~-~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
....|.. .....+||+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223421 1246799999999999999887 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00074 Score=72.57 Aligned_cols=158 Identities=13% Similarity=0.133 Sum_probs=89.7
Q ss_pred ccHHHHHHHhcCccc-----ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc--eeeEE
Q 037607 498 FTFTELQNATQNFDE-----NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH--LVSLI 570 (842)
Q Consensus 498 ~~~~el~~at~~f~~-----~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn--Iv~l~ 570 (842)
++.+++......|.. .+.|+.|....+|+....+| .+++|+..... ...++..|+.+++.|.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445666666666654 23466688889999987666 68899876521 1234567888887774222 23333
Q ss_pred Eee------ccCCeEEEEEEecCCCCcccc--------------cccC--C--CC-----C-CchHHHHH----------
Q 037607 571 GFC------DEQSEMILVYEYMANGPFRDH--------------LYGT--N--QP-----P-LSWKQRLE---------- 610 (842)
Q Consensus 571 g~~------~~~~~~~lV~Ey~~~gsL~~~--------------l~~~--~--~~-----~-l~~~~~~~---------- 610 (842)
... ...+..+++|+|++|..+... +|.. . .. . ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 211 123567899999998765321 1110 0 00 0 12322110
Q ss_pred --HHHHHHHHHHHHHhC----CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 611 --ICIGSARGLHYLHTG----AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 611 --I~~~ia~gL~yLH~~----~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
+...+.+.++.|++. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 235799999999999998876668999997643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0007 Score=76.07 Aligned_cols=79 Identities=16% Similarity=0.156 Sum_probs=46.2
Q ss_pred CCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceeeeeccCCCCCCccccccc---CCCCcccchhHHHHHHHH
Q 037607 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEV 703 (842)
Q Consensus 627 ~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDVwS~GvvL~EL 703 (842)
...++|+|+++.|||++.++ ++|+||+.+............-..-...|.+|+..... .-....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999998876 99999998775431100000000001235555544311 111234555777777777
Q ss_pred HhC
Q 037607 704 LCA 706 (842)
Q Consensus 704 ltG 706 (842)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0022 Score=69.08 Aligned_cols=141 Identities=14% Similarity=0.169 Sum_probs=82.7
Q ss_pred eEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEe-----eccCCeEEEEEEec
Q 037607 514 AVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH--LVSLIGF-----CDEQSEMILVYEYM 586 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn--Iv~l~g~-----~~~~~~~~lV~Ey~ 586 (842)
..|+ |....||+....+|+.+++|...+... ...++..|..+++.|.... +.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 888899998877787899999764321 2356677888888874222 3444432 11234568899999
Q ss_pred CCCCccc----c----------ccc--CC-----CCCCchHHH----HHH---------------HHHHHHHHHHHHhC-
Q 037607 587 ANGPFRD----H----------LYG--TN-----QPPLSWKQR----LEI---------------CIGSARGLHYLHTG- 625 (842)
Q Consensus 587 ~~gsL~~----~----------l~~--~~-----~~~l~~~~~----~~I---------------~~~ia~gL~yLH~~- 625 (842)
+|..+.. . +|. .. ...+++... ..+ ...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8866531 0 111 00 111222111 001 00111222333221
Q ss_pred ---CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 626 ---AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 626 ---~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245689999999999999 4 899999997654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0014 Score=73.94 Aligned_cols=74 Identities=22% Similarity=0.255 Sum_probs=51.1
Q ss_pred ceEEeecCcEEEEEEEEcC--------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEE
Q 037607 513 NAVIGVGGFGKVYIGVLED--------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVY 583 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~--------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~ 583 (842)
...|+.|-...+|+....+ +..+++|+...... ...+.+|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3467888889999998753 47899998743211 1455689999988853333 567776653 2899
Q ss_pred EecCCCCcc
Q 037607 584 EYMANGPFR 592 (842)
Q Consensus 584 Ey~~~gsL~ 592 (842)
||++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0021 Score=71.15 Aligned_cols=140 Identities=17% Similarity=0.170 Sum_probs=83.7
Q ss_pred eEEeecCcEEEEEEEEc--------CCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeEEEEEE
Q 037607 514 AVIGVGGFGKVYIGVLE--------DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~--------~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~~lV~E 584 (842)
+.|..|-...+|+.... +++.+++|+.-.. ........+|..+++.|. +.-..++++++.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 35666778889998864 2478999985332 223456678999998884 32235667776542 9999
Q ss_pred ecCCCCcccc-----------------cccCC---CCCC--chHHHHHHHHHHHH-------------------HHHHHH
Q 037607 585 YMANGPFRDH-----------------LYGTN---QPPL--SWKQRLEICIGSAR-------------------GLHYLH 623 (842)
Q Consensus 585 y~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~I~~~ia~-------------------gL~yLH 623 (842)
|++|.+|... ||... .... -|.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 11111 1111 23444444433321 223332
Q ss_pred ----h-CCCCceEeccCCCCCEEEcCC----CceEEeecccccc
Q 037607 624 ----T-GAAQGIIHRDVKTTNILLDEN----LVAKVADFGLSKA 658 (842)
Q Consensus 624 ----~-~~~~~ivHrDIKp~NILld~~----~~~kl~DFGla~~ 658 (842)
. .....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123569999999999999876 7899999998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0031 Score=71.70 Aligned_cols=75 Identities=13% Similarity=0.061 Sum_probs=48.9
Q ss_pred ceEEeecCcEEEEEEEEcC-CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEEEecCCCC
Q 037607 513 NAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVYEYMANGP 590 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gs 590 (842)
...|+.|-...+|+....+ +..+++|+........ -+-.+|..+++.|...++ .++++.+.. .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3468888889999998765 4788898764432211 112588999998865444 567777642 25999999866
Q ss_pred cc
Q 037607 591 FR 592 (842)
Q Consensus 591 L~ 592 (842)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0021 Score=68.56 Aligned_cols=72 Identities=10% Similarity=0.062 Sum_probs=45.6
Q ss_pred ceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEEEec-CCCC
Q 037607 513 NAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVYEYM-ANGP 590 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~-~~gs 590 (842)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .++++++. +.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 567999999999998 568888865432211 123568888877753333 35555443 3347899999 6655
Q ss_pred cc
Q 037607 591 FR 592 (842)
Q Consensus 591 L~ 592 (842)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0038 Score=67.41 Aligned_cols=140 Identities=14% Similarity=0.101 Sum_probs=73.4
Q ss_pred EEeecCcEE-EEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC--CceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 515 VIGVGGFGK-VYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH--RHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 515 ~LG~G~fg~-Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
.|+.|.... +|+....+|..+++|...+... .++..|+.+++.|.. -.+.+++.+....+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455554444 6676654467788887554321 234566777776642 23556676654443 789999976555
Q ss_pred cccc---------------------ccCCC---CCCchHHHH-------H-------------HHHHHHHHHHHHH---h
Q 037607 592 RDHL---------------------YGTNQ---PPLSWKQRL-------E-------------ICIGSARGLHYLH---T 624 (842)
Q Consensus 592 ~~~l---------------------~~~~~---~~l~~~~~~-------~-------------I~~~ia~gL~yLH---~ 624 (842)
.+.+ |.... ..++..... . ....+.+.++.|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 4322 11110 111111000 0 0001111222221 1
Q ss_pred CCCCceEeccCCCCCEEEcCC----CceEEeeccccccc
Q 037607 625 GAAQGIIHRDVKTTNILLDEN----LVAKVADFGLSKAA 659 (842)
Q Consensus 625 ~~~~~ivHrDIKp~NILld~~----~~~kl~DFGla~~~ 659 (842)
.....++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124679999999999999874 68899999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0042 Score=68.23 Aligned_cols=73 Identities=11% Similarity=0.126 Sum_probs=45.2
Q ss_pred eEEeecCcEEEEEEEEcC---------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEeeccCCeEEEEE
Q 037607 514 AVIGVGGFGKVYIGVLED---------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH-LVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~---------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn-Iv~l~g~~~~~~~~~lV~ 583 (842)
..|+.|....+|+....+ +..+++|+...... ...+...|.++++.|...+ +.++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 457778888999998754 26788888654322 1223467888888885333 346665542 26899
Q ss_pred EecCCCCc
Q 037607 584 EYMANGPF 591 (842)
Q Consensus 584 Ey~~~gsL 591 (842)
||++|.+|
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.012 Score=64.03 Aligned_cols=64 Identities=13% Similarity=0.089 Sum_probs=42.2
Q ss_pred cEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC---CceeeEEEe------eccCCeEEEEEEecCCCCc
Q 037607 521 FGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH---RHLVSLIGF------CDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 521 fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H---pnIv~l~g~------~~~~~~~~lV~Ey~~~gsL 591 (842)
...||+....+| .+++|+...... ..|+.+++.|.. |++.+.+.. ....+..++||+|++|..+
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 578999987777 899998654331 356666666632 224454432 2234678999999998766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.15 Score=57.16 Aligned_cols=140 Identities=12% Similarity=0.143 Sum_probs=84.6
Q ss_pred ceEEeecCcEEEEEEEEcC--------CcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEeeccCCeEEEEE
Q 037607 513 NAVIGVGGFGKVYIGVLED--------GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRH-LVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~--------g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~Hpn-Iv~l~g~~~~~~~~~lV~ 583 (842)
.+.|..|-...+|+....+ +..+++|+........ -+-.+|..+++.|...+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3467778888999998753 5789999865443221 22367888888885322 345555443 27899
Q ss_pred EecCCCCcccc-c----------------cc----C-------CCCCCchHHHHHHHHHH-------------------H
Q 037607 584 EYMANGPFRDH-L----------------YG----T-------NQPPLSWKQRLEICIGS-------------------A 616 (842)
Q Consensus 584 Ey~~~gsL~~~-l----------------~~----~-------~~~~l~~~~~~~I~~~i-------------------a 616 (842)
||++|.+|... + |. . ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 1 11 0 11122244433333221 1
Q ss_pred HHHHHHHh---------------------CCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 617 RGLHYLHT---------------------GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 617 ~gL~yLH~---------------------~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
+.+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 12345899999999999 7888999999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.63 E-value=0.067 Score=54.02 Aligned_cols=103 Identities=16% Similarity=0.135 Sum_probs=66.2
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCceee
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 668 (842)
-+|.+.|. ....++++++++.++.|.++.|.-+-... .. ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 46777773 35678999999999999999987762111 11 1233456899999999988764 2111
Q ss_pred eeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCC
Q 037607 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709 (842)
Q Consensus 669 ~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p 709 (842)
.....+.|||... ...+.+.=|||+|++||.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 4556788999999999999864433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.28 E-value=0.75 Score=50.86 Aligned_cols=30 Identities=33% Similarity=0.387 Sum_probs=25.3
Q ss_pred ceEeccCCCCCEEE------cCCCceEEeecccccc
Q 037607 629 GIIHRDVKTTNILL------DENLVAKVADFGLSKA 658 (842)
Q Consensus 629 ~ivHrDIKp~NILl------d~~~~~kl~DFGla~~ 658 (842)
-++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 842 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-68
Identities = 69/276 (25%), Positives = 127/276 (46%), Gaps = 20/276 (7%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
IG G FG VY G V + + Q + F+ E+ +L K RH +++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
+G+ ++ +V ++ HL+ + + ++I +A+G+ YLH +
Sbjct: 69 FMGYSTAP-QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHA---K 123
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQ- 686
IIHRD+K+ NI L E+L K+ DFGL+ G + GS ++ PE R Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 687 --LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744
+ +SDVY+FG+VL+E++ + P ++ + + +G L + V +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
C ++++ +CL + +RP +L ++E
Sbjct: 238 --CPKAMK---RLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-64
Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 20/273 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+ +G G FG+V++G KVA+K GS + F E ++ +L+H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L ++ + ++ EYM NG D L + L+ + L++ A G+ ++
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+ IHRD++ NIL+ + L K+ADFGL++ + K + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747
T KSDV+SFG++L E++ + P + +V +Q +G +++ P C
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERG--YRMVRP----DNC 235
Query: 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
E L + C E DRP + LE
Sbjct: 236 PEELY---QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 8e-63
Identities = 69/286 (24%), Positives = 120/286 (41%), Gaps = 20/286 (6%)
Query: 509 NFDENAVIGVGGFGKVYIGVLED-GNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+ +G G +G+VY GV + VA+K + + + EF E ++ +++H +LV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L+G C + ++ E+M G D+L N+ +S L + + + YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 133
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+ IHRD+ N L+ EN + KVADFGLS+ D K + PE +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747
+ KSDV++FGV+L+E+ P + Q + ++++
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRMERP 238
Query: 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQID 793
+ K E C DRP ++ E Q S +++
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-62
Identities = 68/295 (23%), Positives = 130/295 (44%), Gaps = 28/295 (9%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCD 574
IG G FG+V+ G G +VA+K + E+ + EI LRH +++ I +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 575 EQ----SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA--- 627
+ +++ LV +Y +G D+L N+ ++ + +++ + +A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 628 --QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA---VKGSFGYLDPEYF 682
I HRD+K+ NIL+ +N +AD GL+ + A G+ Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 683 RRQ------QLTEKSDVYSFGVVLFEVLCARPVINP----KLPREQVSLAEWALQCHRKG 732
+ +++D+Y+ G+V +E+ + +LP + ++ +++ RK
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 733 ILEKIIDPVIAETIC-KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786
+ E+ + P I E+LR + +C G R + L Q +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-62
Identities = 81/280 (28%), Positives = 129/280 (46%), Gaps = 23/280 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVS 568
IG G FG V++G + +KVAIK G+ +F E +++ KL H LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L G C EQ+ + LV+E+M +G D+ T + + + L +C+ G+ YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE---A 120
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
+IHRD+ N L+ EN V KV+DFG+++ D+ ST K + PE F + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 689 EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICK 748
KSDV+SFGV+++EV + +V ++ G ++ P +A T
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLASTHVY 232
Query: 749 ESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788
+ C E DRP +L L ++ E+
Sbjct: 233 -------QIMNHCWKERPEDRPAFSRLLRQLA---EIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 4e-62
Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 20/273 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
++ +G G FG V G VAIK GS +EF E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L G C +Q + ++ EYMANG ++L + +Q LE+C + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+ +HRD+ N L+++ V KV+DFGLS+ D S K + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747
+ KSD+++FGV+++E+ K+P E+ + +E E I +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLG-----KMPYERFTNSE---------TAEHIAQGLRLY-RP 223
Query: 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ K C E +RP +L N+
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 9e-62
Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 26/275 (9%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
+ IG G FG V +G GNKVA+K ++ F E ++++LRH +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 568 SLIGFC-DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
L+G +E+ + +V EYMA G D+L + L L+ + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQ 686
+HRD+ N+L+ E+ VAKV+DFGL+K A + K + PE R ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKK 176
Query: 687 LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746
+ KSDV+SFG++L+E+ V P++P + V + KG D
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA-- 228
Query: 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEY 781
E + C RP + LE+
Sbjct: 229 -------VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 78/273 (28%), Positives = 117/273 (42%), Gaps = 20/273 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
++ +G G FG+V++G +VAIK P F E Q++ KLRH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
L + + +V EYM+ G D L G L Q +++ A G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 628 QGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL 687
+HRD++ NIL+ ENLV KVADFGL++ + K + PE +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 688 TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETIC 747
T KSDV+SFG++L E+ V P + +V L +G C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPE------C 239
Query: 748 KESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
ESL + +C + +RP + LE
Sbjct: 240 PESLH---DLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-61
Identities = 59/280 (21%), Positives = 112/280 (40%), Gaps = 9/280 (3%)
Query: 503 LQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGI-NEFQTEIQMLSK 560
++ +F++ + +G G G V+ G +A K + + I N+ E+Q+L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLH 620
++V G E+ + E+M G L + + ++ I +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPE 680
YL I+HRDVK +NIL++ K+ DFG+S + + G+ Y+ PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPE 173
Query: 681 YFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740
+ + +SD++S G+ L E+ R I P +E + ++ + P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ R + E P + +++LE
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (524), Expect = 9e-61
Identities = 77/305 (25%), Positives = 134/305 (43%), Gaps = 37/305 (12%)
Query: 498 FTFTELQNATQNFDENA---------VIGVGGFGKVYIGVLEDGNK----VAIKRGNPG- 543
FTF + A + F + VIG G FG+V G L+ K VAIK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 544 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPL 603
+E+ +F +E ++ + H +++ L G + + ++++ E+M NG D N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 604 SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663
+ Q + + G A G+ YL +HRD+ NIL++ NLV KV+DFGLS+ D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 664 GYV----STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV 719
+ K + PE + ++ T SDV+S+G+V++EV+ + P +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237
Query: 720 SLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779
+ + + L +D C +L + C + RP G ++ L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD-------CPSALH---QLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 780 EYAMQ 784
+ ++
Sbjct: 288 DKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-59
Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 27/286 (9%)
Query: 502 ELQNATQNFD-ENAVIGVGGFGKVYIGVLEDGNK---VAIKRGNPGSEQG-INEFQTEIQ 556
+L N + +G G FG V GV K VAIK G+E+ E E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA 616
++ +L + ++V LIG C + ++LV E GP L G + + E+ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 119
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSF 674
G+ YL + +HRD+ N+LL AK++DFGLSKA D Y +A K
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734
+ PE ++ + +SDV+S+GV ++E L + P +++ E ++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYG-----QKPYKKMKGPE---------VM 222
Query: 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
I E E + C DRP V +
Sbjct: 223 AFIEQGKRME-CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-58
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 30/281 (10%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNK----VAIKRGNPGSEQG-INEFQTEIQMLSKLRH 563
+F+E VIG G FG VY G L D + A+K N ++ G +++F TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 564 RHLVSLIGFC-DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
+++SL+G C + ++V YM +G R+ + K + + A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP---MDRGYVSTAVKGSFGYLDP 679
+ + +HRD+ N +LDE KVADFGL++ D + T K ++
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739
E + Q+ T KSDV+SFGV+L+E++ P + + + LQ R E D
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQGRRLLQPEYCPD 261
Query: 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
P+ E KC RP +++ +
Sbjct: 262 PLY-------------EVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 29/295 (9%)
Query: 501 TELQNATQNFDENAVIGVGGFGKVYIGVLEDGN-----KVAIKRGNPG-SEQGINEFQTE 554
TE+ VIG G FG+VY G+L+ + VAIK G +E+ +F E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 555 IQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIG 614
++ + H +++ L G + M+++ EYM NG S Q + + G
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRG 118
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD--RGYVSTAVKG 672
A G+ YL +HRD+ NIL++ NLV KV+DFGLS+ D Y ++ K
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 673 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732
+ PE ++ T SDV+SFG+V++EV+ +L +V
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------------- 222
Query: 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787
K I+ + + +C + RP D++ L+ ++ +
Sbjct: 223 --MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (499), Expect = 3e-57
Identities = 76/311 (24%), Positives = 122/311 (39%), Gaps = 48/311 (15%)
Query: 500 FTELQNATQNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNP-GSEQGINEFQ 552
L+ N + IG G FG+V+ E VA+K S +FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 553 TEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ------------ 600
E ++++ + ++V L+G C M L++EYMA G + L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 601 ----------PPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 650
PPLS ++L I A G+ YL + +HRD+ T N L+ EN+V K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 651 ADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 709
ADFGLS+ Y ++ PE + T +SDV+++GVVL+E+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 710 INPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDR 769
+ E+V + R G + + E C ++ DR
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPLELY---------NLMRLCWSKLPADR 286
Query: 770 PGMGDVLWNLE 780
P + L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-57
Identities = 69/276 (25%), Positives = 106/276 (38%), Gaps = 28/276 (10%)
Query: 512 ENAVIGVGGFGKVYIGVLED---GNKVAIKRGNPGSEQG--INEFQTEIQMLSKLRHRHL 566
E+ +G G FG V G + VA+K + +E E ++ +L + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
V +IG C E +LV E GP +L + K +E+ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST--AVKGSFGYLDPEYFRR 684
+HRD+ N+LL AK++DFGLSKA D Y K + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 685 QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744
+ + KSDV+SFGV+++E + P + +E KG E
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSE-VTAMLEKGERMGCPAGCPRE 238
Query: 745 TICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780
+ C +RPG V L
Sbjct: 239 ---------MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 25/278 (8%)
Query: 505 NATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH 563
N ++ +G G FGKVY E A K + SE+ + ++ EI +L+ H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
++V L+ ++ + ++ E+ A G + + PL+ Q +C + L+YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH 127
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF- 682
IIHRD+K NIL + K+ADFG+S + + G+ ++ PE
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 683 ----RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738
+ + K+DV+S G+ L E+ P P +++ L+ I +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLK-----IAKSEP 232
Query: 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ + + + ++ +KCL + R +L
Sbjct: 233 PTLAQPSRWSSNFKDFL---KKCLEKNVDARWTTSQLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 41/290 (14%)
Query: 495 GRFFTFTELQNATQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEF 551
GRF F IG G F VY G+ E +VA ++ F
Sbjct: 8 GRFLKFDI------------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 55
Query: 552 QTEIQMLSKLRHRHLVSLIGFC----DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQ 607
+ E +ML L+H ++V + ++LV E M +G + +L + K
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKV 113
Query: 608 RLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL-DENLVAKVADFGLSKAAPMDRGYV 666
C +GL +LHT IIHRD+K NI + K+ D GL+ + R
Sbjct: 114 LRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASF 169
Query: 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL 726
+ AV G+ ++ PE + ++ E DVY+FG+ + E+ + ++
Sbjct: 170 AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP--------------YSE 214
Query: 727 QCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ I ++ V + K ++ + E E C+ + +R + D+L
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-56
Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 29/273 (10%)
Query: 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRH 563
++F+ +G G FG VY+ + +A+K + ++ + E+++ S LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
+++ L G+ + + + L+ EY G L ++ A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH 123
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
+ + +IHRD+K N+LL K+ADFG S AP R T + G+ YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIE 177
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743
+ EK D++S GV+ +E L +P +E + + +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRVEFTFPDFVTEGAR 232
Query: 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ I + L RP + +VL
Sbjct: 233 DLI------------SRLLKHNPSQRPMLREVL 253
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 26/277 (9%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRH 565
+++ IG G +G+ DG + K + GS E +E+ +L +L+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 566 LVSLIGFCDEQSE--MILVYEYMANGPFRDHL--YGTNQPPLSWKQRLEICIGSARGLHY 621
+V +++ + +V EY G + + L + L + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 622 LH--TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDP 679
H + ++HRD+K N+ LD K+ DFGL++ D + + A G+ Y+ P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSP 183
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739
E R EKSD++S G +L+E+ P +E R+G +I
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFRRIPY 236
Query: 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ L + + + L RP + ++L
Sbjct: 237 R------YSDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 4e-55
Identities = 68/280 (24%), Positives = 107/280 (38%), Gaps = 32/280 (11%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQG---INEFQTEIQMLS 559
+ + F + IG G FG VY + + VAIK+ + +Q + E++ L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 560 KLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
KLRH + + G + LV EY ++ PL + + G+ +GL
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDP 679
YLH + +IHRDVK NILL E + K+ DFG + +V G+ ++ P
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 180
Query: 680 EYFR---RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736
E Q K DV+S G+ E+ +P P +S Q +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQNESPALQSG 237
Query: 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ + CL + DRP +L
Sbjct: 238 HWSEYFRNFV------------DSCLQKIPQDRPTSEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 6e-55
Identities = 80/314 (25%), Positives = 134/314 (42%), Gaps = 39/314 (12%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNK---VAIKRGNP-GSEQGINEFQTEIQMLSKL-RH 563
+ VIG G FG+V ++ AIKR S+ +F E+++L KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYG--------------TNQPPLSWKQRL 609
++++L+G C+ + + L EY +G D L + LS +Q L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 610 EICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTA 669
ARG+ YL + IHRD+ NIL+ EN VAK+ADFGLS+ + T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTM 185
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729
+ ++ E T SDV+S+GV+L+E++ P ++ AE +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYEKLP 240
Query: 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789
+ LEK ++ C + + + +C E +RP +L +L ++ ++
Sbjct: 241 QGYRLEKPLN-------CDDEVY---DLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290
Query: 790 TQIDHPEDKSANLI 803
E + I
Sbjct: 291 VNTTLYEKFTYAGI 304
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-55
Identities = 65/286 (22%), Positives = 111/286 (38%), Gaps = 25/286 (8%)
Query: 508 QNFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGSEQGINE-FQTEIQMLSKLR 562
+ + IG G FG V+ G+ VAIK + + E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
H H+V LIG E + ++ E G R + L + + L YL
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
+ + +HRD+ N+L+ N K+ DFGLS+ Y ++ K ++ PE
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742
++ T SDV+ FGV ++E+L + P + V + + G +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILM-----HGVKPFQGVKNNDV-IGRIENGERLPMPP--- 232
Query: 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEA 788
C +L + KC A RP ++ L ++ ++A
Sbjct: 233 ---NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 64/300 (21%), Positives = 117/300 (39%), Gaps = 44/300 (14%)
Query: 515 VIGVGGFGKVYIGVL------EDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKL-RHRHL 566
+G G FGKV + VA+K P + +E+++LS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 567 VSLIGFCDEQSEMILVYEYMANGPFRDHLYG----------------TNQPPLSWKQRLE 610
V+L+G C +++ EY G + L ++ L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTA 669
A+G+ +L + + IHRD+ NILL + K+ DFGL++ D Y V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 670 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729
+ ++ PE T +SDV+S+G+ L+E+ P +P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255
Query: 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEAS 789
K+I + + + + + C + RP ++ +E Q+ E++
Sbjct: 256 ---KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISEST 310
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 22/279 (7%)
Query: 499 TFTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQM 557
+ + + + + IG G G VY + + G +VAI++ N + EI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR 617
+ + ++ ++V+ + E+ +V EY+A G D + + + Q +C +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQ 127
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYL 677
L +LH + +IHRD+K+ NILL + K+ DFG ++ ST V G+ ++
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 183
Query: 678 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737
PE R+ K D++S G++ E++ P + P L ++
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPEL 236
Query: 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+P I ++ L +CL R ++L
Sbjct: 237 QNPEKLSAIFRDFLN-------RCLDMDVEKRGSAKELL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 47/302 (15%)
Query: 509 NFDENAVIGVGGFGKVYIGVLEDGNK------VAIKRGNPGSEQG-INEFQTEIQMLSKL 561
N + V+G G FGKV +K VA+K ++ +E++M+++L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 562 -RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQP------------------- 601
H ++V+L+G C + L++EY G ++L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 602 --PLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAA 659
L+++ L A+G+ +L + +HRD+ N+L+ V K+ DFGL++
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 660 PMDRGYVS-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
D YV + ++ PE T KSDV+S+G++L+E+ P +P +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 719 VSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778
K+I + + + C A RP ++
Sbjct: 275 --------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 779 LE 780
L
Sbjct: 321 LG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-53
Identities = 64/273 (23%), Positives = 103/273 (37%), Gaps = 23/273 (8%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINE-FQTEIQMLSKLRHRH 565
+++D +G G +G+V + V VA+K + E + EI + L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+V G E + L EY + G D + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD-RGYVSTAVKGSFGYLDPEYFRR 684
GI HRD+K N+LLDE K++DFGL+ + R + + G+ Y+ PE +R
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 685 QQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743
++ E DV+S G+VL +L + Q K + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKIDS 234
Query: 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
L K L E R + D+
Sbjct: 235 A--PLALLH-------KILVENPSARITIPDIK 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-53
Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 27/294 (9%)
Query: 510 FDENAVIGVGGFGKVYIGVLEDGN-----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRH 563
F + V+G G FG VY G+ VAIK S + E E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
H+ L+G C S + L+ + M G D+ ++ + + L C+ A+G++YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK-AAPMDRGYVSTAVKGSFGYLDPEYF 682
+ ++HRD+ N+L+ K+ DFGL+K ++ Y + K ++ E
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742
+ T +SDV+S+GV ++E++ +P + + I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGE 230
Query: 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPE 796
KC RP +++ + + I E
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 7e-52
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 28/278 (10%)
Query: 508 QNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNP---GSEQGINEFQTEIQMLSK 560
++ +G G FG V G + VA+K P + +++F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLH 620
L HR+L+ L G M +V E G D +Q + A G+
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY--VSTAVKGSFGYLD 678
YL ++ IHRD+ N+LL + K+ DFGL +A P + + + K F +
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 679 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738
PE + + + SD + FGV L+E+ + P ++ ++ IL KI
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQ---------ILHKID 228
Query: 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
++ + +C A DRP +
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 1e-50
Identities = 59/271 (21%), Positives = 111/271 (40%), Gaps = 22/271 (8%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
++D + +G G FG V+ GN A K E + EIQ +S LRH LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 568 SLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAA 627
+L ++ +EM+++YE+M+ G + + + +S + +E +GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHE--- 142
Query: 628 QGIIHRDVKTTNILL--DENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
+H D+K NI+ + K+ DFGL+ +D G+ + PE +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 686 QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745
+ +D++S GV+ + +L + E L+ + +D
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN--MDDSAFSG 251
Query: 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
I ++ + ++ K L R + L
Sbjct: 252 ISED-GKDFI---RKLLLADPNTRMTIHQAL 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 5e-49
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 43/296 (14%)
Query: 515 VIGVGGFGKVYIGVL--------EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHR 564
+G G FG+V + KVA+K +E+ +++ +E++M+ + +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPP--------------LSWKQRLE 610
++++L+G C + + ++ EY + G R++L P LS K +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 611 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAV 670
ARG+ YL ++ IHRD+ N+L+ E+ V K+ADFGL++ Y T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 671 K-GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCH 729
++ PE + T +SDV+SFGV+L+E+ P +P E+ L + + H
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLKEGH 254
Query: 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785
R + + C RP ++ +L+ + L
Sbjct: 255 RMDKPSNCTNELY-------------MMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHR 564
+F ++G G F V + L + AIK + + E + E ++S+L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
V L + ++ Y NG ++ L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH- 125
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA-APMDRGYVSTAVKGSFGYLDPEYFR 683
+GIIHRD+K NILL+E++ ++ DFG +K +P + + + G+ Y+ PE
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARP 708
+ + SD+++ G ++++++ P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 34/293 (11%)
Query: 508 QNFDENAVIGVGGFGKVYIGVL------EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSK 560
+ + +G G FG VY GV E +VAIK N S + EF E ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 561 LRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQ--------PPLSWKQRLEIC 612
H+V L+G + +++ E M G + +L P S + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 613 IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVK 671
A G+ YL+ A +HRD+ N ++ E+ K+ DFG+++ Y
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 672 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731
++ PE + T SDV+SFGVVL+E+ L EQV L+ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVME 250
Query: 732 GILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784
G L D E C RP +++ +++ M+
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (434), Expect = 9e-48
Identities = 53/265 (20%), Positives = 109/265 (41%), Gaps = 22/265 (8%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G FG V+ V G K N + EI ++++L H L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+++ EM+L+ E+++ G D + +S + + + GL ++H I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 634 DVKTTNILLD--ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
D+K NI+ + + K+ DFGL+ ++ + + + PE R+ + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 692 DVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751
D+++ GV+ + +L + E LQ ++ E D ++ E
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE--FDEDAFSSVSPE-A 259
Query: 752 RKYVEAAEKCLAEYGVDRPGMGDVL 776
+ ++ + L + R + D L
Sbjct: 260 KDFI---KNLLQKEPRKRLTVHDAL 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-47
Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 41/300 (13%)
Query: 509 NFDENAVIGVGGFGKVYIGV------LEDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKL 561
+G G FG+V VA+K G+ +E+++L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 562 RHRH-LVSLIGFCDEQSEMI-LVYEYMANGPFRDHLYGTN--------------QPPLSW 605
H +V+L+G C + + ++ E+ G +L + L+
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
+ + A+G+ +L + + IHRD+ NILL E V K+ DFGL++ D Y
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 666 V-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW 724
V + ++ PE + T +SDV+SFGV+L+E+ P V + E
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDEE 245
Query: 725 ALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784
+ ++G + D E + C RP +++ +L +Q
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMY---------QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (416), Expect = 3e-46
Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 29/277 (10%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLI 570
++G GG +V++ L VA+K F+ E Q + L H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 571 GFCDEQSE----MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGA 626
+ ++ +V EY+ RD ++ + P++ K+ +E+ + + L++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH--- 128
Query: 627 AQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTAVKGSFGYLDPEYFRR 684
GIIHRDVK NI++ KV DFG+++ A + + AV G+ YL PE R
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 685 QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744
+ +SDVYS G VL+EVL P P + + E I P
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----------YQHVREDPIPPSARH 238
Query: 745 TICKESLRKYVEAAEKCLAEYGVDRPG-MGDVLWNLE 780
L V K LA+ +R ++ +L
Sbjct: 239 EGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 9e-46
Identities = 59/334 (17%), Positives = 133/334 (39%), Gaps = 45/334 (13%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
+G G FG V+ V K + + EI +L+ RHR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70
Query: 574 DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 633
+ E+++++E+++ + + T+ L+ ++ + L +LH + I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 634 DVKTTNILLD--ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKS 691
D++ NI+ + K+ +FG ++ + G + + Y PE + ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 692 DVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESL 751
D++S G +++ +L + ++ I+E I++ T +E+
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNAEY--TFDEEAF 227
Query: 752 RKYVEAA----EKCLAEYGVDRPGMGDVL---WNLEYAMQLQEASTQIDHPEDKSANLIA 804
++ A ++ L + R + L W L++ +I+ K +
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPW-------LKQ---KIERVSTKVIRTLK 277
Query: 805 LDKPCENLSREDLAVAVSDNSEIAAGSSLFSPVG 838
+ L ++DL + VS I+ G ++ S G
Sbjct: 278 HRRYYHTLIKKDLNMVVSAAR-ISCGGAIRSQKG 310
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 3e-45
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 37/286 (12%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGS---------EQGINEFQTEIQM 557
+N++ ++G G V + + A+K + ++ E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 558 LSKLR-HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA 616
L K+ H +++ L + + LV++ M G D+L T + LS K+ +I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 120
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGY 676
+ LH I+HRD+K NILLD+++ K+ DFG S +D G V G+ Y
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSY 175
Query: 677 LDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730
L PE ++ D++S GV+++ +L P P R+Q+ + + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGNY 232
Query: 731 KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
+ + D ++++ V + L R + L
Sbjct: 233 QFGSPEWDD-------YSDTVKDLV---SRFLVVQPQKRYTAEEAL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-44
Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 25/282 (8%)
Query: 500 FTELQNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINE-FQTEIQM 557
+ + ++ +D V+G G F +V + VAIK + +G + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 558 LSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR 617
L K++H ++V+L + + L+ + ++ G D + + + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLD 118
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILL---DENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
+ YLH GI+HRD+K N+L DE+ ++DFGLSK D G V + G+
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTP 173
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734
GY+ PE ++ ++ D +S GV+ + +LC P + + + K
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-------FEQILKAEY 226
Query: 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
E D + I + ++ + + R L
Sbjct: 227 E--FDSPYWDDISDS-AKDFI---RHLMEKDPEKRFTCEQAL 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-44
Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 26/292 (8%)
Query: 506 ATQNFDENAVIGVGGFGKVYIG--VLEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKL 561
A Q ++ A IG G +GKV+ + G VA+K R G E E+ +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 562 ---RHRHLVSLIGFCDEQSEMILVYEYM----ANGPFRDHLYGTNQPPLSWKQRLEICIG 614
H ++V L C + + +L +P + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 615 SARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSF 674
RGL +LH+ ++HRD+K NIL+ + K+ADFGL++ T+V +
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTL 179
Query: 675 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWAL------QC 728
Y PE + D++S G + E+ +P+ +Q+ +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 729 HRKGILEKIIDPVIAETICKESLRKYVEAA----EKCLAEYGVDRPGMGDVL 776
R L + + ++ + E KCL R L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 2e-43
Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 13/215 (6%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRH 563
Q+F +G G FG+V++ +G A+K + + + E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 564 RHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLH 623
++ + G + ++ ++ +Y+ G L + + P + + L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121
Query: 624 TGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
+ + II+RD+K NILLD+N K+ DFG +K P + G+ Y+ PE
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVS 174
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
+ + D +SFG++++E+L +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 55/283 (19%), Positives = 107/283 (37%), Gaps = 19/283 (6%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRH 565
NF + IG G +G VY G VA+K R + +E + EI +L +L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+V L+ ++++ LV+E++ + + + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
+ ++HRD+K N+L++ K+ADFGL++A + + V + +
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 686 QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV--------SLAEWALQCHRKGILEKI 737
+ D++S G + E++ R + +Q+ + E K
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 738 IDPVIAETICKESLRKYVEAA----EKCLAEYGVDRPGMGDVL 776
P A + + E + L R L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-43
Identities = 72/326 (22%), Positives = 122/326 (37%), Gaps = 35/326 (10%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQG-INEFQTEIQMLSKLRHRHLVSLIGF 572
IG G +G V + +VAIK+ +P Q EI++L + RH +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 573 CD----EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
EQ + + + ++ L LS RGL Y+H+
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHS---A 128
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS--TAVKGSFGYLDPEYFRRQQ 686
++HRD+K +N+LL+ K+ DFGL++ A D + T + Y PE +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 687 L-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745
T+ D++S G +L E+L RP+ K +Q++ L + L II+
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 746 ICKESLRKYVEAAE--------------KCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQ 791
+ + V K L R + L Y Q + S
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL-AHPYLEQYYDPS-- 305
Query: 792 IDHPEDKSANLIALDKPCENLSREDL 817
E + D ++L +E L
Sbjct: 306 ---DEPIAEAPFKFDMELDDLPKEKL 328
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (392), Expect = 6e-43
Identities = 52/276 (18%), Positives = 100/276 (36%), Gaps = 19/276 (6%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGF 572
IG G +G VY G A+K R E + EI +L +L+H ++V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+ ++LV+E++ + + L + G+ Y H + ++H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 633 RDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSD 692
RD+K N+L++ K+ADFGL++A + + + + ++ + D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 693 VYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID--------PVIAE 744
++S G + E++ P+ +Q+ L + + V
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 745 TICKESLRKYVEAA----EKCLAEYGVDRPGMGDVL 776
+ L+ E+ K L R L
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG---SEQGINEFQTEIQMLSK-LR 562
++F + ++G G FGKV++ + AIK + + E ++LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 563 HRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYL 622
H L + + + V EY+ G H+ + + GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFL 119
Query: 623 HTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYF 682
H+ +GI++RD+K NILLD++ K+ADFG+ K + +T G+ Y+ PE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 683 RRQQLTEKSDVYSFGVVLFEVLCARP 708
Q+ D +SFGV+L+E+L +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (394), Expect = 3e-42
Identities = 50/231 (21%), Positives = 95/231 (41%), Gaps = 16/231 (6%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG---SEQGINEFQTE---IQMLSKL 561
+F + +IG GGFG+VY + G A+K + +QG E + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 562 RHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHY 621
+V + ++ + + M G HL + S GL +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 122
Query: 622 LHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEY 681
+H + +++RD+K NILLDE+ +++D GL+ + A G+ GY+ PE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 176
Query: 682 FRRQQ-LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731
++ +D +S G +LF++L +++ + L +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-42
Identities = 51/294 (17%), Positives = 96/294 (32%), Gaps = 29/294 (9%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFC 573
IG G FG +Y+G + G +VAIK ++ + E ++ ++ + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 574 DEQSEM-ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
+ + ++V E + + S K L + + Y+H ++ IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 633 RDVKTTNIL---LDENLVAKVADFGLSKAAPMDRGYV------STAVKGSFGYLDPEYFR 683
RDVK N L + + + DFGL+K R + + + G+ Y
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 684 RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743
+ + + D+ S G VL + E + +E +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG--- 243
Query: 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPED 797
Y+ C + D+P + D+ D
Sbjct: 244 ---YPSEFATYL---NFCRSLRFDDKPDYSYLRQLFRNLF--HRQGFSYDYVFD 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 5e-42
Identities = 48/296 (16%), Positives = 89/296 (30%), Gaps = 31/296 (10%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHR-HLVSLIGF 572
IG G FG ++ G L + +VAIK + + E + L + ++ F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIH 632
E +LV + + GP + L S K + +H + +++
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 633 RDVKTTNILLDENLV-----AKVADFGLSKAAPMDRG------YVSTAVKGSFGYLDPEY 681
RD+K N L+ V DFG+ K + G+ Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 682 FRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741
++ + + D+ + G V L E + + L ++
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG- 243
Query: 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQEASTQIDHPED 797
E KY+ P + + + +T D D
Sbjct: 244 -----FPEEFYKYM---HYARNLAFDATPDYDYLQGLFSKVL--ERLNTTEDENFD 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 22/279 (7%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINE-----FQTEIQMLSKLRHRHLVS 568
+G G F VY VAIK+ G + EI++L +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 569 LIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
L+ +S + LV+++M + + N L+ + + +GL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 629 GIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLT 688
I+HRD+K N+LLDEN V K+ADFGL+K+ + V + F +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 689 EKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII---DPVIAET 745
D+++ G +L E+L P + +Q++ L + + D V ++
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 746 ICKESLRKYVEAA--------EKCLAEYGVDRPGMGDVL 776
L AA + R L
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 49/271 (18%), Positives = 101/271 (37%), Gaps = 28/271 (10%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGF 572
V+G+G GKV K A+K + + E+++ + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 573 CD----EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQ 628
+ + +++V E + G + + ++ EI + YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 629 GIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
I HRDVK N+L N + K+ DFG +K + + Y+ PE +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 686 QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745
+ + D++S GV+++ +LC P P + + + + P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776
E ++ + L R + + +
Sbjct: 243 EVSEEVKMLI---RNLLKTEPTQRMTITEFM 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-40
Identities = 63/309 (20%), Positives = 124/309 (40%), Gaps = 35/309 (11%)
Query: 504 QNATQNFDENAVIGVGGFGKVYIGV-LEDGNKVAIKR------GNPGSEQGINEFQTEIQ 556
+N +D +G G F V G + A K + + + E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 557 MLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSA 616
+L +++H ++++L + ++++IL+ E +A G D L + L+ ++ E
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQIL 123
Query: 617 RGLHYLHTGAAQGIIHRDVKTTNILLDEN----LVAKVADFGLSKAAPMDRGYVSTAVKG 672
G++YLH+ I H D+K NI+L + K+ DFGL+ +D G + G
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFG 178
Query: 673 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKG 732
+ ++ PE + L ++D++S GV+ + +L +E A
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNY 233
Query: 733 ILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL---WNLEYAMQLQEAS 789
E + + K+ +R + L + R + D L W ++ Q S
Sbjct: 234 EFEDEYFSNTSA-LAKDFIR-------RLLVKDPKKRMTIQDSLQHPW-IKPKDTQQALS 284
Query: 790 TQIDHPEDK 798
+ HP+ +
Sbjct: 285 SAWSHPQFE 293
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-39
Identities = 64/269 (23%), Positives = 102/269 (37%), Gaps = 17/269 (6%)
Query: 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLV 567
++ + VIG G FG VY L + G VAIK+ E+Q++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 568 SLIGFCDEQSE------MILVYEYMANGPFRDHL-YGTNQPPLSWKQRLEICIGSARGLH 620
L F E + LV +Y+ +R Y + L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 621 YLHTGAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDP 679
Y+H + GI HRD+K N+LLD + V K+ DFG +K VS + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPE 192
Query: 680 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739
F T DV+S G VL E+L +P+ +Q+ L + + ++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 740 PVIAETICKESLRKYVEAAEKCLAEYGVD 768
+ + + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIA 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 31/237 (13%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKR------GNPGSEQGINEFQTEIQMLSKLRHRH-- 565
++G GGFG VY G+ + D VAIK + G E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 566 LVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
++ L+ + + +L+ E T + L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 626 AAQGIIHRDVKTTNILLDEN-LVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
G++HRD+K NIL+D N K+ DFG T G+ Y PE+ R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRY 183
Query: 685 QQL-TEKSDVYSFGVVLFEVLCARP-------------VINPKLPREQVSLAEWALQ 727
+ + V+S G++L++++C ++ E L W L
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 58/285 (20%), Positives = 107/285 (37%), Gaps = 21/285 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINEFQTEIQMLSKLRHR 564
Q +++ IG G +G V+ E VA+K R + E + EI +L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
++V L ++ LV+E+ + + +GL + H+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS 119
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ ++HRD+K N+L++ N K+A+FGL++A + S V + F
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 685 QQLTEKSDVYSFGVVLFEVLCARPVINP---------KLPREQVSLAEWALQCHRKGILE 735
+ + D++S G + E+ A + P ++ R + E K
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 736 KIIDPVIAETICKESLRKYVEAA----EKCLAEYGVDRPGMGDVL 776
K A T + K + L V R + L
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 10/204 (4%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHR 564
+FD ++G G FGKV + G A+K + ++ + TE ++L RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
L +L + V EY G HL + + ++ L YLH+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS 123
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ +++RD+K N++LD++ K+ DFGL K D G G+ YL PE
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED 179
Query: 685 QQLTEKSDVYSFGVVLFEVLCARP 708
D + GVV++E++C R
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 1e-37
Identities = 62/306 (20%), Positives = 107/306 (34%), Gaps = 37/306 (12%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIK---RGNPGSEQGINEFQTEIQMLSKLRHR 564
FD +G G FG+V + E GN A+K + + I E ++L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 565 HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
LV L + S + +V EY+A G HL S YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH- 158
Query: 625 GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRR 684
+ +I+RD+K N+L+D+ +V DFG +K + G+ L PE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILS 212
Query: 685 QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAE 744
+ + D ++ GV+++E+ P P + + G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKIVSG------KVRFPS 259
Query: 745 TICKESLRKYVEAAEKCLAE-YGVDRPGMGDVL---------WNLEYAMQLQEAST-QID 793
+ + L + +G + G+ D+ W Y +++ +
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319
Query: 794 HPEDKS 799
P D S
Sbjct: 320 GPGDTS 325
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 65/298 (21%), Positives = 122/298 (40%), Gaps = 35/298 (11%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRH 565
+++ A IG G FG+V+ + G KVA+K+ + E EI++L L+H +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 566 LVSLIGFCDEQSE--------MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSAR 617
+V+LI C ++ + LV+++ + + LS +R+ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---- 126
Query: 618 GLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA---APMDRGYVSTAVKGSF 674
L+ L+ I+HRD+K N+L+ + V K+ADFGL++A A + T +
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 675 GYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733
Y PE ++ D++ G ++ E+ P++ + Q++L +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 734 LEKIIDPVIAETIC---------KESLRKYVEAAE------KCLAEYGVDRPGMGDVL 776
+ + + E + K+ L+ YV K L R D L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-36
Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 15/230 (6%)
Query: 498 FTFTELQNATQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIK--RGNPGSEQGINE 550
F E+ +G G +G V V G KVAIK SE
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGT--NQPPLSWKQR 608
E+++L +RH +++ L+ + ++ PF G L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 609 LEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVST 668
+ +GL Y+H A GIIHRD+K N+ ++E+ K+ DFGL++ A + +
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TG 177
Query: 669 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
V + + T+ D++S G ++ E++ + + +Q
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 508 QNFDENAVIGVGGFGKVYIGVL----EDGNKVAIKRGNPGS----EQGINEFQTEIQMLS 559
+NF+ V+G G +GKV++ + G A+K + + +TE Q+L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 560 KLRHR-HLVSLIGFCDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARG 618
+R LV+L ++++ L+ +Y+ G HL + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLA 141
Query: 619 LHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLD 678
L +LH GII+RD+K NILLD N + DFGLSK D + G+ Y+
Sbjct: 142 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 679 PEYFRRQQ--LTEKSDVYSFGVVLFEVLCARP 708
P+ R + D +S GV+++E+L
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 53/295 (17%), Positives = 109/295 (36%), Gaps = 40/295 (13%)
Query: 509 NFDENAVIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHL 566
++ +G G + +V+ + + + KV +K P ++ + + EI++L LR ++
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 567 VSLIGFCDEQSE--MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT 624
++L + LV+E++ N F+ L+ + L Y H+
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS 147
Query: 625 GAAQGIIHRDVKTTNILLD-ENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFR 683
GI+HRDVK N+++D E+ ++ D+GL++ G S + PE
Sbjct: 148 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLV 202
Query: 684 RQQL-TEKSDVYSFGVVLFEVLCARP-----------------VINPKLPREQVSLAEWA 725
Q+ D++S G +L ++ + V+ + + +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 726 LQCHRKGILEKIIDPVIAETICKESLRKYVEAA----EKCLAEYGVDRPGMGDVL 776
L IL + + E+ A +K L R + +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-31
Identities = 47/213 (22%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIG 571
IG G G V VAIK+ + ++ E+ ++ + H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 572 FC------DEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG 625
+E ++ LV E M + Q L ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH-- 136
Query: 626 AAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQ 685
+ GIIHRD+K +NI++ + K+ DFGL++ ++ T + Y PE
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 686 QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ 718
E D++S G ++ E++ + + + +Q
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 45/236 (19%), Positives = 92/236 (38%), Gaps = 21/236 (8%)
Query: 498 FTFTELQNATQNFDEN----AVIGVGGFGKVYIGV-LEDGNKVAIKRGNPG--SEQGINE 550
F EL E + +G G +G V + G +VA+K+ + S
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 551 FQTEIQMLSKLRHRHLVSLIGFCDEQS-----EMILVYEYMANGPFRDHLYGTNQPPLSW 605
E+++L ++H +++ L+ + + ++ + L+
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTD 120
Query: 606 KQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665
+ RGL Y+H + IIHRD+K +N+ ++E+ K+ DFGL++ +
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-- 175
Query: 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSL 721
+ V + + D++S G ++ E+L R + +Q+ L
Sbjct: 176 -TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 4e-25
Identities = 38/237 (16%), Positives = 78/237 (32%), Gaps = 28/237 (11%)
Query: 515 VIGVGGFGKVYIGV-LEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH---------- 563
+G G F V++ + + VA+K + + EI++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 564 -RHLVSLIGFCDEQSEMILVYEYMA---NGPFRDHLYGTNQPPLSWKQRLEICIGSARGL 619
H++ L+ + + + + + + +I GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 620 HYLHTGAAQGIIHRDVKTTNILLDEN------LVAKVADFGLSKAAPMDRGYVSTAVKGS 673
Y+H GIIH D+K N+L++ + K+AD G + +
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQT 192
Query: 674 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730
Y PE +D++S ++FE++ + P + Q
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 3e-22
Identities = 31/197 (15%), Positives = 57/197 (28%), Gaps = 35/197 (17%)
Query: 515 VIGVGGFGKVYIGVLEDGNKVAIKRGNPGS----------EQGINEFQTEIQMLSKLRHR 564
++G G V+ E + +K G + G F ++ R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 565 HLVSLIGFCD----EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLH 620
L L G ++ E + + E+ +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVA 117
Query: 621 YLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK--AAPMDRGYVSTAVKGSFGYLD 678
+ +GI+H D+ N+L+ E + + DF S R + V+
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNI----- 168
Query: 679 PEYFRRQQLTEKSDVYS 695
YF R + D+ S
Sbjct: 169 ITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 842 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 96.15 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 96.11 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=426.20 Aligned_cols=256 Identities=31% Similarity=0.482 Sum_probs=202.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688899999999999999999889999999987643 335789999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|+|.+++.. ....++|..++.|+.|+|+||+|||+ ++|+||||||+||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 9999998854 44678999999999999999999999 9999999999999999999999999999987755444444
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....||..|+|||++.+..++.|+|||||||+||||+++ ++|+......+ +.+.+.. + .....|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~----~--~~~~~p------ 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST----G--FRLYKP------ 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHH----T--CCCCCC------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHh----c--CCCCCc------
Confidence 556799999999999999999999999999999999995 55555432221 2222211 1 011111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..+..++.+++.+||+.+|.+||+|+||+++|+++.+
T Consensus 225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223467889999999999999999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=425.08 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=210.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46788999999999999999999888899999987643 335789999999999999999999998865 5679999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++......+++|.++++|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999998865555679999999999999999999999 999999999999999999999999999999876544334
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....||+.|||||++.++.++.++|||||||+||||++|..|+....... .+...+. .+. ....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~i~----~~~--~~~~------- 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLE----RGY--RMVR------- 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH----TTC--CCCC-------
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----hcC--CCCC-------
Confidence 455678999999999999999999999999999999999655443332221 1111111 110 0111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+......+.+++.+||+.+|.+||||+||+++|+...
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1123356788999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-50 Score=428.62 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=216.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|++.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467888999999999999999976 58899999987643 3457899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
|++|+|.+++.......+++..++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 999999999977777889999999999999999999999 99999999999999999999999999999987655444
Q ss_pred eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 666 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
......|++.|+|||++.+..++.|+|||||||++|||++|..|+........ +.+.+ ..+... .
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----~~~~~~---------~ 236 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----EKDYRM---------E 236 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----HTTCCC---------C
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----hcCCCC---------C
Confidence 45556789999999999999999999999999999999997666544332221 11111 111111 1
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.......++.+++.+||+.+|.+||||.||++.|+...+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122334568899999999999999999999999986543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-49 Score=427.47 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=201.8
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CC---cEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DG---NKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g---~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|++.++||+|+||+||+|.+. ++ ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34566789999999999999975 23 36899987754 555667899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++|+|.+++.. ....++|.+++.|+.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998743 34579999999999999999999999 99999999999999999999999999999876533
Q ss_pred CCc----eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 663 RGY----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 663 ~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
... ......||+.|||||.+.++.++.++|||||||+||||++ |++||......+ +...+.. +...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~----~~~~-- 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ----DYRL-- 252 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT----TCCC--
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCCC--
Confidence 221 1223457899999999999999999999999999999998 899997654332 2222211 1000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
..+.+....+.+++.+||+.+|.+||+|.||++.|+++++.+
T Consensus 253 -------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 253 -------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 012234456888999999999999999999999999887644
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=421.95 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=206.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|.+.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999864 35999998643 45567889999999999999999999999865 56899999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR- 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~- 663 (842)
||++|+|.+++.. ....+++.+++.|+.||++||+|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999854 34569999999999999999999999 899999999999999999999999999998765332
Q ss_pred CceeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
........||+.|||||++.+ ..++.++|||||||+||||++|+.||......... ...+........+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~p~~------ 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRGYLSPDL------ 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHTSCCCCG------
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCCcc------
Confidence 223456679999999999864 35889999999999999999999999866443322 1111111111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..........+.+++.+||+.+|.+||||+||++.|+.+.+
T Consensus 232 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 ---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11222344678899999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=417.60 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=204.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... .+..+++.+|+++|++++|||||++++++.+.+..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 68999999976543 3344679999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC-
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR- 663 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~- 663 (842)
||++|+|.+++. ....+++.+++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999994 45679999999999999999999999 999999999999999999999999999998764332
Q ss_pred CceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
.......+||+.|||||++.+..+ +.++|||||||+||||++|++||......... ...+ .......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~----~~~~~~~------- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KEKKTYL------- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH----HTTCTTS-------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH----hcCCCCC-------
Confidence 223355789999999999988776 57899999999999999999999765433211 1111 1110000
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.........+.+++.+||+.+|.+|||++|+++.
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011223456789999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=415.93 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=204.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCC-----cEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDG-----NKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g-----~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
+.|+..++||+|+||+||+|.++.. ..||||++... ......+|++|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688889999999999999997642 36999998654 44455689999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|||||.+++|.+.+.. ....++|.+++.++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999887743 44679999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCC--ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRG--YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .......||+.|||||++.++.++.++|||||||+||||++|..|+.......+ +.+.+. .+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~----~~~~----- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN----DGFR----- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH----TTCC-----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHh----ccCC-----
Confidence 322 233455689999999999999999999999999999999996555543332221 222211 1110
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
.........++.+++.+||+.+|.+||+|.||+++|+.+.+.++
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 01122234568899999999999999999999999998776543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=410.89 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=212.8
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMA 587 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 587 (842)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|++|++++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999998888999999876433 34789999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCcee
Q 037607 588 NGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYVS 667 (842)
Q Consensus 588 ~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 667 (842)
+|+|.+++.. ....+++..+++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999998743 34578899999999999999999999 9999999999999999999999999999987655444444
Q ss_pred eeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 668 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 668 ~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
....||..|+|||.+.+..++.|+|||||||++|||++ |+.||......+. ...+ .++. .+..|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~~~i----~~~~--~~~~p------ 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHI----AQGL--RLYRP------ 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHH----HTTC--CCCCC------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---HHHH----HhCC--CCCCc------
Confidence 55679999999999999999999999999999999998 8999987654331 1111 1111 11111
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
......+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 224 -~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 224 -HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 122356889999999999999999999999885
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=411.04 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=208.9
Q ss_pred cCcccceE-EeecCcEEEEEEEEc---CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAV-IGVGGFGKVYIGVLE---DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~-LG~G~fg~Vykg~~~---~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|.+... ||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 3557999998764 44556889999999999999999999999965 568999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++|+|.+++.. .+..+++.+++.++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 999999999998743 34579999999999999999999999 99999999999999999999999999999877543
Q ss_pred CCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 663 RGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 663 ~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... ......||+.|||||++.+..++.++|||||||++|||++ |++||......+ +...+ .++...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i----~~~~~~~--- 232 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGKRME--- 232 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH----HTTCCCC---
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCCCC---
Confidence 322 2234568999999999999999999999999999999998 999998664332 11111 1221111
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.++....++.+++.+||+.+|++||+|.+|++.|+....
T Consensus 233 ------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122334567899999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=410.03 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=206.4
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||+||+|+.. +|+.||+|++... .....+++.+|+++|++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999975 6889999987642 1233567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|.+++. ....+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999984 34579999999999999999999999 99999999999999999999999999999876433
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......||+.|||||++.+..++.++|||||||+||||++|++||......+.. ..+ .+...
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~i----~~~~~--------- 221 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---KRI----SRVEF--------- 221 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH----HTTCC---------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH---HHH----HcCCC---------
Confidence 234567999999999999999999999999999999999999999765433211 111 11110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.++.....++.+++.+||+.||.+|||+.|+++.
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0111223467889999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=414.54 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=208.2
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 469999999987554455678999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.+ ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 99999988743 469999999999999999999999 999999999999999999999999999998764332 23
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....||+.|+|||++.+..++.++|||||||++|||++|++||......+... ... ..+. ..+. .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~---~~~~-~~~~-------~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIA---TNGT-PELQ-------N 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH---HHCS-CCCS-------S
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH---HHH---hCCC-CCCC-------C
Confidence 345679999999999999999999999999999999999999997654332211 111 1110 0110 1
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12223567889999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=419.78 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=206.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC-C-----cEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED-G-----NKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~-g-----~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
.++|++.++||+|+||+||+|++.. + ..||+|++... .......|.+|+.+|+++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678999999999999999999753 2 26999987654 334456799999999998 89999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC---------------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCC
Q 037607 579 MILVYEYMANGPFRDHLYGTN---------------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKT 637 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~---------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 637 (842)
.+||||||++|+|.++|+... ...+++..++.|+.||++||+|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 999999999999999996532 2358999999999999999999999 9999999999
Q ss_pred CCEEEcCCCceEEeecccccccCCCCCc-eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCc
Q 037607 638 TNILLDENLVAKVADFGLSKAAPMDRGY-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLP 715 (842)
Q Consensus 638 ~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~ 715 (842)
+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||++ |++||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 3345678999999999999999999999999999999997 8999986544
Q ss_pred hhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 716 REQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 716 ~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.+. +...+ ..+.-. ..+......+.+++.+||+.+|.+|||++||+++|.
T Consensus 273 ~~~--~~~~~----~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN--FYKLI----QNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH--HHHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HHHHH----hcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 322 11111 111100 111223456889999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=414.59 Aligned_cols=256 Identities=29% Similarity=0.429 Sum_probs=204.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.+|++++|||||+++|+|.+ +..++|||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35799999999999999999999888899999987543 345789999999999999999999999955 5689999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.......++|.+++.|+.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999999876656679999999999999999999999 899999999999999999999999999998775444444
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETI 746 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~ 746 (842)
.....||+.|+|||++..+.++.++|||||||+||||++|..|+....... .+..++.. +... ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i~~----~~~~---------~~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVER----GYRM---------PC 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT----TCCC---------CC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHh----cCCC---------CC
Confidence 455679999999999999999999999999999999999655554332221 12222211 1100 11
Q ss_pred cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 747 CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 747 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
......++.+++.+||+.+|++||+|++|+++|+..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 122345688999999999999999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=409.05 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=200.1
Q ss_pred eEEeecCcEEEEEEEEcC---CcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEecCC
Q 037607 514 AVIGVGGFGKVYIGVLED---GNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYMAN 588 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~---g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 588 (842)
++||+|+||+||+|.+++ ++.||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 467999998653 33345789999999999999999999999965 467899999999
Q ss_pred CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce--
Q 037607 589 GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV-- 666 (842)
Q Consensus 589 gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~-- 666 (842)
|+|.+++. ....+++.+++.|+.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999984 34579999999999999999999999 999999999999999999999999999998765443322
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....||+.|||||.+.+..++.++|||||||++|||++ |++||......+ +...+ .++....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i----~~~~~~~--------- 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML----EKGERMG--------- 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTTCCCC---------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHH----HcCCCCC---------
Confidence 234568999999999999999999999999999999997 899998654332 11111 1111111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
.+.....++.+++.+||+.+|.+||+++||+++|+...
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11223456788999999999999999999999887653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=411.48 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=195.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--CCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE--QSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~--~~~~~lV 582 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999964 6899999987654 34556789999999999999999999999854 4568999
Q ss_pred EEecCCCCccccccc--CCCCCCchHHHHHHHHHHHHHHHHHHhCC--CCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 583 YEYMANGPFRDHLYG--TNQPPLSWKQRLEICIGSARGLHYLHTGA--AQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~--~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
||||++|+|.+++.. +....+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999998853 24567999999999999999999999832 23599999999999999999999999999988
Q ss_pred cCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKII 738 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~ 738 (842)
...... ......||+.|||||++.+..++.++|||||||++|||++|++||......+ +...+ .++....+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i----~~~~~~~~- 234 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----REGKFRRI- 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTCCCCC-
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHH----HcCCCCCC-
Confidence 654322 2345779999999999999999999999999999999999999998654322 11111 11111111
Q ss_pred chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 739 DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 739 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
+.....++.+++.+||+.||.+||++.|+++
T Consensus 235 --------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 --------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122346788999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=403.26 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=196.5
Q ss_pred ccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc----CCeEEEEE
Q 037607 511 DENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE----QSEMILVY 583 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~----~~~~~lV~ 583 (842)
+....||+|+||+||+|... +++.||+|++... .....++|.+|+++|++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999975 6889999987543 45556789999999999999999999999854 45689999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCc--eEeccCCCCCEEEc-CCCceEEeecccccccC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQG--IIHRDVKTTNILLD-ENLVAKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILld-~~~~~kl~DFGla~~~~ 660 (842)
|||++|+|.+++. ....+++.+++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999984 34578999999999999999999998 66 99999999999996 58899999999998653
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.. ......||+.|||||++.+ .++.++|||||||++|||++|++||........ +... ...+.. .+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~----i~~~~~----~~ 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR----VTSGVK----PA 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH----HTTTCC----CG
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHH----HHcCCC----Cc
Confidence 32 2346689999999998865 699999999999999999999999975543221 1111 111110 11
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
. +......++.+++.+||+.+|++|||+.|+++
T Consensus 233 ~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 11122345788999999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=409.32 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=207.1
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
+.|++.+.||+|+||+||+|... +|+.||||++........++|.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999975 68999999987766677788999999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.+++.+ ...++++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 99999998743 24579999999999999999999999 999999999999999999999999999997653211 12
Q ss_pred eeeeccCCCCCCccccc-----ccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchh
Q 037607 667 STAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPV 741 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~ 741 (842)
.....||+.|||||++. ...++.++|||||||+||||++|++||......+.. ..... +....+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~~i~~----~~~~~~~~-- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---LKIAK----SEPPTLAQ-- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHH----SCCCCCSS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH---HHHHc----CCCCCCCc--
Confidence 23467999999999984 456899999999999999999999999876543321 11111 11111111
Q ss_pred HHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 742 IAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 742 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 -----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 -----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11233567889999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=411.57 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=214.2
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEee
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFC 573 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~ 573 (842)
.+++...++|++.+.||+|+||+||+|++. +++.||||+++... .+..++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344455788999999999999999999964 35689999987653 44467899999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCCcccccccCC----------------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceE
Q 037607 574 DEQSEMILVYEYMANGPFRDHLYGTN----------------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGII 631 (842)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iv 631 (842)
...+..++||||+++|+|.++++... ...+++.+++.|+.|++.||+|||+ ++||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 99999999999999999999885321 2358999999999999999999999 9999
Q ss_pred eccCCCCCEEEcCCCceEEeecccccccCCCC-CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCC-CC
Q 037607 632 HRDVKTTNILLDENLVAKVADFGLSKAAPMDR-GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PV 709 (842)
Q Consensus 632 HrDIKp~NILld~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~-~p 709 (842)
||||||+|||||.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++|||||||+||||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654322 22334567899999999999999999999999999999999985 66
Q ss_pred CCCCCchhhhhHHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 037607 710 INPKLPREQVSLAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAM 783 (842)
Q Consensus 710 ~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~ 783 (842)
+......+. ...+ .++.... .+...+.++.+++.+||+.+|.+||||.||+++|+++.
T Consensus 243 ~~~~~~~e~---~~~v----~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEV---IYYV----RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHH---HHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHH---HHHH----HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 765543331 1111 1222111 12233456889999999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=416.03 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=205.8
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.. .....+++.+|+++|++++|||||+++++|.+.+..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999964 6899999997654 33445789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
||++|+|.+++.+ ...+++..+..++.|+++||+|||+ .++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 9999999999943 3569999999999999999999997 148999999999999999999999999999875422
Q ss_pred ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH-HHHhh--------------
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW-ALQCH-------------- 729 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~-~~~~~-------------- 729 (842)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....... .....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 12356899999999999999999999999999999999999999987653321110000 00000
Q ss_pred cc--------cccccccchhHHh---hh-cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 730 RK--------GILEKIIDPVIAE---TI-CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 730 ~~--------~~l~~i~d~~l~~---~~-~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.. ....+..+..... .. ......++.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0000000000000 00 00113568899999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=402.45 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=202.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC----CcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED----GNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~----g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.++|++.+.||+|+||+||+|++.. +..||||+++.. .....+.|.+|+++|++++|||||+++|+|. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678999999999999999998642 356899998754 3444678999999999999999999999996 467899
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
|||||++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999988743 44579999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 662 DRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 662 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
..........||+.|+|||++.+..++.++|||||||++|||++ |++||......+ +...+.. +....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~----~~~~~---- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----GERLP---- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----TCCCC----
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----CCCCC----
Confidence 44444556678999999999999999999999999999999997 899998765433 2222211 11111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
.++.....+.+++.+||+.+|.+|||+.||++.|+.+++.++
T Consensus 230 -----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 230 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 122334568899999999999999999999999998876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-46 Score=411.80 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=211.0
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++|+|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999974 6899999999877777778899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc--CCCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD--ENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld--~~~~~kl~DFGla~~~~~~~ 663 (842)
|++|+|.+++.. ....+++..++.|+.||+.||+|||+ ++||||||||+||||+ .++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999998843 34569999999999999999999999 9999999999999995 46789999999998765332
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
......||+.|||||++.+..++.++|||||||++|||++|++||......+.. .-+... .... ...
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~i~~~--~~~~----~~~-- 247 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNVKSC--DWNM----DDS-- 247 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHT--CCCS----CCG--
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHhC--CCCC----Ccc--
Confidence 345678999999999999999999999999999999999999999866433221 111110 0000 111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
........+.+++.+||+.||.+|||+.|+++.
T Consensus 248 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467889999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=400.48 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=201.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-CCeEEEEEEec
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-QSEMILVYEYM 586 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~~~~lV~Ey~ 586 (842)
++|+..++||+|+||.||+|.++ |+.||||+++... ..++|.+|+++|++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999999985 7899999997543 34789999999999999999999999854 56689999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
++|+|.++|.......++|..+++|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 99999999965555568999999999999999999999 99999999999999999999999999999875422
Q ss_pred eeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHHhh
Q 037607 667 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIAET 745 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~~~ 745 (842)
.....++..|+|||++.+..++.++|||||||++|||++ |++|+...... .+..++.. +....
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~----~~~~~--------- 220 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK----GYKMD--------- 220 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT----TCCCC---------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CCCCC---------
Confidence 234467899999999999999999999999999999998 78887755332 23333221 11111
Q ss_pred hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 746 ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 746 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+......++.+++.+||+.||.+||||.|++++|++++.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 122233567889999999999999999999999988754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=408.12 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=204.3
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999974 6899999987642 2234567999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999884 34579999999999999999999999 999999999999999999999999999998775332
Q ss_pred -CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 664 -GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 664 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
........||+.|||||++.+..++.++|||||||+||||++|++||......+. ...+ .++..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i----~~~~~-------- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKI----IKLEY-------- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HTTCC--------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHH----HcCCC--------
Confidence 2233456799999999999999999999999999999999999999986543321 1111 11111
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.++.....++.+++.+||+.||.+|||++|+++.
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0111223467889999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-47 Score=409.54 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=202.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..|+..+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++|+|||||++++++.+.+..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35889999999999999999964 68899999876542 344567999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|..++ ....++++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~--~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999997665 334679999999999999999999999 9999999999999999999999999999987542
Q ss_pred CceeeeeccCCCCCCcccccc---cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 664 GYVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
.....||+.|||||++.+ ..|+.++|||||||++|||++|++||......+.. .... . +......
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---~~i~---~-~~~~~~~-- 235 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIA---Q-NESPALQ-- 235 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH---H-SCCCCCS--
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH---HHHH---h-CCCCCCC--
Confidence 234579999999999864 46899999999999999999999999765432211 1111 1 1111111
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11223467889999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-46 Score=409.77 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=210.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++|+|||||++++++.+.+.++|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999964 7999999998877666677899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc--CCCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD--ENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld--~~~~~kl~DFGla~~~~~~~ 663 (842)
|++|+|.+++. ....++++.+++.|+.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~-~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 108 LSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCCBHHHHTT-CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCCChHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999988773 334579999999999999999999999 9999999999999997 6789999999999887543
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||+.|||||++.+..++.++|||||||+||||++|++||......+.. ..+.. +... ..
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~~----~~~~------~~ 248 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR----CDWE------FD 248 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH----CCCC------CC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----CCCC------CC
Confidence 2345677999999999999999999999999999999999999999865433211 11111 1000 00
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112234567899999999999999999999763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=407.35 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=192.1
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS-EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
..+.|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999975 68999999876543 233456889999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeecccccccC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAP 660 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~~~ 660 (842)
|||++|+|.+++. ....+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999994 35679999999999999999999999 9999999999999994 57899999999998654
Q ss_pred CCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccch
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDP 740 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~ 740 (842)
... .....+||+.|||||++.+..++.++|||||||+||||++|++||......+ +...... +... ..
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~----~~~~--~~- 229 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILK----AEYE--FD- 229 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHT----TCCC--CC-
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhc----cCCC--CC-
Confidence 322 2345679999999999999999999999999999999999999998654332 1111111 1000 00
Q ss_pred hHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 741 VIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 741 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 ---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01112234567899999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=404.91 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=204.0
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc----EEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN----KVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMIL 581 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~----~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~l 581 (842)
.+|++.++||+|+||+||+|.+. +|+ +||+|+++.. ..+..++|.+|+++|++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 36999999999999999999864 443 6899987653 445568899999999999999999999999764 5778
Q ss_pred EEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCC
Q 037607 582 VYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPM 661 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~ 661 (842)
++||+.+|+|.+.+.. ....+++..+++|+.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 8999999999988754 35679999999999999999999999 8999999999999999999999999999997754
Q ss_pred CCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 662 DRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 662 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .......||+.|||||++.++.++.++|||||||+||||+| |++||+.....+. ...+.. +. ..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i~~----~~--~~-- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEK----GE--RL-- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHHHH----TC--CC--
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc----CC--CC--
Confidence 332 23345578999999999999999999999999999999998 7889876644332 111111 10 00
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
..+......+.+++.+||+.+|.+||++.||++.|+....
T Consensus 233 -----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0112234567889999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=399.20 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=206.1
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC------ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG------SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~------~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.+.|++.+.||+|+||+||+|+.. +|+.||||++... .....++|.+|+++|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 7899999986532 122357899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC----ceEEeeccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL----VAKVADFGL 655 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~----~~kl~DFGl 655 (842)
+||||||++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999843 4579999999999999999999999 9999999999999998766 599999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILE 735 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~ 735 (842)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|++||......+.. .... .....
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~----~~~~~ 234 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVS----AVNYE 234 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----TTCCC
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---HHHH----hcCCC
Confidence 98764332 334567899999999999999999999999999999999999999866433211 1111 11000
Q ss_pred cccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 736 KIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 736 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+ .........+.+++.+||+.||.+|||+.|+++
T Consensus 235 --~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011 111223456788999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=400.67 Aligned_cols=262 Identities=22% Similarity=0.364 Sum_probs=202.0
Q ss_pred HhcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc-C
Q 037607 506 ATQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE-Q 576 (842)
Q Consensus 506 at~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~-~ 576 (842)
..++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+++.+|+.++.++ +|+||+.+++++.+ .
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3478999999999999999999964 2467999998754 345567788999988887 68999999998865 4
Q ss_pred CeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
...++|||||++|+|.++++... ...+++.+++.++.||++||+|||+ ++|+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 56899999999999999985432 3458999999999999999999999 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhC-CCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG-~~p~~~~~~~~~~~ 720 (842)
++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++| .+||......+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999987653332 233456799999999999999999999999999999999986 567765433221
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
+. ....++.... .......++.+++.+||+.+|.+|||+.|++++|+.+++.
T Consensus 246 ~~----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FC----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 1111111111 1122345678999999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=398.12 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=198.2
Q ss_pred cCcccceEEeecCcEEEEEEEEcC--C--cEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLED--G--NKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~--g--~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
++|++.+.||+|+||+||+|++.. + ..||||+++.. ..+..++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 3 36899987653 34456789999999999999999999999976 4678
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|||||++|+|.+.+.. ....+++..+++++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988753 34569999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCCc--eeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 661 MDRGY--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 661 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
..... ......|+..|+|||.+.+..++.++|||||||++|||++ |++||......+ +..++. +.+.-..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~---~~~~~~~- 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KEGERLP- 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TSCCCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH---hCCCCCC-
Confidence 43322 2234567889999999999999999999999999999998 899997654332 222221 1111000
Q ss_pred cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 037607 738 IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYA 782 (842)
Q Consensus 738 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~ 782 (842)
........+.+++.+||+.+|.+||||.||++.|+++
T Consensus 236 --------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 --------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122335688999999999999999999999998865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=400.43 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=212.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~ 578 (842)
.++|++.++||+|+||.||+|++. +++.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468889999999999999999863 3568999998764 344556899999999999 69999999999999999
Q ss_pred EEEEEEecCCCCcccccccCC----------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 579 MILVYEYMANGPFRDHLYGTN----------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
.+||||||++|+|.++++... ...+++..+++++.||++||+|||+ ++++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 999999999999999986432 2368999999999999999999999 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+|+......+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999998764433 33355789999999999999999999999999999999998 5666655443322
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
+.+.+.. +.. ..........+.+++.+||+.+|.+||+|.||+++|++.+.
T Consensus 257 ~~~~i~~----~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 FYKMIKE----GFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHH----TCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhc----CCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111111 100 01112234568899999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=398.65 Aligned_cols=258 Identities=30% Similarity=0.453 Sum_probs=205.9
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCc--EEEEEECCCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGN--KVAIKRGNPG-SEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~--~VAvK~~~~~-~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|++.++||+|+||+||+|++. +|. .||||++... ..+..++|.+|+++|+++ +|||||+++|+|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999975 344 5788887543 344567899999999999 799999999999999999999
Q ss_pred EEecCCCCcccccccC--------------CCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCce
Q 037607 583 YEYMANGPFRDHLYGT--------------NQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVA 648 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~ 648 (842)
|||+++|+|.++|+.. ....+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999998643 34679999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHH
Q 037607 649 KVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWALQ 727 (842)
Q Consensus 649 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~-~p~~~~~~~~~~~l~~~~~~ 727 (842)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||......+ +.+.+
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG--
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHH--
Confidence 999999998654222 223456899999999999999999999999999999999975 5665543222 22111
Q ss_pred hhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 728 CHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 728 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.++.. + ........++.+++.+||+.+|++||+|.||++.|+.+.+..
T Consensus 240 --~~~~~-----~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 --PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp --GGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --HhcCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11110 1 111223456889999999999999999999999999886543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-45 Score=391.70 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=202.6
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC----e
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS----E 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~----~ 578 (842)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....++|.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 47899999998653 3444568999999999999999999999986543 4
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.+||||||++++|.+++. ....+++.+++.|+.||++||+|||+ ++|+||||||+||||+.++..+|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999998883 34579999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC--CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 659 APMDR--GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 659 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
..... ........||+.|||||++.+..++.++|||||||++|||++|++||......+. ...........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~- 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP- 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC-
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCC-
Confidence 54322 2234456799999999999999999999999999999999999999986543321 11111111110
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRP-GMGDVLWNLEYA 782 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~evl~~Le~~ 782 (842)
..........++.+++.+||+.||.+|| +++|++..|.+.
T Consensus 234 ------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0111122345688899999999999999 899999888765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=395.26 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=203.7
Q ss_pred ceEEeecCcEEEEEEEEcCC----cEEEEEECCC-CChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-CCeEEEEEEec
Q 037607 513 NAVIGVGGFGKVYIGVLEDG----NKVAIKRGNP-GSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-QSEMILVYEYM 586 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~~g----~~VAvK~~~~-~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-~~~~~lV~Ey~ 586 (842)
.++||+|+||+||+|.+.++ ..||||+++. ......++|.+|+++|++++||||++++|+|.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 2589999875 356667889999999999999999999999865 56899999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC--
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG-- 664 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~-- 664 (842)
++|+|.+++.. ....+++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999998853 45577889999999999999999999 9999999999999999999999999999987653322
Q ss_pred -ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 665 -YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 665 -~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......||+.|+|||.+....++.++||||||++||||++|+.|+...... ..+..++.... ....|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~------~~~~p--- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR------RLLQP--- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC------CCCCC---
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC------CCCCc---
Confidence 2233457899999999999999999999999999999999987777644322 22223322211 11111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
......+.+++.+||+.+|.+||+|.||++.|+.+.+
T Consensus 257 ----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 ----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1223467889999999999999999999999998865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=394.54 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=208.7
Q ss_pred hcCcccceEEeecCcEEEEEEEEcC--------CcEEEEEECCCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEeeccC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLED--------GNKVAIKRGNPGS-EQGINEFQTEIQMLSKL-RHRHLVSLIGFCDEQ 576 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~~--------g~~VAvK~~~~~~-~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~~ 576 (842)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578889999999999999998532 2479999987654 45568899999999988 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCC--------------CCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEE
Q 037607 577 SEMILVYEYMANGPFRDHLYGTN--------------QPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILL 642 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILl 642 (842)
+..++|||||++|+|.++|.... ...+++.+++.++.||+.||+|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999995432 2468999999999999999999999 999999999999999
Q ss_pred cCCCceEEeecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 037607 643 DENLVAKVADFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVINPKLPREQVS 720 (842)
Q Consensus 643 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELlt-G~~p~~~~~~~~~~~ 720 (842)
+.++.+||+|||+++....... .......|++.|+|||.+.++.++.|+|||||||++|||++ |++||......+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999987754322 23345678999999999999999999999999999999998 788887554322
Q ss_pred HHHHHHHhhcccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhh
Q 037607 721 LAEWALQCHRKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQL 785 (842)
Q Consensus 721 l~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~ 785 (842)
+.+++. .+.... .+......+.+++.+||+.+|.+|||+.||+++|+++..+
T Consensus 246 ~~~~i~----~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 LFKLLK----EGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHH----TTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH----cCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 222211 111111 1112335688999999999999999999999999988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=400.50 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=207.1
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999997 47999999997643 223457789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999884 34578999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. ......+||+.|||||++.+..++.++||||+||+||||++|++||......+ +..... .+.+.
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~----~~~~~------- 223 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL----MEEIR------- 223 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCCCC-------
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHh----cCCCC-------
Confidence 2 23445789999999999999999999999999999999999999998765432 111111 11110
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWN 778 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~ 778 (842)
++.....++.+++.+||+.||.+||+ +.|+++.
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11122345778999999999999995 7777763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=396.49 Aligned_cols=270 Identities=23% Similarity=0.324 Sum_probs=203.3
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC----eEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS----EMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~----~~~lV~ 583 (842)
..|...+.||+|+||.||+|++ +|+.||||++...... ...+..|+..+++++|||||+++++|.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577788999999999999997 5889999998644221 122334555556789999999999996543 689999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhC-----CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG-----AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-----~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
|||++|+|.++|+. .+++|.++++++.|+|.||+|||+. ..++|+||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999954 3699999999999999999999973 246999999999999999999999999999987
Q ss_pred cCCCCCc---eeeeeccCCCCCCccccccc------CCCCcccchhHHHHHHHHHhCCCCCCCCCchhh----h----hH
Q 037607 659 APMDRGY---VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQ----V----SL 721 (842)
Q Consensus 659 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~----~----~l 721 (842)
....... ......||+.|+|||++.+. .++.|+|||||||+||||++|.+|+........ . ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7543322 23456799999999998754 367899999999999999999988754322111 0 01
Q ss_pred HHHHHHhhcccccccccchhHHhh-hcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhh
Q 037607 722 AEWALQCHRKGILEKIIDPVIAET-ICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQ 786 (842)
Q Consensus 722 ~~~~~~~~~~~~l~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~ 786 (842)
.+........ ...+|.+... ...+....+.+++.+||+.+|.+||||.||+++|+++.+.+
T Consensus 238 ~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1111111111 1122222122 13456678999999999999999999999999998876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-45 Score=397.37 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=204.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 6899999997642 2234578999999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
|||++|+|..++. ....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999998883 45567889999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
....+||+.|||||++.+..++.++|||||||+||||++|++||......+.. .-+ ..+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i----~~~~~--------- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---EKI----LNAEL--------- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH----HHCCC---------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH---HHH----HcCCC---------
Confidence 23567999999999999999999999999999999999999999865433211 111 11110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
.++......+.+++.+||+.+|.+|| +++|+++.
T Consensus 219 -~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01112234578899999999999996 88888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=394.17 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=211.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc------CCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE------DGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~------~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~ 579 (842)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. ..+....|.+|++++++++|||||+++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467889999999999999999863 3578999998754 445556799999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccc--------CCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEe
Q 037607 580 ILVYEYMANGPFRDHLYG--------TNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVA 651 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~--------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~ 651 (842)
++|||||++|+|.+++.. .....+++..+++++.|+++||.|||+ ++|+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 999999999999998853 223467999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCC-ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHhh
Q 037607 652 DFGLSKAAPMDRG-YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVINPKLPREQVSLAEWALQCH 729 (842)
Q Consensus 652 DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~-~p~~~~~~~~~~~l~~~~~~~~ 729 (842)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+ +|+......+.. ..+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~---~~i---- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFV---- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHH----
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----
Confidence 9999987643322 2234456899999999999999999999999999999999985 677654332211 111
Q ss_pred cccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHh
Q 037607 730 RKGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQ 784 (842)
Q Consensus 730 ~~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~ 784 (842)
.++....+ .......+.+++.+||+.+|.+||+|.||+++|+..++
T Consensus 249 ~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111111 11233568899999999999999999999999987644
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-44 Score=383.76 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=204.5
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC---------hhhHHHHHHHHHHHHhcC-CCceeeEEEeeccC
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS---------EQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQ 576 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~---------~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~ 576 (842)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 478999999875432 112346889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccc
Q 037607 577 SEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLS 656 (842)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla 656 (842)
+..+||||||++|+|.++|. ...++++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999994 34579999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccc------cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHR 730 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~ 730 (842)
+...... ......||..|+|||.+.+ ..++.++||||+||+||||++|++||......+.. ... .
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~---~~i----~ 228 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMI----M 228 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----H
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH---HHH----H
Confidence 8764322 3345679999999999864 35688999999999999999999999876533211 111 1
Q ss_pred ccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 731 KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 731 ~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.+... ...+ .......++.+++.+||+.+|.+||++.|+++.
T Consensus 229 ~~~~~-~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCCC-CCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111 0000 111233568899999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=386.02 Aligned_cols=259 Identities=24% Similarity=0.265 Sum_probs=198.5
Q ss_pred ceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChh-----hHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEec
Q 037607 513 NAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQ-----GINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEYM 586 (842)
Q Consensus 513 ~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~-----~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 586 (842)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++...+..+||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999964 6899999998654321 1246889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCce
Q 037607 587 ANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGYV 666 (842)
Q Consensus 587 ~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 666 (842)
.++++..++ .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 83 ~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp SEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred cchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 988777665 455679999999999999999999999 9999999999999999999999999999987654322 2
Q ss_pred eeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc------------
Q 037607 667 STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI------------ 733 (842)
Q Consensus 667 ~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------------ 733 (842)
.....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+......-.........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 234579999999999875 4679999999999999999999999987655443221111100000000
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
...... .............+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~-~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 237 FKSFPG-IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCC-CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCCC-CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 00111112234568899999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=391.57 Aligned_cols=253 Identities=20% Similarity=0.311 Sum_probs=201.2
Q ss_pred hcCcccce-EEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhc-CCCceeeEEEeecc----CCeE
Q 037607 507 TQNFDENA-VIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKL-RHRHLVSLIGFCDE----QSEM 579 (842)
Q Consensus 507 t~~f~~~~-~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L-~HpnIv~l~g~~~~----~~~~ 579 (842)
.++|.+.. +||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788765 699999999999996 47899999998643 4578899987655 89999999999864 5678
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC---CCceEEeecccc
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE---NLVAKVADFGLS 656 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~---~~~~kl~DFGla 656 (842)
+||||||+||+|.++|.......+++.+++.|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 999999999999999976556789999999999999999999999 99999999999999975 567999999999
Q ss_pred cccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 657 KAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 657 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
+...... ......||+.|||||++.+..++.++|||||||+||||++|++||......+.. .........+...
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~~- 235 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYE- 235 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS-
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCCC-
Confidence 8765432 234567999999999999999999999999999999999999999765432211 1111111111100
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+..........++.+++.+||+.+|.+||++.|+++.
T Consensus 236 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 -----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011112334568899999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=387.66 Aligned_cols=254 Identities=17% Similarity=0.232 Sum_probs=208.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
.++|.+.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|++++|||||++++++.+.+.++|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999975 688999999876543 345688999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC--CCceEEeecccccccCCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE--NLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~--~~~~kl~DFGla~~~~~~~ 663 (842)
|++|+|.+++.. ....+++.++..|+.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999843 33479999999999999999999999 99999999999999974 458999999999876432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.......+|+.|+|||.+.+..++.++||||+||++|||++|++||......+.. .-+. .+.. ..+....
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~~i~----~~~~--~~~~~~~ 227 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIM----NAEY--TFDEEAF 227 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHH----HTCC--CCCHHHH
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC--CCChhhc
Confidence 2345567999999999999999999999999999999999999999876443211 1111 0100 0111111
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLE 780 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le 780 (842)
.....++.+++.+||+.||.+||++.|+++.-+
T Consensus 228 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 228 ----KEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 122345788999999999999999999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-44 Score=395.68 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=204.7
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~ 583 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999974 7999999987542 2234567899999999999999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDR 663 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~ 663 (842)
||+.+|+|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999998843 3579999999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhHH
Q 037607 664 GYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVIA 743 (842)
Q Consensus 664 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l~ 743 (842)
.....||+.|||||++.+..++.++|||||||+||||++|++||........ ...+. .+...
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~----~~~~~-------- 256 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIV----SGKVR-------- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCCC--------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---HHHHh----cCCCC--------
Confidence 2346799999999999999999999999999999999999999986543221 11111 11110
Q ss_pred hhhcHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 037607 744 ETICKESLRKYVEAAEKCLAEYGVDRP-----GMGDVLWN 778 (842)
Q Consensus 744 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~evl~~ 778 (842)
.+.....++.+++.+||+.||.+|+ ++.|+++.
T Consensus 257 --~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1112234678899999999999994 88888763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-44 Score=394.53 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=199.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC---hhhHHHHH---HHHHHHHhcCCCceeeEEEeeccCCeEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS---EQGINEFQ---TEIQMLSKLRHRHLVSLIGFCDEQSEMI 580 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~---~~~~~~f~---~Ei~il~~L~HpnIv~l~g~~~~~~~~~ 580 (842)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+. +|+++++.++|||||++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 68999999875321 11223344 4467777788999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
+|||||++|+|.++|. ....+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999984 34578899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccc
Q 037607 661 MDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIID 739 (842)
Q Consensus 661 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d 739 (842)
... .....||+.|||||++.. ..++.++|||||||+||||++|++||......+...+. ........
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~~~----- 226 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMAV----- 226 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSCCC-----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccCCC-----
Confidence 332 345679999999999875 56899999999999999999999999876543322111 11111100
Q ss_pred hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 037607 740 PVIAETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLWN 778 (842)
Q Consensus 740 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~~ 778 (842)
.+......++.+++.+||+.||.+||+ ++|+++.
T Consensus 227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011122345788999999999999999 5777753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=380.19 Aligned_cols=265 Identities=20% Similarity=0.266 Sum_probs=203.5
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999996 578999999986532 2335789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
|+.++ +.+++.......+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 99754 5555545566789999999999999999999999 999999999999999999999999999998765332
Q ss_pred ceeeeeccCCCCCCcccccccC-CCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc-------
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK------- 736 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~------- 736 (842)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+......-......+.....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2234557999999999877655 57899999999999999999999987654332211100000000000000
Q ss_pred ------ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 737 ------IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 737 ------i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQD-FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCC-HHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccc-hhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 001112233577899999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-43 Score=377.76 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=204.1
Q ss_pred cCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS--EQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~--~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~Ey 585 (842)
++|+..+.||+|+||+||+|+..+|+.||||++.... ....+++.+|+.+|++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999986543 23357899999999999999999999999999999999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCCc
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRGY 665 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~~ 665 (842)
+.++.+..+. .....+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||++....... .
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 9887776665 445789999999999999999999999 999999999999999999999999999998764332 2
Q ss_pred eeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc-------
Q 037607 666 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI------- 737 (842)
Q Consensus 666 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i------- 737 (842)
......+++.|+|||.+.+ ..++.++|||||||++|||++|++||......+....................
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 2344568999999999875 56799999999999999999999999876544332211111100000000000
Q ss_pred -----cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 738 -----IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 738 -----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
..+.............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011112223456889999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=390.86 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=203.2
Q ss_pred cCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC---ChhhHHHHHHHHHHHH-hcCCCceeeEEEeeccCCeEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG---SEQGINEFQTEIQMLS-KLRHRHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~---~~~~~~~f~~Ei~il~-~L~HpnIv~l~g~~~~~~~~~lV 582 (842)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+..|+.++. .++|||||++++++.+.+..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 6899999998642 1233466778887765 68999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCC
Q 037607 583 YEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~ 662 (842)
||||++|+|.+++. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999984 34568999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccccchhH
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKIIDPVI 742 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i~d~~l 742 (842)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .-+ ..+. +.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i----~~~~------~~- 221 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---HSI----RMDN------PF- 221 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCC------CC-
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHH----HcCC------CC-
Confidence 2 2334567999999999999999999999999999999999999999876543311 111 1110 00
Q ss_pred HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 037607 743 AETICKESLRKYVEAAEKCLAEYGVDRPGMG-DVLW 777 (842)
Q Consensus 743 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~-evl~ 777 (842)
++.....++.+++.+||+.+|.+||++. |+++
T Consensus 222 ---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1112234578999999999999999985 6754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=375.99 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=200.6
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-C-CcEEEEEECCCC--ChhhHHHHHHHHHHHHhc---CCCceeeEEEeec-----
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-D-GNKVAIKRGNPG--SEQGINEFQTEIQMLSKL---RHRHLVSLIGFCD----- 574 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~-g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L---~HpnIv~l~g~~~----- 574 (842)
.++|++.+.||+|+||+||+|+.. + ++.||||++... .......+.+|+++|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999973 4 567999987532 222233566788777766 7999999999984
Q ss_pred cCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecc
Q 037607 575 EQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFG 654 (842)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFG 654 (842)
.....+++||||.++.+.... ......+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 345789999999987765443 3456678999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 655 LSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 655 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|++||......+.................
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98865322 2335667999999999999999999999999999999999999999877554433222111111000000
Q ss_pred cc-------c---cchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EK-------I---IDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~-------i---~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.. . ..+.....+.......+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0 00000111222234567889999999999999999998763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=377.03 Aligned_cols=241 Identities=22% Similarity=0.372 Sum_probs=194.9
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCC------hhhHHHHHHHHHHHHhcC--CCceeeEEEeeccCC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGS------EQGINEFQTEIQMLSKLR--HRHLVSLIGFCDEQS 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~------~~~~~~f~~Ei~il~~L~--HpnIv~l~g~~~~~~ 577 (842)
.++|++.++||+|+||+||+|+.. +|+.||||++.... .....++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 78999999875321 111234779999999996 899999999999999
Q ss_pred eEEEEEEecCC-CCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-CCceEEeeccc
Q 037607 578 EMILVYEYMAN-GPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-NLVAKVADFGL 655 (842)
Q Consensus 578 ~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-~~~~kl~DFGl 655 (842)
..++||||+.+ +++.+++. ....+++.+++.++.||++||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 56666663 34579999999999999999999999 99999999999999985 47999999999
Q ss_pred ccccCCCCCceeeeeccCCCCCCcccccccCC-CCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccc
Q 037607 656 SKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGIL 734 (842)
Q Consensus 656 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l 734 (842)
|+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... + .. ..-.+
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i----~~--~~~~~ 223 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I----IR--GQVFF 223 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H----HH--CCCCC
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H----hh--cccCC
Confidence 9875432 2345679999999999987765 5779999999999999999999964310 0 00 00000
Q ss_pred ccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 735 EKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 735 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
......++.+++.+||+.||.+|||++|+++.
T Consensus 224 ------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 224 ------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11123457889999999999999999998764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=366.33 Aligned_cols=264 Identities=19% Similarity=0.236 Sum_probs=201.5
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeE-EEeeccCCeEEEEEEe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSL-IGFCDEQSEMILVYEY 585 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l-~g~~~~~~~~~lV~Ey 585 (842)
++|++.+.||+|+||+||+|++ .+|+.||||++...... .++..|++++++++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999996 46899999986654332 457899999999987765555 4555777889999999
Q ss_pred cCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEc---CCCceEEeecccccccCCC
Q 037607 586 MANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLD---ENLVAKVADFGLSKAAPMD 662 (842)
Q Consensus 586 ~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld---~~~~~kl~DFGla~~~~~~ 662 (842)
+. ++|.+.+. .....+++..++.++.|+++||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~~-~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhh-hccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 94 56666553 344679999999999999999999999 9999999999999985 4567999999999977543
Q ss_pred CC------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 663 RG------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 663 ~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
.. .......||+.|||||.+.+..++.++|||||||++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~----- 234 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----- 234 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-----
Confidence 22 1234567999999999999999999999999999999999999999876543322111111000000
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
..........+.++.+++.+|++.+|.+||++.++.+.|+.......
T Consensus 235 ----~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 235 ----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp ----SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 00111222344678899999999999999999999999987765433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=369.34 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=201.5
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc--------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-------- 575 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-------- 575 (842)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999997 47999999987543 33345778999999999999999999998844
Q ss_pred CCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccc
Q 037607 576 QSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGL 655 (842)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGl 655 (842)
....++||||+.++.+.... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 34689999999887766554 455678899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC---ceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcc
Q 037607 656 SKAAPMDRG---YVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRK 731 (842)
Q Consensus 656 a~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 731 (842)
++....... .......||+.|+|||++.+. .++.++|||||||++|||++|++||......+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 986653221 122345699999999998764 6899999999999999999999999876554433322222111111
Q ss_pred cccccccc--------------hhHHhhh-cHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 732 GILEKIID--------------PVIAETI-CKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 732 ~~l~~i~d--------------~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
........ ..+...+ .......+++++.+||+.||++|||++|+++.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 11111000 0001100 011134567899999999999999999998643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-41 Score=363.57 Aligned_cols=265 Identities=15% Similarity=0.153 Sum_probs=211.4
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC-CceeeEEEeeccCCeEEEEEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH-RHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H-pnIv~l~g~~~~~~~~~lV~E 584 (842)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ..++.+|+++++.|+| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999965 689999998754432 2457889999999975 899999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcC-----CCceEEeeccccccc
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDE-----NLVAKVADFGLSKAA 659 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~-----~~~~kl~DFGla~~~ 659 (842)
|+ +++|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 6899888743 34578999999999999999999999 99999999999999964 578999999999876
Q ss_pred CCCCC------ceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc
Q 037607 660 PMDRG------YVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI 733 (842)
Q Consensus 660 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 733 (842)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||..............+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-
Confidence 43221 12345679999999999999999999999999999999999999998665443322221111111100
Q ss_pred cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHhhhh
Q 037607 734 LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNLEYAMQLQE 787 (842)
Q Consensus 734 l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~Le~~~~~~~ 787 (842)
...+++...+.++.+++..|+..+|.+||+++.+.+.|+.+++...
T Consensus 236 --------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 --------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp --------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1122223344668889999999999999999999999988766443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=371.37 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=199.2
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC----eEE
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG-SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS----EMI 580 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~-~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~----~~~ 580 (842)
+.+|++.+.||+|+||+||+|.. .+|+.||||++... .....+++++|+++|++|+||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 47999999998754 3445678999999999999999999999986543 335
Q ss_pred EEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccC
Q 037607 581 LVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAP 660 (842)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~ 660 (842)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+ ++||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55566779999999843 369999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCC--ceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccccccc
Q 037607 661 MDRG--YVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEKI 737 (842)
Q Consensus 661 ~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~i 737 (842)
.... .......||+.|+|||.+.. ..++.++||||+||++|||++|++||......+....................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3211 12345679999999999854 56789999999999999999999999876544332221111110000000000
Q ss_pred cc--------------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 738 ID--------------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 738 ~d--------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
.. +............++.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000001111223468899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=369.90 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=195.5
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCC------
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQS------ 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~------ 577 (842)
.++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 6999999998753 4455678999999999999999999999996554
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
++++||||| +.+|...+. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 556666552 3469999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc---
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI--- 733 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 733 (842)
..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|++||.......................
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 76432 245679999999999876 4678999999999999999999999987654333221111100000000
Q ss_pred ------------cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 ------------LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 ------------l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.+.....+ ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 01111223467889999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=371.73 Aligned_cols=261 Identities=25% Similarity=0.277 Sum_probs=195.8
Q ss_pred CcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCceeeEEEeecc------CCeEEE
Q 037607 509 NFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE------QSEMIL 581 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~------~~~~~l 581 (842)
+|...++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||++++++|.. ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 689999999865432 23579999999999999999999843 335799
Q ss_pred EEEecCCCCcccccc-cCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeeccccccc
Q 037607 582 VYEYMANGPFRDHLY-GTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAA 659 (842)
Q Consensus 582 V~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~ 659 (842)
|||||+++.+..+.+ ......+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998764444332 2345679999999999999999999998 9999999999999999775 8999999999876
Q ss_pred CCCCCceeeeeccCCCCCCcccccc-cCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHH---------HHHhh
Q 037607 660 PMDRGYVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEW---------ALQCH 729 (842)
Q Consensus 660 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~---------~~~~~ 729 (842)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|++||......+....... .....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4332 2234579999999998765 5789999999999999999999999987654433221111 00000
Q ss_pred c---ccccccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 730 R---KGILEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 730 ~---~~~l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
. ...+...................+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000011000001111112234567899999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=354.05 Aligned_cols=265 Identities=21% Similarity=0.262 Sum_probs=204.0
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeeccCCeEEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~~~~~~lV~E 584 (842)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ......++.+|+.+|++++||||++++++|......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 47889999987533 34456889999999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccccCCCCC
Q 037607 585 YMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKAAPMDRG 664 (842)
Q Consensus 585 y~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~~~~~~~ 664 (842)
++.+++|..++ .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccc--ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999888877 345678899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeeeccCCCCCCcccccccC-CCCcccchhHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhccccc---ccccc
Q 037607 665 YVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVINPKLPR-EQVSLAEWALQCHRKGIL---EKIID 739 (842)
Q Consensus 665 ~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwS~GvvL~ELltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~l---~~i~d 739 (842)
......++..|+|||.+.... ++.++|||||||++|||++|+.||...... +.............+... .+..+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 233445788999999987654 689999999999999999999886543322 221111111100000000 00000
Q ss_pred ---------hhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 740 ---------PVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 740 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
..-...........+.+++.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011122234567889999999999999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8e-40 Score=357.42 Aligned_cols=257 Identities=18% Similarity=0.249 Sum_probs=197.6
Q ss_pred cCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeecc--CCeEEEEE
Q 037607 508 QNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDE--QSEMILVY 583 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~--~~~~~lV~ 583 (842)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 478999999987543 357899999999995 9999999999863 45699999
Q ss_pred EecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC-ceEEeecccccccCCC
Q 037607 584 EYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL-VAKVADFGLSKAAPMD 662 (842)
Q Consensus 584 Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~-~~kl~DFGla~~~~~~ 662 (842)
|||.+++|.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 368999999999999999999999 9999999999999998654 6999999999876433
Q ss_pred CCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhh--H---------HHHHHHhhc
Q 037607 663 RGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVS--L---------AEWALQCHR 730 (842)
Q Consensus 663 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~--l---------~~~~~~~~~ 730 (842)
. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... + ..|......
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 23456789999999998764 57999999999999999999999997665432111 0 011111000
Q ss_pred cc--cccccc--------chhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 037607 731 KG--ILEKII--------DPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLW 777 (842)
Q Consensus 731 ~~--~l~~i~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~ 777 (842)
.. ...... ..............++.+++.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000 000001111122356789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=364.36 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=201.6
Q ss_pred cCcccceEEeecCcEEEEEEEEc----CCcEEEEEECCCC----ChhhHHHHHHHHHHHHhcCC-CceeeEEEeeccCCe
Q 037607 508 QNFDENAVIGVGGFGKVYIGVLE----DGNKVAIKRGNPG----SEQGINEFQTEIQMLSKLRH-RHLVSLIGFCDEQSE 578 (842)
Q Consensus 508 ~~f~~~~~LG~G~fg~Vykg~~~----~g~~VAvK~~~~~----~~~~~~~f~~Ei~il~~L~H-pnIv~l~g~~~~~~~ 578 (842)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 4789999987643 12334678899999999976 899999999999999
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.+++||||.+|+|.+++. ....+.+..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999984 33466788999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccCCCCCCccccccc--CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhccccccc
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGILEK 736 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~l~~ 736 (842)
.............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+..... ..... ...
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~-~~~--- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL-KSE--- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH-HCC---
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc-cCC---
Confidence 654433344556799999999998764 4788999999999999999999999876544322111 00000 000
Q ss_pred ccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 037607 737 IIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPG-----MGDVLW 777 (842)
Q Consensus 737 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~evl~ 777 (842)
..+......++.+++.+||+.+|.+||+ ++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0112234467888999999999999994 778775
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=359.75 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=193.2
Q ss_pred hcCcccceEEeecCcEEEEEEEEc-CCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeec------cCC
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVLE-DGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCD------EQS 577 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~~-~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~------~~~ 577 (842)
.++|++.++||+|+||+||+|... +|+.||||++... ......++.+|+.+|++++|||||++++++. ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 6999999997643 4455677999999999999999999999985 346
Q ss_pred eEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeeccccc
Q 037607 578 EMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSK 657 (842)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~ 657 (842)
.+|+|||||.++.+. .+ ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~----~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VI----QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHH-HH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHH-hh----hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence 889999999766554 33 2358999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHH---------HH---
Q 037607 658 AAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAE---------WA--- 725 (842)
Q Consensus 658 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~---------~~--- 725 (842)
..... .......+|+.|+|||++.+..++.++||||+||+++||++|++||............. +.
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 76432 23355678999999999999999999999999999999999999998664332211100 00
Q ss_pred ----HHhhcc-ccc-----ccccchhH---HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 037607 726 ----LQCHRK-GIL-----EKIIDPVI---AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWNL 779 (842)
Q Consensus 726 ----~~~~~~-~~l-----~~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~L 779 (842)
...... ... ..+..... ...........+.+++.+||+.||++|||++|+++.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 000000 000 00000000 0011233456789999999999999999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=359.62 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=197.4
Q ss_pred hcCcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEeecc-----CCe
Q 037607 507 TQNFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPG--SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDE-----QSE 578 (842)
Q Consensus 507 t~~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~--~~~~~~~f~~Ei~il~~L~HpnIv~l~g~~~~-----~~~ 578 (842)
.++|++.+.||+|+||+||+|+. .+|+.||||++... +....+++.+|+++|++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999996 47999999998754 34455678999999999999999999999853 334
Q ss_pred EEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 579 MILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
.+++++|+.+|+|.+++. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 567778888999999883 3469999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeeeeccCCCCCCccccccc-CCCCcccchhHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcccc----
Q 037607 659 APMDRGYVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVINPKLPREQVSLAEWALQCHRKGI---- 733 (842)
Q Consensus 659 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---- 733 (842)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.....................
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 532 23446689999999987764 568999999999999999999999987654332221111100000000
Q ss_pred -----------cccccchhHHhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 037607 734 -----------LEKIIDPVIAETICKESLRKYVEAAEKCLAEYGVDRPGMGDVLWN 778 (842)
Q Consensus 734 -----------l~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl~~ 778 (842)
+.+.....+. .........+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 0111223567899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-34 Score=320.41 Aligned_cols=263 Identities=18% Similarity=0.225 Sum_probs=192.2
Q ss_pred CcccceEEeecCcEEEEEEEE-cCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-----------CCceeeEEEeecc-
Q 037607 509 NFDENAVIGVGGFGKVYIGVL-EDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-----------HRHLVSLIGFCDE- 575 (842)
Q Consensus 509 ~f~~~~~LG~G~fg~Vykg~~-~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-----------HpnIv~l~g~~~~- 575 (842)
+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 599999999999999999997 479999999987543 33467889999998885 5789999988854
Q ss_pred -CCeEEEEEEecCCCCccc-ccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCC------c
Q 037607 576 -QSEMILVYEYMANGPFRD-HLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENL------V 647 (842)
Q Consensus 576 -~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~------~ 647 (842)
....+++|+++..+.... .........+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 345677777765544333 2334566788999999999999999999996 37899999999999997654 4
Q ss_pred eEEeecccccccCCCCCceeeeeccCCCCCCcccccccCCCCcccchhHHHHHHHHHhCCCCCCCCCchhhh----hHHH
Q 037607 648 AKVADFGLSKAAPMDRGYVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVINPKLPREQV----SLAE 723 (842)
Q Consensus 648 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwS~GvvL~ELltG~~p~~~~~~~~~~----~l~~ 723 (842)
+|++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||......... .+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999998765322 23467999999999999999999999999999999999999999754322111 1111
Q ss_pred HHHHhhc------------------cc---ccccccc----hhH--HhhhcHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 037607 724 WALQCHR------------------KG---ILEKIID----PVI--AETICKESLRKYVEAAEKCLAEYGVDRPGMGDVL 776 (842)
Q Consensus 724 ~~~~~~~------------------~~---~l~~i~d----~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~evl 776 (842)
.+..+.. .. .+..... ..+ ...........+.+++.+||..||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111000 00 0000000 000 1123456678899999999999999999999987
Q ss_pred HH
Q 037607 777 WN 778 (842)
Q Consensus 777 ~~ 778 (842)
+.
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 53
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.5e-22 Score=202.46 Aligned_cols=165 Identities=16% Similarity=0.152 Sum_probs=123.3
Q ss_pred ccceEEeecCcEEEEEEEEcCCcEEEEEECCCCC------------------hhhHHHHHHHHHHHHhcCCCceeeEEEe
Q 037607 511 DENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGS------------------EQGINEFQTEIQMLSKLRHRHLVSLIGF 572 (842)
Q Consensus 511 ~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~------------------~~~~~~f~~Ei~il~~L~HpnIv~l~g~ 572 (842)
.+.++||+|+||+||+|...+|+.||||+++... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999998889999999754321 0112345678999999999999998866
Q ss_pred eccCCeEEEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhCCCCceEeccCCCCCEEEcCCCceEEee
Q 037607 573 CDEQSEMILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVAD 652 (842)
Q Consensus 573 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILld~~~~~kl~D 652 (842)
.. .+++|||+++..+.+ +++....+++.|++++|+|||+ ++|+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 42 379999998765543 3445667899999999999999 999999999999999865 589999
Q ss_pred cccccccCCCCCceeeeeccCCCCCCc--cc---ccccCCCCcccchhHHHHHH
Q 037607 653 FGLSKAAPMDRGYVSTAVKGSFGYLDP--EY---FRRQQLTEKSDVYSFGVVLF 701 (842)
Q Consensus 653 FGla~~~~~~~~~~~~~~~gt~~Y~AP--E~---l~~~~~s~ksDVwS~GvvL~ 701 (842)
||+|......... .|... +. +..+.|+.++|+||+.--++
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9998765432211 01110 00 12367889999999865544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=3.9e-07 Score=92.94 Aligned_cols=150 Identities=15% Similarity=0.103 Sum_probs=104.0
Q ss_pred HHHHHHhcCcccceEEeecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcC-CCceeeEEEeeccCCeE
Q 037607 501 TELQNATQNFDENAVIGVGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLR-HRHLVSLIGFCDEQSEM 579 (842)
Q Consensus 501 ~el~~at~~f~~~~~LG~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~-HpnIv~l~g~~~~~~~~ 579 (842)
.+++....+|...+..+.++-+.||+... +++.++||+...........+.+|..++..|. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46677777887665544444578998865 46678888866544334446788999888774 43366778888888889
Q ss_pred EEEEEecCCCCcccccccCCCCCCchHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 037607 580 ILVYEYMANGPFRDHLYGTNQPPLSWKQRLEICIGSARGLHYLHTG---------------------------------- 625 (842)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~---------------------------------- 625 (842)
++||++++|.++.+.... ......++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999887654311 122334556666666666642
Q ss_pred ----------------------CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 626 ----------------------AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 626 ----------------------~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
....++|+|+.|.|||+++++..-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012389999999999999876667999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=2.3e-05 Score=78.88 Aligned_cols=131 Identities=18% Similarity=0.148 Sum_probs=87.8
Q ss_pred EEeecCc-EEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCC--CceeeEEEeeccCCeEEEEEEecCCCCc
Q 037607 515 VIGVGGF-GKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRH--RHLVSLIGFCDEQSEMILVYEYMANGPF 591 (842)
Q Consensus 515 ~LG~G~f-g~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (842)
.+..|.. +.||+...+++..+++|....... ..+..|...|+.|.. -.+.++++++.+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 679999988888899998665533 346778888887743 3356678888888889999999998776
Q ss_pred ccccccCCCCCCchHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 037607 592 RDHLYGTNQPPLSWKQRLEICIGSARGLHYLHT----------------------------------------------- 624 (842)
Q Consensus 592 ~~~l~~~~~~~l~~~~~~~I~~~ia~gL~yLH~----------------------------------------------- 624 (842)
.+... . ...++.++++.|.-||+
T Consensus 94 ~~~~~-------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSHL-------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSCC-------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc-------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 54220 0 11122233333333332
Q ss_pred ----C----CCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 625 ----G----AAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 625 ----~----~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122389999999999999877678999997643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.12 E-value=0.0003 Score=75.77 Aligned_cols=76 Identities=17% Similarity=0.132 Sum_probs=48.5
Q ss_pred eEEeecCcEEEEEEEEcC-CcEEEEEECCCC-------ChhhHHHHHHHHHHHHhcC-C--CceeeEEEeeccCCeEEEE
Q 037607 514 AVIGVGGFGKVYIGVLED-GNKVAIKRGNPG-------SEQGINEFQTEIQMLSKLR-H--RHLVSLIGFCDEQSEMILV 582 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~-g~~VAvK~~~~~-------~~~~~~~f~~Ei~il~~L~-H--pnIv~l~g~~~~~~~~~lV 582 (842)
+.||.|....||+....+ ++.++||...+. ......+...|.+.|+.+. + ..+.+++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 368999999999998654 678999964331 1112234567888887663 2 3455566554 4456899
Q ss_pred EEecCCCCc
Q 037607 583 YEYMANGPF 591 (842)
Q Consensus 583 ~Ey~~~gsL 591 (842)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.92 E-value=0.00082 Score=70.23 Aligned_cols=134 Identities=14% Similarity=0.185 Sum_probs=79.1
Q ss_pred EEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce--eeEEE-----eeccCCeEEEEEEecCCCCcccc
Q 037607 522 GKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL--VSLIG-----FCDEQSEMILVYEYMANGPFRDH 594 (842)
Q Consensus 522 g~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI--v~l~g-----~~~~~~~~~lV~Ey~~~gsL~~~ 594 (842)
-.||+...++|+.+++|...+... ..+++..|...|..|....+ +..+. .....+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999999999999999776522 34667888888888743221 11111 22345668899999987554321
Q ss_pred ----c----------c----cC---CCCCCch-------------------HHHHHHHHHHHHHHHHHHh----CCCCce
Q 037607 595 ----L----------Y----GT---NQPPLSW-------------------KQRLEICIGSARGLHYLHT----GAAQGI 630 (842)
Q Consensus 595 ----l----------~----~~---~~~~l~~-------------------~~~~~I~~~ia~gL~yLH~----~~~~~i 630 (842)
+ | .. ....+++ ..+..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0 00 0111111 1111122222223333322 234679
Q ss_pred EeccCCCCCEEEcCCCceEEeecccccc
Q 037607 631 IHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 631 vHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899997764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.20 E-value=0.0049 Score=63.40 Aligned_cols=158 Identities=13% Similarity=0.084 Sum_probs=86.4
Q ss_pred ccHHHHHHHhcCcccceEEe-----ecCcEEEEEEEEcCCcEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce--eeEE
Q 037607 498 FTFTELQNATQNFDENAVIG-----VGGFGKVYIGVLEDGNKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL--VSLI 570 (842)
Q Consensus 498 ~~~~el~~at~~f~~~~~LG-----~G~fg~Vykg~~~~g~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI--v~l~ 570 (842)
.+.+|+.....+|.+.+... .|---+.|+...++|+ +++|+...... .++...|+++|..|.+.++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 46678888888897754443 4445678998876654 89998764321 2345566777777743221 1111
Q ss_pred E------eeccCCeEEEEEEecCCCCcccccc-----------------cC-----CCCCC-----------------ch
Q 037607 571 G------FCDEQSEMILVYEYMANGPFRDHLY-----------------GT-----NQPPL-----------------SW 605 (842)
Q Consensus 571 g------~~~~~~~~~lV~Ey~~~gsL~~~l~-----------------~~-----~~~~l-----------------~~ 605 (842)
. +.........++.++.+......-. .. ..... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122345677777776654422110 00 00000 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCceEeccCCCCCEEEcCCCceEEeecccccc
Q 037607 606 KQRLEICIGSARGLHYLHT-GAAQGIIHRDVKTTNILLDENLVAKVADFGLSKA 658 (842)
Q Consensus 606 ~~~~~I~~~ia~gL~yLH~-~~~~~ivHrDIKp~NILld~~~~~kl~DFGla~~ 658 (842)
......+..+...+.-.+. ....++||+|+.+.||+++.+...-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111222222222222221 2457899999999999999887778999997653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.0084 Score=63.93 Aligned_cols=73 Identities=23% Similarity=0.289 Sum_probs=49.3
Q ss_pred eEEeecCcEEEEEEEEcCC--------cEEEEEECCCCChhhHHHHHHHHHHHHhcCCCce-eeEEEeeccCCeEEEEEE
Q 037607 514 AVIGVGGFGKVYIGVLEDG--------NKVAIKRGNPGSEQGINEFQTEIQMLSKLRHRHL-VSLIGFCDEQSEMILVYE 584 (842)
Q Consensus 514 ~~LG~G~fg~Vykg~~~~g--------~~VAvK~~~~~~~~~~~~f~~Ei~il~~L~HpnI-v~l~g~~~~~~~~~lV~E 584 (842)
+.|+.|-.=.+|+....++ +.|++++.- ... ......+|..+++.+.-.++ .+++++|.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4688888889999987543 456666644 222 23345689999988853344 477777754 68999
Q ss_pred ecCCCCcc
Q 037607 585 YMANGPFR 592 (842)
Q Consensus 585 y~~~gsL~ 592 (842)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876553
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=96.15 E-value=0.014 Score=53.07 Aligned_cols=81 Identities=11% Similarity=0.154 Sum_probs=66.4
Q ss_pred cccceEEEeeccCcceEEEEeeccCCCCCCCccCcEEEEEeCceEEeccccCCCCCcceEEEEEEeecC-ceEEEEeeCC
Q 037607 86 TGESRYRFFISQPGPHWVRLHFYPVPHSSIKLTDAVFTVQTDKFVLLHDFSIGNTTSLVFKEYLINITG-RLSIIFKPHK 164 (842)
Q Consensus 86 ~~~~~y~f~~~~~g~~~~rl~f~~~~~~~~~~~~~~f~v~~~~~~~l~~f~~~~~~~~~~~e~~~~~~~-~~~i~f~p~~ 164 (842)
...+.|.+++ ++|.|-|+++|-.. ....|.+.|...+.+|.. .+.-+.|.|+|.. .|+|.|+...
T Consensus 62 ~~~~~f~v~v-PnG~Y~Vtv~~Gd~---------~~~~~~~eg~~~~~~~~g----~~~~~~~~V~VtDG~L~l~ft~~~ 127 (146)
T d2o14a1 62 KSNNTFNVDL-PNGLYEVKVTLGNT---------ARASVAAEGVFQVINMTG----DGAEDTFQIPVTDGQLNLLVTEGK 127 (146)
T ss_dssp TCSCCEEEEC-CSEEEEEEEEESSC---------SEEEEEETTEEEEEEEES----TTCEEEEEEEECSSEEEEEEEESS
T ss_pred CCCceEEEEC-CCCeEEEEEEEecC---------CCccEEEeeEEeccccCC----ccEEEEEEEEEECCeEEEEEecCC
Confidence 3356899999 79999999999863 245799999999999865 4567899999995 5999998775
Q ss_pred -CCcceeeeeEEEecCC
Q 037607 165 -DSHAFINAIEVVSAPG 180 (842)
Q Consensus 165 -~~~~fvn~ie~~~~p~ 180 (842)
+..+=||+|||-.+++
T Consensus 128 ~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 128 AGTAFTLSALKIKKLSD 144 (146)
T ss_dssp TTSCCEEEEEEEEEEES
T ss_pred CCCccEEEEEEEEeccc
Confidence 5788899999988764
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=96.11 E-value=0.006 Score=55.66 Aligned_cols=81 Identities=14% Similarity=0.202 Sum_probs=58.6
Q ss_pred eeEEEEeeCCCCceEEEEeeeccccccCCcEEEEEEEcCccccCCCChhhhccccCceEEEEEEEEecccCCcceEEEec
Q 037607 285 NLTWKMSVDPSFSYLIRFHFCDIVSKSLNDLLFNVYINEFMAASSLDLSSLTNALSTAYYKDFVLNATAVKNDSITVQVG 364 (842)
Q Consensus 285 ~lt~~~~v~~~~~y~vrlhF~ei~~~~~~~r~Fdiyi~~~~~~~~~di~~~~~~~~~~~~~~~~v~~~~~~~~~l~i~~~ 364 (842)
...|.++|. ||+|.|+++|.|.. -.++.+.|+.++.++ .+....+.|.|.+ +++.|+|+|-
T Consensus 64 ~~~f~v~vP-nG~Y~Vtv~~Gd~~-------~~~~~~eg~~~~~~~--------~g~~~~~~~~V~V---tDG~L~l~ft 124 (146)
T d2o14a1 64 NNTFNVDLP-NGLYEVKVTLGNTA-------RASVAAEGVFQVINM--------TGDGAEDTFQIPV---TDGQLNLLVT 124 (146)
T ss_dssp SCCEEEECC-SEEEEEEEEESSCS-------EEEEEETTEEEEEEE--------ESTTCEEEEEEEE---CSSEEEEEEE
T ss_pred CceEEEECC-CCeEEEEEEEecCC-------CccEEEeeEEecccc--------CCccEEEEEEEEE---ECCeEEEEEe
Confidence 357888887 77999999999943 246778887665543 3344467889999 7999999884
Q ss_pred cCCCCCCCCccccccceeEeeccC
Q 037607 365 PASNAQSSLPNAILNGLEVIKLSN 388 (842)
Q Consensus 365 p~~~~~~~i~~~~lnG~ei~~l~~ 388 (842)
-... + .+..||.+||.++..
T Consensus 125 ~~~~--G--~~~~in~l~I~~~~d 144 (146)
T d2o14a1 125 EGKA--G--TAFTLSALKIKKLSD 144 (146)
T ss_dssp ESST--T--SCCEEEEEEEEEEES
T ss_pred cCCC--C--CccEEEEEEEEeccc
Confidence 3322 0 167799999988743
|